data_1ggw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ggw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -65.88 -46.16 64.99 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.245 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 6.2 Cg_exo -78.33 -17.13 13.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.787 2.325 . . . . 0.0 113.632 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -110.9 -60.01 1.89 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -60.18 2.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.566 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.0 -48.07 82.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.61 -38.15 77.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.528 ' CE2' HG12 ' A' ' 23' ' ' ILE . 15.4 t80 -57.75 -45.62 85.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -62.56 -33.55 75.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.9 mt -61.04 -36.59 79.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.302 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -92.85 24.5 3.6 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.99 94.78 8.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.801 0.334 . . . . 0.0 110.416 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -33.11 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -86.19 -31.0 22.0 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.467 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.45 26.53 59.11 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -115.93 21.82 13.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.625 0.213 . . . . 0.0 111.26 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.18 19.81 77.61 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.321 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.407 ' CD ' ' HB3' ' A' ' 54' ' ' GLU . 6.7 mtt85 -130.4 151.4 50.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.096 0.448 . . . . 0.0 110.631 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 6.5 pt -140.97 142.42 27.72 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 27' ' ' SER . 88.7 Cg_endo -87.03 170.95 6.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.283 2.655 . . . . 0.0 112.487 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 44' ' ' ILE . 49.5 pttt -44.24 -39.16 4.25 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.8 p -60.41 -43.95 96.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.46 0.171 . . . . 0.0 111.396 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.5 m -70.34 -45.74 65.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.657 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.52 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.45 -33.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.178 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 -68.21 1.8 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.309 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -28.27 69.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.51 -48.11 83.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.52 -33.16 73.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -56.13 -38.98 71.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.087 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.0 70.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.678 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -116.88 46.33 1.68 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.781 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.1 -106.59 0.42 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.974 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.2 -179.46 5.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 111.919 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 28.9 t-20 -118.35 112.55 37.51 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.58 -162.97 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.953 2.435 . . . . 0.0 112.683 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -105.65 163.77 12.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.1 -35.96 62.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.6 82.6 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.815 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.98 -55.78 17.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.85 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.52 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.11 -46.56 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.901 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.7 m -57.53 -41.48 80.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -38.09 78.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.4 mt -62.92 -46.58 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -57.24 -28.43 62.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.353 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -13.39 45.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 p -118.13 -46.52 2.61 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' CD1' HG23 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.56 146.55 34.53 Favored Pre-proline 0 N--CA 1.463 0.225 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -36.44 139.01 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.496 2.798 . . . . 0.0 113.039 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.84 -63.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.707 0.63 . . . . 0.0 112.477 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.89 120.66 25.95 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.709 0.29 . . . . 0.0 110.369 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.08 87.18 2.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.4 p30 -84.96 178.35 7.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.589 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -41.14 -44.5 2.55 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.78 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.1 -53.61 29.2 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.76 -52.57 64.48 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.186 0.304 . . . . 0.0 111.703 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.44 81.63 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.35 -33.26 73.33 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -51.95 67.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.55 0.214 . . . . 0.0 110.996 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.508 HG23 ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.59 -39.24 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.108 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 120.399 0.142 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.09 -43.93 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.342 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -40.14 94.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.669 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.21 88.93 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.696 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.76 -30.15 66.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.454 0.168 . . . . 0.0 111.454 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.05 -14.96 62.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.1 t -47.86 -56.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.403 0.144 . . . . 0.0 111.305 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -113.49 39.84 2.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.027 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.51 62.24 1.46 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -63.74 -50.56 68.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.747 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.34 -54.76 2.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.85 81.17 0.15 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.958 0.409 . . . . 0.0 111.539 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -103.18 64.23 0.83 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.554 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.67 37.9 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.939 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 ptp -174.66 137.29 0.46 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.784 0.292 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -107.1 -39.96 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.427 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 79.24 0.61 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.479 ' CG2' ' HA3' ' A' ' 127' ' ' GLY . 54.6 t -45.22 -36.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.98 -42.73 16.1 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.288 -0.482 . . . . 0.0 113.305 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.94 -43.31 35.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.61 0.205 . . . . 0.0 111.135 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.06 -39.02 80.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.143 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.425 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 10.6 ptp180 -74.54 -37.09 63.12 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.854 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.71 -36.64 72.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.87 -52.56 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.715 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 6.0 mt -62.5 -50.1 72.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.5 m -60.73 -38.26 84.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.497 0.189 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.8 t -73.26 -19.05 61.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.73 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.72 -55.83 10.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.618 0.246 . . . . 0.0 111.028 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.19 45.81 0.29 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.371 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.99 48.02 13.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.49 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.768 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.4 mt -68.16 79.84 0.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 110.691 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.4 p -64.06 -175.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.126 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -47.7 -34.5 8.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.504 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.21 -60.02 4.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -41.11 95.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.199 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 100' ' ' ARG . 5.5 mmt -66.79 -34.82 78.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.513 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -46.07 86.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.437 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -64.81 -37.94 89.3 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -64.5 -44.14 91.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.729 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.442 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.9 mt -65.03 -34.93 79.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -39.76 94.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.902 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.17 -49.52 26.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.752 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 18.7 t -79.85 127.58 76.99 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.612 0.206 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 4.6 Cg_exo -74.11 63.19 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.962 2.441 . . . . 0.0 112.33 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.36 175.9 10.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -121.4 19.1 11.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.739 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.37 26.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.479 ' HA3' ' CG2' ' A' ' 96' ' ' VAL . . . 54.97 50.99 56.74 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.666 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.7 112.8 25.91 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.275 0.559 . . . . 0.0 110.752 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.469 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 43.2 t -142.35 20.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 59.74 21.88 10.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.843 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 48.38 41.52 16.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.764 0.316 . . . . 0.0 111.326 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -114.2 -54.46 2.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.401 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.14 -36.33 70.58 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.8 m-85 -68.05 -59.0 3.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.617 0.246 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.7 t -62.56 -33.05 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.463 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -61.63 -56.85 15.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.056 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.8 ttp . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.484 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.845 0.355 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.16 -46.14 95.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.536 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 89.4 Cg_endo -80.73 -16.0 10.53 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.503 2.135 . . . . 0.0 113.96 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -110.68 -60.83 1.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -61.43 1.8 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.341 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.467 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 6.0 tt0 -58.38 -46.85 85.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.839 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.552 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.56 -37.51 81.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.074 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.493 ' CE2' HG12 ' A' ' 23' ' ' ILE . 20.5 t80 -56.29 -49.76 73.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -61.63 -33.76 74.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.333 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 8.4 mt -59.76 -33.92 72.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.43 0.157 . . . . 0.0 111.221 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 77.3 m-85 -93.28 32.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 121.63 30.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.759 0.314 . . . . 0.0 110.814 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -60.79 -52.22 66.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -107.11 -28.24 10.11 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.25 37.06 4.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.552 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.6 p -104.08 -20.76 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.17 3.61 8.06 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.444 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -122.59 162.46 21.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.253 0.527 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.493 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.1 pt -146.85 133.63 9.91 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.559 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.74 169.71 9.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.998 2.465 . . . . 0.0 112.345 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -43.89 -35.62 2.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.2 p -62.32 -45.04 95.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.493 0.187 . . . . 0.0 111.384 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.484 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 59.9 m -70.59 -44.82 66.53 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.823 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.497 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.83 -35.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.523 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.85 -66.92 2.43 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -29.87 71.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.511 0.155 . . . . 0.0 111.002 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 7.6 tp -61.11 -47.28 86.99 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.33 -32.72 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.049 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -40.48 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.027 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.18 -30.61 71.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.709 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.6 m -83.39 -44.36 14.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.591 0.234 . . . . 0.0 110.936 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.27 -81.55 0.04 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.707 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.2 -179.82 5.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.78 110.32 38.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.628 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.0 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.854 2.369 . . . . 0.0 112.361 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -104.53 166.59 10.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -54.93 -35.55 64.3 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.88 76.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.761 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -56.43 9.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.15 -48.39 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.945 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.2 m -58.15 -41.29 83.45 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.04 -42.87 86.28 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.491 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mt -63.04 -48.26 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -57.19 -25.12 58.49 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.844 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -63.86 -13.61 46.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -118.41 7.48 11.93 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.21 151.45 61.72 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 90.2 Cg_exo -38.3 143.76 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.275 2.65 . . . . 0.0 113.018 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.77 -58.62 0.13 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -92.27 125.43 36.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.592 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.79 83.51 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -81.72 177.29 8.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.562 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 60.9 mtm -40.68 -44.65 2.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.745 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.88 -51.57 46.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.918 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.604 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -58.09 -52.35 65.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -48.44 81.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 mt -61.54 -38.23 86.69 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.173 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.52 -54.39 41.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -35.33 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.938 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.571 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.373 0.13 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.77 -40.01 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.943 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -48.49 80.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.86 95.91 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.66 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -70.2 -24.45 63.12 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.529 0.164 . . . . 0.0 111.407 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.17 -15.4 61.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.11 -59.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.187 0.195 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -110.33 44.02 1.3 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.981 0.42 . . . . 0.0 110.558 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.35 51.86 1.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -51.15 69.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -115.68 -59.31 2.01 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.08 90.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.561 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -105.69 56.71 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 110.79 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.51 49.42 1.84 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.927 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.15 135.87 0.48 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.68 0.276 . . . . 0.0 111.127 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -109.01 -42.75 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.336 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.12 81.58 0.33 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.949 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.458 HG12 HD22 ' A' ' 118' ' ' LEU . 86.6 t -43.55 -36.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.79 -37.98 15.44 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.594 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.537 ' HG3' ' CB ' ' A' ' 86' ' ' PHE . 2.6 tm-20 -73.2 -51.32 18.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.239 0.215 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.422 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.46 -37.18 74.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 115' ' ' MET . 4.9 tmm_? -65.57 -47.89 74.24 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -53.96 -38.09 64.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.323 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.73 -49.03 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.299 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 3.3 mt -65.02 -38.29 90.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.993 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 23.0 p -64.75 -35.44 81.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.523 0.202 . . . . 0.0 110.878 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -66.93 -19.75 65.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.651 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt -69.46 -61.19 1.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.584 0.23 . . . . 0.0 110.534 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.8 51.63 0.18 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.329 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 59.92 46.74 10.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.868 0.366 . . . . 0.0 110.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.74 -137.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.277 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD23 ' HG2' ' A' ' 114' ' ' GLU . 21.4 mt -69.16 79.24 0.35 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 92.6 p -64.36 -172.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.252 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -51.65 -31.17 24.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.265 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.81 -51.18 69.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' HG2' HD23 ' A' ' 110' ' ' LEU . 4.7 tp10 -58.76 -52.82 64.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.407 ' HG2' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ppp? -66.16 -26.15 67.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -48.51 80.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.16 -45.14 89.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.405 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.458 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -58.91 -41.26 86.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.408 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.209 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -36.76 84.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.91 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.68 49.78 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.05 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.3 128.45 55.19 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.803 0.302 . . . . 0.0 111.14 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.59 58.05 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.63 2.22 . . . . 0.0 112.595 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.39 -177.67 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.284 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 131.53 55.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.649 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.16 9.17 6.95 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.03 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.38 49.96 23.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.554 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.78 115.16 29.96 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.206 0.526 . . . . 0.0 110.725 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.51 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 37.4 t -142.45 25.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.841 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 58.58 22.57 9.92 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.932 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 54.05 -158.7 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 68.78 -60.63 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.406 0.282 . . . . 0.0 111.569 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.01 -38.76 62.61 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.9 m-85 -68.36 -54.58 16.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.714 0.292 . . . . 0.0 110.695 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.5 t -62.15 -32.96 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.511 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.44 -52.19 54.91 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.686 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.9 ttp . . . . . 0 CA--C 1.533 0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.212 179.619 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.936 0.398 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.443 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.4 t -66.07 -46.92 63.46 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.6 Cg_endo -79.34 -14.04 13.35 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.516 2.144 . . . . 0.0 114.166 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.15 -61.59 1.7 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -72.29 -62.86 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -58.47 -47.73 83.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -45.26 87.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.936 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 23' ' ' ILE . 23.0 t80 -54.49 -45.99 73.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.74 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 m -59.27 -35.37 73.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.392 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 9.0 mt -60.53 -29.34 69.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.325 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -95.03 27.69 3.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.71 123.07 40.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 110.551 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -52.3 66.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.369 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -130.86 27.65 4.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.71 49.45 61.49 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.682 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -93.72 -29.01 15.62 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.1 -1.42 16.96 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.108 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.561 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -127.74 167.56 16.31 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.01 0.405 . . . . 0.0 110.607 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 9.5 pt -144.23 134.31 11.87 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.56 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 23' ' ' ILE . 4.4 Cg_endo -86.32 171.75 7.46 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.39 2.727 . . . . 0.0 111.852 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.1 pttt -44.24 -36.6 2.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -61.01 -45.89 92.97 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.54 0.209 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.508 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.1 m -70.49 -46.6 63.41 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.933 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.499 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -55.39 -33.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.413 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.71 -68.89 1.41 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.444 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -26.69 68.87 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 111.407 0.151 . . . . 0.0 111.407 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.07 -48.9 74.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.47 -30.61 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.62 -38.71 69.86 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.909 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.593 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.5 -42.31 25.52 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.748 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.3 -79.35 0.03 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.643 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.32 176.59 8.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.489 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -119.72 113.12 34.85 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.464 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.69 -162.63 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.755 2.304 . . . . 0.0 112.459 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -99.28 166.03 11.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.13 -33.64 63.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.887 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.2 79.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.34 -53.98 20.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.81 -46.88 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.003 0.189 . . . . 0.0 110.766 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 m -60.15 -39.74 87.45 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.34 -37.52 75.33 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.452 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.0 mt -67.01 -45.63 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.896 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -56.66 -27.12 57.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.524 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -64.61 -7.72 11.56 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 p -117.7 -52.73 2.44 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 117.893 0.315 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 154.88 54.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.527 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -38.36 142.74 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.082 2.522 . . . . 0.0 113.07 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.51 -64.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.3 0.64 . . . . 0.0 112.599 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.1 123.18 31.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.494 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.42 86.33 2.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.561 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.7 p30 -85.08 179.66 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.357 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -41.55 -47.59 3.82 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.532 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.58 -52.54 60.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.79 -53.91 52.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.7 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -49.83 73.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.72 -28.98 69.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -63.77 -49.76 71.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.606 0.241 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.36 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.6 t -64.53 -53.76 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.552 0.215 . . . . 0.0 110.97 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -29.46 70.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.69 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -65.19 -49.04 63.77 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.555 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.09 -37.76 69.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.427 0.156 . . . . 0.0 110.969 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -78.91 73.16 5.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.9 t -135.1 -64.71 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.96 34.95 4.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.531 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -129.32 51.85 2.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.457 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 64.97 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.231 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -136.52 -72.88 0.44 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.69 45.82 27.21 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.626 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.37 44.6 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.11 33.7 3.92 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.624 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 ttt -171.73 134.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.152 0.476 . . . . 0.0 111.531 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.613 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -114.52 -42.1 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.28 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.66 80.49 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.22 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.465 ' HA ' ' CD2' ' A' ' 99' ' ' LEU . 81.7 t -44.41 -34.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -40.06 11.01 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.824 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.09 -50.71 13.94 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.457 0.17 . . . . 0.0 110.783 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.465 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.13 -35.34 73.3 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -55.96 12.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.101 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -52.45 -38.59 59.61 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.475 HG12 ' HA2' ' A' ' 82' ' ' GLY . 42.1 t -72.12 -58.0 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 2.8 mt -60.99 -36.41 79.39 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 m -61.68 -36.84 82.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.588 0.232 . . . . 0.0 111.093 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.6 t -65.02 -22.8 67.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.994 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 3.7 mt -64.88 -72.95 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.508 0.194 . . . . 0.0 111.232 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.85 50.98 0.46 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 64.23 47.24 3.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.175 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 14.4 tptt -68.57 -138.12 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.455 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.9 mm? -69.18 77.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.8 p -69.89 -175.27 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.59 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -51.02 -38.83 53.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.704 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.47 -48.89 63.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.576 0.227 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 5.2 mm-40 -59.01 -51.64 69.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -27.36 67.86 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -46.34 86.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -65.68 -44.34 86.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.369 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -59.99 -43.5 95.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.405 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.412 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -69.2 -32.97 72.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.35 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -61.68 -38.39 87.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.986 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 -46.62 43.66 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.953 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.92 127.12 63.51 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.706 0.253 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 59.61 6.19 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.72 2.28 . . . . 0.0 112.647 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.61 176.63 8.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.264 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -119.3 132.16 55.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.535 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t70 76.61 -1.92 2.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.887 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.26 51.02 5.89 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.461 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttp -104.2 113.17 26.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.54 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 40.5 t -142.35 19.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.03 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 59.37 22.14 10.53 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 53.65 -158.12 0.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.5 t60 69.62 -60.19 0.48 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.168 0.187 . . . . 0.0 111.206 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.67 -41.76 64.13 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.5 m-85 -65.44 -57.06 9.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.07 -28.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.507 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.61 -49.83 73.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.683 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.416 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -67.03 -47.37 52.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 6' ' ' SER . 75.4 Cg_endo -79.55 -13.17 13.53 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.534 2.156 . . . . 0.0 114.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.75 -63.16 1.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -72.85 -61.45 1.8 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.433 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.03 81.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.731 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.1 -44.27 87.58 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.478 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.5 t80 -52.05 -46.39 65.07 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.197 0.311 . . . . 0.0 110.471 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.6 t -60.5 -36.38 78.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.216 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.9 mt -59.78 -28.51 67.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.389 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 m-85 -89.02 19.99 3.86 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.24 92.36 4.48 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -61.66 -36.37 80.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -86.76 -37.01 18.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.117 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.34 45.32 5.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.439 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -109.25 -30.21 8.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.44 8.15 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.272 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -127.06 163.63 23.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.152 0.476 . . . . 0.0 110.655 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.478 HG12 ' CE2' ' A' ' 12' ' ' PHE . 3.7 pt -143.7 136.03 13.34 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.98 171.93 5.57 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.256 2.637 . . . . 0.0 112.287 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' HG13 ' A' ' 44' ' ' ILE . 14.3 pttm -43.83 -38.4 3.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -60.31 -44.89 95.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.496 0.189 . . . . 0.0 111.22 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.7 m -71.01 -47.41 58.93 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.492 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -55.19 -35.61 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.635 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.88 -68.08 1.79 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.456 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -28.09 69.26 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 5.7 tp -61.98 -46.46 89.15 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.63 -31.8 71.91 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -58.26 -41.83 85.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.16 68.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.488 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.25 42.59 2.67 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.16 -107.77 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.949 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.22 179.55 6.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.829 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 28.6 t-20 -118.57 106.38 44.47 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.78 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.55 -163.71 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.053 2.502 . . . . 0.0 112.576 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -104.95 164.31 11.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.868 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.15 -37.65 62.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.994 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.15 77.91 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.695 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.12 -55.14 17.91 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.492 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.3 -46.89 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.875 -0.148 . . . . 0.0 111.106 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -55.37 -43.84 75.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -37.76 76.14 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.755 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 44' ' ' ILE . 64.7 mt -61.09 -51.78 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -56.86 -27.45 60.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.753 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.76 -13.86 47.46 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 p -119.06 5.84 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.19 157.67 68.44 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 110.523 -0.176 . . . . 0.0 110.523 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.563 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 92.8 Cg_exo -42.05 146.39 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.141 2.561 . . . . 0.0 113.164 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.4 -63.02 0.09 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -95.1 131.15 41.42 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.477 0.18 . . . . 0.0 110.65 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.05 87.16 2.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.045 0.45 . . . . 0.0 110.924 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.97 -177.56 6.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.459 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mtt -41.21 -46.97 3.24 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -52.84 32.38 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.563 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.88 -49.77 75.6 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -48.64 79.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.833 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.87 -29.3 70.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.451 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -65.77 -48.08 73.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.994 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.19 -43.17 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.983 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.427 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 120.313 0.102 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.57 -50.25 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.013 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.03 67.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' HA2' ' CG1' ' A' ' 102' ' ' VAL . . . -71.59 -56.35 6.77 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.161 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -77.98 -39.82 41.24 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.13 73.54 4.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.186 0.517 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 p -118.09 -43.69 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.786 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 86' ' ' PHE . 9.4 t80 -154.46 25.78 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 110.393 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.67 51.41 0.75 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.928 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -28.84 64.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.382 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.24 -57.79 3.23 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.037 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.98 -174.21 0.11 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p 44.64 59.98 3.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.038 0.447 . . . . 0.0 111.314 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.24 -33.43 0.27 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.08 144.24 9.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.66 -41.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.249 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.9 77.9 0.25 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.559 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.44 ' HA ' ' CD2' ' A' ' 99' ' ' LEU . 90.0 t -45.28 -42.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.89 -37.26 9.24 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.856 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.449 ' HG3' ' HD2' ' A' ' 86' ' ' PHE . 4.6 mm-40 -80.59 -47.23 14.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.5 0.191 . . . . 0.0 110.544 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.44 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -41.93 84.34 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -34.83 65.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.803 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -55.57 -38.34 69.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.561 0.219 . . . . 0.0 110.939 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.47 ' CG1' ' HA2' ' A' ' 82' ' ' GLY . 2.5 t -78.55 -46.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.236 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.99 -46.21 78.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.9 m -55.88 -35.51 66.58 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.469 0.176 . . . . 0.0 111.43 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 t -71.81 -19.01 62.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.843 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.18 -68.22 0.41 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.444 0.164 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.89 55.85 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.566 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 58.69 45.54 15.72 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.333 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -68.9 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.222 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.47 78.4 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.8 p -64.87 -176.6 0.28 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -52.62 -32.58 42.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.787 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -53.79 52.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.75 -51.45 69.5 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.953 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.405 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.38 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -49.07 78.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.639 0.257 . . . . 0.0 110.471 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -42.12 86.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -61.99 -43.55 98.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.431 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -71.07 -31.91 68.44 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.262 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -61.74 -40.83 96.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.634 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 -46.23 19.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.922 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.35 119.15 72.02 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 116.787 0.294 . . . . 0.0 111.13 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.07 63.9 6.91 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.56 2.173 . . . . 0.0 112.588 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.3 m -130.77 -175.95 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.253 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -118.87 127.3 53.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 t70 72.53 6.86 5.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.852 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.85 53.67 7.92 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.915 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -104.03 116.97 33.19 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 40.3 t -142.39 30.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 36.6 t30 61.38 19.0 9.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.946 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 56.36 -176.67 0.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.8 -52.04 0.68 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.384 0.273 . . . . 0.0 111.667 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.89 -45.72 67.65 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -68.78 -49.87 55.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.99 -31.68 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.411 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -66.08 -51.07 61.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.5 ttt . . . . . 0 CA--C 1.531 0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.697 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.786 0.327 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 5.0 t -65.22 -46.07 71.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.379 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.15 -15.21 11.69 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.514 2.143 . . . . 0.0 113.824 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -110.14 -60.43 1.8 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -72.6 -61.02 1.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.444 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -59.03 -47.52 84.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.496 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.25 -39.23 82.17 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.012 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.507 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.7 t80 -56.03 -44.66 78.97 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -62.33 -35.97 80.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.272 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.57 -33.94 73.43 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.428 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -91.04 20.06 5.22 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.44 89.82 3.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 120.839 0.352 . . . . 0.0 110.193 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -66.41 -29.16 69.25 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.878 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -85.97 -28.35 24.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.52 31.67 65.34 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.1 p -101.02 -30.0 11.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.282 0.233 . . . . 0.0 111.246 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.05 11.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.266 -0.493 . . . . 0.0 113.092 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -119.53 157.91 27.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.01 0.405 . . . . 0.0 110.742 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG12 ' CE2' ' A' ' 12' ' ' PHE . 4.3 pt -138.3 139.75 26.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.46 170.42 7.9 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.096 2.531 . . . . 0.0 112.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HB2' HG13 ' A' ' 44' ' ' ILE . 10.7 pttp -45.14 -39.12 5.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 p -60.03 -43.3 95.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.545 0.212 . . . . 0.0 111.197 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.9 t -68.55 -51.95 37.2 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.167 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.579 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -54.92 -36.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.519 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.83 -71.98 0.58 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.649 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -27.98 69.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.8 -50.58 70.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.607 0.241 . . . . 0.0 110.356 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -61.44 -29.53 70.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.267 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.34 -38.75 69.16 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.061 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.51 69.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.704 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 t -114.66 40.04 2.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.33 -107.15 0.36 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 174.81 9.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.909 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 3.8 t-20 -119.5 107.04 41.45 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.156 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.91 -162.76 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.89 2.394 . . . . 0.0 112.75 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -93.63 166.53 12.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.188 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.46 -34.73 67.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.81 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.18 79.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.585 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.84 -55.17 24.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.055 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.579 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.96 -47.16 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.689 179.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -58.55 -39.9 81.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.42 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -58.71 -40.82 84.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.372 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.1 mt -61.73 -50.21 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -56.98 -23.9 49.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.696 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -7.75 10.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 p -117.89 -45.44 2.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 117.627 0.194 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.97 159.01 43.69 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 72.0 Cg_exo -40.17 146.08 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 113.026 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -31.1 -60.37 0.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.205 0.602 . . . . 0.0 112.597 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -91.07 127.12 36.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.641 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.7 t -86.91 86.81 2.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.8 p30 -84.55 178.81 7.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.38 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtm -41.56 -47.94 3.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.689 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.95 -50.54 62.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.851 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.601 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -56.81 -51.07 70.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.586 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -48.28 80.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.9 mt -61.17 -34.28 74.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.425 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -60.96 -53.11 61.28 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -42.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.889 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.17 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.77 -56.73 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.182 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -35.05 79.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -64.99 -47.12 86.16 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.637 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -77.56 -36.71 51.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.776 0.288 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -74.94 75.51 2.18 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.518 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 82' ' ' GLY . 45.1 t -127.31 -66.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.81 38.24 2.32 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 111.79 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.443 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 5.3 p30 -130.06 72.6 1.49 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.001 0.429 . . . . 0.0 110.782 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -31.16 68.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.655 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.18 -53.94 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 87' ' ' ASP . . . 60.58 69.06 0.71 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.271 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 -40.55 6.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.368 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -166.5 62.01 0.22 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.446 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 ptt? -175.68 140.24 0.45 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.268 0.227 . . . . 0.0 110.483 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.442 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.2 OUTLIER -106.12 -43.32 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.599 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.75 81.15 0.1 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.158 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.602 HG12 HD22 ' A' ' 118' ' ' LEU . 70.6 t -42.84 -33.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.81 -39.12 17.0 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.749 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.9 -44.59 31.23 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.609 0.205 . . . . 0.0 111.202 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -64.8 -37.44 87.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.531 0.205 . . . . 0.0 111.223 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -49.79 60.29 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.763 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -53.79 -42.39 68.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.296 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.76 -51.17 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.522 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 5.0 mt -64.63 -50.69 66.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.977 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -56.86 -31.37 64.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.6 t -66.95 -24.85 66.11 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.25 -67.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.79 55.84 0.29 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 45.13 7.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.952 0.406 . . . . 0.0 111.215 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 2.3 mmtm -68.61 -137.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.24 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.41 78.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.656 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.7 p -68.65 -171.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -52.54 -33.17 44.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.385 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.52 -51.81 63.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.52 0.2 . . . . 0.0 111.497 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.38 -51.56 68.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.416 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -66.77 -26.72 67.1 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -46.81 86.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.28 -43.97 84.89 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.602 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.7 -41.55 95.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.564 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.424 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -69.54 -30.82 68.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -62.99 -40.18 96.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.502 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -45.43 42.06 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.736 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.68 116.33 66.17 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.612 0.206 . . . . 0.0 111.007 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.56 64.59 4.67 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.591 2.194 . . . . 0.0 112.658 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 m -130.05 -175.44 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.084 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -118.62 124.59 47.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.443 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t70 76.55 -2.36 2.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.949 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 81.13 50.97 4.9 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.789 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 ttt -104.45 119.35 38.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 27.9 t -141.14 28.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.62 24.27 13.08 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.027 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.442 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.3 t80 46.11 48.16 12.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 111.556 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -122.91 -53.05 1.87 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.507 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -35.09 73.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.0 m-85 -68.15 -55.41 12.47 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.584 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.7 -34.09 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.021 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.54 -52.64 64.34 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.5 ttt . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.197 179.673 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 1.8 m-20 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.434 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.6 t -67.32 -48.02 47.73 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.706 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 6' ' ' SER . 80.3 Cg_endo -78.54 -9.05 16.11 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.483 2.122 . . . . 0.0 114.237 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 84.7 m-85 -118.94 -59.65 1.84 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -72.2 -56.87 4.82 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.221 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.8 -48.03 80.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.448 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.531 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.54 -38.18 77.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CE2' HG12 ' A' ' 23' ' ' ILE . 26.5 t80 -59.14 -46.87 87.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.431 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -62.76 -30.44 71.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.692 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.531 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 18.2 mt -57.32 -38.35 73.92 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.13 31.55 2.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.81 91.69 4.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.582 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -25.63 63.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.654 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -86.38 -35.57 19.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.062 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.64 26.37 59.04 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.618 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -109.64 -19.83 13.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.1 19.94 6.96 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.992 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtp180 -130.2 150.09 51.61 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.978 0.389 . . . . 0.0 110.687 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.559 HG12 ' CE2' ' A' ' 12' ' ' PHE . 7.9 pt -136.88 138.07 24.99 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.749 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.76 171.8 6.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.177 2.585 . . . . 0.0 112.52 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.517 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -45.28 -36.85 4.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -60.83 -44.89 96.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.459 0.171 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.524 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 24.1 m -70.81 -45.61 64.29 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.06 -33.27 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.76 -68.12 1.86 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.453 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -29.47 70.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.406 0.146 . . . . 0.0 111.24 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 tp -62.01 -50.47 71.93 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.13 -28.38 69.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.04 -41.04 74.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.048 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.0 -26.51 68.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -121.74 39.4 3.87 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.699 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.66 -110.1 0.43 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.798 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.7 178.21 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.082 0.468 . . . . 0.0 111.938 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 20.4 t-20 -119.68 97.27 49.86 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.443 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.07 -162.55 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.822 2.348 . . . . 0.0 112.587 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 169.23 9.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.408 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.1 mm? -56.04 -33.85 65.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.6 78.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.671 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -54.2 41.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.249 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' CB ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -59.74 -47.8 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.865 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 m -54.42 -43.53 71.6 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -56.49 -38.93 72.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.57 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 HG21 HG12 ' A' ' 63' ' ' VAL . 33.2 mt -63.03 -49.77 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -56.39 -24.94 47.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.99 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -63.88 -8.23 10.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.4 p -118.03 -46.32 2.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.584 0.174 . . . . 0.0 111.014 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.44 156.03 41.81 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 87.6 Cg_exo -41.84 150.24 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.238 2.625 . . . . 0.0 113.088 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.65 -62.86 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.373 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -84.77 121.66 28.0 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.44 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.13 89.28 2.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -83.68 178.03 8.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.3 mtm -41.18 -46.73 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.834 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.32 -52.08 50.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.889 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.474 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.8 -51.26 69.65 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -48.77 80.14 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.013 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.35 -35.16 76.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.69 -54.99 39.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.415 HG12 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.04 -36.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.87 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.339 0.137 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.104 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.465 0.174 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.9 t -64.52 -40.97 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.75 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -40.26 95.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.491 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -62.97 -48.07 83.59 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.07 -33.12 75.07 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.48 0.181 . . . . 0.0 110.865 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -62.26 -29.04 70.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.073 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.31 138.51 19.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.851 0.357 . . . . 0.0 110.393 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.35 22.79 3.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.728 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -136.71 62.12 1.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -70.79 -55.68 8.04 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.31 -60.08 1.6 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.046 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 67.81 -76.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.412 0.445 . . . . 0.0 111.764 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m 69.08 -77.6 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.755 0.422 . . . . 0.0 111.23 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.32 53.16 0.79 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.447 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.5 135.97 0.57 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.729 0.299 . . . . 0.0 110.786 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.83 -42.85 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.279 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 98' ' ' GLU . . . 66.25 81.84 0.14 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.481 HG12 HD22 ' A' ' 118' ' ' LEU . 78.8 t -43.38 -32.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.84 -36.09 32.72 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.103 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -79.84 -40.66 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.936 0.368 . . . . 0.0 111.181 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -65.44 -37.12 85.96 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.029 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.429 ' CB ' ' HE3' ' A' ' 115' ' ' MET . 0.0 OUTLIER -77.13 -37.21 54.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.218 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -60.1 -36.54 77.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.571 0.224 . . . . 0.0 110.911 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.491 HG12 ' HA2' ' A' ' 82' ' ' GLY . 21.4 t -82.65 -47.24 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.702 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.43 HD23 ' HG2' ' A' ' 109' ' ' LYS . 6.1 mt -70.35 -49.95 44.02 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.9 m -60.57 -34.25 73.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.441 0.163 . . . . 0.0 111.19 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -72.02 -20.29 61.72 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.548 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.57 0.224 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.7 53.2 0.28 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.405 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.71 45.37 10.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.43 ' HG2' HD23 ' A' ' 103' ' ' LEU . 4.2 tptt -68.63 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.117 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 54.7 mt -67.41 79.11 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.875 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -64.55 -168.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.99 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.53 ' HA ' ' HE1' ' A' ' 115' ' ' MET . 34.5 m120 -53.19 -31.05 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.381 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.4 -50.78 72.65 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.554 0.216 . . . . 0.0 111.297 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -56.26 -53.66 54.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.53 ' HE1' ' HA ' ' A' ' 112' ' ' ASN . 16.0 ptp -66.68 -25.1 66.39 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.368 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -47.72 83.15 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.732 0.301 . . . . 0.0 110.267 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -40.52 68.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.481 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -65.11 -43.77 90.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.178 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.415 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 8.7 mt -72.55 -26.91 61.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.362 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -66.54 -43.77 84.21 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.603 0.239 . . . . 0.0 110.728 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.1 -40.47 34.6 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.964 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.88 130.46 55.12 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.679 0.24 . . . . 0.0 111.192 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.21 61.96 6.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.733 2.289 . . . . 0.0 112.38 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.2 p -131.19 168.05 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 50.52 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.098 0.475 . . . . 0.0 111.314 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.82 -36.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 114.7 35.62 1.38 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.034 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.38 117.35 34.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.467 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 39.8 t -142.1 20.77 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 62.44 22.78 13.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.54 -167.43 0.11 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.21 -59.05 0.57 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.185 0.194 . . . . 0.0 111.165 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.95 -41.06 64.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 111.2 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.467 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 26.9 m-85 -68.28 -50.0 56.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.175 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.1 t -62.07 -27.56 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.352 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.83 -42.63 66.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.03 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.1 t -55.94 -46.24 99.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.753 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 6' ' ' SER . 86.1 Cg_endo -83.28 -8.95 10.59 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.563 2.175 . . . . 0.0 114.531 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -119.96 -63.99 1.31 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -60.1 2.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.232 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.42 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.55 -47.45 85.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.01 -41.07 82.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.228 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.0 t80 -57.94 -46.48 84.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.357 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -29.64 70.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.872 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 19.5 mt -59.04 -31.6 69.0 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -92.14 22.57 4.31 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.42 95.96 6.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.197 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -47.51 81.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.8 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.85 -30.48 21.43 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.74 40.08 8.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.389 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 p -95.62 -29.13 14.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.112 0.165 . . . . 0.0 111.313 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.64 12.77 7.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.417 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.58 162.35 29.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.085 0.442 . . . . 0.0 110.91 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 3.1 pt -143.77 140.57 17.42 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.565 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.75 171.82 8.13 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.185 2.59 . . . . 0.0 112.302 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.6 -39.61 3.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.2 p -60.29 -45.94 91.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.141 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.615 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.2 m -66.79 -45.59 77.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.833 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.555 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.54 -35.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.396 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -66.89 2.45 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.654 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.29 -27.94 69.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.702 0.251 . . . . 0.0 111.142 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.08 -48.65 80.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.15 -35.88 78.28 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -40.61 68.36 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.67 74.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.466 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 m -98.26 42.92 1.08 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.733 0.302 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.3 -93.77 0.58 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.95 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.8 167.36 19.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.907 0.384 . . . . 0.0 111.633 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.08 141.73 42.2 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.2 Cg_endo -86.77 -162.33 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.15 2.567 . . . . 0.0 112.29 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 p -97.65 167.33 11.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.939 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.403 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.4 mm? -54.14 -37.46 64.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.6 84.58 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -64.93 -52.27 57.27 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.19 -45.36 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.596 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -59.41 -42.97 93.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -40.37 79.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.541 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG2' HD13 ' A' ' 51' ' ' LEU . 17.6 mt -63.3 -47.91 89.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.38 -24.35 54.82 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.759 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.9 t -64.14 -10.31 21.97 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 p -117.88 -33.32 4.52 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.385 -0.197 . . . . 0.0 111.466 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.452 HD13 ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -97.46 156.82 35.73 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 96.1 Cg_exo -41.87 148.11 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.12 2.547 . . . . 0.0 112.814 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -33.04 -52.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -97.76 126.75 43.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.784 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -87.26 89.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.455 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.6 p30 -84.58 178.56 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.394 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 40.5 mtm -41.09 -45.7 2.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.016 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.77 -52.55 42.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.969 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.588 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.25 -50.91 71.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -49.5 77.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.811 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.59 -32.61 72.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.484 0.183 . . . . 0.0 111.22 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -50.6 71.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.252 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -73.32 -44.8 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.2 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 120.298 0.094 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -64.65 -65.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 tppt? -58.85 -23.76 61.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.053 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.88 -51.37 35.18 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.695 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -75.38 -42.92 52.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.545 0.212 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.46 ' HG3' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.32 5.3 12.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.7 -45.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -148.57 46.48 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 110.89 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -129.33 66.58 1.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -35.86 82.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.21 -64.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.725 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.67 -174.67 0.1 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.889 0.376 . . . . 0.0 111.773 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 56.96 29.51 16.46 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.727 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.32 36.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.241 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 167.93 132.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.805 0.442 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.408 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -103.43 -45.37 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.337 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.57 77.35 0.23 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.864 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.526 ' HA ' ' CD2' ' A' ' 99' ' ' LEU . 90.4 t -45.41 -33.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.16 -54.47 15.08 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.693 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -72.95 -39.24 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.549 0.175 . . . . 0.0 111.32 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.67 -38.97 89.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.2 -47.27 74.46 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -54.29 -36.55 63.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.154 0.284 . . . . 0.0 111.196 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.85 -47.52 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.232 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 7.3 mt -66.39 -34.43 77.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.416 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 17.6 p -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.415 0.15 . . . . 0.0 111.3 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 t -74.82 -16.77 60.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.827 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.25 -57.49 5.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.692 0.282 . . . . 0.0 110.941 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.42 55.73 0.07 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.221 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 60.0 43.74 14.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 36.3 mmtt -68.86 -138.56 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.23 77.03 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.416 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 77.4 p -72.66 -175.79 1.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.964 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -49.24 -37.51 23.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.416 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.28 -52.73 37.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.637 0.256 . . . . 0.0 111.323 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.07 -50.73 72.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -66.77 -27.73 67.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.286 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -47.66 83.36 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.5 -41.34 93.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.785 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.508 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.98 -41.89 97.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.724 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.427 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.091 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.1 -40.03 92.2 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.74 -46.69 29.47 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.014 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.6 t -86.17 121.49 72.67 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.803 0.301 . . . . 0.0 111.179 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.4 63.98 7.2 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.58 2.187 . . . . 0.0 112.568 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.3 m -131.02 -179.85 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.241 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.17 135.28 54.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 68.07 11.91 8.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.862 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.79 48.55 54.72 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.101 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.82 119.22 38.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.3 t -141.2 29.45 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.232 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.4 t30 56.1 21.87 5.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.408 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.8 t80 47.41 39.78 9.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -116.95 -39.84 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.6 -35.45 75.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -67.54 -54.73 17.55 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.232 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.39 -34.52 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.459 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -62.68 -52.48 63.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 33.4 tpp . . . . . 0 CA--C 1.53 0.211 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.583 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.321 0.582 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.417 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -68.53 -45.53 35.73 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.69 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.2 Cg_endo -79.86 -20.56 8.93 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.466 2.111 . . . . 0.0 114.901 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 14.1 m-30 -105.76 -59.41 1.77 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.1 0.409 . . . . 0.0 111.806 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -73.03 -63.31 1.2 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.49 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -57.62 -49.18 77.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.222 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.66 -38.28 81.01 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.456 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' CE2' HG12 ' A' ' 23' ' ' ILE . 33.5 t80 -58.43 -44.15 89.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.694 0.283 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -61.88 -35.32 78.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -61.96 -39.03 90.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.91 22.99 7.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 130.79 41.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.579 0.228 . . . . 0.0 110.85 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -52.49 -58.0 8.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -133.97 24.41 3.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.398 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.61 30.75 78.11 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.934 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -95.15 -27.61 15.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.587 0.194 . . . . 0.0 111.295 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.69 10.9 6.78 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.292 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.53 160.41 34.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.272 0.536 . . . . 0.0 110.88 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.468 HG12 ' CE2' ' A' ' 12' ' ' PHE . 6.1 pt -147.34 135.68 11.0 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.873 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 90.7 Cg_endo -89.42 171.5 4.37 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.179 2.586 . . . . 0.0 112.541 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' HG13 ' A' ' 44' ' ' ILE . 5.3 pttm -43.05 -40.29 3.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 p -59.82 -42.71 94.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.472 0.177 . . . . 0.0 111.185 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 4.5 t -70.75 -52.82 18.29 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.453 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.57 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -51.03 -37.39 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.19 -69.1 1.34 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.474 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.55 69.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.27 -50.78 68.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.688 0.28 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -61.37 -30.43 70.53 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.023 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -35.44 67.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.95 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.86 70.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.665 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.91 -45.68 9.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.651 0.262 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.63 -87.86 0.15 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.43 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.25 175.81 9.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.987 0.422 . . . . 0.0 111.826 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.57 112.95 35.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.697 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -82.03 -162.98 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 113.024 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -95.17 165.37 12.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.89 -37.08 63.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.49 73.11 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.916 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.64 -53.91 16.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.291 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.57 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -59.91 -47.67 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.291 -0.164 . . . . 0.0 110.91 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.3 m -59.27 -38.53 80.36 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -41.78 90.61 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.367 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.5 mt -63.43 -49.12 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.979 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.37 -26.84 61.67 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.728 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.99 -12.7 40.34 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -118.33 2.47 11.9 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.433 HD12 HG22 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -136.65 154.73 76.79 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.517 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 70.8 Cg_exo -38.59 140.98 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.28 2.653 . . . . 0.0 112.966 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -26.13 -60.69 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.761 0.663 . . . . 0.0 112.755 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -91.44 125.93 36.36 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.411 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.9 t -86.27 86.35 2.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 121.161 0.505 . . . . 0.0 110.44 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.27 177.24 8.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.2 mtm -41.9 -45.37 3.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.543 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -51.17 56.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.853 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.517 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -56.41 -53.61 55.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.486 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -49.3 76.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.192 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.18 -33.29 73.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.49 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -61.33 -50.55 72.5 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.259 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.433 HG22 HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.64 -37.46 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.606 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 120.508 0.194 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.67 -45.78 97.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.855 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -33.93 76.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.266 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.23 -44.63 97.24 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.085 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -70.24 -34.06 72.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.479 0.181 . . . . 0.0 110.624 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.96 73.15 5.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.857 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.43 -64.2 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.854 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.78 28.44 6.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -139.91 70.0 1.36 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.133 0.492 . . . . 0.0 110.149 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -61.09 -44.58 97.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.894 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -49.2 10.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.43 55.52 7.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.492 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 m -82.81 -57.37 3.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.35 57.78 0.22 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.798 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.52 119.6 0.9 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.584 0.231 . . . . 0.0 110.991 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -103.92 139.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.909 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.14 82.73 0.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.883 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.504 HG12 HD22 ' A' ' 118' ' ' LEU . 55.0 t -41.74 -34.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.39 -50.05 58.05 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.917 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 99' ' ' LEU . 1.2 pt-20 -75.65 -34.95 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.356 0.122 . . . . 0.0 110.92 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.496 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -63.02 -41.42 99.55 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 110.493 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -67.42 -47.45 70.19 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -51.7 -46.99 64.08 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.174 0.296 . . . . 0.0 111.385 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.05 -49.49 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.363 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.414 ' CD2' ' HG3' ' A' ' 109' ' ' LYS . 3.8 mt -67.81 -28.15 67.33 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.1 m -65.33 -41.52 93.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.574 0.226 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -74.52 -7.86 54.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -50.74 20.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.644 0.259 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.67 53.73 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.558 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.42 41.72 15.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.414 ' HG3' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.81 -138.91 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.301 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.419 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 3.6 mt -68.74 78.85 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -64.52 -174.61 0.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.143 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 8.8 p30 -49.22 -35.36 17.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.573 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -57.49 -51.08 70.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 11.3 mm-40 -56.74 -52.46 64.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.869 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.415 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 9.1 ptm -67.0 -25.99 66.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -48.11 81.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.661 0.267 . . . . 0.0 110.43 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.77 -41.96 78.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.504 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.66 -41.72 99.22 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.148 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.85 -33.12 70.32 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.514 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -63.54 -41.38 98.46 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.952 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.24 -40.97 39.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.985 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 63.9 t -81.83 132.79 53.36 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.874 0.337 . . . . 0.0 111.193 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.9 58.68 7.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.802 2.334 . . . . 0.0 112.614 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.48 175.03 12.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -125.5 18.71 8.13 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.835 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -159.96 22.63 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 54.39 40.82 70.1 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.811 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.96 112.96 26.16 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.271 0.558 . . . . 0.0 111.353 -179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 32.3 t -142.84 25.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.292 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.48 26.6 16.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.434 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.5 t80 45.62 41.53 7.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.416 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -114.8 -53.56 2.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.406 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.13 -34.7 75.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.51 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -67.76 -56.62 8.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.371 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.92 -32.66 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.124 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -62.81 -48.37 79.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.83 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.5 ttm . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 179.418 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 22.0 m-20 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.993 0.425 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.423 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -62.41 -47.14 89.78 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.5 Cg_endo -83.75 1.64 8.76 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.574 2.183 . . . . 0.0 114.371 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 86.6 m-85 -126.9 -63.5 1.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.795 0.27 . . . . 0.0 111.609 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 2.1 mtpm? -72.44 -58.01 3.72 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.065 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -48.4 80.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.592 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.91 -38.25 78.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.289 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.526 ' CE2' HG12 ' A' ' 23' ' ' ILE . 13.8 t80 -59.16 -45.81 90.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.374 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 m -62.65 -32.62 73.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.643 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.2 mt -61.03 -33.67 73.64 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 66.5 m-85 -94.26 33.1 1.42 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.16 127.66 33.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.961 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -70.9 -56.72 5.64 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -112.2 -21.38 11.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.907 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.81 30.67 5.1 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.917 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -105.84 -29.02 10.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.622 0.211 . . . . 0.0 111.263 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.69 28.34 1.44 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.322 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.75 156.02 45.66 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.987 0.393 . . . . 0.0 110.183 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.526 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.6 pt -143.22 133.17 11.98 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.79 170.06 11.55 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.049 2.499 . . . . 0.0 112.309 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.512 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.68 -38.6 4.47 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 p -60.95 -43.91 98.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.512 0.196 . . . . 0.0 111.109 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 20.7 m -68.22 -46.47 70.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.565 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.53 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.35 -35.66 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.462 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.64 -69.22 1.33 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.584 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -26.03 68.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.529 0.164 . . . . 0.0 111.313 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 12.0 tp -61.62 -49.15 77.72 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -61.79 -32.27 72.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.056 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -39.18 69.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.8 71.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.699 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.61 -45.47 13.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.99 -80.34 0.03 OUTLIER Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.942 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.97 178.79 6.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.651 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -119.02 118.81 32.64 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.501 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 -162.43 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.397 . . . . 0.0 112.601 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 p -102.69 162.43 12.93 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.22 -33.94 63.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.98 80.74 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.933 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.68 -56.37 9.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.225 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -56.83 -47.24 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.327 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -61.17 -43.38 98.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.71 -40.01 78.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 44' ' ' ILE . 24.8 mt -61.63 -52.66 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -56.63 -23.41 40.99 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.826 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -63.74 -8.19 9.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.9 p -118.17 -46.74 2.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.599 0.181 . . . . 0.0 111.001 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -86.25 156.54 57.05 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.9 Cg_exo -39.32 145.43 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.359 2.706 . . . . 0.0 113.317 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.24 -64.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.471 0.708 . . . . 0.0 112.805 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -88.58 127.52 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.448 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -86.42 84.56 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.01 0.433 . . . . 0.0 110.512 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -81.71 179.24 7.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -41.1 -45.57 2.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -68.67 -52.05 35.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.611 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.2 mp0 -56.86 -51.83 67.5 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.563 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -48.85 79.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.624 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.7 mt -61.5 -31.69 71.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -61.46 -50.49 72.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.604 0.24 . . . . 0.0 111.01 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -40.62 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.95 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.4 -43.87 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.715 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -30.21 69.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.303 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.81 -50.54 63.04 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.026 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.75 -41.0 72.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.73 0.3 . . . . 0.0 110.219 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -79.81 70.54 6.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.028 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.9 t -124.94 -64.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.409 ' HB2' ' HG2' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -99.37 43.15 1.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.499 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 1.8 m-20 -137.96 71.2 1.39 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -51.38 68.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.13 -54.89 3.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.674 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 87' ' ' ASP . . . 51.47 56.27 8.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.656 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -110.3 69.4 0.69 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.95 49.3 1.63 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.99 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.98 144.84 0.62 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.788 0.327 . . . . 0.0 111.378 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.43 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.2 OUTLIER -114.88 -44.38 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.285 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.47 80.84 0.21 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.368 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG12 HD22 ' A' ' 118' ' ' LEU . 72.8 t -44.27 -36.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.99 -42.03 22.38 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.565 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 86' ' ' PHE . 1.4 tm-20 -71.98 -50.97 24.33 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.524 0.202 . . . . 0.0 110.518 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.91 -35.19 70.71 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.226 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -66.25 -48.95 68.86 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.678 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.61 -36.18 69.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.04 -46.79 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.786 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.78 -49.32 21.27 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -57.32 -36.04 70.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.4 t -69.42 -21.69 63.74 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.79 -62.61 1.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.529 0.204 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.76 52.54 0.26 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 59.92 45.23 12.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.966 0.412 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -68.55 -137.97 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.078 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -68.21 79.04 0.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.1 p -62.12 178.88 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.52 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.55 -30.99 14.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.207 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.4 -54.59 41.61 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -58.31 -46.6 85.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.8 mmt -67.12 -31.84 72.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.41 77.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.581 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.26 -42.63 93.08 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.529 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.439 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.97 -42.68 94.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.464 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.422 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -68.33 -33.08 73.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -39.43 92.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.76 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -48.81 32.56 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.92 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.8 t -84.31 121.43 75.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.741 0.27 . . . . 0.0 110.964 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 62.96 5.7 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.668 2.245 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.51 177.9 6.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -119.34 133.43 55.73 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.732 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 73.03 5.57 5.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.938 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.12 51.19 14.67 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.97 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -106.06 115.64 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.436 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 38.8 t -142.34 30.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.74 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 57.69 25.35 11.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.43 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 47.24 45.78 16.52 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.774 0.321 . . . . 0.0 111.499 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -120.57 -54.26 2.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.259 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.0 -38.88 76.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.723 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.4 m-85 -66.43 -56.93 8.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.574 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.3 t -61.84 -31.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.313 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -57.74 -55.95 28.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.953 0.406 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.8 -46.62 92.87 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.7 Cg_endo -82.6 -12.94 9.86 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.585 2.19 . . . . 0.0 114.077 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -111.35 -61.28 1.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -72.57 -62.1 1.56 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.394 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.44 -48.86 79.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.809 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.86 -41.6 82.76 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.2 t80 -54.21 -44.68 71.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.325 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.59 -36.1 81.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.339 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.7 mt -60.91 -35.87 77.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.447 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' A' ' 31' ' ' LEU . 96.0 m-85 -90.93 33.74 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.18 133.17 49.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.689 0.28 . . . . 0.0 111.053 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -54.63 12.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.483 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.47 25.24 2.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.454 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.7 40.67 99.09 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.736 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 p -106.08 -31.27 8.8 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.79 -8.91 6.83 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.46 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -118.91 162.64 18.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.12 0.46 . . . . 0.0 111.037 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.52 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.8 pt -138.54 132.21 16.39 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.71 169.25 13.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.944 2.429 . . . . 0.0 112.435 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.494 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -45.16 -36.28 3.68 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.119 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.5 p -62.13 -44.18 97.19 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.404 0.145 . . . . 0.0 111.334 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.409 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 32.6 m -69.19 -45.7 69.29 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.488 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.94 -35.26 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.36 -67.66 2.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.678 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.92 71.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.549 0.174 . . . . 0.0 111.058 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.428 HD11 ' CD2' ' A' ' 15' ' ' PHE . 5.8 tp -59.18 -50.14 75.18 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.448 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . 47.0 mt -59.06 -32.52 69.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -55.41 -41.18 72.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -69.68 -28.79 66.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 32' ' ' LEU . 30.8 p -113.79 36.29 3.71 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.064 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.94 -104.6 0.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.658 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 175.84 8.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 111.562 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.54 105.26 19.18 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.45 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.05 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.762 2.308 . . . . 0.0 112.535 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.54 167.51 11.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.432 HD11 ' HD2' ' A' ' 25' ' ' LYS . 2.9 mm? -55.78 -33.05 64.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.07 75.51 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.014 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -56.53 9.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.011 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.494 ' HB ' ' CB ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.45 -45.65 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.208 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -59.45 -42.69 92.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -57.42 -38.36 74.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.721 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.4 mt -62.69 -51.29 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -56.79 -24.05 47.78 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.659 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.0 m -64.62 -8.67 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -118.01 -46.43 2.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.706 0.23 . . . . 0.0 111.179 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.07 158.24 41.84 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.3 Cg_exo -40.95 147.76 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.416 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.98 -67.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.597 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.54 124.9 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.624 0.249 . . . . 0.0 110.392 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.47 90.81 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -87.67 -179.31 6.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.7 mtp -40.86 -49.91 3.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.603 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -63.29 -53.31 54.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.529 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -56.51 -53.55 56.18 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -49.57 76.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.92 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 mt -61.69 -29.68 70.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -65.33 -48.15 74.04 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.594 0.235 . . . . 0.0 111.264 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -41.77 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.163 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.231 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 CA-C-O 120.433 0.159 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.37 -43.67 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.088 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.69 -35.04 79.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.582 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' A' ' 102' ' ' VAL . . . -70.75 -43.88 58.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.561 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -76.48 -39.09 54.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.509 0.155 . . . . 0.0 111.302 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.45 73.66 5.0 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.106 0.479 . . . . 0.0 110.704 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.83 -45.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.5 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 98' ' ' GLU . 10.0 m-85 -134.36 39.84 3.04 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -109.81 60.58 0.6 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -39.72 79.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.81 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.57 -64.8 1.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.26 -86.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.429 0.456 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t 42.62 45.78 4.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.03 40.09 0.39 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.329 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.6 ptp -176.68 136.05 0.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.93 0.365 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.87 -43.26 8.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.22 80.53 0.15 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.532 HG12 HD22 ' A' ' 118' ' ' LEU . 97.0 t -44.09 -36.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.24 -38.65 19.4 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.777 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 86' ' ' PHE . 15.5 mt-10 -74.11 -52.26 13.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.522 0.201 . . . . 0.0 110.684 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.16 -38.25 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -73.46 -41.02 63.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.935 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -53.51 -42.13 67.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.527 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.482 ' CG1' ' HA2' ' A' ' 82' ' ' GLY . 4.1 t -74.11 -50.77 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.436 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.67 -45.76 88.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.884 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 56.3 m -65.41 -36.83 85.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.567 0.222 . . . . 0.0 110.952 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 t -63.62 -23.13 67.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.31 -70.67 0.23 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.518 0.199 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.25 48.95 0.49 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 61.16 45.99 8.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 111.012 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.62 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.985 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.6 mt -66.94 79.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.291 0.496 . . . . 0.0 110.679 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.429 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 99.5 p -63.59 -170.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.045 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -52.67 -32.7 43.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.148 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -57.29 -50.58 72.46 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.18 -54.47 44.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.742 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.436 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 4.1 ptt? -66.68 -25.41 66.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.457 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -46.32 87.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.97 -45.83 73.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.294 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.532 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.09 -40.57 90.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.9 mt -69.5 -32.13 70.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -61.27 -40.93 95.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.362 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.38 51.65 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.989 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.23 116.67 66.9 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.749 0.274 . . . . 0.0 110.989 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.08 65.03 4.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.492 2.128 . . . . 0.0 112.632 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.12 -179.24 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -118.68 132.7 56.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.567 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.99 6.18 5.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.955 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.42 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 71.03 53.33 10.95 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.909 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttt -106.83 119.61 39.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.503 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 39.3 t -142.34 20.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.56 22.06 10.66 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.09 -164.53 0.14 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 m170 71.37 -58.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.28 0.232 . . . . 0.0 111.209 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -52.72 -39.68 62.3 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.503 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 17.8 m-85 -68.11 -52.72 31.73 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.73 -30.79 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.225 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -62.51 -54.14 44.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.846 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.6 ttt . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.587 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.932 0.396 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.3 t -58.69 -45.79 99.62 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.343 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 85.3 Cg_endo -84.63 -3.74 9.95 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.543 2.162 . . . . 0.0 114.641 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -123.99 -62.64 1.27 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.972 0.351 . . . . 0.0 111.809 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -72.66 -60.84 2.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.944 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.51 -45.57 93.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.11 -44.88 87.92 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.181 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CE2' HG12 ' A' ' 23' ' ' ILE . 25.9 t80 -56.78 -43.12 80.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.823 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -62.48 -34.05 76.08 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -59.5 -34.05 72.1 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -94.25 33.22 1.4 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.92 129.4 39.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.618 0.247 . . . . 0.0 111.015 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.58 -61.89 1.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.512 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -130.95 25.75 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.184 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.75 39.18 95.09 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.535 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -104.57 -24.43 12.99 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.49 11.63 17.01 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.891 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 4.8 mtt-85 -129.0 163.17 25.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.746 0.273 . . . . 0.0 110.445 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.465 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.4 pt -140.14 133.74 15.3 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.49 172.43 8.11 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.158 2.572 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.6 pttp -43.49 -40.97 4.13 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -60.06 -43.13 95.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.507 0.194 . . . . 0.0 111.404 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.0 m -70.95 -45.57 63.93 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.766 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.582 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.32 -33.06 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.477 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.53 -67.54 2.16 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.25 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.4 -28.13 69.48 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.46 -46.76 88.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.28 -34.85 75.87 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.753 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.33 -41.08 65.37 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.794 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.426 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -63.68 -34.9 78.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.682 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -101.03 44.35 1.02 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.845 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.69 -97.78 0.57 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.817 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.68 170.43 14.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.721 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -122.47 131.96 24.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 59.3 Cg_endo -85.82 -163.27 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.973 2.449 . . . . 0.0 112.743 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p -98.15 163.25 12.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -51.53 -37.51 49.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.145 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.606 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -61.24 -55.12 35.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.0 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -55.58 -47.97 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.819 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -57.56 -41.73 81.59 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.75 -40.7 76.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.423 HG21 HG12 ' A' ' 63' ' ' VAL . 20.2 mt -62.79 -51.01 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.037 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -56.44 -23.54 39.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.905 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 t -63.97 -7.6 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 p -118.23 -46.17 2.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.684 0.22 . . . . 0.0 111.146 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -88.76 156.57 49.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.569 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.7 Cg_exo -39.01 146.11 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.355 2.703 . . . . 0.0 113.279 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.08 -68.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.744 0.653 . . . . 0.0 112.609 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.5 tt0 -85.84 127.68 34.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.643 0.259 . . . . 0.0 110.399 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.65 87.77 2.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.032 0.444 . . . . 0.0 111.314 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -82.33 177.56 8.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 ttm -41.61 -45.09 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.78 -51.54 47.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.572 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.569 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mp0 -56.82 -51.85 67.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.527 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -48.88 79.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.93 -32.6 72.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.427 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -61.47 -51.77 67.29 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.066 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -70.43 -41.7 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.563 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -26.56 66.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.81 -50.4 58.6 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.466 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -72.96 -37.51 67.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.562 0.22 . . . . 0.0 111.008 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -79.12 4.78 13.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.76 -43.8 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -145.75 33.6 1.03 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.765 0.316 . . . . 0.0 111.413 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.92 76.24 1.71 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.063 0.459 . . . . 0.0 110.347 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.93 -48.94 78.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.178 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -91.82 -64.02 1.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.99 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 48.82 52.86 13.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.803 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.4 p -102.73 -48.05 4.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.85 26.22 9.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.0 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.484 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -174.59 148.64 1.18 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.862 0.331 . . . . 0.0 110.974 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.464 HG22 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -118.11 -44.25 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.79 81.15 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.337 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.447 ' HA ' HD21 ' A' ' 99' ' ' LEU . 73.3 t -44.3 -34.81 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.68 -35.73 17.29 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.093 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -80.65 -46.34 15.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.619 0.21 . . . . 0.0 110.916 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.99 -39.92 83.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.857 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.477 ' HG2' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -75.07 -36.12 61.79 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.611 179.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.78 -40.54 63.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.905 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.33 -51.46 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.532 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 2.4 mt -58.31 -49.85 75.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 m -59.7 -39.3 84.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.445 0.164 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -72.13 -19.82 61.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.81 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt -65.35 -66.69 0.51 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.603 0.239 . . . . 0.0 110.97 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.92 47.86 0.47 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.336 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.61 45.89 7.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -68.77 -137.7 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.158 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.43 79.33 0.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.619 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -64.97 -173.02 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.913 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 4.3 p-10 -51.88 -34.89 43.09 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.606 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.6 -55.44 30.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -55.34 -51.28 67.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.477 ' SD ' ' HG2' ' A' ' 100' ' ' ARG . 22.0 ptm -66.82 -27.6 67.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -47.3 83.58 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.82 -43.47 79.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -60.49 -43.11 97.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.634 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 124' ' ' VAL . 1.4 mt -67.95 -32.62 73.19 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.236 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -41.58 98.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.617 0.246 . . . . 0.0 110.724 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.99 -44.2 37.53 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.878 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.97 133.21 61.84 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.675 0.237 . . . . 0.0 111.189 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.39 59.94 7.31 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.788 2.326 . . . . 0.0 112.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.437 HG22 HD22 ' A' ' 119' ' ' LEU . 17.2 m -131.49 174.12 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 48.2 2.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.27 0.557 . . . . 0.0 110.555 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 175.13 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.834 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.426 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 112.71 50.3 0.56 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.922 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.484 ' SD ' ' HA ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.35 114.46 28.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.268 0.556 . . . . 0.0 110.698 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.433 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 40.4 t -142.18 26.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.101 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 62.67 24.34 14.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.122 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.438 ' CD1' HG13 ' A' ' 94' ' ' ILE . 4.8 t80 48.45 51.97 14.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 111.372 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.06 -54.31 1.12 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.82 -36.52 72.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.676 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.464 ' CE2' HG22 ' A' ' 94' ' ' ILE . 1.8 m-85 -68.46 -55.49 11.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.697 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.3 -31.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.568 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.03 -47.85 78.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.191 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.6 ttt . . . . . 0 CA--C 1.533 0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.504 -179.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 38.9 m-20 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -67.2 -47.1 51.32 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.864 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 3.3 Cg_exo -75.17 -16.27 19.93 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.758 2.305 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -110.88 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 14.5 mmmt -72.3 -57.97 3.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -58.82 -45.95 88.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.603 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -63.82 -35.52 80.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.125 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.513 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.0 t80 -57.89 -47.95 81.27 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 m -62.71 -33.87 75.99 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.198 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -58.59 -37.15 75.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.344 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 89.0 m-85 -95.75 34.0 1.57 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 83.11 6.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.681 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -68.16 -30.84 70.06 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -86.22 -29.93 22.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.554 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.34 30.26 58.87 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.631 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -129.77 27.81 5.17 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.74 21.82 71.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.986 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 42.7 mtt180 -130.23 157.04 43.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.916 0.358 . . . . 0.0 110.805 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.513 HG12 ' CE2' ' A' ' 12' ' ' PHE . 3.8 pt -146.86 133.93 10.08 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.816 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.01 168.34 12.18 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.992 2.461 . . . . 0.0 112.172 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.5 -38.01 3.87 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -60.46 -43.74 96.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 111.145 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 m -71.03 -46.57 61.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.647 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.64 -34.06 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.099 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.03 -70.37 0.99 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.504 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.68 68.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.496 0.148 . . . . 0.0 111.297 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.434 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 9.2 tp -62.34 -48.41 79.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.33 -33.19 73.19 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.769 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.43 -36.85 66.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.74 -36.69 58.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.713 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t -93.64 53.51 1.86 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 111.001 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.84 -89.51 0.81 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.854 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 169.11 14.87 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.441 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 11.1 p-10 -133.77 155.32 80.5 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.329 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.02 -162.09 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.415 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -102.54 168.06 9.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -54.63 -33.17 60.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.19 85.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.71 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.37 -55.0 15.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.065 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.525 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -55.49 -46.04 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.934 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.6 m -61.47 -39.62 91.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -58.11 -38.4 76.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.316 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.422 ' CG2' HD13 ' A' ' 51' ' ' LEU . 50.0 mt -63.55 -46.72 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.898 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.8 -28.77 61.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 m -63.88 -12.21 34.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.8 p -118.28 -14.66 9.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -125.05 153.36 71.34 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.3 Cg_exo -39.38 146.65 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.366 2.711 . . . . 0.0 113.077 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.05 -65.4 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -88.12 125.88 34.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.576 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.55 89.82 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.2 p30 -83.17 176.94 8.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.388 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -41.49 -44.65 2.99 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.717 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -52.04 46.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.966 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.523 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.95 78.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.6 mt -61.38 -31.87 71.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.571 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -63.18 -52.16 63.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.161 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.06 -43.84 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.282 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.579 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.352 0.12 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.85 -53.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.317 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -40.68 97.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.277 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.14 -47.1 88.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.544 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.08 -26.45 65.84 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.496 0.148 . . . . 0.0 111.357 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.03 73.58 3.61 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.854 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.96 -66.32 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.523 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.405 ' CB ' ' HG2' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -135.58 33.21 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.652 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -137.25 53.2 1.89 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.617 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HE2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -70.95 -3.21 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.451 ' N ' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -97.87 -60.69 1.51 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.722 0.237 . . . . 0.0 111.056 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.57 51.4 12.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.304 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 p -142.19 80.81 1.72 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.77 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.7 15.89 50.93 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.292 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptm -172.57 131.37 0.56 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.12 0.46 . . . . 0.0 111.402 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.402 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -105.9 -35.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.42 80.31 0.26 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.446 HG12 HD22 ' A' ' 118' ' ' LEU . 81.4 t -44.86 -34.43 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.21 -37.26 17.24 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.51 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG2' ' CB ' ' A' ' 86' ' ' PHE . 1.5 mp0 -75.57 -53.36 8.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.548 0.214 . . . . 0.0 110.63 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.27 -36.82 73.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.287 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HG3' ' HG2' ' A' ' 115' ' ' MET . 2.1 tmt_? -68.48 -49.95 56.0 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -57.61 -36.85 72.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.34 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.97 -47.75 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.763 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 mt -73.4 -52.5 13.55 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 84.8 m -55.3 -37.03 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 t -76.79 -17.67 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -66.57 0.53 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.509 0.195 . . . . 0.0 111.212 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 58.67 0.27 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.59 39.38 17.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.404 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -68.92 -137.77 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.197 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.79 78.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 110.754 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -66.07 -170.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.938 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -51.0 -38.37 50.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.943 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.31 -51.17 68.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -57.69 -53.21 60.8 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.848 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.446 ' HG2' ' HG3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -66.83 -27.88 67.91 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -45.23 89.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.677 0.275 . . . . 0.0 110.555 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.38 -40.29 74.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.79 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.446 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.97 -42.22 99.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.826 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -30.86 63.37 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.407 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -63.14 -41.14 99.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.77 -0.195 . . . . 0.0 110.958 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.36 -43.16 39.25 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.985 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.2 t -81.83 130.29 61.47 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.705 0.253 . . . . 0.0 111.155 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.96 62.45 6.62 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.7 p -131.2 167.42 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.824 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.48 54.44 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.088 0.47 . . . . 0.0 111.154 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.4 -37.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.561 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.96 39.19 1.08 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.296 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.16 113.96 27.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.26 0.552 . . . . 0.0 110.762 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 37.9 t -142.31 21.39 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.433 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.75 22.39 12.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 2.1 t80 46.63 45.42 14.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 -51.08 2.52 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.407 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.83 -36.62 77.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.788 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -68.16 -55.74 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.685 0.278 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.57 -32.73 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.232 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.84 -49.7 76.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.712 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 179.273 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.422 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t -64.0 -48.31 78.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.771 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 6' ' ' SER . 71.5 Cg_endo -78.75 -14.36 14.04 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.389 2.06 . . . . 0.0 114.074 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -111.26 -61.41 1.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -60.13 2.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.597 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 8.1 tt0 -58.97 -47.04 86.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.631 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.6 -36.3 78.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.096 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.447 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.6 t80 -58.47 -49.31 77.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -61.92 -34.3 75.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 14.2 mt -55.62 -36.95 67.52 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 111.358 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -96.15 33.5 1.73 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -84.67 84.31 7.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.242 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -67.26 -34.49 77.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.46 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -86.55 -32.59 20.61 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.4 26.79 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.508 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.2 p -137.25 30.16 2.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.668 0.27 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.23 20.63 71.41 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.812 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 13.3 mtt180 -130.65 158.62 39.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.777 0.288 . . . . 0.0 110.533 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.447 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.7 pt -145.49 138.08 13.7 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 95.7 Cg_endo -88.67 172.73 4.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.207 2.605 . . . . 0.0 112.131 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 4.5 pttm -44.33 -36.25 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -59.9 -46.25 89.93 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.435 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -71.22 -50.51 32.21 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.553 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -48.85 -35.45 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.338 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.18 -70.95 0.83 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.235 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.17 -28.26 69.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.59 0.195 . . . . 0.0 111.453 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.72 -48.01 83.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.6 -34.47 75.7 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.858 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -32.41 64.71 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.297 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.56 -43.48 65.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.5 m -64.32 -43.73 93.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.925 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.18 -65.97 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.984 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.63 163.46 28.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -136.07 151.72 74.17 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.7 Cg_endo -86.47 -163.28 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.138 2.559 . . . . 0.0 112.74 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -99.58 169.05 9.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.261 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.3 mm? -54.09 -36.09 62.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.113 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.52 80.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.559 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -67.71 -52.23 40.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.85 -45.65 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.337 -0.145 . . . . 0.0 110.641 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -40.02 78.05 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -40.92 88.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.614 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.7 mt -63.36 -49.08 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -57.22 -24.86 57.45 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.678 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -64.03 -10.69 23.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.4 p -117.92 -41.54 2.89 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 120.34 0.114 . . . . 0.0 111.025 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -92.84 150.78 40.06 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.3 Cg_exo -38.32 143.31 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.233 2.622 . . . . 0.0 112.821 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.25 -61.35 0.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.73 0.644 . . . . 0.0 112.659 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -87.29 121.01 29.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.491 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.64 83.64 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.3 p30 -82.77 178.11 8.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.494 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.9 mtp -41.43 -46.01 3.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.59 -52.16 54.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.962 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.524 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.57 -52.59 64.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -49.31 75.92 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.121 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.57 -30.04 70.41 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -64.2 -49.46 71.93 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.433 0.159 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.422 HG22 HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.51 -45.92 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.849 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.334 -0.066 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 120.356 0.122 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.85 -56.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -24.77 67.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.687 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.21 -52.72 38.29 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.4 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -77.69 -41.47 37.92 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.437 0.16 . . . . 0.0 111.053 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -78.65 71.76 5.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.957 0.408 . . . . 0.0 110.986 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HB ' HG23 ' A' ' 102' ' ' VAL . 14.9 p -111.99 -42.01 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.29 40.36 1.76 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -125.25 57.53 1.31 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -49.24 74.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.556 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -97.83 -48.31 5.24 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.444 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.02 73.48 0.47 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -92.06 70.29 5.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.813 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.29 57.34 17.27 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.62 135.74 1.97 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 111.015 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -108.89 -44.16 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.46 80.12 0.12 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.422 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 118' ' ' LEU . 95.4 t -44.44 -40.07 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.71 -36.15 8.09 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.163 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.85 -46.01 15.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.63 0.215 . . . . 0.0 110.909 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -42.08 84.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.893 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -75.01 -36.06 61.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.828 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -52.82 -41.34 64.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.522 0.201 . . . . 0.0 111.014 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.424 HG23 ' HB ' ' A' ' 85' ' ' VAL . 2.6 t -83.04 -52.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.649 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -56.45 -47.12 79.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -58.22 -35.38 71.58 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -67.86 -21.47 65.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.1 mt -66.35 -67.43 0.45 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.512 0.196 . . . . 0.0 111.026 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.31 49.65 0.46 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.542 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.2 48.68 4.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.345 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -68.49 -138.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.125 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' A' ' 114' ' ' GLU . 15.1 mt -69.68 78.01 0.44 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.885 0.374 . . . . 0.0 110.639 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.3 p -68.78 -171.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.867 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -50.88 -39.54 54.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.03 -53.52 48.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.524 0.202 . . . . 0.0 111.275 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.505 ' HG2' ' CD2' ' A' ' 110' ' ' LEU . 4.1 tp10 -54.78 -52.86 61.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.61 -27.76 68.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -44.77 90.46 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.32 -43.82 80.69 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.547 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.92 -42.5 98.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.06 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.434 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.3 mt -71.52 -28.95 64.25 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.146 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -63.97 -41.21 97.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.572 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.12 -48.79 24.33 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.829 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.73 123.69 80.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.62 0.21 . . . . 0.0 110.808 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.75 62.23 6.41 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.565 2.177 . . . . 0.0 112.864 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.73 178.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.212 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -119.29 130.43 55.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.48 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 22.8 m-20 80.7 -34.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.061 0.544 . . . . 0.0 111.814 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.07 50.69 0.34 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.457 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.413 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.7 OUTLIER -104.01 116.84 32.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.705 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.44 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 36.7 t -142.32 20.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.258 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 56.72 25.31 10.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.458 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.7 t80 44.77 44.49 7.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -53.54 2.53 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.13 -37.08 68.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.44 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.3 m-85 -68.2 -58.95 3.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.83 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -62.27 -32.99 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -61.2 -52.66 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 110.645 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.807 0.336 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.427 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.6 t -59.41 -48.04 96.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.69 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.0 Cg_endo -81.74 -14.39 10.13 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.513 2.142 . . . . 0.0 114.123 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -110.52 -61.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -62.7 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.547 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -57.29 -47.6 81.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.677 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.2 -41.92 85.02 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.6 t80 -56.71 -42.82 79.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.592 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -61.4 -36.49 80.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.2 mt -63.26 -34.1 76.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -93.96 29.65 2.06 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.08 125.02 29.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.733 0.301 . . . . 0.0 110.821 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.53 -58.3 3.84 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.398 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -108.28 6.03 26.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.17 43.13 99.8 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.792 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.0 p -118.41 10.83 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 1.19 68.95 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.381 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -125.04 167.29 14.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.149 0.475 . . . . 0.0 110.898 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 7.6 pt -147.41 136.43 11.53 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -87.38 172.01 6.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.245 2.63 . . . . 0.0 112.488 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 6.0 pttt -44.41 -39.27 4.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.2 p -59.5 -43.31 93.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.453 0.168 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.482 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 25.4 m -71.16 -52.37 19.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.614 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.501 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -51.86 -35.36 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.76 -71.22 0.75 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -26.59 68.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.8 -50.14 67.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.702 0.287 . . . . 0.0 110.276 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.33 -28.11 68.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -54.75 -37.95 66.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.519 0.2 . . . . 0.0 110.749 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.18 72.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.577 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -83.74 -41.89 17.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.476 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.39 -84.32 0.05 OUTLIER Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.59 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.1 171.65 13.7 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.6 t-20 -123.3 108.77 31.6 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.317 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.38 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.849 2.366 . . . . 0.0 112.552 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 p -90.42 166.4 13.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.5 mm? -55.7 -34.53 65.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.789 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.54 -37.22 77.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.52 -54.2 31.56 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.06 -44.29 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.748 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 m -58.07 -43.59 87.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.343 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.47 -40.12 74.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.645 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.425 HG21 HG12 ' A' ' 63' ' ' VAL . 24.6 mt -64.99 -49.35 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.8 -23.37 43.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.748 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -64.56 -6.49 7.65 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -117.76 -45.59 2.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.789 0.268 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.36 156.19 48.48 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.4 Cg_exo -41.67 149.31 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 113.116 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.72 -64.18 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.646 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.1 mt-10 -86.44 123.58 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.704 0.288 . . . . 0.0 110.614 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.92 87.85 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.9 p30 -83.92 -179.93 7.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 37.2 mtt -41.41 -44.59 2.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -69.12 -52.27 29.98 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.535 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.27 -51.57 68.83 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.614 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -48.54 81.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.921 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.0 mt -61.01 -34.51 74.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.505 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -60.28 -49.81 76.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.577 0.227 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.425 HG12 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.57 -36.49 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.03 179.619 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.55 0.214 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.92 -39.04 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.926 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -35.36 77.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.324 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.63 -54.69 8.25 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.755 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -57.9 -45.64 86.15 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.512 0.196 . . . . 0.0 110.666 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.98 65.13 5.04 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.85 -41.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.479 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -121.83 32.16 5.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.01 75.0 1.48 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.548 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -44.15 92.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.5 -59.28 2.36 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.846 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . . . 55.71 70.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -128.22 68.36 1.35 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.0 38.76 3.27 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.802 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.86 134.56 0.59 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.675 0.238 . . . . 0.0 110.976 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -107.26 -41.78 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.12 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.54 80.96 0.38 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.328 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.419 ' HA ' HD21 ' A' ' 99' ' ' LEU . 79.6 t -45.12 -39.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.03 -40.04 42.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.258 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 1.4 tt0 -71.93 -47.92 49.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.225 0.21 . . . . 0.0 110.474 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.455 HD11 HD13 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -58.35 -37.74 75.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.207 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.475 ' HG3' ' HG3' ' A' ' 115' ' ' MET . 0.2 OUTLIER -68.16 -43.99 77.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.675 179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -58.47 -36.79 74.25 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.361 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 t -77.8 -50.28 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.602 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 4.6 mt -63.73 -42.61 97.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.6 m -64.73 -41.72 95.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.499 0.19 . . . . 0.0 111.007 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.5 p -70.37 -15.2 62.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.861 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.55 -56.92 4.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.46 42.99 0.23 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.84 47.28 15.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 46.9 mmtm -68.52 -138.66 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.51 79.67 0.57 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.0 p -62.21 -177.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.933 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -48.9 -29.75 5.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.468 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -60.0 -62.75 1.64 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -42.04 86.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.475 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 6.0 mmt -65.95 -33.84 76.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -48.9 77.98 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.233 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.59 -40.65 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -60.33 -42.16 95.08 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.409 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.418 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -68.91 -31.17 69.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.324 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -62.94 -42.24 99.74 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.5 65.62 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.902 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.73 126.35 71.06 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.667 0.234 . . . . 0.0 111.176 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.25 61.07 5.79 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.598 2.199 . . . . 0.0 112.333 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.87 171.46 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.294 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -118.28 132.17 56.31 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 26.8 m-20 81.35 -47.51 0.24 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.523 0.514 . . . . 0.0 110.841 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.2 53.16 0.16 Allowed Glycine 0 C--N 1.339 0.71 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.711 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -107.22 107.41 18.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.544 0.688 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 47.7 t -142.32 19.59 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.624 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.85 21.69 7.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.853 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.411 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.9 OUTLIER 54.79 -164.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.21 -57.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.235 0.214 . . . . 0.0 111.359 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -52.65 -39.18 61.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.7 m-85 -68.65 -54.81 14.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.637 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.03 -31.31 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.293 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -69.6 -54.23 15.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.492 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.46 0.031 0 CA-C-O 120.772 0.32 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.6 t -61.72 -46.02 93.11 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 5.0 Cg_exo -75.39 -14.4 20.33 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.987 2.458 . . . . 0.0 114.046 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -118.12 -63.13 1.46 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -66.21 -60.68 2.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -60.56 -47.14 87.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.61 -37.05 80.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' A' ' 23' ' ' ILE . 24.7 t80 -59.01 -46.77 87.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.326 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -62.41 -32.73 73.61 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.266 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -59.95 -34.07 72.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.497 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -102.05 36.33 2.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.92 101.68 14.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -50.05 67.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -86.84 -35.79 18.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.386 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.08 40.01 6.74 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.584 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.3 p -127.83 32.72 4.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.06 19.2 73.62 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.984 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 1.1 mtt-85 -130.98 157.2 43.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.794 0.297 . . . . 0.0 110.688 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.523 HG12 ' CE2' ' A' ' 12' ' ' PHE . 7.0 pt -143.57 137.94 14.93 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 84.1 Cg_endo -88.3 171.53 5.4 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.166 2.577 . . . . 0.0 112.702 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.437 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 15.8 pttm -44.19 -36.63 2.75 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.5 p -60.15 -46.21 90.45 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.439 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -70.72 -49.95 41.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.563 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -50.94 -34.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.346 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.12 -72.56 0.56 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.215 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -27.19 65.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.593 0.196 . . . . 0.0 111.456 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.13 -48.38 78.74 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -61.55 -31.5 71.53 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.962 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -56.13 -33.67 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.142 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.3 -38.02 68.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.28 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -92.66 58.15 3.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.0 0.428 . . . . 0.0 110.477 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.41 -91.71 1.09 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.406 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 172.37 12.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 12.4 p-10 -132.05 155.82 80.87 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 65.3 Cg_endo -85.03 -161.91 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.034 2.489 . . . . 0.0 112.41 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 p -102.17 167.32 10.08 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.076 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -53.58 -35.23 60.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.17 88.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.708 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -66.76 -52.22 46.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.271 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -54.95 -46.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -58.42 -43.08 88.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.307 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.51 -40.97 75.9 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.562 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 44' ' ' ILE . 38.8 mt -63.59 -48.2 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.23 -23.58 48.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -63.69 -12.09 31.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.4 p -118.04 -41.11 2.91 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.946 0.098 . . . . 0.0 110.911 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD13 ' CG2' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -91.2 148.35 37.6 Favored Pre-proline 0 N--CA 1.465 0.286 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -36.62 140.43 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.391 2.727 . . . . 0.0 113.148 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.86 -58.5 0.13 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.636 . . . . 0.0 112.448 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -89.4 122.32 32.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.185 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.36 88.49 2.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 121.029 0.443 . . . . 0.0 110.647 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.6 177.77 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.498 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.9 mtm -41.36 -43.73 2.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.907 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.84 -51.19 35.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.451 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -56.29 -50.74 70.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.504 0.192 . . . . 0.0 111.08 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -47.59 83.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.86 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.1 -30.93 71.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -63.65 -54.58 33.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.507 0.194 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -64.24 -40.9 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.903 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.859 179.631 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.393 0 CA-C-O 120.461 0.172 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.84 -50.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.602 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -60.13 -32.87 71.42 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.405 ' HA2' HG13 ' A' ' 102' ' ' VAL . . . -63.21 -54.08 35.22 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.502 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -78.02 -22.37 49.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.66 75.02 4.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.1 0.476 . . . . 0.0 111.031 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HB ' HG23 ' A' ' 102' ' ' VAL . 7.1 p -141.75 -49.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.906 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -156.29 43.44 0.4 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 110.722 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.96 59.95 1.72 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -50.23 74.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.93 -46.08 5.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.888 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.24 38.77 28.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.54 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 p -118.47 82.55 1.87 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.7 -18.02 5.44 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.157 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.1 OUTLIER -163.77 132.37 3.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.085 0.442 . . . . 0.0 110.898 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.38 -41.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.853 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.52 80.4 0.2 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.705 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.534 HG12 HD22 ' A' ' 118' ' ' LEU . 96.9 t -45.12 -38.61 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 122.3 0.24 . . . . 0.0 111.641 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.55 -36.36 17.79 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.45 -48.1 18.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 0.173 . . . . 0.0 110.71 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.72 -39.36 80.61 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.744 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -75.71 -39.47 57.32 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -53.9 -40.78 66.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 85' ' ' VAL . 3.8 t -77.91 -52.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.653 0.264 . . . . 0.0 111.412 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mt -56.5 -46.77 80.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.948 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.2 m -66.56 -35.59 80.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -66.02 -22.07 66.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.728 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.01 -67.86 0.43 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 110.983 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.55 44.68 0.56 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.258 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.4 50.41 4.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 111.182 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.902 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 114' ' ' GLU . 62.3 mt -67.23 79.44 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.372 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.8 p -63.8 -169.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.438 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' A' ' 115' ' ' MET . 3.5 m120 -50.43 -33.71 21.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.521 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -56.37 -51.72 67.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.568 0.223 . . . . 0.0 111.483 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 110' ' ' LEU . 1.6 tm-20 -56.58 -56.79 16.93 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.463 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -65.45 -24.68 67.24 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.638 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -48.28 81.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -68.01 -43.54 78.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.71 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.534 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.73 -42.19 96.82 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.944 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.411 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 4.1 mt -69.79 -30.24 67.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.073 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -40.39 96.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.625 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.48 -47.48 16.26 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.952 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.2 t -81.35 125.8 78.08 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.688 0.244 . . . . 0.0 110.977 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.49 61.61 7.96 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.652 2.235 . . . . 0.0 112.662 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.57 -177.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.236 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -119.05 129.91 55.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.083 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 21.0 m-20 78.71 -49.38 0.45 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.851 0.46 . . . . 0.0 111.049 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.14 51.27 0.07 OUTLIER Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.618 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.473 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 1.9 ttp -104.17 116.73 32.71 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.121 0.486 . . . . 0.0 110.659 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.7 t -142.03 20.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.463 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 59.92 25.77 14.95 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.472 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.0 t80 44.31 41.63 4.58 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.236 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -52.98 2.69 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.839 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -56.9 -36.75 70.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -67.93 -57.35 6.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.55 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.94 -35.19 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.41 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.77 -56.03 26.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.2 tpp . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.074 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.491 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 4.1 t -67.31 -47.64 48.66 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.785 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 6' ' ' SER . 98.8 Cg_endo -80.73 -13.34 11.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.466 2.11 . . . . 0.0 114.193 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.37 -61.27 1.69 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -59.62 2.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.336 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.35 -47.42 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.716 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.79 -41.02 85.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.966 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CE2' HG12 ' A' ' 23' ' ' ILE . 6.1 t80 -56.39 -45.39 80.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.456 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.8 m -62.64 -33.82 75.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.733 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 16.1 mt -57.52 -30.28 65.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -91.69 33.22 1.03 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.54 112.3 14.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.909 0.385 . . . . 0.0 110.846 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -49.72 42.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -115.53 -0.92 12.91 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 48.5 33.57 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.559 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.5 p -121.38 16.64 11.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.65 14.01 80.01 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.194 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' CG ' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -130.29 158.45 39.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.922 0.361 . . . . 0.0 110.668 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 27' ' ' SER . 8.8 pt -140.96 135.04 15.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.73 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.25 170.66 9.36 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.074 2.516 . . . . 0.0 112.477 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -42.81 -38.16 2.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.6 p -60.41 -45.38 93.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.506 0.193 . . . . 0.0 111.293 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.455 ' CB ' ' HB ' ' A' ' 23' ' ' ILE . 2.9 m -69.97 -44.73 68.85 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.55 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.21 -33.47 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.411 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.45 -65.99 3.15 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.392 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -28.02 69.24 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.56 -49.18 77.7 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.32 -29.48 69.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.076 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -36.63 70.6 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.85 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.23 -30.14 71.0 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.418 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -109.4 32.05 5.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.799 0.333 . . . . 0.0 110.84 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.55 -105.08 0.28 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.366 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -132.4 178.81 6.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.615 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.74 116.04 34.88 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.369 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -84.57 -162.63 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.016 2.478 . . . . 0.0 112.764 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 p -98.16 164.06 12.48 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.24 -36.48 63.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.021 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.82 80.59 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.02 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -54.6 20.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.55 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -56.64 -44.95 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.484 0.183 . . . . 0.0 110.632 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.7 m -59.1 -38.99 80.86 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -40.5 85.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.277 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mt -63.56 -47.94 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -56.82 -25.48 56.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.414 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 t -64.47 -7.42 9.97 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -117.75 -50.52 2.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.748 0.249 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.66 53.92 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 85.6 Cg_exo -38.85 144.95 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.265 2.643 . . . . 0.0 113.044 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.68 -68.66 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.74 126.78 33.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.637 0.256 . . . . 0.0 110.601 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.55 89.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HB3' ' CG ' ' A' ' 22' ' ' ARG . 1.5 p30 -86.08 -179.69 6.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.539 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -41.28 -45.15 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.817 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -67.55 -53.62 26.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.491 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.31 -51.99 67.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -50.1 75.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.46 -32.47 72.46 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.414 0.15 . . . . 0.0 111.326 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.19 -50.3 74.57 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.025 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.57 -34.45 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.356 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.635 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.48 0.181 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.43 -44.56 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.276 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -34.62 77.6 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.65 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -61.07 -48.36 86.46 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.214 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -70.97 -34.36 71.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.508 0.194 . . . . 0.0 110.724 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -78.78 72.27 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.2 -63.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.465 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -116.5 42.21 2.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.141 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.33 65.42 0.67 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.671 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -59.64 -53.51 57.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.87 -66.95 1.0 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.595 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.21 63.75 1.84 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.572 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -64.84 -47.72 76.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.27 64.77 0.5 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.403 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -178.1 150.22 0.59 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.224 0.21 . . . . 0.0 110.487 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.25 -41.53 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.507 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.51 80.34 0.18 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.334 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.447 HG22 ' HA3' ' A' ' 127' ' ' GLY . 91.3 t -45.14 -33.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -43.76 15.62 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.109 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.465 ' HG3' ' CB ' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -76.93 -49.91 14.49 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.583 0.192 . . . . 0.0 111.045 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -37.58 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.272 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' A' ' 104' ' ' THR . 35.7 ttp85 -70.8 -46.98 61.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.79 -38.05 54.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.284 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.489 HG12 ' HA2' ' A' ' 82' ' ' GLY . 22.4 t -75.11 -49.03 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.468 HD23 ' HG2' ' A' ' 109' ' ' LYS . 9.4 mt -63.07 -35.27 79.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.407 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 100' ' ' ARG . 68.2 p -63.75 -37.8 88.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.603 0.24 . . . . 0.0 111.021 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.1 m -72.74 -17.05 61.64 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.05 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -67.34 -56.91 7.79 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 110.772 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.06 48.78 0.07 OUTLIER Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.156 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 64.01 39.12 8.16 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 111.035 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.468 ' HG2' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.66 -137.05 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.593 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.413 ' C ' ' CD2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -67.51 83.56 0.17 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.416 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 0.0 OUTLIER -86.71 -167.55 1.92 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.967 -178.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 11.1 p30 -55.43 -28.86 56.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -67.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -44.98 77.95 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.148 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.422 ' CG ' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -66.54 -29.27 69.32 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.106 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER -58.69 -47.52 84.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.25 -42.71 99.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -61.8 -41.72 98.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.742 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.406 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 4.3 mt -67.7 -32.18 72.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -45.22 91.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.967 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.94 -45.66 41.01 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.785 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.7 t -75.63 133.49 73.62 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.488 0.185 . . . . 0.0 111.111 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 58.48 6.5 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.84 2.36 . . . . 0.0 112.657 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.43 166.84 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 3.0 mtpp -124.33 55.56 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.92 0.391 . . . . 0.0 111.25 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.7 p-10 170.26 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 116.45 40.98 0.76 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.25 114.26 28.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 110.618 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.463 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 25.8 t -142.44 27.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.225 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 60.21 20.23 9.61 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.5 t80 46.61 41.75 10.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.821 0.343 . . . . 0.0 111.187 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -50.07 2.37 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.667 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -56.37 -41.29 75.95 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.463 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -66.4 -57.85 6.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.77 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.11 -30.09 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.512 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.17 -57.4 12.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.659 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.902 179.235 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 12.0 m-20 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.1 0.476 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.433 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -67.41 -46.64 48.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.984 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.3 Cg_endo -82.82 1.98 8.78 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.438 2.092 . . . . 0.0 114.106 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.489 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 56.9 m-85 -124.27 -66.76 0.96 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -55.27 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -62.36 -49.33 75.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.676 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.51 -38.2 77.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.9 t80 -58.83 -46.48 87.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.401 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -62.57 -31.6 72.44 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.656 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 12.8 mt -60.31 -38.1 82.62 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -96.04 34.47 1.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.4 95.27 9.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.07 -36.43 77.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.566 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -86.91 -41.28 14.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.369 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.22 10.51 55.92 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.165 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -103.96 -12.91 16.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.075 0.437 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.45 28.85 3.61 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.54 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.512 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -130.56 155.59 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.371 0.268 . . . . 0.0 110.367 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.4 pt -145.24 132.5 10.19 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 27' ' ' SER . 94.6 Cg_endo -84.43 171.4 9.97 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.975 2.45 . . . . 0.0 111.985 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.498 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.17 -37.83 7.52 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.3 p -61.94 -41.89 98.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.372 0.13 . . . . 0.0 111.152 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.402 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 9.8 m -70.41 -46.35 64.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.403 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.03 -34.87 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.482 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.01 -70.63 0.9 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.54 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -27.86 69.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.349 0.119 . . . . 0.0 111.291 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -61.54 -50.91 70.77 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.645 0.26 . . . . 0.0 110.366 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.58 -31.53 71.59 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.119 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.45 -39.64 70.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.01 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.84 75.5 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.533 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -77.45 -44.03 30.39 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.662 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.43 -76.98 0.02 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 168.5 17.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.879 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -122.45 117.12 29.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.447 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.31 -162.25 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.893 2.396 . . . . 0.0 112.464 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -94.26 164.28 13.1 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.107 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.71 -30.95 64.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.44 86.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.723 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -55.53 16.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.498 ' HB ' ' CB ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -56.18 -45.11 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.906 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.2 m -61.27 -40.15 93.05 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.57 -38.68 78.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.3 mt -61.9 -51.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.6 -23.78 43.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.72 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -9.58 15.21 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -118.24 -46.42 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.647 0.203 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.24 158.39 43.82 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.8 Cg_exo -42.49 150.21 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.14 2.56 . . . . 0.0 113.214 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.14 -64.92 0.33 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.099 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.512 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.39 119.83 24.66 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.8 89.47 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.212 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.45 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 4.2 p30 -84.48 -179.89 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.49 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 mtt -41.92 -46.59 4.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.827 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -67.11 -51.03 59.21 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.56 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.17 -51.12 70.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -50.89 69.72 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.724 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.12 -26.15 68.14 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.473 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -65.57 -51.47 59.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.67 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.61 -41.58 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.828 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.08 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.873 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.296 0.109 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -65.41 -53.04 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.465 0.174 . . . . 0.0 110.843 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -60.82 -29.49 69.51 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA2' ' CG1' ' A' ' 102' ' ' VAL . . . -69.79 -53.38 15.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.063 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -77.89 -36.81 49.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.93 74.05 2.16 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.201 0.524 . . . . 0.0 111.243 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 102' ' ' VAL . 61.0 t -143.88 -55.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.232 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -144.14 49.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.317 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.63 74.82 1.61 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.709 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -47.34 78.22 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.73 -71.3 0.51 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.69 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.34 -170.14 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.218 0.324 . . . . 0.0 111.657 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 m 72.11 -69.93 0.17 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.666 0.386 . . . . 0.0 111.542 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.72 6.45 83.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.562 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 143.86 5.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.274 0.537 . . . . 0.0 111.025 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -124.32 141.12 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.27 81.22 0.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.058 -0.591 . . . . 0.0 111.639 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.507 HG11 ' HD3' ' A' ' 100' ' ' ARG . 93.9 t -43.32 -41.18 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.06 -46.65 33.22 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.038 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.59 -41.12 21.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.101 0.161 . . . . 0.0 110.958 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.477 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.01 -47.18 78.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.704 0.288 . . . . 0.0 110.702 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.507 ' HD3' HG11 ' A' ' 96' ' ' VAL . 3.0 mpt_? -72.57 -37.08 68.32 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.33 -38.68 63.46 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.538 0.209 . . . . 0.0 111.123 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 85' ' ' VAL . 2.6 t -75.13 -49.12 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.1 mt -63.54 -34.99 79.02 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.36 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.9 m -62.24 -32.45 73.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.567 0.223 . . . . 0.0 111.163 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 m -69.54 -17.0 63.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 3.7 mt -63.97 -71.81 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 110.977 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.4 51.3 0.43 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.974 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 61.14 49.1 5.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.013 0.435 . . . . 0.0 110.732 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -68.32 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.21 79.82 0.52 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.5 p -61.7 -175.39 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.011 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -50.22 -32.57 16.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.408 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.89 -51.84 67.57 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.48 -53.36 59.04 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.939 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.403 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -66.3 -26.8 67.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.402 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.86 -48.59 80.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.676 0.274 . . . . 0.0 110.339 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.88 -40.62 87.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -62.42 -41.6 98.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.694 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.409 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.1 mt -68.54 -33.26 73.8 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.983 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -63.32 -41.0 98.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.66 -45.06 18.74 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.844 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.8 t -79.24 125.22 83.74 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.693 0.247 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 5.2 Cg_exo -73.76 62.79 4.76 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.909 2.406 . . . . 0.0 112.32 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.35 175.15 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.242 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -124.19 47.62 2.05 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.084 0.469 . . . . 0.0 110.855 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.8 p-10 173.03 -34.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.7 48.49 0.73 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -103.87 117.66 34.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.37 31.16 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.989 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 59.24 23.12 11.45 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 46.33 44.5 12.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.926 0.394 . . . . 0.0 111.297 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.84 -52.69 2.43 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.35 -37.24 80.06 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.181 0.301 . . . . 0.0 111.757 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -66.39 -56.46 10.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.83 -31.28 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.462 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.42 -55.14 37.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 CA--C 1.531 0.224 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.57 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.993 0.425 . . . . 0.0 110.895 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.448 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -66.75 -46.55 56.2 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.412 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 6' ' ' SER . 11.5 Cg_exo -71.36 -17.95 30.3 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.898 2.398 . . . . 0.0 113.85 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -114.46 -63.41 1.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.405 ' H ' ' HB3' ' A' ' 5' ' ' ASP . 8.0 tptt -65.88 -61.11 2.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.369 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -59.85 -45.69 91.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.401 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.536 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.57 -40.51 87.57 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.489 ' CE2' HG12 ' A' ' 23' ' ' ILE . 10.6 t80 -54.69 -45.64 73.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.297 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -36.38 81.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.14 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 6.0 mt -62.14 -33.23 74.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.382 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -93.29 34.12 1.17 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.51 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.51 96.23 8.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -42.4 99.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.048 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -87.39 -37.26 17.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.42 33.11 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.712 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.1 p -117.38 -11.42 10.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.17 2.94 9.92 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.353 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 2.6 mtt-85 -117.08 163.14 16.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 117.241 0.52 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.489 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.2 pt -144.98 131.21 9.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.668 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.61 169.74 10.62 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.066 2.511 . . . . 0.0 112.412 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.43 -37.9 5.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -60.78 -44.07 97.25 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.538 0.209 . . . . 0.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -67.99 -51.07 51.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.496 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -53.17 -37.33 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -70.58 0.9 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.668 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -26.14 68.54 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -64.71 -48.31 75.13 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -29.62 70.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.232 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.99 -41.52 68.02 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.704 179.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -64.75 -28.02 69.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.711 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.88 39.38 1.87 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.809 0.338 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.2 -102.3 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.748 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.05 -176.43 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -118.68 114.75 35.69 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.823 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.78 -162.54 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.796 2.331 . . . . 0.0 112.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 p -102.97 162.16 13.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -55.06 -32.9 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.13 79.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.696 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.37 -54.43 20.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.496 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.21 -47.78 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.895 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.2 m -59.21 -38.86 80.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.69 -38.07 80.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.516 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.2 mt -65.36 -50.16 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.99 -24.23 51.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.048 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 p -64.65 -7.34 10.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 p -117.75 -43.6 2.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.652 0.206 . . . . 0.0 111.269 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.37 158.92 36.2 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 99.0 Cg_exo -42.82 151.71 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.151 2.568 . . . . 0.0 113.12 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.64 -64.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.61 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.1 mt-10 -87.5 124.4 33.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.516 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 59' ' ' GLN . 48.3 t -86.61 88.92 2.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -82.21 177.2 8.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -41.38 -45.47 3.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.662 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -66.9 -51.38 56.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.043 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.537 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.71 -51.44 68.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -49.83 74.02 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.498 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.63 -47.98 79.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.115 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.47 -39.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.164 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.669 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.407 0.146 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.72 -48.4 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.826 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -31.05 70.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.449 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -69.17 -55.79 9.91 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.344 0.116 . . . . 0.0 110.7 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -79.01 69.15 5.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.052 0.453 . . . . 0.0 110.683 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.14 -45.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.04 19.69 7.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.45 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.7 80.49 1.73 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -55.48 33.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.75 -35.51 9.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 87' ' ' ASP . . . 62.18 65.77 0.86 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -69.12 -38.0 78.63 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.73 64.78 0.06 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.031 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.63 129.82 0.43 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.507 0.194 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -103.76 -45.88 9.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.356 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 94' ' ' ILE . . . 57.1 80.26 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.469 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 118' ' ' LEU . 77.8 t -44.08 -36.62 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.38 -39.89 14.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.764 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -80.92 -45.01 17.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.444 0.164 . . . . 0.0 110.809 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.16 -40.54 90.26 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.957 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.49 -41.27 66.15 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.612 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -52.33 -39.52 60.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.693 0.282 . . . . 0.0 111.034 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.449 HG12 ' HA2' ' A' ' 82' ' ' GLY . 30.6 t -73.21 -49.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 2.9 mt -64.48 -44.3 91.45 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.007 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 54.7 p -57.85 -40.86 81.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.507 0.194 . . . . 0.0 111.229 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.0 t -78.33 -12.21 59.99 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -61.34 1.91 Allowed 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 111.281 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 57.81 0.12 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.368 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.35 39.61 18.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 111.022 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 49.3 mmtt -68.68 -137.93 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.036 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.442 HD21 ' HG2' ' A' ' 114' ' ' GLU . 19.7 mt -68.49 79.63 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.667 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -65.1 -170.21 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.069 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.408 ' HA ' ' HE1' ' A' ' 115' ' ' MET . 78.3 m-20 -53.44 -36.87 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.07 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.02 -51.23 70.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HG2' HD21 ' A' ' 110' ' ' LEU . 5.3 tp10 -57.34 -53.65 55.71 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.85 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.408 ' HE1' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -67.44 -25.85 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.419 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -47.85 83.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.97 -43.16 75.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.795 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.523 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.27 -42.68 95.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.428 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.3 mt -72.17 -30.71 65.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -61.16 -41.21 96.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.804 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.19 20.46 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.917 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.75 117.97 69.96 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.739 0.269 . . . . 0.0 111.019 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.85 63.95 6.74 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.628 2.219 . . . . 0.0 112.461 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.16 -176.43 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.77 132.49 56.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.323 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 67.04 14.77 9.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.366 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.401 ' HA3' ' HB ' ' A' ' 96' ' ' VAL . . . 63.3 49.89 67.02 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.075 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 ttp -103.47 120.21 40.4 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.515 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.1 t -142.31 24.02 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.663 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 60.84 24.9 14.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.495 0.188 . . . . 0.0 111.405 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.1 t80 46.14 42.21 9.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.775 0.322 . . . . 0.0 111.377 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -115.49 -51.37 2.69 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -57.39 -38.24 73.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.79 -56.68 7.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.766 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.0 t -62.65 -34.66 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.308 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -64.26 -53.9 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ttp . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.063 179.6 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 8.8 m-20 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.916 0.388 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.436 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 4.0 t -67.03 -48.35 50.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.294 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 83.9 Cg_endo -83.46 -3.42 10.75 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.525 2.15 . . . . 0.0 114.294 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 77.6 m-85 -118.26 -66.69 1.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 4.9 ttmm -72.72 -57.8 3.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.424 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -49.19 77.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.688 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.49 -40.31 90.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.54 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.5 t80 -56.5 -42.97 79.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.479 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.85 -36.11 82.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.045 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 9.6 mt -60.71 -33.14 72.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.302 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 32.58 2.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.444 ' HA ' HG21 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -93.19 91.55 7.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -63.38 -33.15 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.459 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -86.52 -35.58 19.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.133 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.29 32.32 52.24 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.774 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -118.73 -19.02 8.82 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.66 -8.04 5.54 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.086 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.623 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -121.57 162.86 19.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.065 0.432 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.54 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.8 pt -135.79 134.92 20.99 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.755 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.87 169.42 9.08 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.08 2.52 . . . . 0.0 112.612 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . 16.0 pttm -43.85 -38.52 3.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.9 p -60.13 -44.31 95.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.498 0.189 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 49.3 m -70.43 -46.74 63.32 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.875 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -54.79 -35.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.04 3.13 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.286 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 121.961 0.105 . . . . 0.0 111.108 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.32 -46.01 88.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.49 -31.61 70.64 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -51.42 -38.67 54.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -53.36 -44.55 68.64 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.65 -47.05 82.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.681 0.277 . . . . 0.0 110.774 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.85 -66.11 0.03 OUTLIER Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.094 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.99 173.36 11.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.862 0.363 . . . . 0.0 111.282 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -125.81 133.83 25.29 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.591 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -81.5 -163.17 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.849 2.366 . . . . 0.0 112.764 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 p -103.08 164.46 11.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -52.07 -37.71 54.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.46 86.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -53.93 29.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.541 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.03 -46.56 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -56.9 -39.97 75.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -40.85 83.99 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.89 -52.08 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -56.74 -25.02 53.84 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.699 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -10.42 22.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 p -118.1 -50.37 2.47 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.59 0.177 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.3 156.85 56.79 Favored Pre-proline 0 N--CA 1.464 0.263 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 78.2 Cg_exo -39.78 145.01 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.216 2.611 . . . . 0.0 113.199 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.18 -61.27 0.16 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.658 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -89.79 125.31 35.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.671 179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.0 t -87.19 90.14 3.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.623 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.5 p30 -86.59 -179.73 6.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.601 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.16 -46.5 3.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.817 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -67.77 -52.16 40.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.058 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.512 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.82 -50.75 72.23 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -48.91 79.68 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.912 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.59 -34.36 75.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.338 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -60.06 -48.05 83.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.308 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -42.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.386 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.407 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 120.384 0.135 . . . . 0.0 110.984 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 79' ' ' PHE . 53.2 t -63.14 -49.03 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.139 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -26.51 68.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.82 -53.67 14.78 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.27 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.92 -47.18 47.94 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.31 71.4 5.85 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.29 -45.76 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.462 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -144.74 58.07 1.3 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 111.036 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -116.42 66.89 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.543 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.27 -36.18 79.34 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.84 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.79 -70.13 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.36 154.73 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.997 0.427 . . . . 0.0 112.018 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.5 m 59.8 80.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.261 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.84 -0.25 11.97 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.437 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -163.97 138.97 6.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 117.184 0.492 . . . . 0.0 110.629 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.36 -39.86 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.442 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.44 81.41 0.15 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.323 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.605 HG12 HD22 ' A' ' 118' ' ' LEU . 79.5 t -43.73 -36.49 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.97 -38.65 17.54 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.602 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.45 -46.47 22.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.24 0.216 . . . . 0.0 110.968 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -60.81 -42.16 97.08 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.464 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -36.39 69.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.093 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -59.31 -37.53 77.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.595 0.236 . . . . 0.0 111.078 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.6 t -77.56 -42.07 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.302 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.5 mt -72.42 -33.39 67.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 p -59.47 -35.02 73.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.6 p -70.45 -18.04 63.0 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.14 -62.32 1.49 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.756 0.313 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.84 49.51 0.18 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.169 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.49 49.85 3.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 110.624 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 8.8 mmtp -68.55 -137.89 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.2 mt -69.96 77.5 0.48 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.888 0.375 . . . . 0.0 110.549 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.5 p -74.93 -165.66 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.873 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -51.4 -40.06 58.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.21 -52.93 61.8 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.52 0.2 . . . . 0.0 111.523 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.23 -51.35 69.71 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.455 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 1.2 ptt? -67.14 -26.88 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.442 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -48.12 82.15 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.58 -43.56 84.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.605 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.56 -40.99 93.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.413 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 mt -71.27 -30.13 65.92 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.155 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.41 -40.44 97.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.575 0.226 . . . . 0.0 110.72 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.27 -46.44 26.89 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.847 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.9 t -86.15 121.68 72.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.805 0.302 . . . . 0.0 111.314 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 62.98 7.29 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.689 2.26 . . . . 0.0 112.546 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.4 m -131.42 -177.35 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.222 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -119.21 126.22 51.01 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.45 -2.96 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.087 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.77 49.57 5.04 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.768 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.6 OUTLIER -103.99 113.64 27.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.233 0.54 . . . . 0.0 110.674 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.459 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 35.8 t -142.91 30.35 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.063 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.53 23.16 11.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.781 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.4 t80 47.62 48.18 17.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.9 0.381 . . . . 0.0 111.438 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -121.93 -54.69 1.92 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.309 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.04 -36.46 75.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -67.9 -54.95 14.85 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.9 t -62.08 -33.39 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -58.86 -53.07 62.56 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.719 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttp . . . . . 0 CA--C 1.532 0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.443 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.343 0.592 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -67.36 -47.47 48.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.096 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 97.5 Cg_endo -87.21 7.96 4.55 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.63 2.22 . . . . 0.0 114.37 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -129.2 -67.96 0.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.679 0.218 . . . . 0.0 111.584 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -58.43 3.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.974 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -60.6 -48.49 81.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.658 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -42.98 87.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CE2' HG12 ' A' ' 23' ' ' ILE . 30.5 t80 -54.83 -44.13 73.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.454 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -62.59 -35.22 78.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.525 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -63.0 -34.26 77.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 4.6 m-85 -93.93 34.31 1.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.633 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.26 117.13 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.861 0.363 . . . . 0.0 111.219 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -71.34 -50.08 36.01 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.609 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -103.44 -38.72 7.06 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.309 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.67 37.15 4.05 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.466 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -116.81 -8.64 11.34 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.77 7.96 14.65 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -130.56 164.1 25.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.173 0.486 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 6.4 pt -146.48 137.25 12.52 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.693 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -85.62 171.49 8.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.129 2.552 . . . . 0.0 112.4 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -44.26 -39.31 4.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 p -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.451 0.167 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.9 m -69.87 -46.46 65.47 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.697 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.15 -33.68 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.32 -73.0 0.45 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.838 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -64.75 -21.32 66.73 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -65.78 -49.4 68.47 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.4 mt -61.71 -26.88 68.32 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.225 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -36.79 70.05 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.795 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.797 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -109.21 31.06 6.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.57 -103.86 0.25 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.732 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.24 179.46 6.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -119.38 113.19 35.29 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.419 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.19 -162.76 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -98.53 163.93 12.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -56.4 -34.17 66.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.68 73.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.838 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.37 -58.66 4.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -53.62 -47.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 123.098 0.249 . . . . 0.0 111.134 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.6 m -61.84 -44.27 97.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.43 -41.3 80.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.522 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.9 mt -63.65 -48.04 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.936 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.36 -24.57 56.06 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.999 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 p -63.81 -10.27 19.24 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.2 p -117.72 -31.76 5.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.41 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -97.18 152.78 38.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.589 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 77.9 Cg_exo -38.71 146.53 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.348 2.699 . . . . 0.0 113.055 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.88 -54.91 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -97.53 129.57 44.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.718 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.15 86.08 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.044 0.45 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.3 p30 -83.08 -179.86 7.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.575 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.6 mtm -41.47 -47.55 3.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.847 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -51.68 55.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.995 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.589 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.6 mp0 -57.91 -51.62 68.86 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.099 0.25 . . . . 0.0 111.643 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -49.9 75.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.098 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.68 -35.28 77.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.539 0.209 . . . . 0.0 110.972 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.18 -53.98 52.12 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' CG2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.37 -31.08 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.065 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.034 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.429 0.156 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.97 -40.07 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.799 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -44.72 94.92 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.062 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 85' ' ' VAL . . . -62.13 -45.54 95.85 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.149 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.76 -25.69 65.74 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.14 74.5 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 82' ' ' GLY . 33.6 t -127.52 -60.76 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.194 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -105.49 48.99 0.82 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -115.72 64.63 0.69 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -67.58 -47.47 69.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.81 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.31 -50.19 2.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.33 68.66 0.82 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.44 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 m -128.04 62.99 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.747 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.26 46.98 1.77 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.0 ptm -173.09 144.5 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.766 0.283 . . . . 0.0 111.527 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.493 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.2 OUTLIER -118.82 -42.92 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.22 81.32 0.34 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.285 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.527 HG12 HD22 ' A' ' 118' ' ' LEU . 46.6 t -44.31 -40.99 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.19 -38.34 18.62 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.617 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -81.44 -41.94 21.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.489 0.185 . . . . 0.0 110.513 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.729 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -35.47 65.05 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.662 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.73 -34.33 69.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.72 -47.49 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 3.9 mt -70.66 -38.91 73.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.1 m -61.06 -31.15 70.8 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -70.18 -17.13 63.15 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.92 -66.02 0.8 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.51 0.195 . . . . 0.0 111.086 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.65 52.14 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.803 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 57.85 53.56 6.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 2.6 tptp -67.64 -137.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.079 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.94 77.39 0.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.994 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 96.0 p -67.15 -173.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.43 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -48.84 -42.47 36.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.039 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.18 -52.28 65.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.98 -51.59 69.03 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.427 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 3.4 ptm -66.88 -27.58 67.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.311 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -49.18 78.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.62 0.248 . . . . 0.0 110.454 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.26 -42.25 88.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.527 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.92 -41.93 99.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.412 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -67.18 -35.48 79.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.216 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -38.29 90.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.4 -39.1 36.72 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.046 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.48 133.12 42.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.854 0.327 . . . . 0.0 111.122 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.08 58.08 6.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.789 2.326 . . . . 0.0 112.826 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.2 m -131.66 176.36 9.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 19.23 11.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.788 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -168.21 25.92 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 56.83 45.97 90.76 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.961 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.3 ttt -103.5 115.64 30.89 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.197 0.522 . . . . 0.0 110.751 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 39.5 t -141.16 22.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.082 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 58.55 24.11 11.59 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.493 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER 56.18 -166.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t60 72.29 -58.89 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.109 0.164 . . . . 0.0 111.084 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -52.89 -39.99 63.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.537 0.208 . . . . 0.0 111.421 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 21.8 m-85 -67.96 -52.39 36.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.377 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.43 -31.65 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.64 -53.37 58.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.53 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 178.957 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.445 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 4.7 t -66.95 -45.63 53.56 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 6' ' ' SER . 2.8 Cg_exo -75.62 -13.39 20.18 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.774 2.316 . . . . 0.0 113.852 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -118.87 -61.68 1.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.58 -59.89 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.247 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.404 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 28.6 tp60 -60.54 -48.21 82.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.512 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.45 -38.16 73.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.355 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' A' ' 23' ' ' ILE . 14.7 t80 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -62.22 -30.69 71.27 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.733 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -62.83 -39.63 94.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -95.69 33.39 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 103.28 15.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -71.2 -35.23 71.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -86.51 -38.67 17.01 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.04 -8.3 63.01 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.252 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -86.76 -32.12 20.56 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.991 0.396 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.9 40.68 0.18 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.414 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.85 157.77 41.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.315 0.246 . . . . 0.0 110.732 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 HG12 ' CE2' ' A' ' 12' ' ' PHE . 4.1 pt -150.51 129.41 6.22 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.09 172.53 8.52 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.058 2.505 . . . . 0.0 112.148 179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.46 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.98 -37.96 4.39 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.8 p -60.91 -43.6 98.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.486 0.184 . . . . 0.0 111.067 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 38.6 m -70.07 -48.82 56.2 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.609 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.514 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.29 -33.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.47 -69.47 1.26 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.389 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -30.99 72.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.346 0.117 . . . . 0.0 111.275 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.32 -51.3 69.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.717 0.294 . . . . 0.0 110.325 179.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.68 -32.29 72.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.17 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -35.98 63.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.128 179.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.36 75.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.631 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.2 t -66.83 -44.33 81.4 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.683 0.277 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.99 -69.46 0.03 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.5 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 166.13 22.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.982 0.42 . . . . 0.0 111.509 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.95 121.92 23.1 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.432 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.94 -161.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.726 2.284 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -90.34 166.17 13.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.235 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -56.68 -29.3 62.2 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.223 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.69 93.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.711 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -53.53 51.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.994 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.96 -44.82 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -61.4 -39.98 92.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.194 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -57.79 -38.92 76.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 mt -63.73 -46.75 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.994 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.01 -27.2 61.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.464 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -5.54 6.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 p -118.6 -33.96 4.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.899 0.318 . . . . 0.0 111.436 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.478 HD13 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -105.03 161.5 22.56 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.487 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.543 ' HD2' ' HG2' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -46.11 162.05 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.131 2.554 . . . . 0.0 113.083 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.35 -67.62 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -83.23 119.75 24.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.614 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.89 96.12 4.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.101 0.476 . . . . 0.0 110.945 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -82.57 174.35 11.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.677 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.4 mtt -42.52 -43.6 3.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.672 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.48 -50.92 56.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.824 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.543 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 31.9 mt-30 -57.14 -51.27 69.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.84 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -49.25 77.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.762 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 mt -61.43 -31.44 71.38 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -63.64 -55.05 26.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.495 0.188 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.478 HG22 HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.69 -42.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.115 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 120.431 0.158 . . . . 0.0 111.059 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG21 ' CE2' ' A' ' 79' ' ' PHE . 59.3 t -64.68 -46.36 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.35 -40.03 95.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.779 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.67 -45.48 96.3 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.474 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -76.86 -27.48 55.09 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.68 -16.57 63.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -45.29 -56.12 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.3 19.32 4.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.597 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.17 68.72 1.32 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.262 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.27 -54.39 29.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.27 -63.62 1.32 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.27 82.92 0.06 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.784 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.99 -53.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.15 42.12 1.45 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.001 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -170.71 137.26 1.29 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.749 0.275 . . . . 0.0 111.346 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.523 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -112.21 -43.43 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.451 179.532 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.6 79.58 0.17 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.199 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 118' ' ' LEU . 91.1 t -45.07 -35.64 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.34 -43.88 20.25 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.741 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.01 -50.18 21.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.279 0.232 . . . . 0.0 110.802 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.13 -36.33 75.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.434 ' HD2' ' HG2' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.12 -50.46 68.18 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.603 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -53.05 -42.05 65.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.122 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.06 -52.16 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.282 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 4.6 mt -66.12 -40.73 90.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.7 m -58.05 -33.29 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.337 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.1 m -74.47 -17.84 60.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.42 -60.95 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.529 0.204 . . . . 0.0 111.119 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.55 52.73 0.22 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.93 48.69 8.55 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.99 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 5.3 mmtp -68.64 -138.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.1 mt -68.07 78.56 0.23 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.287 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.3 p -69.29 -171.11 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.013 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.52 -37.41 17.54 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.265 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -67.23 -55.01 15.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.548 0.213 . . . . 0.0 111.478 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -57.12 -49.11 76.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.434 ' HG2' ' HD2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -67.08 -27.88 67.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.095 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -47.03 85.96 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.33 -44.47 83.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.462 179.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.482 ' CD2' HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.39 -41.7 90.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.265 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 124' ' ' VAL . 2.2 mt -71.55 -29.83 65.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -41.24 97.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.527 0.203 . . . . 0.0 110.598 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.16 -44.35 44.61 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.089 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.64 131.65 54.32 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.764 0.282 . . . . 0.0 111.174 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.65 61.38 7.48 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.756 2.304 . . . . 0.0 112.666 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.496 HG22 HD22 ' A' ' 119' ' ' LEU . 12.7 m -131.8 177.37 7.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.449 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -126.94 47.3 2.35 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.181 0.515 . . . . 0.0 110.745 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 173.64 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.37 51.46 0.58 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.97 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.454 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.27 116.96 33.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 0.0 110.671 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.0 t -142.2 19.64 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.74 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.32 23.42 10.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.523 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 48.11 47.23 19.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 111.599 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 -51.61 2.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -60.09 -35.21 74.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.784 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 5.7 m-85 -66.04 -58.26 5.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.703 0.287 . . . . 0.0 110.35 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.75 -32.59 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.417 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -60.1 -50.53 73.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.491 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.015 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 7.5 m-20 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -66.99 -46.52 53.63 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.957 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 6' ' ' SER . 83.2 Cg_endo -82.97 -3.88 11.17 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.411 2.074 . . . . 0.0 114.045 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 46.4 m-85 -120.83 -62.51 1.44 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.7 -59.44 2.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.072 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -60.59 -47.24 87.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.486 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.19 -40.66 82.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.492 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.4 t80 -57.08 -44.37 83.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.604 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -62.06 -33.84 75.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.248 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.84 -30.99 70.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.369 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.32 20.37 4.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.425 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -101.73 120.31 40.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.188 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -55.74 31.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.498 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -101.94 -24.46 14.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.801 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . 93.82 44.33 3.65 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.451 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -89.46 -26.03 21.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.041 0.136 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.08 10.17 14.43 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.106 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 2.1 mtt180 -130.24 160.91 32.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.055 0.427 . . . . 0.0 110.551 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 5.7 pt -146.33 138.51 13.63 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -87.02 171.55 6.7 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.234 2.623 . . . . 0.0 112.482 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 10.5 ptpt -42.5 -40.97 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 p -59.9 -44.62 94.15 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 12.5 m -69.1 -48.0 63.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.586 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.506 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.04 -34.24 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.09 -68.72 1.51 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.281 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -30.62 71.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.98 -50.88 71.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 110.423 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.47 -30.19 70.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.039 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -57.02 -37.81 72.25 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.842 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.51 -29.12 70.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.8 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -88.28 -42.68 12.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.604 0.24 . . . . 0.0 110.55 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.9 -87.38 0.09 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.512 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -132.61 175.74 9.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 2.5 t-20 -119.37 112.36 35.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.122 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.68 -162.84 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.915 2.41 . . . . 0.0 112.856 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 p -95.59 166.52 11.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.82 -37.17 65.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.34 73.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.813 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -55.97 13.1 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.01 -48.57 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.584 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.6 m -56.98 -39.74 75.19 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.66 -41.94 87.28 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.357 179.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.503 HG21 HG13 ' A' ' 63' ' ' VAL . 19.5 mt -62.54 -49.4 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.74 -25.84 55.81 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.384 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -64.8 -8.21 14.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 p -117.83 -49.02 2.54 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.656 0.207 . . . . 0.0 110.968 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -86.61 158.2 54.41 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.796 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.3 Cg_exo -40.93 149.75 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.188 2.592 . . . . 0.0 113.072 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.05 -63.68 0.18 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -89.68 127.68 35.97 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.791 0.329 . . . . 0.0 110.66 179.716 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.82 89.59 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.284 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.07 179.65 7.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.7 mtp -41.41 -46.27 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.39 -52.37 40.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.504 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.96 -50.95 71.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.729 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -48.9 79.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.06 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.82 -39.37 88.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.448 0.166 . . . . 0.0 111.396 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -55.43 -49.2 73.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.483 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.503 HG13 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -76.4 -35.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 179.92 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.42 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 120.448 0.166 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.38 -47.84 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.875 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -31.12 70.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.597 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -61.81 -47.84 87.72 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.553 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -74.91 -32.78 61.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 0.127 . . . . 0.0 111.052 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.88 73.19 5.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.07 -65.19 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.13 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.493 ' HB2' ' CB ' ' A' ' 98' ' ' GLU . 1.4 m-85 -109.55 34.41 3.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.346 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 49.74 2.29 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -69.89 -54.81 11.72 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.206 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.88 -47.6 11.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.75 66.65 0.97 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -102.04 67.04 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.27 56.05 11.3 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.529 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -174.93 138.65 0.47 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.714 0.293 . . . . 0.0 111.192 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -107.23 -41.65 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.547 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.86 78.95 0.34 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.499 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.516 HG12 HD22 ' A' ' 118' ' ' LEU . 70.8 t -44.75 -35.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.53 -41.77 18.57 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.252 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.493 ' CB ' ' HB2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -80.16 -36.71 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.661 0.23 . . . . 0.0 111.549 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -67.25 -40.83 86.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.485 0.183 . . . . 0.0 110.957 179.886 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -38.64 66.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.975 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -56.37 -45.85 80.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.67 0.271 . . . . 0.0 110.924 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.439 HG12 ' HA2' ' A' ' 82' ' ' GLY . 47.6 t -65.77 -46.71 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.222 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -67.1 -37.55 84.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.371 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 85.3 m -67.19 -42.96 83.3 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.485 0.183 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.1 p -68.0 -16.06 63.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.29 -65.29 0.7 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.709 0.29 . . . . 0.0 110.927 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.5 49.08 0.28 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.121 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 61.16 41.5 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 -179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HG2' ' CD2' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -68.9 -137.92 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.987 178.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 42.1 mt -68.56 80.02 0.27 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.405 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 79.7 p -66.38 -170.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 115' ' ' MET . 4.6 p-10 -53.26 -33.7 54.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.226 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -48.9 79.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.542 0.21 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 17.9 mm-40 -59.14 -53.41 58.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -66.76 -26.44 66.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.258 179.365 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -47.11 86.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.239 179.125 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.0 -43.77 82.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.516 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.0 -42.18 89.47 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.695 179.432 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.407 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.2 mt -67.89 -33.48 74.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -39.78 91.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.0 -48.28 21.04 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.004 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.8 t -83.89 125.09 73.89 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.792 0.296 . . . . 0.0 111.286 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.56 63.23 7.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.694 2.262 . . . . 0.0 112.549 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.459 HG12 HG21 ' A' ' 129' ' ' VAL . 20.1 m -131.26 179.41 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -119.3 130.28 55.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 70.61 10.69 7.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.829 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 69.62 44.47 63.5 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.702 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.87 114.39 28.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.372 0.606 . . . . 0.0 110.601 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 124' ' ' VAL . 22.1 t -142.58 26.14 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.083 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.25 21.09 5.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.0 t80 48.97 38.29 12.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -116.88 -38.86 3.35 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.63 -37.44 84.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -67.94 -54.91 15.08 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.45 -31.7 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.95 -50.39 72.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 ttm . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.245 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.837 0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -64.72 -46.58 76.23 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.624 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.0 Cg_endo -82.17 -11.64 10.87 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.506 2.138 . . . . 0.0 114.072 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -114.5 -60.41 1.89 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.492 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.33 -48.49 81.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.596 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.48 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.14 -40.03 76.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.035 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.9 t80 -59.17 -44.51 92.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.315 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.4 m -62.5 -31.45 72.21 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.747 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 5.8 mt -65.91 -36.95 84.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -95.34 38.53 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.196 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -83.27 88.77 6.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.226 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -62.85 -37.71 87.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -86.54 -36.32 19.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.108 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.28 27.18 56.03 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.452 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.1 p -129.28 10.4 5.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.91 8.63 47.76 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.742 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -129.22 163.16 26.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.355 0.578 . . . . 0.0 110.958 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.484 HG12 ' CE2' ' A' ' 12' ' ' PHE . 6.3 pt -147.24 138.64 13.32 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.918 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.58 172.27 6.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.455 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.91 -37.63 6.57 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.8 p -60.14 -41.63 93.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.453 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 3.3 m -70.88 -54.73 10.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.372 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -50.04 -35.76 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.15 -74.44 0.29 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.535 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -28.56 69.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -61.45 -51.95 66.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 mt -60.92 -29.33 69.53 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.261 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.42 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -55.53 -39.9 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.052 0.22 . . . . 0.0 110.871 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.15 70.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.846 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -90.1 -43.06 10.73 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.681 0.277 . . . . 0.0 110.611 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.08 -88.19 0.1 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.505 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.95 172.79 12.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.962 0.41 . . . . 0.0 112.018 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.9 t-20 -122.06 110.23 33.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.21 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -84.19 -162.88 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.905 2.403 . . . . 0.0 112.53 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -92.96 166.52 12.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -54.71 -33.53 61.13 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.797 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.51 86.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.828 179.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -55.55 16.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -55.96 -45.39 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.103 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 m -62.16 -41.1 97.97 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.61 -38.27 77.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 63' ' ' VAL . 14.4 mt -64.9 -49.82 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.16 -25.33 46.15 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.882 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -64.21 -7.15 8.23 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.2 p -117.78 -46.59 2.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.775 0.261 . . . . 0.0 111.204 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.472 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -86.55 157.47 55.49 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.094 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -39.41 150.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.285 2.657 . . . . 0.0 113.39 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.6 -61.34 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.6 130.0 38.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.683 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.37 86.71 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.043 0.449 . . . . 0.0 111.061 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -82.95 -179.56 7.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.672 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 mtm -41.41 -46.79 3.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.944 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -68.66 -50.55 50.28 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.8 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.617 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.4 mp0 -58.0 -51.74 68.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -48.35 82.01 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.78 -36.46 79.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.285 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -52.61 64.67 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.187 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG13 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.6 -38.71 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.314 179.847 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 C--O 1.234 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.025 179.68 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 120.651 0.262 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.29 -39.13 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.706 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -39.05 93.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.513 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -62.81 -47.23 90.61 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.4 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -74.84 -36.79 62.38 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.964 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -78.86 72.3 5.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.036 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.62 -62.74 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -113.3 23.62 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.498 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.27 73.85 1.56 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.008 0.432 . . . . 0.0 110.863 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -69.34 -43.37 73.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -89.07 -63.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.58 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.421 0.45 . . . . 0.0 111.292 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m 69.28 -74.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.772 0.429 . . . . 0.0 111.349 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.03 61.3 0.42 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 ptp -176.23 131.3 0.23 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -103.84 145.57 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.61 82.79 0.31 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.58 HG12 HD22 ' A' ' 118' ' ' LEU . 59.3 t -37.48 -39.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.6 -42.74 27.88 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.623 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 99' ' ' LEU . 2.0 pt-20 -81.24 -37.79 27.98 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.932 -0.157 . . . . 0.0 111.128 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.468 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.55 -39.9 89.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.549 0.214 . . . . 0.0 110.549 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -38.84 59.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.687 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.57 -36.2 71.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.623 0.249 . . . . 0.0 111.324 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 82' ' ' GLY . 26.3 t -82.7 -38.9 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.908 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mt -79.71 -48.98 12.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.4 m -53.57 -38.57 64.04 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.9 p -60.5 -25.56 66.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.95 -83.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -133.13 46.14 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.715 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 62.46 50.85 3.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.377 . . . . 0.0 111.157 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -67.92 -137.83 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.282 179.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.3 mt -68.32 76.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.4 p -68.29 -172.72 0.34 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.65 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -51.28 -42.95 61.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -64.34 -48.48 75.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.52 -53.31 59.64 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.622 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -66.78 -27.67 67.78 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.302 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -46.07 87.19 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.628 0.252 . . . . 0.0 110.474 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.18 -41.83 76.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.635 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.58 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.09 -43.19 99.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.971 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 3.2 mt -70.13 -32.9 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.274 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -39.94 95.77 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.015 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.11 -48.74 30.6 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.986 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 t -82.45 125.29 76.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.679 0.24 . . . . 0.0 111.142 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.17 58.54 6.99 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.661 2.241 . . . . 0.0 112.401 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 m -131.33 -178.67 2.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.138 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -119.18 135.86 54.47 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.499 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.49 14.66 9.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.811 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 64.26 55.65 22.44 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.794 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttp -103.54 113.03 26.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.255 0.55 . . . . 0.0 111.099 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 45.5 t -142.94 26.53 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.23 21.34 9.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.535 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 132' ' ' HIS . 0.5 OUTLIER 54.34 -166.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -178.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 131' ' ' TYR . 12.3 m170 71.34 -57.77 0.6 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.579 0.352 . . . . 0.0 111.24 -179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -52.56 -39.37 61.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.541 0.21 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 19.8 m-85 -68.26 -58.0 5.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.584 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.45 -32.21 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.29 -54.61 41.85 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.691 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 42.8 tpp . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.391 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 121.059 0.456 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -66.68 -46.65 56.97 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.767 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 6' ' ' SER . 8.0 Cg_exo -73.41 -21.29 19.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.808 2.339 . . . . 0.0 113.822 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -107.74 -63.52 1.3 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -62.08 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.697 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 5.8 tt0 -56.67 -48.58 77.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.949 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.67 -40.43 87.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.1 t80 -60.12 -44.84 94.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.758 0.313 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -62.43 -31.29 71.97 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.748 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 20.1 mt -56.99 -40.35 76.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 31' ' ' LEU . 8.5 m-30 -97.73 32.28 2.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -61.63 130.0 43.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.957 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -56.61 8.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.778 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -136.3 26.02 3.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.412 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.94 27.61 72.96 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.728 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.6 p -95.86 -26.65 15.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.454 0.169 . . . . 0.0 111.258 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.34 18.63 8.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.883 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.493 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 36.9 mtt180 -129.69 160.51 33.15 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.878 0.339 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.563 HG12 ' CE2' ' A' ' 12' ' ' PHE . 4.1 pt -143.78 137.67 14.53 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.511 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.73 170.62 7.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.148 2.565 . . . . 0.0 113.027 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.437 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 18.7 pttp -43.78 -35.37 1.86 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -61.36 -46.11 91.57 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.464 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.2 t -70.41 -49.47 48.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.621 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -51.17 -34.94 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.496 -179.678 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.77 -67.7 2.06 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.331 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.22 -28.12 69.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 15' ' ' PHE . 10.4 tp -62.05 -48.6 79.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.9 -32.14 72.5 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.59 -40.29 71.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.816 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.48 70.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.472 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 m -107.14 40.03 1.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 110.498 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.31 -102.94 0.4 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.545 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 171.23 14.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 111.692 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -119.48 114.88 34.29 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.384 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.02 -162.08 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.896 2.397 . . . . 0.0 112.477 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.9 p -94.74 166.95 11.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.7 mm? -56.5 -34.49 67.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.41 75.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.644 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.26 -55.16 17.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.08 -49.3 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.828 179.635 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.0 m -55.65 -42.12 74.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.416 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -59.2 -42.86 91.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 mt -61.64 -41.98 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -56.63 -36.07 69.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -65.85 -1.77 3.23 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.6 m -118.07 -40.32 2.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.228 0.211 . . . . 0.0 110.937 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -102.89 156.41 35.34 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.332 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.6 Cg_exo -40.45 143.65 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.085 2.523 . . . . 0.0 113.083 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -22.85 -67.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.2 tt0 -91.66 129.35 37.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.609 0.242 . . . . 0.0 110.518 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -86.75 88.44 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.015 0.436 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.7 p30 -87.01 -179.85 6.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.306 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mtm -41.27 -46.98 3.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -53.41 41.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.529 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.18 -52.98 63.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -49.26 78.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.677 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.14 -27.92 69.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.387 0.136 . . . . 0.0 111.264 178.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -65.38 -43.19 91.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.965 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.466 HG22 HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.12 -38.91 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.995 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.488 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.429 0.157 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.31 -49.77 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.009 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.64 -31.46 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.854 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -65.14 -51.64 48.49 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.643 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -76.59 -36.26 57.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.403 0.144 . . . . 0.0 110.934 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -78.68 73.44 5.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.969 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.43 -61.23 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.29 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.55 43.64 1.6 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.525 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 3.8 m-20 -130.79 75.63 1.67 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -51.67 67.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.05 -49.9 3.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.265 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 87' ' ' ASP . . . 58.13 53.97 6.24 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -74.79 -48.09 27.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.178 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.73 58.67 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.665 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 ptm -166.95 147.97 5.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.92 143.35 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.08 81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.052 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.529 ' HA ' ' CD2' ' A' ' 99' ' ' LEU . 72.6 t -43.3 -38.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.25 -48.2 54.06 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.744 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -77.03 -40.68 45.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.253 0.221 . . . . 0.0 110.657 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -59.25 -40.59 86.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.552 179.517 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -66.51 -49.35 66.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.518 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -52.13 -37.97 55.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.48 HG12 ' HA2' ' A' ' 82' ' ' GLY . 41.5 t -74.04 -49.26 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.804 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 4.8 mt -69.13 -28.3 66.33 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.0 m -64.3 -38.4 90.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.312 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.4 p -70.82 -12.98 61.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.1 -66.14 0.68 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.567 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.14 49.05 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.333 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.31 50.52 6.11 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 111.453 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 26.5 tptt -68.53 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.428 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 mt -71.21 76.96 0.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -62.43 -176.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.106 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -52.32 -35.98 52.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.99 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -51.02 63.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.424 0.154 . . . . 0.0 111.297 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.92 -50.01 75.64 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.906 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.427 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -66.6 -27.43 67.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.905 179.03 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -48.55 80.64 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.603 0.239 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.66 -42.05 87.23 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 179.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.479 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.1 -42.37 98.39 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.833 179.457 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.417 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -70.45 -33.07 70.88 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.03 179.616 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -39.99 92.17 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.45 -46.94 30.52 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.937 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.09 117.87 69.22 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.658 0.229 . . . . 0.0 111.036 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.7 64.66 5.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.463 2.109 . . . . 0.0 112.477 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.3 -178.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -118.92 135.65 54.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.638 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.64 17.62 11.0 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.623 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.458 ' HA3' ' HB ' ' A' ' 96' ' ' VAL . . . 61.49 64.05 4.33 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.988 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttt -111.38 116.78 31.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.241 0.543 . . . . 0.0 111.058 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 129' ' ' VAL . 39.5 t -142.23 26.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.8 26.3 15.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.5 t80 46.69 45.45 14.53 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.768 0.318 . . . . 0.0 111.616 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -119.56 -56.03 2.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.352 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -34.34 73.94 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 4.5 m-85 -67.69 -55.4 13.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.271 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.9 -33.95 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.55 -51.85 68.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.668 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 ttp . . . . . 0 CA--C 1.531 0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.326 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -64.3 -47.87 77.2 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.081 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.41 -13.93 12.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.403 2.069 . . . . 0.0 114.114 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -106.65 -65.87 1.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -73.12 -58.87 3.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.501 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 2.4 tt0 -56.8 -49.9 73.98 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.472 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.55 -41.46 85.62 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 23' ' ' ILE . 16.4 t80 -53.57 -45.21 69.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.39 -36.69 83.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.141 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.8 mt -62.86 -27.41 69.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.392 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 3.5 m-85 -94.23 18.93 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.86 99.26 11.66 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -61.1 -35.34 76.76 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.741 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.24 -29.13 23.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.27 42.86 41.03 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -117.87 -36.28 3.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.24 -11.12 2.78 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.587 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -118.1 147.73 43.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.272 0.536 . . . . 0.0 110.626 -179.831 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 12' ' ' PHE . 4.2 pt -127.55 140.88 39.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.848 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.28 173.25 3.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.257 2.638 . . . . 0.0 112.432 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.76 -36.69 2.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 p -59.6 -46.06 90.06 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.492 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 2.5 t -71.33 -49.64 40.52 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.56 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -51.41 -36.18 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.17 -73.1 0.44 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.67 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -65.12 -21.35 66.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.3 tp -65.93 -48.38 71.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -61.18 -30.55 70.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.841 179.124 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.47 -40.73 72.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.679 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.87 75.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.49 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.8 m -112.63 43.55 1.63 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 110.669 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.83 -105.39 0.4 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.808 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.37 169.98 15.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.417 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -119.11 112.48 36.17 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.157 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.74 -162.62 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.036 2.49 . . . . 0.0 112.737 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 p -97.68 165.33 12.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.449 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.4 mm? -54.88 -36.62 65.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.21 78.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.539 0.209 . . . . 0.0 110.453 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -51.48 58.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.56 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.1 -46.18 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.82 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -54.88 -41.52 70.96 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.144 0.278 . . . . 0.0 110.633 178.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -60.2 -41.98 94.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.63 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.405 HG21 HG12 ' A' ' 63' ' ' VAL . 21.1 mt -61.67 -49.53 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -57.46 -26.4 61.17 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.859 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -63.78 -10.08 18.02 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 p -117.91 -35.56 3.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.722 0.237 . . . . 0.0 111.526 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -94.25 151.18 39.33 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.461 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 59.7 Cg_exo -36.97 141.89 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.337 2.691 . . . . 0.0 113.089 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -24.76 -61.31 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -93.63 129.52 39.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.51 86.94 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.03 -179.08 6.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.609 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.5 mtp -41.43 -47.16 3.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.988 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.05 -53.0 35.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.958 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.567 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.8 mp0 -57.49 -51.97 67.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.604 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -45.91 91.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.9 mt -60.73 -39.24 87.87 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -52.14 65.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.802 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 HG12 HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -73.65 -29.12 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.24 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--O 1.227 -0.112 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.942 179.498 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 120.476 0.179 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.96 -45.61 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.4 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.96 94.34 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.507 ' HA2' ' CG1' ' A' ' 102' ' ' VAL . . . -64.11 -46.08 92.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.759 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -75.61 -36.09 60.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.381 0.134 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.81 72.5 5.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.1 t -140.62 -57.4 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.429 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.38 33.11 4.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.75 65.8 1.39 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -31.85 73.18 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.334 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -82.12 -62.04 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.377 179.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 72.96 -64.15 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.497 0.498 . . . . 0.0 111.799 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.1 p -66.67 95.19 0.33 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.8 -26.87 4.46 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.182 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.3 ptp -157.73 138.8 13.37 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.841 0.321 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -115.32 -40.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.027 -179.608 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 58.69 80.22 0.09 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.547 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.451 ' HA ' HD21 ' A' ' 99' ' ' LEU . 61.1 t -44.6 -34.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.93 -46.95 25.99 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.989 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.3 -47.66 26.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.555 0.217 . . . . 0.0 110.991 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -58.48 -38.38 77.48 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.249 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -67.06 -46.96 72.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -53.42 -40.9 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.868 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.507 ' CG1' ' HA2' ' A' ' 82' ' ' GLY . 4.0 t -77.21 -54.35 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 4.8 mt -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.6 m -60.5 -38.88 85.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.554 0.216 . . . . 0.0 111.036 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.4 m -71.18 -15.19 62.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.69 -59.5 2.76 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -158.36 43.56 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.463 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.87 52.37 10.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 111.29 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.41 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.05 179.134 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.44 77.63 0.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.986 0.357 . . . . 0.0 110.334 179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 p -65.79 -172.34 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.411 -178.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -50.75 -39.49 52.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.079 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.37 -49.76 70.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.492 0.187 . . . . 0.0 111.354 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.59 -52.84 63.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.605 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.467 ' HA ' HD21 ' A' ' 118' ' ' LEU . 2.9 ppp? -67.29 -26.24 66.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.405 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -49.31 77.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.352 179.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.79 -43.17 84.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.21 -40.17 92.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 179.684 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.69 -33.2 70.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.44 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.78 -38.46 91.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.749 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.87 -44.97 9.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.728 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.42 130.46 68.43 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.516 0.198 . . . . 0.0 111.175 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.02 62.85 8.09 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.36 176.69 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.229 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 46.78 2.27 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.899 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.94 -35.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.702 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.11 46.09 0.83 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.97 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.46 119.19 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.179 0.514 . . . . 0.0 111.179 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.5 32.01 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.804 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.718 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.453 ' HA ' ' HD2' ' A' ' 134' ' ' PHE . 2.7 t80 44.66 46.8 8.58 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.809 0.337 . . . . 0.0 111.532 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 -55.07 1.97 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.5 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.09 -33.01 71.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.699 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 131' ' ' TYR . 6.5 m-85 -68.15 -56.31 9.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.43 -33.17 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.507 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.29 -51.25 69.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.299 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 32.5 ttp . . . . . 0 CA--C 1.533 0.317 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.603 -179.955 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 19.5 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.511 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -67.41 -48.94 44.55 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.611 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 72.9 Cg_endo -78.44 -12.63 15.38 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.509 2.139 . . . . 0.0 113.995 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 3.2 m-85 -108.97 -64.86 1.19 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -59.0 2.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.554 -179.233 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.1 -49.27 78.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.06 -40.86 82.05 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.807 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.0 t80 -53.51 -45.74 69.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.466 179.156 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 m -62.37 -36.48 82.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.9 mt -60.57 -31.65 70.77 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.393 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 54.6 m-85 -93.77 26.45 3.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.589 0.233 . . . . 0.0 111.591 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -119.11 79.03 1.35 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.222 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -15.98 63.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.37 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -86.0 -24.68 26.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.45 67.02 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.664 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.6 p -105.65 -32.75 8.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.14 0.176 . . . . 0.0 111.397 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.63 23.8 5.53 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.944 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.534 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 2.3 mpt_? -130.56 159.63 36.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.741 0.27 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG12 ' CE2' ' A' ' 12' ' ' PHE . 3.7 pt -144.46 131.04 10.06 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.92 172.31 8.85 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.121 2.547 . . . . 0.0 112.137 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HB2' HG13 ' A' ' 44' ' ' ILE . 6.2 pttt -44.39 -37.65 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 p -62.43 -45.77 91.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.342 0.115 . . . . 0.0 111.225 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 6.3 m -66.91 -46.59 74.37 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.474 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.563 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.98 -35.62 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.052 179.502 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.65 -70.11 1.07 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.518 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -25.58 66.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.67 0.235 . . . . 0.0 111.455 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.406 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -61.31 -48.68 80.24 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.59 -35.55 78.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -32.2 68.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.329 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.89 -46.82 64.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -65.44 -33.64 76.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.257 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.97 -67.88 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.284 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.49 160.21 35.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.706 0.289 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -131.98 153.63 81.44 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.252 179.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.84 -162.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.989 2.459 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -98.59 168.15 10.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.222 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.414 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.6 mm? -55.66 -32.4 63.18 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.58 94.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.192 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -53.61 53.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.388 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.81 -47.67 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.562 179.473 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.6 m -57.98 -40.54 80.93 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -57.35 -39.41 75.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.217 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.9 mt -63.78 -46.73 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -56.69 -25.63 54.63 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.34 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -64.16 -6.93 7.49 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.6 p -118.25 -45.45 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.781 0.264 . . . . 0.0 110.76 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.66 143.48 26.68 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -36.94 150.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.704 2.936 . . . . 0.0 113.534 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.89 -74.48 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -72.73 117.77 14.84 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.728 -179.093 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.98 93.11 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.2 p30 -81.93 177.92 8.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.685 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -41.79 -47.93 4.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.818 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -67.17 -48.24 68.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.645 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.99 -51.62 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.344 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -49.23 76.15 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.3 mt -61.12 -33.91 74.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -61.26 -52.68 63.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.37 -37.9 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.247 179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.129 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.503 0.192 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.6 t -61.72 -44.44 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.048 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.28 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.263 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.1 -47.03 92.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.273 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 15.0 m-85 -68.3 -29.46 68.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.84 1.95 21.64 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -51.08 -38.93 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.542 0.21 . . . . 0.0 111.498 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.67 21.6 1.99 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.46 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 54.09 1.97 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.152 0.501 . . . . 0.0 110.58 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -63.46 -54.19 40.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.28 -62.37 1.64 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.39 71.32 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.436 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -81.14 -41.55 22.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.62 49.1 0.42 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.649 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.5 ptm -176.47 136.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -105.81 -43.45 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.295 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.71 79.58 0.35 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.522 179.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.554 HG12 HD22 ' A' ' 118' ' ' LEU . 90.7 t -44.88 -37.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -45.36 -45.06 11.08 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 121.437 -0.411 . . . . 0.0 113.391 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 7.2 pt-20 -80.07 -39.22 30.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.843 0.322 . . . . 0.0 111.508 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -62.59 -40.29 96.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.612 0.244 . . . . 0.0 110.819 179.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 1.3 ppt_? -75.54 -35.75 60.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.06 -37.6 74.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.602 0.239 . . . . 0.0 111.329 179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.8 t -77.44 -44.08 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 mt -68.28 -34.12 75.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.278 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.457 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 20.0 p -63.01 -31.91 73.15 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.464 0.173 . . . . 0.0 111.356 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 m -67.6 -18.34 64.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.8 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.09 -61.9 1.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.28 52.68 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.427 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.75 51.94 4.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -68.18 -138.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.547 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.497 HD21 ' HG2' ' A' ' 114' ' ' GLU . 12.4 mt -71.21 76.23 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.457 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 62.2 p -66.39 -174.44 0.28 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.194 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.73 -34.67 27.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.313 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -52.19 58.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.534 0.207 . . . . 0.0 111.246 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.497 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.3 tp10 -56.62 -52.37 65.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.696 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.42 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -66.85 -26.62 67.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.446 179.495 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -46.36 87.45 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.076 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -66.94 -44.79 79.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.385 179.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.554 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.72 -39.77 89.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 179.11 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.14 -33.92 75.37 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.367 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -61.91 -38.46 88.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.45 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.16 31.05 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.881 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.496 HG13 HG12 ' A' ' 124' ' ' VAL . 5.7 t -87.79 119.71 70.65 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.724 0.262 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.89 64.56 4.04 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.678 2.252 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.496 HG12 HG13 ' A' ' 122' ' ' VAL . 17.0 m -131.48 -177.76 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.124 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -119.02 126.67 52.25 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.521 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 74.78 0.47 3.56 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.03 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 80.33 49.92 5.65 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.268 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -103.36 116.38 32.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.491 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.1 t -142.35 26.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.999 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 61.77 23.65 13.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.795 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.423 ' CG ' HG13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER 49.71 45.44 24.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 111.467 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -120.05 -57.58 1.93 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.145 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -54.71 -36.08 64.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.72 -60.25 2.68 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.9 t -62.64 -32.48 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.417 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -58.14 -53.78 54.39 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.9 ttp . . . . . 0 CA--C 1.532 0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.213 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.3 p -93.21 25.15 3.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.601 0.239 . . . . 0.0 111.562 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.66 52.97 0.59 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.04 0.447 . . . . 0.0 110.591 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.42 114.08 10.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.871 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -65.88 -46.16 64.99 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.245 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 6.2 Cg_exo -78.33 -17.13 13.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.787 2.325 . . . . 0.0 113.632 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -110.9 -60.01 1.89 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -60.18 2.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.566 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.0 -48.07 82.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.61 -38.15 77.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.528 ' CE2' HG12 ' A' ' 23' ' ' ILE . 15.4 t80 -57.75 -45.62 85.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -62.56 -33.55 75.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.9 mt -61.04 -36.59 79.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.302 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -92.85 24.5 3.6 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.99 94.78 8.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.801 0.334 . . . . 0.0 110.416 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -33.11 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -86.19 -31.0 22.0 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.467 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.45 26.53 59.11 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -115.93 21.82 13.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.625 0.213 . . . . 0.0 111.26 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.18 19.81 77.61 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.321 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.407 ' CD ' ' HB3' ' A' ' 54' ' ' GLU . 6.7 mtt85 -130.4 151.4 50.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.096 0.448 . . . . 0.0 110.631 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 6.5 pt -140.97 142.42 27.72 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 27' ' ' SER . 88.7 Cg_endo -87.03 170.95 6.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.283 2.655 . . . . 0.0 112.487 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HB2' HG13 ' A' ' 44' ' ' ILE . 49.5 pttt -44.24 -39.16 4.25 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.8 p -60.41 -43.95 96.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.46 0.171 . . . . 0.0 111.396 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.5 m -70.34 -45.74 65.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.657 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.52 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.45 -33.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.178 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 -68.21 1.8 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.309 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -28.27 69.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.51 -48.11 83.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.52 -33.16 73.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -56.13 -38.98 71.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.087 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.0 70.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.678 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -116.88 46.33 1.68 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.781 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.1 -106.59 0.42 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.974 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.2 -179.46 5.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 111.919 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 28.9 t-20 -118.35 112.55 37.51 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.58 -162.97 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.953 2.435 . . . . 0.0 112.683 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -105.65 163.77 12.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.1 -35.96 62.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.6 82.6 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.815 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.98 -55.78 17.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.85 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.52 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.11 -46.56 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.901 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.7 m -57.53 -41.48 80.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -38.09 78.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.4 mt -62.92 -46.58 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -57.24 -28.43 62.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.353 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -13.39 45.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 p -118.13 -46.52 2.61 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' CD1' HG23 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.56 146.55 34.53 Favored Pre-proline 0 N--CA 1.463 0.225 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -36.44 139.01 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.496 2.798 . . . . 0.0 113.039 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.84 -63.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.707 0.63 . . . . 0.0 112.477 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.89 120.66 25.95 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.709 0.29 . . . . 0.0 110.369 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.08 87.18 2.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.4 p30 -84.96 178.35 7.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.589 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -41.14 -44.5 2.55 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.78 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.1 -53.61 29.2 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.76 -52.57 64.48 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.186 0.304 . . . . 0.0 111.703 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.44 81.63 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.35 -33.26 73.33 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -51.95 67.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.55 0.214 . . . . 0.0 110.996 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.508 HG23 ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.59 -39.24 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -53.16 58.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.108 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -83.67 61.19 6.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.427 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 1.8 ttt180 -56.81 -49.47 93.62 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.781 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 94.5 Cg_endo -83.8 19.44 1.35 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.525 2.15 . . . . 0.0 113.58 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 61.2 99.73 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.598 0.359 . . . . 0.0 111.893 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.45 -179.13 24.53 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.273 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.77 175.46 5.63 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.648 0.261 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' HA ' ' HG2' ' A' ' 78' ' ' GLU . 4.3 t70 56.29 62.4 2.35 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 110.657 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.547 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 21.9 ttt -179.89 -50.81 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 81.7 Cg_exo -45.75 -40.19 19.01 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.675 2.25 . . . . 0.0 113.159 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.14 54.24 0.31 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.428 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.03 145.15 56.18 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-O 120.503 0.192 . . . . 0.0 110.949 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.1 -39.45 79.59 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.686 2.257 . . . . 0.0 112.375 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.04 -26.4 61.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.523 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -66.77 -49.07 67.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.568 0.223 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.74 81.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.322 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.09 -43.93 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.342 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -40.14 94.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.669 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.21 88.93 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.696 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.76 -30.15 66.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.454 0.168 . . . . 0.0 111.454 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.05 -14.96 62.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.1 t -47.86 -56.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.403 0.144 . . . . 0.0 111.305 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -113.49 39.84 2.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.027 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.51 62.24 1.46 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -63.74 -50.56 68.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.747 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.34 -54.76 2.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.85 81.17 0.15 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.958 0.409 . . . . 0.0 111.539 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -103.18 64.23 0.83 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.554 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.67 37.9 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.939 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 ptp -174.66 137.29 0.46 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.784 0.292 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -107.1 -39.96 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.427 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 79.24 0.61 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.479 ' CG2' ' HA3' ' A' ' 127' ' ' GLY . 54.6 t -45.22 -36.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.98 -42.73 16.1 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.288 -0.482 . . . . 0.0 113.305 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.94 -43.31 35.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.61 0.205 . . . . 0.0 111.135 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.06 -39.02 80.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.143 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.425 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 10.6 ptp180 -74.54 -37.09 63.12 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.854 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.71 -36.64 72.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.7 t -82.87 -52.56 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.715 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 6.0 mt -62.5 -50.1 72.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.5 m -60.73 -38.26 84.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.497 0.189 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.8 t -73.26 -19.05 61.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.73 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.72 -55.83 10.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.618 0.246 . . . . 0.0 111.028 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.19 45.81 0.29 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.371 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.99 48.02 13.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.49 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.768 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.4 mt -68.16 79.84 0.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 110.691 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.4 p -64.06 -175.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.126 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -47.7 -34.5 8.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.504 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.21 -60.02 4.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -41.11 95.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.199 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 100' ' ' ARG . 5.5 mmt -66.79 -34.82 78.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.513 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -46.07 86.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.437 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -64.81 -37.94 89.3 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -64.5 -44.14 91.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.729 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.442 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.9 mt -65.03 -34.93 79.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -39.76 94.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.902 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.17 -49.52 26.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.752 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 18.7 t -79.85 127.58 76.99 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.612 0.206 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 4.6 Cg_exo -74.11 63.19 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.962 2.441 . . . . 0.0 112.33 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.36 175.9 10.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -121.4 19.1 11.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.739 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.37 26.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.479 ' HA3' ' CG2' ' A' ' 96' ' ' VAL . . . 54.97 50.99 56.74 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.666 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.7 112.8 25.91 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.275 0.559 . . . . 0.0 110.752 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.469 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 43.2 t -142.35 20.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 59.74 21.88 10.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.843 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 48.38 41.52 16.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.764 0.316 . . . . 0.0 111.326 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -114.2 -54.46 2.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.401 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.14 -36.33 70.58 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.8 m-85 -68.05 -59.0 3.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.617 0.246 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.7 t -62.56 -33.05 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.463 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -61.63 -56.85 15.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.056 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.8 ttp -66.88 -31.21 71.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.484 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.5 mt -66.79 -41.6 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.476 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.94 -3.66 58.67 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -111.58 90.32 3.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.827 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.062 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.419 0.152 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t -116.52 30.68 7.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.37 50.89 0.57 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.86 112.6 2.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.321 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.16 -46.14 95.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.536 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 89.4 Cg_endo -80.73 -16.0 10.53 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.503 2.135 . . . . 0.0 113.96 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -110.68 -60.83 1.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -61.43 1.8 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.341 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 6.0 tt0 -58.38 -46.85 85.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.839 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.552 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.56 -37.51 81.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.074 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.493 ' CE2' HG12 ' A' ' 23' ' ' ILE . 20.5 t80 -56.29 -49.76 73.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -61.63 -33.76 74.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.333 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 8.4 mt -59.76 -33.92 72.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.43 0.157 . . . . 0.0 111.221 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 77.3 m-85 -93.28 32.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 121.63 30.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.759 0.314 . . . . 0.0 110.814 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -60.79 -52.22 66.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -107.11 -28.24 10.11 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.25 37.06 4.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.552 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.6 p -104.08 -20.76 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.17 3.61 8.06 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.444 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -122.59 162.46 21.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.253 0.527 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.493 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.1 pt -146.85 133.63 9.91 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.559 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.74 169.71 9.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.998 2.465 . . . . 0.0 112.345 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -43.89 -35.62 2.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.2 p -62.32 -45.04 95.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.493 0.187 . . . . 0.0 111.384 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.484 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 59.9 m -70.59 -44.82 66.53 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.823 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.497 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.83 -35.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.523 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.85 -66.92 2.43 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -29.87 71.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.511 0.155 . . . . 0.0 111.002 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 7.6 tp -61.11 -47.28 86.99 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.33 -32.72 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.049 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -40.48 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.027 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.18 -30.61 71.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.709 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.6 m -83.39 -44.36 14.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.591 0.234 . . . . 0.0 110.936 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.27 -81.55 0.04 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.707 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.2 -179.82 5.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.78 110.32 38.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.628 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.0 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.854 2.369 . . . . 0.0 112.361 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -104.53 166.59 10.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -54.93 -35.55 64.3 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.88 76.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.761 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -56.43 9.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.15 -48.39 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.945 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.2 m -58.15 -41.29 83.45 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.04 -42.87 86.28 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.491 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mt -63.04 -48.26 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -57.19 -25.12 58.49 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.844 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -63.86 -13.61 46.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -118.41 7.48 11.93 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.21 151.45 61.72 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 90.2 Cg_exo -38.3 143.76 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.275 2.65 . . . . 0.0 113.018 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.77 -58.62 0.13 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -92.27 125.43 36.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.592 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.79 83.51 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -81.72 177.29 8.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.562 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 60.9 mtm -40.68 -44.65 2.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.745 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.88 -51.57 46.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.918 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.604 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -58.09 -52.35 65.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -48.44 81.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 mt -61.54 -38.23 86.69 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.173 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.52 -54.39 41.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -35.33 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.938 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -33.87 71.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.571 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 4.4 m120 -96.27 42.96 1.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.66 0.267 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.636 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 1.3 ttt180 -61.74 -62.76 5.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 48.6 Cg_endo -89.76 17.4 1.56 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.383 2.056 . . . . 0.0 114.688 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.473 ' HB3' ' CB ' ' A' ' 72' ' ' MET . 12.2 t-20 158.29 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.633 0.373 . . . . 0.0 110.853 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 65' ' ' ASN . . . 174.58 -70.85 0.09 OUTLIER Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.325 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -110.29 -59.44 1.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.2 82.07 3.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.167 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.473 ' CB ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 173.23 -52.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.784 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 26.9 Cg_exo -61.62 91.33 0.11 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.807 2.338 . . . . 0.0 112.123 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.92 25.12 74.37 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.184 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 172.36 10.08 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.996 0.398 . . . . 0.0 111.302 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.84 -42.16 68.77 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.78 2.32 . . . . 0.0 112.362 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -67.47 -27.08 66.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.504 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.47 -50.67 50.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 111.025 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -36.99 84.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.163 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.77 -40.01 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.943 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -48.49 80.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.86 95.91 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.66 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -70.2 -24.45 63.12 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.529 0.164 . . . . 0.0 111.407 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.17 -15.4 61.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.11 -59.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.187 0.195 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -110.33 44.02 1.3 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.981 0.42 . . . . 0.0 110.558 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.35 51.86 1.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -51.15 69.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -115.68 -59.31 2.01 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.08 90.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.561 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -105.69 56.71 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 110.79 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.51 49.42 1.84 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.927 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.15 135.87 0.48 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.68 0.276 . . . . 0.0 111.127 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.577 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -109.01 -42.75 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.336 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.12 81.58 0.33 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.949 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.458 HG12 HD22 ' A' ' 118' ' ' LEU . 86.6 t -43.55 -36.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.79 -37.98 15.44 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.594 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.537 ' HG3' ' CB ' ' A' ' 86' ' ' PHE . 2.6 tm-20 -73.2 -51.32 18.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.239 0.215 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.422 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.46 -37.18 74.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 115' ' ' MET . 4.9 tmm_? -65.57 -47.89 74.24 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -53.96 -38.09 64.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.323 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.73 -49.03 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.299 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 3.3 mt -65.02 -38.29 90.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.993 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 23.0 p -64.75 -35.44 81.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.523 0.202 . . . . 0.0 110.878 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -66.93 -19.75 65.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.651 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt -69.46 -61.19 1.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.584 0.23 . . . . 0.0 110.534 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.8 51.63 0.18 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.329 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 59.92 46.74 10.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.868 0.366 . . . . 0.0 110.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.74 -137.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.277 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD23 ' HG2' ' A' ' 114' ' ' GLU . 21.4 mt -69.16 79.24 0.35 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 92.6 p -64.36 -172.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.252 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -51.65 -31.17 24.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.265 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.81 -51.18 69.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' HG2' HD23 ' A' ' 110' ' ' LEU . 4.7 tp10 -58.76 -52.82 64.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.407 ' HG2' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ppp? -66.16 -26.15 67.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -48.51 80.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.16 -45.14 89.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.405 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.458 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -58.91 -41.26 86.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.408 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.209 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -36.76 84.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.91 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.68 49.78 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.05 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.3 128.45 55.19 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.803 0.302 . . . . 0.0 111.14 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.59 58.05 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.63 2.22 . . . . 0.0 112.595 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.39 -177.67 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.284 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 131.53 55.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.649 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.16 9.17 6.95 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.03 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.38 49.96 23.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.554 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.78 115.16 29.96 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.206 0.526 . . . . 0.0 110.725 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.51 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 37.4 t -142.45 25.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.841 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 58.58 22.57 9.92 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.932 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 54.05 -158.7 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 68.78 -60.63 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.406 0.282 . . . . 0.0 111.569 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.01 -38.76 62.61 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.9 m-85 -68.36 -54.58 16.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.714 0.292 . . . . 0.0 110.695 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.5 t -62.15 -32.96 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.511 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.44 -52.19 54.91 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.686 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.34 -34.23 76.9 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.212 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.4 HG23 HD13 ' A' ' 139' ' ' LEU . 4.0 mt -62.85 -45.55 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.4 HD13 HG23 ' A' ' 138' ' ' ILE . 2.3 mp -91.72 54.57 2.5 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.922 0.392 . . . . 0.0 110.727 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.38 111.19 0.4 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.789 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.212 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.53 0.205 . . . . 0.0 111.431 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t 46.21 45.04 12.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.677 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.63 -58.37 2.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.703 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -140.4 95.81 2.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.443 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.4 t -66.07 -46.92 63.46 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.6 Cg_endo -79.34 -14.04 13.35 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.516 2.144 . . . . 0.0 114.166 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.15 -61.59 1.7 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -72.29 -62.86 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -58.47 -47.73 83.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -45.26 87.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.936 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 23' ' ' ILE . 23.0 t80 -54.49 -45.99 73.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.74 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 m -59.27 -35.37 73.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.392 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 9.0 mt -60.53 -29.34 69.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.325 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -95.03 27.69 3.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.71 123.07 40.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 110.551 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -52.3 66.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.369 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -130.86 27.65 4.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.71 49.45 61.49 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.682 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -93.72 -29.01 15.62 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.1 -1.42 16.96 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.108 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.561 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -127.74 167.56 16.31 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.01 0.405 . . . . 0.0 110.607 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 9.5 pt -144.23 134.31 11.87 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.56 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 23' ' ' ILE . 4.4 Cg_endo -86.32 171.75 7.46 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.39 2.727 . . . . 0.0 111.852 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.1 pttt -44.24 -36.6 2.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -61.01 -45.89 92.97 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.54 0.209 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.508 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.1 m -70.49 -46.6 63.41 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.933 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.499 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -55.39 -33.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.413 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.71 -68.89 1.41 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.444 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -26.69 68.87 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 111.407 0.151 . . . . 0.0 111.407 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.07 -48.9 74.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.47 -30.61 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.62 -38.71 69.86 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.909 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.593 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.5 -42.31 25.52 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.748 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.3 -79.35 0.03 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.643 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.32 176.59 8.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.489 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -119.72 113.12 34.85 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.464 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.69 -162.63 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.755 2.304 . . . . 0.0 112.459 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -99.28 166.03 11.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.13 -33.64 63.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.887 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.2 79.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.34 -53.98 20.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.81 -46.88 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.003 0.189 . . . . 0.0 110.766 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 m -60.15 -39.74 87.45 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.34 -37.52 75.33 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.452 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.0 mt -67.01 -45.63 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.896 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -56.66 -27.12 57.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.524 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -64.61 -7.72 11.56 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 p -117.7 -52.73 2.44 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 117.893 0.315 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 154.88 54.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.527 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -38.36 142.74 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.082 2.522 . . . . 0.0 113.07 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.51 -64.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.3 0.64 . . . . 0.0 112.599 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.1 123.18 31.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.494 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.42 86.33 2.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.561 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.7 p30 -85.08 179.66 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.357 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -41.55 -47.59 3.82 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.532 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.58 -52.54 60.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.79 -53.91 52.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.7 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -49.83 73.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.72 -28.98 69.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -63.77 -49.76 71.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.606 0.241 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.36 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.49 -61.93 1.66 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.312 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -83.26 59.87 5.24 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.814 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.408 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.3 mtp180 -58.3 -49.13 95.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.467 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HG2' ' HB2' ' A' ' 72' ' ' MET . 66.2 Cg_endo -83.94 19.23 1.39 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.655 2.237 . . . . 0.0 113.885 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 55.29 88.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.901 0.382 . . . . 0.0 111.446 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 72' ' ' MET . . . 159.42 -166.79 34.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.674 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -115.54 -51.54 2.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.214 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -98.17 19.39 14.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.616 ' HB2' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -92.78 -48.83 0.29 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.455 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 72' ' ' MET . 81.8 Cg_exo -46.64 -36.59 19.17 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.799 2.333 . . . . 0.0 113.0 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.04 87.22 1.98 Allowed Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.765 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 78' ' ' GLU . 13.5 m-20 -80.93 145.43 57.2 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.465 0.174 . . . . 0.0 111.006 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.58 -49.5 13.27 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.788 2.325 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.05 -20.91 65.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 tt0 -68.88 -50.17 51.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.913 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.78 81.59 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.452 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.6 t -64.53 -53.76 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.552 0.215 . . . . 0.0 110.97 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -29.46 70.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.69 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -65.19 -49.04 63.77 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.555 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.09 -37.76 69.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.427 0.156 . . . . 0.0 110.969 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -78.91 73.16 5.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.9 t -135.1 -64.71 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.96 34.95 4.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.531 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -129.32 51.85 2.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.457 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 64.97 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.231 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -136.52 -72.88 0.44 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.69 45.82 27.21 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.626 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.37 44.6 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.11 33.7 3.92 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.624 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 ttt -171.73 134.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.152 0.476 . . . . 0.0 111.531 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.613 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -114.52 -42.1 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.28 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.66 80.49 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.22 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.465 ' HA ' ' CD2' ' A' ' 99' ' ' LEU . 81.7 t -44.41 -34.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -40.06 11.01 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.824 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.09 -50.71 13.94 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.457 0.17 . . . . 0.0 110.783 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.465 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.13 -35.34 73.3 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -55.96 12.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.101 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -52.45 -38.59 59.61 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.475 HG12 ' HA2' ' A' ' 82' ' ' GLY . 42.1 t -72.12 -58.0 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 2.8 mt -60.99 -36.41 79.39 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 m -61.68 -36.84 82.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.588 0.232 . . . . 0.0 111.093 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.6 t -65.02 -22.8 67.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.994 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 3.7 mt -64.88 -72.95 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.508 0.194 . . . . 0.0 111.232 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.85 50.98 0.46 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 64.23 47.24 3.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.175 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 14.4 tptt -68.57 -138.12 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.455 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.9 mm? -69.18 77.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.8 p -69.89 -175.27 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.59 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -51.02 -38.83 53.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.704 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.47 -48.89 63.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.576 0.227 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 5.2 mm-40 -59.01 -51.64 69.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -27.36 67.86 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -46.34 86.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -65.68 -44.34 86.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.369 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -59.99 -43.5 95.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.405 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.412 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -69.2 -32.97 72.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.35 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -61.68 -38.39 87.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.986 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 -46.62 43.66 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.953 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.92 127.12 63.51 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.706 0.253 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 59.61 6.19 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.72 2.28 . . . . 0.0 112.647 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.61 176.63 8.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.264 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -119.3 132.16 55.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.535 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t70 76.61 -1.92 2.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.887 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.26 51.02 5.89 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.461 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttp -104.2 113.17 26.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.54 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 40.5 t -142.35 19.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.03 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 59.37 22.14 10.53 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.613 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 53.65 -158.12 0.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.5 t60 69.62 -60.19 0.48 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.168 0.187 . . . . 0.0 111.206 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.67 -41.76 64.13 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.5 m-85 -65.44 -57.06 9.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.07 -28.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.507 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.61 -49.83 73.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.67 -33.81 76.76 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.683 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -67.36 -38.81 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.419 HD13 HG23 ' A' ' 138' ' ' ILE . 1.8 mp -90.96 64.34 5.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.41 44.41 2.93 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.311 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t -108.44 28.36 8.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.348 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.28 1.33 16.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.31 97.01 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.416 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -67.03 -47.37 52.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 6' ' ' SER . 75.4 Cg_endo -79.55 -13.17 13.53 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.534 2.156 . . . . 0.0 114.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.75 -63.16 1.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -72.85 -61.45 1.8 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.433 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.03 81.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.731 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.1 -44.27 87.58 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.478 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.5 t80 -52.05 -46.39 65.07 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.197 0.311 . . . . 0.0 110.471 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.6 t -60.5 -36.38 78.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.216 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.9 mt -59.78 -28.51 67.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.389 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 m-85 -89.02 19.99 3.86 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.24 92.36 4.48 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -61.66 -36.37 80.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -86.76 -37.01 18.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.117 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.34 45.32 5.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.439 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -109.25 -30.21 8.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.44 8.15 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.272 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -127.06 163.63 23.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.152 0.476 . . . . 0.0 110.655 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.478 HG12 ' CE2' ' A' ' 12' ' ' PHE . 3.7 pt -143.7 136.03 13.34 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.98 171.93 5.57 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.256 2.637 . . . . 0.0 112.287 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' HG13 ' A' ' 44' ' ' ILE . 14.3 pttm -43.83 -38.4 3.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -60.31 -44.89 95.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.496 0.189 . . . . 0.0 111.22 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.7 m -71.01 -47.41 58.93 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.492 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -55.19 -35.61 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.635 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.88 -68.08 1.79 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.456 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -28.09 69.26 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 5.7 tp -61.98 -46.46 89.15 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.63 -31.8 71.91 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -58.26 -41.83 85.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.16 68.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.488 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.25 42.59 2.67 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.16 -107.77 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.949 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.22 179.55 6.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.829 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 28.6 t-20 -118.57 106.38 44.47 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.78 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.55 -163.71 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.053 2.502 . . . . 0.0 112.576 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -104.95 164.31 11.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.868 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.15 -37.65 62.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.994 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.15 77.91 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.695 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.12 -55.14 17.91 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.492 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.3 -46.89 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.875 -0.148 . . . . 0.0 111.106 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -55.37 -43.84 75.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -37.76 76.14 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.755 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 44' ' ' ILE . 64.7 mt -61.09 -51.78 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -56.86 -27.45 60.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.753 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.76 -13.86 47.46 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 p -119.06 5.84 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.19 157.67 68.44 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 110.523 -0.176 . . . . 0.0 110.523 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.563 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 92.8 Cg_exo -42.05 146.39 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.141 2.561 . . . . 0.0 113.164 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.4 -63.02 0.09 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -95.1 131.15 41.42 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.477 0.18 . . . . 0.0 110.65 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.05 87.16 2.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.045 0.45 . . . . 0.0 110.924 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.97 -177.56 6.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.459 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mtt -41.21 -46.97 3.24 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -52.84 32.38 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.563 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.88 -49.77 75.6 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -48.64 79.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.833 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.87 -29.3 70.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.451 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -65.77 -48.08 73.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.994 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.19 -43.17 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.983 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -44.24 92.71 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.427 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -111.14 45.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -51.51 79.48 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.652 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.492 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 92.8 Cg_endo -83.07 19.9 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.636 2.224 . . . . 0.0 113.574 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.05 77.29 0.32 Allowed 'General case' 0 C--N 1.343 0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 111.163 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.4 172.64 26.81 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.772 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -104.68 -48.71 3.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.408 0.147 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.0 78.9 4.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.154 0.502 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.525 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 8.6 tpt 179.12 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.972 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 77.9 Cg_exo -40.15 -46.91 4.11 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.339 2.693 . . . . 0.0 113.626 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.8 42.76 0.95 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.759 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 50.7 p-10 -80.92 163.29 56.38 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 111.277 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 75' ' ' ASP . 50.5 Cg_exo -54.58 -35.85 87.4 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.977 2.451 . . . . 0.0 112.86 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -34.65 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.404 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -46.32 67.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -42.03 96.44 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.57 -50.25 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.013 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.03 67.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' HA2' ' CG1' ' A' ' 102' ' ' VAL . . . -71.59 -56.35 6.77 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.161 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -77.98 -39.82 41.24 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.13 73.54 4.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.186 0.517 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 p -118.09 -43.69 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.786 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 86' ' ' PHE . 9.4 t80 -154.46 25.78 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 110.393 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.67 51.41 0.75 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.928 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -28.84 64.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.382 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.24 -57.79 3.23 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.037 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.98 -174.21 0.11 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p 44.64 59.98 3.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.038 0.447 . . . . 0.0 111.314 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.24 -33.43 0.27 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.08 144.24 9.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.66 -41.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.249 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.9 77.9 0.25 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.559 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.44 ' HA ' ' CD2' ' A' ' 99' ' ' LEU . 90.0 t -45.28 -42.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.89 -37.26 9.24 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.856 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.449 ' HG3' ' HD2' ' A' ' 86' ' ' PHE . 4.6 mm-40 -80.59 -47.23 14.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.5 0.191 . . . . 0.0 110.544 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.44 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -41.93 84.34 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -34.83 65.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.803 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -55.57 -38.34 69.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.561 0.219 . . . . 0.0 110.939 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.47 ' CG1' ' HA2' ' A' ' 82' ' ' GLY . 2.5 t -78.55 -46.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.236 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.99 -46.21 78.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.9 m -55.88 -35.51 66.58 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.469 0.176 . . . . 0.0 111.43 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 t -71.81 -19.01 62.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.843 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.18 -68.22 0.41 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.444 0.164 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.89 55.85 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.566 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 58.69 45.54 15.72 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.333 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -68.9 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.222 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.47 78.4 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.8 p -64.87 -176.6 0.28 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -52.62 -32.58 42.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.787 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -53.79 52.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.75 -51.45 69.5 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.953 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.405 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.38 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -49.07 78.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.639 0.257 . . . . 0.0 110.471 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -42.12 86.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -61.99 -43.55 98.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.431 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -71.07 -31.91 68.44 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.262 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -61.74 -40.83 96.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.634 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 -46.23 19.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.922 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.35 119.15 72.02 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 116.787 0.294 . . . . 0.0 111.13 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.07 63.9 6.91 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.56 2.173 . . . . 0.0 112.588 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.3 m -130.77 -175.95 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.253 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -118.87 127.3 53.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 t70 72.53 6.86 5.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.852 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.85 53.67 7.92 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.915 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -104.03 116.97 33.19 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 40.3 t -142.39 30.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 36.6 t30 61.38 19.0 9.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.946 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 56.36 -176.67 0.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.8 -52.04 0.68 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.384 0.273 . . . . 0.0 111.667 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.89 -45.72 67.65 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -68.78 -49.87 55.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.99 -31.68 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.411 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -66.08 -51.07 61.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.5 ttt -62.24 -35.86 80.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.19 -35.49 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.052 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.1 mp -89.14 17.26 6.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -157.1 95.15 1.47 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 110.757 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.256 -179.535 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.809 0.338 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -134.69 48.54 2.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 t70 61.6 51.7 3.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.312 0.577 . . . . 0.0 110.143 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -55.54 114.31 1.79 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.524 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 5.0 t -65.22 -46.07 71.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.379 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.15 -15.21 11.69 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.514 2.143 . . . . 0.0 113.824 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -110.14 -60.43 1.8 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -72.6 -61.02 1.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.444 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -59.03 -47.52 84.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.496 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.25 -39.23 82.17 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.012 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.507 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.7 t80 -56.03 -44.66 78.97 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -62.33 -35.97 80.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.272 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.57 -33.94 73.43 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.428 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -91.04 20.06 5.22 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.44 89.82 3.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 120.839 0.352 . . . . 0.0 110.193 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -66.41 -29.16 69.25 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.878 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -85.97 -28.35 24.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.52 31.67 65.34 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.1 p -101.02 -30.0 11.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.282 0.233 . . . . 0.0 111.246 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.05 11.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.266 -0.493 . . . . 0.0 113.092 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -119.53 157.91 27.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.01 0.405 . . . . 0.0 110.742 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG12 ' CE2' ' A' ' 12' ' ' PHE . 4.3 pt -138.3 139.75 26.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.46 170.42 7.9 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.096 2.531 . . . . 0.0 112.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HB2' HG13 ' A' ' 44' ' ' ILE . 10.7 pttp -45.14 -39.12 5.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 p -60.03 -43.3 95.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.545 0.212 . . . . 0.0 111.197 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.9 t -68.55 -51.95 37.2 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.167 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.579 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -54.92 -36.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.519 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.83 -71.98 0.58 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.649 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -27.98 69.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.8 -50.58 70.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.607 0.241 . . . . 0.0 110.356 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -61.44 -29.53 70.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.267 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.52 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.34 -38.75 69.16 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.061 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.51 69.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.704 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 t -114.66 40.04 2.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.33 -107.15 0.36 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 174.81 9.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.909 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 3.8 t-20 -119.5 107.04 41.45 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.156 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.91 -162.76 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.89 2.394 . . . . 0.0 112.75 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -93.63 166.53 12.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.188 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.46 -34.73 67.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.81 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.18 79.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.585 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.84 -55.17 24.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.055 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.579 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.96 -47.16 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.689 179.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -58.55 -39.9 81.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.42 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -58.71 -40.82 84.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.372 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.1 mt -61.73 -50.21 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -56.98 -23.9 49.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.696 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -7.75 10.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 p -117.89 -45.44 2.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 117.627 0.194 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.97 159.01 43.69 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 72.0 Cg_exo -40.17 146.08 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 113.026 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -31.1 -60.37 0.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.205 0.602 . . . . 0.0 112.597 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -91.07 127.12 36.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.641 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.7 t -86.91 86.81 2.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.8 p30 -84.55 178.81 7.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.38 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtm -41.56 -47.94 3.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.689 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.95 -50.54 62.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.851 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.601 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -56.81 -51.07 70.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.586 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -48.28 80.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.9 mt -61.17 -34.28 74.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.425 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -60.96 -53.11 61.28 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -42.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.889 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -46.77 88.06 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.17 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -98.2 49.39 1.0 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.702 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.93 69.88 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 65.7 Cg_endo -85.51 19.53 1.38 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.824 2.349 . . . . 0.0 113.321 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.46 78.86 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.214 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.17 172.33 19.4 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.923 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.11 -42.98 5.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.483 0.182 . . . . 0.0 110.972 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.42 72.57 7.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.138 0.494 . . . . 0.0 110.139 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.609 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.7 -53.6 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.263 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 80.5 Cg_exo -43.67 -52.07 5.62 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.819 2.346 . . . . 0.0 113.041 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.72 58.75 0.02 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.729 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.59 140.5 51.58 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-O 120.476 0.179 . . . . 0.0 111.008 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.25 -45.3 32.04 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.36 -24.92 59.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.293 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -47.33 70.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.557 0.218 . . . . 0.0 110.983 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -35.33 63.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.556 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.77 -56.73 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.182 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -35.05 79.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -64.99 -47.12 86.16 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.637 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -77.56 -36.71 51.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.776 0.288 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -74.94 75.51 2.18 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.518 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 82' ' ' GLY . 45.1 t -127.31 -66.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.81 38.24 2.32 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 111.79 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.443 ' HB2' ' HB1' ' A' ' 90' ' ' ALA . 5.3 p30 -130.06 72.6 1.49 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.001 0.429 . . . . 0.0 110.782 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -31.16 68.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.655 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.18 -53.94 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 87' ' ' ASP . . . 60.58 69.06 0.71 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.271 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 -40.55 6.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.368 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -166.5 62.01 0.22 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.446 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 ptt? -175.68 140.24 0.45 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.268 0.227 . . . . 0.0 110.483 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.442 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.2 OUTLIER -106.12 -43.32 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.599 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.75 81.15 0.1 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.158 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.602 HG12 HD22 ' A' ' 118' ' ' LEU . 70.6 t -42.84 -33.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.81 -39.12 17.0 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.749 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.9 -44.59 31.23 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.609 0.205 . . . . 0.0 111.202 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -64.8 -37.44 87.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.531 0.205 . . . . 0.0 111.223 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -49.79 60.29 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.763 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -53.79 -42.39 68.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.296 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.76 -51.17 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.522 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 5.0 mt -64.63 -50.69 66.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.977 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -56.86 -31.37 64.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.6 t -66.95 -24.85 66.11 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.25 -67.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.79 55.84 0.29 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 45.13 7.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.952 0.406 . . . . 0.0 111.215 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 2.3 mmtm -68.61 -137.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.24 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.41 78.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.656 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.7 p -68.65 -171.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -52.54 -33.17 44.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.385 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.52 -51.81 63.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.52 0.2 . . . . 0.0 111.497 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.38 -51.56 68.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.416 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -66.77 -26.72 67.1 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -46.81 86.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.28 -43.97 84.89 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.602 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.7 -41.55 95.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.564 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.424 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -69.54 -30.82 68.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -62.99 -40.18 96.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.502 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -45.43 42.06 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.736 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.68 116.33 66.17 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.612 0.206 . . . . 0.0 111.007 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.56 64.59 4.67 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.591 2.194 . . . . 0.0 112.658 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 m -130.05 -175.44 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.084 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -118.62 124.59 47.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.443 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t70 76.55 -2.36 2.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.949 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 81.13 50.97 4.9 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.789 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 ttt -104.45 119.35 38.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 27.9 t -141.14 28.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.62 24.27 13.08 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.027 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.442 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.3 t80 46.11 48.16 12.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 111.556 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -122.91 -53.05 1.87 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.507 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -35.09 73.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.0 m-85 -68.15 -55.41 12.47 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.584 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.7 -34.09 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.021 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.54 -52.64 64.34 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.5 ttt -64.54 -33.77 76.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.197 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.98 -45.29 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.894 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mp -96.86 59.83 1.73 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.111 0.481 . . . . 0.0 110.754 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -154.75 54.8 0.67 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.975 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.0 -179.792 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.704 0.288 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m 60.04 63.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.23 -50.33 2.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.187 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 1.8 m-20 -76.06 102.02 5.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.052 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.434 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.6 t -67.32 -48.02 47.73 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.706 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 6' ' ' SER . 80.3 Cg_endo -78.54 -9.05 16.11 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.483 2.122 . . . . 0.0 114.237 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 84.7 m-85 -118.94 -59.65 1.84 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -72.2 -56.87 4.82 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.221 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.8 -48.03 80.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.448 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.531 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.54 -38.18 77.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CE2' HG12 ' A' ' 23' ' ' ILE . 26.5 t80 -59.14 -46.87 87.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.431 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -62.76 -30.44 71.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.692 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.531 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 18.2 mt -57.32 -38.35 73.92 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.13 31.55 2.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.81 91.69 4.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.582 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -25.63 63.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.654 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -86.38 -35.57 19.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.062 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.64 26.37 59.04 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.618 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -109.64 -19.83 13.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.1 19.94 6.96 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.992 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtp180 -130.2 150.09 51.61 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.978 0.389 . . . . 0.0 110.687 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.559 HG12 ' CE2' ' A' ' 12' ' ' PHE . 7.9 pt -136.88 138.07 24.99 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.749 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.76 171.8 6.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.177 2.585 . . . . 0.0 112.52 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.517 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -45.28 -36.85 4.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -60.83 -44.89 96.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.459 0.171 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.524 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 24.1 m -70.81 -45.61 64.29 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.06 -33.27 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.76 -68.12 1.86 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.453 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -29.47 70.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.406 0.146 . . . . 0.0 111.24 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 tp -62.01 -50.47 71.93 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.13 -28.38 69.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.04 -41.04 74.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.048 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.0 -26.51 68.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -121.74 39.4 3.87 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.699 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.66 -110.1 0.43 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.798 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.7 178.21 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.082 0.468 . . . . 0.0 111.938 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 20.4 t-20 -119.68 97.27 49.86 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.443 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.07 -162.55 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.822 2.348 . . . . 0.0 112.587 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 169.23 9.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.1 mm? -56.04 -33.85 65.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.6 78.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.671 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -54.2 41.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.249 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' CB ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -59.74 -47.8 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.865 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 m -54.42 -43.53 71.6 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -56.49 -38.93 72.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.57 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 HG21 HG12 ' A' ' 63' ' ' VAL . 33.2 mt -63.03 -49.77 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -56.39 -24.94 47.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.99 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -63.88 -8.23 10.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.4 p -118.03 -46.32 2.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.584 0.174 . . . . 0.0 111.014 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.44 156.03 41.81 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 87.6 Cg_exo -41.84 150.24 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.238 2.625 . . . . 0.0 113.088 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.65 -62.86 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.373 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -84.77 121.66 28.0 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.44 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.13 89.28 2.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -83.68 178.03 8.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.3 mtm -41.18 -46.73 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.834 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.32 -52.08 50.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.889 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.474 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.8 -51.26 69.65 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -48.77 80.14 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.013 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.35 -35.16 76.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.69 -54.99 39.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.415 HG12 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.04 -36.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.87 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -44.78 96.17 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.104 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.04 51.59 1.84 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.952 0.405 . . . . 0.0 110.745 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -60.83 -51.46 79.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 72' ' ' MET . 44.7 Cg_endo -88.06 37.65 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 112.83 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 39.98 49.34 2.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.846 0.458 . . . . 0.0 111.754 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 72' ' ' MET . . . -159.4 174.55 36.3 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.938 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -100.41 -50.71 3.84 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -99.99 19.13 16.82 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.586 ' HB2' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -94.8 -44.33 0.28 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 72' ' ' MET . 87.9 Cg_exo -47.79 -52.83 7.48 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.08 61.07 0.07 OUTLIER Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.869 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.89 161.67 62.63 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.75 -38.81 93.93 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.865 2.376 . . . . 0.0 112.366 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.45 -32.49 73.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.39 -45.49 79.86 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.861 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.834 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.9 t -64.52 -40.97 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.75 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -40.26 95.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.491 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -62.97 -48.07 83.59 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.07 -33.12 75.07 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.48 0.181 . . . . 0.0 110.865 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -62.26 -29.04 70.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.073 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.31 138.51 19.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.851 0.357 . . . . 0.0 110.393 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.35 22.79 3.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.728 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -136.71 62.12 1.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -70.79 -55.68 8.04 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.31 -60.08 1.6 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.046 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 67.81 -76.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.412 0.445 . . . . 0.0 111.764 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m 69.08 -77.6 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.755 0.422 . . . . 0.0 111.23 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.32 53.16 0.79 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.447 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.5 135.97 0.57 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.729 0.299 . . . . 0.0 110.786 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.83 -42.85 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.279 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 98' ' ' GLU . . . 66.25 81.84 0.14 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.481 HG12 HD22 ' A' ' 118' ' ' LEU . 78.8 t -43.38 -32.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.84 -36.09 32.72 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.103 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -79.84 -40.66 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.936 0.368 . . . . 0.0 111.181 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -65.44 -37.12 85.96 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.029 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.429 ' CB ' ' HE3' ' A' ' 115' ' ' MET . 0.0 OUTLIER -77.13 -37.21 54.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.218 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -60.1 -36.54 77.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.571 0.224 . . . . 0.0 110.911 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.491 HG12 ' HA2' ' A' ' 82' ' ' GLY . 21.4 t -82.65 -47.24 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.702 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.43 HD23 ' HG2' ' A' ' 109' ' ' LYS . 6.1 mt -70.35 -49.95 44.02 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.9 m -60.57 -34.25 73.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.441 0.163 . . . . 0.0 111.19 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -72.02 -20.29 61.72 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.548 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.57 0.224 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.7 53.2 0.28 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.405 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.71 45.37 10.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' HG2' HD23 ' A' ' 103' ' ' LEU . 4.2 tptt -68.63 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.117 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 54.7 mt -67.41 79.11 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.875 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -64.55 -168.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.99 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.53 ' HA ' ' HE1' ' A' ' 115' ' ' MET . 34.5 m120 -53.19 -31.05 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.381 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.4 -50.78 72.65 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.554 0.216 . . . . 0.0 111.297 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -56.26 -53.66 54.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.53 ' HE1' ' HA ' ' A' ' 112' ' ' ASN . 16.0 ptp -66.68 -25.1 66.39 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.368 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -47.72 83.15 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.732 0.301 . . . . 0.0 110.267 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -40.52 68.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.481 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -65.11 -43.77 90.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.178 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.415 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 8.7 mt -72.55 -26.91 61.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.362 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -66.54 -43.77 84.21 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.603 0.239 . . . . 0.0 110.728 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.1 -40.47 34.6 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.964 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.88 130.46 55.12 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.679 0.24 . . . . 0.0 111.192 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.21 61.96 6.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.733 2.289 . . . . 0.0 112.38 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.2 p -131.19 168.05 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.76 50.52 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.098 0.475 . . . . 0.0 111.314 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.82 -36.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 114.7 35.62 1.38 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.034 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.38 117.35 34.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.467 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 39.8 t -142.1 20.77 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 62.44 22.78 13.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.54 -167.43 0.11 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.21 -59.05 0.57 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.185 0.194 . . . . 0.0 111.165 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.95 -41.06 64.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 111.2 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.467 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 26.9 m-85 -68.28 -50.0 56.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.175 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.1 t -62.07 -27.56 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.352 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.83 -42.63 66.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.03 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mt -83.41 -56.39 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.365 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.19 -52.71 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.473 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 73.69 96.92 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.062 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.654 0.264 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m 61.84 46.03 7.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.97 62.58 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -42.03 107.06 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.629 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.1 t -55.94 -46.24 99.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.753 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 6' ' ' SER . 86.1 Cg_endo -83.28 -8.95 10.59 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.563 2.175 . . . . 0.0 114.531 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -119.96 -63.99 1.31 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -60.1 2.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.232 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.42 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.55 -47.45 85.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.01 -41.07 82.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.228 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.0 t80 -57.94 -46.48 84.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.357 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -29.64 70.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.872 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 19.5 mt -59.04 -31.6 69.0 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -92.14 22.57 4.31 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.42 95.96 6.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.197 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -47.51 81.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.8 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.85 -30.48 21.43 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.74 40.08 8.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.389 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 p -95.62 -29.13 14.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.112 0.165 . . . . 0.0 111.313 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.64 12.77 7.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.417 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.58 162.35 29.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.085 0.442 . . . . 0.0 110.91 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 3.1 pt -143.77 140.57 17.42 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.565 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.75 171.82 8.13 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.185 2.59 . . . . 0.0 112.302 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.6 -39.61 3.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.2 p -60.29 -45.94 91.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.141 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.615 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.2 m -66.79 -45.59 77.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.833 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.555 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.54 -35.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.396 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -66.89 2.45 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.654 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.29 -27.94 69.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.702 0.251 . . . . 0.0 111.142 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.08 -48.65 80.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.15 -35.88 78.28 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -40.61 68.36 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.67 74.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.466 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 m -98.26 42.92 1.08 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.733 0.302 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.3 -93.77 0.58 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.95 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.8 167.36 19.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.907 0.384 . . . . 0.0 111.633 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.08 141.73 42.2 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.2 Cg_endo -86.77 -162.33 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.15 2.567 . . . . 0.0 112.29 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 p -97.65 167.33 11.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.939 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.403 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.4 mm? -54.14 -37.46 64.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.6 84.58 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -64.93 -52.27 57.27 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.19 -45.36 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.596 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -59.41 -42.97 93.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -40.37 79.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.541 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.452 ' CG2' HD13 ' A' ' 51' ' ' LEU . 17.6 mt -63.3 -47.91 89.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.38 -24.35 54.82 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.759 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.9 t -64.14 -10.31 21.97 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 p -117.88 -33.32 4.52 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.385 -0.197 . . . . 0.0 111.466 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.452 HD13 ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -97.46 156.82 35.73 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 96.1 Cg_exo -41.87 148.11 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.12 2.547 . . . . 0.0 112.814 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -33.04 -52.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -97.76 126.75 43.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.784 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -87.26 89.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.455 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.6 p30 -84.58 178.56 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.394 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 40.5 mtm -41.09 -45.7 2.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.016 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.77 -52.55 42.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.969 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.588 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.25 -50.91 71.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -49.5 77.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.811 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.59 -32.61 72.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.484 0.183 . . . . 0.0 111.22 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -50.6 71.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.252 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -73.32 -44.8 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.2 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -47.7 83.67 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -101.25 52.3 0.84 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.045 0.45 . . . . 0.0 110.467 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 57.8 ttp180 -58.66 -52.02 77.71 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.091 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 81.0 Cg_endo -83.99 19.5 1.35 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.55 2.166 . . . . 0.0 113.111 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 56.87 79.24 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.635 0.374 . . . . 0.0 111.454 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.63 173.76 13.61 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.091 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -104.25 167.05 10.01 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.621 0.248 . . . . 0.0 111.002 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 57.05 66.54 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.061 0.458 . . . . 0.0 110.487 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.553 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.6 ttp 174.96 -50.82 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.892 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 88.1 Cg_exo -45.06 -47.34 12.32 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.776 2.318 . . . . 0.0 112.928 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.13 56.58 0.49 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -75.58 120.81 83.38 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-O 120.494 0.188 . . . . 0.0 110.897 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.06 -44.34 35.56 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.628 2.219 . . . . 0.0 112.39 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -33.15 74.61 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.366 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -65.67 -43.57 88.93 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -46.73 54.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -64.65 -65.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 tppt? -58.85 -23.76 61.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.053 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.88 -51.37 35.18 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.695 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -75.38 -42.92 52.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.545 0.212 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.46 ' HG3' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.32 5.3 12.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.7 -45.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -148.57 46.48 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 110.89 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -129.33 66.58 1.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -35.86 82.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.21 -64.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.725 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.67 -174.67 0.1 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.889 0.376 . . . . 0.0 111.773 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 56.96 29.51 16.46 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.727 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.32 36.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.241 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 167.93 132.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.805 0.442 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.408 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -103.43 -45.37 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.337 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.57 77.35 0.23 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.864 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.526 ' HA ' ' CD2' ' A' ' 99' ' ' LEU . 90.4 t -45.41 -33.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.16 -54.47 15.08 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.693 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -72.95 -39.24 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.549 0.175 . . . . 0.0 111.32 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.67 -38.97 89.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.2 -47.27 74.46 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -54.29 -36.55 63.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.154 0.284 . . . . 0.0 111.196 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.85 -47.52 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.232 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 7.3 mt -66.39 -34.43 77.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.416 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 17.6 p -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.415 0.15 . . . . 0.0 111.3 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 t -74.82 -16.77 60.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.827 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.25 -57.49 5.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.692 0.282 . . . . 0.0 110.941 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.42 55.73 0.07 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.221 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 60.0 43.74 14.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 36.3 mmtt -68.86 -138.56 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.23 77.03 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.416 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 77.4 p -72.66 -175.79 1.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.964 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -49.24 -37.51 23.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.416 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.28 -52.73 37.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.637 0.256 . . . . 0.0 111.323 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.07 -50.73 72.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -66.77 -27.73 67.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.286 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -47.66 83.36 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.5 -41.34 93.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.785 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.508 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.98 -41.89 97.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.724 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.427 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.091 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.1 -40.03 92.2 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.74 -46.69 29.47 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.014 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.6 t -86.17 121.49 72.67 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.803 0.301 . . . . 0.0 111.179 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.4 63.98 7.2 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.58 2.187 . . . . 0.0 112.568 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.3 m -131.02 -179.85 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.241 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.17 135.28 54.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 68.07 11.91 8.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.862 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.79 48.55 54.72 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.101 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.82 119.22 38.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.3 t -141.2 29.45 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.232 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.4 t30 56.1 21.87 5.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.408 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.8 t80 47.41 39.78 9.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -116.95 -39.84 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.6 -35.45 75.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -67.54 -54.73 17.55 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.232 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.39 -34.52 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.459 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -62.68 -52.48 63.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 33.4 tpp -63.09 -36.41 83.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.96 -32.24 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.274 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mt -92.56 -4.9 52.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -96.14 96.01 8.54 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.845 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.219 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.58 0.228 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.0 m -103.84 65.07 0.81 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.147 0.498 . . . . 0.0 110.176 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.92 34.21 17.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.49 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -158.36 80.74 0.82 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.321 0.582 . . . . 0.0 111.403 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.417 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -68.53 -45.53 35.73 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.69 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.2 Cg_endo -79.86 -20.56 8.93 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.466 2.111 . . . . 0.0 114.901 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 14.1 m-30 -105.76 -59.41 1.77 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.1 0.409 . . . . 0.0 111.806 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -73.03 -63.31 1.2 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.49 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -57.62 -49.18 77.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.222 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.66 -38.28 81.01 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.456 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' CE2' HG12 ' A' ' 23' ' ' ILE . 33.5 t80 -58.43 -44.15 89.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.694 0.283 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -61.88 -35.32 78.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -61.96 -39.03 90.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.91 22.99 7.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 130.79 41.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.579 0.228 . . . . 0.0 110.85 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -52.49 -58.0 8.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -133.97 24.41 3.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.398 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.61 30.75 78.11 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.934 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -95.15 -27.61 15.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.587 0.194 . . . . 0.0 111.295 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.69 10.9 6.78 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.292 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.53 160.41 34.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.272 0.536 . . . . 0.0 110.88 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.468 HG12 ' CE2' ' A' ' 12' ' ' PHE . 6.1 pt -147.34 135.68 11.0 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.873 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 90.7 Cg_endo -89.42 171.5 4.37 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.179 2.586 . . . . 0.0 112.541 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' HG13 ' A' ' 44' ' ' ILE . 5.3 pttm -43.05 -40.29 3.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 p -59.82 -42.71 94.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.472 0.177 . . . . 0.0 111.185 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 4.5 t -70.75 -52.82 18.29 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.453 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.57 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -51.03 -37.39 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.19 -69.1 1.34 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.474 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.55 69.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.27 -50.78 68.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.688 0.28 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -61.37 -30.43 70.53 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.023 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -35.44 67.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.95 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.86 70.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.665 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.91 -45.68 9.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.651 0.262 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.63 -87.86 0.15 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.43 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.25 175.81 9.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.987 0.422 . . . . 0.0 111.826 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.57 112.95 35.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.697 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -82.03 -162.98 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 113.024 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -95.17 165.37 12.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.89 -37.08 63.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.49 73.11 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.916 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.64 -53.91 16.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.291 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.57 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -59.91 -47.67 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.291 -0.164 . . . . 0.0 110.91 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.3 m -59.27 -38.53 80.36 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -41.78 90.61 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.367 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.5 mt -63.43 -49.12 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.979 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.37 -26.84 61.67 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.728 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.99 -12.7 40.34 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -118.33 2.47 11.9 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.433 HD12 HG22 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -136.65 154.73 76.79 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.517 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 70.8 Cg_exo -38.59 140.98 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.28 2.653 . . . . 0.0 112.966 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -26.13 -60.69 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.761 0.663 . . . . 0.0 112.755 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -91.44 125.93 36.36 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.411 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.9 t -86.27 86.35 2.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 121.161 0.505 . . . . 0.0 110.44 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.27 177.24 8.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.684 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.2 mtm -41.9 -45.37 3.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.543 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -51.17 56.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.853 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.517 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -56.41 -53.61 55.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.486 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -49.3 76.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.192 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.18 -33.29 73.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.49 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -61.33 -50.55 72.5 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.259 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 HG22 HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.64 -37.46 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.606 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 -33.5 63.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -112.99 39.48 2.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -59.91 -55.29 47.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 61.6 Cg_endo -87.6 20.0 1.26 Allowed 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.884 2.39 . . . . 0.0 113.232 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 m120 60.74 79.37 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.969 0.414 . . . . 0.0 111.052 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 158.4 -177.35 35.1 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.82 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -105.07 -52.55 2.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.497 0.189 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 72' ' ' MET . 7.3 m-20 -95.78 94.46 7.69 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.324 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.515 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 16.2 ttm 170.5 -49.48 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.929 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 81.4 Cg_exo -43.33 -48.6 8.1 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 123.126 2.55 . . . . 0.0 113.223 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.5 58.91 0.29 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.763 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.72 170.85 13.99 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 120.426 0.155 . . . . 0.0 111.097 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 73.7 Cg_exo -50.51 -47.39 24.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.924 2.416 . . . . 0.0 112.799 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.39 -26.0 60.8 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.334 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -47.5 69.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.457 0.17 . . . . 0.0 110.808 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -37.09 80.86 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.952 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.67 -45.78 97.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.855 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -33.93 76.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.266 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.23 -44.63 97.24 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.085 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -70.24 -34.06 72.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.479 0.181 . . . . 0.0 110.624 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.96 73.15 5.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.857 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.43 -64.2 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.854 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.78 28.44 6.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -139.91 70.0 1.36 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.133 0.492 . . . . 0.0 110.149 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -61.09 -44.58 97.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.894 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -49.2 10.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.43 55.52 7.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.492 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 m -82.81 -57.37 3.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.35 57.78 0.22 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.798 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.52 119.6 0.9 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.584 0.231 . . . . 0.0 110.991 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -103.92 139.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.909 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.14 82.73 0.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.883 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.504 HG12 HD22 ' A' ' 118' ' ' LEU . 55.0 t -41.74 -34.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.39 -50.05 58.05 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.917 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 99' ' ' LEU . 1.2 pt-20 -75.65 -34.95 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.356 0.122 . . . . 0.0 110.92 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.496 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -63.02 -41.42 99.55 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 110.493 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -67.42 -47.45 70.19 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -51.7 -46.99 64.08 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.174 0.296 . . . . 0.0 111.385 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.05 -49.49 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.363 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.414 ' CD2' ' HG3' ' A' ' 109' ' ' LYS . 3.8 mt -67.81 -28.15 67.33 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.1 m -65.33 -41.52 93.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.574 0.226 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -74.52 -7.86 54.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -50.74 20.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.644 0.259 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.67 53.73 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.558 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.42 41.72 15.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.414 ' HG3' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.81 -138.91 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.301 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.419 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 3.6 mt -68.74 78.85 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -64.52 -174.61 0.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.143 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 8.8 p30 -49.22 -35.36 17.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.573 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -57.49 -51.08 70.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 11.3 mm-40 -56.74 -52.46 64.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.869 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.415 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 9.1 ptm -67.0 -25.99 66.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -48.11 81.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.661 0.267 . . . . 0.0 110.43 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.77 -41.96 78.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.504 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.66 -41.72 99.22 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.148 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.85 -33.12 70.32 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.514 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -63.54 -41.38 98.46 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.952 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.24 -40.97 39.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.985 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 63.9 t -81.83 132.79 53.36 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.874 0.337 . . . . 0.0 111.193 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.9 58.68 7.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.802 2.334 . . . . 0.0 112.614 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.48 175.03 12.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -125.5 18.71 8.13 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.835 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -159.96 22.63 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 54.39 40.82 70.1 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.811 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.96 112.96 26.16 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.271 0.558 . . . . 0.0 111.353 -179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 32.3 t -142.84 25.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.292 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.48 26.6 16.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.434 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.5 t80 45.62 41.53 7.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.416 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -114.8 -53.56 2.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.406 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.13 -34.7 75.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.51 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -67.76 -56.62 8.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.371 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.92 -32.66 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.124 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -62.81 -48.37 79.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.83 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.16 -34.58 78.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -43.3 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.861 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.2 mp -93.75 63.53 3.36 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.86 62.53 0.68 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.531 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.967 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.751 0.31 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -114.38 -49.72 2.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.039 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.92 -58.39 0.51 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.724 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 22.0 m-20 -139.73 87.24 2.16 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.993 0.425 . . . . 0.0 110.345 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.423 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -62.41 -47.14 89.78 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.5 Cg_endo -83.75 1.64 8.76 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.574 2.183 . . . . 0.0 114.371 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 86.6 m-85 -126.9 -63.5 1.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.795 0.27 . . . . 0.0 111.609 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 2.1 mtpm? -72.44 -58.01 3.72 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.065 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -48.4 80.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.592 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.91 -38.25 78.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.289 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.526 ' CE2' HG12 ' A' ' 23' ' ' ILE . 13.8 t80 -59.16 -45.81 90.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.374 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 m -62.65 -32.62 73.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.643 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.2 mt -61.03 -33.67 73.64 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 66.5 m-85 -94.26 33.1 1.42 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.16 127.66 33.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.961 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -70.9 -56.72 5.64 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -112.2 -21.38 11.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.907 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.81 30.67 5.1 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.917 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -105.84 -29.02 10.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.622 0.211 . . . . 0.0 111.263 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.69 28.34 1.44 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.322 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.75 156.02 45.66 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.987 0.393 . . . . 0.0 110.183 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.526 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.6 pt -143.22 133.17 11.98 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.79 170.06 11.55 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.049 2.499 . . . . 0.0 112.309 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.512 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.68 -38.6 4.47 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 p -60.95 -43.91 98.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.512 0.196 . . . . 0.0 111.109 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 20.7 m -68.22 -46.47 70.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.565 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.53 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.35 -35.66 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.462 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.64 -69.22 1.33 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.584 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -26.03 68.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.529 0.164 . . . . 0.0 111.313 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 12.0 tp -61.62 -49.15 77.72 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -61.79 -32.27 72.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.056 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -39.18 69.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.8 71.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.699 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.61 -45.47 13.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.99 -80.34 0.03 OUTLIER Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.942 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.97 178.79 6.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.651 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -119.02 118.81 32.64 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.501 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 -162.43 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.397 . . . . 0.0 112.601 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 p -102.69 162.43 12.93 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.22 -33.94 63.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.98 80.74 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.933 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.68 -56.37 9.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.225 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -56.83 -47.24 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.327 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -61.17 -43.38 98.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.71 -40.01 78.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 44' ' ' ILE . 24.8 mt -61.63 -52.66 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -56.63 -23.41 40.99 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.826 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -63.74 -8.19 9.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.9 p -118.17 -46.74 2.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.599 0.181 . . . . 0.0 111.001 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -86.25 156.54 57.05 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.9 Cg_exo -39.32 145.43 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.359 2.706 . . . . 0.0 113.317 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.24 -64.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.471 0.708 . . . . 0.0 112.805 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -88.58 127.52 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.448 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -86.42 84.56 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.01 0.433 . . . . 0.0 110.512 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -81.71 179.24 7.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -41.1 -45.57 2.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -68.67 -52.05 35.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.611 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.2 mp0 -56.86 -51.83 67.5 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.563 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -48.85 79.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.624 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.7 mt -61.5 -31.69 71.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -61.46 -50.49 72.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.604 0.24 . . . . 0.0 111.01 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -40.62 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -58.55 6.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.95 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -83.19 63.14 7.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.4 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 11.8 mtm180 -53.23 -50.21 83.69 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.457 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.582 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 67.2 Cg_endo -85.12 18.69 1.53 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.66 2.24 . . . . 0.0 113.445 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 59.97 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.746 0.418 . . . . 0.0 112.08 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.97 -179.31 19.54 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.393 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.37 166.85 10.53 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.565 0.222 . . . . 0.0 110.975 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HA ' ' CG ' ' A' ' 75' ' ' ASP . 19.1 m-20 55.8 66.57 1.18 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.137 0.494 . . . . 0.0 110.425 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.585 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.8 tpt -177.63 -52.1 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.591 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 86.2 Cg_exo -45.92 -46.32 15.92 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.494 2.129 . . . . 0.0 112.824 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.98 51.32 0.07 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.49 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.431 ' CG ' ' HA ' ' A' ' 71' ' ' ASP . 1.2 m-20 -81.47 157.64 69.88 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.442 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -57.78 -41.83 65.81 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.862 2.375 . . . . 0.0 112.058 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.33 -35.32 79.98 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -40.19 96.74 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.922 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -45.1 89.06 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.525 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.4 -43.87 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.715 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -30.21 69.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.303 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.81 -50.54 63.04 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.026 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.75 -41.0 72.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.73 0.3 . . . . 0.0 110.219 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -79.81 70.54 6.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.028 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.9 t -124.94 -64.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.409 ' HB2' ' HG2' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -99.37 43.15 1.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.499 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 1.8 m-20 -137.96 71.2 1.39 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -51.38 68.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.13 -54.89 3.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.674 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 87' ' ' ASP . . . 51.47 56.27 8.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.656 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -110.3 69.4 0.69 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.95 49.3 1.63 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.99 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.98 144.84 0.62 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.788 0.327 . . . . 0.0 111.378 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.43 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.2 OUTLIER -114.88 -44.38 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.285 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.47 80.84 0.21 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.368 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG12 HD22 ' A' ' 118' ' ' LEU . 72.8 t -44.27 -36.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.99 -42.03 22.38 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.565 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 86' ' ' PHE . 1.4 tm-20 -71.98 -50.97 24.33 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.524 0.202 . . . . 0.0 110.518 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.91 -35.19 70.71 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.226 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -66.25 -48.95 68.86 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.678 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.61 -36.18 69.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.04 -46.79 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.786 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.78 -49.32 21.27 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -57.32 -36.04 70.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.4 t -69.42 -21.69 63.74 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.79 -62.61 1.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.529 0.204 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.76 52.54 0.26 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 59.92 45.23 12.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.966 0.412 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -68.55 -137.97 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.078 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -68.21 79.04 0.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.1 p -62.12 178.88 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.52 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.55 -30.99 14.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.207 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.4 -54.59 41.61 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -58.31 -46.6 85.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.8 mmt -67.12 -31.84 72.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.41 77.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.581 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.26 -42.63 93.08 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.529 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.439 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.97 -42.68 94.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.464 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.422 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -68.33 -33.08 73.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -39.43 92.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.76 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -48.81 32.56 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.92 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.8 t -84.31 121.43 75.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.741 0.27 . . . . 0.0 110.964 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 62.96 5.7 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.668 2.245 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.51 177.9 6.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -119.34 133.43 55.73 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.732 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 73.03 5.57 5.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.938 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.12 51.19 14.67 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.97 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -106.06 115.64 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.436 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 38.8 t -142.34 30.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.74 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 57.69 25.35 11.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.43 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 47.24 45.78 16.52 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.774 0.321 . . . . 0.0 111.499 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -120.57 -54.26 2.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.259 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.0 -38.88 76.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.723 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.4 m-85 -66.43 -56.93 8.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.574 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 138' ' ' ILE . 19.3 t -61.84 -31.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.313 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -57.74 -55.95 28.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -29.26 63.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 135' ' ' VAL . 2.0 mm -62.72 -42.54 96.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 mt -67.55 -89.91 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.91 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.72 91.64 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.4 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.114 -179.328 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.492 0.186 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p -141.74 -63.18 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.85 59.37 0.09 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.34 109.21 2.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.281 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.8 -46.62 92.87 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.7 Cg_endo -82.6 -12.94 9.86 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.585 2.19 . . . . 0.0 114.077 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -111.35 -61.28 1.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -72.57 -62.1 1.56 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.394 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.44 -48.86 79.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.809 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.86 -41.6 82.76 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.2 t80 -54.21 -44.68 71.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.325 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.59 -36.1 81.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.339 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.7 mt -60.91 -35.87 77.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.447 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' A' ' 31' ' ' LEU . 96.0 m-85 -90.93 33.74 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.18 133.17 49.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.689 0.28 . . . . 0.0 111.053 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -54.63 12.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.483 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.47 25.24 2.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.454 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.7 40.67 99.09 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.736 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 p -106.08 -31.27 8.8 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.79 -8.91 6.83 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.46 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -118.91 162.64 18.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.12 0.46 . . . . 0.0 111.037 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.52 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.8 pt -138.54 132.21 16.39 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.71 169.25 13.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.944 2.429 . . . . 0.0 112.435 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.494 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -45.16 -36.28 3.68 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.119 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.5 p -62.13 -44.18 97.19 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.404 0.145 . . . . 0.0 111.334 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.409 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 32.6 m -69.19 -45.7 69.29 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.488 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.94 -35.26 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.36 -67.66 2.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.678 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.92 71.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.549 0.174 . . . . 0.0 111.058 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.428 HD11 ' CD2' ' A' ' 15' ' ' PHE . 5.8 tp -59.18 -50.14 75.18 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . 47.0 mt -59.06 -32.52 69.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -55.41 -41.18 72.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -69.68 -28.79 66.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 32' ' ' LEU . 30.8 p -113.79 36.29 3.71 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.064 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.94 -104.6 0.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.658 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 175.84 8.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 111.562 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.54 105.26 19.18 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.45 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.05 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.762 2.308 . . . . 0.0 112.535 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.54 167.51 11.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.432 HD11 ' HD2' ' A' ' 25' ' ' LYS . 2.9 mm? -55.78 -33.05 64.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.07 75.51 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.014 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -56.53 9.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.011 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.494 ' HB ' ' CB ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -58.45 -45.65 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.208 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -59.45 -42.69 92.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -57.42 -38.36 74.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.721 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.4 mt -62.69 -51.29 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -56.79 -24.05 47.78 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.659 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.0 m -64.62 -8.67 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -118.01 -46.43 2.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.706 0.23 . . . . 0.0 111.179 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.07 158.24 41.84 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.3 Cg_exo -40.95 147.76 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.416 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.98 -67.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.597 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.54 124.9 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.624 0.249 . . . . 0.0 110.392 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.47 90.81 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -87.67 -179.31 6.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.7 mtp -40.86 -49.91 3.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.603 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -63.29 -53.31 54.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.529 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -56.51 -53.55 56.18 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -49.57 76.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.92 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 mt -61.69 -29.68 70.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -65.33 -48.15 74.04 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.594 0.235 . . . . 0.0 111.264 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -41.77 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.163 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -57.66 5.65 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -88.95 58.45 4.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.988 0.423 . . . . 0.0 110.804 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.26 -51.79 77.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.42 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 85.0 Cg_endo -84.35 18.78 1.48 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.631 2.221 . . . . 0.0 113.715 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 61.62 105.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.683 0.393 . . . . 0.0 111.975 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.97 173.99 23.61 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.161 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.72 172.05 7.31 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 t70 57.45 60.19 2.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.526 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.577 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 10.9 tpt -177.89 -52.44 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.301 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 83.8 Cg_exo -45.29 -43.86 16.53 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.61 2.207 . . . . 0.0 113.046 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.2 55.55 0.09 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.509 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.93 160.85 65.25 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-O 120.635 0.255 . . . . 0.0 111.204 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.79 -39.95 88.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.886 2.391 . . . . 0.0 112.413 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -31.24 72.08 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.386 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.28 -45.68 87.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -37.94 79.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.37 -43.67 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.088 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.69 -35.04 79.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.582 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' A' ' 102' ' ' VAL . . . -70.75 -43.88 58.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.561 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -76.48 -39.09 54.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.509 0.155 . . . . 0.0 111.302 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.45 73.66 5.0 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.106 0.479 . . . . 0.0 110.704 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.83 -45.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.5 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 98' ' ' GLU . 10.0 m-85 -134.36 39.84 3.04 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -109.81 60.58 0.6 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -39.72 79.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.81 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.57 -64.8 1.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.26 -86.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.429 0.456 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t 42.62 45.78 4.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.03 40.09 0.39 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.329 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.6 ptp -176.68 136.05 0.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.93 0.365 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.87 -43.26 8.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.22 80.53 0.15 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.532 HG12 HD22 ' A' ' 118' ' ' LEU . 97.0 t -44.09 -36.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.24 -38.65 19.4 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.777 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 86' ' ' PHE . 15.5 mt-10 -74.11 -52.26 13.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.522 0.201 . . . . 0.0 110.684 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.16 -38.25 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -73.46 -41.02 63.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.935 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -53.51 -42.13 67.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.527 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.482 ' CG1' ' HA2' ' A' ' 82' ' ' GLY . 4.1 t -74.11 -50.77 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.436 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.67 -45.76 88.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.884 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 56.3 m -65.41 -36.83 85.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.567 0.222 . . . . 0.0 110.952 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 t -63.62 -23.13 67.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.31 -70.67 0.23 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.518 0.199 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.25 48.95 0.49 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 61.16 45.99 8.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 111.012 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.62 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.985 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.6 mt -66.94 79.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.291 0.496 . . . . 0.0 110.679 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.429 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 99.5 p -63.59 -170.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.045 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -52.67 -32.7 43.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.148 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -57.29 -50.58 72.46 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.18 -54.47 44.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.742 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.436 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 4.1 ptt? -66.68 -25.41 66.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.457 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -46.32 87.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.97 -45.83 73.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.294 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.532 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.09 -40.57 90.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.9 mt -69.5 -32.13 70.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -61.27 -40.93 95.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.362 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.38 51.65 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.989 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.23 116.67 66.9 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.749 0.274 . . . . 0.0 110.989 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.08 65.03 4.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.492 2.128 . . . . 0.0 112.632 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.12 -179.24 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -118.68 132.7 56.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.567 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.99 6.18 5.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.955 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.42 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 71.03 53.33 10.95 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.909 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttt -106.83 119.61 39.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.503 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 39.3 t -142.34 20.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.56 22.06 10.66 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.09 -164.53 0.14 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 m170 71.37 -58.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.28 0.232 . . . . 0.0 111.209 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -52.72 -39.68 62.3 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.503 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 17.8 m-85 -68.11 -52.72 31.73 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.73 -30.79 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.225 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -62.51 -54.14 44.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.846 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.6 ttt -67.21 -34.85 78.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.7 mt -65.33 -41.12 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.962 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.8 mp -98.57 46.66 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.902 0.382 . . . . 0.0 110.948 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.0 50.24 1.1 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.138 -179.592 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.723 0.297 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 t -139.58 -49.3 0.48 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.91 -63.38 0.57 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.407 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -130.28 89.28 2.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.121 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.3 t -58.69 -45.79 99.62 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.343 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 85.3 Cg_endo -84.63 -3.74 9.95 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.543 2.162 . . . . 0.0 114.641 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -123.99 -62.64 1.27 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.972 0.351 . . . . 0.0 111.809 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -72.66 -60.84 2.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.944 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.51 -45.57 93.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.11 -44.88 87.92 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.181 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CE2' HG12 ' A' ' 23' ' ' ILE . 25.9 t80 -56.78 -43.12 80.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.823 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -62.48 -34.05 76.08 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -59.5 -34.05 72.1 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -94.25 33.22 1.4 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.92 129.4 39.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.618 0.247 . . . . 0.0 111.015 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.58 -61.89 1.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.512 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -130.95 25.75 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.184 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.75 39.18 95.09 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.535 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -104.57 -24.43 12.99 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.49 11.63 17.01 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.891 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 4.8 mtt-85 -129.0 163.17 25.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.746 0.273 . . . . 0.0 110.445 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.465 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.4 pt -140.14 133.74 15.3 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.49 172.43 8.11 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.158 2.572 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.6 pttp -43.49 -40.97 4.13 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -60.06 -43.13 95.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.507 0.194 . . . . 0.0 111.404 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.0 m -70.95 -45.57 63.93 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.766 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.582 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.32 -33.06 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.477 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.53 -67.54 2.16 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.25 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.4 -28.13 69.48 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.46 -46.76 88.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.28 -34.85 75.87 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.753 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.33 -41.08 65.37 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.794 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.426 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -63.68 -34.9 78.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.682 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -101.03 44.35 1.02 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.845 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.69 -97.78 0.57 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.817 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.68 170.43 14.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.721 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -122.47 131.96 24.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 59.3 Cg_endo -85.82 -163.27 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.973 2.449 . . . . 0.0 112.743 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p -98.15 163.25 12.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -51.53 -37.51 49.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.145 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.606 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -61.24 -55.12 35.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.0 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -55.58 -47.97 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.819 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -57.56 -41.73 81.59 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.75 -40.7 76.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.423 HG21 HG12 ' A' ' 63' ' ' VAL . 20.2 mt -62.79 -51.01 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.037 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -56.44 -23.54 39.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.905 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 t -63.97 -7.6 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 p -118.23 -46.17 2.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.684 0.22 . . . . 0.0 111.146 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -88.76 156.57 49.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.569 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.7 Cg_exo -39.01 146.11 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.355 2.703 . . . . 0.0 113.279 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.08 -68.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.744 0.653 . . . . 0.0 112.609 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.5 tt0 -85.84 127.68 34.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.643 0.259 . . . . 0.0 110.399 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.65 87.77 2.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.032 0.444 . . . . 0.0 111.314 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -82.33 177.56 8.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 ttm -41.61 -45.09 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.78 -51.54 47.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.572 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.569 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mp0 -56.82 -51.85 67.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.527 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -48.88 79.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.93 -32.6 72.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.427 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -61.47 -51.77 67.29 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.066 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -70.43 -41.7 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -42.58 98.54 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.563 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -105.27 50.68 0.78 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.086 0.469 . . . . 0.0 110.455 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -57.28 -58.15 20.03 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.246 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.59 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 66.3 Cg_endo -86.34 18.88 1.49 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.736 2.291 . . . . 0.0 113.173 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 53.78 82.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.565 0.346 . . . . 0.0 111.657 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.7 -167.11 35.16 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.188 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.53 154.33 45.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.547 0.213 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.06 65.61 1.35 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.071 0.462 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.542 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 3.7 ttt 177.73 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 80.2 Cg_exo -42.25 -52.98 3.88 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.891 2.394 . . . . 0.0 112.996 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.16 45.52 0.58 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.503 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 154.68 73.21 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.581 0.229 . . . . 0.0 111.272 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.39 -39.5 76.12 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 112.464 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.73 -30.12 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.361 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.9 -47.46 68.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.921 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -40.59 96.54 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.63 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -26.56 66.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.81 -50.4 58.6 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.466 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -72.96 -37.51 67.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.562 0.22 . . . . 0.0 111.008 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -79.12 4.78 13.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.76 -43.8 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -145.75 33.6 1.03 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.765 0.316 . . . . 0.0 111.413 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.92 76.24 1.71 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.063 0.459 . . . . 0.0 110.347 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.93 -48.94 78.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.178 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -91.82 -64.02 1.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.99 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 48.82 52.86 13.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.803 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.4 p -102.73 -48.05 4.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.85 26.22 9.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.0 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.484 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -174.59 148.64 1.18 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.862 0.331 . . . . 0.0 110.974 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.464 HG22 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -118.11 -44.25 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.79 81.15 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.337 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.447 ' HA ' HD21 ' A' ' 99' ' ' LEU . 73.3 t -44.3 -34.81 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.68 -35.73 17.29 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.093 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -80.65 -46.34 15.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.619 0.21 . . . . 0.0 110.916 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.99 -39.92 83.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.857 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.477 ' HG2' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -75.07 -36.12 61.79 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.611 179.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.78 -40.54 63.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.905 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.33 -51.46 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.532 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 2.4 mt -58.31 -49.85 75.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 m -59.7 -39.3 84.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.445 0.164 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -72.13 -19.82 61.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.81 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt -65.35 -66.69 0.51 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.603 0.239 . . . . 0.0 110.97 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.92 47.86 0.47 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.336 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.61 45.89 7.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -68.77 -137.7 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.158 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.43 79.33 0.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.619 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -64.97 -173.02 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.913 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 4.3 p-10 -51.88 -34.89 43.09 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.606 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.6 -55.44 30.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -55.34 -51.28 67.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.477 ' SD ' ' HG2' ' A' ' 100' ' ' ARG . 22.0 ptm -66.82 -27.6 67.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -47.3 83.58 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.82 -43.47 79.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -60.49 -43.11 97.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.634 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 124' ' ' VAL . 1.4 mt -67.95 -32.62 73.19 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.236 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -41.58 98.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.617 0.246 . . . . 0.0 110.724 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.99 -44.2 37.53 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.878 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.97 133.21 61.84 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.675 0.237 . . . . 0.0 111.189 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.39 59.94 7.31 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.788 2.326 . . . . 0.0 112.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.437 HG22 HD22 ' A' ' 119' ' ' LEU . 17.2 m -131.49 174.12 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 48.2 2.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.27 0.557 . . . . 0.0 110.555 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 175.13 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.834 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.426 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 112.71 50.3 0.56 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.922 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.484 ' SD ' ' HA ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.35 114.46 28.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.268 0.556 . . . . 0.0 110.698 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.433 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 40.4 t -142.18 26.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.101 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 62.67 24.34 14.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.122 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.438 ' CD1' HG13 ' A' ' 94' ' ' ILE . 4.8 t80 48.45 51.97 14.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 111.372 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.06 -54.31 1.12 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.82 -36.52 72.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.676 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.464 ' CE2' HG22 ' A' ' 94' ' ' ILE . 1.8 m-85 -68.46 -55.49 11.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.697 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.3 -31.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.568 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.03 -47.85 78.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.191 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.6 ttt -73.57 -32.02 63.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mt -66.56 -46.97 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.408 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.5 mp -83.4 -55.4 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.208 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.88 107.09 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.356 0.41 . . . . 0.0 111.015 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.039 -0.982 . . . . 0.0 111.055 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.714 0.292 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -97.27 28.29 3.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -131.38 13.69 5.05 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 38.9 m-20 57.38 80.28 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -67.2 -47.1 51.32 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.864 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 3.3 Cg_exo -75.17 -16.27 19.93 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.758 2.305 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -110.88 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 14.5 mmmt -72.3 -57.97 3.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -58.82 -45.95 88.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.603 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -63.82 -35.52 80.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.125 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.513 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.0 t80 -57.89 -47.95 81.27 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 m -62.71 -33.87 75.99 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.198 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -58.59 -37.15 75.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.344 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 89.0 m-85 -95.75 34.0 1.57 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 83.11 6.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.681 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -68.16 -30.84 70.06 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -86.22 -29.93 22.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.554 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.34 30.26 58.87 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.631 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -129.77 27.81 5.17 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.74 21.82 71.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.986 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 42.7 mtt180 -130.23 157.04 43.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.916 0.358 . . . . 0.0 110.805 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.513 HG12 ' CE2' ' A' ' 12' ' ' PHE . 3.8 pt -146.86 133.93 10.08 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.816 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.01 168.34 12.18 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.992 2.461 . . . . 0.0 112.172 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.5 -38.01 3.87 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -60.46 -43.74 96.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 111.145 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 m -71.03 -46.57 61.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.647 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.64 -34.06 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.099 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.03 -70.37 0.99 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.504 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.68 68.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.496 0.148 . . . . 0.0 111.297 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.434 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 9.2 tp -62.34 -48.41 79.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.33 -33.19 73.19 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.769 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.43 -36.85 66.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.74 -36.69 58.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.713 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t -93.64 53.51 1.86 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 111.001 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.84 -89.51 0.81 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.854 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 169.11 14.87 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.441 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 11.1 p-10 -133.77 155.32 80.5 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.329 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.02 -162.09 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.415 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -102.54 168.06 9.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -54.63 -33.17 60.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.19 85.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.71 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.37 -55.0 15.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.065 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.525 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -55.49 -46.04 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.934 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.6 m -61.47 -39.62 91.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -58.11 -38.4 76.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.316 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.422 ' CG2' HD13 ' A' ' 51' ' ' LEU . 50.0 mt -63.55 -46.72 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.898 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.8 -28.77 61.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 m -63.88 -12.21 34.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.8 p -118.28 -14.66 9.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -125.05 153.36 71.34 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.3 Cg_exo -39.38 146.65 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.366 2.711 . . . . 0.0 113.077 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.05 -65.4 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -88.12 125.88 34.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.576 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.55 89.82 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.2 p30 -83.17 176.94 8.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.388 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -41.49 -44.65 2.99 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.717 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -52.04 46.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.966 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.523 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.95 78.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.6 mt -61.38 -31.87 71.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.571 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -63.18 -52.16 63.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.161 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.06 -43.84 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.282 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.61 -51.5 59.15 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.579 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -98.85 53.91 1.0 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -55.75 42.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.205 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 67.5 Cg_endo -86.83 18.72 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.645 2.23 . . . . 0.0 113.431 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 52.25 87.32 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.61 0.364 . . . . 0.0 111.963 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.6 172.21 18.21 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.157 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -103.93 152.03 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.538 0.209 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 57.86 70.32 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.05 0.452 . . . . 0.0 110.244 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.565 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 26.1 ttt -179.69 -52.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.049 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 99.7 Cg_exo -42.3 -43.38 7.84 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.898 2.399 . . . . 0.0 113.217 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.74 92.96 0.84 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.583 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.11 135.33 94.83 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 120.448 0.166 . . . . 0.0 110.959 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.79 -46.5 32.86 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.804 2.336 . . . . 0.0 112.456 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -65.46 -35.5 81.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.408 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.37 -43.26 81.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.371 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -44.74 59.63 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.184 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.85 -53.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.317 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -40.68 97.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.277 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.14 -47.1 88.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.544 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.08 -26.45 65.84 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.496 0.148 . . . . 0.0 111.357 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.03 73.58 3.61 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.854 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.96 -66.32 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.523 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.405 ' CB ' ' HG2' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -135.58 33.21 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.652 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -137.25 53.2 1.89 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.617 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HE2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -70.95 -3.21 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.451 ' N ' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -97.87 -60.69 1.51 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.722 0.237 . . . . 0.0 111.056 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.57 51.4 12.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.304 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 p -142.19 80.81 1.72 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.77 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.7 15.89 50.93 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.292 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptm -172.57 131.37 0.56 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.12 0.46 . . . . 0.0 111.402 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.402 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.1 OUTLIER -105.9 -35.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.42 80.31 0.26 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.446 HG12 HD22 ' A' ' 118' ' ' LEU . 81.4 t -44.86 -34.43 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.21 -37.26 17.24 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.51 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG2' ' CB ' ' A' ' 86' ' ' PHE . 1.5 mp0 -75.57 -53.36 8.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.548 0.214 . . . . 0.0 110.63 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.27 -36.82 73.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.287 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HG3' ' HG2' ' A' ' 115' ' ' MET . 2.1 tmt_? -68.48 -49.95 56.0 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -57.61 -36.85 72.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.34 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.97 -47.75 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.763 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 mt -73.4 -52.5 13.55 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 84.8 m -55.3 -37.03 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 t -76.79 -17.67 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -66.57 0.53 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.509 0.195 . . . . 0.0 111.212 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 58.67 0.27 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.59 39.38 17.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.404 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -68.92 -137.77 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.197 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.79 78.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 110.754 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -66.07 -170.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.938 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -51.0 -38.37 50.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.943 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.31 -51.17 68.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -57.69 -53.21 60.8 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.848 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.446 ' HG2' ' HG3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -66.83 -27.88 67.91 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -45.23 89.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.677 0.275 . . . . 0.0 110.555 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.38 -40.29 74.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.79 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.446 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.97 -42.22 99.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.826 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -30.86 63.37 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.407 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -63.14 -41.14 99.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.77 -0.195 . . . . 0.0 110.958 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.36 -43.16 39.25 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.985 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.2 t -81.83 130.29 61.47 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.705 0.253 . . . . 0.0 111.155 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.96 62.45 6.62 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.7 p -131.2 167.42 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.824 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.48 54.44 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.088 0.47 . . . . 0.0 111.154 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.4 -37.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.561 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.96 39.19 1.08 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.296 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.16 113.96 27.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.26 0.552 . . . . 0.0 110.762 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 37.9 t -142.31 21.39 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.433 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.75 22.39 12.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 2.1 t80 46.63 45.42 14.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 -51.08 2.52 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.407 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.83 -36.62 77.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.788 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -68.16 -55.74 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.685 0.278 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.57 -32.73 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.232 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.84 -49.7 76.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.712 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.2 ttt -70.8 -27.11 63.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.5 -39.56 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.888 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mp -100.01 43.98 1.04 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.72 83.19 1.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.1 -0.952 . . . . 0.0 111.066 -179.664 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.99 34.59 5.12 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 110.36 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -147.73 44.11 1.09 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.618 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -119.94 108.03 13.84 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.916 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.422 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t -64.0 -48.31 78.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.771 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 6' ' ' SER . 71.5 Cg_endo -78.75 -14.36 14.04 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.389 2.06 . . . . 0.0 114.074 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -111.26 -61.41 1.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -60.13 2.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.597 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 8.1 tt0 -58.97 -47.04 86.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.631 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.6 -36.3 78.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.096 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.447 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.6 t80 -58.47 -49.31 77.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -61.92 -34.3 75.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 14.2 mt -55.62 -36.95 67.52 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 111.358 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -96.15 33.5 1.73 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -84.67 84.31 7.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.242 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -67.26 -34.49 77.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.46 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -86.55 -32.59 20.61 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.4 26.79 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.508 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.2 p -137.25 30.16 2.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.668 0.27 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.23 20.63 71.41 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.812 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 13.3 mtt180 -130.65 158.62 39.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.777 0.288 . . . . 0.0 110.533 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.447 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.7 pt -145.49 138.08 13.7 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 95.7 Cg_endo -88.67 172.73 4.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.207 2.605 . . . . 0.0 112.131 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 4.5 pttm -44.33 -36.25 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -59.9 -46.25 89.93 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.435 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -71.22 -50.51 32.21 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.553 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -48.85 -35.45 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.338 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.18 -70.95 0.83 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.235 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.17 -28.26 69.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.59 0.195 . . . . 0.0 111.453 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.72 -48.01 83.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.6 -34.47 75.7 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.858 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -32.41 64.71 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.297 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.56 -43.48 65.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.5 m -64.32 -43.73 93.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.925 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.18 -65.97 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.984 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.63 163.46 28.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -136.07 151.72 74.17 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.7 Cg_endo -86.47 -163.28 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.138 2.559 . . . . 0.0 112.74 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -99.58 169.05 9.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.261 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.3 mm? -54.09 -36.09 62.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.113 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.52 80.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.559 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -67.71 -52.23 40.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.85 -45.65 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.337 -0.145 . . . . 0.0 110.641 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -40.02 78.05 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -40.92 88.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.614 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.7 mt -63.36 -49.08 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -57.22 -24.86 57.45 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.678 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -64.03 -10.69 23.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.4 p -117.92 -41.54 2.89 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 120.34 0.114 . . . . 0.0 111.025 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -92.84 150.78 40.06 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.3 Cg_exo -38.32 143.31 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.233 2.622 . . . . 0.0 112.821 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.25 -61.35 0.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.73 0.644 . . . . 0.0 112.659 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -87.29 121.01 29.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.491 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.64 83.64 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.3 p30 -82.77 178.11 8.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.494 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.9 mtp -41.43 -46.01 3.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.59 -52.16 54.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.962 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.524 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.57 -52.59 64.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -49.31 75.92 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.121 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.57 -30.04 70.41 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -64.2 -49.46 71.93 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.433 0.159 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.422 HG22 HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.51 -45.92 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.849 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -57.9 8.11 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.26 55.66 2.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.78 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -51.89 76.95 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.247 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 69.5 Cg_endo -86.74 19.02 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.754 2.302 . . . . 0.0 113.249 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 62.96 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.679 0.392 . . . . 0.0 111.812 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.37 176.46 22.61 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.285 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.77 166.8 10.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.536 0.208 . . . . 0.0 111.011 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 56.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 110.657 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.541 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER 177.46 -51.95 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.796 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 72.4 Cg_exo -41.02 -45.35 5.12 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.988 2.458 . . . . 0.0 113.4 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.74 82.83 0.72 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.452 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.71 137.78 73.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.95 -41.62 66.89 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.568 2.179 . . . . 0.0 112.136 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.49 -33.54 73.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -65.3 -41.85 93.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.032 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -42.31 68.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.988 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.85 -56.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -24.77 67.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.687 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.21 -52.72 38.29 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.4 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -77.69 -41.47 37.92 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.437 0.16 . . . . 0.0 111.053 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -78.65 71.76 5.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.957 0.408 . . . . 0.0 110.986 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HB ' HG23 ' A' ' 102' ' ' VAL . 14.9 p -111.99 -42.01 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.29 40.36 1.76 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -125.25 57.53 1.31 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -49.24 74.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.556 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -97.83 -48.31 5.24 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.444 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.02 73.48 0.47 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 t -92.06 70.29 5.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.813 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.29 57.34 17.27 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.62 135.74 1.97 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 111.015 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -108.89 -44.16 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.46 80.12 0.12 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.422 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 118' ' ' LEU . 95.4 t -44.44 -40.07 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.71 -36.15 8.09 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.163 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -80.85 -46.01 15.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.63 0.215 . . . . 0.0 110.909 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -42.08 84.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.893 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -75.01 -36.06 61.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.828 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -52.82 -41.34 64.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.522 0.201 . . . . 0.0 111.014 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.424 HG23 ' HB ' ' A' ' 85' ' ' VAL . 2.6 t -83.04 -52.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.649 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -56.45 -47.12 79.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -58.22 -35.38 71.58 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -67.86 -21.47 65.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.1 mt -66.35 -67.43 0.45 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.512 0.196 . . . . 0.0 111.026 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.31 49.65 0.46 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.542 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.2 48.68 4.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.345 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -68.49 -138.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.125 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' A' ' 114' ' ' GLU . 15.1 mt -69.68 78.01 0.44 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.885 0.374 . . . . 0.0 110.639 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.3 p -68.78 -171.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.867 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -50.88 -39.54 54.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.03 -53.52 48.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.524 0.202 . . . . 0.0 111.275 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.505 ' HG2' ' CD2' ' A' ' 110' ' ' LEU . 4.1 tp10 -54.78 -52.86 61.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.61 -27.76 68.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -44.77 90.46 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.32 -43.82 80.69 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.547 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.92 -42.5 98.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.06 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.434 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.3 mt -71.52 -28.95 64.25 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.146 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -63.97 -41.21 97.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.572 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.12 -48.79 24.33 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.829 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.73 123.69 80.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.62 0.21 . . . . 0.0 110.808 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.75 62.23 6.41 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.565 2.177 . . . . 0.0 112.864 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.73 178.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.212 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -119.29 130.43 55.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.48 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 22.8 m-20 80.7 -34.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.061 0.544 . . . . 0.0 111.814 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.07 50.69 0.34 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.457 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.413 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.7 OUTLIER -104.01 116.84 32.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.705 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.44 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 36.7 t -142.32 20.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.258 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 56.72 25.31 10.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.458 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.7 t80 44.77 44.49 7.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -53.54 2.53 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.13 -37.08 68.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.44 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.3 m-85 -68.2 -58.95 3.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.83 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -62.27 -32.99 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -61.2 -52.66 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 110.645 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.53 -27.7 67.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.8 mm -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.333 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.65 40.39 1.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.702 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.36 67.28 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.877 -179.71 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.782 0.325 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -120.44 -46.63 2.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -135.68 -58.7 0.77 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.636 0.255 . . . . 0.0 110.62 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -141.39 112.09 7.1 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.609 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.427 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.6 t -59.41 -48.04 96.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.69 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.0 Cg_endo -81.74 -14.39 10.13 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.513 2.142 . . . . 0.0 114.123 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -110.52 -61.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -62.7 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.547 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -57.29 -47.6 81.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.677 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.2 -41.92 85.02 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.6 t80 -56.71 -42.82 79.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.592 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -61.4 -36.49 80.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.2 mt -63.26 -34.1 76.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -93.96 29.65 2.06 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.08 125.02 29.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.733 0.301 . . . . 0.0 110.821 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.53 -58.3 3.84 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.398 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -108.28 6.03 26.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.17 43.13 99.8 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.792 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.0 p -118.41 10.83 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 1.19 68.95 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.381 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -125.04 167.29 14.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.149 0.475 . . . . 0.0 110.898 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 7.6 pt -147.41 136.43 11.53 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -87.38 172.01 6.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.245 2.63 . . . . 0.0 112.488 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 6.0 pttt -44.41 -39.27 4.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.2 p -59.5 -43.31 93.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.453 0.168 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.482 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 25.4 m -71.16 -52.37 19.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.614 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.501 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -51.86 -35.36 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.76 -71.22 0.75 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -26.59 68.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.8 -50.14 67.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.702 0.287 . . . . 0.0 110.276 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.33 -28.11 68.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -54.75 -37.95 66.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.519 0.2 . . . . 0.0 110.749 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.18 72.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.577 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -83.74 -41.89 17.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.476 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.39 -84.32 0.05 OUTLIER Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.59 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.1 171.65 13.7 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.6 t-20 -123.3 108.77 31.6 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.317 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.38 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.849 2.366 . . . . 0.0 112.552 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 p -90.42 166.4 13.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.5 mm? -55.7 -34.53 65.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.789 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.54 -37.22 77.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.52 -54.2 31.56 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.06 -44.29 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.748 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 m -58.07 -43.59 87.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.343 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.47 -40.12 74.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.645 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.425 HG21 HG12 ' A' ' 63' ' ' VAL . 24.6 mt -64.99 -49.35 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.8 -23.37 43.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.748 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -64.56 -6.49 7.65 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -117.76 -45.59 2.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.789 0.268 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.36 156.19 48.48 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.4 Cg_exo -41.67 149.31 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 113.116 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.72 -64.18 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.646 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.1 mt-10 -86.44 123.58 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.704 0.288 . . . . 0.0 110.614 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.92 87.85 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.9 p30 -83.92 -179.93 7.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 37.2 mtt -41.41 -44.59 2.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -69.12 -52.27 29.98 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.535 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.27 -51.57 68.83 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.614 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -48.54 81.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.921 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.0 mt -61.01 -34.51 74.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.505 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -60.28 -49.81 76.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.577 0.227 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.425 HG12 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.57 -36.49 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 tp -62.05 -51.59 67.36 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.03 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -96.35 48.45 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.443 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.49 -49.15 91.4 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 85.6 Cg_endo -83.97 18.85 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.621 2.214 . . . . 0.0 113.563 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 55.4 92.13 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.638 0.375 . . . . 0.0 111.947 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.47 176.93 14.93 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.287 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -101.97 169.04 9.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.56 0.219 . . . . 0.0 110.806 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HA ' ' CG ' ' A' ' 75' ' ' ASP . 3.3 m-20 54.64 68.06 0.92 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.566 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 11.6 tpt -179.67 -51.37 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.332 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 51.4 Cg_exo -51.89 -57.85 1.92 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.376 2.05 . . . . 0.0 112.484 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.33 36.16 0.7 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.499 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' CG ' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -81.14 173.28 7.94 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.466 0.174 . . . . 0.0 110.86 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 69.1 Cg_exo -51.62 -36.17 59.68 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.719 2.279 . . . . 0.0 112.322 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -38.44 91.19 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.892 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.09 -42.56 96.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.847 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -44.1 97.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.92 -39.04 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.926 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -35.36 77.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.324 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.63 -54.69 8.25 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.755 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -57.9 -45.64 86.15 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.512 0.196 . . . . 0.0 110.666 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.98 65.13 5.04 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.85 -41.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.479 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -121.83 32.16 5.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.01 75.0 1.48 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.548 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -44.15 92.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.5 -59.28 2.36 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.846 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . . . 55.71 70.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -128.22 68.36 1.35 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.0 38.76 3.27 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.802 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.86 134.56 0.59 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.675 0.238 . . . . 0.0 110.976 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -107.26 -41.78 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.12 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.54 80.96 0.38 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.328 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.419 ' HA ' HD21 ' A' ' 99' ' ' LEU . 79.6 t -45.12 -39.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.03 -40.04 42.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.258 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 1.4 tt0 -71.93 -47.92 49.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.225 0.21 . . . . 0.0 110.474 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.455 HD11 HD13 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -58.35 -37.74 75.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.207 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.475 ' HG3' ' HG3' ' A' ' 115' ' ' MET . 0.2 OUTLIER -68.16 -43.99 77.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.675 179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -58.47 -36.79 74.25 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.361 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 t -77.8 -50.28 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.602 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 4.6 mt -63.73 -42.61 97.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.6 m -64.73 -41.72 95.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.499 0.19 . . . . 0.0 111.007 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.5 p -70.37 -15.2 62.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.861 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.55 -56.92 4.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.46 42.99 0.23 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.84 47.28 15.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 46.9 mmtm -68.52 -138.66 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.51 79.67 0.57 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.0 p -62.21 -177.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.933 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -48.9 -29.75 5.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.468 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -60.0 -62.75 1.64 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -42.04 86.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.475 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 6.0 mmt -65.95 -33.84 76.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -48.9 77.98 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.233 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.59 -40.65 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -60.33 -42.16 95.08 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.409 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.418 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -68.91 -31.17 69.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.324 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -62.94 -42.24 99.74 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.5 65.62 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.902 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.73 126.35 71.06 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.667 0.234 . . . . 0.0 111.176 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.25 61.07 5.79 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.598 2.199 . . . . 0.0 112.333 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 p -131.87 171.46 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.294 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -118.28 132.17 56.31 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 26.8 m-20 81.35 -47.51 0.24 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.523 0.514 . . . . 0.0 110.841 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.2 53.16 0.16 Allowed Glycine 0 C--N 1.339 0.71 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.711 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -107.22 107.41 18.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.544 0.688 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.493 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 47.7 t -142.32 19.59 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.624 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.85 21.69 7.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.853 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.411 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.9 OUTLIER 54.79 -164.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.21 -57.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.235 0.214 . . . . 0.0 111.359 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -52.65 -39.18 61.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.493 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.7 m-85 -68.65 -54.81 14.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.637 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.03 -31.31 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.293 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -69.6 -54.23 15.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -34.68 78.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.492 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.9 mt -69.4 -47.95 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.084 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.3 mp -99.17 53.69 0.97 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -171.02 112.65 0.38 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.725 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.136 -179.676 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 51.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.189 0.596 . . . . 0.0 111.76 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -136.18 -56.3 0.76 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.617 0.246 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -128.34 98.34 5.03 Favored 'General case' 0 N--CA 1.46 0.031 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.699 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.6 t -61.72 -46.02 93.11 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 5.0 Cg_exo -75.39 -14.4 20.33 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.987 2.458 . . . . 0.0 114.046 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -118.12 -63.13 1.46 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -66.21 -60.68 2.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -60.56 -47.14 87.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.61 -37.05 80.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' A' ' 23' ' ' ILE . 24.7 t80 -59.01 -46.77 87.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.326 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -62.41 -32.73 73.61 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.266 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -59.95 -34.07 72.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.497 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -102.05 36.33 2.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.92 101.68 14.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -50.05 67.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -86.84 -35.79 18.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.386 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.08 40.01 6.74 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.584 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.3 p -127.83 32.72 4.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.06 19.2 73.62 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.984 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 1.1 mtt-85 -130.98 157.2 43.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.794 0.297 . . . . 0.0 110.688 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.523 HG12 ' CE2' ' A' ' 12' ' ' PHE . 7.0 pt -143.57 137.94 14.93 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 84.1 Cg_endo -88.3 171.53 5.4 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.166 2.577 . . . . 0.0 112.702 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 15.8 pttm -44.19 -36.63 2.75 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.5 p -60.15 -46.21 90.45 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.439 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -70.72 -49.95 41.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.563 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -50.94 -34.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.346 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.12 -72.56 0.56 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.215 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -27.19 65.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.593 0.196 . . . . 0.0 111.456 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.13 -48.38 78.74 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -61.55 -31.5 71.53 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.962 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -56.13 -33.67 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.142 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.3 -38.02 68.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.28 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -92.66 58.15 3.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.0 0.428 . . . . 0.0 110.477 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.41 -91.71 1.09 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.406 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 172.37 12.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 12.4 p-10 -132.05 155.82 80.87 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 65.3 Cg_endo -85.03 -161.91 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.034 2.489 . . . . 0.0 112.41 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 p -102.17 167.32 10.08 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.076 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -53.58 -35.23 60.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.17 88.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.708 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -66.76 -52.22 46.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.271 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -54.95 -46.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -58.42 -43.08 88.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.307 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.51 -40.97 75.9 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.562 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 44' ' ' ILE . 38.8 mt -63.59 -48.2 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.23 -23.58 48.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -63.69 -12.09 31.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.4 p -118.04 -41.11 2.91 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.946 0.098 . . . . 0.0 110.911 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD13 ' CG2' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -91.2 148.35 37.6 Favored Pre-proline 0 N--CA 1.465 0.286 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -36.62 140.43 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.391 2.727 . . . . 0.0 113.148 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.86 -58.5 0.13 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.636 . . . . 0.0 112.448 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -89.4 122.32 32.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.185 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.36 88.49 2.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 121.029 0.443 . . . . 0.0 110.647 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.6 177.77 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.498 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.9 mtm -41.36 -43.73 2.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.907 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.84 -51.19 35.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.451 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -56.29 -50.74 70.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.504 0.192 . . . . 0.0 111.08 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -47.59 83.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.86 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.1 -30.93 71.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -63.65 -54.58 33.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.507 0.194 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -64.24 -40.9 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.903 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.1 -63.79 1.06 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.859 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.03 63.33 7.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.348 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -55.12 -54.14 53.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.707 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.53 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 74.2 Cg_endo -84.8 19.14 1.44 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.625 2.216 . . . . 0.0 113.548 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 54.17 75.87 0.26 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.77 0.319 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.65 -172.6 38.75 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.167 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -121.65 156.43 33.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.776 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 57.39 62.05 2.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.162 0.505 . . . . 0.0 110.274 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.541 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 6.9 tpt 179.46 -52.8 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.933 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 94.9 Cg_exo -42.46 -48.16 7.04 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 122.885 2.39 . . . . 0.0 113.429 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.8 80.16 0.06 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.898 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.58 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . 24.1 m-20 -80.97 117.57 68.63 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 120.432 0.158 . . . . 0.0 110.725 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.76 -51.13 4.27 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.758 2.306 . . . . 0.0 112.487 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -24.17 65.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.676 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 38.1 tt0 -71.84 -52.32 18.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.48 0.181 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -39.85 95.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.973 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.84 -50.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.602 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -60.13 -32.87 71.42 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.405 ' HA2' HG13 ' A' ' 102' ' ' VAL . . . -63.21 -54.08 35.22 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.502 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -78.02 -22.37 49.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.66 75.02 4.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.1 0.476 . . . . 0.0 111.031 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HB ' HG23 ' A' ' 102' ' ' VAL . 7.1 p -141.75 -49.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.906 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -156.29 43.44 0.4 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 110.722 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.96 59.95 1.72 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -50.23 74.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.93 -46.08 5.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.888 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.24 38.77 28.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.54 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 p -118.47 82.55 1.87 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.7 -18.02 5.44 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.157 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.1 OUTLIER -163.77 132.37 3.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.085 0.442 . . . . 0.0 110.898 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.38 -41.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.853 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.52 80.4 0.2 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.705 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.534 HG12 HD22 ' A' ' 118' ' ' LEU . 96.9 t -45.12 -38.61 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 122.3 0.24 . . . . 0.0 111.641 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.55 -36.36 17.79 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.45 -48.1 18.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 0.173 . . . . 0.0 110.71 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.72 -39.36 80.61 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.744 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -75.71 -39.47 57.32 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -53.9 -40.78 66.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 85' ' ' VAL . 3.8 t -77.91 -52.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.653 0.264 . . . . 0.0 111.412 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mt -56.5 -46.77 80.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.948 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.2 m -66.56 -35.59 80.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -66.02 -22.07 66.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.728 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.01 -67.86 0.43 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 110.983 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.55 44.68 0.56 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.258 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.4 50.41 4.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 111.182 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.902 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 114' ' ' GLU . 62.3 mt -67.23 79.44 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.372 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.8 p -63.8 -169.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.438 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' A' ' 115' ' ' MET . 3.5 m120 -50.43 -33.71 21.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.521 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -56.37 -51.72 67.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.568 0.223 . . . . 0.0 111.483 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 110' ' ' LEU . 1.6 tm-20 -56.58 -56.79 16.93 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.463 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -65.45 -24.68 67.24 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.638 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -48.28 81.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -68.01 -43.54 78.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.71 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.534 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.73 -42.19 96.82 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.944 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.411 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 4.1 mt -69.79 -30.24 67.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.073 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -40.39 96.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.625 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.48 -47.48 16.26 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.952 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.2 t -81.35 125.8 78.08 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.688 0.244 . . . . 0.0 110.977 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.49 61.61 7.96 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.652 2.235 . . . . 0.0 112.662 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.57 -177.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.236 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.4 OUTLIER -119.05 129.91 55.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.083 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 21.0 m-20 78.71 -49.38 0.45 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.851 0.46 . . . . 0.0 111.049 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.14 51.27 0.07 OUTLIER Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.618 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.473 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 1.9 ttp -104.17 116.73 32.71 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.121 0.486 . . . . 0.0 110.659 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.7 t -142.03 20.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.463 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 59.92 25.77 14.95 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.472 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.0 t80 44.31 41.63 4.58 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.236 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -52.98 2.69 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.839 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -56.9 -36.75 70.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -67.93 -57.35 6.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.55 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.94 -35.19 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.41 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.77 -56.03 26.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.2 tpp -64.0 -29.66 70.79 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.074 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mt -64.92 -43.11 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.967 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.23 33.06 3.65 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.604 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.52 110.11 0.23 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.951 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.861 -179.676 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.593 0.235 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.79 32.54 21.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.452 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.57 -41.53 3.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -106.83 99.3 8.88 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.491 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 4.1 t -67.31 -47.64 48.66 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.785 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 6' ' ' SER . 98.8 Cg_endo -80.73 -13.34 11.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.466 2.11 . . . . 0.0 114.193 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.37 -61.27 1.69 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -59.62 2.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.336 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.35 -47.42 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.716 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.79 -41.02 85.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.966 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CE2' HG12 ' A' ' 23' ' ' ILE . 6.1 t80 -56.39 -45.39 80.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.456 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.8 m -62.64 -33.82 75.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.733 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 16.1 mt -57.52 -30.28 65.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -91.69 33.22 1.03 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.54 112.3 14.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.909 0.385 . . . . 0.0 110.846 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -49.72 42.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -115.53 -0.92 12.91 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 48.5 33.57 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.559 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.5 p -121.38 16.64 11.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.65 14.01 80.01 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.194 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' CG ' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -130.29 158.45 39.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.922 0.361 . . . . 0.0 110.668 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 27' ' ' SER . 8.8 pt -140.96 135.04 15.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.73 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.25 170.66 9.36 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.074 2.516 . . . . 0.0 112.477 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -42.81 -38.16 2.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.6 p -60.41 -45.38 93.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.506 0.193 . . . . 0.0 111.293 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.455 ' CB ' ' HB ' ' A' ' 23' ' ' ILE . 2.9 m -69.97 -44.73 68.85 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.55 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.21 -33.47 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.411 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.45 -65.99 3.15 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.392 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -28.02 69.24 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.56 -49.18 77.7 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.32 -29.48 69.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.076 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -36.63 70.6 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.85 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.23 -30.14 71.0 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.418 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -109.4 32.05 5.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.799 0.333 . . . . 0.0 110.84 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.55 -105.08 0.28 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.366 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -132.4 178.81 6.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.615 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.74 116.04 34.88 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.369 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -84.57 -162.63 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.016 2.478 . . . . 0.0 112.764 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 p -98.16 164.06 12.48 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.24 -36.48 63.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.021 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.82 80.59 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.02 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -54.6 20.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.55 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -56.64 -44.95 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.484 0.183 . . . . 0.0 110.632 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.7 m -59.1 -38.99 80.86 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -40.5 85.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.277 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mt -63.56 -47.94 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -56.82 -25.48 56.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.414 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 t -64.47 -7.42 9.97 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -117.75 -50.52 2.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.748 0.249 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.66 53.92 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 85.6 Cg_exo -38.85 144.95 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.265 2.643 . . . . 0.0 113.044 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.68 -68.66 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.74 126.78 33.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.637 0.256 . . . . 0.0 110.601 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.55 89.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HB3' ' CG ' ' A' ' 22' ' ' ARG . 1.5 p30 -86.08 -179.69 6.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.539 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -41.28 -45.15 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.817 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -67.55 -53.62 26.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.491 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.31 -51.99 67.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -50.1 75.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.46 -32.47 72.46 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.414 0.15 . . . . 0.0 111.326 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.19 -50.3 74.57 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.025 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.57 -34.45 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.356 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.52 -46.16 67.16 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.635 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -93.45 51.77 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 21.6 mtm180 -60.33 -55.24 47.2 Favored Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.785 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.559 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 58.9 Cg_endo -86.86 29.96 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.991 2.461 . . . . 0.0 113.057 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 39.81 71.13 0.19 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.974 0.51 . . . . 0.0 111.808 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.07 173.33 46.2 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.967 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -100.79 -57.1 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.565 0.221 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.33 72.97 2.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.051 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.541 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -165.98 -54.69 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.003 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 81.1 Cg_exo -43.72 -48.93 8.45 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.596 2.198 . . . . 0.0 113.206 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.15 52.74 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.484 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.63 152.82 72.96 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.497 0.189 . . . . 0.0 111.247 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.8 -38.74 87.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.887 2.391 . . . . 0.0 112.512 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -35.97 82.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.369 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -65.37 -42.14 93.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.023 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -43.42 69.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.903 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.43 -44.56 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.276 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -34.62 77.6 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.65 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -61.07 -48.36 86.46 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.214 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -70.97 -34.36 71.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.508 0.194 . . . . 0.0 110.724 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -78.78 72.27 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.2 -63.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.465 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -116.5 42.21 2.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.141 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.33 65.42 0.67 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.671 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -59.64 -53.51 57.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.87 -66.95 1.0 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.595 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.21 63.75 1.84 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.572 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -64.84 -47.72 76.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.27 64.77 0.5 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.403 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -178.1 150.22 0.59 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.224 0.21 . . . . 0.0 110.487 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.25 -41.53 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.507 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.51 80.34 0.18 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.334 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.447 HG22 ' HA3' ' A' ' 127' ' ' GLY . 91.3 t -45.14 -33.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -43.76 15.62 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.109 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.465 ' HG3' ' CB ' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -76.93 -49.91 14.49 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.583 0.192 . . . . 0.0 111.045 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -37.58 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.272 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' A' ' 104' ' ' THR . 35.7 ttp85 -70.8 -46.98 61.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.79 -38.05 54.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.284 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.489 HG12 ' HA2' ' A' ' 82' ' ' GLY . 22.4 t -75.11 -49.03 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.468 HD23 ' HG2' ' A' ' 109' ' ' LYS . 9.4 mt -63.07 -35.27 79.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.407 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 100' ' ' ARG . 68.2 p -63.75 -37.8 88.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.603 0.24 . . . . 0.0 111.021 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.1 m -72.74 -17.05 61.64 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.05 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -67.34 -56.91 7.79 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 110.772 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.06 48.78 0.07 OUTLIER Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.156 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 64.01 39.12 8.16 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 111.035 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.468 ' HG2' HD23 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.66 -137.05 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.593 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.413 ' C ' ' CD2' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -67.51 83.56 0.17 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.416 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 0.0 OUTLIER -86.71 -167.55 1.92 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.967 -178.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 11.1 p30 -55.43 -28.86 56.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -67.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.71 -44.98 77.95 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.148 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.422 ' CG ' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -66.54 -29.27 69.32 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.106 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER -58.69 -47.52 84.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.25 -42.71 99.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -61.8 -41.72 98.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.742 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.406 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 4.3 mt -67.7 -32.18 72.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -45.22 91.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.967 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.94 -45.66 41.01 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.785 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.7 t -75.63 133.49 73.62 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.488 0.185 . . . . 0.0 111.111 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 58.48 6.5 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.84 2.36 . . . . 0.0 112.657 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.43 166.84 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 3.0 mtpp -124.33 55.56 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.92 0.391 . . . . 0.0 111.25 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.7 p-10 170.26 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 116.45 40.98 0.76 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.25 114.26 28.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 110.618 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.463 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 25.8 t -142.44 27.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.225 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 60.21 20.23 9.61 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.5 t80 46.61 41.75 10.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.821 0.343 . . . . 0.0 111.187 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -50.07 2.37 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.667 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -56.37 -41.29 75.95 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.463 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -66.4 -57.85 6.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.77 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 138' ' ' ILE . 14.4 t -62.11 -30.09 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.512 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.17 -57.4 12.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.659 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm -68.97 -32.02 71.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.902 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 135' ' ' VAL . 2.2 mm -62.36 -49.23 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 mp -94.22 64.1 3.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.698 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -161.77 67.62 0.27 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.0 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.905 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.561 0.219 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.6 t -129.59 29.42 5.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.098 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.91 -46.83 4.77 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 12.0 m-20 -79.32 83.09 5.39 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.1 0.476 . . . . 0.0 110.657 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.433 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -67.41 -46.64 48.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.984 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.3 Cg_endo -82.82 1.98 8.78 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.438 2.092 . . . . 0.0 114.106 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.489 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 56.9 m-85 -124.27 -66.76 0.96 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -55.27 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -62.36 -49.33 75.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.676 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.51 -38.2 77.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.9 t80 -58.83 -46.48 87.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.401 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -62.57 -31.6 72.44 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.656 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 12.8 mt -60.31 -38.1 82.62 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -96.04 34.47 1.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.4 95.27 9.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.07 -36.43 77.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.566 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -86.91 -41.28 14.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.369 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.22 10.51 55.92 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.165 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -103.96 -12.91 16.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.075 0.437 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.45 28.85 3.61 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.54 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.512 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -130.56 155.59 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.371 0.268 . . . . 0.0 110.367 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.4 pt -145.24 132.5 10.19 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 27' ' ' SER . 94.6 Cg_endo -84.43 171.4 9.97 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.975 2.45 . . . . 0.0 111.985 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.498 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.17 -37.83 7.52 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.3 p -61.94 -41.89 98.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.372 0.13 . . . . 0.0 111.152 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.402 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 9.8 m -70.41 -46.35 64.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.403 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.03 -34.87 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.482 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.01 -70.63 0.9 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.54 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -27.86 69.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.349 0.119 . . . . 0.0 111.291 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -61.54 -50.91 70.77 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.645 0.26 . . . . 0.0 110.366 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.58 -31.53 71.59 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.119 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.45 -39.64 70.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.01 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.84 75.5 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.533 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -77.45 -44.03 30.39 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.662 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 77' ' ' GLU . . . -156.43 -76.98 0.02 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.749 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 168.5 17.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.879 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -122.45 117.12 29.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.447 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.31 -162.25 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.893 2.396 . . . . 0.0 112.464 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -94.26 164.28 13.1 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.107 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.71 -30.95 64.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.44 86.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.723 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -55.53 16.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.498 ' HB ' ' CB ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -56.18 -45.11 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.906 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.2 m -61.27 -40.15 93.05 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.57 -38.68 78.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.3 mt -61.9 -51.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.6 -23.78 43.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.72 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -9.58 15.21 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -118.24 -46.42 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.647 0.203 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.24 158.39 43.82 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.8 Cg_exo -42.49 150.21 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.14 2.56 . . . . 0.0 113.214 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.14 -64.92 0.33 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.099 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.512 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.39 119.83 24.66 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.8 89.47 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.212 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.45 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 4.2 p30 -84.48 -179.89 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.49 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 mtt -41.92 -46.59 4.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.827 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -67.11 -51.03 59.21 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.56 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.17 -51.12 70.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -50.89 69.72 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.724 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.12 -26.15 68.14 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.473 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -65.57 -51.47 59.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.67 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.61 -41.58 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.828 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.13 -60.05 2.61 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.873 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -87.52 62.87 7.34 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.489 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.4 -54.5 52.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.8 Cg_endo -85.6 19.07 1.45 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.799 2.333 . . . . 0.0 113.188 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 66.0 113.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.814 0.446 . . . . 0.0 111.826 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 168.15 14.64 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.136 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -103.52 171.97 7.07 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.564 -0.162 . . . . 0.0 110.564 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 38.32 64.59 0.7 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.125 0.488 . . . . 0.0 111.384 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.614 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 18.7 ttt -174.23 -53.17 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.802 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 83.7 Cg_exo -48.01 -39.28 32.79 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.557 2.171 . . . . 0.0 112.602 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 91.36 2.14 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.43 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.3 142.77 93.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 120.501 0.191 . . . . 0.0 111.028 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.8 -55.2 3.16 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.798 2.332 . . . . 0.0 112.498 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' HG3' ' HA3' ' A' ' 36' ' ' GLY . 1.2 pm0 -69.4 -26.55 64.69 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.665 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -71.94 -49.83 34.25 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.198 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.26 90.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.296 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -65.41 -53.04 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.465 0.174 . . . . 0.0 110.843 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -60.82 -29.49 69.51 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA2' ' CG1' ' A' ' 102' ' ' VAL . . . -69.79 -53.38 15.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.063 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -77.89 -36.81 49.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.93 74.05 2.16 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.201 0.524 . . . . 0.0 111.243 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 102' ' ' VAL . 61.0 t -143.88 -55.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.232 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -144.14 49.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.317 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.63 74.82 1.61 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.709 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -47.34 78.22 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.73 -71.3 0.51 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.69 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.34 -170.14 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.218 0.324 . . . . 0.0 111.657 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 m 72.11 -69.93 0.17 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.666 0.386 . . . . 0.0 111.542 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.72 6.45 83.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.562 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 143.86 5.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.274 0.537 . . . . 0.0 111.025 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -124.32 141.12 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.27 81.22 0.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.058 -0.591 . . . . 0.0 111.639 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.507 HG11 ' HD3' ' A' ' 100' ' ' ARG . 93.9 t -43.32 -41.18 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.06 -46.65 33.22 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.038 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.59 -41.12 21.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.101 0.161 . . . . 0.0 110.958 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.477 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.01 -47.18 78.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.704 0.288 . . . . 0.0 110.702 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.507 ' HD3' HG11 ' A' ' 96' ' ' VAL . 3.0 mpt_? -72.57 -37.08 68.32 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.33 -38.68 63.46 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.538 0.209 . . . . 0.0 111.123 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 85' ' ' VAL . 2.6 t -75.13 -49.12 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.1 mt -63.54 -34.99 79.02 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.36 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.9 m -62.24 -32.45 73.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.567 0.223 . . . . 0.0 111.163 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 m -69.54 -17.0 63.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 3.7 mt -63.97 -71.81 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 110.977 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.4 51.3 0.43 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.974 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 61.14 49.1 5.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.013 0.435 . . . . 0.0 110.732 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -68.32 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.21 79.82 0.52 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.5 p -61.7 -175.39 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.011 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -50.22 -32.57 16.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.408 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.89 -51.84 67.57 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.48 -53.36 59.04 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.939 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.403 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -66.3 -26.8 67.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.402 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.86 -48.59 80.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.676 0.274 . . . . 0.0 110.339 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.88 -40.62 87.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -62.42 -41.6 98.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.694 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.409 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.1 mt -68.54 -33.26 73.8 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.983 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -63.32 -41.0 98.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.66 -45.06 18.74 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.844 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.8 t -79.24 125.22 83.74 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.693 0.247 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 5.2 Cg_exo -73.76 62.79 4.76 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.909 2.406 . . . . 0.0 112.32 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.35 175.15 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.242 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -124.19 47.62 2.05 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.084 0.469 . . . . 0.0 110.855 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.8 p-10 173.03 -34.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.7 48.49 0.73 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -103.87 117.66 34.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.37 31.16 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.989 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 59.24 23.12 11.45 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 46.33 44.5 12.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.926 0.394 . . . . 0.0 111.297 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.84 -52.69 2.43 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.35 -37.24 80.06 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.181 0.301 . . . . 0.0 111.757 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -66.39 -56.46 10.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.83 -31.28 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.462 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.42 -55.14 37.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.5 ttt -62.76 -36.26 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.2 mt -66.35 -39.32 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.119 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 mp -95.74 48.81 1.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.99 0.424 . . . . 0.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -166.52 80.44 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.097 -179.67 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.38 0.133 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 p 72.17 -54.7 0.68 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.592 0.757 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -131.99 -72.51 0.53 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.459 0.171 . . . . 0.0 110.581 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -174.16 97.78 0.1 Allowed 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.993 0.425 . . . . 0.0 110.895 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.448 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -66.75 -46.55 56.2 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.412 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 6' ' ' SER . 11.5 Cg_exo -71.36 -17.95 30.3 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.898 2.398 . . . . 0.0 113.85 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -114.46 -63.41 1.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' H ' ' HB3' ' A' ' 5' ' ' ASP . 8.0 tptt -65.88 -61.11 2.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.369 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -59.85 -45.69 91.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.401 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.536 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.57 -40.51 87.57 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.489 ' CE2' HG12 ' A' ' 23' ' ' ILE . 10.6 t80 -54.69 -45.64 73.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.297 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -36.38 81.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.14 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 6.0 mt -62.14 -33.23 74.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.382 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -93.29 34.12 1.17 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.51 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.51 96.23 8.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -42.4 99.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.048 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -87.39 -37.26 17.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.42 33.11 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.712 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.1 p -117.38 -11.42 10.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.17 2.94 9.92 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.353 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 2.6 mtt-85 -117.08 163.14 16.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 117.241 0.52 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.489 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.2 pt -144.98 131.21 9.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.668 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.61 169.74 10.62 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.066 2.511 . . . . 0.0 112.412 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.43 -37.9 5.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -60.78 -44.07 97.25 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.538 0.209 . . . . 0.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -67.99 -51.07 51.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.496 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -53.17 -37.33 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -70.58 0.9 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.668 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -26.14 68.54 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -64.71 -48.31 75.13 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -29.62 70.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.232 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.99 -41.52 68.02 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.704 179.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -64.75 -28.02 69.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.711 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.88 39.38 1.87 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.809 0.338 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.2 -102.3 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.748 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.05 -176.43 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -118.68 114.75 35.69 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.823 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.78 -162.54 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.796 2.331 . . . . 0.0 112.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 p -102.97 162.16 13.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -55.06 -32.9 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.13 79.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.696 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.37 -54.43 20.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.496 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.21 -47.78 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.895 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.2 m -59.21 -38.86 80.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.69 -38.07 80.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.516 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.2 mt -65.36 -50.16 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.99 -24.23 51.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.048 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 p -64.65 -7.34 10.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 p -117.75 -43.6 2.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.652 0.206 . . . . 0.0 111.269 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.37 158.92 36.2 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 99.0 Cg_exo -42.82 151.71 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.151 2.568 . . . . 0.0 113.12 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.64 -64.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.61 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.1 mt-10 -87.5 124.4 33.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.516 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 59' ' ' GLN . 48.3 t -86.61 88.92 2.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -82.21 177.2 8.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -41.38 -45.47 3.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.662 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -66.9 -51.38 56.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.043 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.537 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.71 -51.44 68.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -49.83 74.02 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.498 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.63 -47.98 79.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.115 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.47 -39.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.164 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -41.59 86.05 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.669 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -109.6 45.47 1.08 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.848 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.616 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 2.4 ttm180 -60.05 -53.01 69.31 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.229 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 66.0 Cg_endo -87.17 19.54 1.36 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.691 2.261 . . . . 0.0 113.314 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.64 81.98 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 111.321 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.7 -171.07 28.34 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.103 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.21 167.1 15.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.094 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.16 64.54 1.79 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.745 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.546 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 22.2 tpp 174.46 -52.44 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.987 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 85.2 Cg_exo -42.28 -53.99 3.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.019 2.479 . . . . 0.0 113.379 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.72 60.04 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.678 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -79.77 167.61 32.55 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 122.123 0.169 . . . . 0.0 110.622 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.71 -38.17 65.99 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.655 2.237 . . . . 0.0 112.297 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.29 -33.72 76.12 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.268 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.88 -47.19 63.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.262 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -41.3 98.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.134 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.72 -48.4 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.826 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -31.05 70.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.449 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -69.17 -55.79 9.91 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.344 0.116 . . . . 0.0 110.7 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -79.01 69.15 5.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.052 0.453 . . . . 0.0 110.683 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.14 -45.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.04 19.69 7.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.45 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.7 80.49 1.73 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -55.48 33.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.75 -35.51 9.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 87' ' ' ASP . . . 62.18 65.77 0.86 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -69.12 -38.0 78.63 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.73 64.78 0.06 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.031 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.63 129.82 0.43 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.507 0.194 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -103.76 -45.88 9.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.356 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 94' ' ' ILE . . . 57.1 80.26 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.469 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 118' ' ' LEU . 77.8 t -44.08 -36.62 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.38 -39.89 14.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.764 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -80.92 -45.01 17.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.444 0.164 . . . . 0.0 110.809 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.16 -40.54 90.26 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.957 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.49 -41.27 66.15 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.612 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -52.33 -39.52 60.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.693 0.282 . . . . 0.0 111.034 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.449 HG12 ' HA2' ' A' ' 82' ' ' GLY . 30.6 t -73.21 -49.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 2.9 mt -64.48 -44.3 91.45 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.007 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 54.7 p -57.85 -40.86 81.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.507 0.194 . . . . 0.0 111.229 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.0 t -78.33 -12.21 59.99 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -61.34 1.91 Allowed 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 111.281 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 57.81 0.12 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.368 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.35 39.61 18.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 111.022 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 49.3 mmtt -68.68 -137.93 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.036 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.442 HD21 ' HG2' ' A' ' 114' ' ' GLU . 19.7 mt -68.49 79.63 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.667 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.3 p -65.1 -170.21 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.069 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.408 ' HA ' ' HE1' ' A' ' 115' ' ' MET . 78.3 m-20 -53.44 -36.87 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.07 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.02 -51.23 70.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HG2' HD21 ' A' ' 110' ' ' LEU . 5.3 tp10 -57.34 -53.65 55.71 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.85 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.408 ' HE1' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -67.44 -25.85 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.419 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -47.85 83.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.97 -43.16 75.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.795 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.523 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.27 -42.68 95.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.428 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.3 mt -72.17 -30.71 65.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -61.16 -41.21 96.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.804 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.19 20.46 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.917 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.75 117.97 69.96 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.739 0.269 . . . . 0.0 111.019 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.85 63.95 6.74 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.628 2.219 . . . . 0.0 112.461 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.16 -176.43 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.77 132.49 56.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.323 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 67.04 14.77 9.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.366 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.401 ' HA3' ' HB ' ' A' ' 96' ' ' VAL . . . 63.3 49.89 67.02 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.075 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 ttp -103.47 120.21 40.4 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.515 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.1 t -142.31 24.02 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.663 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 60.84 24.9 14.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.495 0.188 . . . . 0.0 111.405 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.1 t80 46.14 42.21 9.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.775 0.322 . . . . 0.0 111.377 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -115.49 -51.37 2.69 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -57.39 -38.24 73.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.79 -56.68 7.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.766 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.0 t -62.65 -34.66 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.308 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -64.26 -53.9 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ttp -62.65 -34.47 77.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.063 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.3 mt -69.7 -39.25 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.005 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.5 mp -93.03 50.94 1.6 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 110.675 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -153.81 32.9 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.3 p30 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.193 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.776 0.322 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m -114.68 19.06 16.29 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.792 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.17 -36.91 17.76 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.487 -0.133 . . . . 0.0 111.173 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 8.8 m-20 59.33 84.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.916 0.388 . . . . 0.0 111.033 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.436 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 4.0 t -67.03 -48.35 50.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.294 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 83.9 Cg_endo -83.46 -3.42 10.75 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.525 2.15 . . . . 0.0 114.294 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 77.6 m-85 -118.26 -66.69 1.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 4.9 ttmm -72.72 -57.8 3.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.424 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -49.19 77.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.688 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.49 -40.31 90.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.54 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.5 t80 -56.5 -42.97 79.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.479 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.85 -36.11 82.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.045 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 9.6 mt -60.71 -33.14 72.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.302 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 32.58 2.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.444 ' HA ' HG21 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -93.19 91.55 7.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -63.38 -33.15 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.459 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -86.52 -35.58 19.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.133 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.29 32.32 52.24 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.774 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -118.73 -19.02 8.82 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.66 -8.04 5.54 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.086 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.623 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -121.57 162.86 19.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.065 0.432 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.54 HG12 ' CE2' ' A' ' 12' ' ' PHE . 5.8 pt -135.79 134.92 20.99 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.755 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.87 169.42 9.08 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.08 2.52 . . . . 0.0 112.612 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . 16.0 pttm -43.85 -38.52 3.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.9 p -60.13 -44.31 95.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.498 0.189 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 49.3 m -70.43 -46.74 63.32 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.875 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -54.79 -35.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.04 3.13 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.286 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 121.961 0.105 . . . . 0.0 111.108 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.32 -46.01 88.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.49 -31.61 70.64 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -51.42 -38.67 54.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -53.36 -44.55 68.64 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.65 -47.05 82.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.681 0.277 . . . . 0.0 110.774 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.85 -66.11 0.03 OUTLIER Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.094 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.99 173.36 11.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.862 0.363 . . . . 0.0 111.282 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -125.81 133.83 25.29 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.591 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -81.5 -163.17 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.849 2.366 . . . . 0.0 112.764 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 p -103.08 164.46 11.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -52.07 -37.71 54.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.46 86.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -53.93 29.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.541 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.03 -46.56 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -56.9 -39.97 75.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -40.85 83.99 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.89 -52.08 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -56.74 -25.02 53.84 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.699 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -10.42 22.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 p -118.1 -50.37 2.47 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.59 0.177 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.3 156.85 56.79 Favored Pre-proline 0 N--CA 1.464 0.263 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 78.2 Cg_exo -39.78 145.01 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.216 2.611 . . . . 0.0 113.199 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.18 -61.27 0.16 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.658 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -89.79 125.31 35.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.671 179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.0 t -87.19 90.14 3.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.623 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.5 p30 -86.59 -179.73 6.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.601 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.16 -46.5 3.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.817 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -67.77 -52.16 40.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.058 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.512 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.82 -50.75 72.23 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -48.91 79.68 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.912 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.59 -34.36 75.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.338 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -60.06 -48.05 83.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.308 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -42.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.386 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -54.59 45.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.407 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -84.62 62.55 7.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -57.7 -52.12 76.69 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.409 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 79.9 Cg_endo -84.89 19.1 1.45 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.638 2.225 . . . . 0.0 113.614 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 57.82 94.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.775 0.321 . . . . 0.0 111.795 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.96 17.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.112 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -100.54 -56.91 2.23 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -86.63 74.88 9.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.635 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 9.0 tpt -170.51 -56.17 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.398 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 84.2 Cg_exo -43.19 -49.33 7.32 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.553 2.169 . . . . 0.0 112.743 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.33 47.67 0.03 OUTLIER Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.186 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.495 ' HB3' ' CB ' ' A' ' 78' ' ' GLU . 40.2 m-20 -81.8 111.36 25.69 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.748 0.274 . . . . 0.0 110.832 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.74 -58.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.865 2.377 . . . . 0.0 112.472 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.74 -30.19 65.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' CB ' ' HB3' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -69.76 -48.08 60.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.359 0.123 . . . . 0.0 111.114 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -63.5 -39.62 94.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.984 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 79' ' ' PHE . 53.2 t -63.14 -49.03 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.139 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -26.51 68.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.82 -53.67 14.78 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.27 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.92 -47.18 47.94 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.31 71.4 5.85 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.29 -45.76 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.462 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -144.74 58.07 1.3 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 111.036 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -116.42 66.89 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.543 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.27 -36.18 79.34 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.84 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.79 -70.13 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.36 154.73 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.997 0.427 . . . . 0.0 112.018 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.5 m 59.8 80.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.261 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.84 -0.25 11.97 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.437 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -163.97 138.97 6.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 117.184 0.492 . . . . 0.0 110.629 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.36 -39.86 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.442 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.44 81.41 0.15 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.323 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.605 HG12 HD22 ' A' ' 118' ' ' LEU . 79.5 t -43.73 -36.49 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.97 -38.65 17.54 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.602 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.45 -46.47 22.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.24 0.216 . . . . 0.0 110.968 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -60.81 -42.16 97.08 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.464 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -36.39 69.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.093 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -59.31 -37.53 77.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.595 0.236 . . . . 0.0 111.078 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.6 t -77.56 -42.07 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.302 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.5 mt -72.42 -33.39 67.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 p -59.47 -35.02 73.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.6 p -70.45 -18.04 63.0 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.14 -62.32 1.49 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.756 0.313 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.84 49.51 0.18 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.169 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.49 49.85 3.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 110.624 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 8.8 mmtp -68.55 -137.89 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.2 mt -69.96 77.5 0.48 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.888 0.375 . . . . 0.0 110.549 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.5 p -74.93 -165.66 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.873 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -51.4 -40.06 58.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.21 -52.93 61.8 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.52 0.2 . . . . 0.0 111.523 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.23 -51.35 69.71 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.455 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 1.2 ptt? -67.14 -26.88 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.442 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -48.12 82.15 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.58 -43.56 84.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.605 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.56 -40.99 93.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.413 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 mt -71.27 -30.13 65.92 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.155 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.41 -40.44 97.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.575 0.226 . . . . 0.0 110.72 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.27 -46.44 26.89 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.847 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.9 t -86.15 121.68 72.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.805 0.302 . . . . 0.0 111.314 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 62.98 7.29 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.689 2.26 . . . . 0.0 112.546 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.4 m -131.42 -177.35 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.222 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -119.21 126.22 51.01 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.45 -2.96 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.087 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.77 49.57 5.04 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.768 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.6 OUTLIER -103.99 113.64 27.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.233 0.54 . . . . 0.0 110.674 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.459 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 35.8 t -142.91 30.35 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.063 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.53 23.16 11.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.781 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.4 t80 47.62 48.18 17.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.9 0.381 . . . . 0.0 111.438 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -121.93 -54.69 1.92 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.309 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.04 -36.46 75.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -67.9 -54.95 14.85 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 138' ' ' ILE . 17.9 t -62.08 -33.39 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -58.86 -53.07 62.56 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.719 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttp -71.57 -30.27 65.67 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 135' ' ' VAL . 1.9 mm -59.58 -45.12 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.397 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.17 -79.23 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.63 100.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 111.106 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.935 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.739 0.304 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m 62.06 30.33 17.86 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.474 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 59.71 37.33 22.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.268 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -119.87 77.16 1.21 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.343 0.592 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.485 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -67.36 -47.47 48.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.096 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 97.5 Cg_endo -87.21 7.96 4.55 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.63 2.22 . . . . 0.0 114.37 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -129.2 -67.96 0.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.679 0.218 . . . . 0.0 111.584 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -58.43 3.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.974 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -60.6 -48.49 81.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.658 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -42.98 87.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CE2' HG12 ' A' ' 23' ' ' ILE . 30.5 t80 -54.83 -44.13 73.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.454 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -62.59 -35.22 78.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.525 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -63.0 -34.26 77.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 4.6 m-85 -93.93 34.31 1.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.633 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.26 117.13 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.861 0.363 . . . . 0.0 111.219 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -71.34 -50.08 36.01 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.609 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -103.44 -38.72 7.06 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.309 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.67 37.15 4.05 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.466 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -116.81 -8.64 11.34 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.77 7.96 14.65 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -130.56 164.1 25.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.173 0.486 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 6.4 pt -146.48 137.25 12.52 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.693 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -85.62 171.49 8.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.129 2.552 . . . . 0.0 112.4 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -44.26 -39.31 4.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 p -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.451 0.167 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.9 m -69.87 -46.46 65.47 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.697 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -58.15 -33.68 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.32 -73.0 0.45 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.838 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -64.75 -21.32 66.73 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -65.78 -49.4 68.47 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.4 mt -61.71 -26.88 68.32 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.225 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -36.79 70.05 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.795 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.797 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -109.21 31.06 6.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.57 -103.86 0.25 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.732 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.24 179.46 6.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -119.38 113.19 35.29 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.419 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.19 -162.76 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -98.53 163.93 12.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -56.4 -34.17 66.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.68 73.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.838 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.37 -58.66 4.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -53.62 -47.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 123.098 0.249 . . . . 0.0 111.134 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.6 m -61.84 -44.27 97.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.43 -41.3 80.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.522 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.9 mt -63.65 -48.04 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.936 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.36 -24.57 56.06 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.999 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 p -63.81 -10.27 19.24 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.2 p -117.72 -31.76 5.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.41 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -97.18 152.78 38.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.589 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 77.9 Cg_exo -38.71 146.53 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.348 2.699 . . . . 0.0 113.055 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.88 -54.91 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -97.53 129.57 44.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.718 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.15 86.08 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.044 0.45 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.3 p30 -83.08 -179.86 7.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.575 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.6 mtm -41.47 -47.55 3.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.847 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -51.68 55.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.995 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.589 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.6 mp0 -57.91 -51.62 68.86 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.099 0.25 . . . . 0.0 111.643 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -49.9 75.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.098 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.68 -35.28 77.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.539 0.209 . . . . 0.0 110.972 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.18 -53.98 52.12 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' CG2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.37 -31.08 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.065 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.05 -35.92 65.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.034 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.0 52.69 2.47 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.472 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.517 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.81 -49.94 87.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.762 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 86.1 Cg_endo -82.88 21.46 1.01 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.438 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.7 t30 58.31 76.45 0.34 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.438 . . . . 0.0 110.994 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.82 19.86 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.669 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -99.93 -36.84 9.26 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.293 0.109 . . . . 0.0 111.293 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.71 84.09 3.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.851 0.357 . . . . 0.0 110.25 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.487 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 7.0 tpt 178.01 -51.19 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.726 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 74.1 Cg_exo -41.35 -43.58 5.65 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.039 2.493 . . . . 0.0 113.642 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.21 52.02 0.06 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.071 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.3 m-20 -82.25 169.62 17.68 Favored Pre-proline 0 C--O 1.233 0.216 0 C-N-CA 122.657 0.383 . . . . 0.0 111.425 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 45.3 Cg_exo -56.02 -38.61 94.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.565 2.176 . . . . 0.0 111.891 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.3 -31.29 72.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.088 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.91 -46.77 77.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.97 -40.07 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.799 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -44.72 94.92 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.062 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 85' ' ' VAL . . . -62.13 -45.54 95.85 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.149 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.76 -25.69 65.74 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.14 74.5 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 82' ' ' GLY . 33.6 t -127.52 -60.76 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.194 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -105.49 48.99 0.82 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -115.72 64.63 0.69 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -67.58 -47.47 69.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.81 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.31 -50.19 2.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.33 68.66 0.82 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.44 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 m -128.04 62.99 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.747 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.26 46.98 1.77 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.0 ptm -173.09 144.5 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.766 0.283 . . . . 0.0 111.527 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.493 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.2 OUTLIER -118.82 -42.92 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.22 81.32 0.34 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.285 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.527 HG12 HD22 ' A' ' 118' ' ' LEU . 46.6 t -44.31 -40.99 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.19 -38.34 18.62 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.617 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -81.44 -41.94 21.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.489 0.185 . . . . 0.0 110.513 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.729 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -35.47 65.05 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.662 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.73 -34.33 69.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.1 t -82.72 -47.49 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 3.9 mt -70.66 -38.91 73.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.1 m -61.06 -31.15 70.8 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -70.18 -17.13 63.15 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.92 -66.02 0.8 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.51 0.195 . . . . 0.0 111.086 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.65 52.14 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.803 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 57.85 53.56 6.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 2.6 tptp -67.64 -137.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.079 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.94 77.39 0.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.994 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 96.0 p -67.15 -173.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.43 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -48.84 -42.47 36.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.039 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.18 -52.28 65.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.98 -51.59 69.03 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.427 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 3.4 ptm -66.88 -27.58 67.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.311 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -49.18 78.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.62 0.248 . . . . 0.0 110.454 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.26 -42.25 88.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.527 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.92 -41.93 99.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.412 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -67.18 -35.48 79.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.216 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -38.29 90.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.4 -39.1 36.72 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.046 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.48 133.12 42.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.854 0.327 . . . . 0.0 111.122 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.08 58.08 6.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.789 2.326 . . . . 0.0 112.826 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.2 m -131.66 176.36 9.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 19.23 11.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.788 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -168.21 25.92 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 56.83 45.97 90.76 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.961 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.3 ttt -103.5 115.64 30.89 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.197 0.522 . . . . 0.0 110.751 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 39.5 t -141.16 22.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.082 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 58.55 24.11 11.59 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.493 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER 56.18 -166.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t60 72.29 -58.89 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.109 0.164 . . . . 0.0 111.084 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -52.89 -39.99 63.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.537 0.208 . . . . 0.0 111.421 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 21.8 m-85 -67.96 -52.39 36.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.377 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.43 -31.65 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.64 -53.37 58.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.53 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.8 ttt -69.11 -26.95 65.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.86 -49.47 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.21 -74.89 0.38 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.2 108.18 0.05 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.095 -179.34 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.817 0.342 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m 57.56 41.26 26.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -112.17 -46.65 3.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.208 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.02 101.44 1.4 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.445 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 4.7 t -66.95 -45.63 53.56 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 6' ' ' SER . 2.8 Cg_exo -75.62 -13.39 20.18 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.774 2.316 . . . . 0.0 113.852 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -118.87 -61.68 1.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.58 -59.89 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.247 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.404 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 28.6 tp60 -60.54 -48.21 82.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.512 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.45 -38.16 73.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.355 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' A' ' 23' ' ' ILE . 14.7 t80 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -62.22 -30.69 71.27 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.733 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -62.83 -39.63 94.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -95.69 33.39 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 103.28 15.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -71.2 -35.23 71.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -86.51 -38.67 17.01 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.04 -8.3 63.01 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.252 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -86.76 -32.12 20.56 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.991 0.396 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.9 40.68 0.18 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.414 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.85 157.77 41.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.315 0.246 . . . . 0.0 110.732 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 HG12 ' CE2' ' A' ' 12' ' ' PHE . 4.1 pt -150.51 129.41 6.22 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.09 172.53 8.52 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.058 2.505 . . . . 0.0 112.148 179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.98 -37.96 4.39 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.8 p -60.91 -43.6 98.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.486 0.184 . . . . 0.0 111.067 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 38.6 m -70.07 -48.82 56.2 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.609 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.514 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -56.29 -33.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.47 -69.47 1.26 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.389 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -30.99 72.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.346 0.117 . . . . 0.0 111.275 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.32 -51.3 69.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.717 0.294 . . . . 0.0 110.325 179.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.68 -32.29 72.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.17 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -35.98 63.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.128 179.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.36 75.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.631 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.2 t -66.83 -44.33 81.4 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.683 0.277 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.99 -69.46 0.03 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.5 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 166.13 22.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.982 0.42 . . . . 0.0 111.509 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.95 121.92 23.1 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.432 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.94 -161.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.726 2.284 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -90.34 166.17 13.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.235 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -56.68 -29.3 62.2 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.223 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.69 93.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.711 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -53.53 51.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.994 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.96 -44.82 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -61.4 -39.98 92.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.194 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -57.79 -38.92 76.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 mt -63.73 -46.75 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.994 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.01 -27.2 61.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.464 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -5.54 6.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 p -118.6 -33.96 4.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.899 0.318 . . . . 0.0 111.436 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.478 HD13 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -105.03 161.5 22.56 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.487 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.543 ' HD2' ' HG2' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -46.11 162.05 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.131 2.554 . . . . 0.0 113.083 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.35 -67.62 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -83.23 119.75 24.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.614 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.89 96.12 4.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.101 0.476 . . . . 0.0 110.945 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -82.57 174.35 11.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.677 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.4 mtt -42.52 -43.6 3.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.672 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.48 -50.92 56.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.824 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.543 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 31.9 mt-30 -57.14 -51.27 69.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.84 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -49.25 77.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.762 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 mt -61.43 -31.44 71.38 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -63.64 -55.05 26.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.495 0.188 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 HG22 HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.69 -42.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -50.07 67.37 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.115 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.47 50.74 1.25 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -60.53 -58.01 22.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.525 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.589 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.7 Cg_endo -86.07 19.45 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.635 2.223 . . . . 0.0 113.637 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.03 87.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.903 0.383 . . . . 0.0 111.529 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.06 -178.33 43.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.817 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -101.3 -60.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.516 0.198 . . . . 0.0 110.773 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -104.09 18.29 22.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.253 179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 9.2 tpt -87.92 -45.6 0.48 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.57 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.589 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 58.1 Cg_exo -52.07 -41.94 61.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.819 2.346 . . . . 0.0 113.083 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.17 111.8 3.35 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.589 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.97 53.57 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 120.509 0.195 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.27 -37.26 94.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.584 2.19 . . . . 0.0 112.305 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.3 -27.8 64.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.09 -48.85 55.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.452 0.168 . . . . 0.0 111.288 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -64.59 -39.73 94.25 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.059 179.923 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG21 ' CE2' ' A' ' 79' ' ' PHE . 59.3 t -64.68 -46.36 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.35 -40.03 95.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.779 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.67 -45.48 96.3 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.474 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -76.86 -27.48 55.09 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.68 -16.57 63.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -45.29 -56.12 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.3 19.32 4.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.597 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.17 68.72 1.32 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.262 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.27 -54.39 29.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.27 -63.62 1.32 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.27 82.92 0.06 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.784 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.99 -53.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.15 42.12 1.45 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.001 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -170.71 137.26 1.29 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.749 0.275 . . . . 0.0 111.346 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.523 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -112.21 -43.43 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.451 179.532 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.6 79.58 0.17 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.199 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 118' ' ' LEU . 91.1 t -45.07 -35.64 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.34 -43.88 20.25 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.741 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.01 -50.18 21.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.279 0.232 . . . . 0.0 110.802 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.13 -36.33 75.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.434 ' HD2' ' HG2' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.12 -50.46 68.18 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.603 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -53.05 -42.05 65.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.122 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.06 -52.16 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.282 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 4.6 mt -66.12 -40.73 90.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.7 m -58.05 -33.29 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.337 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.1 m -74.47 -17.84 60.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.42 -60.95 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.529 0.204 . . . . 0.0 111.119 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.55 52.73 0.22 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.93 48.69 8.55 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.99 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 5.3 mmtp -68.64 -138.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.1 mt -68.07 78.56 0.23 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.287 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.3 p -69.29 -171.11 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.013 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.52 -37.41 17.54 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.265 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -67.23 -55.01 15.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.548 0.213 . . . . 0.0 111.478 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -57.12 -49.11 76.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.434 ' HG2' ' HD2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -67.08 -27.88 67.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.095 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -47.03 85.96 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.33 -44.47 83.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.462 179.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.482 ' CD2' HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.39 -41.7 90.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.265 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 124' ' ' VAL . 2.2 mt -71.55 -29.83 65.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -41.24 97.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.527 0.203 . . . . 0.0 110.598 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.16 -44.35 44.61 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.089 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.64 131.65 54.32 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.764 0.282 . . . . 0.0 111.174 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.65 61.38 7.48 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.756 2.304 . . . . 0.0 112.666 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.496 HG22 HD22 ' A' ' 119' ' ' LEU . 12.7 m -131.8 177.37 7.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.449 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -126.94 47.3 2.35 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.181 0.515 . . . . 0.0 110.745 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 173.64 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.37 51.46 0.58 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.97 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.454 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.27 116.96 33.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 0.0 110.671 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.0 t -142.2 19.64 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.74 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.32 23.42 10.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.523 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 48.11 47.23 19.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 111.599 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 -51.61 2.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -60.09 -35.21 74.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.784 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 5.7 m-85 -66.04 -58.26 5.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.703 0.287 . . . . 0.0 110.35 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.75 -32.59 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.417 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -60.1 -50.53 73.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.491 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.9 ttt -66.9 -31.88 72.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.1 mm -61.31 -39.79 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -84.03 58.69 4.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.87 79.93 0.08 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.907 -179.847 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t 44.33 45.54 7.36 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.748 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 -52.17 2.8 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 7.5 m-20 -110.51 99.04 8.1 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -66.99 -46.52 53.63 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.957 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 6' ' ' SER . 83.2 Cg_endo -82.97 -3.88 11.17 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.411 2.074 . . . . 0.0 114.045 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 46.4 m-85 -120.83 -62.51 1.44 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.7 -59.44 2.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.072 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -60.59 -47.24 87.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.486 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.19 -40.66 82.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.492 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.4 t80 -57.08 -44.37 83.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.604 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -62.06 -33.84 75.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.248 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.84 -30.99 70.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.369 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.32 20.37 4.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.425 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -101.73 120.31 40.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.188 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -55.74 31.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.498 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -101.94 -24.46 14.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.801 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . 93.82 44.33 3.65 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.451 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -89.46 -26.03 21.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.041 0.136 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.08 10.17 14.43 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.106 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 2.1 mtt180 -130.24 160.91 32.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.055 0.427 . . . . 0.0 110.551 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 27' ' ' SER . 5.7 pt -146.33 138.51 13.63 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -87.02 171.55 6.7 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.234 2.623 . . . . 0.0 112.482 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 10.5 ptpt -42.5 -40.97 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 p -59.9 -44.62 94.15 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 12.5 m -69.1 -48.0 63.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.586 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.506 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.04 -34.24 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.09 -68.72 1.51 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.281 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -30.62 71.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.98 -50.88 71.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 110.423 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.47 -30.19 70.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.039 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -57.02 -37.81 72.25 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.842 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.51 -29.12 70.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.8 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -88.28 -42.68 12.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.604 0.24 . . . . 0.0 110.55 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.9 -87.38 0.09 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.512 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -132.61 175.74 9.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 2.5 t-20 -119.37 112.36 35.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.122 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.68 -162.84 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.915 2.41 . . . . 0.0 112.856 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 p -95.59 166.52 11.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.82 -37.17 65.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.34 73.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.813 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -55.97 13.1 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -57.01 -48.57 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.584 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.6 m -56.98 -39.74 75.19 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.66 -41.94 87.28 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.357 179.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.503 HG21 HG13 ' A' ' 63' ' ' VAL . 19.5 mt -62.54 -49.4 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.74 -25.84 55.81 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.384 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -64.8 -8.21 14.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 p -117.83 -49.02 2.54 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.656 0.207 . . . . 0.0 110.968 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -86.61 158.2 54.41 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.796 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.3 Cg_exo -40.93 149.75 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.188 2.592 . . . . 0.0 113.072 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.05 -63.68 0.18 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -89.68 127.68 35.97 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.791 0.329 . . . . 0.0 110.66 179.716 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.82 89.59 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.284 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.07 179.65 7.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.7 mtp -41.41 -46.27 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.39 -52.37 40.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.504 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.96 -50.95 71.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.729 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -48.9 79.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.06 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.82 -39.37 88.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.448 0.166 . . . . 0.0 111.396 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -55.43 -49.2 73.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.483 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.503 HG13 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -76.4 -35.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 179.92 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -38.36 84.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.42 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.489 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 4.1 m-80 -98.75 43.05 1.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.922 0.391 . . . . 0.0 110.234 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . 2.2 mtp85 -62.39 -65.79 1.93 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.0 Cg_endo -86.58 18.18 1.62 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.44 2.093 . . . . 0.0 114.975 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 9.7 t-20 156.02 -71.95 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.733 0.413 . . . . 0.0 110.527 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 65' ' ' ASN . . . -177.37 -86.28 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.715 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -115.27 -46.92 2.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.107 0.163 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.23 68.57 9.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.118 0.485 . . . . 0.0 110.87 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.471 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -179.52 -55.47 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.267 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.533 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 85.9 Cg_exo -45.96 -46.49 15.79 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.4 61.29 0.1 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.446 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.84 144.69 56.07 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.345 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.74 -48.7 6.54 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.928 2.419 . . . . 0.0 112.274 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -30.35 71.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -43.67 81.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.42 87.33 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.38 -47.84 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.875 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -31.12 70.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.597 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -61.81 -47.84 87.72 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.553 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -74.91 -32.78 61.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 0.127 . . . . 0.0 111.052 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.88 73.19 5.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.07 -65.19 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.13 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.493 ' HB2' ' CB ' ' A' ' 98' ' ' GLU . 1.4 m-85 -109.55 34.41 3.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.346 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 49.74 2.29 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -69.89 -54.81 11.72 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.206 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.88 -47.6 11.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.75 66.65 0.97 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -102.04 67.04 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.27 56.05 11.3 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.529 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -174.93 138.65 0.47 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.714 0.293 . . . . 0.0 111.192 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -107.23 -41.65 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.547 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.86 78.95 0.34 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.499 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.516 HG12 HD22 ' A' ' 118' ' ' LEU . 70.8 t -44.75 -35.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.53 -41.77 18.57 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.252 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.493 ' CB ' ' HB2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -80.16 -36.71 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.661 0.23 . . . . 0.0 111.549 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -67.25 -40.83 86.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.485 0.183 . . . . 0.0 110.957 179.886 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -38.64 66.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.975 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -56.37 -45.85 80.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.67 0.271 . . . . 0.0 110.924 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.439 HG12 ' HA2' ' A' ' 82' ' ' GLY . 47.6 t -65.77 -46.71 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.222 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.474 ' CD2' ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -67.1 -37.55 84.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.371 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 85.3 m -67.19 -42.96 83.3 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.485 0.183 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.1 p -68.0 -16.06 63.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.29 -65.29 0.7 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.709 0.29 . . . . 0.0 110.927 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.5 49.08 0.28 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.121 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 61.16 41.5 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 -179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HG2' ' CD2' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -68.9 -137.92 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.987 178.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 42.1 mt -68.56 80.02 0.27 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.405 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 79.7 p -66.38 -170.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 115' ' ' MET . 4.6 p-10 -53.26 -33.7 54.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.226 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -48.9 79.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.542 0.21 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 17.9 mm-40 -59.14 -53.41 58.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -66.76 -26.44 66.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.258 179.365 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -47.11 86.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.239 179.125 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.0 -43.77 82.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.516 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.0 -42.18 89.47 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.695 179.432 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.407 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.2 mt -67.89 -33.48 74.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -39.78 91.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.0 -48.28 21.04 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.004 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.8 t -83.89 125.09 73.89 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.792 0.296 . . . . 0.0 111.286 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.56 63.23 7.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.694 2.262 . . . . 0.0 112.549 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.459 HG12 HG21 ' A' ' 129' ' ' VAL . 20.1 m -131.26 179.41 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -119.3 130.28 55.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 70.61 10.69 7.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.829 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 69.62 44.47 63.5 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.702 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.87 114.39 28.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.372 0.606 . . . . 0.0 110.601 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 124' ' ' VAL . 22.1 t -142.58 26.14 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.083 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.25 21.09 5.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.0 t80 48.97 38.29 12.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -116.88 -38.86 3.35 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.63 -37.44 84.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -67.94 -54.91 15.08 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.45 -31.7 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.95 -50.39 72.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 ttm -63.03 -32.24 73.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.37 -48.22 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.82 54.41 0.86 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.729 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.38 60.16 1.71 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.689 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.003 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.4 p -99.98 21.25 12.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.509 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.79 42.02 0.47 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.819 0.343 . . . . 0.0 111.011 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.4 113.05 4.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -64.72 -46.58 76.23 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.624 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.0 Cg_endo -82.17 -11.64 10.87 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.506 2.138 . . . . 0.0 114.072 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -114.5 -60.41 1.89 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.492 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.33 -48.49 81.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.596 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.48 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.14 -40.03 76.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.035 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.9 t80 -59.17 -44.51 92.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.315 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.4 m -62.5 -31.45 72.21 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.747 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 5.8 mt -65.91 -36.95 84.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -95.34 38.53 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.196 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -83.27 88.77 6.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.226 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -62.85 -37.71 87.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -86.54 -36.32 19.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.108 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.28 27.18 56.03 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.452 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.1 p -129.28 10.4 5.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.91 8.63 47.76 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.742 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -129.22 163.16 26.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.355 0.578 . . . . 0.0 110.958 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.484 HG12 ' CE2' ' A' ' 12' ' ' PHE . 6.3 pt -147.24 138.64 13.32 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.918 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.58 172.27 6.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.455 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.91 -37.63 6.57 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.8 p -60.14 -41.63 93.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.453 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 3.3 m -70.88 -54.73 10.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.372 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -50.04 -35.76 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.15 -74.44 0.29 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.535 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -28.56 69.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -61.45 -51.95 66.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 mt -60.92 -29.33 69.53 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.261 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.42 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -55.53 -39.9 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.052 0.22 . . . . 0.0 110.871 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.15 70.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.846 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -90.1 -43.06 10.73 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.681 0.277 . . . . 0.0 110.611 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.08 -88.19 0.1 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.505 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.95 172.79 12.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.962 0.41 . . . . 0.0 112.018 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.9 t-20 -122.06 110.23 33.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.21 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -84.19 -162.88 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.905 2.403 . . . . 0.0 112.53 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -92.96 166.52 12.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -54.71 -33.53 61.13 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.797 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.51 86.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.828 179.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -55.55 16.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -55.96 -45.39 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.103 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 m -62.16 -41.1 97.97 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.61 -38.27 77.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 63' ' ' VAL . 14.4 mt -64.9 -49.82 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.16 -25.33 46.15 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.882 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -64.21 -7.15 8.23 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.2 p -117.78 -46.59 2.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.775 0.261 . . . . 0.0 111.204 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.472 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -86.55 157.47 55.49 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.094 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -39.41 150.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.285 2.657 . . . . 0.0 113.39 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.6 -61.34 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.6 130.0 38.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.683 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.37 86.71 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.043 0.449 . . . . 0.0 111.061 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -82.95 -179.56 7.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.672 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 mtm -41.41 -46.79 3.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.944 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -68.66 -50.55 50.28 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.8 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.617 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.4 mp0 -58.0 -51.74 68.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -48.35 82.01 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.78 -36.46 79.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.285 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -52.61 64.67 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.187 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG13 HG21 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.6 -38.71 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.314 179.847 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.3 -51.98 64.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.025 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -84.46 61.68 6.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.313 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 50.4 ttp180 -58.05 -52.15 76.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.533 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 98.0 Cg_endo -80.53 18.66 1.2 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.495 2.13 . . . . 0.0 113.671 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 58.83 98.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.84 0.353 . . . . 0.0 111.787 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.45 176.97 14.63 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.145 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -100.63 -50.57 3.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.461 0.172 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -88.24 62.1 6.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.27 0.557 . . . . 0.0 110.362 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.76 -57.85 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.009 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.604 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 53.4 Cg_exo -51.03 -44.23 43.41 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.78 80.88 0.04 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.493 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.18 122.83 83.34 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.424 0.154 . . . . 0.0 111.131 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.94 -41.67 51.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.719 2.279 . . . . 0.0 112.118 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -67.14 -27.64 67.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -68.29 -50.85 50.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.638 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.45 95.77 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.597 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.29 -39.13 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.706 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -39.05 93.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.513 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -62.81 -47.23 90.61 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.4 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -74.84 -36.79 62.38 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.964 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -78.86 72.3 5.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.036 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.62 -62.74 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -113.3 23.62 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.498 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.27 73.85 1.56 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.008 0.432 . . . . 0.0 110.863 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -69.34 -43.37 73.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -89.07 -63.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.58 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.421 0.45 . . . . 0.0 111.292 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m 69.28 -74.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.772 0.429 . . . . 0.0 111.349 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.03 61.3 0.42 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 ptp -176.23 131.3 0.23 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -103.84 145.57 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.61 82.79 0.31 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.58 HG12 HD22 ' A' ' 118' ' ' LEU . 59.3 t -37.48 -39.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.6 -42.74 27.88 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.623 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 99' ' ' LEU . 2.0 pt-20 -81.24 -37.79 27.98 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.932 -0.157 . . . . 0.0 111.128 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.468 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.55 -39.9 89.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.549 0.214 . . . . 0.0 110.549 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -38.84 59.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.687 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.57 -36.2 71.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.623 0.249 . . . . 0.0 111.324 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 82' ' ' GLY . 26.3 t -82.7 -38.9 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.908 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mt -79.71 -48.98 12.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.4 m -53.57 -38.57 64.04 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.9 p -60.5 -25.56 66.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.95 -83.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -133.13 46.14 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.715 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 62.46 50.85 3.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.377 . . . . 0.0 111.157 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -67.92 -137.83 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.282 179.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.3 mt -68.32 76.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.4 p -68.29 -172.72 0.34 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.65 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -51.28 -42.95 61.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -64.34 -48.48 75.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.52 -53.31 59.64 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.622 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -66.78 -27.67 67.78 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.302 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -46.07 87.19 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.628 0.252 . . . . 0.0 110.474 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.18 -41.83 76.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.635 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.58 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.09 -43.19 99.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.971 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.432 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 3.2 mt -70.13 -32.9 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.274 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -39.94 95.77 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.015 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.11 -48.74 30.6 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.986 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 t -82.45 125.29 76.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.679 0.24 . . . . 0.0 111.142 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.17 58.54 6.99 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.661 2.241 . . . . 0.0 112.401 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 m -131.33 -178.67 2.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.138 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -119.18 135.86 54.47 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.499 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.49 14.66 9.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.811 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 64.26 55.65 22.44 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.794 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttp -103.54 113.03 26.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.255 0.55 . . . . 0.0 111.099 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 45.5 t -142.94 26.53 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.23 21.34 9.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.535 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 132' ' ' HIS . 0.5 OUTLIER 54.34 -166.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -178.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 131' ' ' TYR . 12.3 m170 71.34 -57.77 0.6 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.579 0.352 . . . . 0.0 111.24 -179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -52.56 -39.37 61.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.541 0.21 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 19.8 m-85 -68.26 -58.0 5.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.584 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.45 -32.21 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.29 -54.61 41.85 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.691 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 42.8 tpp -66.47 -30.49 70.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.4 mm -63.43 -49.98 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.916 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -104.68 64.47 0.74 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -148.65 42.27 0.97 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.16 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.6 p30 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.293 -179.921 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.4 m -74.54 -62.06 1.66 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.53 55.14 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.077 0.465 . . . . 0.0 110.754 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.98 86.01 7.07 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.765 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -66.68 -46.65 56.97 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.767 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 6' ' ' SER . 8.0 Cg_exo -73.41 -21.29 19.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.808 2.339 . . . . 0.0 113.822 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -107.74 -63.52 1.3 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -62.08 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.697 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 5.8 tt0 -56.67 -48.58 77.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.949 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.67 -40.43 87.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.1 t80 -60.12 -44.84 94.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.758 0.313 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -62.43 -31.29 71.97 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.748 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 20.1 mt -56.99 -40.35 76.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 31' ' ' LEU . 8.5 m-30 -97.73 32.28 2.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -61.63 130.0 43.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.957 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -56.61 8.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.778 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -136.3 26.02 3.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.412 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.94 27.61 72.96 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.728 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.6 p -95.86 -26.65 15.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.454 0.169 . . . . 0.0 111.258 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.34 18.63 8.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.883 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.493 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 36.9 mtt180 -129.69 160.51 33.15 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.878 0.339 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.563 HG12 ' CE2' ' A' ' 12' ' ' PHE . 4.1 pt -143.78 137.67 14.53 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.511 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.73 170.62 7.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.148 2.565 . . . . 0.0 113.027 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 18.7 pttp -43.78 -35.37 1.86 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -61.36 -46.11 91.57 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.464 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.2 t -70.41 -49.47 48.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.621 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -51.17 -34.94 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.496 -179.678 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.77 -67.7 2.06 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.331 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.22 -28.12 69.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 15' ' ' PHE . 10.4 tp -62.05 -48.6 79.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.9 -32.14 72.5 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.59 -40.29 71.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.816 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.48 70.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.472 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 m -107.14 40.03 1.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 110.498 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.31 -102.94 0.4 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.545 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 171.23 14.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 111.692 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -119.48 114.88 34.29 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.384 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.02 -162.08 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.896 2.397 . . . . 0.0 112.477 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.9 p -94.74 166.95 11.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.7 mm? -56.5 -34.49 67.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.41 75.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.644 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.26 -55.16 17.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.08 -49.3 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.828 179.635 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.0 m -55.65 -42.12 74.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.416 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -59.2 -42.86 91.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 mt -61.64 -41.98 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -56.63 -36.07 69.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -65.85 -1.77 3.23 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.6 m -118.07 -40.32 2.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.228 0.211 . . . . 0.0 110.937 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -102.89 156.41 35.34 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.332 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.6 Cg_exo -40.45 143.65 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.085 2.523 . . . . 0.0 113.083 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -22.85 -67.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.2 tt0 -91.66 129.35 37.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.609 0.242 . . . . 0.0 110.518 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -86.75 88.44 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.015 0.436 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.7 p30 -87.01 -179.85 6.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.306 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mtm -41.27 -46.98 3.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -53.41 41.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.529 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.18 -52.98 63.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -49.26 78.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.677 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.14 -27.92 69.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.387 0.136 . . . . 0.0 111.264 178.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -65.38 -43.19 91.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.965 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.466 HG22 HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.12 -38.91 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.995 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -36.26 77.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.488 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -118.03 37.43 3.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.87 0.367 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -60.18 -52.59 72.2 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.618 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 81.4 Cg_endo -85.15 19.41 1.4 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.647 2.231 . . . . 0.0 113.483 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 t30 54.73 80.26 0.13 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.879 0.371 . . . . 0.0 111.589 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.38 -169.66 25.0 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.993 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -116.93 168.67 10.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.554 0.216 . . . . 0.0 110.724 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 57.24 66.61 1.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.5 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 5.1 ttm 172.13 -50.71 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.277 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 90.3 Cg_exo -42.75 -55.21 2.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 123.123 2.549 . . . . 0.0 113.283 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.0 52.25 0.49 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.636 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.1 146.36 58.58 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.467 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.92 -44.75 28.21 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.783 2.322 . . . . 0.0 112.105 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.55 -26.7 67.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -48.24 65.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -37.9 79.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.036 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.31 -49.77 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.009 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.64 -31.46 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.854 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 102' ' ' VAL . . . -65.14 -51.64 48.49 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.643 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -76.59 -36.26 57.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.403 0.144 . . . . 0.0 110.934 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -78.68 73.44 5.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.969 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.43 -61.23 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.29 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.55 43.64 1.6 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.525 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' HB1' ' A' ' 90' ' ' ALA . 3.8 m-20 -130.79 75.63 1.67 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -51.67 67.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.05 -49.9 3.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.265 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 87' ' ' ASP . . . 58.13 53.97 6.24 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -74.79 -48.09 27.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.178 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.73 58.67 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.665 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 ptm -166.95 147.97 5.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.92 143.35 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.08 81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.052 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.529 ' HA ' ' CD2' ' A' ' 99' ' ' LEU . 72.6 t -43.3 -38.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.25 -48.2 54.06 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.744 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -77.03 -40.68 45.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.253 0.221 . . . . 0.0 110.657 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -59.25 -40.59 86.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.552 179.517 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -66.51 -49.35 66.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.518 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -52.13 -37.97 55.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.48 HG12 ' HA2' ' A' ' 82' ' ' GLY . 41.5 t -74.04 -49.26 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.804 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 4.8 mt -69.13 -28.3 66.33 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.0 m -64.3 -38.4 90.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.312 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.4 p -70.82 -12.98 61.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.1 -66.14 0.68 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.567 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.14 49.05 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.333 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.31 50.52 6.11 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 111.453 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 26.5 tptt -68.53 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.428 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 mt -71.21 76.96 0.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -62.43 -176.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.106 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -52.32 -35.98 52.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.99 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -51.02 63.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.424 0.154 . . . . 0.0 111.297 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.92 -50.01 75.64 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.906 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.427 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -66.6 -27.43 67.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.905 179.03 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -48.55 80.64 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.603 0.239 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.66 -42.05 87.23 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 179.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.479 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.1 -42.37 98.39 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.833 179.457 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.417 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -70.45 -33.07 70.88 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.03 179.616 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -39.99 92.17 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.45 -46.94 30.52 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.937 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.09 117.87 69.22 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.658 0.229 . . . . 0.0 111.036 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.7 64.66 5.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.463 2.109 . . . . 0.0 112.477 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.3 -178.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -118.92 135.65 54.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.638 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.64 17.62 11.0 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.623 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.458 ' HA3' ' HB ' ' A' ' 96' ' ' VAL . . . 61.49 64.05 4.33 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.988 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttt -111.38 116.78 31.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.241 0.543 . . . . 0.0 111.058 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 129' ' ' VAL . 39.5 t -142.23 26.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.8 26.3 15.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.5 t80 46.69 45.45 14.53 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.768 0.318 . . . . 0.0 111.616 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -119.56 -56.03 2.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.352 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -34.34 73.94 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 4.5 m-85 -67.69 -55.4 13.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.271 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.9 -33.95 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.55 -51.85 68.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.668 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.05 -33.77 76.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 139' ' ' LEU . 1.4 mt -65.62 -30.13 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.248 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.453 HD13 HG23 ' A' ' 138' ' ' ILE . 1.1 mp -99.14 -3.21 35.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.19 89.49 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.035 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.644 0.259 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 t -127.03 32.9 5.01 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.322 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -124.6 -72.88 0.65 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.462 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 54.51 81.41 0.1 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 111.18 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -64.3 -47.87 77.2 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.081 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.41 -13.93 12.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.403 2.069 . . . . 0.0 114.114 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -106.65 -65.87 1.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -73.12 -58.87 3.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.501 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 2.4 tt0 -56.8 -49.9 73.98 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.472 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.55 -41.46 85.62 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 23' ' ' ILE . 16.4 t80 -53.57 -45.21 69.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.39 -36.69 83.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.141 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.8 mt -62.86 -27.41 69.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.392 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 3.5 m-85 -94.23 18.93 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.86 99.26 11.66 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -61.1 -35.34 76.76 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.741 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.24 -29.13 23.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.27 42.86 41.03 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -117.87 -36.28 3.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.24 -11.12 2.78 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.587 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -118.1 147.73 43.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.272 0.536 . . . . 0.0 110.626 -179.831 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 12' ' ' PHE . 4.2 pt -127.55 140.88 39.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.848 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.28 173.25 3.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.257 2.638 . . . . 0.0 112.432 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.76 -36.69 2.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 p -59.6 -46.06 90.06 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.492 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 2.5 t -71.33 -49.64 40.52 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.56 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -51.41 -36.18 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.17 -73.1 0.44 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.67 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -65.12 -21.35 66.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.3 tp -65.93 -48.38 71.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -61.18 -30.55 70.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.841 179.124 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.47 -40.73 72.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.679 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.87 75.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.49 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.8 m -112.63 43.55 1.63 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 110.669 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.83 -105.39 0.4 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.808 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.37 169.98 15.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.417 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -119.11 112.48 36.17 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.157 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.74 -162.62 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.036 2.49 . . . . 0.0 112.737 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 p -97.68 165.33 12.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.4 mm? -54.88 -36.62 65.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.21 78.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.539 0.209 . . . . 0.0 110.453 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -51.48 58.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.56 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -61.1 -46.18 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.82 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.6 m -54.88 -41.52 70.96 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.144 0.278 . . . . 0.0 110.633 178.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -60.2 -41.98 94.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.63 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.405 HG21 HG12 ' A' ' 63' ' ' VAL . 21.1 mt -61.67 -49.53 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -57.46 -26.4 61.17 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.859 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -63.78 -10.08 18.02 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 p -117.91 -35.56 3.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.722 0.237 . . . . 0.0 111.526 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' HB3' ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -94.25 151.18 39.33 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.461 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 59.7 Cg_exo -36.97 141.89 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.337 2.691 . . . . 0.0 113.089 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -24.76 -61.31 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -93.63 129.52 39.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.51 86.94 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.03 -179.08 6.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.609 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.5 mtp -41.43 -47.16 3.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.988 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.05 -53.0 35.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.958 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.567 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.8 mp0 -57.49 -51.97 67.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.604 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -45.91 91.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.9 mt -60.73 -39.24 87.87 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -52.14 65.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.802 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 HG12 HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -73.65 -29.12 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.24 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 tp -60.46 -49.03 79.19 Favored 'General case' 0 C--O 1.227 -0.112 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.942 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.58 44.55 1.06 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -56.07 37.79 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.18 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 86.5 Cg_endo -83.73 18.73 1.47 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.624 2.216 . . . . 0.0 113.264 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.2 m120 59.07 98.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.7 176.34 18.82 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.427 179.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.06 174.15 6.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.187 0.195 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t70 50.9 62.26 2.8 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.389 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.539 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.57 -51.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.079 -179.114 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 37.4 Cg_exo -60.07 -44.39 29.81 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.659 2.239 . . . . 0.0 112.748 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -49.51 -78.49 0.09 OUTLIER Glycine 0 C--N 1.339 0.726 0 O-C-N 123.398 0.436 . . . . 0.0 112.962 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' HB3' ' CB ' ' A' ' 78' ' ' GLU . 19.6 m-20 -81.82 111.45 26.54 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.44 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.779 2.319 . . . . 0.0 112.786 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -71.94 -23.83 61.52 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.559 ' CB ' ' HB3' ' A' ' 75' ' ' ASP . 9.6 tt0 -69.22 -51.56 36.49 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.545 0.212 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -39.36 90.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.042 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.96 -45.61 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.4 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.96 94.34 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.507 ' HA2' ' CG1' ' A' ' 102' ' ' VAL . . . -64.11 -46.08 92.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.759 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -75.61 -36.09 60.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.381 0.134 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.81 72.5 5.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.1 t -140.62 -57.4 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.429 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.38 33.11 4.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.75 65.8 1.39 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -31.85 73.18 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.334 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -82.12 -62.04 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.377 179.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 72.96 -64.15 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.497 0.498 . . . . 0.0 111.799 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.1 p -66.67 95.19 0.33 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.8 -26.87 4.46 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.182 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.3 ptp -157.73 138.8 13.37 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.841 0.321 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -115.32 -40.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.027 -179.608 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 58.69 80.22 0.09 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.547 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.451 ' HA ' HD21 ' A' ' 99' ' ' LEU . 61.1 t -44.6 -34.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.93 -46.95 25.99 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.989 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.3 -47.66 26.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.555 0.217 . . . . 0.0 110.991 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -58.48 -38.38 77.48 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.249 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -67.06 -46.96 72.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -53.42 -40.9 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.868 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.507 ' CG1' ' HA2' ' A' ' 82' ' ' GLY . 4.0 t -77.21 -54.35 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 4.8 mt -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.6 m -60.5 -38.88 85.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.554 0.216 . . . . 0.0 111.036 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.4 m -71.18 -15.19 62.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.69 -59.5 2.76 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -158.36 43.56 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.463 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.87 52.37 10.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 111.29 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.41 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.05 179.134 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.44 77.63 0.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.986 0.357 . . . . 0.0 110.334 179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 p -65.79 -172.34 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.411 -178.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -50.75 -39.49 52.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.079 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.37 -49.76 70.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.492 0.187 . . . . 0.0 111.354 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.59 -52.84 63.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.605 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.467 ' HA ' HD21 ' A' ' 118' ' ' LEU . 2.9 ppp? -67.29 -26.24 66.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.405 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -49.31 77.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.352 179.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.79 -43.17 84.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.21 -40.17 92.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 179.684 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.69 -33.2 70.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.44 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.78 -38.46 91.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.749 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.87 -44.97 9.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.728 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.42 130.46 68.43 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.516 0.198 . . . . 0.0 111.175 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.02 62.85 8.09 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.36 176.69 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.229 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 46.78 2.27 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.899 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.94 -35.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.702 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.11 46.09 0.83 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.97 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.46 119.19 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.179 0.514 . . . . 0.0 111.179 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.5 32.01 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.804 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.718 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.453 ' HA ' ' HD2' ' A' ' 134' ' ' PHE . 2.7 t80 44.66 46.8 8.58 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.809 0.337 . . . . 0.0 111.532 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 -55.07 1.97 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.5 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.09 -33.01 71.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.699 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 131' ' ' TYR . 6.5 m-85 -68.15 -56.31 9.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.43 -33.17 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.507 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.29 -51.25 69.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.299 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 32.5 ttp -74.86 -31.66 61.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.603 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.1 mt -60.86 -39.94 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.614 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -88.18 63.67 7.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -153.6 70.73 0.85 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.825 -179.834 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.747 0.308 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.38 -46.61 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.621 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 19.5 m-20 72.39 81.37 0.14 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.689 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.511 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -67.41 -48.94 44.55 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.611 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 72.9 Cg_endo -78.44 -12.63 15.38 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.509 2.139 . . . . 0.0 113.995 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 3.2 m-85 -108.97 -64.86 1.19 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -59.0 2.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.554 -179.233 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.1 -49.27 78.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.06 -40.86 82.05 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.807 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.0 t80 -53.51 -45.74 69.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.466 179.156 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 m -62.37 -36.48 82.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.9 mt -60.57 -31.65 70.77 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.393 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 54.6 m-85 -93.77 26.45 3.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.589 0.233 . . . . 0.0 111.591 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -119.11 79.03 1.35 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.222 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -15.98 63.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.37 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -86.0 -24.68 26.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.45 67.02 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.664 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.6 p -105.65 -32.75 8.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.14 0.176 . . . . 0.0 111.397 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.63 23.8 5.53 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.944 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.534 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 2.3 mpt_? -130.56 159.63 36.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.741 0.27 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG12 ' CE2' ' A' ' 12' ' ' PHE . 3.7 pt -144.46 131.04 10.06 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.92 172.31 8.85 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.121 2.547 . . . . 0.0 112.137 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HB2' HG13 ' A' ' 44' ' ' ILE . 6.2 pttt -44.39 -37.65 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 p -62.43 -45.77 91.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.342 0.115 . . . . 0.0 111.225 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 6.3 m -66.91 -46.59 74.37 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.474 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.563 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.98 -35.62 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.052 179.502 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.65 -70.11 1.07 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.518 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -25.58 66.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.67 0.235 . . . . 0.0 111.455 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.406 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -61.31 -48.68 80.24 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.59 -35.55 78.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -32.2 68.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.329 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.89 -46.82 64.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 76' ' ' PRO . 7.5 p -65.44 -33.64 76.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.257 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.97 -67.88 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.284 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.49 160.21 35.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.706 0.289 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -131.98 153.63 81.44 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.252 179.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.84 -162.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.989 2.459 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -98.59 168.15 10.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.222 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.414 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.6 mm? -55.66 -32.4 63.18 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.58 94.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.192 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -53.61 53.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.388 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.81 -47.67 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.562 179.473 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.6 m -57.98 -40.54 80.93 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -57.35 -39.41 75.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.217 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.9 mt -63.78 -46.73 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -56.69 -25.63 54.63 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.34 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -64.16 -6.93 7.49 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.6 p -118.25 -45.45 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.781 0.264 . . . . 0.0 110.76 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.66 143.48 26.68 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -36.94 150.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.704 2.936 . . . . 0.0 113.534 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.89 -74.48 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -72.73 117.77 14.84 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.728 -179.093 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.98 93.11 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.2 p30 -81.93 177.92 8.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.685 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -41.79 -47.93 4.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.818 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -67.17 -48.24 68.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.645 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.99 -51.62 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.344 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -49.23 76.15 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.3 mt -61.12 -33.91 74.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -61.26 -52.68 63.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.37 -37.9 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.247 179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -48.42 75.7 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -96.44 54.11 1.35 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -60.42 -52.46 72.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.544 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 78.3 Cg_endo -82.76 18.89 1.39 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.682 2.254 . . . . 0.0 113.537 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 m120 60.08 98.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.592 0.357 . . . . 0.0 111.867 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.16 174.69 19.61 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.174 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -100.41 173.6 6.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.529 0.204 . . . . 0.0 111.085 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 54.93 61.9 2.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.149 0.499 . . . . 0.0 110.539 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.632 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 3.0 ttp -178.48 -51.75 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.331 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 72.7 Cg_exo -48.88 -45.36 28.84 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.528 2.152 . . . . 0.0 112.757 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.17 78.17 0.04 OUTLIER Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.06 132.64 56.14 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.44 0.162 . . . . 0.0 111.007 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.403 ' HG2' ' SG ' ' A' ' 35' ' ' CYS . 31.4 Cg_exo -58.74 -39.07 85.46 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.692 2.261 . . . . 0.0 112.13 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.13 -34.37 77.9 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.64 -47.47 78.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -41.27 92.24 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.708 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.6 t -61.72 -44.44 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.048 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.28 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.263 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.1 -47.03 92.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.273 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 15.0 m-85 -68.3 -29.46 68.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.84 1.95 21.64 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -51.08 -38.93 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.542 0.21 . . . . 0.0 111.498 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.67 21.6 1.99 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.46 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 54.09 1.97 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.152 0.501 . . . . 0.0 110.58 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -63.46 -54.19 40.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.28 -62.37 1.64 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.39 71.32 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.436 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -81.14 -41.55 22.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.62 49.1 0.42 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.649 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.5 ptm -176.47 136.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -105.81 -43.45 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.295 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.71 79.58 0.35 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.522 179.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.554 HG12 HD22 ' A' ' 118' ' ' LEU . 90.7 t -44.88 -37.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -45.36 -45.06 11.08 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 121.437 -0.411 . . . . 0.0 113.391 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 7.2 pt-20 -80.07 -39.22 30.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.843 0.322 . . . . 0.0 111.508 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -62.59 -40.29 96.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.612 0.244 . . . . 0.0 110.819 179.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 1.3 ppt_? -75.54 -35.75 60.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.06 -37.6 74.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.602 0.239 . . . . 0.0 111.329 179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.8 t -77.44 -44.08 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 mt -68.28 -34.12 75.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.278 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.457 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 20.0 p -63.01 -31.91 73.15 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.464 0.173 . . . . 0.0 111.356 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 m -67.6 -18.34 64.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.8 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.09 -61.9 1.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.28 52.68 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.427 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.75 51.94 4.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -68.18 -138.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.547 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.497 HD21 ' HG2' ' A' ' 114' ' ' GLU . 12.4 mt -71.21 76.23 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.457 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 62.2 p -66.39 -174.44 0.28 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.194 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.73 -34.67 27.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.313 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -52.19 58.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.534 0.207 . . . . 0.0 111.246 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.497 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.3 tp10 -56.62 -52.37 65.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.696 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.42 ' HA ' ' CD2' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -66.85 -26.62 67.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.446 179.495 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -46.36 87.45 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.076 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -66.94 -44.79 79.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.385 179.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.554 HD22 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.72 -39.77 89.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 179.11 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.14 -33.92 75.37 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.367 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -61.91 -38.46 88.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.45 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.16 31.05 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.881 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.496 HG13 HG12 ' A' ' 124' ' ' VAL . 5.7 t -87.79 119.71 70.65 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.724 0.262 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.89 64.56 4.04 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.678 2.252 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.496 HG12 HG13 ' A' ' 122' ' ' VAL . 17.0 m -131.48 -177.76 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.124 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -119.02 126.67 52.25 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.521 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 74.78 0.47 3.56 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.03 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 96' ' ' VAL . . . 80.33 49.92 5.65 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.268 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -103.36 116.38 32.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.491 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.1 t -142.35 26.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.999 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 61.77 23.65 13.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.795 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.423 ' CG ' HG13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER 49.71 45.44 24.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 111.467 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -120.05 -57.58 1.93 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.145 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -54.71 -36.08 64.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.72 -60.25 2.68 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.9 t -62.64 -32.48 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.417 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -58.14 -53.78 54.39 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.9 ttp -68.34 -29.28 67.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.5 mm -64.0 -43.31 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 mp -95.94 48.16 1.11 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 111.012 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.34 66.38 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.644 179.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.88 -179.668 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -65.88 -46.16 64.99 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.245 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 6.2 Cg_exo -78.33 -17.13 13.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.787 2.325 . . . . 0.0 113.632 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -110.9 -60.01 1.89 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -60.18 2.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.566 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.0 -48.07 82.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.61 -38.15 77.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 15.4 t80 -57.75 -45.62 85.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -62.56 -33.55 75.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.9 mt -61.04 -36.59 79.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.302 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -92.85 24.5 3.6 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.99 94.78 8.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.801 0.334 . . . . 0.0 110.416 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -33.11 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -86.19 -31.0 22.0 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.467 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.45 26.53 59.11 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -115.93 21.82 13.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.625 0.213 . . . . 0.0 111.26 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.18 19.81 77.61 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.321 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' CD ' ' HB3' ' A' ' 54' ' ' GLU . 6.7 mtt85 -130.4 151.4 50.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.096 0.448 . . . . 0.0 110.631 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 HD13 ' A' ' 28' ' ' ILE . 6.5 pt -140.97 142.42 27.72 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.03 170.95 6.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.283 2.655 . . . . 0.0 112.487 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HB2' HG13 ' A' ' 44' ' ' ILE . 49.5 pttt -44.24 -39.16 4.25 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.8 p -60.41 -43.95 96.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.46 0.171 . . . . 0.0 111.396 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.5 m -70.34 -45.74 65.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.657 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.763 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.45 -33.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.178 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 -68.21 1.8 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.309 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -28.27 69.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.51 -48.11 83.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.52 -33.16 73.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -56.13 -38.98 71.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.087 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.0 70.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.678 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -116.88 46.33 1.68 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.781 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.1 -106.59 0.42 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.974 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.2 -179.46 5.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 111.919 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 10.0 t30 -118.35 112.55 37.51 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.58 -162.97 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.953 2.435 . . . . 0.0 112.683 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -105.65 163.77 12.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.1 -35.96 62.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.6 82.6 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.815 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.98 -55.78 17.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.85 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.942 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.11 -46.56 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.901 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.7 m -57.53 -41.48 80.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -38.09 78.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.942 HD12 ' HA ' ' A' ' 44' ' ' ILE . 20.4 mt -62.92 -46.58 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -57.24 -28.43 62.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.353 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -13.39 45.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 p -118.13 -46.52 2.61 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.553 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.56 146.55 34.53 Favored Pre-proline 0 N--CA 1.463 0.225 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.2 Cg_exo -36.44 139.01 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.496 2.798 . . . . 0.0 113.039 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.84 -63.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.707 0.63 . . . . 0.0 112.477 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.89 120.66 25.95 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.709 0.29 . . . . 0.0 110.369 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.08 87.18 2.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.4 p30 -84.96 178.35 7.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.589 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -41.14 -44.5 2.55 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.78 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.1 -53.61 29.2 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.404 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.76 -52.57 64.48 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.186 0.304 . . . . 0.0 111.703 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.44 81.63 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 61' ' ' LEU . 25.1 mt -61.35 -33.26 73.33 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -51.95 67.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.55 0.214 . . . . 0.0 110.996 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG2' HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.59 -39.24 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.108 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 120.399 0.142 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.09 -43.93 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.342 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -40.14 94.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.669 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.74 ' HA3' HG11 ' A' ' 102' ' ' VAL . . . -63.6 -47.21 88.93 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.696 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.76 -30.15 66.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.454 0.168 . . . . 0.0 111.454 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.05 -14.96 62.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.1 t -47.86 -56.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.403 0.144 . . . . 0.0 111.305 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -113.49 39.84 2.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.027 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.51 62.24 1.46 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -63.74 -50.56 68.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.747 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.34 -54.76 2.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.85 81.17 0.15 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.958 0.409 . . . . 0.0 111.539 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -103.18 64.23 0.83 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.554 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.67 37.9 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.939 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 ptp -174.66 137.29 0.46 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.784 0.292 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.56 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -107.1 -39.96 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.427 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 79.24 0.61 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.83 ' HA ' HD23 ' A' ' 99' ' ' LEU . 54.6 t -45.22 -36.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.98 -42.73 16.1 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.288 -0.482 . . . . 0.0 113.305 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.94 -43.31 35.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.61 0.205 . . . . 0.0 111.135 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.83 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.06 -39.02 80.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.143 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.444 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 10.6 ptp180 -74.54 -37.09 63.12 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.854 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.71 -36.64 72.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.74 HG11 ' HA3' ' A' ' 82' ' ' GLY . 24.7 t -82.87 -52.56 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.715 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.856 HD22 ' HG3' ' A' ' 109' ' ' LYS . 6.0 mt -62.5 -50.1 72.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.5 m -60.73 -38.26 84.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.497 0.189 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.8 t -73.26 -19.05 61.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.73 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.72 -55.83 10.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.618 0.246 . . . . 0.0 111.028 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.19 45.81 0.29 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.371 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.99 48.02 13.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.856 ' HG3' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.49 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.768 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.401 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 18.4 mt -68.16 79.84 0.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 110.691 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.4 p -64.06 -175.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.126 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -47.7 -34.5 8.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.504 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.21 -60.02 4.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -41.11 95.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.199 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.802 ' HA ' HD23 ' A' ' 118' ' ' LEU . 5.5 mmt -66.79 -34.82 78.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.513 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -46.07 86.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.437 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -64.81 -37.94 89.3 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.802 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.5 -44.14 91.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.729 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.462 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.9 mt -65.03 -34.93 79.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -39.76 94.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.902 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.17 -49.52 26.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.752 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 18.7 t -79.85 127.58 76.99 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.612 0.206 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 4.6 Cg_exo -74.11 63.19 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.962 2.441 . . . . 0.0 112.33 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.36 175.9 10.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -121.4 19.1 11.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.739 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.37 26.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.49 ' HA3' ' CG2' ' A' ' 96' ' ' VAL . . . 54.97 50.99 56.74 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.666 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.7 112.8 25.91 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.275 0.559 . . . . 0.0 110.752 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 129' ' ' VAL . 43.2 t -142.35 20.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 59.74 21.88 10.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.843 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.418 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 48.38 41.52 16.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.764 0.316 . . . . 0.0 111.326 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -114.2 -54.46 2.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.401 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.506 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.9 t70 -57.14 -36.33 70.58 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.8 m-85 -68.05 -59.0 3.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.617 0.246 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.7 t -62.56 -33.05 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.463 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -61.63 -56.85 15.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.056 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.8 ttp . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.484 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.845 0.355 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.16 -46.14 95.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.536 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 89.4 Cg_endo -80.73 -16.0 10.53 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.503 2.135 . . . . 0.0 113.96 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -110.68 -60.83 1.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -61.43 1.8 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.341 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.475 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 6.0 tt0 -58.38 -46.85 85.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.839 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.56 -37.51 81.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.074 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 23' ' ' ILE . 20.5 t80 -56.29 -49.76 73.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -61.63 -33.76 74.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.333 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 8.4 mt -59.76 -33.92 72.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.43 0.157 . . . . 0.0 111.221 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 77.3 m-85 -93.28 32.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 121.63 30.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.759 0.314 . . . . 0.0 110.814 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -60.79 -52.22 66.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -107.11 -28.24 10.11 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.25 37.06 4.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.552 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.6 p -104.08 -20.76 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.17 3.61 8.06 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.444 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.619 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -122.59 162.46 21.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.253 0.527 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.789 HD12 HD13 ' A' ' 28' ' ' ILE . 5.1 pt -146.85 133.63 9.91 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.559 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.74 169.71 9.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.998 2.465 . . . . 0.0 112.345 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -43.89 -35.62 2.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.2 p -62.32 -45.04 95.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.493 0.187 . . . . 0.0 111.384 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.516 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 59.9 m -70.59 -44.82 66.53 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.823 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.789 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.83 -35.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.523 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.85 -66.92 2.43 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.67 -29.87 71.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.511 0.155 . . . . 0.0 111.002 179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 7.6 tp -61.11 -47.28 86.99 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.33 -32.72 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.049 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -40.48 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.027 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.18 -30.61 71.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.709 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.6 m -83.39 -44.36 14.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.591 0.234 . . . . 0.0 110.936 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.27 -81.55 0.04 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.707 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.2 -179.82 5.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -118.78 110.32 38.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.628 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.0 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.854 2.369 . . . . 0.0 112.361 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -104.53 166.59 10.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 25' ' ' LYS . 2.0 mm? -54.93 -35.55 64.3 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.88 76.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.761 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -56.43 9.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.706 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.15 -48.39 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.945 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.2 m -58.15 -41.29 83.45 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.04 -42.87 86.28 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.491 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.706 HD12 ' HA ' ' A' ' 44' ' ' ILE . 11.5 mt -63.04 -48.26 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.19 -25.12 58.49 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.844 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -63.86 -13.61 46.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -118.41 7.48 11.93 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.661 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -141.21 151.45 61.72 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 90.2 Cg_exo -38.3 143.76 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.275 2.65 . . . . 0.0 113.018 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.77 -58.62 0.13 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -92.27 125.43 36.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.592 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.1 t -86.79 83.51 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.619 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -81.72 177.29 8.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.562 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 60.9 mtm -40.68 -44.65 2.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.745 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.88 -51.57 46.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.918 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -58.09 -52.35 65.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -48.44 81.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt -61.54 -38.23 86.69 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.173 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.52 -54.39 41.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.661 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.66 -35.33 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.938 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.571 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.373 0.13 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.77 -40.01 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.943 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -48.49 80.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.86 95.91 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.66 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -70.2 -24.45 63.12 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.529 0.164 . . . . 0.0 111.407 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.17 -15.4 61.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.11 -59.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.187 0.195 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.551 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -110.33 44.02 1.3 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.981 0.42 . . . . 0.0 110.558 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.35 51.86 1.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -51.15 69.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -115.68 -59.31 2.01 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.08 90.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.561 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -105.69 56.71 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 110.79 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.51 49.42 1.84 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.927 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.15 135.87 0.48 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.68 0.276 . . . . 0.0 111.127 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -109.01 -42.75 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.336 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.12 81.58 0.33 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.949 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.734 ' HA ' HD23 ' A' ' 99' ' ' LEU . 86.6 t -43.55 -36.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.79 -37.98 15.44 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.594 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.551 ' HG3' ' CB ' ' A' ' 86' ' ' PHE . 2.6 tm-20 -73.2 -51.32 18.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.239 0.215 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.46 -37.18 74.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.489 ' HD3' HG21 ' A' ' 104' ' ' THR . 4.9 tmm_? -65.57 -47.89 74.24 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -53.96 -38.09 64.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.323 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' GLU . 21.4 t -70.73 -49.03 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.299 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.689 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.3 mt -65.02 -38.29 90.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.993 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 23.0 p -64.75 -35.44 81.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.523 0.202 . . . . 0.0 110.878 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -66.93 -19.75 65.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.651 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt -69.46 -61.19 1.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.584 0.23 . . . . 0.0 110.534 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.8 51.63 0.18 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.329 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 59.92 46.74 10.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.868 0.366 . . . . 0.0 110.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.689 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.74 -137.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.277 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.508 HD22 ' HG2' ' A' ' 114' ' ' GLU . 21.4 mt -69.16 79.24 0.35 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 92.6 p -64.36 -172.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.252 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -51.65 -31.17 24.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.265 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.81 -51.18 69.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.508 ' HG2' HD22 ' A' ' 110' ' ' LEU . 4.7 tp10 -58.76 -52.82 64.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.774 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.4 ppp? -66.16 -26.15 67.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -48.51 80.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.16 -45.14 89.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.405 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -58.91 -41.26 86.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.543 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.209 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -36.76 84.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.91 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.68 49.78 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.05 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 129' ' ' VAL . 21.5 t -87.3 128.45 55.19 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.803 0.302 . . . . 0.0 111.14 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.59 58.05 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.63 2.22 . . . . 0.0 112.595 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.39 -177.67 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.284 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 131.53 55.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.649 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.16 9.17 6.95 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.03 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.725 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 71.38 49.96 23.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.554 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -103.78 115.16 29.96 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.206 0.526 . . . . 0.0 110.725 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 129' ' ' VAL . 37.4 t -142.45 25.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.841 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 58.58 22.57 9.92 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.932 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 54.05 -158.7 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 68.78 -60.63 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.406 0.282 . . . . 0.0 111.569 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.01 -38.76 62.61 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.9 m-85 -68.36 -54.58 16.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.714 0.292 . . . . 0.0 110.695 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.5 t -62.15 -32.96 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.511 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.44 -52.19 54.91 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.686 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.9 ttp . . . . . 0 CA--C 1.533 0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.212 179.619 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.936 0.398 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.4 t -66.07 -46.92 63.46 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 6' ' ' SER . 84.6 Cg_endo -79.34 -14.04 13.35 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.516 2.144 . . . . 0.0 114.166 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.15 -61.59 1.7 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -72.29 -62.86 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -58.47 -47.73 83.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -45.26 87.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.936 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CE2' HG12 ' A' ' 23' ' ' ILE . 23.0 t80 -54.49 -45.99 73.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.74 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 m -59.27 -35.37 73.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.392 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 9.0 mt -60.53 -29.34 69.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.325 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 23' ' ' ILE . 49.1 m-85 -95.03 27.69 3.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.71 123.07 40.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 110.551 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -52.3 66.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.369 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -130.86 27.65 4.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.71 49.45 61.49 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.682 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -93.72 -29.01 15.62 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.1 -1.42 16.96 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.108 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.597 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -127.74 167.56 16.31 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.01 0.405 . . . . 0.0 110.607 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 28' ' ' ILE . 9.5 pt -144.23 134.31 11.87 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.56 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 23' ' ' ILE . 4.4 Cg_endo -86.32 171.75 7.46 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.39 2.727 . . . . 0.0 111.852 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.1 pttt -44.24 -36.6 2.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -61.01 -45.89 92.97 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.54 0.209 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.1 m -70.49 -46.6 63.41 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.933 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.645 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.39 -33.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.413 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.71 -68.89 1.41 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.444 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -26.69 68.87 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 111.407 0.151 . . . . 0.0 111.407 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.454 HD13 ' CE2' ' A' ' 15' ' ' PHE . 9.4 tp -64.07 -48.9 74.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.47 -30.61 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.62 -38.71 69.86 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.909 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.593 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.5 -42.31 25.52 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.748 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.3 -79.35 0.03 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.643 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.32 176.59 8.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.489 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -119.72 113.12 34.85 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.464 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.69 -162.63 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.755 2.304 . . . . 0.0 112.459 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -99.28 166.03 11.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.13 -33.64 63.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.887 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.2 79.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.34 -53.98 20.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.641 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.81 -46.88 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.003 0.189 . . . . 0.0 110.766 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 m -60.15 -39.74 87.45 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.34 -37.52 75.33 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.452 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 44' ' ' ILE . 39.0 mt -67.01 -45.63 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.896 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -56.66 -27.12 57.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.524 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -64.61 -7.72 11.56 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 p -117.7 -52.73 2.44 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 117.893 0.315 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.604 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -87.27 154.88 54.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.541 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -38.36 142.74 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.082 2.522 . . . . 0.0 113.07 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.51 -64.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.3 0.64 . . . . 0.0 112.599 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.1 123.18 31.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.494 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.42 86.33 2.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.597 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.7 p30 -85.08 179.66 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.357 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -41.55 -47.59 3.82 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.532 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.58 -52.54 60.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.541 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.79 -53.91 52.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.7 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -49.83 73.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.72 -28.98 69.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -63.77 -49.76 71.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.606 0.241 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.36 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.6 t -64.53 -53.76 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.552 0.215 . . . . 0.0 110.97 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -29.46 70.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.69 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.812 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -65.19 -49.04 63.77 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.555 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.09 -37.76 69.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.427 0.156 . . . . 0.0 110.969 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -78.91 73.16 5.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.9 t -135.1 -64.71 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.96 34.95 4.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.531 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -129.32 51.85 2.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.457 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 64.97 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.231 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -136.52 -72.88 0.44 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.69 45.82 27.21 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.626 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.37 44.6 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.11 33.7 3.92 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.624 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 ttt -171.73 134.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.152 0.476 . . . . 0.0 111.531 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.643 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -114.52 -42.1 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.28 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.66 80.49 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.22 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.745 ' HA ' HD23 ' A' ' 99' ' ' LEU . 81.7 t -44.41 -34.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -40.06 11.01 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.824 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.1 mp0 -76.09 -50.71 13.94 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.457 0.17 . . . . 0.0 110.783 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.745 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.13 -35.34 73.3 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -55.96 12.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.101 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -52.45 -38.59 59.61 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.812 HG11 ' CA ' ' A' ' 82' ' ' GLY . 42.1 t -72.12 -58.0 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.738 HD22 ' HG2' ' A' ' 109' ' ' LYS . 2.8 mt -60.99 -36.41 79.39 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 m -61.68 -36.84 82.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.588 0.232 . . . . 0.0 111.093 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.6 t -65.02 -22.8 67.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.994 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 3.7 mt -64.88 -72.95 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.508 0.194 . . . . 0.0 111.232 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.85 50.98 0.46 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 64.23 47.24 3.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.175 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.738 ' HG2' HD22 ' A' ' 103' ' ' LEU . 14.4 tptt -68.57 -138.12 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.455 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.9 mm? -69.18 77.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.8 p -69.89 -175.27 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.59 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -51.02 -38.83 53.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.704 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.47 -48.89 63.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.576 0.227 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 5.2 mm-40 -59.01 -51.64 69.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.635 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.3 -27.36 67.86 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -46.34 86.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -65.68 -44.34 86.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.369 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.99 -43.5 95.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.405 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -69.2 -32.97 72.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.35 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -61.68 -38.39 87.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.986 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 -46.62 43.66 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.953 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.92 127.12 63.51 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.706 0.253 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 59.61 6.19 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.72 2.28 . . . . 0.0 112.647 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.61 176.63 8.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.264 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -119.3 132.16 55.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.535 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t70 76.61 -1.92 2.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.887 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 78.26 51.02 5.89 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttp -104.2 113.17 26.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.54 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.652 ' O ' HG12 ' A' ' 129' ' ' VAL . 40.5 t -142.35 19.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.03 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.37 22.14 10.53 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.632 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 53.65 -158.12 0.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.5 t60 69.62 -60.19 0.48 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.168 0.187 . . . . 0.0 111.206 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.67 -41.76 64.13 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.5 m-85 -65.44 -57.06 9.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.07 -28.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.507 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.61 -49.83 73.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.683 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t -67.03 -47.37 52.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 6' ' ' SER . 75.4 Cg_endo -79.55 -13.17 13.53 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.534 2.156 . . . . 0.0 114.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.75 -63.16 1.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -72.85 -61.45 1.8 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.433 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.03 81.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.731 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.1 -44.27 87.58 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.481 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.5 t80 -52.05 -46.39 65.07 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.197 0.311 . . . . 0.0 110.471 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.6 t -60.5 -36.38 78.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.216 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.9 mt -59.78 -28.51 67.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.389 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 m-85 -89.02 19.99 3.86 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.24 92.36 4.48 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -61.66 -36.37 80.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -86.76 -37.01 18.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.117 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.34 45.32 5.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.439 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -109.25 -30.21 8.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.44 8.15 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.272 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -127.06 163.63 23.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.152 0.476 . . . . 0.0 110.655 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.786 HD12 HD13 ' A' ' 28' ' ' ILE . 3.7 pt -143.7 136.03 13.34 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.98 171.93 5.57 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.256 2.637 . . . . 0.0 112.287 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.508 ' HB2' HG13 ' A' ' 44' ' ' ILE . 14.3 pttm -43.83 -38.4 3.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -60.31 -44.89 95.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.496 0.189 . . . . 0.0 111.22 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.7 m -71.01 -47.41 58.93 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.786 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.19 -35.61 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.635 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.88 -68.08 1.79 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.456 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -28.09 69.26 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 5.7 tp -61.98 -46.46 89.15 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.63 -31.8 71.91 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -58.26 -41.83 85.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.16 68.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.488 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.25 42.59 2.67 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.16 -107.77 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.949 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.22 179.55 6.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.829 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 14.9 t30 -118.57 106.38 44.47 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.78 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.55 -163.71 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.053 2.502 . . . . 0.0 112.576 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -104.95 164.31 11.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.868 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.15 -37.65 62.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.994 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.15 77.91 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.695 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.12 -55.14 17.91 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.3 -46.89 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.875 -0.148 . . . . 0.0 111.106 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -55.37 -43.84 75.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -37.76 76.14 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.755 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.786 HG23 HG11 ' A' ' 63' ' ' VAL . 64.7 mt -61.09 -51.78 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -56.86 -27.45 60.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.753 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.76 -13.86 47.46 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 p -119.06 5.84 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.688 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -140.19 157.67 68.44 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 110.523 -0.176 . . . . 0.0 110.523 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 92.8 Cg_exo -42.05 146.39 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.141 2.561 . . . . 0.0 113.164 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.4 -63.02 0.09 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -95.1 131.15 41.42 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.477 0.18 . . . . 0.0 110.65 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.05 87.16 2.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.045 0.45 . . . . 0.0 110.924 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.97 -177.56 6.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.459 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mtt -41.21 -46.97 3.24 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -52.84 32.38 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.586 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.88 -49.77 75.6 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -48.64 79.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.833 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.87 -29.3 70.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.451 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -65.77 -48.08 73.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.994 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.786 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.19 -43.17 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.983 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.427 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 120.313 0.102 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.57 -50.25 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.013 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.03 67.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -71.59 -56.35 6.77 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.161 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -77.98 -39.82 41.24 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.13 73.54 4.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.186 0.517 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 86' ' ' PHE . 10.9 p -118.09 -43.69 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 86' ' ' PHE . 9.4 t80 -154.46 25.78 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 110.393 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.67 51.41 0.75 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.928 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -28.84 64.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.382 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.24 -57.79 3.23 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.037 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.98 -174.21 0.11 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p 44.64 59.98 3.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.038 0.447 . . . . 0.0 111.314 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.24 -33.43 0.27 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.08 144.24 9.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.556 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.66 -41.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.249 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.9 77.9 0.25 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.559 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.778 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.0 t -45.28 -42.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.89 -37.26 9.24 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.856 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.6 mm-40 -80.59 -47.23 14.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.5 0.191 . . . . 0.0 110.544 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.778 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -41.93 84.34 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -34.83 65.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.803 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -55.57 -38.34 69.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.561 0.219 . . . . 0.0 110.939 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.544 HG11 ' HA2' ' A' ' 82' ' ' GLY . 2.5 t -78.55 -46.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.236 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.3 mt -65.99 -46.21 78.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.9 m -55.88 -35.51 66.58 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.469 0.176 . . . . 0.0 111.43 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 t -71.81 -19.01 62.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.843 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.18 -68.22 0.41 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.444 0.164 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.89 55.85 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.566 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 58.69 45.54 15.72 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.333 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 10.4 mmtp -68.9 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.222 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.47 78.4 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.8 p -64.87 -176.6 0.28 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -52.62 -32.58 42.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.787 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -53.79 52.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.75 -51.45 69.5 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.953 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.871 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.38 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -49.07 78.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.639 0.257 . . . . 0.0 110.471 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -42.12 86.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.99 -43.55 98.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -71.07 -31.91 68.44 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.262 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -61.74 -40.83 96.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.634 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 -46.23 19.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.922 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.481 HG11 ' CG2' ' A' ' 129' ' ' VAL . 21.4 t -85.35 119.15 72.02 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 116.787 0.294 . . . . 0.0 111.13 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.07 63.9 6.91 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.56 2.173 . . . . 0.0 112.588 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 122' ' ' VAL . 23.3 m -130.77 -175.95 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.253 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -118.87 127.3 53.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 t70 72.53 6.86 5.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.852 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 72.85 53.67 7.92 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.915 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -104.03 116.97 33.19 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 129' ' ' VAL . 40.3 t -142.39 30.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 36.6 t30 61.38 19.0 9.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.946 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 56.36 -176.67 0.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.8 -52.04 0.68 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.384 0.273 . . . . 0.0 111.667 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.89 -45.72 67.65 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -68.78 -49.87 55.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.99 -31.68 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.411 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -66.08 -51.07 61.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.5 ttt . . . . . 0 CA--C 1.531 0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.697 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.786 0.327 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 5.0 t -65.22 -46.07 71.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.379 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.15 -15.21 11.69 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.514 2.143 . . . . 0.0 113.824 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -110.14 -60.43 1.8 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -72.6 -61.02 1.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.444 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.402 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 9.5 tp60 -59.03 -47.52 84.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.25 -39.23 82.17 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.012 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.7 t80 -56.03 -44.66 78.97 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -62.33 -35.97 80.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.272 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.57 -33.94 73.43 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.428 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -91.04 20.06 5.22 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.44 89.82 3.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 120.839 0.352 . . . . 0.0 110.193 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -66.41 -29.16 69.25 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.878 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -85.97 -28.35 24.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.52 31.67 65.34 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.1 p -101.02 -30.0 11.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.282 0.233 . . . . 0.0 111.246 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.05 11.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.266 -0.493 . . . . 0.0 113.092 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.56 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -119.53 157.91 27.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.01 0.405 . . . . 0.0 110.742 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.852 HD12 HD13 ' A' ' 28' ' ' ILE . 4.3 pt -138.3 139.75 26.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.46 170.42 7.9 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.096 2.531 . . . . 0.0 112.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HB2' HG13 ' A' ' 44' ' ' ILE . 10.7 pttp -45.14 -39.12 5.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 p -60.03 -43.3 95.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.545 0.212 . . . . 0.0 111.197 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.9 t -68.55 -51.95 37.2 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.167 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.852 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.92 -36.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.519 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.83 -71.98 0.58 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.649 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -27.98 69.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.8 -50.58 70.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.607 0.241 . . . . 0.0 110.356 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -61.44 -29.53 70.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.267 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.34 -38.75 69.16 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.061 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.51 69.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.704 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 t -114.66 40.04 2.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.33 -107.15 0.36 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 174.81 9.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.909 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 3.8 t-20 -119.5 107.04 41.45 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.156 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.91 -162.76 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.89 2.394 . . . . 0.0 112.75 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -93.63 166.53 12.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.188 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.46 -34.73 67.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.81 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.18 79.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.585 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.84 -55.17 24.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.055 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.615 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.96 -47.16 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.689 179.54 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -58.55 -39.9 81.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.42 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -58.71 -40.82 84.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.372 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.54 ' O ' HD22 ' A' ' 51' ' ' LEU . 55.1 mt -61.73 -50.21 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -56.98 -23.9 49.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.696 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -7.75 10.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 p -117.89 -45.44 2.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 117.627 0.194 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.6 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -89.97 159.01 43.69 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.092 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 72.0 Cg_exo -40.17 146.08 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 113.026 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -31.1 -60.37 0.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.205 0.602 . . . . 0.0 112.597 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -91.07 127.12 36.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.641 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.7 t -86.91 86.81 2.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.56 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.8 p30 -84.55 178.81 7.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.38 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtm -41.56 -47.94 3.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.689 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.95 -50.54 62.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.851 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.592 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.6 mp0 -56.81 -51.07 70.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.586 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -48.28 80.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 61' ' ' LEU . 35.9 mt -61.17 -34.28 74.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.425 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -60.96 -53.11 61.28 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.492 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -64.05 -42.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.889 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.17 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.77 -56.73 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.182 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -35.05 79.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.818 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.99 -47.12 86.16 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.637 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -77.56 -36.71 51.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.776 0.288 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -74.94 75.51 2.18 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.518 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 102' ' ' VAL . 45.1 t -127.31 -66.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.81 38.24 2.32 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 111.79 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.665 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 5.3 p30 -130.06 72.6 1.49 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.001 0.429 . . . . 0.0 110.782 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -31.16 68.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.655 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.18 -53.94 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . . . 60.58 69.06 0.71 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.271 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 -40.55 6.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.368 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -166.5 62.01 0.22 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.446 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 ptt? -175.68 140.24 0.45 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.268 0.227 . . . . 0.0 110.483 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.589 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.12 -43.32 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.599 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.75 81.15 0.1 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.158 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.741 HG21 HD21 ' A' ' 118' ' ' LEU . 70.6 t -42.84 -33.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.81 -39.12 17.0 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.749 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.677 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.3 pt-20 -76.9 -44.59 31.23 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.609 0.205 . . . . 0.0 111.202 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -64.8 -37.44 87.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.531 0.205 . . . . 0.0 111.223 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -49.79 60.29 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.763 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -53.79 -42.39 68.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.296 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.818 HG21 ' O ' ' A' ' 82' ' ' GLY . 48.0 t -66.76 -51.17 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.522 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 5.0 mt -64.63 -50.69 66.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.977 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -56.86 -31.37 64.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.6 t -66.95 -24.85 66.11 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.25 -67.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.79 55.84 0.29 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 45.13 7.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.952 0.406 . . . . 0.0 111.215 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 2.3 mmtm -68.61 -137.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.24 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.648 HD22 ' HG2' ' A' ' 114' ' ' GLU . 17.5 mt -69.41 78.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.656 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.7 p -68.65 -171.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -52.54 -33.17 44.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.385 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.52 -51.81 63.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.52 0.2 . . . . 0.0 111.497 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.648 ' HG2' HD22 ' A' ' 110' ' ' LEU . 2.5 tp10 -57.38 -51.56 68.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.79 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.899 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -66.77 -26.72 67.1 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -46.81 86.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.28 -43.97 84.89 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.899 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.7 -41.55 95.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.564 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -69.54 -30.82 68.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -62.99 -40.18 96.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.502 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -45.43 42.06 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.736 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.467 HG11 ' CG2' ' A' ' 129' ' ' VAL . 12.7 t -90.68 116.33 66.17 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.612 0.206 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.56 64.59 4.67 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.591 2.194 . . . . 0.0 112.658 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 122' ' ' VAL . 25.1 m -130.05 -175.44 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.084 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -118.62 124.59 47.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.443 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t70 76.55 -2.36 2.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.949 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 81.13 50.97 4.9 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.789 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 ttt -104.45 119.35 38.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 133' ' ' ASP . 27.9 t -141.14 28.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.62 24.27 13.08 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.027 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.3 t80 46.11 48.16 12.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 111.556 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -122.91 -53.05 1.87 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.507 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.658 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -59.57 -35.09 73.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.0 m-85 -68.15 -55.41 12.47 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.584 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.7 -34.09 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.021 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.54 -52.64 64.34 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.5 ttt . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.197 179.673 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 1.8 m-20 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.454 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.6 t -67.32 -48.02 47.73 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.706 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 6' ' ' SER . 80.3 Cg_endo -78.54 -9.05 16.11 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.483 2.122 . . . . 0.0 114.237 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.456 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 84.7 m-85 -118.94 -59.65 1.84 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -72.2 -56.87 4.82 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.221 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.8 -48.03 80.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.448 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.54 -38.18 77.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 23' ' ' ILE . 26.5 t80 -59.14 -46.87 87.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.431 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 1.1 t -62.76 -30.44 71.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.692 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 18.2 mt -57.32 -38.35 73.92 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.13 31.55 2.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -101.81 91.69 4.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.582 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -25.63 63.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.654 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -86.38 -35.57 19.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.062 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.64 26.37 59.04 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.618 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -109.64 -19.83 13.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.1 19.94 6.96 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.992 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtp180 -130.2 150.09 51.61 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.978 0.389 . . . . 0.0 110.687 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.703 HD12 HD13 ' A' ' 28' ' ' ILE . 7.9 pt -136.88 138.07 24.99 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.749 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.76 171.8 6.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.177 2.585 . . . . 0.0 112.52 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -45.28 -36.85 4.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -60.83 -44.89 96.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.459 0.171 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.553 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 24.1 m -70.81 -45.61 64.29 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.703 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.06 -33.27 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.76 -68.12 1.86 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.453 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -29.47 70.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.406 0.146 . . . . 0.0 111.24 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 tp -62.01 -50.47 71.93 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.13 -28.38 69.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.04 -41.04 74.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.048 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.0 -26.51 68.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -121.74 39.4 3.87 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.699 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.66 -110.1 0.43 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.798 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.7 178.21 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.082 0.468 . . . . 0.0 111.938 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 33.5 t30 -119.68 97.27 49.86 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.443 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.07 -162.55 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.822 2.348 . . . . 0.0 112.587 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 169.23 9.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.1 mm? -56.04 -33.85 65.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.6 78.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.671 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -54.2 41.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.249 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.792 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -59.74 -47.8 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.865 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.41 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 57.7 m -54.42 -43.53 71.6 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -56.49 -38.93 72.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.57 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 44' ' ' ILE . 33.2 mt -63.03 -49.77 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -56.39 -24.94 47.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.99 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -63.88 -8.23 10.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.4 p -118.03 -46.32 2.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.584 0.174 . . . . 0.0 111.014 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.607 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.44 156.03 41.81 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 87.6 Cg_exo -41.84 150.24 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.238 2.625 . . . . 0.0 113.088 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.65 -62.86 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.373 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -84.77 121.66 28.0 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.44 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.13 89.28 2.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -83.68 178.03 8.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.3 mtm -41.18 -46.73 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.834 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.32 -52.08 50.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.889 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.472 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.8 -51.26 69.65 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.476 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.1 -48.77 80.14 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.013 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.35 -35.16 76.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.69 -54.99 39.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.487 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.04 -36.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.87 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD13 ' HE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.339 0.137 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.104 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.465 0.174 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.9 t -64.52 -40.97 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.75 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -40.26 95.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.901 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -62.97 -48.07 83.59 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.07 -33.12 75.07 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.48 0.181 . . . . 0.0 110.865 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -62.26 -29.04 70.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.073 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.715 ' HB ' HG21 ' A' ' 102' ' ' VAL . 89.1 t -58.31 138.51 19.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.851 0.357 . . . . 0.0 110.393 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.35 22.79 3.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.728 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -136.71 62.12 1.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -70.79 -55.68 8.04 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.31 -60.08 1.6 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.046 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 67.81 -76.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.412 0.445 . . . . 0.0 111.764 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m 69.08 -77.6 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.755 0.422 . . . . 0.0 111.23 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.32 53.16 0.79 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.447 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.5 135.97 0.57 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.729 0.299 . . . . 0.0 110.786 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.83 -42.85 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.279 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 98' ' ' GLU . . . 66.25 81.84 0.14 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.858 HG21 HD21 ' A' ' 118' ' ' LEU . 78.8 t -43.38 -32.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.84 -36.09 32.72 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.103 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -79.84 -40.66 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.936 0.368 . . . . 0.0 111.181 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -65.44 -37.12 85.96 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.029 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.517 ' CB ' ' HE2' ' A' ' 115' ' ' MET . 0.0 OUTLIER -77.13 -37.21 54.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.218 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -60.1 -36.54 77.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.571 0.224 . . . . 0.0 110.911 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.901 HG11 ' HA2' ' A' ' 82' ' ' GLY . 21.4 t -82.65 -47.24 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.702 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.89 HD22 ' HG2' ' A' ' 109' ' ' LYS . 6.1 mt -70.35 -49.95 44.02 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.9 m -60.57 -34.25 73.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.441 0.163 . . . . 0.0 111.19 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -72.02 -20.29 61.72 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.548 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.57 0.224 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.7 53.2 0.28 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.405 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.71 45.37 10.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.89 ' HG2' HD22 ' A' ' 103' ' ' LEU . 4.2 tptt -68.63 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.117 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.828 HD22 ' HG3' ' A' ' 114' ' ' GLU . 54.7 mt -67.41 79.11 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -64.55 -168.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.99 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.48 ' HA ' ' HE3' ' A' ' 115' ' ' MET . 34.5 m120 -53.19 -31.05 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.381 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.4 -50.78 72.65 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.554 0.216 . . . . 0.0 111.297 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.828 ' HG3' HD22 ' A' ' 110' ' ' LEU . 5.0 tm-20 -56.26 -53.66 54.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.797 ' HA ' HD23 ' A' ' 118' ' ' LEU . 16.0 ptp -66.68 -25.1 66.39 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.368 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -47.72 83.15 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.732 0.301 . . . . 0.0 110.267 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -40.52 68.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -65.11 -43.77 90.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.178 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 8.7 mt -72.55 -26.91 61.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.362 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -66.54 -43.77 84.21 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.603 0.239 . . . . 0.0 110.728 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.1 -40.47 34.6 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.964 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 129' ' ' VAL . 47.3 t -83.88 130.46 55.12 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.679 0.24 . . . . 0.0 111.192 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.21 61.96 6.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.733 2.289 . . . . 0.0 112.38 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.561 HG21 ' H ' ' A' ' 128' ' ' MET . 5.2 p -131.19 168.05 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.76 50.52 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.098 0.475 . . . . 0.0 111.314 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.82 -36.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.413 ' HA3' HG23 ' A' ' 96' ' ' VAL . . . 114.7 35.62 1.38 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.034 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.561 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -103.38 117.35 34.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.66 ' O ' HG12 ' A' ' 129' ' ' VAL . 39.8 t -142.1 20.77 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 62.44 22.78 13.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.54 -167.43 0.11 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.21 -59.05 0.57 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.185 0.194 . . . . 0.0 111.165 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.95 -41.06 64.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 111.2 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 26.9 m-85 -68.28 -50.0 56.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.175 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.1 t -62.07 -27.56 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.352 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.83 -42.63 66.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.03 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.1 t -55.94 -46.24 99.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.753 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 6' ' ' SER . 86.1 Cg_endo -83.28 -8.95 10.59 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.563 2.175 . . . . 0.0 114.531 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -119.96 -63.99 1.31 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -60.1 2.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.232 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.43 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.55 -47.45 85.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.01 -41.07 82.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.228 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.0 t80 -57.94 -46.48 84.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.357 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -29.64 70.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.872 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 19.5 mt -59.04 -31.6 69.0 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -92.14 22.57 4.31 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.42 95.96 6.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.197 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -47.51 81.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.8 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.85 -30.48 21.43 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.74 40.08 8.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.389 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 p -95.62 -29.13 14.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.112 0.165 . . . . 0.0 111.313 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.64 12.77 7.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.417 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.58 162.35 29.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.085 0.442 . . . . 0.0 110.91 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.861 HD12 HD13 ' A' ' 28' ' ' ILE . 3.1 pt -143.77 140.57 17.42 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.565 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.75 171.82 8.13 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.185 2.59 . . . . 0.0 112.302 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.6 -39.61 3.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.2 p -60.29 -45.94 91.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.141 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.2 m -66.79 -45.59 77.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.833 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.861 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.54 -35.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.396 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -66.89 2.45 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.654 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.29 -27.94 69.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.702 0.251 . . . . 0.0 111.142 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.08 -48.65 80.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.15 -35.88 78.28 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -40.61 68.36 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.67 74.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.466 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 m -98.26 42.92 1.08 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.733 0.302 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.3 -93.77 0.58 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.95 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.8 167.36 19.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.907 0.384 . . . . 0.0 111.633 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -128.08 141.73 42.2 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.449 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.2 Cg_endo -86.77 -162.33 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.15 2.567 . . . . 0.0 112.29 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 p -97.65 167.33 11.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.939 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.4 mm? -54.14 -37.46 64.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.6 84.58 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -64.93 -52.27 57.27 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.804 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.19 -45.36 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.596 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -59.41 -42.97 93.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -40.37 79.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.541 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.971 HG23 HG11 ' A' ' 63' ' ' VAL . 17.6 mt -63.3 -47.91 89.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.38 -24.35 54.82 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.759 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.9 t -64.14 -10.31 21.97 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 p -117.88 -33.32 4.52 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.385 -0.197 . . . . 0.0 111.466 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -97.46 156.82 35.73 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 96.1 Cg_exo -41.87 148.11 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.12 2.547 . . . . 0.0 112.814 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -33.04 -52.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -97.76 126.75 43.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.784 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -87.26 89.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.6 p30 -84.58 178.56 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.394 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 40.5 mtm -41.09 -45.7 2.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.016 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.77 -52.55 42.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.969 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.586 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.25 -50.91 71.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -49.5 77.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.811 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.59 -32.61 72.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.484 0.183 . . . . 0.0 111.22 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -50.6 71.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.252 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.971 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.32 -44.8 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.2 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 120.298 0.094 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -64.65 -65.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 tppt? -58.85 -23.76 61.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.053 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.717 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -67.88 -51.37 35.18 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.695 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -75.38 -42.92 52.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.545 0.212 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.32 5.3 12.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 86' ' ' PHE . 7.1 p -49.7 -45.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.414 ' N ' HG13 ' A' ' 85' ' ' VAL . 41.0 m-85 -148.57 46.48 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 110.89 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -129.33 66.58 1.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -35.86 82.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.21 -64.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.725 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.67 -174.67 0.1 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.889 0.376 . . . . 0.0 111.773 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 56.96 29.51 16.46 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.727 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.32 36.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.241 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 167.93 132.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.805 0.442 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.459 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -103.43 -45.37 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.337 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.57 77.35 0.23 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.864 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.863 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.4 t -45.41 -33.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.16 -54.47 15.08 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.693 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 pm0 -72.95 -39.24 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.549 0.175 . . . . 0.0 111.32 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.863 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.67 -38.97 89.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.2 -47.27 74.46 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -54.29 -36.55 63.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.154 0.284 . . . . 0.0 111.196 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.717 HG21 ' O ' ' A' ' 82' ' ' GLY . 24.1 t -74.85 -47.52 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.709 HD12 ' CD1' ' A' ' 99' ' ' LEU . 7.3 mt -66.39 -34.43 77.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 17.6 p -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.415 0.15 . . . . 0.0 111.3 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 t -74.82 -16.77 60.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.827 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.421 HD12 HD23 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -68.25 -57.49 5.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.692 0.282 . . . . 0.0 110.941 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.42 55.73 0.07 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.221 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 60.0 43.74 14.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 36.3 mmtt -68.86 -138.56 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.23 77.03 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 77.4 p -72.66 -175.79 1.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.964 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -49.24 -37.51 23.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.416 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.28 -52.73 37.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.637 0.256 . . . . 0.0 111.323 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.07 -50.73 72.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.843 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.7 ppp? -66.77 -27.73 67.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.286 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -47.66 83.36 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.5 -41.34 93.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.785 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.843 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.98 -41.89 97.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.724 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.548 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.091 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.1 -40.03 92.2 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.74 -46.69 29.47 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.014 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.505 HG11 ' CG2' ' A' ' 129' ' ' VAL . 17.6 t -86.17 121.49 72.67 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.803 0.301 . . . . 0.0 111.179 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.4 63.98 7.2 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.58 2.187 . . . . 0.0 112.568 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 122' ' ' VAL . 23.3 m -131.02 -179.85 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.241 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.17 135.28 54.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 68.07 11.91 8.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.862 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.719 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 67.79 48.55 54.72 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.101 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.82 119.22 38.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 129' ' ' VAL . 28.3 t -141.2 29.45 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.4 t30 56.1 21.87 5.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.8 t80 47.41 39.78 9.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -116.95 -39.84 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' HB3' HG11 ' A' ' 129' ' ' VAL . 24.4 t70 -69.6 -35.45 75.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -67.54 -54.73 17.55 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.232 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.39 -34.52 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.459 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -62.68 -52.48 63.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 33.4 tpp . . . . . 0 CA--C 1.53 0.211 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.583 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.321 0.582 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.417 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -68.53 -45.53 35.73 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.69 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 88.2 Cg_endo -79.86 -20.56 8.93 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.466 2.111 . . . . 0.0 114.901 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 14.1 m-30 -105.76 -59.41 1.77 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.1 0.409 . . . . 0.0 111.806 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -73.03 -63.31 1.2 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.49 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -57.62 -49.18 77.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.222 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.66 -38.28 81.01 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.456 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' HG12 ' A' ' 23' ' ' ILE . 33.5 t80 -58.43 -44.15 89.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.694 0.283 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -61.88 -35.32 78.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -61.96 -39.03 90.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.91 22.99 7.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 130.79 41.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.579 0.228 . . . . 0.0 110.85 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -52.49 -58.0 8.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -133.97 24.41 3.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.398 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.61 30.75 78.11 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.934 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -95.15 -27.61 15.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.587 0.194 . . . . 0.0 111.295 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.69 10.9 6.78 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.292 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.53 160.41 34.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.272 0.536 . . . . 0.0 110.88 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 28' ' ' ILE . 6.1 pt -147.34 135.68 11.0 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.873 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 90.7 Cg_endo -89.42 171.5 4.37 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.179 2.586 . . . . 0.0 112.541 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HG13 ' A' ' 44' ' ' ILE . 5.3 pttm -43.05 -40.29 3.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 p -59.82 -42.71 94.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.472 0.177 . . . . 0.0 111.185 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 4.5 t -70.75 -52.82 18.29 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.453 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.767 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.03 -37.39 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.19 -69.1 1.34 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.474 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.55 69.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.27 -50.78 68.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.688 0.28 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -61.37 -30.43 70.53 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.023 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -35.44 67.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.95 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.86 70.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.665 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.91 -45.68 9.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.651 0.262 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.63 -87.86 0.15 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.43 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.25 175.81 9.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.987 0.422 . . . . 0.0 111.826 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.57 112.95 35.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.697 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -82.03 -162.98 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 113.024 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -95.17 165.37 12.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.89 -37.08 63.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.49 73.11 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.916 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.64 -53.91 16.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.291 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -59.91 -47.67 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.291 -0.164 . . . . 0.0 110.91 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.3 m -59.27 -38.53 80.36 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -41.78 90.61 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.367 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 44' ' ' ILE . 10.5 mt -63.43 -49.12 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.979 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.37 -26.84 61.67 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.728 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.99 -12.7 40.34 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -118.33 2.47 11.9 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -136.65 154.73 76.79 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 70.8 Cg_exo -38.59 140.98 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.28 2.653 . . . . 0.0 112.966 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -26.13 -60.69 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.761 0.663 . . . . 0.0 112.755 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -91.44 125.93 36.36 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.411 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.9 t -86.27 86.35 2.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 121.161 0.505 . . . . 0.0 110.44 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.3 p-10 -83.27 177.24 8.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.2 mtm -41.9 -45.37 3.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.543 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -51.17 56.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.853 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.0 OUTLIER -56.41 -53.61 55.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.486 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -49.3 76.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.192 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.18 -33.29 73.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.49 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -61.33 -50.55 72.5 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.259 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.531 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.64 -37.46 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.606 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 120.508 0.194 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.67 -45.78 97.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.855 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -33.93 76.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.266 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.699 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -60.23 -44.63 97.24 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.085 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -70.24 -34.06 72.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.479 0.181 . . . . 0.0 110.624 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.96 73.15 5.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.857 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.43 -64.2 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.854 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.78 28.44 6.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -139.91 70.0 1.36 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.133 0.492 . . . . 0.0 110.149 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -61.09 -44.58 97.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.894 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -49.2 10.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.43 55.52 7.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.492 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 m -82.81 -57.37 3.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.35 57.78 0.22 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.798 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.52 119.6 0.9 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.584 0.231 . . . . 0.0 110.991 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -103.92 139.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.909 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -105.14 82.73 0.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.883 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.81 ' HA ' HD23 ' A' ' 99' ' ' LEU . 55.0 t -41.74 -34.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.39 -50.05 58.05 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.917 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.2 pt-20 -75.65 -34.95 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.356 0.122 . . . . 0.0 110.92 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -63.02 -41.42 99.55 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 110.493 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -67.42 -47.45 70.19 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -51.7 -46.99 64.08 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.174 0.296 . . . . 0.0 111.385 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.699 HG11 ' CA ' ' A' ' 82' ' ' GLY . 53.2 t -61.05 -49.49 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.363 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 99' ' ' LEU . 3.8 mt -67.81 -28.15 67.33 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.1 m -65.33 -41.52 93.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.574 0.226 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -74.52 -7.86 54.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -50.74 20.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.644 0.259 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.67 53.73 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.558 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.42 41.72 15.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HG3' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.81 -138.91 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.301 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 114' ' ' GLU . 3.6 mt -68.74 78.85 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -64.52 -174.61 0.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.143 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.439 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 8.8 p30 -49.22 -35.36 17.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.573 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -57.49 -51.08 70.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.547 ' HG3' HD23 ' A' ' 110' ' ' LEU . 11.3 mm-40 -56.74 -52.46 64.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.869 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.82 ' HA ' HD23 ' A' ' 118' ' ' LEU . 9.1 ptm -67.0 -25.99 66.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -48.11 81.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.661 0.267 . . . . 0.0 110.43 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.77 -41.96 78.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.66 -41.72 99.22 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.148 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER -70.85 -33.12 70.32 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.514 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -63.54 -41.38 98.46 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.952 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.24 -40.97 39.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.985 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.559 HG11 ' CG2' ' A' ' 129' ' ' VAL . 63.9 t -81.83 132.79 53.36 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.874 0.337 . . . . 0.0 111.193 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.9 58.68 7.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.802 2.334 . . . . 0.0 112.614 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.488 HG22 HG12 ' A' ' 122' ' ' VAL . 25.1 m -131.48 175.03 12.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -125.5 18.71 8.13 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.835 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -159.96 22.63 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 54.39 40.82 70.1 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.811 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.96 112.96 26.16 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.271 0.558 . . . . 0.0 111.353 -179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 129' ' ' VAL . 32.3 t -142.84 25.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.292 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.48 26.6 16.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.434 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.5 t80 45.62 41.53 7.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.416 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -114.8 -53.56 2.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.406 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.5 ' CB ' HG11 ' A' ' 129' ' ' VAL . 34.7 t70 -61.13 -34.7 75.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.51 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 4.9 m-85 -67.76 -56.62 8.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.371 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.92 -32.66 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.124 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -62.81 -48.37 79.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.83 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.5 ttm . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 179.418 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 22.0 m-20 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.993 0.425 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.423 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -62.41 -47.14 89.78 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.5 Cg_endo -83.75 1.64 8.76 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.574 2.183 . . . . 0.0 114.371 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 86.6 m-85 -126.9 -63.5 1.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.795 0.27 . . . . 0.0 111.609 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 2.1 mtpm? -72.44 -58.01 3.72 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.065 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -48.4 80.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.592 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.546 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.91 -38.25 78.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.289 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 23' ' ' ILE . 13.8 t80 -59.16 -45.81 90.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.374 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 m -62.65 -32.62 73.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.643 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.2 mt -61.03 -33.67 73.64 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 23' ' ' ILE . 66.5 m-85 -94.26 33.1 1.42 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.16 127.66 33.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.961 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -70.9 -56.72 5.64 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -112.2 -21.38 11.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.907 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.81 30.67 5.1 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.917 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -105.84 -29.02 10.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.622 0.211 . . . . 0.0 111.263 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.69 28.34 1.44 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.322 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.536 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.75 156.02 45.66 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.987 0.393 . . . . 0.0 110.183 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.743 HD12 HD13 ' A' ' 28' ' ' ILE . 5.6 pt -143.22 133.17 11.98 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.79 170.06 11.55 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.049 2.499 . . . . 0.0 112.309 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.68 -38.6 4.47 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 p -60.95 -43.91 98.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.512 0.196 . . . . 0.0 111.109 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.467 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 20.7 m -68.22 -46.47 70.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.565 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.743 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.35 -35.66 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.462 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.64 -69.22 1.33 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.584 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -26.03 68.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.529 0.164 . . . . 0.0 111.313 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 12.0 tp -61.62 -49.15 77.72 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -61.79 -32.27 72.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.056 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -55.36 -39.18 69.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.216 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.8 71.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.699 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.61 -45.47 13.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.99 -80.34 0.03 OUTLIER Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.942 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.97 178.79 6.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.651 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 6.5 t-20 -119.02 118.81 32.64 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.501 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 -162.43 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.397 . . . . 0.0 112.601 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 p -102.69 162.43 12.93 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.22 -33.94 63.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.98 80.74 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.933 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.68 -56.37 9.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.225 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.646 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.83 -47.24 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.327 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -61.17 -43.38 98.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.71 -40.01 78.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 44' ' ' ILE . 24.8 mt -61.63 -52.66 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -56.63 -23.41 40.99 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.826 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -63.74 -8.19 9.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.9 p -118.17 -46.74 2.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.599 0.181 . . . . 0.0 111.001 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.25 156.54 57.05 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.627 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.9 Cg_exo -39.32 145.43 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.359 2.706 . . . . 0.0 113.317 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.24 -64.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.471 0.708 . . . . 0.0 112.805 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -88.58 127.52 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.448 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -86.42 84.56 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.01 0.433 . . . . 0.0 110.512 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -81.71 179.24 7.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -41.1 -45.57 2.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -68.67 -52.05 35.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.627 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.2 mp0 -56.86 -51.83 67.5 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.563 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -48.85 79.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.624 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 61' ' ' LEU . 27.7 mt -61.5 -31.69 71.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -61.46 -50.49 72.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.604 0.24 . . . . 0.0 111.01 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.559 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.57 -40.62 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.95 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.4 -43.87 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.715 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -30.21 69.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.303 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -62.81 -50.54 63.04 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.026 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.75 -41.0 72.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.73 0.3 . . . . 0.0 110.219 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -79.81 70.54 6.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.028 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.9 t -124.94 -64.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.455 ' HB2' ' HG2' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -99.37 43.15 1.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 1.8 m-20 -137.96 71.2 1.39 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -51.38 68.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.13 -54.89 3.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.674 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 51.47 56.27 8.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.656 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -110.3 69.4 0.69 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.95 49.3 1.63 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.99 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.98 144.84 0.62 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.788 0.327 . . . . 0.0 111.378 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.88 -44.38 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.285 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.47 80.84 0.21 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.368 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.789 ' HA ' HD23 ' A' ' 99' ' ' LEU . 72.8 t -44.27 -36.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.99 -42.03 22.38 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.565 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.4 tm-20 -71.98 -50.97 24.33 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.524 0.202 . . . . 0.0 110.518 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.91 -35.19 70.71 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.226 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -66.25 -48.95 68.86 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.678 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.61 -36.18 69.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 98' ' ' GLU . 43.4 t -72.04 -46.79 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.786 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 99' ' ' LEU . 3.8 mt -74.78 -49.32 21.27 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -57.32 -36.04 70.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.4 t -69.42 -21.69 63.74 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.79 -62.61 1.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.529 0.204 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.76 52.54 0.26 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 59.92 45.23 12.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.966 0.412 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 4.6 mmmm -68.55 -137.97 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.078 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -68.21 79.04 0.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.1 p -62.12 178.88 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.52 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.55 -30.99 14.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.207 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.4 -54.59 41.61 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -58.31 -46.6 85.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.827 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.8 mmt -67.12 -31.84 72.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.41 77.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.581 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.26 -42.63 93.08 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.529 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.827 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.97 -42.68 94.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.464 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.571 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -68.33 -33.08 73.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -39.43 92.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.76 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -48.81 32.56 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.92 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 129' ' ' VAL . 14.8 t -84.31 121.43 75.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.741 0.27 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 62.96 5.7 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.668 2.245 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.51 177.9 6.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -119.34 133.43 55.73 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.732 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 73.03 5.57 5.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.938 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 72.12 51.19 14.67 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.97 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -106.06 115.64 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 129' ' ' VAL . 38.8 t -142.34 30.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.74 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.69 25.35 11.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.439 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 47.24 45.78 16.52 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.774 0.321 . . . . 0.0 111.499 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -120.57 -54.26 2.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.259 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.501 ' CB ' HG11 ' A' ' 129' ' ' VAL . 31.3 t70 -58.0 -38.88 76.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.723 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.4 m-85 -66.43 -56.93 8.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.574 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.3 t -61.84 -31.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.313 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -57.74 -55.95 28.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.953 0.406 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.8 -46.62 92.87 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.7 Cg_endo -82.6 -12.94 9.86 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.585 2.19 . . . . 0.0 114.077 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -111.35 -61.28 1.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -72.57 -62.1 1.56 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.394 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.44 -48.86 79.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.809 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.86 -41.6 82.76 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.522 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.2 t80 -54.21 -44.68 71.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.325 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.59 -36.1 81.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.339 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.7 mt -60.91 -35.87 77.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.447 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.93 33.74 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.18 133.17 49.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.689 0.28 . . . . 0.0 111.053 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -54.63 12.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.483 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.47 25.24 2.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.454 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.7 40.67 99.09 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.736 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 p -106.08 -31.27 8.8 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.79 -8.91 6.83 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.46 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -118.91 162.64 18.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.12 0.46 . . . . 0.0 111.037 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.711 HD12 HD13 ' A' ' 28' ' ' ILE . 5.8 pt -138.54 132.21 16.39 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.71 169.25 13.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.944 2.429 . . . . 0.0 112.435 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -45.16 -36.28 3.68 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.119 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.5 p -62.13 -44.18 97.19 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.404 0.145 . . . . 0.0 111.334 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 32.6 m -69.19 -45.7 69.29 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.711 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.94 -35.26 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.36 -67.66 2.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.678 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.92 71.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.549 0.174 . . . . 0.0 111.058 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -59.18 -50.14 75.18 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . 47.0 mt -59.06 -32.52 69.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -55.41 -41.18 72.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -69.68 -28.79 66.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 32' ' ' LEU . 30.8 p -113.79 36.29 3.71 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.064 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.94 -104.6 0.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.658 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 175.84 8.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 111.562 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -128.54 105.26 19.18 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.45 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.05 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.762 2.308 . . . . 0.0 112.535 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.54 167.51 11.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 25' ' ' LYS . 2.9 mm? -55.78 -33.05 64.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.07 75.51 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.014 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -56.53 9.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.011 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.755 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.45 -45.65 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.208 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -59.45 -42.69 92.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -57.42 -38.36 74.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.721 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 44' ' ' ILE . 39.4 mt -62.69 -51.29 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -56.79 -24.05 47.78 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.659 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.0 m -64.62 -8.67 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -118.01 -46.43 2.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.706 0.23 . . . . 0.0 111.179 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.587 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -91.07 158.24 41.84 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.3 Cg_exo -40.95 147.76 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.416 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.98 -67.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.597 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.54 124.9 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.624 0.249 . . . . 0.0 110.392 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 59' ' ' GLN . 57.0 t -86.47 90.81 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -87.67 -179.31 6.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.7 mtp -40.86 -49.91 3.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.603 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -63.29 -53.31 54.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.554 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -56.51 -53.55 56.18 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.154 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -49.57 76.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.92 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 mt -61.69 -29.68 70.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -65.33 -48.15 74.04 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.594 0.235 . . . . 0.0 111.264 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -41.77 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.163 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.231 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 CA-C-O 120.433 0.159 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.37 -43.67 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.088 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.69 -35.04 79.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.582 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.887 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -70.75 -43.88 58.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.561 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -76.48 -39.09 54.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.509 0.155 . . . . 0.0 111.302 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.45 73.66 5.0 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.106 0.479 . . . . 0.0 110.704 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 86' ' ' PHE . 13.2 p -131.83 -45.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.5 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.431 ' N ' HG13 ' A' ' 85' ' ' VAL . 10.0 m-85 -134.36 39.84 3.04 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -109.81 60.58 0.6 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -39.72 79.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.81 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.57 -64.8 1.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.26 -86.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.429 0.456 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t 42.62 45.78 4.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.03 40.09 0.39 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.329 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.6 ptp -176.68 136.05 0.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.93 0.365 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.55 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.87 -43.26 8.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.22 80.53 0.15 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.747 ' HA ' HD23 ' A' ' 99' ' ' LEU . 97.0 t -44.09 -36.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.24 -38.65 19.4 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.777 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.5 mt-10 -74.11 -52.26 13.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.522 0.201 . . . . 0.0 110.684 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.16 -38.25 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -73.46 -41.02 63.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.935 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -53.51 -42.13 67.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.527 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.887 HG11 ' HA2' ' A' ' 82' ' ' GLY . 4.1 t -74.11 -50.77 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.436 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 99' ' ' LEU . 2.9 mt -58.67 -45.76 88.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.884 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 56.3 m -65.41 -36.83 85.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.567 0.222 . . . . 0.0 110.952 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 t -63.62 -23.13 67.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.31 -70.67 0.23 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.518 0.199 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.25 48.95 0.49 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 61.16 45.99 8.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 111.012 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.62 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.985 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 114' ' ' GLU . 55.6 mt -66.94 79.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.291 0.496 . . . . 0.0 110.679 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.437 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 99.5 p -63.59 -170.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.045 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -52.67 -32.7 43.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.148 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -57.29 -50.58 72.46 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.704 ' HG2' HD22 ' A' ' 110' ' ' LEU . 11.4 tp10 -56.18 -54.47 44.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.742 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.889 ' HA ' HD23 ' A' ' 118' ' ' LEU . 4.1 ptt? -66.68 -25.41 66.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.457 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -46.32 87.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.97 -45.83 73.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.294 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.889 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.09 -40.57 90.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.594 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.9 mt -69.5 -32.13 70.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -61.27 -40.93 95.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.362 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.38 51.65 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.989 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 129' ' ' VAL . 10.8 t -91.23 116.67 66.9 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.749 0.274 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.08 65.03 4.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.492 2.128 . . . . 0.0 112.632 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.12 -179.24 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -118.68 132.7 56.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.567 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.99 6.18 5.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.955 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.619 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 71.03 53.33 10.95 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.909 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttt -106.83 119.61 39.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.641 ' O ' HG12 ' A' ' 129' ' ' VAL . 39.3 t -142.34 20.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.56 22.06 10.66 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.09 -164.53 0.14 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 m170 71.37 -58.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.28 0.232 . . . . 0.0 111.209 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -52.72 -39.68 62.3 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.509 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 17.8 m-85 -68.11 -52.72 31.73 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.73 -30.79 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.225 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -62.51 -54.14 44.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.846 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.6 ttt . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.587 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 62.1 m-20 . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.932 0.396 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.3 t -58.69 -45.79 99.62 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.343 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 85.3 Cg_endo -84.63 -3.74 9.95 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.543 2.162 . . . . 0.0 114.641 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 59.0 m-85 -123.99 -62.64 1.27 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.972 0.351 . . . . 0.0 111.809 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -72.66 -60.84 2.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.944 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -60.51 -45.57 93.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.11 -44.88 87.92 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.181 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 23' ' ' ILE . 25.9 t80 -56.78 -43.12 80.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.823 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -62.48 -34.05 76.08 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -59.5 -34.05 72.1 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 23' ' ' ILE . 44.1 m-85 -94.25 33.22 1.4 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.92 129.4 39.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.618 0.247 . . . . 0.0 111.015 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.58 -61.89 1.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.512 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -130.95 25.75 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.184 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.75 39.18 95.09 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.535 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -104.57 -24.43 12.99 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.49 11.63 17.01 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.891 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 4.8 mtt-85 -129.0 163.17 25.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.746 0.273 . . . . 0.0 110.445 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.781 HD12 HD13 ' A' ' 28' ' ' ILE . 5.4 pt -140.14 133.74 15.3 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.49 172.43 8.11 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.158 2.572 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.6 pttp -43.49 -40.97 4.13 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -60.06 -43.13 95.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.507 0.194 . . . . 0.0 111.404 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.0 m -70.95 -45.57 63.93 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.766 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.781 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.32 -33.06 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.477 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.53 -67.54 2.16 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.25 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.4 -28.13 69.48 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.46 -46.76 88.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.28 -34.85 75.87 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.753 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.419 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.33 -41.08 65.37 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.794 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -63.68 -34.9 78.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.682 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -101.03 44.35 1.02 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.845 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.69 -97.78 0.57 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.817 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.68 170.43 14.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.721 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -122.47 131.96 24.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 59.3 Cg_endo -85.82 -163.27 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.973 2.449 . . . . 0.0 112.743 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p -98.15 163.25 12.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -51.53 -37.51 49.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.145 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.606 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -61.24 -55.12 35.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.0 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.73 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.58 -47.97 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.819 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -57.56 -41.73 81.59 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.75 -40.7 76.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 44' ' ' ILE . 20.2 mt -62.79 -51.01 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.037 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -56.44 -23.54 39.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.905 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 t -63.97 -7.6 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 p -118.23 -46.17 2.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.684 0.22 . . . . 0.0 111.146 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.76 156.57 49.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.7 Cg_exo -39.01 146.11 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.355 2.703 . . . . 0.0 113.279 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.08 -68.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.744 0.653 . . . . 0.0 112.609 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.5 tt0 -85.84 127.68 34.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.643 0.259 . . . . 0.0 110.399 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.65 87.77 2.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.032 0.444 . . . . 0.0 111.314 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -82.33 177.56 8.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 ttm -41.61 -45.09 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.78 -51.54 47.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.572 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mp0 -56.82 -51.85 67.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.527 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -48.88 79.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.93 -32.6 72.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.427 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -61.47 -51.77 67.29 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.066 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -70.43 -41.7 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.563 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -26.56 66.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.672 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.81 -50.4 58.6 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.466 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -72.96 -37.51 67.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.562 0.22 . . . . 0.0 111.008 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -79.12 4.78 13.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.76 -43.8 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -145.75 33.6 1.03 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.765 0.316 . . . . 0.0 111.413 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.448 ' CG ' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -130.92 76.24 1.71 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.063 0.459 . . . . 0.0 110.347 179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.93 -48.94 78.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.178 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -91.82 -64.02 1.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.99 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.448 ' HB2' ' CG ' ' A' ' 87' ' ' ASP . . . 48.82 52.86 13.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.803 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.4 p -102.73 -48.05 4.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.85 26.22 9.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.0 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.491 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -174.59 148.64 1.18 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.862 0.331 . . . . 0.0 110.974 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.521 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -118.11 -44.25 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.79 81.15 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.337 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.75 ' HA ' HD23 ' A' ' 99' ' ' LEU . 73.3 t -44.3 -34.81 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.68 -35.73 17.29 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.093 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -80.65 -46.34 15.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.619 0.21 . . . . 0.0 110.916 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.99 -39.92 83.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.857 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.471 ' HG2' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -75.07 -36.12 61.79 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.611 179.042 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.78 -40.54 63.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.905 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 82' ' ' GLY . 21.3 t -82.33 -51.46 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.532 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 99' ' ' LEU . 2.4 mt -58.31 -49.85 75.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 m -59.7 -39.3 84.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.445 0.164 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -72.13 -19.82 61.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.81 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt -65.35 -66.69 0.51 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.603 0.239 . . . . 0.0 110.97 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.92 47.86 0.47 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.336 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.61 45.89 7.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.8 mmmm -68.77 -137.7 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.158 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.843 HD22 ' HG2' ' A' ' 114' ' ' GLU . 34.6 mt -69.43 79.33 0.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.619 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -64.97 -173.02 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.913 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 4.3 p-10 -51.88 -34.89 43.09 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.606 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.6 -55.44 30.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.843 ' HG2' HD22 ' A' ' 110' ' ' LEU . 3.2 tp10 -55.34 -51.28 67.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.848 ' HA ' HD23 ' A' ' 118' ' ' LEU . 22.0 ptm -66.82 -27.6 67.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -47.3 83.58 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.82 -43.47 79.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.848 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.49 -43.11 97.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.634 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.451 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.4 mt -67.95 -32.62 73.19 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.236 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -41.58 98.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.617 0.246 . . . . 0.0 110.724 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.99 -44.2 37.53 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.878 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 124' ' ' VAL . 58.6 t -78.97 133.21 61.84 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.675 0.237 . . . . 0.0 111.189 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.39 59.94 7.31 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.788 2.326 . . . . 0.0 112.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 128' ' ' MET . 17.2 m -131.49 174.12 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 48.2 2.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.27 0.557 . . . . 0.0 110.555 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 175.13 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.834 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 112.71 50.3 0.56 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.922 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.35 114.46 28.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.268 0.556 . . . . 0.0 110.698 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 129' ' ' VAL . 40.4 t -142.18 26.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.101 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 62.67 24.34 14.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.122 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.451 ' CD1' HG13 ' A' ' 94' ' ' ILE . 4.8 t80 48.45 51.97 14.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 111.372 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.06 -54.31 1.12 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.564 ' CB ' HG11 ' A' ' 129' ' ' VAL . 19.5 t70 -57.82 -36.52 72.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.676 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' A' ' 94' ' ' ILE . 1.8 m-85 -68.46 -55.49 11.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.697 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.3 -31.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.568 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.03 -47.85 78.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.191 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.6 ttt . . . . . 0 CA--C 1.533 0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.504 -179.935 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 38.9 m-20 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -67.2 -47.1 51.32 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.864 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 3.3 Cg_exo -75.17 -16.27 19.93 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.758 2.305 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -110.88 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 14.5 mmmt -72.3 -57.97 3.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 9.8 tp60 -58.82 -45.95 88.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.603 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -63.82 -35.52 80.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.125 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.0 t80 -57.89 -47.95 81.27 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 m -62.71 -33.87 75.99 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.198 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -58.59 -37.15 75.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.344 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 89.0 m-85 -95.75 34.0 1.57 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 83.11 6.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.681 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -68.16 -30.84 70.06 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -86.22 -29.93 22.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.554 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.34 30.26 58.87 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.631 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -129.77 27.81 5.17 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.74 21.82 71.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.986 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 42.7 mtt180 -130.23 157.04 43.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.916 0.358 . . . . 0.0 110.805 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.818 HD12 HD13 ' A' ' 28' ' ' ILE . 3.8 pt -146.86 133.93 10.08 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.816 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.01 168.34 12.18 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.992 2.461 . . . . 0.0 112.172 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.5 -38.01 3.87 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -60.46 -43.74 96.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 111.145 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.3 m -71.03 -46.57 61.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.647 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.818 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.64 -34.06 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.099 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.03 -70.37 0.99 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.504 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.68 68.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.496 0.148 . . . . 0.0 111.297 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 9.2 tp -62.34 -48.41 79.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.33 -33.19 73.19 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.769 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.454 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.43 -36.85 66.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.74 -36.69 58.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.713 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t -93.64 53.51 1.86 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 111.001 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.84 -89.51 0.81 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.854 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 169.11 14.87 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.441 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 11.1 p-10 -133.77 155.32 80.5 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.329 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 68.1 Cg_endo -84.02 -162.09 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.415 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -102.54 168.06 9.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -54.63 -33.17 60.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.19 85.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.71 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -67.37 -55.0 15.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.065 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.66 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.49 -46.04 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.934 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.6 m -61.47 -39.62 91.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -58.11 -38.4 76.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.316 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 44' ' ' ILE . 50.0 mt -63.55 -46.72 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.898 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.8 -28.77 61.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 m -63.88 -12.21 34.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.8 p -118.28 -14.66 9.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.735 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -125.05 153.36 71.34 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.549 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.3 Cg_exo -39.38 146.65 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.366 2.711 . . . . 0.0 113.077 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.05 -65.4 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -88.12 125.88 34.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.576 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 59' ' ' GLN . 58.8 t -86.55 89.82 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.2 p30 -83.17 176.94 8.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.388 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -41.49 -44.65 2.99 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.717 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -52.04 46.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.966 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.549 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.95 78.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.6 mt -61.38 -31.87 71.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.571 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -63.18 -52.16 63.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.161 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.735 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.06 -43.84 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.282 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.579 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.352 0.12 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.85 -53.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.317 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -40.68 97.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.277 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.596 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.14 -47.1 88.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.544 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.08 -26.45 65.84 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.496 0.148 . . . . 0.0 111.357 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.03 73.58 3.61 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.854 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.96 -66.32 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.523 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CB ' ' HG2' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -135.58 33.21 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.652 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -137.25 53.2 1.89 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.617 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.492 ' HE2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -70.95 -3.21 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.475 ' N ' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -97.87 -60.69 1.51 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.722 0.237 . . . . 0.0 111.056 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.57 51.4 12.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.304 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 p -142.19 80.81 1.72 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.77 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.7 15.89 50.93 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.292 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptm -172.57 131.37 0.56 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.12 0.46 . . . . 0.0 111.402 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.596 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.9 -35.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.42 80.31 0.26 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.686 ' HA ' HD23 ' A' ' 99' ' ' LEU . 81.4 t -44.86 -34.43 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.21 -37.26 17.24 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.51 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.5 mp0 -75.57 -53.36 8.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.548 0.214 . . . . 0.0 110.63 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.27 -36.82 73.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.287 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.46 ' HG3' ' HG2' ' A' ' 115' ' ' MET . 2.1 tmt_? -68.48 -49.95 56.0 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -57.61 -36.85 72.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.34 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 98' ' ' GLU . 48.7 t -71.97 -47.75 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.763 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 110' ' ' LEU . 1.6 mt -73.4 -52.5 13.55 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 84.8 m -55.3 -37.03 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 t -76.79 -17.67 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -66.57 0.53 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.509 0.195 . . . . 0.0 111.212 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 58.67 0.27 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.59 39.38 17.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.404 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -68.92 -137.77 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.197 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.596 HD23 ' HG2' ' A' ' 114' ' ' GLU . 9.4 mt -68.79 78.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 110.754 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -66.07 -170.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.938 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -51.0 -38.37 50.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.943 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.31 -51.17 68.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HG2' HD23 ' A' ' 110' ' ' LEU . 2.2 mp0 -57.69 -53.21 60.8 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.848 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.855 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.83 -27.88 67.91 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -45.23 89.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.677 0.275 . . . . 0.0 110.555 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.38 -40.29 74.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.79 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.97 -42.22 99.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.826 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.411 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -73.52 -30.86 63.37 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.407 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -63.14 -41.14 99.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.77 -0.195 . . . . 0.0 110.958 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.36 -43.16 39.25 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.985 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.478 HG11 ' CG2' ' A' ' 129' ' ' VAL . 46.2 t -81.83 130.29 61.47 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.705 0.253 . . . . 0.0 111.155 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.96 62.45 6.62 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.585 HG21 ' H ' ' A' ' 128' ' ' MET . 4.7 p -131.2 167.42 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.444 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.5 OUTLIER -127.48 54.44 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.088 0.47 . . . . 0.0 111.154 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.4 -37.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.561 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.521 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 113.96 39.19 1.08 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.296 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.585 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -103.16 113.96 27.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.26 0.552 . . . . 0.0 110.762 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 129' ' ' VAL . 37.9 t -142.31 21.39 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.433 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.75 22.39 12.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.446 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 2.1 t80 46.63 45.42 14.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 -51.08 2.52 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.407 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.83 -36.62 77.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.788 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -68.16 -55.74 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.685 0.278 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.57 -32.73 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.232 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.84 -49.7 76.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.712 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 179.273 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.442 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t -64.0 -48.31 78.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.771 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 6' ' ' SER . 71.5 Cg_endo -78.75 -14.36 14.04 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.389 2.06 . . . . 0.0 114.074 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -111.26 -61.41 1.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -60.13 2.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.597 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.463 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 8.1 tt0 -58.97 -47.04 86.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.631 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.6 -36.3 78.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.096 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.455 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.6 t80 -58.47 -49.31 77.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -61.92 -34.3 75.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 14.2 mt -55.62 -36.95 67.52 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 111.358 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -96.15 33.5 1.73 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -84.67 84.31 7.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.242 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -67.26 -34.49 77.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.46 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -86.55 -32.59 20.61 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.4 26.79 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.508 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.2 p -137.25 30.16 2.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.668 0.27 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.23 20.63 71.41 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.812 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 13.3 mtt180 -130.65 158.62 39.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.777 0.288 . . . . 0.0 110.533 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 28' ' ' ILE . 5.7 pt -145.49 138.08 13.7 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 95.7 Cg_endo -88.67 172.73 4.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.207 2.605 . . . . 0.0 112.131 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 4.5 pttm -44.33 -36.25 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -59.9 -46.25 89.93 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -71.22 -50.51 32.21 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.84 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.85 -35.45 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.338 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.18 -70.95 0.83 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.235 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.17 -28.26 69.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.59 0.195 . . . . 0.0 111.453 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.72 -48.01 83.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.6 -34.47 75.7 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.858 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -32.41 64.71 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.297 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.56 -43.48 65.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.5 m -64.32 -43.73 93.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.925 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.18 -65.97 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.984 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.63 163.46 28.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -136.07 151.72 74.17 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.477 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.7 Cg_endo -86.47 -163.28 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.138 2.559 . . . . 0.0 112.74 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -99.58 169.05 9.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.261 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.3 mm? -54.09 -36.09 62.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.113 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.52 80.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.559 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -67.71 -52.23 40.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.834 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.85 -45.65 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.337 -0.145 . . . . 0.0 110.641 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -40.02 78.05 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -40.92 88.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.614 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 44' ' ' ILE . 18.7 mt -63.36 -49.08 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -57.22 -24.86 57.45 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.678 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -64.03 -10.69 23.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.4 p -117.92 -41.54 2.89 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 120.34 0.114 . . . . 0.0 111.025 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -92.84 150.78 40.06 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.544 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.3 Cg_exo -38.32 143.31 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.233 2.622 . . . . 0.0 112.821 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.25 -61.35 0.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.73 0.644 . . . . 0.0 112.659 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -87.29 121.01 29.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.491 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.64 83.64 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.3 p30 -82.77 178.11 8.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.494 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.9 mtp -41.43 -46.01 3.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.59 -52.16 54.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.962 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.544 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.57 -52.59 64.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -49.31 75.92 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.121 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.57 -30.04 70.41 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -64.2 -49.46 71.93 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.433 0.159 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.616 HG21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.51 -45.92 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.849 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.334 -0.066 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 120.356 0.122 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.85 -56.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -24.77 67.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.687 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -65.21 -52.72 38.29 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.4 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -77.69 -41.47 37.92 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.437 0.16 . . . . 0.0 111.053 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -78.65 71.76 5.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.957 0.408 . . . . 0.0 110.986 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.646 ' HB ' HG21 ' A' ' 102' ' ' VAL . 14.9 p -111.99 -42.01 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.29 40.36 1.76 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -125.25 57.53 1.31 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -49.24 74.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.556 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -97.83 -48.31 5.24 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.444 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.02 73.48 0.47 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 91' ' ' THR . 10.1 t -92.06 70.29 5.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.29 57.34 17.27 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.62 135.74 1.97 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 111.015 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -108.89 -44.16 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.46 80.12 0.12 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.422 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.794 ' HA ' HD23 ' A' ' 99' ' ' LEU . 95.4 t -44.44 -40.07 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.71 -36.15 8.09 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.163 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 mm-40 -80.85 -46.01 15.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.63 0.215 . . . . 0.0 110.909 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -42.08 84.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.893 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -75.01 -36.06 61.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.828 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -52.82 -41.34 64.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.522 0.201 . . . . 0.0 111.014 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.646 HG21 ' HB ' ' A' ' 85' ' ' VAL . 2.6 t -83.04 -52.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.649 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -56.45 -47.12 79.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -58.22 -35.38 71.58 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -67.86 -21.47 65.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.1 mt -66.35 -67.43 0.45 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.512 0.196 . . . . 0.0 111.026 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.31 49.65 0.46 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.542 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.2 48.68 4.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.345 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -68.49 -138.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.125 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.803 HD22 ' HG2' ' A' ' 114' ' ' GLU . 15.1 mt -69.68 78.01 0.44 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.885 0.374 . . . . 0.0 110.639 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.3 p -68.78 -171.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.867 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -50.88 -39.54 54.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.03 -53.52 48.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.524 0.202 . . . . 0.0 111.275 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.803 ' HG2' HD22 ' A' ' 110' ' ' LEU . 4.1 tp10 -54.78 -52.86 61.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.88 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -65.61 -27.76 68.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -44.77 90.46 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.32 -43.82 80.69 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.92 -42.5 98.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.06 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.3 mt -71.52 -28.95 64.25 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.146 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -63.97 -41.21 97.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.572 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.12 -48.79 24.33 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.829 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.497 HG11 HG22 ' A' ' 129' ' ' VAL . 21.4 t -81.73 123.69 80.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.62 0.21 . . . . 0.0 110.808 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.75 62.23 6.41 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.565 2.177 . . . . 0.0 112.864 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.73 178.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.212 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -119.29 130.43 55.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.48 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 22.8 m-20 80.7 -34.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.061 0.544 . . . . 0.0 111.814 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 118.07 50.69 0.34 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.457 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.425 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.7 OUTLIER -104.01 116.84 32.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.705 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 129' ' ' VAL . 36.7 t -142.32 20.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.258 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 56.72 25.31 10.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.7 t80 44.77 44.49 7.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -53.54 2.53 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.575 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.9 t70 -56.13 -37.08 68.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.3 m-85 -68.2 -58.95 3.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.83 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -62.27 -32.99 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -61.2 -52.66 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 110.645 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.807 0.336 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -59.41 -48.04 96.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.69 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.0 Cg_endo -81.74 -14.39 10.13 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.513 2.142 . . . . 0.0 114.123 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -110.52 -61.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -62.7 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.547 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -57.29 -47.6 81.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.677 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.2 -41.92 85.02 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.6 t80 -56.71 -42.82 79.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.592 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -61.4 -36.49 80.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.2 mt -63.26 -34.1 76.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -93.96 29.65 2.06 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.08 125.02 29.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.733 0.301 . . . . 0.0 110.821 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.53 -58.3 3.84 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.398 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -108.28 6.03 26.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.17 43.13 99.8 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.792 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.0 p -118.41 10.83 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 1.19 68.95 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.381 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -125.04 167.29 14.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.149 0.475 . . . . 0.0 110.898 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.74 HD12 HD13 ' A' ' 28' ' ' ILE . 7.6 pt -147.41 136.43 11.53 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -87.38 172.01 6.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.245 2.63 . . . . 0.0 112.488 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 6.0 pttt -44.41 -39.27 4.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.2 p -59.5 -43.31 93.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.453 0.168 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 25.4 m -71.16 -52.37 19.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.614 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.74 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.86 -35.36 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.76 -71.22 0.75 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -26.59 68.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.8 -50.14 67.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.702 0.287 . . . . 0.0 110.276 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.33 -28.11 68.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -54.75 -37.95 66.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.519 0.2 . . . . 0.0 110.749 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.18 72.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.577 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -83.74 -41.89 17.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.476 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.39 -84.32 0.05 OUTLIER Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.59 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.1 171.65 13.7 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 2.7 t30 -123.3 108.77 31.6 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.317 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.38 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.849 2.366 . . . . 0.0 112.552 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 p -90.42 166.4 13.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.5 mm? -55.7 -34.53 65.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.789 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.54 -37.22 77.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.52 -54.2 31.56 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.653 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.06 -44.29 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.748 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 m -58.07 -43.59 87.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.343 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.47 -40.12 74.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.645 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 44' ' ' ILE . 24.6 mt -64.99 -49.35 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.8 -23.37 43.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.748 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -64.56 -6.49 7.65 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -117.76 -45.59 2.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.789 0.268 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.606 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -89.36 156.19 48.48 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.4 Cg_exo -41.67 149.31 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 113.116 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.72 -64.18 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.646 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.1 mt-10 -86.44 123.58 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.704 0.288 . . . . 0.0 110.614 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.92 87.85 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.9 p30 -83.92 -179.93 7.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 37.2 mtt -41.41 -44.59 2.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -69.12 -52.27 29.98 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.56 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.27 -51.57 68.83 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.614 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.437 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.68 -48.54 81.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.921 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 61' ' ' LEU . 35.0 mt -61.01 -34.51 74.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.505 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -60.28 -49.81 76.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.577 0.227 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.477 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.57 -36.49 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD13 ' HE1' ' A' ' 60' ' ' PHE . 1.6 tp . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.03 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.55 0.214 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.92 -39.04 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.926 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -35.36 77.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.324 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' C ' HG11 ' A' ' 102' ' ' VAL . . . -71.63 -54.69 8.25 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.755 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -57.9 -45.64 86.15 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.512 0.196 . . . . 0.0 110.666 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.98 65.13 5.04 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.85 -41.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.496 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -121.83 32.16 5.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.01 75.0 1.48 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.548 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -44.15 92.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.5 -59.28 2.36 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.846 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 55.71 70.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -128.22 68.36 1.35 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.0 38.76 3.27 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.802 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.41 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.0 OUTLIER -172.86 134.56 0.59 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.675 0.238 . . . . 0.0 110.976 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -107.26 -41.78 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.12 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.54 80.96 0.38 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.328 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.756 ' HA ' HD23 ' A' ' 99' ' ' LEU . 79.6 t -45.12 -39.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.03 -40.04 42.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.258 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.4 tt0 -71.93 -47.92 49.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.225 0.21 . . . . 0.0 110.474 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.35 -37.74 75.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.207 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.489 ' HG3' ' HG3' ' A' ' 115' ' ' MET . 0.2 OUTLIER -68.16 -43.99 77.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.675 179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -58.47 -36.79 74.25 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.361 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 98' ' ' GLU . 16.1 t -77.8 -50.28 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.602 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.557 HD12 ' CD1' ' A' ' 99' ' ' LEU . 4.6 mt -63.73 -42.61 97.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.6 m -64.73 -41.72 95.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.499 0.19 . . . . 0.0 111.007 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.5 p -70.37 -15.2 62.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.861 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.55 -56.92 4.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.46 42.99 0.23 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.84 47.28 15.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 46.9 mmtm -68.52 -138.66 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.51 79.67 0.57 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.0 p -62.21 -177.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.933 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.416 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 7.2 p30 -48.9 -29.75 5.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.468 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -60.0 -62.75 1.64 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -42.04 86.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.793 ' HA ' HD23 ' A' ' 118' ' ' LEU . 6.0 mmt -65.95 -33.84 76.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -48.9 77.98 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.233 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.59 -40.65 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.33 -42.16 95.08 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.409 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.436 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -68.91 -31.17 69.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.324 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -62.94 -42.24 99.74 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.5 65.62 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.902 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.73 126.35 71.06 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.667 0.234 . . . . 0.0 111.176 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.25 61.07 5.79 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.598 2.199 . . . . 0.0 112.333 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 125' ' ' LYS . 2.2 p -131.87 171.46 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.294 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -118.28 132.17 56.31 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 26.8 m-20 81.35 -47.51 0.24 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.523 0.514 . . . . 0.0 110.841 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.2 53.16 0.16 Allowed Glycine 0 C--N 1.339 0.71 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.711 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.454 ' O ' HG21 ' A' ' 124' ' ' VAL . 0.3 OUTLIER -107.22 107.41 18.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.544 0.688 . . . . 0.0 110.904 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 129' ' ' VAL . 47.7 t -142.32 19.59 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.624 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.85 21.69 7.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.853 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.413 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.9 OUTLIER 54.79 -164.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.21 -57.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.235 0.214 . . . . 0.0 111.359 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -52.65 -39.18 61.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.7 m-85 -68.65 -54.81 14.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.637 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.03 -31.31 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.293 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -69.6 -54.23 15.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.492 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.46 0.031 0 CA-C-O 120.772 0.32 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.6 t -61.72 -46.02 93.11 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 5.0 Cg_exo -75.39 -14.4 20.33 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.987 2.458 . . . . 0.0 114.046 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -118.12 -63.13 1.46 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -66.21 -60.68 2.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 8.0 tt0 -60.56 -47.14 87.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.61 -37.05 80.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 23' ' ' ILE . 24.7 t80 -59.01 -46.77 87.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.326 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -62.41 -32.73 73.61 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.266 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -59.95 -34.07 72.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.497 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -102.05 36.33 2.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.92 101.68 14.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -50.05 67.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -86.84 -35.79 18.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.386 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.08 40.01 6.74 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.584 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.3 p -127.83 32.72 4.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.06 19.2 73.62 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.984 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 1.1 mtt-85 -130.98 157.2 43.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.794 0.297 . . . . 0.0 110.688 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.806 HD12 HD13 ' A' ' 28' ' ' ILE . 7.0 pt -143.57 137.94 14.93 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 84.1 Cg_endo -88.3 171.53 5.4 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.166 2.577 . . . . 0.0 112.702 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 15.8 pttm -44.19 -36.63 2.75 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.5 p -60.15 -46.21 90.45 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -70.72 -49.95 41.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.94 -34.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.346 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.12 -72.56 0.56 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.215 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -27.19 65.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.593 0.196 . . . . 0.0 111.456 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.13 -48.38 78.74 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -61.55 -31.5 71.53 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.962 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.426 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -56.13 -33.67 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.142 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.3 -38.02 68.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.28 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -92.66 58.15 3.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.0 0.428 . . . . 0.0 110.477 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.41 -91.71 1.09 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.406 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 172.37 12.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 12.4 p-10 -132.05 155.82 80.87 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 65.3 Cg_endo -85.03 -161.91 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.034 2.489 . . . . 0.0 112.41 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 p -102.17 167.32 10.08 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.076 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.407 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.5 mm? -53.58 -35.23 60.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.17 88.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.708 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -66.76 -52.22 46.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.271 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.598 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -54.95 -46.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -58.42 -43.08 88.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.307 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.51 -40.97 75.9 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.562 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 44' ' ' ILE . 38.8 mt -63.59 -48.2 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.23 -23.58 48.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -63.69 -12.09 31.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.4 p -118.04 -41.11 2.91 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.946 0.098 . . . . 0.0 110.911 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.499 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -91.2 148.35 37.6 Favored Pre-proline 0 N--CA 1.465 0.286 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.47 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -36.62 140.43 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.391 2.727 . . . . 0.0 113.148 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.86 -58.5 0.13 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.636 . . . . 0.0 112.448 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -89.4 122.32 32.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.185 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.36 88.49 2.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 121.029 0.443 . . . . 0.0 110.647 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.2 p30 -82.6 177.77 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.498 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.9 mtm -41.36 -43.73 2.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.907 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.84 -51.19 35.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.47 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -56.29 -50.74 70.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.504 0.192 . . . . 0.0 111.08 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -47.59 83.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.86 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 61' ' ' LEU . 26.8 mt -62.1 -30.93 71.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -63.65 -54.58 33.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.507 0.194 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.24 -40.9 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.903 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.859 179.631 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.393 0 CA-C-O 120.461 0.172 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.84 -50.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.602 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.466 ' O ' HG11 ' A' ' 102' ' ' VAL . 1.4 tppt? -60.13 -32.87 71.42 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -63.21 -54.08 35.22 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.502 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -78.02 -22.37 49.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.66 75.02 4.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.1 0.476 . . . . 0.0 111.031 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 86' ' ' PHE . 7.1 p -141.75 -49.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.906 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.447 ' N ' HG13 ' A' ' 85' ' ' VAL . 9.6 m-85 -156.29 43.44 0.4 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 110.722 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.96 59.95 1.72 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -50.23 74.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.93 -46.08 5.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.888 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.24 38.77 28.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.54 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 p -118.47 82.55 1.87 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.7 -18.02 5.44 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.157 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.1 OUTLIER -163.77 132.37 3.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.085 0.442 . . . . 0.0 110.898 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.587 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.38 -41.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.853 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.52 80.4 0.2 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.705 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.782 ' HA ' HD23 ' A' ' 99' ' ' LEU . 96.9 t -45.12 -38.61 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 122.3 0.24 . . . . 0.0 111.641 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.55 -36.36 17.79 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.9 mm-40 -77.45 -48.1 18.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 0.173 . . . . 0.0 110.71 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.72 -39.36 80.61 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.744 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HD3' ' HG2' ' A' ' 115' ' ' MET . 14.1 ttp180 -75.71 -39.47 57.32 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -53.9 -40.78 66.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 98' ' ' GLU . 3.8 t -77.91 -52.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.653 0.264 . . . . 0.0 111.412 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.899 HD22 ' HG2' ' A' ' 109' ' ' LYS . 5.7 mt -56.5 -46.77 80.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.948 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.2 m -66.56 -35.59 80.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -66.02 -22.07 66.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.728 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.01 -67.86 0.43 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 110.983 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.55 44.68 0.56 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.258 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.4 50.41 4.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 111.182 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.899 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -68.51 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.902 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.617 HD22 ' HG3' ' A' ' 114' ' ' GLU . 62.3 mt -67.23 79.44 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.372 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.8 p -63.8 -169.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.438 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 115' ' ' MET . 3.5 m120 -50.43 -33.71 21.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.521 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -56.37 -51.72 67.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.568 0.223 . . . . 0.0 111.483 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.617 ' HG3' HD22 ' A' ' 110' ' ' LEU . 1.6 tm-20 -56.58 -56.79 16.93 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.922 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.6 OUTLIER -65.45 -24.68 67.24 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.638 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -48.28 81.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -68.01 -43.54 78.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.71 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.922 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.73 -42.19 96.82 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.944 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 4.1 mt -69.79 -30.24 67.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.073 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -40.39 96.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.625 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.48 -47.48 16.26 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.952 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.458 HG11 HG22 ' A' ' 129' ' ' VAL . 26.2 t -81.35 125.8 78.08 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.688 0.244 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.49 61.61 7.96 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.652 2.235 . . . . 0.0 112.662 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 128' ' ' MET . 22.9 m -131.57 -177.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.236 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.05 129.91 55.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.083 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 78.71 -49.38 0.45 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.851 0.46 . . . . 0.0 111.049 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 136.14 51.27 0.07 OUTLIER Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.618 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.488 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 1.9 ttp -104.17 116.73 32.71 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.121 0.486 . . . . 0.0 110.659 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 129' ' ' VAL . 29.7 t -142.03 20.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.463 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 59.92 25.77 14.95 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.472 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 3.0 t80 44.31 41.63 4.58 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.236 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -52.98 2.69 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.839 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.526 ' HB3' HG11 ' A' ' 129' ' ' VAL . 23.6 t70 -56.9 -36.75 70.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.8 m-85 -67.93 -57.35 6.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.55 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.94 -35.19 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.41 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.77 -56.03 26.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.2 tpp . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.074 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 4.1 t -67.31 -47.64 48.66 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.785 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 6' ' ' SER . 98.8 Cg_endo -80.73 -13.34 11.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.466 2.11 . . . . 0.0 114.193 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.37 -61.27 1.69 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -59.62 2.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.336 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.35 -47.42 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.716 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.79 -41.02 85.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.966 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.454 ' CE2' HG12 ' A' ' 23' ' ' ILE . 6.1 t80 -56.39 -45.39 80.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.456 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.8 m -62.64 -33.82 75.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.733 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 16.1 mt -57.52 -30.28 65.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 23' ' ' ILE . 69.5 m-85 -91.69 33.22 1.03 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.54 112.3 14.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.909 0.385 . . . . 0.0 110.846 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -49.72 42.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -115.53 -0.92 12.91 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 48.5 33.57 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.559 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.5 p -121.38 16.64 11.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.65 14.01 80.01 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.194 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -130.29 158.45 39.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.922 0.361 . . . . 0.0 110.668 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.61 HD12 HD13 ' A' ' 28' ' ' ILE . 8.8 pt -140.96 135.04 15.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.73 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.25 170.66 9.36 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.074 2.516 . . . . 0.0 112.477 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -42.81 -38.16 2.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.6 p -60.41 -45.38 93.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.506 0.193 . . . . 0.0 111.293 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.459 ' CB ' ' HB ' ' A' ' 23' ' ' ILE . 2.9 m -69.97 -44.73 68.85 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.61 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.21 -33.47 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.411 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.45 -65.99 3.15 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.392 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -28.02 69.24 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.56 -49.18 77.7 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.32 -29.48 69.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.076 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -36.63 70.6 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.85 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.23 -30.14 71.0 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.418 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -109.4 32.05 5.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.799 0.333 . . . . 0.0 110.84 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.55 -105.08 0.28 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.366 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -132.4 178.81 6.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.615 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.74 116.04 34.88 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.369 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -84.57 -162.63 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.016 2.478 . . . . 0.0 112.764 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 p -98.16 164.06 12.48 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.24 -36.48 63.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.021 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.82 80.59 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.02 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -54.6 20.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.64 -44.95 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.484 0.183 . . . . 0.0 110.632 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.7 m -59.1 -38.99 80.86 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -40.5 85.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.277 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 44' ' ' ILE . 22.5 mt -63.56 -47.94 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -56.82 -25.48 56.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.414 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 t -64.47 -7.42 9.97 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -117.75 -50.52 2.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.748 0.249 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -87.27 153.66 53.92 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.507 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 85.6 Cg_exo -38.85 144.95 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.265 2.643 . . . . 0.0 113.044 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.68 -68.66 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.74 126.78 33.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.637 0.256 . . . . 0.0 110.601 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.55 89.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.5 p30 -86.08 -179.69 6.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.539 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -41.28 -45.15 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.817 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -67.55 -53.62 26.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.507 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.31 -51.99 67.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -50.1 75.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.46 -32.47 72.46 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.414 0.15 . . . . 0.0 111.326 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.19 -50.3 74.57 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.025 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.57 -34.45 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.356 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.635 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.48 0.181 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.43 -44.56 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.276 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -34.62 77.6 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.65 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.818 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -61.07 -48.36 86.46 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.214 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -70.97 -34.36 71.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.508 0.194 . . . . 0.0 110.724 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -78.78 72.27 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.2 -63.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.475 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -116.5 42.21 2.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.141 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.33 65.42 0.67 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.671 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -59.64 -53.51 57.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.87 -66.95 1.0 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.595 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.21 63.75 1.84 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.572 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -64.84 -47.72 76.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.27 64.77 0.5 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.403 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -178.1 150.22 0.59 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.224 0.21 . . . . 0.0 110.487 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.588 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.25 -41.53 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.507 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.51 80.34 0.18 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.334 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.704 ' HA ' HD23 ' A' ' 99' ' ' LEU . 91.3 t -45.14 -33.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -43.76 15.62 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.109 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -76.93 -49.91 14.49 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.583 0.192 . . . . 0.0 111.045 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.725 HD12 HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -57.32 -37.58 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.272 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 104' ' ' THR . 35.7 ttp85 -70.8 -46.98 61.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.79 -38.05 54.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.284 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.818 HG11 ' HA2' ' A' ' 82' ' ' GLY . 22.4 t -75.11 -49.03 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.815 HD22 ' HG2' ' A' ' 109' ' ' LYS . 9.4 mt -63.07 -35.27 79.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.407 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 111' ' ' SER . 68.2 p -63.75 -37.8 88.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.603 0.24 . . . . 0.0 111.021 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.1 m -72.74 -17.05 61.64 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.05 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -67.34 -56.91 7.79 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 110.772 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.06 48.78 0.07 OUTLIER Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.156 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 64.01 39.12 8.16 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 111.035 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.815 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.66 -137.05 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.593 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.804 HD23 ' HB3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -67.51 83.56 0.17 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.603 ' HA ' HG22 ' A' ' 104' ' ' THR . 0.0 OUTLIER -86.71 -167.55 1.92 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.967 -178.792 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 11.1 p30 -55.43 -28.86 56.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -67.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.804 ' HB3' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -55.71 -44.98 77.95 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.148 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.804 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.54 -29.27 69.32 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.106 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER -58.69 -47.52 84.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.25 -42.71 99.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.8 -41.72 98.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.742 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.456 HD12 ' SD ' ' A' ' 115' ' ' MET . 4.3 mt -67.7 -32.18 72.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -45.22 91.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.967 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.94 -45.66 41.01 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.785 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 129' ' ' VAL . 86.7 t -75.63 133.49 73.62 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.488 0.185 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 58.48 6.5 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.84 2.36 . . . . 0.0 112.657 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.593 HG21 ' H ' ' A' ' 128' ' ' MET . 5.1 p -131.43 166.84 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 124' ' ' VAL . 3.0 mtpp -124.33 55.56 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.92 0.391 . . . . 0.0 111.25 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.7 p-10 170.26 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 116.45 40.98 0.76 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.593 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -103.25 114.26 28.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 110.618 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 129' ' ' VAL . 25.8 t -142.44 27.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.225 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.21 20.23 9.61 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.5 t80 46.61 41.75 10.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.821 0.343 . . . . 0.0 111.187 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -50.07 2.37 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.667 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' HB3' HG11 ' A' ' 129' ' ' VAL . 20.6 t70 -56.37 -41.29 75.95 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -66.4 -57.85 6.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.77 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.11 -30.09 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.512 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.17 -57.4 12.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.659 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.902 179.235 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 12.0 m-20 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.1 0.476 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.433 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -67.41 -46.64 48.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.984 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.3 Cg_endo -82.82 1.98 8.78 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.438 2.092 . . . . 0.0 114.106 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.506 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 56.9 m-85 -124.27 -66.76 0.96 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -55.27 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 1.4 tp60 -62.36 -49.33 75.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.676 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.51 -38.2 77.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.9 t80 -58.83 -46.48 87.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.401 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -62.57 -31.6 72.44 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.656 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 12.8 mt -60.31 -38.1 82.62 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 23' ' ' ILE . 24.3 m-85 -96.04 34.47 1.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.4 95.27 9.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.07 -36.43 77.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.566 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -86.91 -41.28 14.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.369 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.22 10.51 55.92 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.165 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -103.96 -12.91 16.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.075 0.437 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.45 28.85 3.61 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.54 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -130.56 155.59 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.371 0.268 . . . . 0.0 110.367 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.745 HD12 HD13 ' A' ' 28' ' ' ILE . 5.4 pt -145.24 132.5 10.19 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.43 171.4 9.97 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.975 2.45 . . . . 0.0 111.985 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.17 -37.83 7.52 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.3 p -61.94 -41.89 98.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.372 0.13 . . . . 0.0 111.152 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 9.8 m -70.41 -46.35 64.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.403 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.745 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.03 -34.87 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.482 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.01 -70.63 0.9 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.54 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -27.86 69.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.349 0.119 . . . . 0.0 111.291 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -61.54 -50.91 70.77 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.645 0.26 . . . . 0.0 110.366 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.58 -31.53 71.59 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.119 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.45 -39.64 70.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.01 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.84 75.5 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.533 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -77.45 -44.03 30.39 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.662 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.43 -76.98 0.02 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 168.5 17.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.879 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -122.45 117.12 29.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.447 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.31 -162.25 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.893 2.396 . . . . 0.0 112.464 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -94.26 164.28 13.1 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.107 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.8 mm? -56.71 -30.95 64.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.44 86.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.723 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -55.53 16.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.83 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.18 -45.11 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.906 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.2 m -61.27 -40.15 93.05 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.57 -38.68 78.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 44' ' ' ILE . 23.3 mt -61.9 -51.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.6 -23.78 43.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.72 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -9.58 15.21 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -118.24 -46.42 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.647 0.203 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.555 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -90.24 158.39 43.82 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.8 Cg_exo -42.49 150.21 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.14 2.56 . . . . 0.0 113.214 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.14 -64.92 0.33 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.099 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.39 119.83 24.66 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 59' ' ' GLN . 59.7 t -86.8 89.47 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.212 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 4.2 p30 -84.48 -179.89 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.49 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 mtt -41.92 -46.59 4.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.827 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -67.11 -51.03 59.21 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.586 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.17 -51.12 70.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -50.89 69.72 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.724 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.12 -26.15 68.14 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.473 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -65.57 -51.47 59.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.67 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.61 -41.58 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.828 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.08 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.873 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.296 0.109 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -65.41 -53.04 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.465 0.174 . . . . 0.0 110.843 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -60.82 -29.49 69.51 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.689 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.79 -53.38 15.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.063 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -77.89 -36.81 49.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.93 74.05 2.16 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.201 0.524 . . . . 0.0 111.243 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.88 -55.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.232 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -144.14 49.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.317 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 1.1 m-20 -129.63 74.82 1.61 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.709 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -47.34 78.22 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.73 -71.3 0.51 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.69 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 57.34 -170.14 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.218 0.324 . . . . 0.0 111.657 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 m 72.11 -69.93 0.17 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.666 0.386 . . . . 0.0 111.542 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.72 6.45 83.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.562 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 143.86 5.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.274 0.537 . . . . 0.0 111.025 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -124.32 141.12 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -109.27 81.22 0.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.058 -0.591 . . . . 0.0 111.639 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.021 HG11 HD21 ' A' ' 118' ' ' LEU . 93.9 t -43.32 -41.18 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.06 -46.65 33.22 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.038 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -81.59 -41.12 21.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.101 0.161 . . . . 0.0 110.958 179.042 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.01 -47.18 78.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.704 0.288 . . . . 0.0 110.702 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' HD3' HG13 ' A' ' 96' ' ' VAL . 3.0 mpt_? -72.57 -37.08 68.32 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.33 -38.68 63.46 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.538 0.209 . . . . 0.0 111.123 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.689 HG11 ' HA2' ' A' ' 82' ' ' GLY . 2.6 t -75.13 -49.12 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.456 HD23 HD12 ' A' ' 106' ' ' LEU . 1.1 mt -63.54 -34.99 79.02 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.36 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.9 m -62.24 -32.45 73.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.567 0.223 . . . . 0.0 111.163 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 m -69.54 -17.0 63.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.456 HD12 HD23 ' A' ' 103' ' ' LEU . 3.7 mt -63.97 -71.81 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 110.977 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.4 51.3 0.43 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.974 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 61.14 49.1 5.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.013 0.435 . . . . 0.0 110.732 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -68.32 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.495 HD22 ' OE2' ' A' ' 114' ' ' GLU . 19.0 mt -70.21 79.82 0.52 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.5 p -61.7 -175.39 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.011 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -50.22 -32.57 16.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.408 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.89 -51.84 67.57 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.495 ' OE2' HD22 ' A' ' 110' ' ' LEU . 1.2 tp10 -57.48 -53.36 59.04 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.894 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -66.3 -26.8 67.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.402 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.86 -48.59 80.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.676 0.274 . . . . 0.0 110.339 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.88 -40.62 87.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.021 HD21 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.42 -41.6 98.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.694 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.427 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.1 mt -68.54 -33.26 73.8 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.983 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -63.32 -41.0 98.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.66 -45.06 18.74 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.844 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.8 t -79.24 125.22 83.74 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.693 0.247 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 5.2 Cg_exo -73.76 62.79 4.76 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.909 2.406 . . . . 0.0 112.32 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 128' ' ' MET . 16.0 m -131.35 175.15 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.242 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -124.19 47.62 2.05 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.084 0.469 . . . . 0.0 110.855 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.8 p-10 173.03 -34.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.72 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 110.7 48.49 0.73 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -103.87 117.66 34.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 129' ' ' VAL . 38.4 t -142.37 31.16 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.989 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 59.24 23.12 11.45 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 46.33 44.5 12.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.926 0.394 . . . . 0.0 111.297 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.84 -52.69 2.43 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.35 -37.24 80.06 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.181 0.301 . . . . 0.0 111.757 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -66.39 -56.46 10.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.83 -31.28 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.462 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.42 -55.14 37.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 CA--C 1.531 0.224 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.57 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.993 0.425 . . . . 0.0 110.895 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.448 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -66.75 -46.55 56.2 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.412 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 6' ' ' SER . 11.5 Cg_exo -71.36 -17.95 30.3 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.898 2.398 . . . . 0.0 113.85 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -114.46 -63.41 1.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 5' ' ' ASP . 8.0 tptt -65.88 -61.11 2.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.369 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -59.85 -45.69 91.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.401 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.57 -40.51 87.57 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CE2' HG12 ' A' ' 23' ' ' ILE . 10.6 t80 -54.69 -45.64 73.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.297 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -36.38 81.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.14 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.547 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 6.0 mt -62.14 -33.23 74.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.382 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -93.29 34.12 1.17 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.51 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.51 96.23 8.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -42.4 99.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.048 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -87.39 -37.26 17.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.42 33.11 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.712 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.1 p -117.38 -11.42 10.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.17 2.94 9.92 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.353 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 2.6 mtt-85 -117.08 163.14 16.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 117.241 0.52 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.801 HD12 HD13 ' A' ' 28' ' ' ILE . 5.2 pt -144.98 131.21 9.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.668 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 89.1 Cg_endo -84.61 169.74 10.62 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.066 2.511 . . . . 0.0 112.412 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.43 -37.9 5.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -60.78 -44.07 97.25 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.538 0.209 . . . . 0.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 7.5 t -67.99 -51.07 51.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.801 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.17 -37.33 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -70.58 0.9 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.668 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -26.14 68.54 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -64.71 -48.31 75.13 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -29.62 70.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.232 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -41.52 68.02 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.704 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.02 69.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.711 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.88 39.38 1.87 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.809 0.338 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.2 -102.3 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.748 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.05 -176.43 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -118.68 114.75 35.69 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.823 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.78 -162.54 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.796 2.331 . . . . 0.0 112.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 p -102.97 162.16 13.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -55.06 -32.9 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.13 79.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.696 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.37 -54.43 20.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -60.21 -47.78 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.895 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.2 m -59.21 -38.86 80.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.69 -38.07 80.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.516 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 44' ' ' ILE . 19.2 mt -65.36 -50.16 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.99 -24.23 51.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.048 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 p -64.65 -7.34 10.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 p -117.75 -43.6 2.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.652 0.206 . . . . 0.0 111.269 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.579 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -93.37 158.92 36.2 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 99.0 Cg_exo -42.82 151.71 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.151 2.568 . . . . 0.0 113.12 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.64 -64.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.61 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.1 mt-10 -87.5 124.4 33.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.516 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 59' ' ' GLN . 48.3 t -86.61 88.92 2.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -82.21 177.2 8.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.405 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -41.38 -45.47 3.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.662 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -66.9 -51.38 56.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.043 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.53 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.71 -51.44 68.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -49.83 74.02 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.498 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.63 -47.98 79.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.115 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.47 -39.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.164 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.669 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.407 0.146 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.72 -48.4 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.826 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -31.05 70.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.849 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.17 -55.79 9.91 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.344 0.116 . . . . 0.0 110.7 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -79.01 69.15 5.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.052 0.453 . . . . 0.0 110.683 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.14 -45.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.04 19.69 7.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.45 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.7 80.49 1.73 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -55.48 33.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.75 -35.51 9.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . . . 62.18 65.77 0.86 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -69.12 -38.0 78.63 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.73 64.78 0.06 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.031 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.63 129.82 0.43 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.507 0.194 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -103.76 -45.88 9.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.356 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 94' ' ' ILE . . . 57.1 80.26 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.469 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.781 ' HA ' HD23 ' A' ' 99' ' ' LEU . 77.8 t -44.08 -36.62 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.38 -39.89 14.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.764 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.2 mm-40 -80.92 -45.01 17.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.444 0.164 . . . . 0.0 110.809 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.16 -40.54 90.26 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.957 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 104' ' ' THR . 0.7 OUTLIER -72.49 -41.27 66.15 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.612 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -52.33 -39.52 60.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.693 0.282 . . . . 0.0 111.034 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.849 HG11 ' HA2' ' A' ' 82' ' ' GLY . 30.6 t -73.21 -49.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.629 HD12 HD12 ' A' ' 99' ' ' LEU . 2.9 mt -64.48 -44.3 91.45 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.007 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 111' ' ' SER . 54.7 p -57.85 -40.86 81.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.507 0.194 . . . . 0.0 111.229 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.0 t -78.33 -12.21 59.99 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -61.34 1.91 Allowed 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 111.281 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 57.81 0.12 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.368 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.35 39.61 18.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 111.022 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 49.3 mmtt -68.68 -137.93 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.036 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD22 ' HG2' ' A' ' 114' ' ' GLU . 19.7 mt -68.49 79.63 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.667 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.757 ' HA ' HG22 ' A' ' 104' ' ' THR . 80.3 p -65.1 -170.21 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.069 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 115' ' ' MET . 78.3 m-20 -53.44 -36.87 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.07 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.02 -51.23 70.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.67 ' HG2' HD22 ' A' ' 110' ' ' LEU . 5.3 tp10 -57.34 -53.65 55.71 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.85 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.88 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.44 -25.85 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.419 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -47.85 83.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.97 -43.16 75.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.795 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.27 -42.68 95.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 127' ' ' GLY . 1.3 mt -72.17 -30.71 65.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -61.16 -41.21 96.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.804 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.19 20.46 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.917 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 129' ' ' VAL . 16.4 t -84.75 117.97 69.96 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.739 0.269 . . . . 0.0 111.019 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.85 63.95 6.74 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.628 2.219 . . . . 0.0 112.461 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.467 HG13 HG12 ' A' ' 122' ' ' VAL . 31.6 m -131.16 -176.43 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.77 132.49 56.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.323 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 67.04 14.77 9.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.366 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 63.3 49.89 67.02 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.075 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 ttp -103.47 120.21 40.4 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.515 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 129' ' ' VAL . 24.1 t -142.31 24.02 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.663 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 60.84 24.9 14.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.495 0.188 . . . . 0.0 111.405 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.448 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.1 t80 46.14 42.21 9.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.775 0.322 . . . . 0.0 111.377 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -115.49 -51.37 2.69 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.518 ' CB ' HG11 ' A' ' 129' ' ' VAL . 29.4 t70 -57.39 -38.24 73.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.79 -56.68 7.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.766 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.0 t -62.65 -34.66 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.308 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -64.26 -53.9 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ttp . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.063 179.6 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 8.8 m-20 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.916 0.388 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.457 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 4.0 t -67.03 -48.35 50.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.294 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 83.9 Cg_endo -83.46 -3.42 10.75 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.525 2.15 . . . . 0.0 114.294 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 77.6 m-85 -118.26 -66.69 1.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 4.9 ttmm -72.72 -57.8 3.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.424 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.535 ' OE1' HD21 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -57.75 -49.19 77.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.688 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.49 -40.31 90.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.542 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.5 t80 -56.5 -42.97 79.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.479 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.85 -36.11 82.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.045 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.535 HD21 ' OE1' ' A' ' 10' ' ' GLN . 9.6 mt -60.71 -33.14 72.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.302 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 32.58 2.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -93.19 91.55 7.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -63.38 -33.15 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.459 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -86.52 -35.58 19.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.133 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.29 32.32 52.24 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.774 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -118.73 -19.02 8.82 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.66 -8.04 5.54 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.086 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.656 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -121.57 162.86 19.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.065 0.432 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.785 HD12 HD13 ' A' ' 28' ' ' ILE . 5.8 pt -135.79 134.92 20.99 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.755 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.87 169.42 9.08 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.08 2.52 . . . . 0.0 112.612 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 44' ' ' ILE . 16.0 pttm -43.85 -38.52 3.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.9 p -60.13 -44.31 95.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.498 0.189 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.432 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 49.3 m -70.43 -46.74 63.32 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.875 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.785 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.79 -35.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.04 3.13 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.286 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 121.961 0.105 . . . . 0.0 111.108 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.32 -46.01 88.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.49 -31.61 70.64 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -51.42 -38.67 54.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -53.36 -44.55 68.64 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.65 -47.05 82.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.681 0.277 . . . . 0.0 110.774 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.85 -66.11 0.03 OUTLIER Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.094 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.99 173.36 11.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.862 0.363 . . . . 0.0 111.282 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -125.81 133.83 25.29 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.591 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -81.5 -163.17 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.849 2.366 . . . . 0.0 112.764 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 p -103.08 164.46 11.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.9 mm? -52.07 -37.71 54.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.46 86.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -53.93 29.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.811 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.03 -46.56 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -56.9 -39.97 75.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -40.85 83.99 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 44' ' ' ILE . 21.6 mt -59.89 -52.08 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -56.74 -25.02 53.84 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.699 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -10.42 22.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 p -118.1 -50.37 2.47 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.59 0.177 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.3 156.85 56.79 Favored Pre-proline 0 N--CA 1.464 0.263 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.736 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.536 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 78.2 Cg_exo -39.78 145.01 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.216 2.611 . . . . 0.0 113.199 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.18 -61.27 0.16 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.658 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -89.79 125.31 35.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.671 179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.0 t -87.19 90.14 3.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.5 p30 -86.59 -179.73 6.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.601 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.16 -46.5 3.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.817 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -67.77 -52.16 40.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.058 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.536 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.82 -50.75 72.23 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -48.91 79.68 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.912 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.59 -34.36 75.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.338 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -60.06 -48.05 83.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.308 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.465 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.72 -42.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.386 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.407 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 120.384 0.135 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.14 -49.03 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.139 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -26.51 68.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.684 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.82 -53.67 14.78 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.27 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.92 -47.18 47.94 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.31 71.4 5.85 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 86' ' ' PHE . 11.8 p -133.29 -45.76 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.462 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.418 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 4.4 m-85 -144.74 58.07 1.3 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 111.036 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -116.42 66.89 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.543 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.27 -36.18 79.34 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.84 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.79 -70.13 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.36 154.73 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.997 0.427 . . . . 0.0 112.018 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.5 m 59.8 80.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.261 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.84 -0.25 11.97 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.437 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -163.97 138.97 6.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 117.184 0.492 . . . . 0.0 110.629 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.541 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.36 -39.86 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.442 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.44 81.41 0.15 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.323 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.767 HG21 HD21 ' A' ' 118' ' ' LEU . 79.5 t -43.73 -36.49 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.97 -38.65 17.54 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.602 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -77.45 -46.47 22.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.24 0.216 . . . . 0.0 110.968 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -60.81 -42.16 97.08 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.464 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 104' ' ' THR . 0.2 OUTLIER -72.18 -36.39 69.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.093 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -59.31 -37.53 77.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.595 0.236 . . . . 0.0 111.078 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.684 HG11 ' HA2' ' A' ' 82' ' ' GLY . 29.6 t -77.56 -42.07 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.302 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.5 mt -72.42 -33.39 67.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 100' ' ' ARG . 15.1 p -59.47 -35.02 73.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.6 p -70.45 -18.04 63.0 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.14 -62.32 1.49 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.756 0.313 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.84 49.51 0.18 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.169 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.49 49.85 3.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 110.624 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 8.8 mmtp -68.55 -137.89 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.759 HD22 ' HG2' ' A' ' 114' ' ' GLU . 12.2 mt -69.96 77.5 0.48 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.888 0.375 . . . . 0.0 110.549 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.5 p -74.93 -165.66 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.873 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 115' ' ' MET . 15.1 m120 -51.4 -40.06 58.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.21 -52.93 61.8 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.52 0.2 . . . . 0.0 111.523 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.759 ' HG2' HD22 ' A' ' 110' ' ' LEU . 1.6 tp10 -57.23 -51.35 69.71 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.902 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.2 ptt? -67.14 -26.88 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.442 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -48.12 82.15 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.58 -43.56 84.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.902 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.56 -40.99 93.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.556 HD21 ' N ' ' A' ' 127' ' ' GLY . 2.4 mt -71.27 -30.13 65.92 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.155 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.41 -40.44 97.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.575 0.226 . . . . 0.0 110.72 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.27 -46.44 26.89 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.847 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.614 HG11 ' CG2' ' A' ' 129' ' ' VAL . 16.9 t -86.15 121.68 72.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.805 0.302 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 62.98 7.29 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.689 2.26 . . . . 0.0 112.546 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 122' ' ' VAL . 30.4 m -131.42 -177.35 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -119.21 126.22 51.01 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.45 -2.96 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.087 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 82.77 49.57 5.04 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.768 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.6 OUTLIER -103.99 113.64 27.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.233 0.54 . . . . 0.0 110.674 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 129' ' ' VAL . 35.8 t -142.91 30.35 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.063 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.53 23.16 11.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.781 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.443 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.4 t80 47.62 48.18 17.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.9 0.381 . . . . 0.0 111.438 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -121.93 -54.69 1.92 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.309 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.646 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -59.04 -36.46 75.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -67.9 -54.95 14.85 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.9 t -62.08 -33.39 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -58.86 -53.07 62.56 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.719 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttp . . . . . 0 CA--C 1.532 0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.443 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 65.4 m-20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.343 0.592 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -67.36 -47.47 48.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.096 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 97.5 Cg_endo -87.21 7.96 4.55 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.63 2.22 . . . . 0.0 114.37 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 70.6 m-85 -129.2 -67.96 0.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.679 0.218 . . . . 0.0 111.584 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -58.43 3.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.974 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -60.6 -48.49 81.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.658 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.513 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -42.98 87.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CE2' HG12 ' A' ' 23' ' ' ILE . 30.5 t80 -54.83 -44.13 73.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.454 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -62.59 -35.22 78.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.525 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -63.0 -34.26 77.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 4.6 m-85 -93.93 34.31 1.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.633 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.26 117.13 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.861 0.363 . . . . 0.0 111.219 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -71.34 -50.08 36.01 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.609 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -103.44 -38.72 7.06 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.309 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.67 37.15 4.05 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.466 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -116.81 -8.64 11.34 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.77 7.96 14.65 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -130.56 164.1 25.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.173 0.486 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 HD13 ' A' ' 28' ' ' ILE . 6.4 pt -146.48 137.25 12.52 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.693 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -85.62 171.49 8.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.129 2.552 . . . . 0.0 112.4 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -44.26 -39.31 4.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 p -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.451 0.167 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.9 m -69.87 -46.46 65.47 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.697 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.681 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.15 -33.68 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.32 -73.0 0.45 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.838 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -64.75 -21.32 66.73 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -65.78 -49.4 68.47 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.4 mt -61.71 -26.88 68.32 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.225 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -36.79 70.05 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.795 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.797 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -109.21 31.06 6.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.57 -103.86 0.25 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.732 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.24 179.46 6.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -119.38 113.19 35.29 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.419 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.19 -162.76 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -98.53 163.93 12.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -56.4 -34.17 66.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.68 73.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.838 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.37 -58.66 4.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.608 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -53.62 -47.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 123.098 0.249 . . . . 0.0 111.134 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.6 m -61.84 -44.27 97.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.43 -41.3 80.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.522 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.916 HG23 HG11 ' A' ' 63' ' ' VAL . 12.9 mt -63.65 -48.04 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.936 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.36 -24.57 56.06 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.999 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 p -63.81 -10.27 19.24 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.2 p -117.72 -31.76 5.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -97.18 152.78 38.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 77.9 Cg_exo -38.71 146.53 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.348 2.699 . . . . 0.0 113.055 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.88 -54.91 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -97.53 129.57 44.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.718 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.15 86.08 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.044 0.45 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.3 p30 -83.08 -179.86 7.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.575 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.6 mtm -41.47 -47.55 3.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.847 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -51.68 55.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.995 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.604 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.7 mp0 -57.91 -51.62 68.86 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.099 0.25 . . . . 0.0 111.643 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.74 -49.9 75.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.098 -179.496 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.68 -35.28 77.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.539 0.209 . . . . 0.0 110.972 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.18 -53.98 52.12 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.916 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -67.37 -31.08 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.065 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.034 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.429 0.156 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.97 -40.07 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.799 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -44.72 94.92 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.062 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.634 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -62.13 -45.54 95.85 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.149 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.76 -25.69 65.74 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.14 74.5 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 82' ' ' GLY . 33.6 t -127.52 -60.76 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.194 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -105.49 48.99 0.82 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -115.72 64.63 0.69 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -67.58 -47.47 69.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.81 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.31 -50.19 2.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.33 68.66 0.82 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.44 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 m -128.04 62.99 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.747 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.26 46.98 1.77 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.0 ptm -173.09 144.5 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.766 0.283 . . . . 0.0 111.527 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -118.82 -42.92 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.22 81.32 0.34 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.285 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.813 ' HA ' HD23 ' A' ' 99' ' ' LEU . 46.6 t -44.31 -40.99 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.19 -38.34 18.62 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.617 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.7 mm-40 -81.44 -41.94 21.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.489 0.185 . . . . 0.0 110.513 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.729 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -35.47 65.05 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.662 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.73 -34.33 69.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.634 HG11 ' CA ' ' A' ' 82' ' ' GLY . 40.1 t -82.72 -47.49 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.747 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -70.66 -38.91 73.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.1 m -61.06 -31.15 70.8 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -70.18 -17.13 63.15 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.92 -66.02 0.8 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.51 0.195 . . . . 0.0 111.086 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.65 52.14 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.803 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 57.85 53.56 6.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.747 ' HG2' HD22 ' A' ' 103' ' ' LEU . 2.6 tptp -67.64 -137.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.079 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.94 77.39 0.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.994 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 96.0 p -67.15 -173.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.43 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 24.4 t-20 -48.84 -42.47 36.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.039 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.18 -52.28 65.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.98 -51.59 69.03 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.893 ' HA ' HD23 ' A' ' 118' ' ' LEU . 3.4 ptm -66.88 -27.58 67.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.311 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -49.18 78.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.62 0.248 . . . . 0.0 110.454 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.26 -42.25 88.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.893 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.92 -41.93 99.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -67.18 -35.48 79.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.216 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -38.29 90.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.4 -39.1 36.72 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.046 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 124' ' ' VAL . 48.5 t -85.48 133.12 42.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.854 0.327 . . . . 0.0 111.122 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.08 58.08 6.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.789 2.326 . . . . 0.0 112.826 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 128' ' ' MET . 15.2 m -131.66 176.36 9.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 19.23 11.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.788 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -168.21 25.92 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.687 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 56.83 45.97 90.76 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.961 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.606 ' O ' HG11 ' A' ' 124' ' ' VAL . 1.3 ttt -103.5 115.64 30.89 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.197 0.522 . . . . 0.0 110.751 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.641 ' O ' HG12 ' A' ' 129' ' ' VAL . 39.5 t -141.16 22.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.082 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 58.55 24.11 11.59 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.505 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER 56.18 -166.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t60 72.29 -58.89 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.109 0.164 . . . . 0.0 111.084 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -52.89 -39.99 63.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.537 0.208 . . . . 0.0 111.421 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 21.8 m-85 -67.96 -52.39 36.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.377 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.43 -31.65 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.64 -53.37 58.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.53 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 178.957 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.445 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 4.7 t -66.95 -45.63 53.56 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 6' ' ' SER . 2.8 Cg_exo -75.62 -13.39 20.18 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.774 2.316 . . . . 0.0 113.852 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -118.87 -61.68 1.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.58 -59.89 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.247 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.415 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 28.6 tp60 -60.54 -48.21 82.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.45 -38.16 73.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.355 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 14.7 t80 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -62.22 -30.69 71.27 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.733 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -62.83 -39.63 94.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.59 ' O ' HG22 ' A' ' 23' ' ' ILE . 52.6 m-85 -95.69 33.39 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 103.28 15.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -71.2 -35.23 71.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -86.51 -38.67 17.01 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.04 -8.3 63.01 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.252 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -86.76 -32.12 20.56 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.991 0.396 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.9 40.68 0.18 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.414 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.85 157.77 41.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.315 0.246 . . . . 0.0 110.732 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.8 HD12 HD13 ' A' ' 28' ' ' ILE . 4.1 pt -150.51 129.41 6.22 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.09 172.53 8.52 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.058 2.505 . . . . 0.0 112.148 179.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.98 -37.96 4.39 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.8 p -60.91 -43.6 98.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.486 0.184 . . . . 0.0 111.067 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 38.6 m -70.07 -48.82 56.2 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.609 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.8 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.29 -33.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.47 -69.47 1.26 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.389 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -30.99 72.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.346 0.117 . . . . 0.0 111.275 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.32 -51.3 69.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.717 0.294 . . . . 0.0 110.325 179.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.68 -32.29 72.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.17 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -35.98 63.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.128 179.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.36 75.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.631 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.2 t -66.83 -44.33 81.4 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.683 0.277 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.99 -69.46 0.03 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.5 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 166.13 22.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.982 0.42 . . . . 0.0 111.509 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.95 121.92 23.1 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.432 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.94 -161.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.726 2.284 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -90.34 166.17 13.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.235 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -56.68 -29.3 62.2 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.223 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.69 93.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.711 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -53.53 51.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.994 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.635 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.96 -44.82 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -61.4 -39.98 92.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.194 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -57.79 -38.92 76.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 178.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 44' ' ' ILE . 21.0 mt -63.73 -46.75 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.994 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.01 -27.2 61.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.464 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -5.54 6.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 p -118.6 -33.96 4.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.899 0.318 . . . . 0.0 111.436 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.763 HD11 HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -105.03 161.5 22.56 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.487 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD2' ' HG2' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -46.11 162.05 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.131 2.554 . . . . 0.0 113.083 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.35 -67.62 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -83.23 119.75 24.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.614 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.89 96.12 4.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.101 0.476 . . . . 0.0 110.945 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.4 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 22.9 p30 -82.57 174.35 11.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.677 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.4 mtt -42.52 -43.6 3.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.672 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.48 -50.92 56.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.824 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 31.9 mt-30 -57.14 -51.27 69.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.84 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -49.25 77.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.762 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 mt -61.43 -31.44 71.38 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -63.64 -55.05 26.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.495 0.188 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.763 HG21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.69 -42.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.115 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 120.431 0.158 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.68 -46.36 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.999 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.35 -40.03 95.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.779 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -60.67 -45.48 96.3 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.474 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 23.0 m-85 -76.86 -27.48 55.09 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.68 -16.57 63.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -45.29 -56.12 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.3 19.32 4.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.597 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -142.17 68.72 1.32 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.262 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.27 -54.39 29.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.27 -63.62 1.32 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.27 82.92 0.06 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.784 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.99 -53.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.15 42.12 1.45 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.001 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.47 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -170.71 137.26 1.29 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.749 0.275 . . . . 0.0 111.346 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.558 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -112.21 -43.43 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.451 179.532 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.6 79.58 0.17 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.199 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.999 HG11 HD21 ' A' ' 118' ' ' LEU . 91.1 t -45.07 -35.64 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.34 -43.88 20.25 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.741 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.4 mp0 -74.01 -50.18 21.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.279 0.232 . . . . 0.0 110.802 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.13 -36.33 75.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.12 -50.46 68.18 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.603 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -53.05 -42.05 65.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.122 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 82' ' ' GLY . 47.2 t -63.06 -52.16 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 99' ' ' LEU . 4.6 mt -66.12 -40.73 90.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.7 m -58.05 -33.29 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.337 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.1 m -74.47 -17.84 60.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.42 -60.95 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.529 0.204 . . . . 0.0 111.119 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.55 52.73 0.22 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.93 48.69 8.55 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.99 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 5.3 mmtp -68.64 -138.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 114' ' ' GLU . 11.1 mt -68.07 78.56 0.23 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.287 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.3 p -69.29 -171.11 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.013 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 115' ' ' MET . 18.4 t-20 -48.52 -37.41 17.54 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.265 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -67.23 -55.01 15.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.548 0.213 . . . . 0.0 111.478 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG2' HD23 ' A' ' 110' ' ' LEU . 1.3 mp0 -57.12 -49.11 76.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.768 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -67.08 -27.88 67.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.095 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -47.03 85.96 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.33 -44.47 83.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.462 179.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.999 HD21 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.39 -41.7 90.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.265 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 124' ' ' VAL . 2.2 mt -71.55 -29.83 65.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -41.24 97.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.527 0.203 . . . . 0.0 110.598 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.16 -44.35 44.61 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.089 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 124' ' ' VAL . 44.2 t -82.64 131.65 54.32 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.764 0.282 . . . . 0.0 111.174 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.65 61.38 7.48 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.756 2.304 . . . . 0.0 112.666 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.452 HG23 HD23 ' A' ' 119' ' ' LEU . 12.7 m -131.8 177.37 7.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.449 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -126.94 47.3 2.35 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.181 0.515 . . . . 0.0 110.745 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' C ' HD21 ' A' ' 119' ' ' LEU . 5.2 p-10 173.64 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 111.37 51.46 0.58 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.47 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.27 116.96 33.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 0.0 110.671 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.642 ' O ' HG12 ' A' ' 129' ' ' VAL . 25.0 t -142.2 19.64 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.74 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.32 23.42 10.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.544 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 48.11 47.23 19.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 111.599 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 -51.61 2.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.633 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.7 t70 -60.09 -35.21 74.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.784 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 5.7 m-85 -66.04 -58.26 5.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.703 0.287 . . . . 0.0 110.35 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.75 -32.59 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.417 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -60.1 -50.53 73.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.491 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.015 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 7.5 m-20 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -66.99 -46.52 53.63 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.957 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 6' ' ' SER . 83.2 Cg_endo -82.97 -3.88 11.17 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.411 2.074 . . . . 0.0 114.045 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 46.4 m-85 -120.83 -62.51 1.44 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.7 -59.44 2.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.072 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -60.59 -47.24 87.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.19 -40.66 82.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.493 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.4 t80 -57.08 -44.37 83.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.604 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -62.06 -33.84 75.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.248 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.84 -30.99 70.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.369 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.32 20.37 4.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -101.73 120.31 40.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.188 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -55.74 31.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.498 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -101.94 -24.46 14.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.801 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . 93.82 44.33 3.65 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.451 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -89.46 -26.03 21.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.041 0.136 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.08 10.17 14.43 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.106 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 2.1 mtt180 -130.24 160.91 32.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.055 0.427 . . . . 0.0 110.551 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.743 HD12 HD13 ' A' ' 28' ' ' ILE . 5.7 pt -146.33 138.51 13.63 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -87.02 171.55 6.7 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.234 2.623 . . . . 0.0 112.482 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.506 ' O ' HG21 ' A' ' 44' ' ' ILE . 10.5 ptpt -42.5 -40.97 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 p -59.9 -44.62 94.15 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 12.5 m -69.1 -48.0 63.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.586 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.743 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -57.04 -34.24 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.09 -68.72 1.51 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.281 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -30.62 71.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.98 -50.88 71.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 110.423 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.47 -30.19 70.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.039 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -57.02 -37.81 72.25 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.842 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.51 -29.12 70.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.8 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -88.28 -42.68 12.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.604 0.24 . . . . 0.0 110.55 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.9 -87.38 0.09 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.512 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -132.61 175.74 9.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 2.5 t-20 -119.37 112.36 35.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.122 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.68 -162.84 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.915 2.41 . . . . 0.0 112.856 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 p -95.59 166.52 11.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.82 -37.17 65.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.34 73.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.813 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -55.97 13.1 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.681 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.01 -48.57 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.584 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.6 m -56.98 -39.74 75.19 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.66 -41.94 87.28 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.357 179.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 44' ' ' ILE . 19.5 mt -62.54 -49.4 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.74 -25.84 55.81 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.384 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -64.8 -8.21 14.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 p -117.83 -49.02 2.54 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.656 0.207 . . . . 0.0 110.968 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.61 158.2 54.41 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.796 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.3 Cg_exo -40.93 149.75 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.188 2.592 . . . . 0.0 113.072 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.05 -63.68 0.18 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -89.68 127.68 35.97 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.791 0.329 . . . . 0.0 110.66 179.716 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.82 89.59 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.284 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.07 179.65 7.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.7 mtp -41.41 -46.27 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.39 -52.37 40.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.96 -50.95 71.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.729 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.23 -48.9 79.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.06 -179.749 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.82 -39.37 88.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.448 0.166 . . . . 0.0 111.396 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -55.43 -49.2 73.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.483 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.659 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -76.4 -35.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 179.92 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.427 HD13 ' CE1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.42 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 120.448 0.166 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.38 -47.84 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.875 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -31.12 70.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.597 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.721 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -61.81 -47.84 87.72 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.553 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -74.91 -32.78 61.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 0.127 . . . . 0.0 111.052 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.88 73.19 5.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.07 -65.19 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.13 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.508 ' HB2' ' CB ' ' A' ' 98' ' ' GLU . 1.4 m-85 -109.55 34.41 3.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.346 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 49.74 2.29 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -69.89 -54.81 11.72 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.206 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.88 -47.6 11.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.75 66.65 0.97 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -102.04 67.04 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.27 56.05 11.3 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.529 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -174.93 138.65 0.47 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.714 0.293 . . . . 0.0 111.192 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -107.23 -41.65 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.547 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.86 78.95 0.34 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.499 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.796 ' HA ' HD23 ' A' ' 99' ' ' LEU . 70.8 t -44.75 -35.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.53 -41.77 18.57 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.252 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -80.16 -36.71 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.661 0.23 . . . . 0.0 111.549 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -67.25 -40.83 86.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.485 0.183 . . . . 0.0 110.957 179.886 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -38.64 66.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.975 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -56.37 -45.85 80.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.67 0.271 . . . . 0.0 110.924 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.721 HG11 ' CA ' ' A' ' 82' ' ' GLY . 47.6 t -65.77 -46.71 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.222 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.715 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -67.1 -37.55 84.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.371 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 85.3 m -67.19 -42.96 83.3 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.485 0.183 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.1 p -68.0 -16.06 63.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.29 -65.29 0.7 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.709 0.29 . . . . 0.0 110.927 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.5 49.08 0.28 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.121 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 61.16 41.5 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 -179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.715 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -68.9 -137.92 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.987 178.977 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 42.1 mt -68.56 80.02 0.27 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.414 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 79.7 p -66.38 -170.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 115' ' ' MET . 4.6 p-10 -53.26 -33.7 54.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.226 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -48.9 79.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.542 0.21 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.5 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 17.9 mm-40 -59.14 -53.41 58.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.854 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.76 -26.44 66.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.258 179.365 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -47.11 86.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.239 179.125 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.0 -43.77 82.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.0 -42.18 89.47 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.695 179.432 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.636 HD21 ' H ' ' A' ' 127' ' ' GLY . 1.2 mt -67.89 -33.48 74.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -39.78 91.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.0 -48.28 21.04 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.004 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 129' ' ' VAL . 18.8 t -83.89 125.09 73.89 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.792 0.296 . . . . 0.0 111.286 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.56 63.23 7.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.694 2.262 . . . . 0.0 112.549 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.42 HG13 HG12 ' A' ' 122' ' ' VAL . 20.1 m -131.26 179.41 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -119.3 130.28 55.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 70.61 10.69 7.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.829 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.636 ' H ' HD21 ' A' ' 119' ' ' LEU . . . 69.62 44.47 63.5 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.702 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.87 114.39 28.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.372 0.606 . . . . 0.0 110.601 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 129' ' ' VAL . 22.1 t -142.58 26.14 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.083 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.25 21.09 5.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.0 t80 48.97 38.29 12.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -116.88 -38.86 3.35 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.607 ' HB3' HG11 ' A' ' 129' ' ' VAL . 33.0 t70 -66.63 -37.44 84.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.7 m-85 -67.94 -54.91 15.08 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.45 -31.7 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.95 -50.39 72.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 ttm . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.245 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.837 0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -64.72 -46.58 76.23 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.624 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.0 Cg_endo -82.17 -11.64 10.87 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.506 2.138 . . . . 0.0 114.072 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -114.5 -60.41 1.89 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.492 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.33 -48.49 81.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.596 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.14 -40.03 76.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.035 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.486 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.9 t80 -59.17 -44.51 92.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.315 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.4 m -62.5 -31.45 72.21 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.747 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 5.8 mt -65.91 -36.95 84.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -95.34 38.53 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.196 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -83.27 88.77 6.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.226 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -62.85 -37.71 87.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -86.54 -36.32 19.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.108 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.28 27.18 56.03 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.452 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.1 p -129.28 10.4 5.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.91 8.63 47.76 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.742 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -129.22 163.16 26.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.355 0.578 . . . . 0.0 110.958 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.819 HD12 HD13 ' A' ' 28' ' ' ILE . 6.3 pt -147.24 138.64 13.32 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.918 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.58 172.27 6.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.455 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.91 -37.63 6.57 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.8 p -60.14 -41.63 93.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.482 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 3.3 m -70.88 -54.73 10.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.372 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.819 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.04 -35.76 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.15 -74.44 0.29 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.535 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -28.56 69.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 23' ' ' ILE . 13.5 tp -61.45 -51.95 66.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 mt -60.92 -29.33 69.53 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.261 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.443 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -55.53 -39.9 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.052 0.22 . . . . 0.0 110.871 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.15 70.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.846 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -90.1 -43.06 10.73 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.681 0.277 . . . . 0.0 110.611 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.08 -88.19 0.1 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.505 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.95 172.79 12.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.962 0.41 . . . . 0.0 112.018 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 3.4 t30 -122.06 110.23 33.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.21 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -84.19 -162.88 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.905 2.403 . . . . 0.0 112.53 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -92.96 166.52 12.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -54.71 -33.53 61.13 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.797 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.51 86.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.828 179.028 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -55.55 16.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.96 -45.39 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.103 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 m -62.16 -41.1 97.97 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.61 -38.27 77.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.923 HG23 HG11 ' A' ' 63' ' ' VAL . 14.4 mt -64.9 -49.82 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.16 -25.33 46.15 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.882 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -64.21 -7.15 8.23 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.2 p -117.78 -46.59 2.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.775 0.261 . . . . 0.0 111.204 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -86.55 157.47 55.49 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.094 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -39.41 150.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.285 2.657 . . . . 0.0 113.39 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.6 -61.34 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.6 130.0 38.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.683 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.37 86.71 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.043 0.449 . . . . 0.0 111.061 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.486 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -82.95 -179.56 7.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.672 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 mtm -41.41 -46.79 3.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.944 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -68.66 -50.55 50.28 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.8 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.6 mp0 -58.0 -51.74 68.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.585 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.71 -48.35 82.01 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.78 -36.46 79.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.285 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -52.61 64.67 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.187 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.923 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.6 -38.71 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.314 179.847 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.585 HD13 ' HE1' ' A' ' 60' ' ' PHE . 1.2 tp . . . . . 0 C--O 1.234 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.025 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 120.651 0.262 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.29 -39.13 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.706 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -39.05 93.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.513 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.758 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -62.81 -47.23 90.61 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.4 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -74.84 -36.79 62.38 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.964 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -78.86 72.3 5.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.036 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.62 -62.74 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -113.3 23.62 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.498 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.27 73.85 1.56 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.008 0.432 . . . . 0.0 110.863 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -69.34 -43.37 73.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -89.07 -63.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.58 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.421 0.45 . . . . 0.0 111.292 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m 69.28 -74.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.772 0.429 . . . . 0.0 111.349 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.03 61.3 0.42 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 ptp -176.23 131.3 0.23 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.583 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -103.84 145.57 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.583 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -109.61 82.79 0.31 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.825 ' HA ' HD23 ' A' ' 99' ' ' LEU . 59.3 t -37.48 -39.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.6 -42.74 27.88 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.623 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.0 pt-20 -81.24 -37.79 27.98 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.932 -0.157 . . . . 0.0 111.128 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.825 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.55 -39.9 89.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.549 0.214 . . . . 0.0 110.549 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -38.84 59.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.687 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.57 -36.2 71.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.623 0.249 . . . . 0.0 111.324 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 82' ' ' GLY . 26.3 t -82.7 -38.9 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.908 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 2.1 mt -79.71 -48.98 12.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.4 m -53.57 -38.57 64.04 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.9 p -60.5 -25.56 66.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.95 -83.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -133.13 46.14 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.715 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 62.46 50.85 3.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.377 . . . . 0.0 111.157 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 9.4 mmtp -67.92 -137.83 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.282 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.3 mt -68.32 76.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.4 p -68.29 -172.72 0.34 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.65 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -51.28 -42.95 61.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -64.34 -48.48 75.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.52 -53.31 59.64 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.622 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.857 ' HA ' HD23 ' A' ' 118' ' ' LEU . 3.3 ppp? -66.78 -27.67 67.78 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.302 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -46.07 87.19 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.628 0.252 . . . . 0.0 110.474 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.18 -41.83 76.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.635 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.857 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.09 -43.19 99.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.971 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.55 HD21 ' H ' ' A' ' 127' ' ' GLY . 3.2 mt -70.13 -32.9 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.274 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -39.94 95.77 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.015 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.11 -48.74 30.6 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.986 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 124' ' ' VAL . 14.0 t -82.45 125.29 76.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.679 0.24 . . . . 0.0 111.142 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.17 58.54 6.99 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.661 2.241 . . . . 0.0 112.401 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 122' ' ' VAL . 22.8 m -131.33 -178.67 2.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.138 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -119.18 135.86 54.47 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.499 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.49 14.66 9.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.811 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.55 ' H ' HD21 ' A' ' 119' ' ' LEU . . . 64.26 55.65 22.44 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.794 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttp -103.54 113.03 26.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.255 0.55 . . . . 0.0 111.099 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 129' ' ' VAL . 45.5 t -142.94 26.53 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t30 59.23 21.34 9.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.535 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 132' ' ' HIS . 0.5 OUTLIER 54.34 -166.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -178.667 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 131' ' ' TYR . 1.5 m80 71.34 -57.77 0.6 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.579 0.352 . . . . 0.0 111.24 -179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -52.56 -39.37 61.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.541 0.21 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 19.8 m-85 -68.26 -58.0 5.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.584 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.45 -32.21 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.29 -54.61 41.85 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.691 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 42.8 tpp . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.391 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 121.059 0.456 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -66.68 -46.65 56.97 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.767 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 6' ' ' SER . 8.0 Cg_exo -73.41 -21.29 19.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.808 2.339 . . . . 0.0 113.822 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -107.74 -63.52 1.3 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -62.08 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.697 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 5.8 tt0 -56.67 -48.58 77.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.949 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.67 -40.43 87.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.569 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.1 t80 -60.12 -44.84 94.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.758 0.313 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -62.43 -31.29 71.97 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.748 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 20.1 mt -56.99 -40.35 76.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 31' ' ' LEU . 8.5 m-30 -97.73 32.28 2.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -61.63 130.0 43.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.957 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -56.61 8.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.778 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -136.3 26.02 3.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.412 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.94 27.61 72.96 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.728 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.6 p -95.86 -26.65 15.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.454 0.169 . . . . 0.0 111.258 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.34 18.63 8.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.883 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 36.9 mtt180 -129.69 160.51 33.15 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.878 0.339 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.86 HD12 HD13 ' A' ' 28' ' ' ILE . 4.1 pt -143.78 137.67 14.53 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.511 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.73 170.62 7.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.148 2.565 . . . . 0.0 113.027 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 18.7 pttp -43.78 -35.37 1.86 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -61.36 -46.11 91.57 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.466 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.2 t -70.41 -49.47 48.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.621 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.17 -34.94 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.496 -179.678 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.77 -67.7 2.06 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.331 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.22 -28.12 69.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 15' ' ' PHE . 10.4 tp -62.05 -48.6 79.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.9 -32.14 72.5 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.59 -40.29 71.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.816 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.48 70.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.472 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 m -107.14 40.03 1.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 110.498 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.31 -102.94 0.4 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.545 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 171.23 14.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 111.692 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -119.48 114.88 34.29 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.384 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.02 -162.08 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.896 2.397 . . . . 0.0 112.477 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.9 p -94.74 166.95 11.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.7 mm? -56.5 -34.49 67.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.41 75.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.644 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.26 -55.16 17.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.08 -49.3 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.828 179.635 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.0 m -55.65 -42.12 74.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.416 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -59.2 -42.86 91.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 44' ' ' ILE . 41.2 mt -61.64 -41.98 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -56.63 -36.07 69.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -65.85 -1.77 3.23 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 51' ' ' LEU . 5.6 m -118.07 -40.32 2.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.228 0.211 . . . . 0.0 110.937 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.637 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -102.89 156.41 35.34 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.332 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.6 Cg_exo -40.45 143.65 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.085 2.523 . . . . 0.0 113.083 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -22.85 -67.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.2 tt0 -91.66 129.35 37.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.609 0.242 . . . . 0.0 110.518 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -86.75 88.44 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.015 0.436 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.7 p30 -87.01 -179.85 6.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.306 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mtm -41.27 -46.98 3.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -53.41 41.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.18 -52.98 63.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -49.26 78.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.677 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.14 -27.92 69.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.387 0.136 . . . . 0.0 111.264 178.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -65.38 -43.19 91.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.965 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.637 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.12 -38.91 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.995 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.488 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.429 0.157 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.31 -49.77 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.009 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.64 -31.46 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.854 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -65.14 -51.64 48.49 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.643 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -76.59 -36.26 57.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.403 0.144 . . . . 0.0 110.934 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -78.68 73.44 5.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.969 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.43 -61.23 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.29 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.55 43.64 1.6 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.525 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 3.8 m-20 -130.79 75.63 1.67 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -51.67 67.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.05 -49.9 3.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.265 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 58.13 53.97 6.24 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -74.79 -48.09 27.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.178 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.73 58.67 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.665 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 ptm -166.95 147.97 5.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER -125.92 143.35 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.508 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -107.08 81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.052 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.805 ' HA ' HD23 ' A' ' 99' ' ' LEU . 72.6 t -43.3 -38.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.25 -48.2 54.06 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.744 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.4 mm-40 -77.03 -40.68 45.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.253 0.221 . . . . 0.0 110.657 178.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -59.25 -40.59 86.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.552 179.517 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -66.51 -49.35 66.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.518 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -52.13 -37.97 55.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.712 HG11 ' CA ' ' A' ' 82' ' ' GLY . 41.5 t -74.04 -49.26 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.804 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.748 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.8 mt -69.13 -28.3 66.33 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.0 m -64.3 -38.4 90.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.312 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.4 p -70.82 -12.98 61.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.1 -66.14 0.68 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.567 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.14 49.05 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.333 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.31 50.52 6.11 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 111.453 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.748 ' HG2' HD22 ' A' ' 103' ' ' LEU . 26.5 tptt -68.53 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.428 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.502 HD23 ' HG2' ' A' ' 114' ' ' GLU . 6.9 mt -71.21 76.96 0.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -62.43 -176.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.106 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -52.32 -35.98 52.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.99 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -51.02 63.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.424 0.154 . . . . 0.0 111.297 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.502 ' HG2' HD23 ' A' ' 110' ' ' LEU . 2.1 tp10 -58.92 -50.01 75.64 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.906 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.873 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -66.6 -27.43 67.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.905 179.03 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -48.55 80.64 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.603 0.239 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.66 -42.05 87.23 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 179.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.1 -42.37 98.39 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.833 179.457 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.596 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.45 -33.07 70.88 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.03 179.616 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -39.99 92.17 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.45 -46.94 30.52 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.937 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.457 HG11 HG22 ' A' ' 129' ' ' VAL . 14.4 t -87.09 117.87 69.22 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.658 0.229 . . . . 0.0 111.036 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.7 64.66 5.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.463 2.109 . . . . 0.0 112.477 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.3 -178.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -118.92 135.65 54.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.638 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.64 17.62 11.0 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.623 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 61.49 64.05 4.33 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.988 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttt -111.38 116.78 31.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.241 0.543 . . . . 0.0 111.058 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.732 HG11 ' HB2' ' A' ' 133' ' ' ASP . 39.5 t -142.23 26.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.8 26.3 15.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.5 t80 46.69 45.45 14.53 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.768 0.318 . . . . 0.0 111.616 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -119.56 -56.03 2.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.352 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.732 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -60.51 -34.34 73.94 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.471 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 4.5 m-85 -67.69 -55.4 13.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.271 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.9 -33.95 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.55 -51.85 68.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.668 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 ttp . . . . . 0 CA--C 1.531 0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.326 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -64.3 -47.87 77.2 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.081 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.41 -13.93 12.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.403 2.069 . . . . 0.0 114.114 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -106.65 -65.87 1.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.638 ' HE3' HD11 ' A' ' 61' ' ' LEU . 8.7 mmtp -73.12 -58.87 3.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.501 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 2.4 tt0 -56.8 -49.9 73.98 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.472 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.55 -41.46 85.62 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 23' ' ' ILE . 16.4 t80 -53.57 -45.21 69.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.39 -36.69 83.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.141 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.8 mt -62.86 -27.41 69.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.392 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 3.5 m-85 -94.23 18.93 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.86 99.26 11.66 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -61.1 -35.34 76.76 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.741 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.24 -29.13 23.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.27 42.86 41.03 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -117.87 -36.28 3.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.24 -11.12 2.78 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.587 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -118.1 147.73 43.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.272 0.536 . . . . 0.0 110.626 -179.831 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.912 HD12 HD13 ' A' ' 28' ' ' ILE . 4.2 pt -127.55 140.88 39.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.848 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.28 173.25 3.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.257 2.638 . . . . 0.0 112.432 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.76 -36.69 2.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 p -59.6 -46.06 90.06 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.495 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 2.5 t -71.33 -49.64 40.52 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.912 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.41 -36.18 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.17 -73.1 0.44 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.67 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -65.12 -21.35 66.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.3 tp -65.93 -48.38 71.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -61.18 -30.55 70.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.841 179.124 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.444 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.47 -40.73 72.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.679 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.87 75.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.49 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.8 m -112.63 43.55 1.63 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 110.669 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.83 -105.39 0.4 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.808 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.37 169.98 15.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.2 t30 -119.11 112.48 36.17 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.157 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.74 -162.62 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.036 2.49 . . . . 0.0 112.737 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 p -97.68 165.33 12.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.499 HD12 ' HE2' ' A' ' 25' ' ' LYS . 1.4 mm? -54.88 -36.62 65.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.21 78.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.539 0.209 . . . . 0.0 110.453 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -51.48 58.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -61.1 -46.18 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.82 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 29.6 m -54.88 -41.52 70.96 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.144 0.278 . . . . 0.0 110.633 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -60.2 -41.98 94.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.63 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.784 HG23 HG11 ' A' ' 63' ' ' VAL . 21.1 mt -61.67 -49.53 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -57.46 -26.4 61.17 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.859 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -63.78 -10.08 18.02 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 p -117.91 -35.56 3.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.722 0.237 . . . . 0.0 111.526 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.583 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -94.25 151.18 39.33 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.461 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.581 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 59.7 Cg_exo -36.97 141.89 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.337 2.691 . . . . 0.0 113.089 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -24.76 -61.31 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -93.63 129.52 39.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.51 86.94 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.03 -179.08 6.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.609 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.5 mtp -41.43 -47.16 3.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.988 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.05 -53.0 35.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.958 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.581 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.8 mp0 -57.49 -51.97 67.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.604 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.1 -45.91 91.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.638 HD11 ' HE3' ' A' ' 9' ' ' LYS . 13.9 mt -60.73 -39.24 87.87 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -52.14 65.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.802 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.784 HG11 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -73.65 -29.12 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.24 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.471 HD13 ' HE1' ' A' ' 60' ' ' PHE . 10.2 tp . . . . . 0 C--O 1.227 -0.112 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.942 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 120.476 0.179 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.96 -45.61 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.4 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.96 94.34 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.881 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -64.11 -46.08 92.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.759 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -75.61 -36.09 60.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.381 0.134 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.81 72.5 5.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.1 t -140.62 -57.4 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.429 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.38 33.11 4.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.75 65.8 1.39 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -31.85 73.18 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.334 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 3.3 t70 -82.12 -62.04 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.377 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 72.96 -64.15 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.497 0.498 . . . . 0.0 111.799 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.1 p -66.67 95.19 0.33 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.8 -26.87 4.46 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.182 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.3 ptp -157.73 138.8 13.37 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.841 0.321 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -115.32 -40.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.027 -179.608 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 58.69 80.22 0.09 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.547 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.772 HG21 HD21 ' A' ' 118' ' ' LEU . 61.1 t -44.6 -34.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.93 -46.95 25.99 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.989 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.6 mt-10 -75.3 -47.66 26.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.555 0.217 . . . . 0.0 110.991 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -58.48 -38.38 77.48 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.249 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -67.06 -46.96 72.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -53.42 -40.9 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.868 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.881 HG11 ' HA2' ' A' ' 82' ' ' GLY . 4.0 t -77.21 -54.35 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.8 mt -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.6 m -60.5 -38.88 85.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.554 0.216 . . . . 0.0 111.036 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.4 m -71.18 -15.19 62.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.69 -59.5 2.76 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -158.36 43.56 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.463 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.87 52.37 10.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 111.29 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.739 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.41 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.05 179.134 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.44 77.63 0.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.986 0.357 . . . . 0.0 110.334 179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 p -65.79 -172.34 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.411 -178.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -50.75 -39.49 52.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.079 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.37 -49.76 70.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.492 0.187 . . . . 0.0 111.354 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.59 -52.84 63.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.605 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.931 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.9 ppp? -67.29 -26.24 66.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.405 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -49.31 77.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.352 179.274 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.79 -43.17 84.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.21 -40.17 92.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 179.684 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.69 -33.2 70.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.44 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.78 -38.46 91.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.749 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.87 -44.97 9.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.728 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 124' ' ' VAL . 48.2 t -79.42 130.46 68.43 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.516 0.198 . . . . 0.0 111.175 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.02 62.85 8.09 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 122' ' ' VAL . 13.4 m -131.36 176.69 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.229 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 46.78 2.27 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.899 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.94 -35.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.702 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.726 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 111.11 46.09 0.83 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.97 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.46 119.19 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.179 0.514 . . . . 0.0 111.179 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 129' ' ' VAL . 38.7 t -142.5 32.01 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.804 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.718 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 134' ' ' PHE . 2.7 t80 44.66 46.8 8.58 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.809 0.337 . . . . 0.0 111.532 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 -55.07 1.97 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.5 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 129' ' ' VAL . 8.6 t70 -60.09 -33.01 71.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.699 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 131' ' ' TYR . 6.5 m-85 -68.15 -56.31 9.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.43 -33.17 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.507 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.29 -51.25 69.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.299 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 32.5 ttp . . . . . 0 CA--C 1.533 0.317 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.603 -179.955 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 19.5 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.549 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -67.41 -48.94 44.55 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.611 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 72.9 Cg_endo -78.44 -12.63 15.38 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.509 2.139 . . . . 0.0 113.995 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 3.2 m-85 -108.97 -64.86 1.19 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -59.0 2.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.554 -179.233 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.549 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.1 -49.27 78.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.06 -40.86 82.05 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.807 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.0 t80 -53.51 -45.74 69.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.466 179.156 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 m -62.37 -36.48 82.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.9 mt -60.57 -31.65 70.77 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.393 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' O ' HG22 ' A' ' 23' ' ' ILE . 54.6 m-85 -93.77 26.45 3.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.589 0.233 . . . . 0.0 111.591 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -119.11 79.03 1.35 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.222 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -15.98 63.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.37 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -86.0 -24.68 26.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.45 67.02 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.664 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.6 p -105.65 -32.75 8.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.14 0.176 . . . . 0.0 111.397 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.63 23.8 5.53 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.944 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 2.3 mpt_? -130.56 159.63 36.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.741 0.27 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 HD13 ' A' ' 28' ' ' ILE . 3.7 pt -144.46 131.04 10.06 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.92 172.31 8.85 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.121 2.547 . . . . 0.0 112.137 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HB2' HG13 ' A' ' 44' ' ' ILE . 6.2 pttt -44.39 -37.65 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 p -62.43 -45.77 91.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.342 0.115 . . . . 0.0 111.225 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 6.3 m -66.91 -46.59 74.37 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.474 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.83 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -57.98 -35.62 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.052 179.502 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.65 -70.11 1.07 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.518 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -25.58 66.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.67 0.235 . . . . 0.0 111.455 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -61.31 -48.68 80.24 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.59 -35.55 78.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -32.2 68.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.329 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.89 -46.82 64.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -65.44 -33.64 76.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.257 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.97 -67.88 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.284 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.49 160.21 35.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.706 0.289 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -131.98 153.63 81.44 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.252 179.819 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.84 -162.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.989 2.459 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -98.59 168.15 10.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.222 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.6 mm? -55.66 -32.4 63.18 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.58 94.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.192 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -53.61 53.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.388 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.855 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.81 -47.67 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.562 179.473 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.6 m -57.98 -40.54 80.93 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.175 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -57.35 -39.41 75.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.217 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.855 HD12 ' HA ' ' A' ' 44' ' ' ILE . 15.9 mt -63.78 -46.73 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -56.69 -25.63 54.63 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.34 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -64.16 -6.93 7.49 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.492 ' C ' HD13 ' A' ' 51' ' ' LEU . 9.6 p -118.25 -45.45 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.781 0.264 . . . . 0.0 110.76 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.66 143.48 26.68 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -36.94 150.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.704 2.936 . . . . 0.0 113.534 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.89 -74.48 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -72.73 117.77 14.84 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.728 -179.093 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.98 93.11 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.57 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.2 p30 -81.93 177.92 8.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.685 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -41.79 -47.93 4.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.818 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -67.17 -48.24 68.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.645 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -56.99 -51.62 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.344 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -49.23 76.15 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.3 mt -61.12 -33.91 74.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -61.26 -52.68 63.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.462 HG11 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.37 -37.9 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.247 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.129 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.503 0.192 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.6 t -61.72 -44.44 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.048 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.28 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.263 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.754 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -62.1 -47.03 92.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.273 179.435 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 15.0 m-85 -68.3 -29.46 68.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.84 1.95 21.64 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -51.08 -38.93 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.542 0.21 . . . . 0.0 111.498 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.67 21.6 1.99 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.46 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 54.09 1.97 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.152 0.501 . . . . 0.0 110.58 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -63.46 -54.19 40.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.28 -62.37 1.64 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.39 71.32 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.436 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -81.14 -41.55 22.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.62 49.1 0.42 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.649 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.5 ptm -176.47 136.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.612 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -105.81 -43.45 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.295 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.71 79.58 0.35 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.522 179.691 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.785 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.7 t -44.88 -37.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -45.36 -45.06 11.08 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 121.437 -0.411 . . . . 0.0 113.391 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 102' ' ' VAL . 7.2 pt-20 -80.07 -39.22 30.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.843 0.322 . . . . 0.0 111.508 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.59 -40.29 96.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.612 0.244 . . . . 0.0 110.819 179.916 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 104' ' ' THR . 1.3 ppt_? -75.54 -35.75 60.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.06 -37.6 74.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.602 0.239 . . . . 0.0 111.329 179.62 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.754 HG11 ' CA ' ' A' ' 82' ' ' GLY . 18.8 t -77.44 -44.08 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.731 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.2 mt -68.28 -34.12 75.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.278 -179.285 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 100' ' ' ARG . 20.0 p -63.01 -31.91 73.15 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.464 0.173 . . . . 0.0 111.356 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 m -67.6 -18.34 64.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.8 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.09 -61.9 1.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.28 52.68 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.427 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.75 51.94 4.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.731 ' HG2' HD22 ' A' ' 103' ' ' LEU . 9.7 tptt -68.18 -138.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.547 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' A' ' 114' ' ' GLU . 12.4 mt -71.21 76.23 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.457 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 62.2 p -66.39 -174.44 0.28 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.194 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.73 -34.67 27.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.313 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -52.19 58.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.534 0.207 . . . . 0.0 111.246 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.568 ' HG2' HD22 ' A' ' 110' ' ' LEU . 2.3 tp10 -56.62 -52.37 65.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.696 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.85 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -66.85 -26.62 67.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.446 179.495 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -46.36 87.45 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.076 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -66.94 -44.79 79.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.385 179.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.72 -39.77 89.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 179.11 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.1 mt -68.14 -33.92 75.37 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -61.91 -38.46 88.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.45 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.16 31.05 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.881 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.506 HG11 ' CG2' ' A' ' 129' ' ' VAL . 5.7 t -87.79 119.71 70.65 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.724 0.262 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.89 64.56 4.04 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.678 2.252 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.48 -177.76 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.124 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -119.02 126.67 52.25 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.521 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 74.78 0.47 3.56 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.03 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.585 ' N ' HD21 ' A' ' 119' ' ' LEU . . . 80.33 49.92 5.65 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.268 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -103.36 116.38 32.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.491 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 129' ' ' VAL . 40.1 t -142.35 26.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.999 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 61.77 23.65 13.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.795 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.448 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER 49.71 45.44 24.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 111.467 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -120.05 -57.58 1.93 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.145 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.476 ' CB ' HG11 ' A' ' 129' ' ' VAL . 24.3 t70 -54.71 -36.08 64.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.72 -60.25 2.68 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.9 t -62.64 -32.48 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.417 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -58.14 -53.78 54.39 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.9 ttp . . . . . 0 CA--C 1.532 0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.213 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.3 p -93.21 25.15 3.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.601 0.239 . . . . 0.0 111.562 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.66 52.97 0.59 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.04 0.447 . . . . 0.0 110.591 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.42 114.08 10.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.871 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -65.88 -46.16 64.99 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.245 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 6.2 Cg_exo -78.33 -17.13 13.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.787 2.325 . . . . 0.0 113.632 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -110.9 -60.01 1.89 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -60.18 2.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.566 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.0 -48.07 82.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.61 -38.15 77.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 15.4 t80 -57.75 -45.62 85.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -62.56 -33.55 75.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.9 mt -61.04 -36.59 79.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.302 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -92.85 24.5 3.6 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.99 94.78 8.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.801 0.334 . . . . 0.0 110.416 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -33.11 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -86.19 -31.0 22.0 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.467 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.45 26.53 59.11 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -115.93 21.82 13.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.625 0.213 . . . . 0.0 111.26 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.18 19.81 77.61 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.321 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' CD ' ' HB3' ' A' ' 54' ' ' GLU . 6.7 mtt85 -130.4 151.4 50.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.096 0.448 . . . . 0.0 110.631 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 HD13 ' A' ' 28' ' ' ILE . 6.5 pt -140.97 142.42 27.72 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.03 170.95 6.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.283 2.655 . . . . 0.0 112.487 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HB2' HG13 ' A' ' 44' ' ' ILE . 49.5 pttt -44.24 -39.16 4.25 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.8 p -60.41 -43.95 96.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.46 0.171 . . . . 0.0 111.396 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.5 m -70.34 -45.74 65.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.657 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.763 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.45 -33.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.178 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 -68.21 1.8 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.309 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -28.27 69.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.51 -48.11 83.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.52 -33.16 73.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -56.13 -38.98 71.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.087 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.0 70.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.678 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -116.88 46.33 1.68 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.781 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.1 -106.59 0.42 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.974 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.2 -179.46 5.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 111.919 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 10.0 t30 -118.35 112.55 37.51 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.58 -162.97 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.953 2.435 . . . . 0.0 112.683 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -105.65 163.77 12.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.1 -35.96 62.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.6 82.6 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.815 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.98 -55.78 17.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.85 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.942 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.11 -46.56 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.901 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.7 m -57.53 -41.48 80.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -38.09 78.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.942 HD12 ' HA ' ' A' ' 44' ' ' ILE . 20.4 mt -62.92 -46.58 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -57.24 -28.43 62.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.353 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -13.39 45.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 p -118.13 -46.52 2.61 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.553 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.56 146.55 34.53 Favored Pre-proline 0 N--CA 1.463 0.225 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.2 Cg_exo -36.44 139.01 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.496 2.798 . . . . 0.0 113.039 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.84 -63.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.707 0.63 . . . . 0.0 112.477 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.89 120.66 25.95 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.709 0.29 . . . . 0.0 110.369 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.08 87.18 2.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.4 p30 -84.96 178.35 7.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.589 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -41.14 -44.5 2.55 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.78 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.1 -53.61 29.2 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.404 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.76 -52.57 64.48 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.186 0.304 . . . . 0.0 111.703 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.44 81.63 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 61' ' ' LEU . 25.1 mt -61.35 -33.26 73.33 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -51.95 67.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.55 0.214 . . . . 0.0 110.996 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG2' HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.59 -39.24 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -53.16 58.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.108 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -83.67 61.19 6.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 1.8 ttt180 -56.81 -49.47 93.62 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.781 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 94.5 Cg_endo -83.8 19.44 1.35 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.525 2.15 . . . . 0.0 113.58 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 61.2 99.73 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.598 0.359 . . . . 0.0 111.893 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.45 -179.13 24.53 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.273 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.77 175.46 5.63 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.648 0.261 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' HG2' ' A' ' 78' ' ' GLU . 4.3 t70 56.29 62.4 2.35 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 110.657 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.563 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 21.9 ttt -179.89 -50.81 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 81.7 Cg_exo -45.75 -40.19 19.01 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.675 2.25 . . . . 0.0 113.159 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.14 54.24 0.31 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.428 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.03 145.15 56.18 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-O 120.503 0.192 . . . . 0.0 110.949 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.3 Cg_exo -59.1 -39.45 79.59 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.686 2.257 . . . . 0.0 112.375 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.04 -26.4 61.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.523 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.509 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -66.77 -49.07 67.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.568 0.223 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.74 81.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.322 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 76' ' ' PRO . 56.1 t -64.09 -43.93 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.342 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -40.14 94.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.669 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.74 ' HA3' HG11 ' A' ' 102' ' ' VAL . . . -63.6 -47.21 88.93 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.696 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.76 -30.15 66.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.454 0.168 . . . . 0.0 111.454 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.05 -14.96 62.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.1 t -47.86 -56.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.403 0.144 . . . . 0.0 111.305 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -113.49 39.84 2.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.027 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.51 62.24 1.46 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -63.74 -50.56 68.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.747 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.34 -54.76 2.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.85 81.17 0.15 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.958 0.409 . . . . 0.0 111.539 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -103.18 64.23 0.83 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.554 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.67 37.9 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.939 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 ptp -174.66 137.29 0.46 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.784 0.292 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.56 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -107.1 -39.96 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.427 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 79.24 0.61 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.83 ' HA ' HD23 ' A' ' 99' ' ' LEU . 54.6 t -45.22 -36.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.98 -42.73 16.1 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.288 -0.482 . . . . 0.0 113.305 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.94 -43.31 35.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.61 0.205 . . . . 0.0 111.135 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.83 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.06 -39.02 80.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.143 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.444 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 10.6 ptp180 -74.54 -37.09 63.12 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.854 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.71 -36.64 72.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.74 HG11 ' HA3' ' A' ' 82' ' ' GLY . 24.7 t -82.87 -52.56 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.715 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.856 HD22 ' HG3' ' A' ' 109' ' ' LYS . 6.0 mt -62.5 -50.1 72.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.5 m -60.73 -38.26 84.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.497 0.189 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.8 t -73.26 -19.05 61.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.73 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.72 -55.83 10.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.618 0.246 . . . . 0.0 111.028 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.19 45.81 0.29 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.371 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.99 48.02 13.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.856 ' HG3' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.49 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.768 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.401 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 18.4 mt -68.16 79.84 0.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 110.691 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.4 p -64.06 -175.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.126 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -47.7 -34.5 8.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.504 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.21 -60.02 4.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -41.11 95.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.199 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.802 ' HA ' HD23 ' A' ' 118' ' ' LEU . 5.5 mmt -66.79 -34.82 78.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.513 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -46.07 86.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.437 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -64.81 -37.94 89.3 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.802 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.5 -44.14 91.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.729 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.462 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.9 mt -65.03 -34.93 79.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -39.76 94.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.902 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.17 -49.52 26.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.752 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 18.7 t -79.85 127.58 76.99 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.612 0.206 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 4.6 Cg_exo -74.11 63.19 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.962 2.441 . . . . 0.0 112.33 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.36 175.9 10.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -121.4 19.1 11.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.739 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.37 26.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.49 ' HA3' ' CG2' ' A' ' 96' ' ' VAL . . . 54.97 50.99 56.74 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.666 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.7 112.8 25.91 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.275 0.559 . . . . 0.0 110.752 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 129' ' ' VAL . 43.2 t -142.35 20.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 59.74 21.88 10.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.843 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.418 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 48.38 41.52 16.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.764 0.316 . . . . 0.0 111.326 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -114.2 -54.46 2.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.401 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.506 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.9 t70 -57.14 -36.33 70.58 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.8 m-85 -68.05 -59.0 3.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.617 0.246 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 139' ' ' LEU . 19.7 t -62.56 -33.05 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.463 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -61.63 -56.85 15.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.056 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.8 ttp -66.88 -31.21 71.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.484 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.492 HG22 HD12 ' A' ' 139' ' ' LEU . 3.5 mt -66.79 -41.6 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.476 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 138' ' ' ILE . 1.4 mp -88.94 -3.66 58.67 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -111.58 90.32 3.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.827 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.062 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.419 0.152 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t -116.52 30.68 7.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.37 50.89 0.57 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.86 112.6 2.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.321 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.16 -46.14 95.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.536 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 89.4 Cg_endo -80.73 -16.0 10.53 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.503 2.135 . . . . 0.0 113.96 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -110.68 -60.83 1.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -61.43 1.8 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.341 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.475 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 6.0 tt0 -58.38 -46.85 85.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.839 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.56 -37.51 81.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.074 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 23' ' ' ILE . 20.5 t80 -56.29 -49.76 73.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -61.63 -33.76 74.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.333 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 8.4 mt -59.76 -33.92 72.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.43 0.157 . . . . 0.0 111.221 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 77.3 m-85 -93.28 32.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 121.63 30.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.759 0.314 . . . . 0.0 110.814 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -60.79 -52.22 66.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -107.11 -28.24 10.11 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.25 37.06 4.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.552 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.6 p -104.08 -20.76 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.17 3.61 8.06 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.444 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.619 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -122.59 162.46 21.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.253 0.527 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.789 HD12 HD13 ' A' ' 28' ' ' ILE . 5.1 pt -146.85 133.63 9.91 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.559 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.74 169.71 9.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.998 2.465 . . . . 0.0 112.345 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -43.89 -35.62 2.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.2 p -62.32 -45.04 95.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.493 0.187 . . . . 0.0 111.384 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.516 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 59.9 m -70.59 -44.82 66.53 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.823 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.789 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.83 -35.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.523 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.85 -66.92 2.43 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.67 -29.87 71.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.511 0.155 . . . . 0.0 111.002 179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 7.6 tp -61.11 -47.28 86.99 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.33 -32.72 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.049 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -40.48 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.027 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.18 -30.61 71.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.709 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.6 m -83.39 -44.36 14.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.591 0.234 . . . . 0.0 110.936 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.27 -81.55 0.04 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.707 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.2 -179.82 5.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -118.78 110.32 38.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.628 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.0 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.854 2.369 . . . . 0.0 112.361 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -104.53 166.59 10.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 25' ' ' LYS . 2.0 mm? -54.93 -35.55 64.3 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.88 76.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.761 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -56.43 9.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.706 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.15 -48.39 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.945 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.2 m -58.15 -41.29 83.45 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.04 -42.87 86.28 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.491 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.706 HD12 ' HA ' ' A' ' 44' ' ' ILE . 11.5 mt -63.04 -48.26 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.19 -25.12 58.49 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.844 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -63.86 -13.61 46.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -118.41 7.48 11.93 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -141.21 151.45 61.72 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 90.2 Cg_exo -38.3 143.76 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.275 2.65 . . . . 0.0 113.018 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.77 -58.62 0.13 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -92.27 125.43 36.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.592 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.1 t -86.79 83.51 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.619 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -81.72 177.29 8.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.562 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 60.9 mtm -40.68 -44.65 2.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.745 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.88 -51.57 46.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.918 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -58.09 -52.35 65.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -48.44 81.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt -61.54 -38.23 86.69 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.173 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.52 -54.39 41.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.661 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.66 -35.33 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.938 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -33.87 71.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.571 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.555 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 4.4 m120 -96.27 42.96 1.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.66 0.267 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.656 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 1.3 ttt180 -61.74 -62.76 5.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 48.6 Cg_endo -89.76 17.4 1.56 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.383 2.056 . . . . 0.0 114.688 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.489 ' HB3' ' CB ' ' A' ' 72' ' ' MET . 12.2 t-20 158.29 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.633 0.373 . . . . 0.0 110.853 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.555 ' HA2' ' CB ' ' A' ' 65' ' ' ASN . . . 174.58 -70.85 0.09 OUTLIER Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.325 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -110.29 -59.44 1.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.2 82.07 3.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.167 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.489 ' CB ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 173.23 -52.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.784 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 26.9 Cg_exo -61.62 91.33 0.11 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.807 2.338 . . . . 0.0 112.123 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.92 25.12 74.37 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.184 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 172.36 10.08 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.996 0.398 . . . . 0.0 111.302 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' O ' HG23 ' A' ' 80' ' ' VAL . 50.4 Cg_exo -53.84 -42.16 68.77 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.78 2.32 . . . . 0.0 112.362 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -67.47 -27.08 66.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.504 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.47 -50.67 50.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 111.025 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -36.99 84.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.163 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 76' ' ' PRO . 81.6 t -64.77 -40.01 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.943 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -48.49 80.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.86 95.91 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.66 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -70.2 -24.45 63.12 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.529 0.164 . . . . 0.0 111.407 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.17 -15.4 61.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.11 -59.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.187 0.195 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.551 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -110.33 44.02 1.3 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.981 0.42 . . . . 0.0 110.558 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.35 51.86 1.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -51.15 69.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -115.68 -59.31 2.01 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.08 90.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.561 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -105.69 56.71 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 110.79 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.51 49.42 1.84 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.927 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.15 135.87 0.48 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.68 0.276 . . . . 0.0 111.127 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -109.01 -42.75 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.336 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.12 81.58 0.33 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.949 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.734 ' HA ' HD23 ' A' ' 99' ' ' LEU . 86.6 t -43.55 -36.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.79 -37.98 15.44 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.594 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.551 ' HG3' ' CB ' ' A' ' 86' ' ' PHE . 2.6 tm-20 -73.2 -51.32 18.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.239 0.215 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.46 -37.18 74.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.489 ' HD3' HG21 ' A' ' 104' ' ' THR . 4.9 tmm_? -65.57 -47.89 74.24 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -53.96 -38.09 64.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.323 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' GLU . 21.4 t -70.73 -49.03 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.299 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.689 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.3 mt -65.02 -38.29 90.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.993 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 23.0 p -64.75 -35.44 81.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.523 0.202 . . . . 0.0 110.878 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -66.93 -19.75 65.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.651 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt -69.46 -61.19 1.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.584 0.23 . . . . 0.0 110.534 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.8 51.63 0.18 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.329 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 59.92 46.74 10.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.868 0.366 . . . . 0.0 110.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.689 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.74 -137.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.277 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.508 HD22 ' HG2' ' A' ' 114' ' ' GLU . 21.4 mt -69.16 79.24 0.35 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 92.6 p -64.36 -172.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.252 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -51.65 -31.17 24.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.265 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.81 -51.18 69.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.508 ' HG2' HD22 ' A' ' 110' ' ' LEU . 4.7 tp10 -58.76 -52.82 64.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.774 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.4 ppp? -66.16 -26.15 67.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -48.51 80.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.16 -45.14 89.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.405 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -58.91 -41.26 86.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.543 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.209 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -36.76 84.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.91 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.68 49.78 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.05 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 129' ' ' VAL . 21.5 t -87.3 128.45 55.19 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.803 0.302 . . . . 0.0 111.14 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.59 58.05 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.63 2.22 . . . . 0.0 112.595 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.39 -177.67 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.284 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 131.53 55.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.649 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.16 9.17 6.95 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.03 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.725 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 71.38 49.96 23.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.554 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -103.78 115.16 29.96 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.206 0.526 . . . . 0.0 110.725 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 129' ' ' VAL . 37.4 t -142.45 25.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.841 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 58.58 22.57 9.92 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.932 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 54.05 -158.7 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 68.78 -60.63 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.406 0.282 . . . . 0.0 111.569 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.01 -38.76 62.61 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.9 m-85 -68.36 -54.58 16.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.714 0.292 . . . . 0.0 110.695 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.5 t -62.15 -32.96 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.511 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.44 -52.19 54.91 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.686 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.34 -34.23 76.9 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.212 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 mt -62.85 -45.55 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.3 mp -91.72 54.57 2.5 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.922 0.392 . . . . 0.0 110.727 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.38 111.19 0.4 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.789 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.212 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.53 0.205 . . . . 0.0 111.431 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t 46.21 45.04 12.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.677 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.63 -58.37 2.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.703 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -140.4 95.81 2.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.4 t -66.07 -46.92 63.46 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 6' ' ' SER . 84.6 Cg_endo -79.34 -14.04 13.35 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.516 2.144 . . . . 0.0 114.166 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.15 -61.59 1.7 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -72.29 -62.86 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -58.47 -47.73 83.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -45.26 87.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.936 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CE2' HG12 ' A' ' 23' ' ' ILE . 23.0 t80 -54.49 -45.99 73.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.74 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 m -59.27 -35.37 73.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.392 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 9.0 mt -60.53 -29.34 69.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.325 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 23' ' ' ILE . 49.1 m-85 -95.03 27.69 3.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.71 123.07 40.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 110.551 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -52.3 66.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.369 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -130.86 27.65 4.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.71 49.45 61.49 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.682 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -93.72 -29.01 15.62 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.1 -1.42 16.96 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.108 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.597 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -127.74 167.56 16.31 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.01 0.405 . . . . 0.0 110.607 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 28' ' ' ILE . 9.5 pt -144.23 134.31 11.87 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.56 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 23' ' ' ILE . 4.4 Cg_endo -86.32 171.75 7.46 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.39 2.727 . . . . 0.0 111.852 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.1 pttt -44.24 -36.6 2.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -61.01 -45.89 92.97 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.54 0.209 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.1 m -70.49 -46.6 63.41 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.933 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.645 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.39 -33.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.413 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.71 -68.89 1.41 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.444 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -26.69 68.87 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 111.407 0.151 . . . . 0.0 111.407 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.454 HD13 ' CE2' ' A' ' 15' ' ' PHE . 9.4 tp -64.07 -48.9 74.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.47 -30.61 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.62 -38.71 69.86 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.909 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.593 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.5 -42.31 25.52 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.748 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.3 -79.35 0.03 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.643 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.32 176.59 8.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.489 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -119.72 113.12 34.85 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.464 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.69 -162.63 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.755 2.304 . . . . 0.0 112.459 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -99.28 166.03 11.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.13 -33.64 63.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.887 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.2 79.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.34 -53.98 20.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.641 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.81 -46.88 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.003 0.189 . . . . 0.0 110.766 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 m -60.15 -39.74 87.45 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.34 -37.52 75.33 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.452 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 44' ' ' ILE . 39.0 mt -67.01 -45.63 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.896 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -56.66 -27.12 57.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.524 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -64.61 -7.72 11.56 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 p -117.7 -52.73 2.44 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 117.893 0.315 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.604 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -87.27 154.88 54.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.541 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -38.36 142.74 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.082 2.522 . . . . 0.0 113.07 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.51 -64.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.3 0.64 . . . . 0.0 112.599 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.1 123.18 31.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.494 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.42 86.33 2.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.597 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.7 p30 -85.08 179.66 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.357 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -41.55 -47.59 3.82 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.532 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.58 -52.54 60.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.541 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.79 -53.91 52.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.7 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -49.83 73.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.72 -28.98 69.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -63.77 -49.76 71.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.606 0.241 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.36 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.493 HD23 ' OD1' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -73.49 -61.93 1.66 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.312 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.493 ' OD1' HD23 ' A' ' 64' ' ' LEU . 78.5 m-20 -83.26 59.87 5.24 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.814 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.408 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.3 mtp180 -58.3 -49.13 95.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.467 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 72' ' ' MET . 66.2 Cg_endo -83.94 19.23 1.39 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.655 2.237 . . . . 0.0 113.885 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 55.29 88.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.901 0.382 . . . . 0.0 111.446 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA3' ' CG ' ' A' ' 72' ' ' MET . . . 159.42 -166.79 34.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.674 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -115.54 -51.54 2.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.214 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -98.17 19.39 14.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.649 ' HB2' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -92.78 -48.83 0.29 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.455 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 72' ' ' MET . 81.8 Cg_exo -46.64 -36.59 19.17 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.799 2.333 . . . . 0.0 113.0 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.04 87.22 1.98 Allowed Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.765 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 78' ' ' GLU . 13.5 m-20 -80.93 145.43 57.2 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.465 0.174 . . . . 0.0 111.006 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' O ' HG23 ' A' ' 80' ' ' VAL . 34.3 Cg_exo -57.58 -49.5 13.27 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.788 2.325 . . . . 0.0 112.449 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.05 -20.91 65.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 tt0 -68.88 -50.17 51.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.913 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.78 81.59 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.452 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 76' ' ' PRO . 51.6 t -64.53 -53.76 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.552 0.215 . . . . 0.0 110.97 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -29.46 70.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.69 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.812 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -65.19 -49.04 63.77 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.555 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.09 -37.76 69.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.427 0.156 . . . . 0.0 110.969 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -78.91 73.16 5.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.9 t -135.1 -64.71 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.96 34.95 4.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.531 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -129.32 51.85 2.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.457 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 64.97 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.231 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -136.52 -72.88 0.44 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.69 45.82 27.21 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.626 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.37 44.6 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.11 33.7 3.92 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.624 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 ttt -171.73 134.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.152 0.476 . . . . 0.0 111.531 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.643 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -114.52 -42.1 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.28 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.66 80.49 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.22 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.745 ' HA ' HD23 ' A' ' 99' ' ' LEU . 81.7 t -44.41 -34.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -40.06 11.01 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.824 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.1 mp0 -76.09 -50.71 13.94 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.457 0.17 . . . . 0.0 110.783 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.745 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.13 -35.34 73.3 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -55.96 12.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.101 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -52.45 -38.59 59.61 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.812 HG11 ' CA ' ' A' ' 82' ' ' GLY . 42.1 t -72.12 -58.0 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.738 HD22 ' HG2' ' A' ' 109' ' ' LYS . 2.8 mt -60.99 -36.41 79.39 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 m -61.68 -36.84 82.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.588 0.232 . . . . 0.0 111.093 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.6 t -65.02 -22.8 67.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.994 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 3.7 mt -64.88 -72.95 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.508 0.194 . . . . 0.0 111.232 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.85 50.98 0.46 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 64.23 47.24 3.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.175 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.738 ' HG2' HD22 ' A' ' 103' ' ' LEU . 14.4 tptt -68.57 -138.12 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.455 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.9 mm? -69.18 77.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.8 p -69.89 -175.27 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.59 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -51.02 -38.83 53.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.704 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.47 -48.89 63.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.576 0.227 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 5.2 mm-40 -59.01 -51.64 69.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.635 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.3 -27.36 67.86 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -46.34 86.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -65.68 -44.34 86.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.369 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.99 -43.5 95.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.405 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -69.2 -32.97 72.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.35 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -61.68 -38.39 87.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.986 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 -46.62 43.66 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.953 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.92 127.12 63.51 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.706 0.253 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 59.61 6.19 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.72 2.28 . . . . 0.0 112.647 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.61 176.63 8.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.264 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -119.3 132.16 55.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.535 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t70 76.61 -1.92 2.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.887 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 78.26 51.02 5.89 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttp -104.2 113.17 26.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.54 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.652 ' O ' HG12 ' A' ' 129' ' ' VAL . 40.5 t -142.35 19.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.03 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.7 t30 59.37 22.14 10.53 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.632 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 53.65 -158.12 0.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.5 t60 69.62 -60.19 0.48 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.168 0.187 . . . . 0.0 111.206 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.67 -41.76 64.13 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.5 m-85 -65.44 -57.06 9.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.688 HG12 HD13 ' A' ' 139' ' ' LEU . 4.1 t -62.07 -28.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.507 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.61 -49.83 73.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.67 -33.81 76.76 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.683 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.36 -38.81 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.688 HD13 HG12 ' A' ' 135' ' ' VAL . 1.8 mp -90.96 64.34 5.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.41 44.41 2.93 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.311 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t -108.44 28.36 8.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.348 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.28 1.33 16.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.31 97.01 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t -67.03 -47.37 52.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 6' ' ' SER . 75.4 Cg_endo -79.55 -13.17 13.53 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.534 2.156 . . . . 0.0 114.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.75 -63.16 1.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -72.85 -61.45 1.8 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.433 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.03 81.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.731 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.1 -44.27 87.58 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.5 t80 -52.05 -46.39 65.07 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.197 0.311 . . . . 0.0 110.471 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.6 t -60.5 -36.38 78.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.216 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.9 mt -59.78 -28.51 67.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.389 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 m-85 -89.02 19.99 3.86 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.24 92.36 4.48 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -61.66 -36.37 80.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -86.76 -37.01 18.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.117 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.34 45.32 5.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.439 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -109.25 -30.21 8.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.44 8.15 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.272 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -127.06 163.63 23.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.152 0.476 . . . . 0.0 110.655 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.786 HD12 HD13 ' A' ' 28' ' ' ILE . 3.7 pt -143.7 136.03 13.34 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.98 171.93 5.57 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.256 2.637 . . . . 0.0 112.287 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.508 ' HB2' HG13 ' A' ' 44' ' ' ILE . 14.3 pttm -43.83 -38.4 3.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -60.31 -44.89 95.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.496 0.189 . . . . 0.0 111.22 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.7 m -71.01 -47.41 58.93 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.786 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.19 -35.61 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.635 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.88 -68.08 1.79 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.456 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -28.09 69.26 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 5.7 tp -61.98 -46.46 89.15 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.63 -31.8 71.91 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -58.26 -41.83 85.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.16 68.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.488 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.25 42.59 2.67 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.16 -107.77 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.949 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.22 179.55 6.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.829 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 14.9 t30 -118.57 106.38 44.47 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.78 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.55 -163.71 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.053 2.502 . . . . 0.0 112.576 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.723 HG21 ' HG ' ' A' ' 139' ' ' LEU . 2.7 p -104.95 164.31 11.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.868 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.15 -37.65 62.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.994 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.15 77.91 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.695 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.12 -55.14 17.91 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.3 -46.89 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.875 -0.148 . . . . 0.0 111.106 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -55.37 -43.84 75.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -37.76 76.14 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.755 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.786 HG23 HG11 ' A' ' 63' ' ' VAL . 64.7 mt -61.09 -51.78 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -56.86 -27.45 60.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.753 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.76 -13.86 47.46 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 p -119.06 5.84 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.688 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -140.19 157.67 68.44 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 110.523 -0.176 . . . . 0.0 110.523 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 92.8 Cg_exo -42.05 146.39 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.141 2.561 . . . . 0.0 113.164 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.4 -63.02 0.09 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -95.1 131.15 41.42 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.477 0.18 . . . . 0.0 110.65 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.05 87.16 2.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.045 0.45 . . . . 0.0 110.924 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.97 -177.56 6.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.459 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mtt -41.21 -46.97 3.24 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -52.84 32.38 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.586 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.88 -49.77 75.6 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -48.64 79.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.833 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.87 -29.3 70.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.451 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -65.77 -48.08 73.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.994 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.786 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.19 -43.17 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.983 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -44.24 92.71 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.427 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -111.14 45.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -51.51 79.48 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.652 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 92.8 Cg_endo -83.07 19.9 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.636 2.224 . . . . 0.0 113.574 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.05 77.29 0.32 Allowed 'General case' 0 C--N 1.343 0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 111.163 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.4 172.64 26.81 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.772 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -104.68 -48.71 3.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.408 0.147 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.0 78.9 4.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.154 0.502 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.544 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 8.6 tpt 179.12 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.972 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 77.9 Cg_exo -40.15 -46.91 4.11 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.339 2.693 . . . . 0.0 113.626 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.8 42.76 0.95 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.759 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 50.7 p-10 -80.92 163.29 56.38 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 111.277 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 75' ' ' ASP . 50.5 Cg_exo -54.58 -35.85 87.4 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.977 2.451 . . . . 0.0 112.86 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -34.65 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.404 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -46.32 67.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -42.03 96.44 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.57 -50.25 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.013 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.03 67.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -71.59 -56.35 6.77 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.161 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -77.98 -39.82 41.24 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.13 73.54 4.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.186 0.517 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 86' ' ' PHE . 10.9 p -118.09 -43.69 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.569 ' O ' ' CG ' ' A' ' 86' ' ' PHE . 9.4 t80 -154.46 25.78 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 110.393 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.67 51.41 0.75 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.928 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -28.84 64.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.382 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.24 -57.79 3.23 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.037 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.98 -174.21 0.11 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p 44.64 59.98 3.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.038 0.447 . . . . 0.0 111.314 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.24 -33.43 0.27 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.08 144.24 9.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.556 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.66 -41.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.249 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.9 77.9 0.25 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.559 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.778 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.0 t -45.28 -42.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.89 -37.26 9.24 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.856 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.6 mm-40 -80.59 -47.23 14.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.5 0.191 . . . . 0.0 110.544 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.778 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -41.93 84.34 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -34.83 65.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.803 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -55.57 -38.34 69.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.561 0.219 . . . . 0.0 110.939 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.544 HG11 ' HA2' ' A' ' 82' ' ' GLY . 2.5 t -78.55 -46.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.236 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.3 mt -65.99 -46.21 78.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.9 m -55.88 -35.51 66.58 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.469 0.176 . . . . 0.0 111.43 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 t -71.81 -19.01 62.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.843 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.18 -68.22 0.41 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.444 0.164 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.89 55.85 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.566 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 58.69 45.54 15.72 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.333 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 10.4 mmtp -68.9 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.222 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.47 78.4 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.8 p -64.87 -176.6 0.28 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -52.62 -32.58 42.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.787 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -53.79 52.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.75 -51.45 69.5 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.953 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.871 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.38 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -49.07 78.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.639 0.257 . . . . 0.0 110.471 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -42.12 86.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.99 -43.55 98.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -71.07 -31.91 68.44 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.262 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -61.74 -40.83 96.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.634 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 -46.23 19.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.922 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.481 HG11 ' CG2' ' A' ' 129' ' ' VAL . 21.4 t -85.35 119.15 72.02 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 116.787 0.294 . . . . 0.0 111.13 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.07 63.9 6.91 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.56 2.173 . . . . 0.0 112.588 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 122' ' ' VAL . 23.3 m -130.77 -175.95 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.253 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -118.87 127.3 53.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 t70 72.53 6.86 5.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.852 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 72.85 53.67 7.92 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.915 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -104.03 116.97 33.19 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 129' ' ' VAL . 40.3 t -142.39 30.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 36.6 t30 61.38 19.0 9.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.946 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 56.36 -176.67 0.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.8 -52.04 0.68 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.384 0.273 . . . . 0.0 111.667 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.89 -45.72 67.65 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -68.78 -49.87 55.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.99 -31.68 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.411 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -66.08 -51.07 61.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.5 ttt -62.24 -35.86 80.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.19 -35.49 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.052 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.723 ' HG ' HG21 ' A' ' 40' ' ' THR . 1.1 mp -89.14 17.26 6.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -157.1 95.15 1.47 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 110.757 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.256 -179.535 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.809 0.338 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -134.69 48.54 2.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 t70 61.6 51.7 3.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.312 0.577 . . . . 0.0 110.143 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -55.54 114.31 1.79 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.524 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 5.0 t -65.22 -46.07 71.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.379 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.15 -15.21 11.69 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.514 2.143 . . . . 0.0 113.824 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -110.14 -60.43 1.8 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -72.6 -61.02 1.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.444 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 9.5 tp60 -59.03 -47.52 84.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.25 -39.23 82.17 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.012 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.7 t80 -56.03 -44.66 78.97 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -62.33 -35.97 80.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.272 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.57 -33.94 73.43 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.428 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -91.04 20.06 5.22 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.44 89.82 3.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 120.839 0.352 . . . . 0.0 110.193 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -66.41 -29.16 69.25 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.878 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -85.97 -28.35 24.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.52 31.67 65.34 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.1 p -101.02 -30.0 11.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.282 0.233 . . . . 0.0 111.246 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.05 11.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.266 -0.493 . . . . 0.0 113.092 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.56 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -119.53 157.91 27.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.01 0.405 . . . . 0.0 110.742 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.852 HD12 HD13 ' A' ' 28' ' ' ILE . 4.3 pt -138.3 139.75 26.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.46 170.42 7.9 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.096 2.531 . . . . 0.0 112.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HB2' HG13 ' A' ' 44' ' ' ILE . 10.7 pttp -45.14 -39.12 5.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 p -60.03 -43.3 95.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.545 0.212 . . . . 0.0 111.197 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.9 t -68.55 -51.95 37.2 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.167 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.852 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.92 -36.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.519 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.83 -71.98 0.58 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.649 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -27.98 69.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.8 -50.58 70.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.607 0.241 . . . . 0.0 110.356 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -61.44 -29.53 70.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.267 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.34 -38.75 69.16 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.061 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.51 69.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.704 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 t -114.66 40.04 2.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.33 -107.15 0.36 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 174.81 9.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.909 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 3.8 t-20 -119.5 107.04 41.45 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.156 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.91 -162.76 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.89 2.394 . . . . 0.0 112.75 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -93.63 166.53 12.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.188 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.46 -34.73 67.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.81 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.18 79.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.585 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.84 -55.17 24.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.055 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.615 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.96 -47.16 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.689 179.54 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -58.55 -39.9 81.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.42 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -58.71 -40.82 84.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.372 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.54 ' O ' HD22 ' A' ' 51' ' ' LEU . 55.1 mt -61.73 -50.21 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -56.98 -23.9 49.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.696 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -7.75 10.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 p -117.89 -45.44 2.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 117.627 0.194 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.6 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -89.97 159.01 43.69 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.092 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 72.0 Cg_exo -40.17 146.08 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 113.026 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -31.1 -60.37 0.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.205 0.602 . . . . 0.0 112.597 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -91.07 127.12 36.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.641 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.7 t -86.91 86.81 2.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.56 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.8 p30 -84.55 178.81 7.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.38 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtm -41.56 -47.94 3.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.689 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.95 -50.54 62.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.851 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.592 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.6 mp0 -56.81 -51.07 70.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.586 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -48.28 80.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 61' ' ' LEU . 35.9 mt -61.17 -34.28 74.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.425 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -60.96 -53.11 61.28 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.492 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -64.05 -42.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.889 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -46.77 88.06 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.17 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -98.2 49.39 1.0 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.702 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.93 69.88 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.542 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 65.7 Cg_endo -85.51 19.53 1.38 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.824 2.349 . . . . 0.0 113.321 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.46 78.86 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.214 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.17 172.33 19.4 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.923 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.11 -42.98 5.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.483 0.182 . . . . 0.0 110.972 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.42 72.57 7.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.138 0.494 . . . . 0.0 110.139 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.635 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.7 -53.6 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.263 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 80.5 Cg_exo -43.67 -52.07 5.62 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.819 2.346 . . . . 0.0 113.041 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.72 58.75 0.02 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.729 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -80.59 140.5 51.58 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-O 120.476 0.179 . . . . 0.0 111.008 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.7 Cg_exo -58.25 -45.3 32.04 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.36 -24.92 59.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.293 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -47.33 70.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.557 0.218 . . . . 0.0 110.983 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -35.33 63.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.556 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 76' ' ' PRO . 48.9 t -66.77 -56.73 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.182 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -35.05 79.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.818 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.99 -47.12 86.16 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.637 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -77.56 -36.71 51.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.776 0.288 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -74.94 75.51 2.18 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.518 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 102' ' ' VAL . 45.1 t -127.31 -66.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.81 38.24 2.32 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 111.79 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.665 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 5.3 p30 -130.06 72.6 1.49 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.001 0.429 . . . . 0.0 110.782 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -31.16 68.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.655 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.18 -53.94 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . . . 60.58 69.06 0.71 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.271 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 -40.55 6.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.368 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -166.5 62.01 0.22 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.446 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 ptt? -175.68 140.24 0.45 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.268 0.227 . . . . 0.0 110.483 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.589 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.12 -43.32 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.599 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.75 81.15 0.1 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.158 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.741 HG21 HD21 ' A' ' 118' ' ' LEU . 70.6 t -42.84 -33.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.81 -39.12 17.0 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.749 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.677 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.3 pt-20 -76.9 -44.59 31.23 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.609 0.205 . . . . 0.0 111.202 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -64.8 -37.44 87.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.531 0.205 . . . . 0.0 111.223 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -49.79 60.29 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.763 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -53.79 -42.39 68.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.296 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.818 HG21 ' O ' ' A' ' 82' ' ' GLY . 48.0 t -66.76 -51.17 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.522 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 5.0 mt -64.63 -50.69 66.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.977 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -56.86 -31.37 64.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.6 t -66.95 -24.85 66.11 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.25 -67.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.79 55.84 0.29 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 45.13 7.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.952 0.406 . . . . 0.0 111.215 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 2.3 mmtm -68.61 -137.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.24 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.648 HD22 ' HG2' ' A' ' 114' ' ' GLU . 17.5 mt -69.41 78.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.656 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.7 p -68.65 -171.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -52.54 -33.17 44.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.385 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.52 -51.81 63.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.52 0.2 . . . . 0.0 111.497 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.648 ' HG2' HD22 ' A' ' 110' ' ' LEU . 2.5 tp10 -57.38 -51.56 68.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.79 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.899 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -66.77 -26.72 67.1 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -46.81 86.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.28 -43.97 84.89 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.899 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.7 -41.55 95.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.564 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -69.54 -30.82 68.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -62.99 -40.18 96.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.502 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -45.43 42.06 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.736 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.467 HG11 ' CG2' ' A' ' 129' ' ' VAL . 12.7 t -90.68 116.33 66.17 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.612 0.206 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.56 64.59 4.67 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.591 2.194 . . . . 0.0 112.658 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 122' ' ' VAL . 25.1 m -130.05 -175.44 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.084 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -118.62 124.59 47.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.443 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t70 76.55 -2.36 2.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.949 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 81.13 50.97 4.9 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.789 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 ttt -104.45 119.35 38.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 133' ' ' ASP . 27.9 t -141.14 28.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.62 24.27 13.08 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.027 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.3 t80 46.11 48.16 12.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 111.556 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -122.91 -53.05 1.87 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.507 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.658 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -59.57 -35.09 73.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.0 m-85 -68.15 -55.41 12.47 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.584 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.7 -34.09 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.021 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.54 -52.64 64.34 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.5 ttt -64.54 -33.77 76.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.197 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 139' ' ' LEU . 3.2 mt -63.98 -45.29 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.894 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.467 HD12 HG22 ' A' ' 138' ' ' ILE . 2.0 mp -96.86 59.83 1.73 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.111 0.481 . . . . 0.0 110.754 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -154.75 54.8 0.67 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.975 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.0 -179.792 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.704 0.288 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 2.5 m 60.04 63.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.23 -50.33 2.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.187 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 1.8 m-20 -76.06 102.02 5.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.052 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.454 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.6 t -67.32 -48.02 47.73 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.706 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 6' ' ' SER . 80.3 Cg_endo -78.54 -9.05 16.11 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.483 2.122 . . . . 0.0 114.237 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.456 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 84.7 m-85 -118.94 -59.65 1.84 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -72.2 -56.87 4.82 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.221 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.8 -48.03 80.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.448 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.54 -38.18 77.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 23' ' ' ILE . 26.5 t80 -59.14 -46.87 87.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.431 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 1.1 t -62.76 -30.44 71.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.692 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 18.2 mt -57.32 -38.35 73.92 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.13 31.55 2.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -101.81 91.69 4.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.582 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -25.63 63.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.654 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -86.38 -35.57 19.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.062 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.64 26.37 59.04 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.618 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -109.64 -19.83 13.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.1 19.94 6.96 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.992 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtp180 -130.2 150.09 51.61 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.978 0.389 . . . . 0.0 110.687 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.703 HD12 HD13 ' A' ' 28' ' ' ILE . 7.9 pt -136.88 138.07 24.99 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.749 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.76 171.8 6.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.177 2.585 . . . . 0.0 112.52 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -45.28 -36.85 4.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -60.83 -44.89 96.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.459 0.171 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.553 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 24.1 m -70.81 -45.61 64.29 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.703 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.06 -33.27 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.76 -68.12 1.86 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.453 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -29.47 70.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.406 0.146 . . . . 0.0 111.24 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 tp -62.01 -50.47 71.93 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.13 -28.38 69.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.04 -41.04 74.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.048 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.0 -26.51 68.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -121.74 39.4 3.87 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.699 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.66 -110.1 0.43 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.798 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.7 178.21 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.082 0.468 . . . . 0.0 111.938 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 33.5 t30 -119.68 97.27 49.86 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.443 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.07 -162.55 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.822 2.348 . . . . 0.0 112.587 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 169.23 9.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.1 mm? -56.04 -33.85 65.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.6 78.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.671 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -54.2 41.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.249 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.792 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -59.74 -47.8 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.865 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.41 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 57.7 m -54.42 -43.53 71.6 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -56.49 -38.93 72.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.57 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 44' ' ' ILE . 33.2 mt -63.03 -49.77 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -56.39 -24.94 47.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.99 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -63.88 -8.23 10.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.4 p -118.03 -46.32 2.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.584 0.174 . . . . 0.0 111.014 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.607 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.44 156.03 41.81 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 87.6 Cg_exo -41.84 150.24 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.238 2.625 . . . . 0.0 113.088 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.65 -62.86 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.373 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -84.77 121.66 28.0 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.44 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.13 89.28 2.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -83.68 178.03 8.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.3 mtm -41.18 -46.73 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.834 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.32 -52.08 50.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.889 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.472 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.8 -51.26 69.65 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.476 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.1 -48.77 80.14 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.013 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.35 -35.16 76.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.69 -54.99 39.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.487 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.04 -36.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.87 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD13 ' HE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -60.71 -44.78 96.17 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.104 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.04 51.59 1.84 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.952 0.405 . . . . 0.0 110.745 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -60.83 -51.46 79.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HG2' ' HB2' ' A' ' 72' ' ' MET . 44.7 Cg_endo -88.06 37.65 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 112.83 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 39.98 49.34 2.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.846 0.458 . . . . 0.0 111.754 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA3' ' HG2' ' A' ' 72' ' ' MET . . . -159.4 174.55 36.3 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.938 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -100.41 -50.71 3.84 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -99.99 19.13 16.82 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.612 ' HB2' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -94.8 -44.33 0.28 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 87.9 Cg_exo -47.79 -52.83 7.48 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.08 61.07 0.07 OUTLIER Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.869 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.89 161.67 62.63 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' O ' HG23 ' A' ' 80' ' ' VAL . 49.7 Cg_exo -55.75 -38.81 93.93 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.865 2.376 . . . . 0.0 112.366 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.45 -32.49 73.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.39 -45.49 79.86 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.861 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.834 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 76' ' ' PRO . 99.9 t -64.52 -40.97 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.75 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -40.26 95.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.901 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -62.97 -48.07 83.59 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.07 -33.12 75.07 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.48 0.181 . . . . 0.0 110.865 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -62.26 -29.04 70.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.073 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.715 ' HB ' HG21 ' A' ' 102' ' ' VAL . 89.1 t -58.31 138.51 19.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.851 0.357 . . . . 0.0 110.393 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.35 22.79 3.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.728 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -136.71 62.12 1.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -70.79 -55.68 8.04 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.31 -60.08 1.6 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.046 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 67.81 -76.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.412 0.445 . . . . 0.0 111.764 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m 69.08 -77.6 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.755 0.422 . . . . 0.0 111.23 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.32 53.16 0.79 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.447 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.5 135.97 0.57 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.729 0.299 . . . . 0.0 110.786 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.83 -42.85 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.279 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 98' ' ' GLU . . . 66.25 81.84 0.14 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.858 HG21 HD21 ' A' ' 118' ' ' LEU . 78.8 t -43.38 -32.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.84 -36.09 32.72 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.103 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -79.84 -40.66 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.936 0.368 . . . . 0.0 111.181 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -65.44 -37.12 85.96 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.029 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.517 ' CB ' ' HE2' ' A' ' 115' ' ' MET . 0.0 OUTLIER -77.13 -37.21 54.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.218 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -60.1 -36.54 77.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.571 0.224 . . . . 0.0 110.911 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.901 HG11 ' HA2' ' A' ' 82' ' ' GLY . 21.4 t -82.65 -47.24 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.702 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.89 HD22 ' HG2' ' A' ' 109' ' ' LYS . 6.1 mt -70.35 -49.95 44.02 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.9 m -60.57 -34.25 73.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.441 0.163 . . . . 0.0 111.19 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -72.02 -20.29 61.72 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.548 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.57 0.224 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.7 53.2 0.28 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.405 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.71 45.37 10.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.89 ' HG2' HD22 ' A' ' 103' ' ' LEU . 4.2 tptt -68.63 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.117 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.828 HD22 ' HG3' ' A' ' 114' ' ' GLU . 54.7 mt -67.41 79.11 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -64.55 -168.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.99 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.48 ' HA ' ' HE3' ' A' ' 115' ' ' MET . 34.5 m120 -53.19 -31.05 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.381 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.4 -50.78 72.65 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.554 0.216 . . . . 0.0 111.297 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.828 ' HG3' HD22 ' A' ' 110' ' ' LEU . 5.0 tm-20 -56.26 -53.66 54.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.797 ' HA ' HD23 ' A' ' 118' ' ' LEU . 16.0 ptp -66.68 -25.1 66.39 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.368 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -47.72 83.15 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.732 0.301 . . . . 0.0 110.267 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -40.52 68.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -65.11 -43.77 90.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.178 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 8.7 mt -72.55 -26.91 61.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.362 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -66.54 -43.77 84.21 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.603 0.239 . . . . 0.0 110.728 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.1 -40.47 34.6 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.964 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 129' ' ' VAL . 47.3 t -83.88 130.46 55.12 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.679 0.24 . . . . 0.0 111.192 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.21 61.96 6.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.733 2.289 . . . . 0.0 112.38 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.561 HG21 ' H ' ' A' ' 128' ' ' MET . 5.2 p -131.19 168.05 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.76 50.52 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.098 0.475 . . . . 0.0 111.314 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.82 -36.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.413 ' HA3' HG23 ' A' ' 96' ' ' VAL . . . 114.7 35.62 1.38 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.034 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.561 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -103.38 117.35 34.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.66 ' O ' HG12 ' A' ' 129' ' ' VAL . 39.8 t -142.1 20.77 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 62.44 22.78 13.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.54 -167.43 0.11 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.21 -59.05 0.57 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.185 0.194 . . . . 0.0 111.165 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.95 -41.06 64.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 111.2 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 26.9 m-85 -68.28 -50.0 56.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.175 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.1 t -62.07 -27.56 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.352 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.83 -42.63 66.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.03 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mt -83.41 -56.39 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.365 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -85.19 -52.71 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.473 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 139' ' ' LEU . . . 73.69 96.92 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.062 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.654 0.264 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m 61.84 46.03 7.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.97 62.58 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -42.03 107.06 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.629 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.1 t -55.94 -46.24 99.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.753 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 6' ' ' SER . 86.1 Cg_endo -83.28 -8.95 10.59 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.563 2.175 . . . . 0.0 114.531 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -119.96 -63.99 1.31 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -60.1 2.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.232 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.43 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.55 -47.45 85.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.01 -41.07 82.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.228 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.0 t80 -57.94 -46.48 84.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.357 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -29.64 70.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.872 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 19.5 mt -59.04 -31.6 69.0 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -92.14 22.57 4.31 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.42 95.96 6.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.197 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -47.51 81.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.8 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.85 -30.48 21.43 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.74 40.08 8.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.389 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 p -95.62 -29.13 14.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.112 0.165 . . . . 0.0 111.313 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.64 12.77 7.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.417 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.58 162.35 29.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.085 0.442 . . . . 0.0 110.91 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.861 HD12 HD13 ' A' ' 28' ' ' ILE . 3.1 pt -143.77 140.57 17.42 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.565 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.75 171.82 8.13 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.185 2.59 . . . . 0.0 112.302 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.6 -39.61 3.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.2 p -60.29 -45.94 91.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.141 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.2 m -66.79 -45.59 77.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.833 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.861 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.54 -35.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.396 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -66.89 2.45 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.654 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.29 -27.94 69.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.702 0.251 . . . . 0.0 111.142 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.08 -48.65 80.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.15 -35.88 78.28 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -40.61 68.36 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.67 74.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.466 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 m -98.26 42.92 1.08 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.733 0.302 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.3 -93.77 0.58 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.95 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.8 167.36 19.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.907 0.384 . . . . 0.0 111.633 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -128.08 141.73 42.2 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.449 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.2 Cg_endo -86.77 -162.33 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.15 2.567 . . . . 0.0 112.29 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 p -97.65 167.33 11.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.939 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.4 mm? -54.14 -37.46 64.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.6 84.58 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -64.93 -52.27 57.27 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.804 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.19 -45.36 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.596 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -59.41 -42.97 93.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -40.37 79.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.541 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.971 HG23 HG11 ' A' ' 63' ' ' VAL . 17.6 mt -63.3 -47.91 89.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.38 -24.35 54.82 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.759 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.9 t -64.14 -10.31 21.97 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 p -117.88 -33.32 4.52 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.385 -0.197 . . . . 0.0 111.466 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -97.46 156.82 35.73 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 96.1 Cg_exo -41.87 148.11 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.12 2.547 . . . . 0.0 112.814 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -33.04 -52.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -97.76 126.75 43.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.784 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -87.26 89.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.6 p30 -84.58 178.56 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.394 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 40.5 mtm -41.09 -45.7 2.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.016 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.77 -52.55 42.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.969 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.586 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.25 -50.91 71.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -49.5 77.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.811 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.59 -32.61 72.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.484 0.183 . . . . 0.0 111.22 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -50.6 71.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.252 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.971 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.32 -44.8 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.2 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -47.7 83.67 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -101.25 52.3 0.84 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.045 0.45 . . . . 0.0 110.467 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.573 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 57.8 ttp180 -58.66 -52.02 77.71 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.091 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 81.0 Cg_endo -83.99 19.5 1.35 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.55 2.166 . . . . 0.0 113.111 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 56.87 79.24 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.635 0.374 . . . . 0.0 111.454 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.63 173.76 13.61 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.091 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -104.25 167.05 10.01 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.621 0.248 . . . . 0.0 111.002 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 57.05 66.54 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.061 0.458 . . . . 0.0 110.487 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.571 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.6 ttp 174.96 -50.82 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.892 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 88.1 Cg_exo -45.06 -47.34 12.32 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.776 2.318 . . . . 0.0 112.928 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.13 56.58 0.49 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -75.58 120.81 83.38 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-O 120.494 0.188 . . . . 0.0 110.897 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.06 -44.34 35.56 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.628 2.219 . . . . 0.0 112.39 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -33.15 74.61 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.366 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -65.67 -43.57 88.93 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -46.73 54.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -64.65 -65.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 tppt? -58.85 -23.76 61.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.053 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.717 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -67.88 -51.37 35.18 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.695 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -75.38 -42.92 52.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.545 0.212 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.32 5.3 12.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 86' ' ' PHE . 7.1 p -49.7 -45.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.414 ' N ' HG13 ' A' ' 85' ' ' VAL . 41.0 m-85 -148.57 46.48 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 110.89 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -129.33 66.58 1.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -35.86 82.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.21 -64.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.725 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.67 -174.67 0.1 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.889 0.376 . . . . 0.0 111.773 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 56.96 29.51 16.46 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.727 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.32 36.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.241 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 167.93 132.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.805 0.442 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.459 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -103.43 -45.37 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.337 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.57 77.35 0.23 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.864 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.863 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.4 t -45.41 -33.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.16 -54.47 15.08 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.693 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 pm0 -72.95 -39.24 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.549 0.175 . . . . 0.0 111.32 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.863 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.67 -38.97 89.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.2 -47.27 74.46 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -54.29 -36.55 63.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.154 0.284 . . . . 0.0 111.196 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.717 HG21 ' O ' ' A' ' 82' ' ' GLY . 24.1 t -74.85 -47.52 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.709 HD12 ' CD1' ' A' ' 99' ' ' LEU . 7.3 mt -66.39 -34.43 77.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 17.6 p -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.415 0.15 . . . . 0.0 111.3 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 t -74.82 -16.77 60.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.827 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.421 HD12 HD23 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -68.25 -57.49 5.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.692 0.282 . . . . 0.0 110.941 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.42 55.73 0.07 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.221 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 60.0 43.74 14.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 36.3 mmtt -68.86 -138.56 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.23 77.03 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 77.4 p -72.66 -175.79 1.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.964 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -49.24 -37.51 23.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.416 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.28 -52.73 37.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.637 0.256 . . . . 0.0 111.323 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.07 -50.73 72.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.843 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.7 ppp? -66.77 -27.73 67.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.286 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -47.66 83.36 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.5 -41.34 93.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.785 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.843 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.98 -41.89 97.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.724 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.548 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.091 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.1 -40.03 92.2 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.74 -46.69 29.47 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.014 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.505 HG11 ' CG2' ' A' ' 129' ' ' VAL . 17.6 t -86.17 121.49 72.67 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.803 0.301 . . . . 0.0 111.179 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.4 63.98 7.2 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.58 2.187 . . . . 0.0 112.568 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 122' ' ' VAL . 23.3 m -131.02 -179.85 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.241 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.17 135.28 54.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 68.07 11.91 8.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.862 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.719 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 67.79 48.55 54.72 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.101 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.82 119.22 38.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 129' ' ' VAL . 28.3 t -141.2 29.45 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.4 t30 56.1 21.87 5.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.8 t80 47.41 39.78 9.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -116.95 -39.84 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' HB3' HG11 ' A' ' 129' ' ' VAL . 24.4 t70 -69.6 -35.45 75.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -67.54 -54.73 17.55 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.232 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.773 HG12 HD12 ' A' ' 139' ' ' LEU . 21.2 t -63.39 -34.52 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.459 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -62.68 -52.48 63.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 33.4 tpp -63.09 -36.41 83.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.96 -32.24 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.274 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.773 HD12 HG12 ' A' ' 135' ' ' VAL . 2.1 mt -92.56 -4.9 52.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -96.14 96.01 8.54 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.845 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.219 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.58 0.228 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.0 m -103.84 65.07 0.81 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.147 0.498 . . . . 0.0 110.176 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.92 34.21 17.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.49 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -158.36 80.74 0.82 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.321 0.582 . . . . 0.0 111.403 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.417 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -68.53 -45.53 35.73 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.69 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 88.2 Cg_endo -79.86 -20.56 8.93 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.466 2.111 . . . . 0.0 114.901 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 14.1 m-30 -105.76 -59.41 1.77 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.1 0.409 . . . . 0.0 111.806 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -73.03 -63.31 1.2 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.49 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -57.62 -49.18 77.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.222 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.66 -38.28 81.01 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.456 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' HG12 ' A' ' 23' ' ' ILE . 33.5 t80 -58.43 -44.15 89.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.694 0.283 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -61.88 -35.32 78.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -61.96 -39.03 90.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.91 22.99 7.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 130.79 41.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.579 0.228 . . . . 0.0 110.85 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -52.49 -58.0 8.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -133.97 24.41 3.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.398 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.61 30.75 78.11 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.934 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -95.15 -27.61 15.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.587 0.194 . . . . 0.0 111.295 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.69 10.9 6.78 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.292 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.53 160.41 34.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.272 0.536 . . . . 0.0 110.88 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 28' ' ' ILE . 6.1 pt -147.34 135.68 11.0 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.873 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 90.7 Cg_endo -89.42 171.5 4.37 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.179 2.586 . . . . 0.0 112.541 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HG13 ' A' ' 44' ' ' ILE . 5.3 pttm -43.05 -40.29 3.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 p -59.82 -42.71 94.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.472 0.177 . . . . 0.0 111.185 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 4.5 t -70.75 -52.82 18.29 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.453 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.767 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.03 -37.39 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.19 -69.1 1.34 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.474 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.55 69.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.27 -50.78 68.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.688 0.28 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -61.37 -30.43 70.53 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.023 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -35.44 67.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.95 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.86 70.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.665 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.91 -45.68 9.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.651 0.262 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.63 -87.86 0.15 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.43 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.25 175.81 9.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.987 0.422 . . . . 0.0 111.826 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.57 112.95 35.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.697 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -82.03 -162.98 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 113.024 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -95.17 165.37 12.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.89 -37.08 63.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.49 73.11 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.916 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.64 -53.91 16.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.291 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -59.91 -47.67 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.291 -0.164 . . . . 0.0 110.91 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.3 m -59.27 -38.53 80.36 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -41.78 90.61 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.367 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 44' ' ' ILE . 10.5 mt -63.43 -49.12 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.979 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.37 -26.84 61.67 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.728 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.99 -12.7 40.34 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -118.33 2.47 11.9 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -136.65 154.73 76.79 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 70.8 Cg_exo -38.59 140.98 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.28 2.653 . . . . 0.0 112.966 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -26.13 -60.69 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.761 0.663 . . . . 0.0 112.755 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -91.44 125.93 36.36 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.411 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.9 t -86.27 86.35 2.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 121.161 0.505 . . . . 0.0 110.44 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.3 p-10 -83.27 177.24 8.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.2 mtm -41.9 -45.37 3.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.543 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -51.17 56.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.853 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.0 OUTLIER -56.41 -53.61 55.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.486 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -49.3 76.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.192 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.18 -33.29 73.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.49 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -61.33 -50.55 72.5 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.259 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.531 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.64 -37.46 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.606 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -74.04 -33.5 63.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -112.99 39.48 2.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -59.91 -55.29 47.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.502 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 61.6 Cg_endo -87.6 20.0 1.26 Allowed 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.884 2.39 . . . . 0.0 113.232 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 m120 60.74 79.37 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.969 0.414 . . . . 0.0 111.052 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 158.4 -177.35 35.1 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.82 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -105.07 -52.55 2.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.497 0.189 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 72' ' ' MET . 7.3 m-20 -95.78 94.46 7.69 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.324 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.532 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 16.2 ttm 170.5 -49.48 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.929 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 81.4 Cg_exo -43.33 -48.6 8.1 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 123.126 2.55 . . . . 0.0 113.223 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.5 58.91 0.29 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.763 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.72 170.85 13.99 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 120.426 0.155 . . . . 0.0 111.097 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' VAL . 73.7 Cg_exo -50.51 -47.39 24.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.924 2.416 . . . . 0.0 112.799 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.39 -26.0 60.8 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.334 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -47.5 69.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.457 0.17 . . . . 0.0 110.808 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -37.09 80.86 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.952 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 76' ' ' PRO . 56.0 t -62.67 -45.78 97.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.855 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -33.93 76.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.266 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.699 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -60.23 -44.63 97.24 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.085 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -70.24 -34.06 72.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.479 0.181 . . . . 0.0 110.624 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.96 73.15 5.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.857 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.43 -64.2 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.854 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.78 28.44 6.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -139.91 70.0 1.36 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.133 0.492 . . . . 0.0 110.149 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -61.09 -44.58 97.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.894 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -49.2 10.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.43 55.52 7.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.492 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 m -82.81 -57.37 3.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.35 57.78 0.22 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.798 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.52 119.6 0.9 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.584 0.231 . . . . 0.0 110.991 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -103.92 139.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.909 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -105.14 82.73 0.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.883 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.81 ' HA ' HD23 ' A' ' 99' ' ' LEU . 55.0 t -41.74 -34.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.39 -50.05 58.05 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.917 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.2 pt-20 -75.65 -34.95 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.356 0.122 . . . . 0.0 110.92 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -63.02 -41.42 99.55 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 110.493 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -67.42 -47.45 70.19 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -51.7 -46.99 64.08 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.174 0.296 . . . . 0.0 111.385 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.699 HG11 ' CA ' ' A' ' 82' ' ' GLY . 53.2 t -61.05 -49.49 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.363 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 99' ' ' LEU . 3.8 mt -67.81 -28.15 67.33 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.1 m -65.33 -41.52 93.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.574 0.226 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -74.52 -7.86 54.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -50.74 20.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.644 0.259 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.67 53.73 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.558 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.42 41.72 15.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HG3' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.81 -138.91 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.301 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 114' ' ' GLU . 3.6 mt -68.74 78.85 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -64.52 -174.61 0.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.143 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.439 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 8.8 p30 -49.22 -35.36 17.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.573 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -57.49 -51.08 70.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.547 ' HG3' HD23 ' A' ' 110' ' ' LEU . 11.3 mm-40 -56.74 -52.46 64.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.869 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.82 ' HA ' HD23 ' A' ' 118' ' ' LEU . 9.1 ptm -67.0 -25.99 66.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -48.11 81.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.661 0.267 . . . . 0.0 110.43 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.77 -41.96 78.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.66 -41.72 99.22 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.148 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER -70.85 -33.12 70.32 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.514 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -63.54 -41.38 98.46 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.952 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.24 -40.97 39.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.985 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.559 HG11 ' CG2' ' A' ' 129' ' ' VAL . 63.9 t -81.83 132.79 53.36 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.874 0.337 . . . . 0.0 111.193 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.9 58.68 7.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.802 2.334 . . . . 0.0 112.614 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.488 HG22 HG12 ' A' ' 122' ' ' VAL . 25.1 m -131.48 175.03 12.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -125.5 18.71 8.13 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.835 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -159.96 22.63 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 54.39 40.82 70.1 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.811 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.96 112.96 26.16 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.271 0.558 . . . . 0.0 111.353 -179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 129' ' ' VAL . 32.3 t -142.84 25.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.292 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.48 26.6 16.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.434 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.5 t80 45.62 41.53 7.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.416 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -114.8 -53.56 2.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.406 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.5 ' CB ' HG11 ' A' ' 129' ' ' VAL . 34.7 t70 -61.13 -34.7 75.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.51 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 4.9 m-85 -67.76 -56.62 8.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.371 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 139' ' ' LEU . 18.7 t -62.92 -32.66 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.124 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -62.81 -48.37 79.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.83 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.16 -34.58 78.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.496 HG22 HD12 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -68.43 -43.3 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.861 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.496 HD12 HG22 ' A' ' 138' ' ' ILE . 2.2 mp -93.75 63.53 3.36 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 110.789 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.86 62.53 0.68 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.531 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.967 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.751 0.31 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -114.38 -49.72 2.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.039 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.92 -58.39 0.51 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.724 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 22.0 m-20 -139.73 87.24 2.16 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.993 0.425 . . . . 0.0 110.345 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.423 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -62.41 -47.14 89.78 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.5 Cg_endo -83.75 1.64 8.76 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.574 2.183 . . . . 0.0 114.371 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 86.6 m-85 -126.9 -63.5 1.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.795 0.27 . . . . 0.0 111.609 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 2.1 mtpm? -72.44 -58.01 3.72 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.065 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -48.4 80.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.592 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.546 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.91 -38.25 78.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.289 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 23' ' ' ILE . 13.8 t80 -59.16 -45.81 90.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.374 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 m -62.65 -32.62 73.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.643 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.2 mt -61.03 -33.67 73.64 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 23' ' ' ILE . 66.5 m-85 -94.26 33.1 1.42 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.16 127.66 33.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.961 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -70.9 -56.72 5.64 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -112.2 -21.38 11.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.907 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.81 30.67 5.1 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.917 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -105.84 -29.02 10.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.622 0.211 . . . . 0.0 111.263 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.69 28.34 1.44 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.322 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.536 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.75 156.02 45.66 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.987 0.393 . . . . 0.0 110.183 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.743 HD12 HD13 ' A' ' 28' ' ' ILE . 5.6 pt -143.22 133.17 11.98 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.79 170.06 11.55 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.049 2.499 . . . . 0.0 112.309 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.68 -38.6 4.47 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 p -60.95 -43.91 98.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.512 0.196 . . . . 0.0 111.109 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.467 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 20.7 m -68.22 -46.47 70.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.565 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.743 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.35 -35.66 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.462 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.64 -69.22 1.33 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.584 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -26.03 68.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.529 0.164 . . . . 0.0 111.313 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 12.0 tp -61.62 -49.15 77.72 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -61.79 -32.27 72.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.056 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -55.36 -39.18 69.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.216 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.8 71.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.699 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.61 -45.47 13.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.99 -80.34 0.03 OUTLIER Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.942 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.97 178.79 6.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.651 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 6.5 t-20 -119.02 118.81 32.64 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.501 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 -162.43 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.397 . . . . 0.0 112.601 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 p -102.69 162.43 12.93 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.22 -33.94 63.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.98 80.74 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.933 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.68 -56.37 9.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.225 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.646 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.83 -47.24 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.327 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -61.17 -43.38 98.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.71 -40.01 78.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 44' ' ' ILE . 24.8 mt -61.63 -52.66 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -56.63 -23.41 40.99 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.826 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -63.74 -8.19 9.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.9 p -118.17 -46.74 2.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.599 0.181 . . . . 0.0 111.001 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.25 156.54 57.05 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.627 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.9 Cg_exo -39.32 145.43 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.359 2.706 . . . . 0.0 113.317 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.24 -64.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.471 0.708 . . . . 0.0 112.805 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -88.58 127.52 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.448 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -86.42 84.56 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.01 0.433 . . . . 0.0 110.512 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -81.71 179.24 7.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -41.1 -45.57 2.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -68.67 -52.05 35.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.627 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.2 mp0 -56.86 -51.83 67.5 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.563 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -48.85 79.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.624 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 61' ' ' LEU . 27.7 mt -61.5 -31.69 71.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -61.46 -50.49 72.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.604 0.24 . . . . 0.0 111.01 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.559 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.57 -40.62 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -58.55 6.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.95 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -83.19 63.14 7.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.4 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 11.8 mtm180 -53.23 -50.21 83.69 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.457 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.597 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 67.2 Cg_endo -85.12 18.69 1.53 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.66 2.24 . . . . 0.0 113.445 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 59.97 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.746 0.418 . . . . 0.0 112.08 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.97 -179.31 19.54 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.393 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.37 166.85 10.53 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.565 0.222 . . . . 0.0 110.975 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' HA ' ' CG ' ' A' ' 75' ' ' ASP . 19.1 m-20 55.8 66.57 1.18 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.137 0.494 . . . . 0.0 110.425 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.605 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.8 tpt -177.63 -52.1 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.591 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 86.2 Cg_exo -45.92 -46.32 15.92 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.494 2.129 . . . . 0.0 112.824 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.98 51.32 0.07 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.49 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.438 ' CG ' ' HA ' ' A' ' 71' ' ' ASP . 1.2 m-20 -81.47 157.64 69.88 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.442 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -57.78 -41.83 65.81 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.862 2.375 . . . . 0.0 112.058 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.33 -35.32 79.98 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -40.19 96.74 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.922 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -45.1 89.06 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.525 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.4 -43.87 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.715 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -30.21 69.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.303 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -62.81 -50.54 63.04 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.026 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.75 -41.0 72.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.73 0.3 . . . . 0.0 110.219 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -79.81 70.54 6.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.028 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.9 t -124.94 -64.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.455 ' HB2' ' HG2' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -99.37 43.15 1.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 1.8 m-20 -137.96 71.2 1.39 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -51.38 68.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.13 -54.89 3.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.674 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 51.47 56.27 8.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.656 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -110.3 69.4 0.69 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.95 49.3 1.63 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.99 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.98 144.84 0.62 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.788 0.327 . . . . 0.0 111.378 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.88 -44.38 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.285 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.47 80.84 0.21 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.368 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.789 ' HA ' HD23 ' A' ' 99' ' ' LEU . 72.8 t -44.27 -36.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.99 -42.03 22.38 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.565 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.4 tm-20 -71.98 -50.97 24.33 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.524 0.202 . . . . 0.0 110.518 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.91 -35.19 70.71 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.226 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -66.25 -48.95 68.86 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.678 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.61 -36.18 69.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 98' ' ' GLU . 43.4 t -72.04 -46.79 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.786 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 99' ' ' LEU . 3.8 mt -74.78 -49.32 21.27 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -57.32 -36.04 70.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.4 t -69.42 -21.69 63.74 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.79 -62.61 1.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.529 0.204 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.76 52.54 0.26 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 59.92 45.23 12.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.966 0.412 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 4.6 mmmm -68.55 -137.97 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.078 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -68.21 79.04 0.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.1 p -62.12 178.88 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.52 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.55 -30.99 14.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.207 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.4 -54.59 41.61 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -58.31 -46.6 85.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.827 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.8 mmt -67.12 -31.84 72.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.41 77.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.581 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.26 -42.63 93.08 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.529 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.827 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.97 -42.68 94.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.464 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.571 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -68.33 -33.08 73.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -39.43 92.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.76 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -48.81 32.56 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.92 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 129' ' ' VAL . 14.8 t -84.31 121.43 75.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.741 0.27 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 62.96 5.7 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.668 2.245 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.51 177.9 6.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -119.34 133.43 55.73 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.732 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 73.03 5.57 5.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.938 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 72.12 51.19 14.67 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.97 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -106.06 115.64 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 129' ' ' VAL . 38.8 t -142.34 30.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.74 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.69 25.35 11.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 47.24 45.78 16.52 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.774 0.321 . . . . 0.0 111.499 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -120.57 -54.26 2.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.259 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.501 ' CB ' HG11 ' A' ' 129' ' ' VAL . 31.3 t70 -58.0 -38.88 76.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.723 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.4 m-85 -66.43 -56.93 8.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.574 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.503 ' HA ' ' HB ' ' A' ' 138' ' ' ILE . 19.3 t -61.84 -31.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.313 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -57.74 -55.95 28.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -29.26 63.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 135' ' ' VAL . 2.0 mm -62.72 -42.54 96.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 135' ' ' VAL . 1.4 mt -67.55 -89.91 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.91 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.72 91.64 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.4 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.114 -179.328 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.492 0.186 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p -141.74 -63.18 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.85 59.37 0.09 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.34 109.21 2.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.281 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.8 -46.62 92.87 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.7 Cg_endo -82.6 -12.94 9.86 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.585 2.19 . . . . 0.0 114.077 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -111.35 -61.28 1.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -72.57 -62.1 1.56 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.394 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.44 -48.86 79.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.809 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.86 -41.6 82.76 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.522 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.2 t80 -54.21 -44.68 71.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.325 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.59 -36.1 81.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.339 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.7 mt -60.91 -35.87 77.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.447 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.93 33.74 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.18 133.17 49.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.689 0.28 . . . . 0.0 111.053 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -54.63 12.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.483 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.47 25.24 2.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.454 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.7 40.67 99.09 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.736 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 p -106.08 -31.27 8.8 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.79 -8.91 6.83 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.46 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -118.91 162.64 18.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.12 0.46 . . . . 0.0 111.037 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.711 HD12 HD13 ' A' ' 28' ' ' ILE . 5.8 pt -138.54 132.21 16.39 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.71 169.25 13.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.944 2.429 . . . . 0.0 112.435 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -45.16 -36.28 3.68 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.119 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.5 p -62.13 -44.18 97.19 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.404 0.145 . . . . 0.0 111.334 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 32.6 m -69.19 -45.7 69.29 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.711 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.94 -35.26 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.36 -67.66 2.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.678 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.92 71.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.549 0.174 . . . . 0.0 111.058 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -59.18 -50.14 75.18 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . 47.0 mt -59.06 -32.52 69.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -55.41 -41.18 72.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -69.68 -28.79 66.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 32' ' ' LEU . 30.8 p -113.79 36.29 3.71 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.064 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.94 -104.6 0.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.658 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 175.84 8.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 111.562 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -128.54 105.26 19.18 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.45 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.05 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.762 2.308 . . . . 0.0 112.535 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.54 167.51 11.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 25' ' ' LYS . 2.9 mm? -55.78 -33.05 64.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.07 75.51 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.014 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -56.53 9.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.011 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.755 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.45 -45.65 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.208 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -59.45 -42.69 92.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -57.42 -38.36 74.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.721 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 44' ' ' ILE . 39.4 mt -62.69 -51.29 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -56.79 -24.05 47.78 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.659 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.0 m -64.62 -8.67 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -118.01 -46.43 2.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.706 0.23 . . . . 0.0 111.179 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.587 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -91.07 158.24 41.84 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.3 Cg_exo -40.95 147.76 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.416 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.98 -67.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.597 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.54 124.9 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.624 0.249 . . . . 0.0 110.392 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 59' ' ' GLN . 57.0 t -86.47 90.81 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -87.67 -179.31 6.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.7 mtp -40.86 -49.91 3.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.603 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -63.29 -53.31 54.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.554 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -56.51 -53.55 56.18 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.154 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -49.57 76.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.92 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 mt -61.69 -29.68 70.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -65.33 -48.15 74.04 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.594 0.235 . . . . 0.0 111.264 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -41.77 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.163 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -57.66 5.65 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -88.95 58.45 4.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.988 0.423 . . . . 0.0 110.804 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.26 -51.79 77.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.42 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.509 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 85.0 Cg_endo -84.35 18.78 1.48 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.631 2.221 . . . . 0.0 113.715 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 61.62 105.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.683 0.393 . . . . 0.0 111.975 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.97 173.99 23.61 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.161 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.72 172.05 7.31 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 t70 57.45 60.19 2.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.526 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.602 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 10.9 tpt -177.89 -52.44 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.301 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 83.8 Cg_exo -45.29 -43.86 16.53 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.61 2.207 . . . . 0.0 113.046 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.2 55.55 0.09 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.509 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.93 160.85 65.25 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-O 120.635 0.255 . . . . 0.0 111.204 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' O ' HG23 ' A' ' 80' ' ' VAL . 46.1 Cg_exo -55.79 -39.95 88.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.886 2.391 . . . . 0.0 112.413 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -31.24 72.08 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.386 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.28 -45.68 87.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -37.94 79.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 76' ' ' PRO . 99.1 t -64.37 -43.67 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.088 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.69 -35.04 79.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.582 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.887 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -70.75 -43.88 58.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.561 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -76.48 -39.09 54.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.509 0.155 . . . . 0.0 111.302 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.45 73.66 5.0 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.106 0.479 . . . . 0.0 110.704 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 86' ' ' PHE . 13.2 p -131.83 -45.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.5 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.431 ' N ' HG13 ' A' ' 85' ' ' VAL . 10.0 m-85 -134.36 39.84 3.04 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -109.81 60.58 0.6 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -39.72 79.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.81 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.57 -64.8 1.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.26 -86.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.429 0.456 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t 42.62 45.78 4.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.03 40.09 0.39 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.329 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.6 ptp -176.68 136.05 0.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.93 0.365 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.55 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.87 -43.26 8.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.22 80.53 0.15 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.747 ' HA ' HD23 ' A' ' 99' ' ' LEU . 97.0 t -44.09 -36.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.24 -38.65 19.4 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.777 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.5 mt-10 -74.11 -52.26 13.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.522 0.201 . . . . 0.0 110.684 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.16 -38.25 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -73.46 -41.02 63.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.935 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -53.51 -42.13 67.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.527 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.887 HG11 ' HA2' ' A' ' 82' ' ' GLY . 4.1 t -74.11 -50.77 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.436 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 99' ' ' LEU . 2.9 mt -58.67 -45.76 88.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.884 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 56.3 m -65.41 -36.83 85.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.567 0.222 . . . . 0.0 110.952 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 t -63.62 -23.13 67.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.31 -70.67 0.23 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.518 0.199 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.25 48.95 0.49 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 61.16 45.99 8.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 111.012 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.62 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.985 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 114' ' ' GLU . 55.6 mt -66.94 79.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.291 0.496 . . . . 0.0 110.679 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.437 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 99.5 p -63.59 -170.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.045 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -52.67 -32.7 43.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.148 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -57.29 -50.58 72.46 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.704 ' HG2' HD22 ' A' ' 110' ' ' LEU . 11.4 tp10 -56.18 -54.47 44.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.742 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.889 ' HA ' HD23 ' A' ' 118' ' ' LEU . 4.1 ptt? -66.68 -25.41 66.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.457 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -46.32 87.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.97 -45.83 73.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.294 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.889 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.09 -40.57 90.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.594 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.9 mt -69.5 -32.13 70.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -61.27 -40.93 95.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.362 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.38 51.65 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.989 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 129' ' ' VAL . 10.8 t -91.23 116.67 66.9 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.749 0.274 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.08 65.03 4.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.492 2.128 . . . . 0.0 112.632 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.12 -179.24 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -118.68 132.7 56.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.567 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.99 6.18 5.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.955 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.619 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 71.03 53.33 10.95 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.909 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttt -106.83 119.61 39.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.641 ' O ' HG12 ' A' ' 129' ' ' VAL . 39.3 t -142.34 20.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.56 22.06 10.66 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.09 -164.53 0.14 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 m170 71.37 -58.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.28 0.232 . . . . 0.0 111.209 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -52.72 -39.68 62.3 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.509 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 17.8 m-85 -68.11 -52.72 31.73 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.417 HG12 HD13 ' A' ' 139' ' ' LEU . 20.2 t -61.73 -30.79 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.225 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -62.51 -54.14 44.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.846 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.6 ttt -67.21 -34.85 78.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 139' ' ' LEU . 1.7 mt -65.33 -41.12 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.962 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 138' ' ' ILE . 1.8 mp -98.57 46.66 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.902 0.382 . . . . 0.0 110.948 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.0 50.24 1.1 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.138 -179.592 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.723 0.297 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 t -139.58 -49.3 0.48 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.91 -63.38 0.57 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.407 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 62.1 m-20 -130.28 89.28 2.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.121 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.3 t -58.69 -45.79 99.62 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.343 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 85.3 Cg_endo -84.63 -3.74 9.95 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.543 2.162 . . . . 0.0 114.641 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 59.0 m-85 -123.99 -62.64 1.27 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.972 0.351 . . . . 0.0 111.809 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -72.66 -60.84 2.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.944 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.51 -45.57 93.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.11 -44.88 87.92 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.181 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 23' ' ' ILE . 25.9 t80 -56.78 -43.12 80.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.823 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -62.48 -34.05 76.08 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -59.5 -34.05 72.1 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 23' ' ' ILE . 44.1 m-85 -94.25 33.22 1.4 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.92 129.4 39.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.618 0.247 . . . . 0.0 111.015 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.58 -61.89 1.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.512 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -130.95 25.75 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.184 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.75 39.18 95.09 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.535 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -104.57 -24.43 12.99 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.49 11.63 17.01 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.891 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 4.8 mtt-85 -129.0 163.17 25.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.746 0.273 . . . . 0.0 110.445 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.781 HD12 HD13 ' A' ' 28' ' ' ILE . 5.4 pt -140.14 133.74 15.3 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.49 172.43 8.11 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.158 2.572 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.6 pttp -43.49 -40.97 4.13 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -60.06 -43.13 95.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.507 0.194 . . . . 0.0 111.404 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.0 m -70.95 -45.57 63.93 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.766 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.781 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.32 -33.06 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.477 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.53 -67.54 2.16 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.25 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.4 -28.13 69.48 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.46 -46.76 88.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.28 -34.85 75.87 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.753 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.419 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.33 -41.08 65.37 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.794 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -63.68 -34.9 78.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.682 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -101.03 44.35 1.02 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.845 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.69 -97.78 0.57 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.817 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.68 170.43 14.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.721 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -122.47 131.96 24.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 59.3 Cg_endo -85.82 -163.27 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.973 2.449 . . . . 0.0 112.743 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p -98.15 163.25 12.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -51.53 -37.51 49.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.145 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.606 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -61.24 -55.12 35.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.0 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.73 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.58 -47.97 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.819 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -57.56 -41.73 81.59 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.75 -40.7 76.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 44' ' ' ILE . 20.2 mt -62.79 -51.01 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.037 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -56.44 -23.54 39.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.905 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 t -63.97 -7.6 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 p -118.23 -46.17 2.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.684 0.22 . . . . 0.0 111.146 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.76 156.57 49.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.7 Cg_exo -39.01 146.11 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.355 2.703 . . . . 0.0 113.279 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.08 -68.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.744 0.653 . . . . 0.0 112.609 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.5 tt0 -85.84 127.68 34.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.643 0.259 . . . . 0.0 110.399 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.65 87.77 2.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.032 0.444 . . . . 0.0 111.314 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -82.33 177.56 8.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 ttm -41.61 -45.09 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.78 -51.54 47.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.572 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mp0 -56.82 -51.85 67.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.527 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -48.88 79.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.93 -32.6 72.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.427 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -61.47 -51.77 67.29 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.066 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -70.43 -41.7 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -42.58 98.54 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.563 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -105.27 50.68 0.78 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.086 0.469 . . . . 0.0 110.455 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.411 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . 7.0 mtm180 -57.28 -58.15 20.03 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.246 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 66.3 Cg_endo -86.34 18.88 1.49 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.736 2.291 . . . . 0.0 113.173 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 53.78 82.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.565 0.346 . . . . 0.0 111.657 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.7 -167.11 35.16 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.188 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.53 154.33 45.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.547 0.213 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.06 65.61 1.35 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.071 0.462 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.561 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 3.7 ttt 177.73 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.584 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 80.2 Cg_exo -42.25 -52.98 3.88 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.891 2.394 . . . . 0.0 112.996 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.16 45.52 0.58 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.503 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 154.68 73.21 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.581 0.229 . . . . 0.0 111.272 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' O ' HG23 ' A' ' 80' ' ' VAL . 33.1 Cg_exo -59.39 -39.5 76.12 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 112.464 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.73 -30.12 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.361 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.9 -47.46 68.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.921 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -40.59 96.54 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.63 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 76' ' ' PRO . 73.4 t -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.936 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -26.56 66.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.672 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.81 -50.4 58.6 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.466 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -72.96 -37.51 67.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.562 0.22 . . . . 0.0 111.008 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -79.12 4.78 13.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.76 -43.8 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -145.75 33.6 1.03 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.765 0.316 . . . . 0.0 111.413 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.448 ' CG ' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -130.92 76.24 1.71 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.063 0.459 . . . . 0.0 110.347 179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.93 -48.94 78.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.178 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -91.82 -64.02 1.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.99 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.448 ' HB2' ' CG ' ' A' ' 87' ' ' ASP . . . 48.82 52.86 13.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.803 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.4 p -102.73 -48.05 4.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.85 26.22 9.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.0 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.491 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -174.59 148.64 1.18 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.862 0.331 . . . . 0.0 110.974 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.521 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -118.11 -44.25 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.79 81.15 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.337 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.75 ' HA ' HD23 ' A' ' 99' ' ' LEU . 73.3 t -44.3 -34.81 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.68 -35.73 17.29 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.093 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -80.65 -46.34 15.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.619 0.21 . . . . 0.0 110.916 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.99 -39.92 83.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.857 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.471 ' HG2' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -75.07 -36.12 61.79 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.611 179.042 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.78 -40.54 63.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.905 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 82' ' ' GLY . 21.3 t -82.33 -51.46 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.532 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 99' ' ' LEU . 2.4 mt -58.31 -49.85 75.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 m -59.7 -39.3 84.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.445 0.164 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -72.13 -19.82 61.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.81 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt -65.35 -66.69 0.51 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.603 0.239 . . . . 0.0 110.97 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.92 47.86 0.47 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.336 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.61 45.89 7.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.8 mmmm -68.77 -137.7 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.158 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.843 HD22 ' HG2' ' A' ' 114' ' ' GLU . 34.6 mt -69.43 79.33 0.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.619 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -64.97 -173.02 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.913 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 4.3 p-10 -51.88 -34.89 43.09 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.606 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.6 -55.44 30.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.843 ' HG2' HD22 ' A' ' 110' ' ' LEU . 3.2 tp10 -55.34 -51.28 67.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.848 ' HA ' HD23 ' A' ' 118' ' ' LEU . 22.0 ptm -66.82 -27.6 67.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -47.3 83.58 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.82 -43.47 79.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.848 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.49 -43.11 97.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.634 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.451 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.4 mt -67.95 -32.62 73.19 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.236 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -41.58 98.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.617 0.246 . . . . 0.0 110.724 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.99 -44.2 37.53 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.878 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 124' ' ' VAL . 58.6 t -78.97 133.21 61.84 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.675 0.237 . . . . 0.0 111.189 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.39 59.94 7.31 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.788 2.326 . . . . 0.0 112.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 128' ' ' MET . 17.2 m -131.49 174.12 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 48.2 2.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.27 0.557 . . . . 0.0 110.555 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 175.13 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.834 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 112.71 50.3 0.56 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.922 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.35 114.46 28.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.268 0.556 . . . . 0.0 110.698 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 129' ' ' VAL . 40.4 t -142.18 26.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.101 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 62.67 24.34 14.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.122 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' CD1' HG13 ' A' ' 94' ' ' ILE . 4.8 t80 48.45 51.97 14.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 111.372 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.06 -54.31 1.12 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.564 ' CB ' HG11 ' A' ' 129' ' ' VAL . 19.5 t70 -57.82 -36.52 72.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.676 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' A' ' 94' ' ' ILE . 1.8 m-85 -68.46 -55.49 11.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.697 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.416 HG12 HD13 ' A' ' 139' ' ' LEU . 21.7 t -62.3 -31.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.568 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.03 -47.85 78.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.191 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.6 ttt -73.57 -32.02 63.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.524 HG22 HD12 ' A' ' 139' ' ' LEU . 1.5 mt -66.56 -46.97 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.408 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 138' ' ' ILE . 2.5 mp -83.4 -55.4 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.208 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' LEU . . . 69.88 107.09 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.356 0.41 . . . . 0.0 111.015 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.039 -0.982 . . . . 0.0 111.055 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.714 0.292 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -97.27 28.29 3.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -131.38 13.69 5.05 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 38.9 m-20 57.38 80.28 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -67.2 -47.1 51.32 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.864 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 3.3 Cg_exo -75.17 -16.27 19.93 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.758 2.305 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -110.88 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 14.5 mmmt -72.3 -57.97 3.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 9.8 tp60 -58.82 -45.95 88.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.603 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -63.82 -35.52 80.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.125 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.0 t80 -57.89 -47.95 81.27 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 m -62.71 -33.87 75.99 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.198 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -58.59 -37.15 75.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.344 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 89.0 m-85 -95.75 34.0 1.57 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 83.11 6.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.681 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -68.16 -30.84 70.06 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -86.22 -29.93 22.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.554 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.34 30.26 58.87 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.631 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -129.77 27.81 5.17 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.74 21.82 71.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.986 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 42.7 mtt180 -130.23 157.04 43.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.916 0.358 . . . . 0.0 110.805 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.818 HD12 HD13 ' A' ' 28' ' ' ILE . 3.8 pt -146.86 133.93 10.08 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.816 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.01 168.34 12.18 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.992 2.461 . . . . 0.0 112.172 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.5 -38.01 3.87 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -60.46 -43.74 96.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 111.145 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.3 m -71.03 -46.57 61.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.647 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.818 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.64 -34.06 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.099 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.03 -70.37 0.99 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.504 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.68 68.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.496 0.148 . . . . 0.0 111.297 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 9.2 tp -62.34 -48.41 79.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.33 -33.19 73.19 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.769 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.454 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.43 -36.85 66.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.74 -36.69 58.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.713 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t -93.64 53.51 1.86 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 111.001 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.84 -89.51 0.81 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.854 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 169.11 14.87 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.441 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 11.1 p-10 -133.77 155.32 80.5 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.329 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 68.1 Cg_endo -84.02 -162.09 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.415 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -102.54 168.06 9.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -54.63 -33.17 60.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.19 85.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.71 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -67.37 -55.0 15.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.065 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.66 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.49 -46.04 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.934 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.6 m -61.47 -39.62 91.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -58.11 -38.4 76.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.316 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 44' ' ' ILE . 50.0 mt -63.55 -46.72 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.898 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.8 -28.77 61.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 m -63.88 -12.21 34.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.8 p -118.28 -14.66 9.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.735 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -125.05 153.36 71.34 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.549 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.3 Cg_exo -39.38 146.65 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.366 2.711 . . . . 0.0 113.077 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.05 -65.4 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -88.12 125.88 34.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.576 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 59' ' ' GLN . 58.8 t -86.55 89.82 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.2 p30 -83.17 176.94 8.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.388 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -41.49 -44.65 2.99 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.717 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -52.04 46.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.966 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.549 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.95 78.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.6 mt -61.38 -31.87 71.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.571 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -63.18 -52.16 63.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.161 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.735 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.06 -43.84 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.282 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.61 -51.5 59.15 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.579 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -98.85 53.91 1.0 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -55.75 42.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.205 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 67.5 Cg_endo -86.83 18.72 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.645 2.23 . . . . 0.0 113.431 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 52.25 87.32 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.61 0.364 . . . . 0.0 111.963 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.6 172.21 18.21 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.157 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -103.93 152.03 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.538 0.209 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 57.86 70.32 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.05 0.452 . . . . 0.0 110.244 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.584 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 26.1 ttt -179.69 -52.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.049 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 99.7 Cg_exo -42.3 -43.38 7.84 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.898 2.399 . . . . 0.0 113.217 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.74 92.96 0.84 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.583 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.11 135.33 94.83 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 120.448 0.166 . . . . 0.0 110.959 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' O ' HG23 ' A' ' 80' ' ' VAL . 52.4 Cg_exo -54.79 -46.5 32.86 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.804 2.336 . . . . 0.0 112.456 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -65.46 -35.5 81.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.408 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.37 -43.26 81.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.371 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -44.74 59.63 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.184 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 76' ' ' PRO . 52.9 t -59.85 -53.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.317 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -40.68 97.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.277 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.596 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.14 -47.1 88.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.544 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.08 -26.45 65.84 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.496 0.148 . . . . 0.0 111.357 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.03 73.58 3.61 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.854 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.96 -66.32 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.523 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CB ' ' HG2' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -135.58 33.21 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.652 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -137.25 53.2 1.89 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.617 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.492 ' HE2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -70.95 -3.21 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.475 ' N ' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -97.87 -60.69 1.51 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.722 0.237 . . . . 0.0 111.056 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.57 51.4 12.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.304 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 p -142.19 80.81 1.72 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.77 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.7 15.89 50.93 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.292 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptm -172.57 131.37 0.56 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.12 0.46 . . . . 0.0 111.402 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.596 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.9 -35.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.42 80.31 0.26 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.686 ' HA ' HD23 ' A' ' 99' ' ' LEU . 81.4 t -44.86 -34.43 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.21 -37.26 17.24 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.51 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.5 mp0 -75.57 -53.36 8.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.548 0.214 . . . . 0.0 110.63 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.27 -36.82 73.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.287 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.46 ' HG3' ' HG2' ' A' ' 115' ' ' MET . 2.1 tmt_? -68.48 -49.95 56.0 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -57.61 -36.85 72.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.34 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 98' ' ' GLU . 48.7 t -71.97 -47.75 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.763 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 110' ' ' LEU . 1.6 mt -73.4 -52.5 13.55 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 84.8 m -55.3 -37.03 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 t -76.79 -17.67 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -66.57 0.53 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.509 0.195 . . . . 0.0 111.212 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 58.67 0.27 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.59 39.38 17.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.404 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -68.92 -137.77 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.197 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.596 HD23 ' HG2' ' A' ' 114' ' ' GLU . 9.4 mt -68.79 78.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 110.754 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -66.07 -170.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.938 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -51.0 -38.37 50.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.943 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.31 -51.17 68.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HG2' HD23 ' A' ' 110' ' ' LEU . 2.2 mp0 -57.69 -53.21 60.8 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.848 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.855 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.83 -27.88 67.91 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -45.23 89.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.677 0.275 . . . . 0.0 110.555 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.38 -40.29 74.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.79 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.97 -42.22 99.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.826 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.411 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -73.52 -30.86 63.37 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.407 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -63.14 -41.14 99.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.77 -0.195 . . . . 0.0 110.958 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.36 -43.16 39.25 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.985 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.478 HG11 ' CG2' ' A' ' 129' ' ' VAL . 46.2 t -81.83 130.29 61.47 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.705 0.253 . . . . 0.0 111.155 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.96 62.45 6.62 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.585 HG21 ' H ' ' A' ' 128' ' ' MET . 4.7 p -131.2 167.42 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.444 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.5 OUTLIER -127.48 54.44 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.088 0.47 . . . . 0.0 111.154 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.4 -37.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.561 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.521 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 113.96 39.19 1.08 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.296 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.585 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -103.16 113.96 27.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.26 0.552 . . . . 0.0 110.762 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 129' ' ' VAL . 37.9 t -142.31 21.39 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.433 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.75 22.39 12.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.446 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 2.1 t80 46.63 45.42 14.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 -51.08 2.52 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.407 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.83 -36.62 77.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.788 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -68.16 -55.74 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.685 0.278 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.601 ' O ' HD12 ' A' ' 139' ' ' LEU . 23.1 t -62.57 -32.73 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.232 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.84 -49.7 76.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.712 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.2 ttt -70.8 -27.11 63.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 138' ' ' ILE . 1.6 mm -60.5 -39.56 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.888 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 135' ' ' VAL . 2.1 mp -100.01 43.98 1.04 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.72 83.19 1.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.1 -0.952 . . . . 0.0 111.066 -179.664 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.99 34.59 5.12 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 110.36 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -147.73 44.11 1.09 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.618 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -119.94 108.03 13.84 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.916 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.442 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t -64.0 -48.31 78.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.771 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 6' ' ' SER . 71.5 Cg_endo -78.75 -14.36 14.04 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.389 2.06 . . . . 0.0 114.074 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -111.26 -61.41 1.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -60.13 2.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.597 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.463 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 8.1 tt0 -58.97 -47.04 86.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.631 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.6 -36.3 78.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.096 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.455 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.6 t80 -58.47 -49.31 77.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -61.92 -34.3 75.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 14.2 mt -55.62 -36.95 67.52 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 111.358 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -96.15 33.5 1.73 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -84.67 84.31 7.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.242 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -67.26 -34.49 77.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.46 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -86.55 -32.59 20.61 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.4 26.79 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.508 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.2 p -137.25 30.16 2.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.668 0.27 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.23 20.63 71.41 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.812 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 13.3 mtt180 -130.65 158.62 39.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.777 0.288 . . . . 0.0 110.533 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 28' ' ' ILE . 5.7 pt -145.49 138.08 13.7 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 95.7 Cg_endo -88.67 172.73 4.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.207 2.605 . . . . 0.0 112.131 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 4.5 pttm -44.33 -36.25 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -59.9 -46.25 89.93 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -71.22 -50.51 32.21 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.84 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.85 -35.45 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.338 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.18 -70.95 0.83 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.235 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.17 -28.26 69.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.59 0.195 . . . . 0.0 111.453 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.72 -48.01 83.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.6 -34.47 75.7 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.858 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -32.41 64.71 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.297 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.56 -43.48 65.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.5 m -64.32 -43.73 93.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.925 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.18 -65.97 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.984 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.63 163.46 28.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -136.07 151.72 74.17 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.477 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.7 Cg_endo -86.47 -163.28 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.138 2.559 . . . . 0.0 112.74 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -99.58 169.05 9.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.261 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.3 mm? -54.09 -36.09 62.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.113 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.52 80.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.559 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -67.71 -52.23 40.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.834 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.85 -45.65 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.337 -0.145 . . . . 0.0 110.641 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -40.02 78.05 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -40.92 88.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.614 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 44' ' ' ILE . 18.7 mt -63.36 -49.08 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -57.22 -24.86 57.45 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.678 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -64.03 -10.69 23.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.4 p -117.92 -41.54 2.89 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 120.34 0.114 . . . . 0.0 111.025 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -92.84 150.78 40.06 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.544 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.3 Cg_exo -38.32 143.31 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.233 2.622 . . . . 0.0 112.821 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.25 -61.35 0.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.73 0.644 . . . . 0.0 112.659 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -87.29 121.01 29.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.491 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.64 83.64 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.3 p30 -82.77 178.11 8.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.494 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.9 mtp -41.43 -46.01 3.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.59 -52.16 54.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.962 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.544 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.57 -52.59 64.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -49.31 75.92 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.121 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.57 -30.04 70.41 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -64.2 -49.46 71.93 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.433 0.159 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.616 HG21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.51 -45.92 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.849 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -57.9 8.11 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.26 55.66 2.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.78 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -51.89 76.95 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.247 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.532 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 69.5 Cg_endo -86.74 19.02 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.754 2.302 . . . . 0.0 113.249 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 62.96 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.679 0.392 . . . . 0.0 111.812 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.37 176.46 22.61 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.285 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.77 166.8 10.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.536 0.208 . . . . 0.0 111.011 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 56.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 110.657 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.562 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER 177.46 -51.95 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.796 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 72.4 Cg_exo -41.02 -45.35 5.12 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.988 2.458 . . . . 0.0 113.4 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.74 82.83 0.72 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.452 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.71 137.78 73.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' O ' HG23 ' A' ' 80' ' ' VAL . 32.2 Cg_exo -57.95 -41.62 66.89 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.568 2.179 . . . . 0.0 112.136 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.49 -33.54 73.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -65.3 -41.85 93.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.032 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -42.31 68.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.988 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 76' ' ' PRO . 75.2 t -61.85 -56.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -24.77 67.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.687 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -65.21 -52.72 38.29 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.4 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -77.69 -41.47 37.92 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.437 0.16 . . . . 0.0 111.053 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -78.65 71.76 5.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.957 0.408 . . . . 0.0 110.986 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.646 ' HB ' HG21 ' A' ' 102' ' ' VAL . 14.9 p -111.99 -42.01 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.29 40.36 1.76 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -125.25 57.53 1.31 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -49.24 74.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.556 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -97.83 -48.31 5.24 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.444 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.02 73.48 0.47 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 91' ' ' THR . 10.1 t -92.06 70.29 5.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.29 57.34 17.27 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.62 135.74 1.97 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 111.015 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -108.89 -44.16 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.46 80.12 0.12 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.422 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.794 ' HA ' HD23 ' A' ' 99' ' ' LEU . 95.4 t -44.44 -40.07 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.71 -36.15 8.09 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.163 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 mm-40 -80.85 -46.01 15.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.63 0.215 . . . . 0.0 110.909 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -42.08 84.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.893 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -75.01 -36.06 61.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.828 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -52.82 -41.34 64.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.522 0.201 . . . . 0.0 111.014 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.646 HG21 ' HB ' ' A' ' 85' ' ' VAL . 2.6 t -83.04 -52.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.649 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -56.45 -47.12 79.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -58.22 -35.38 71.58 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -67.86 -21.47 65.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.1 mt -66.35 -67.43 0.45 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.512 0.196 . . . . 0.0 111.026 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.31 49.65 0.46 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.542 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.2 48.68 4.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.345 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -68.49 -138.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.125 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.803 HD22 ' HG2' ' A' ' 114' ' ' GLU . 15.1 mt -69.68 78.01 0.44 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.885 0.374 . . . . 0.0 110.639 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.3 p -68.78 -171.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.867 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -50.88 -39.54 54.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.03 -53.52 48.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.524 0.202 . . . . 0.0 111.275 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.803 ' HG2' HD22 ' A' ' 110' ' ' LEU . 4.1 tp10 -54.78 -52.86 61.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.88 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -65.61 -27.76 68.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -44.77 90.46 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.32 -43.82 80.69 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.92 -42.5 98.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.06 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.3 mt -71.52 -28.95 64.25 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.146 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -63.97 -41.21 97.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.572 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.12 -48.79 24.33 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.829 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.497 HG11 HG22 ' A' ' 129' ' ' VAL . 21.4 t -81.73 123.69 80.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.62 0.21 . . . . 0.0 110.808 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.75 62.23 6.41 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.565 2.177 . . . . 0.0 112.864 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.73 178.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.212 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -119.29 130.43 55.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.48 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 22.8 m-20 80.7 -34.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.061 0.544 . . . . 0.0 111.814 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 118.07 50.69 0.34 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.457 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.425 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.7 OUTLIER -104.01 116.84 32.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.705 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 129' ' ' VAL . 36.7 t -142.32 20.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.258 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 56.72 25.31 10.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.7 t80 44.77 44.49 7.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -53.54 2.53 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.575 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.9 t70 -56.13 -37.08 68.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.3 m-85 -68.2 -58.95 3.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.83 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -62.27 -32.99 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -61.2 -52.66 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 110.645 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.53 -27.7 67.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.8 mm -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.333 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.65 40.39 1.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.702 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.36 67.28 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.877 -179.71 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.782 0.325 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -120.44 -46.63 2.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -135.68 -58.7 0.77 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.636 0.255 . . . . 0.0 110.62 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -141.39 112.09 7.1 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.609 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -59.41 -48.04 96.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.69 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.0 Cg_endo -81.74 -14.39 10.13 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.513 2.142 . . . . 0.0 114.123 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -110.52 -61.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -62.7 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.547 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -57.29 -47.6 81.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.677 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.2 -41.92 85.02 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.6 t80 -56.71 -42.82 79.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.592 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -61.4 -36.49 80.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.2 mt -63.26 -34.1 76.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -93.96 29.65 2.06 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.08 125.02 29.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.733 0.301 . . . . 0.0 110.821 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.53 -58.3 3.84 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.398 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -108.28 6.03 26.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.17 43.13 99.8 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.792 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.0 p -118.41 10.83 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 1.19 68.95 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.381 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -125.04 167.29 14.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.149 0.475 . . . . 0.0 110.898 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.74 HD12 HD13 ' A' ' 28' ' ' ILE . 7.6 pt -147.41 136.43 11.53 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -87.38 172.01 6.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.245 2.63 . . . . 0.0 112.488 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 6.0 pttt -44.41 -39.27 4.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.2 p -59.5 -43.31 93.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.453 0.168 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 25.4 m -71.16 -52.37 19.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.614 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.74 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.86 -35.36 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.76 -71.22 0.75 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -26.59 68.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.8 -50.14 67.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.702 0.287 . . . . 0.0 110.276 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.33 -28.11 68.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -54.75 -37.95 66.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.519 0.2 . . . . 0.0 110.749 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.18 72.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.577 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -83.74 -41.89 17.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.476 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.39 -84.32 0.05 OUTLIER Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.59 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.1 171.65 13.7 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 2.7 t30 -123.3 108.77 31.6 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.317 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.38 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.849 2.366 . . . . 0.0 112.552 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 p -90.42 166.4 13.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.5 mm? -55.7 -34.53 65.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.789 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.54 -37.22 77.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.52 -54.2 31.56 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.653 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.06 -44.29 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.748 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 m -58.07 -43.59 87.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.343 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.47 -40.12 74.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.645 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 44' ' ' ILE . 24.6 mt -64.99 -49.35 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.8 -23.37 43.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.748 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -64.56 -6.49 7.65 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -117.76 -45.59 2.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.789 0.268 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.606 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -89.36 156.19 48.48 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.4 Cg_exo -41.67 149.31 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 113.116 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.72 -64.18 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.646 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.1 mt-10 -86.44 123.58 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.704 0.288 . . . . 0.0 110.614 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.92 87.85 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.9 p30 -83.92 -179.93 7.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 37.2 mtt -41.41 -44.59 2.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -69.12 -52.27 29.98 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.56 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.27 -51.57 68.83 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.614 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.437 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.68 -48.54 81.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.921 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 61' ' ' LEU . 35.0 mt -61.01 -34.51 74.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.505 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -60.28 -49.81 76.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.577 0.227 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.57 -36.49 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD13 ' HE1' ' A' ' 60' ' ' PHE . 1.6 tp -62.05 -51.59 67.36 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.03 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.35 48.45 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.49 -49.15 91.4 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 85.6 Cg_endo -83.97 18.85 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.621 2.214 . . . . 0.0 113.563 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 55.4 92.13 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.638 0.375 . . . . 0.0 111.947 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.47 176.93 14.93 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.287 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -101.97 169.04 9.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.56 0.219 . . . . 0.0 110.806 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.458 ' HA ' ' CG ' ' A' ' 75' ' ' ASP . 3.3 m-20 54.64 68.06 0.92 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 11.6 tpt -179.67 -51.37 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.332 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 51.4 Cg_exo -51.89 -57.85 1.92 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.376 2.05 . . . . 0.0 112.484 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.33 36.16 0.7 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.499 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' CG ' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -81.14 173.28 7.94 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.466 0.174 . . . . 0.0 110.86 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 69.1 Cg_exo -51.62 -36.17 59.68 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.719 2.279 . . . . 0.0 112.322 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -38.44 91.19 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.892 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.09 -42.56 96.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.847 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -44.1 97.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.92 -39.04 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.926 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -35.36 77.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.324 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' C ' HG11 ' A' ' 102' ' ' VAL . . . -71.63 -54.69 8.25 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.755 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -57.9 -45.64 86.15 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.512 0.196 . . . . 0.0 110.666 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.98 65.13 5.04 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.85 -41.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.496 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -121.83 32.16 5.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.01 75.0 1.48 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.548 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -44.15 92.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.5 -59.28 2.36 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.846 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 55.71 70.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -128.22 68.36 1.35 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.0 38.76 3.27 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.802 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.41 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.0 OUTLIER -172.86 134.56 0.59 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.675 0.238 . . . . 0.0 110.976 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -107.26 -41.78 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.12 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.54 80.96 0.38 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.328 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.756 ' HA ' HD23 ' A' ' 99' ' ' LEU . 79.6 t -45.12 -39.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.03 -40.04 42.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.258 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.4 tt0 -71.93 -47.92 49.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.225 0.21 . . . . 0.0 110.474 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.35 -37.74 75.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.207 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.489 ' HG3' ' HG3' ' A' ' 115' ' ' MET . 0.2 OUTLIER -68.16 -43.99 77.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.675 179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -58.47 -36.79 74.25 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.361 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 98' ' ' GLU . 16.1 t -77.8 -50.28 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.602 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.557 HD12 ' CD1' ' A' ' 99' ' ' LEU . 4.6 mt -63.73 -42.61 97.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.6 m -64.73 -41.72 95.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.499 0.19 . . . . 0.0 111.007 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.5 p -70.37 -15.2 62.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.861 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.55 -56.92 4.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.46 42.99 0.23 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.84 47.28 15.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 46.9 mmtm -68.52 -138.66 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.51 79.67 0.57 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.0 p -62.21 -177.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.933 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.416 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 7.2 p30 -48.9 -29.75 5.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.468 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -60.0 -62.75 1.64 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -42.04 86.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.793 ' HA ' HD23 ' A' ' 118' ' ' LEU . 6.0 mmt -65.95 -33.84 76.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -48.9 77.98 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.233 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.59 -40.65 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.33 -42.16 95.08 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.409 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.436 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -68.91 -31.17 69.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.324 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -62.94 -42.24 99.74 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.5 65.62 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.902 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.73 126.35 71.06 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.667 0.234 . . . . 0.0 111.176 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.25 61.07 5.79 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.598 2.199 . . . . 0.0 112.333 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 125' ' ' LYS . 2.2 p -131.87 171.46 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.294 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -118.28 132.17 56.31 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 26.8 m-20 81.35 -47.51 0.24 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.523 0.514 . . . . 0.0 110.841 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.2 53.16 0.16 Allowed Glycine 0 C--N 1.339 0.71 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.711 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.454 ' O ' HG21 ' A' ' 124' ' ' VAL . 0.3 OUTLIER -107.22 107.41 18.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.544 0.688 . . . . 0.0 110.904 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 129' ' ' VAL . 47.7 t -142.32 19.59 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.624 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.85 21.69 7.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.853 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.413 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.9 OUTLIER 54.79 -164.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.21 -57.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.235 0.214 . . . . 0.0 111.359 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -52.65 -39.18 61.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.7 m-85 -68.65 -54.81 14.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.637 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.03 -31.31 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.293 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -69.6 -54.23 15.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -34.68 78.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.492 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 134' ' ' PHE . 1.9 mt -69.4 -47.95 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.084 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.3 mp -99.17 53.69 0.97 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -171.02 112.65 0.38 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.725 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.136 -179.676 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 51.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.189 0.596 . . . . 0.0 111.76 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -136.18 -56.3 0.76 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.617 0.246 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -128.34 98.34 5.03 Favored 'General case' 0 N--CA 1.46 0.031 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.699 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.6 t -61.72 -46.02 93.11 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 5.0 Cg_exo -75.39 -14.4 20.33 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.987 2.458 . . . . 0.0 114.046 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -118.12 -63.13 1.46 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -66.21 -60.68 2.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 8.0 tt0 -60.56 -47.14 87.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.61 -37.05 80.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 23' ' ' ILE . 24.7 t80 -59.01 -46.77 87.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.326 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -62.41 -32.73 73.61 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.266 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -59.95 -34.07 72.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.497 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -102.05 36.33 2.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.92 101.68 14.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -50.05 67.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -86.84 -35.79 18.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.386 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.08 40.01 6.74 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.584 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.3 p -127.83 32.72 4.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.06 19.2 73.62 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.984 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 1.1 mtt-85 -130.98 157.2 43.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.794 0.297 . . . . 0.0 110.688 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.806 HD12 HD13 ' A' ' 28' ' ' ILE . 7.0 pt -143.57 137.94 14.93 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 84.1 Cg_endo -88.3 171.53 5.4 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.166 2.577 . . . . 0.0 112.702 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 15.8 pttm -44.19 -36.63 2.75 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.5 p -60.15 -46.21 90.45 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -70.72 -49.95 41.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.94 -34.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.346 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.12 -72.56 0.56 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.215 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -27.19 65.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.593 0.196 . . . . 0.0 111.456 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.13 -48.38 78.74 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -61.55 -31.5 71.53 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.962 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.426 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -56.13 -33.67 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.142 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.3 -38.02 68.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.28 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -92.66 58.15 3.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.0 0.428 . . . . 0.0 110.477 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.41 -91.71 1.09 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.406 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 172.37 12.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 12.4 p-10 -132.05 155.82 80.87 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 65.3 Cg_endo -85.03 -161.91 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.034 2.489 . . . . 0.0 112.41 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 p -102.17 167.32 10.08 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.076 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.407 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.5 mm? -53.58 -35.23 60.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.17 88.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.708 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -66.76 -52.22 46.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.271 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.598 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -54.95 -46.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -58.42 -43.08 88.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.307 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.51 -40.97 75.9 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.562 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 44' ' ' ILE . 38.8 mt -63.59 -48.2 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.23 -23.58 48.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -63.69 -12.09 31.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.4 p -118.04 -41.11 2.91 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.946 0.098 . . . . 0.0 110.911 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -91.2 148.35 37.6 Favored Pre-proline 0 N--CA 1.465 0.286 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.47 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -36.62 140.43 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.391 2.727 . . . . 0.0 113.148 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.86 -58.5 0.13 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.636 . . . . 0.0 112.448 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -89.4 122.32 32.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.185 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.36 88.49 2.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 121.029 0.443 . . . . 0.0 110.647 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.2 p30 -82.6 177.77 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.498 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.9 mtm -41.36 -43.73 2.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.907 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.84 -51.19 35.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.47 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -56.29 -50.74 70.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.504 0.192 . . . . 0.0 111.08 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -47.59 83.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.86 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 61' ' ' LEU . 26.8 mt -62.1 -30.93 71.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -63.65 -54.58 33.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.507 0.194 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.24 -40.9 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.903 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.1 -63.79 1.06 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.859 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.03 63.33 7.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.348 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -55.12 -54.14 53.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.707 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.53 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 74.2 Cg_endo -84.8 19.14 1.44 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.625 2.216 . . . . 0.0 113.548 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 54.17 75.87 0.26 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.77 0.319 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.65 -172.6 38.75 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.167 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -121.65 156.43 33.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.776 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 57.39 62.05 2.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.162 0.505 . . . . 0.0 110.274 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.561 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 6.9 tpt 179.46 -52.8 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.933 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 94.9 Cg_exo -42.46 -48.16 7.04 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 122.885 2.39 . . . . 0.0 113.429 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.8 80.16 0.06 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.898 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.628 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . 24.1 m-20 -80.97 117.57 68.63 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 120.432 0.158 . . . . 0.0 110.725 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 80' ' ' VAL . 29.6 Cg_exo -61.76 -51.13 4.27 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.758 2.306 . . . . 0.0 112.487 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -24.17 65.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.676 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 38.1 tt0 -71.84 -52.32 18.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.48 0.181 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -39.85 95.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.973 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 76' ' ' PRO . 53.9 t -61.84 -50.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.602 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.466 ' O ' HG11 ' A' ' 102' ' ' VAL . 1.4 tppt? -60.13 -32.87 71.42 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -63.21 -54.08 35.22 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.502 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -78.02 -22.37 49.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.66 75.02 4.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.1 0.476 . . . . 0.0 111.031 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 86' ' ' PHE . 7.1 p -141.75 -49.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.906 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.447 ' N ' HG13 ' A' ' 85' ' ' VAL . 9.6 m-85 -156.29 43.44 0.4 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 110.722 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.96 59.95 1.72 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -50.23 74.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.93 -46.08 5.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.888 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.24 38.77 28.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.54 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 p -118.47 82.55 1.87 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.7 -18.02 5.44 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.157 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.1 OUTLIER -163.77 132.37 3.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.085 0.442 . . . . 0.0 110.898 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.587 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.38 -41.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.853 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.52 80.4 0.2 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.705 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.782 ' HA ' HD23 ' A' ' 99' ' ' LEU . 96.9 t -45.12 -38.61 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 122.3 0.24 . . . . 0.0 111.641 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.55 -36.36 17.79 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.9 mm-40 -77.45 -48.1 18.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 0.173 . . . . 0.0 110.71 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.72 -39.36 80.61 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.744 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HD3' ' HG2' ' A' ' 115' ' ' MET . 14.1 ttp180 -75.71 -39.47 57.32 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -53.9 -40.78 66.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 98' ' ' GLU . 3.8 t -77.91 -52.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.653 0.264 . . . . 0.0 111.412 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.899 HD22 ' HG2' ' A' ' 109' ' ' LYS . 5.7 mt -56.5 -46.77 80.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.948 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.2 m -66.56 -35.59 80.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -66.02 -22.07 66.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.728 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.01 -67.86 0.43 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 110.983 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.55 44.68 0.56 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.258 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.4 50.41 4.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 111.182 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.899 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -68.51 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.902 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.617 HD22 ' HG3' ' A' ' 114' ' ' GLU . 62.3 mt -67.23 79.44 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.372 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.8 p -63.8 -169.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.438 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 115' ' ' MET . 3.5 m120 -50.43 -33.71 21.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.521 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -56.37 -51.72 67.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.568 0.223 . . . . 0.0 111.483 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.617 ' HG3' HD22 ' A' ' 110' ' ' LEU . 1.6 tm-20 -56.58 -56.79 16.93 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.922 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.6 OUTLIER -65.45 -24.68 67.24 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.638 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -48.28 81.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -68.01 -43.54 78.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.71 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.922 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.73 -42.19 96.82 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.944 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 4.1 mt -69.79 -30.24 67.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.073 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -40.39 96.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.625 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.48 -47.48 16.26 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.952 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.458 HG11 HG22 ' A' ' 129' ' ' VAL . 26.2 t -81.35 125.8 78.08 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.688 0.244 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.49 61.61 7.96 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.652 2.235 . . . . 0.0 112.662 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 128' ' ' MET . 22.9 m -131.57 -177.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.236 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.05 129.91 55.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.083 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 78.71 -49.38 0.45 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.851 0.46 . . . . 0.0 111.049 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 136.14 51.27 0.07 OUTLIER Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.618 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.488 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 1.9 ttp -104.17 116.73 32.71 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.121 0.486 . . . . 0.0 110.659 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 129' ' ' VAL . 29.7 t -142.03 20.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.463 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 59.92 25.77 14.95 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.472 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 3.0 t80 44.31 41.63 4.58 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.236 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -52.98 2.69 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.839 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.526 ' HB3' HG11 ' A' ' 129' ' ' VAL . 23.6 t70 -56.9 -36.75 70.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.8 m-85 -67.93 -57.35 6.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.55 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.94 -35.19 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.41 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.77 -56.03 26.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.2 tpp -64.0 -29.66 70.79 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.074 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mt -64.92 -43.11 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.967 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.23 33.06 3.65 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.604 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.52 110.11 0.23 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.951 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.861 -179.676 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.593 0.235 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.79 32.54 21.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.452 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.57 -41.53 3.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -106.83 99.3 8.88 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 4.1 t -67.31 -47.64 48.66 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.785 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 6' ' ' SER . 98.8 Cg_endo -80.73 -13.34 11.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.466 2.11 . . . . 0.0 114.193 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.37 -61.27 1.69 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -59.62 2.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.336 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.35 -47.42 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.716 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.79 -41.02 85.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.966 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.454 ' CE2' HG12 ' A' ' 23' ' ' ILE . 6.1 t80 -56.39 -45.39 80.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.456 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.8 m -62.64 -33.82 75.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.733 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 16.1 mt -57.52 -30.28 65.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 23' ' ' ILE . 69.5 m-85 -91.69 33.22 1.03 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.54 112.3 14.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.909 0.385 . . . . 0.0 110.846 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -49.72 42.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -115.53 -0.92 12.91 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 48.5 33.57 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.559 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.5 p -121.38 16.64 11.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.65 14.01 80.01 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.194 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -130.29 158.45 39.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.922 0.361 . . . . 0.0 110.668 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.61 HD12 HD13 ' A' ' 28' ' ' ILE . 8.8 pt -140.96 135.04 15.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.73 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.25 170.66 9.36 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.074 2.516 . . . . 0.0 112.477 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -42.81 -38.16 2.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.6 p -60.41 -45.38 93.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.506 0.193 . . . . 0.0 111.293 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.459 ' CB ' ' HB ' ' A' ' 23' ' ' ILE . 2.9 m -69.97 -44.73 68.85 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.61 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.21 -33.47 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.411 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.45 -65.99 3.15 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.392 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -28.02 69.24 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.56 -49.18 77.7 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.32 -29.48 69.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.076 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -36.63 70.6 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.85 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.23 -30.14 71.0 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.418 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -109.4 32.05 5.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.799 0.333 . . . . 0.0 110.84 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.55 -105.08 0.28 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.366 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -132.4 178.81 6.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.615 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.74 116.04 34.88 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.369 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -84.57 -162.63 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.016 2.478 . . . . 0.0 112.764 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 p -98.16 164.06 12.48 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.24 -36.48 63.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.021 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.82 80.59 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.02 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -54.6 20.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.64 -44.95 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.484 0.183 . . . . 0.0 110.632 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.7 m -59.1 -38.99 80.86 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -40.5 85.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.277 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 44' ' ' ILE . 22.5 mt -63.56 -47.94 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -56.82 -25.48 56.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.414 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 t -64.47 -7.42 9.97 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -117.75 -50.52 2.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.748 0.249 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -87.27 153.66 53.92 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.507 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 85.6 Cg_exo -38.85 144.95 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.265 2.643 . . . . 0.0 113.044 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.68 -68.66 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.74 126.78 33.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.637 0.256 . . . . 0.0 110.601 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.55 89.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.5 p30 -86.08 -179.69 6.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.539 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -41.28 -45.15 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.817 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -67.55 -53.62 26.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.507 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.31 -51.99 67.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -50.1 75.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.46 -32.47 72.46 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.414 0.15 . . . . 0.0 111.326 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.19 -50.3 74.57 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.025 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.57 -34.45 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.356 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.52 -46.16 67.16 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.635 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -93.45 51.77 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 21.6 mtm180 -60.33 -55.24 47.2 Favored Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.785 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.559 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 58.9 Cg_endo -86.86 29.96 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.991 2.461 . . . . 0.0 113.057 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 39.81 71.13 0.19 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.974 0.51 . . . . 0.0 111.808 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.07 173.33 46.2 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.967 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -100.79 -57.1 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.565 0.221 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.33 72.97 2.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.051 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.57 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -165.98 -54.69 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.003 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD3' ' CG ' ' A' ' 72' ' ' MET . 81.1 Cg_exo -43.72 -48.93 8.45 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.596 2.198 . . . . 0.0 113.206 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.15 52.74 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.484 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.63 152.82 72.96 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.497 0.189 . . . . 0.0 111.247 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.3 Cg_exo -58.8 -38.74 87.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.887 2.391 . . . . 0.0 112.512 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -35.97 82.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.369 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -65.37 -42.14 93.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.023 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -43.42 69.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.903 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 76' ' ' PRO . 78.1 t -60.43 -44.56 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.276 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -34.62 77.6 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.65 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.818 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -61.07 -48.36 86.46 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.214 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -70.97 -34.36 71.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.508 0.194 . . . . 0.0 110.724 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -78.78 72.27 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.2 -63.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.475 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -116.5 42.21 2.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.141 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.33 65.42 0.67 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.671 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -59.64 -53.51 57.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.87 -66.95 1.0 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.595 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.21 63.75 1.84 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.572 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -64.84 -47.72 76.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.27 64.77 0.5 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.403 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -178.1 150.22 0.59 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.224 0.21 . . . . 0.0 110.487 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.588 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.25 -41.53 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.507 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.51 80.34 0.18 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.334 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.704 ' HA ' HD23 ' A' ' 99' ' ' LEU . 91.3 t -45.14 -33.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -43.76 15.62 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.109 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -76.93 -49.91 14.49 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.583 0.192 . . . . 0.0 111.045 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.725 HD12 HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -57.32 -37.58 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.272 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 104' ' ' THR . 35.7 ttp85 -70.8 -46.98 61.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.79 -38.05 54.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.284 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.818 HG11 ' HA2' ' A' ' 82' ' ' GLY . 22.4 t -75.11 -49.03 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.815 HD22 ' HG2' ' A' ' 109' ' ' LYS . 9.4 mt -63.07 -35.27 79.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.407 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 111' ' ' SER . 68.2 p -63.75 -37.8 88.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.603 0.24 . . . . 0.0 111.021 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.1 m -72.74 -17.05 61.64 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.05 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -67.34 -56.91 7.79 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 110.772 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.06 48.78 0.07 OUTLIER Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.156 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 64.01 39.12 8.16 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 111.035 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.815 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.66 -137.05 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.593 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.804 HD23 ' HB3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -67.51 83.56 0.17 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.603 ' HA ' HG22 ' A' ' 104' ' ' THR . 0.0 OUTLIER -86.71 -167.55 1.92 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.967 -178.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 11.1 p30 -55.43 -28.86 56.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -67.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.804 ' HB3' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -55.71 -44.98 77.95 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.148 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.804 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.54 -29.27 69.32 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.106 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER -58.69 -47.52 84.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.25 -42.71 99.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.8 -41.72 98.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.742 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.456 HD12 ' SD ' ' A' ' 115' ' ' MET . 4.3 mt -67.7 -32.18 72.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -45.22 91.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.967 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.94 -45.66 41.01 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.785 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 129' ' ' VAL . 86.7 t -75.63 133.49 73.62 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.488 0.185 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 58.48 6.5 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.84 2.36 . . . . 0.0 112.657 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.593 HG21 ' H ' ' A' ' 128' ' ' MET . 5.1 p -131.43 166.84 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 124' ' ' VAL . 3.0 mtpp -124.33 55.56 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.92 0.391 . . . . 0.0 111.25 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.7 p-10 170.26 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 116.45 40.98 0.76 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.593 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -103.25 114.26 28.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 110.618 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 129' ' ' VAL . 25.8 t -142.44 27.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.225 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.21 20.23 9.61 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.5 t80 46.61 41.75 10.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.821 0.343 . . . . 0.0 111.187 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -50.07 2.37 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.667 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' HB3' HG11 ' A' ' 129' ' ' VAL . 20.6 t70 -56.37 -41.29 75.95 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -66.4 -57.85 6.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.77 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.491 ' CG1' HD13 ' A' ' 139' ' ' LEU . 14.4 t -62.11 -30.09 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.512 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.17 -57.4 12.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.659 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm -68.97 -32.02 71.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.902 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 139' ' ' LEU . 2.2 mm -62.36 -49.23 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 138' ' ' ILE . 2.6 mp -94.22 64.1 3.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -161.77 67.62 0.27 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.0 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.905 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.561 0.219 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.6 t -129.59 29.42 5.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.098 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.91 -46.83 4.77 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 12.0 m-20 -79.32 83.09 5.39 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.1 0.476 . . . . 0.0 110.657 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.433 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -67.41 -46.64 48.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.984 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.3 Cg_endo -82.82 1.98 8.78 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.438 2.092 . . . . 0.0 114.106 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.506 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 56.9 m-85 -124.27 -66.76 0.96 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -55.27 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 1.4 tp60 -62.36 -49.33 75.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.676 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.51 -38.2 77.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.9 t80 -58.83 -46.48 87.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.401 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -62.57 -31.6 72.44 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.656 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 12.8 mt -60.31 -38.1 82.62 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 23' ' ' ILE . 24.3 m-85 -96.04 34.47 1.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.4 95.27 9.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.07 -36.43 77.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.566 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -86.91 -41.28 14.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.369 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.22 10.51 55.92 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.165 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -103.96 -12.91 16.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.075 0.437 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.45 28.85 3.61 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.54 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -130.56 155.59 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.371 0.268 . . . . 0.0 110.367 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.745 HD12 HD13 ' A' ' 28' ' ' ILE . 5.4 pt -145.24 132.5 10.19 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.43 171.4 9.97 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.975 2.45 . . . . 0.0 111.985 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.17 -37.83 7.52 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.3 p -61.94 -41.89 98.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.372 0.13 . . . . 0.0 111.152 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 9.8 m -70.41 -46.35 64.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.403 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.745 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.03 -34.87 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.482 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.01 -70.63 0.9 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.54 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -27.86 69.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.349 0.119 . . . . 0.0 111.291 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -61.54 -50.91 70.77 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.645 0.26 . . . . 0.0 110.366 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.58 -31.53 71.59 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.119 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.45 -39.64 70.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.01 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.84 75.5 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.533 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -77.45 -44.03 30.39 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.662 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' ' 77' ' ' GLU . . . -156.43 -76.98 0.02 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.749 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 168.5 17.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.879 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -122.45 117.12 29.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.447 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.31 -162.25 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.893 2.396 . . . . 0.0 112.464 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -94.26 164.28 13.1 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.107 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.8 mm? -56.71 -30.95 64.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.44 86.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.723 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -55.53 16.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.83 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.18 -45.11 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.906 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.2 m -61.27 -40.15 93.05 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.57 -38.68 78.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 44' ' ' ILE . 23.3 mt -61.9 -51.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.6 -23.78 43.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.72 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -9.58 15.21 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -118.24 -46.42 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.647 0.203 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.555 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -90.24 158.39 43.82 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.8 Cg_exo -42.49 150.21 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.14 2.56 . . . . 0.0 113.214 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.14 -64.92 0.33 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.099 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.39 119.83 24.66 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 59' ' ' GLN . 59.7 t -86.8 89.47 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.212 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 4.2 p30 -84.48 -179.89 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.49 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 mtt -41.92 -46.59 4.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.827 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -67.11 -51.03 59.21 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.586 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.17 -51.12 70.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -50.89 69.72 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.724 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.12 -26.15 68.14 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.473 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -65.57 -51.47 59.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.67 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.61 -41.58 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.828 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.533 HD23 ' ND2' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -69.13 -60.05 2.61 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.873 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.533 ' ND2' HD23 ' A' ' 64' ' ' LEU . 1.6 m120 -87.52 62.87 7.34 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.489 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.428 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -56.4 -54.5 52.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.135 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.8 Cg_endo -85.6 19.07 1.45 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.799 2.333 . . . . 0.0 113.188 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 66.0 113.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.814 0.446 . . . . 0.0 111.826 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 168.15 14.64 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.136 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -103.52 171.97 7.07 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.564 -0.162 . . . . 0.0 110.564 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 38.32 64.59 0.7 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.125 0.488 . . . . 0.0 111.384 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.63 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 18.7 ttt -174.23 -53.17 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.802 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 83.7 Cg_exo -48.01 -39.28 32.79 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.557 2.171 . . . . 0.0 112.602 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 91.36 2.14 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.43 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -61.3 142.77 93.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 120.501 0.191 . . . . 0.0 111.028 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.605 ' O ' HG23 ' A' ' 80' ' ' VAL . 51.0 Cg_exo -55.8 -55.2 3.16 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.798 2.332 . . . . 0.0 112.498 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' HG3' ' HA3' ' A' ' 36' ' ' GLY . 1.2 pm0 -69.4 -26.55 64.69 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.665 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -71.94 -49.83 34.25 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.198 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.26 90.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.296 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 76' ' ' PRO . 89.2 t -65.41 -53.04 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.465 0.174 . . . . 0.0 110.843 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -60.82 -29.49 69.51 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.689 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.79 -53.38 15.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.063 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -77.89 -36.81 49.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.93 74.05 2.16 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.201 0.524 . . . . 0.0 111.243 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.88 -55.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.232 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -144.14 49.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.317 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 1.1 m-20 -129.63 74.82 1.61 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.709 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -47.34 78.22 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.73 -71.3 0.51 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.69 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 57.34 -170.14 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.218 0.324 . . . . 0.0 111.657 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 m 72.11 -69.93 0.17 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.666 0.386 . . . . 0.0 111.542 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.72 6.45 83.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.562 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 143.86 5.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.274 0.537 . . . . 0.0 111.025 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -124.32 141.12 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -109.27 81.22 0.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.058 -0.591 . . . . 0.0 111.639 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.021 HG11 HD21 ' A' ' 118' ' ' LEU . 93.9 t -43.32 -41.18 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.06 -46.65 33.22 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.038 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -81.59 -41.12 21.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.101 0.161 . . . . 0.0 110.958 179.042 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.01 -47.18 78.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.704 0.288 . . . . 0.0 110.702 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' HD3' HG13 ' A' ' 96' ' ' VAL . 3.0 mpt_? -72.57 -37.08 68.32 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.33 -38.68 63.46 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.538 0.209 . . . . 0.0 111.123 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.689 HG11 ' HA2' ' A' ' 82' ' ' GLY . 2.6 t -75.13 -49.12 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.456 HD23 HD12 ' A' ' 106' ' ' LEU . 1.1 mt -63.54 -34.99 79.02 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.36 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.9 m -62.24 -32.45 73.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.567 0.223 . . . . 0.0 111.163 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 m -69.54 -17.0 63.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.456 HD12 HD23 ' A' ' 103' ' ' LEU . 3.7 mt -63.97 -71.81 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 110.977 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.4 51.3 0.43 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.974 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 61.14 49.1 5.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.013 0.435 . . . . 0.0 110.732 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -68.32 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.495 HD22 ' OE2' ' A' ' 114' ' ' GLU . 19.0 mt -70.21 79.82 0.52 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.5 p -61.7 -175.39 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.011 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -50.22 -32.57 16.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.408 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.89 -51.84 67.57 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.495 ' OE2' HD22 ' A' ' 110' ' ' LEU . 1.2 tp10 -57.48 -53.36 59.04 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.894 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -66.3 -26.8 67.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.402 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.86 -48.59 80.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.676 0.274 . . . . 0.0 110.339 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.88 -40.62 87.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.021 HD21 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.42 -41.6 98.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.694 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.427 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.1 mt -68.54 -33.26 73.8 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.983 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -63.32 -41.0 98.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.66 -45.06 18.74 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.844 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.8 t -79.24 125.22 83.74 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.693 0.247 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 5.2 Cg_exo -73.76 62.79 4.76 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.909 2.406 . . . . 0.0 112.32 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 128' ' ' MET . 16.0 m -131.35 175.15 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.242 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -124.19 47.62 2.05 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.084 0.469 . . . . 0.0 110.855 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.8 p-10 173.03 -34.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.72 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 110.7 48.49 0.73 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -103.87 117.66 34.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 129' ' ' VAL . 38.4 t -142.37 31.16 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.989 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 59.24 23.12 11.45 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 46.33 44.5 12.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.926 0.394 . . . . 0.0 111.297 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.84 -52.69 2.43 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.35 -37.24 80.06 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.181 0.301 . . . . 0.0 111.757 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -66.39 -56.46 10.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.563 HG12 HD13 ' A' ' 139' ' ' LEU . 21.4 t -62.83 -31.28 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.462 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.42 -55.14 37.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.5 ttt -62.76 -36.26 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.757 HG22 HD12 ' A' ' 139' ' ' LEU . 3.2 mt -66.35 -39.32 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.119 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.757 HD12 HG22 ' A' ' 138' ' ' ILE . 2.4 mp -95.74 48.81 1.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.99 0.424 . . . . 0.0 110.879 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -166.52 80.44 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.097 -179.67 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.38 0.133 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 p 72.17 -54.7 0.68 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.592 0.757 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -131.99 -72.51 0.53 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.459 0.171 . . . . 0.0 110.581 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -174.16 97.78 0.1 Allowed 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.993 0.425 . . . . 0.0 110.895 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.448 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -66.75 -46.55 56.2 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.412 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 6' ' ' SER . 11.5 Cg_exo -71.36 -17.95 30.3 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.898 2.398 . . . . 0.0 113.85 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -114.46 -63.41 1.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 5' ' ' ASP . 8.0 tptt -65.88 -61.11 2.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.369 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -59.85 -45.69 91.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.401 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.57 -40.51 87.57 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CE2' HG12 ' A' ' 23' ' ' ILE . 10.6 t80 -54.69 -45.64 73.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.297 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -36.38 81.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.14 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.547 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 6.0 mt -62.14 -33.23 74.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.382 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -93.29 34.12 1.17 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.51 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.51 96.23 8.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -42.4 99.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.048 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -87.39 -37.26 17.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.42 33.11 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.712 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.1 p -117.38 -11.42 10.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.17 2.94 9.92 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.353 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 2.6 mtt-85 -117.08 163.14 16.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 117.241 0.52 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.801 HD12 HD13 ' A' ' 28' ' ' ILE . 5.2 pt -144.98 131.21 9.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.668 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 89.1 Cg_endo -84.61 169.74 10.62 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.066 2.511 . . . . 0.0 112.412 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.43 -37.9 5.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -60.78 -44.07 97.25 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.538 0.209 . . . . 0.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 7.5 t -67.99 -51.07 51.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.801 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.17 -37.33 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -70.58 0.9 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.668 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -26.14 68.54 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -64.71 -48.31 75.13 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -29.62 70.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.232 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -41.52 68.02 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.704 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.02 69.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.711 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.88 39.38 1.87 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.809 0.338 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.2 -102.3 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.748 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.05 -176.43 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -118.68 114.75 35.69 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.823 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.78 -162.54 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.796 2.331 . . . . 0.0 112.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 p -102.97 162.16 13.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -55.06 -32.9 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.13 79.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.696 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.37 -54.43 20.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -60.21 -47.78 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.895 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.2 m -59.21 -38.86 80.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.69 -38.07 80.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.516 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 44' ' ' ILE . 19.2 mt -65.36 -50.16 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.99 -24.23 51.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.048 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 p -64.65 -7.34 10.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 p -117.75 -43.6 2.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.652 0.206 . . . . 0.0 111.269 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.579 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -93.37 158.92 36.2 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 99.0 Cg_exo -42.82 151.71 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.151 2.568 . . . . 0.0 113.12 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.64 -64.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.61 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.1 mt-10 -87.5 124.4 33.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.516 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 59' ' ' GLN . 48.3 t -86.61 88.92 2.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -82.21 177.2 8.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.405 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -41.38 -45.47 3.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.662 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -66.9 -51.38 56.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.043 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.53 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.71 -51.44 68.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -49.83 74.02 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.498 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.63 -47.98 79.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.115 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.47 -39.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.164 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -41.59 86.05 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.669 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -109.6 45.47 1.08 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.848 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 2.4 ttm180 -60.05 -53.01 69.31 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.229 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 66.0 Cg_endo -87.17 19.54 1.36 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.691 2.261 . . . . 0.0 113.314 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.64 81.98 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 111.321 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.7 -171.07 28.34 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.103 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.21 167.1 15.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.094 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.16 64.54 1.79 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.745 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.564 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 22.2 tpp 174.46 -52.44 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.987 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 85.2 Cg_exo -42.28 -53.99 3.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.019 2.479 . . . . 0.0 113.379 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.72 60.04 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.678 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-20 -79.77 167.61 32.55 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 122.123 0.169 . . . . 0.0 110.622 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' VAL . 57.1 Cg_exo -51.71 -38.17 65.99 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.655 2.237 . . . . 0.0 112.297 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.29 -33.72 76.12 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.268 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.88 -47.19 63.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.262 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -41.3 98.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.134 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 76' ' ' PRO . 98.9 t -64.72 -48.4 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.826 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -31.05 70.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.849 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.17 -55.79 9.91 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.344 0.116 . . . . 0.0 110.7 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -79.01 69.15 5.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.052 0.453 . . . . 0.0 110.683 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.14 -45.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.04 19.69 7.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.45 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.7 80.49 1.73 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -55.48 33.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.75 -35.51 9.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . . . 62.18 65.77 0.86 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -69.12 -38.0 78.63 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.73 64.78 0.06 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.031 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.63 129.82 0.43 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.507 0.194 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -103.76 -45.88 9.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.356 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 94' ' ' ILE . . . 57.1 80.26 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.469 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.781 ' HA ' HD23 ' A' ' 99' ' ' LEU . 77.8 t -44.08 -36.62 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.38 -39.89 14.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.764 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.2 mm-40 -80.92 -45.01 17.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.444 0.164 . . . . 0.0 110.809 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.16 -40.54 90.26 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.957 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 104' ' ' THR . 0.7 OUTLIER -72.49 -41.27 66.15 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.612 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -52.33 -39.52 60.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.693 0.282 . . . . 0.0 111.034 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.849 HG11 ' HA2' ' A' ' 82' ' ' GLY . 30.6 t -73.21 -49.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.629 HD12 HD12 ' A' ' 99' ' ' LEU . 2.9 mt -64.48 -44.3 91.45 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.007 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 111' ' ' SER . 54.7 p -57.85 -40.86 81.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.507 0.194 . . . . 0.0 111.229 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.0 t -78.33 -12.21 59.99 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -61.34 1.91 Allowed 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 111.281 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 57.81 0.12 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.368 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.35 39.61 18.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 111.022 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 49.3 mmtt -68.68 -137.93 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.036 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD22 ' HG2' ' A' ' 114' ' ' GLU . 19.7 mt -68.49 79.63 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.667 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.757 ' HA ' HG22 ' A' ' 104' ' ' THR . 80.3 p -65.1 -170.21 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.069 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 115' ' ' MET . 78.3 m-20 -53.44 -36.87 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.07 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.02 -51.23 70.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.67 ' HG2' HD22 ' A' ' 110' ' ' LEU . 5.3 tp10 -57.34 -53.65 55.71 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.85 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.88 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.44 -25.85 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.419 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -47.85 83.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.97 -43.16 75.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.795 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.27 -42.68 95.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 127' ' ' GLY . 1.3 mt -72.17 -30.71 65.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -61.16 -41.21 96.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.804 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.19 20.46 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.917 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 129' ' ' VAL . 16.4 t -84.75 117.97 69.96 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.739 0.269 . . . . 0.0 111.019 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.85 63.95 6.74 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.628 2.219 . . . . 0.0 112.461 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.467 HG13 HG12 ' A' ' 122' ' ' VAL . 31.6 m -131.16 -176.43 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.77 132.49 56.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.323 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 67.04 14.77 9.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.366 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 63.3 49.89 67.02 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.075 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 ttp -103.47 120.21 40.4 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.515 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 129' ' ' VAL . 24.1 t -142.31 24.02 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.663 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 60.84 24.9 14.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.495 0.188 . . . . 0.0 111.405 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.448 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.1 t80 46.14 42.21 9.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.775 0.322 . . . . 0.0 111.377 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -115.49 -51.37 2.69 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.518 ' CB ' HG11 ' A' ' 129' ' ' VAL . 29.4 t70 -57.39 -38.24 73.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.79 -56.68 7.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.766 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 139' ' ' LEU . 20.0 t -62.65 -34.66 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.308 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -64.26 -53.9 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ttp -62.65 -34.47 77.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.063 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 139' ' ' LEU . 3.3 mt -69.7 -39.25 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.005 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 138' ' ' ILE . 2.5 mp -93.03 50.94 1.6 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 110.675 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -153.81 32.9 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.3 p30 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.193 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.776 0.322 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m -114.68 19.06 16.29 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.792 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.17 -36.91 17.76 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.487 -0.133 . . . . 0.0 111.173 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 8.8 m-20 59.33 84.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.916 0.388 . . . . 0.0 111.033 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.457 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 4.0 t -67.03 -48.35 50.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.294 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 83.9 Cg_endo -83.46 -3.42 10.75 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.525 2.15 . . . . 0.0 114.294 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 77.6 m-85 -118.26 -66.69 1.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 4.9 ttmm -72.72 -57.8 3.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.424 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.535 ' OE1' HD21 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -57.75 -49.19 77.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.688 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.49 -40.31 90.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.5 t80 -56.5 -42.97 79.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.479 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.85 -36.11 82.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.045 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.535 HD21 ' OE1' ' A' ' 10' ' ' GLN . 9.6 mt -60.71 -33.14 72.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.302 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 32.58 2.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -93.19 91.55 7.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -63.38 -33.15 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.459 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -86.52 -35.58 19.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.133 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.29 32.32 52.24 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.774 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -118.73 -19.02 8.82 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.66 -8.04 5.54 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.086 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.656 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -121.57 162.86 19.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.065 0.432 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.785 HD12 HD13 ' A' ' 28' ' ' ILE . 5.8 pt -135.79 134.92 20.99 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.755 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.87 169.42 9.08 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.08 2.52 . . . . 0.0 112.612 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 44' ' ' ILE . 16.0 pttm -43.85 -38.52 3.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.9 p -60.13 -44.31 95.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.498 0.189 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.432 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 49.3 m -70.43 -46.74 63.32 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.875 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.785 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.79 -35.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.04 3.13 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.286 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 121.961 0.105 . . . . 0.0 111.108 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.32 -46.01 88.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.49 -31.61 70.64 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -51.42 -38.67 54.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -53.36 -44.55 68.64 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.65 -47.05 82.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.681 0.277 . . . . 0.0 110.774 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.85 -66.11 0.03 OUTLIER Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.094 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.99 173.36 11.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.862 0.363 . . . . 0.0 111.282 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -125.81 133.83 25.29 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.591 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -81.5 -163.17 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.849 2.366 . . . . 0.0 112.764 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 p -103.08 164.46 11.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.9 mm? -52.07 -37.71 54.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.46 86.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -53.93 29.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.811 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.03 -46.56 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -56.9 -39.97 75.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -40.85 83.99 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 44' ' ' ILE . 21.6 mt -59.89 -52.08 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -56.74 -25.02 53.84 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.699 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -10.42 22.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 p -118.1 -50.37 2.47 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.59 0.177 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.3 156.85 56.79 Favored Pre-proline 0 N--CA 1.464 0.263 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.536 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 78.2 Cg_exo -39.78 145.01 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.216 2.611 . . . . 0.0 113.199 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.18 -61.27 0.16 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.658 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -89.79 125.31 35.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.671 179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.0 t -87.19 90.14 3.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.5 p30 -86.59 -179.73 6.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.601 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.16 -46.5 3.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.817 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -67.77 -52.16 40.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.058 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.536 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.82 -50.75 72.23 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -48.91 79.68 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.912 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.59 -34.36 75.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.338 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -60.06 -48.05 83.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.308 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.465 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.72 -42.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.386 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -54.59 45.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.407 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -84.62 62.55 7.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -57.7 -52.12 76.69 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.409 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 79.9 Cg_endo -84.89 19.1 1.45 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.638 2.225 . . . . 0.0 113.614 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 57.82 94.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.775 0.321 . . . . 0.0 111.795 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.96 17.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.112 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -100.54 -56.91 2.23 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -86.63 74.88 9.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.658 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 9.0 tpt -170.51 -56.17 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.398 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.658 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 84.2 Cg_exo -43.19 -49.33 7.32 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.553 2.169 . . . . 0.0 112.743 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.33 47.67 0.03 OUTLIER Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.186 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.501 ' HB3' ' CB ' ' A' ' 78' ' ' GLU . 40.2 m-20 -81.8 111.36 25.69 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.748 0.274 . . . . 0.0 110.832 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.46 ' O ' HG23 ' A' ' 80' ' ' VAL . 5.9 Cg_exo -77.74 -58.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.865 2.377 . . . . 0.0 112.472 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.74 -30.19 65.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.501 ' CB ' ' HB3' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -69.76 -48.08 60.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.359 0.123 . . . . 0.0 111.114 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -63.5 -39.62 94.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.984 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 76' ' ' PRO . 53.2 t -63.14 -49.03 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.139 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -26.51 68.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.684 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.82 -53.67 14.78 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.27 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.92 -47.18 47.94 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.31 71.4 5.85 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 86' ' ' PHE . 11.8 p -133.29 -45.76 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.462 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.418 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 4.4 m-85 -144.74 58.07 1.3 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 111.036 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -116.42 66.89 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.543 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.27 -36.18 79.34 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.84 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.79 -70.13 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.36 154.73 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.997 0.427 . . . . 0.0 112.018 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.5 m 59.8 80.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.261 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.84 -0.25 11.97 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.437 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -163.97 138.97 6.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 117.184 0.492 . . . . 0.0 110.629 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.541 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.36 -39.86 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.442 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.44 81.41 0.15 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.323 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.767 HG21 HD21 ' A' ' 118' ' ' LEU . 79.5 t -43.73 -36.49 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.97 -38.65 17.54 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.602 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -77.45 -46.47 22.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.24 0.216 . . . . 0.0 110.968 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -60.81 -42.16 97.08 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.464 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 104' ' ' THR . 0.2 OUTLIER -72.18 -36.39 69.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.093 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -59.31 -37.53 77.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.595 0.236 . . . . 0.0 111.078 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.684 HG11 ' HA2' ' A' ' 82' ' ' GLY . 29.6 t -77.56 -42.07 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.302 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.5 mt -72.42 -33.39 67.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 100' ' ' ARG . 15.1 p -59.47 -35.02 73.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.6 p -70.45 -18.04 63.0 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.14 -62.32 1.49 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.756 0.313 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.84 49.51 0.18 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.169 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.49 49.85 3.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 110.624 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 8.8 mmtp -68.55 -137.89 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.759 HD22 ' HG2' ' A' ' 114' ' ' GLU . 12.2 mt -69.96 77.5 0.48 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.888 0.375 . . . . 0.0 110.549 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.5 p -74.93 -165.66 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.873 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 115' ' ' MET . 15.1 m120 -51.4 -40.06 58.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.21 -52.93 61.8 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.52 0.2 . . . . 0.0 111.523 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.759 ' HG2' HD22 ' A' ' 110' ' ' LEU . 1.6 tp10 -57.23 -51.35 69.71 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.902 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.2 ptt? -67.14 -26.88 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.442 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -48.12 82.15 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.58 -43.56 84.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.902 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.56 -40.99 93.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.556 HD21 ' N ' ' A' ' 127' ' ' GLY . 2.4 mt -71.27 -30.13 65.92 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.155 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.41 -40.44 97.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.575 0.226 . . . . 0.0 110.72 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.27 -46.44 26.89 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.847 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.614 HG11 ' CG2' ' A' ' 129' ' ' VAL . 16.9 t -86.15 121.68 72.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.805 0.302 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 62.98 7.29 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.689 2.26 . . . . 0.0 112.546 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 122' ' ' VAL . 30.4 m -131.42 -177.35 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -119.21 126.22 51.01 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.45 -2.96 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.087 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 82.77 49.57 5.04 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.768 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.6 OUTLIER -103.99 113.64 27.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.233 0.54 . . . . 0.0 110.674 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 129' ' ' VAL . 35.8 t -142.91 30.35 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.063 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.53 23.16 11.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.781 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.443 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.4 t80 47.62 48.18 17.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.9 0.381 . . . . 0.0 111.438 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -121.93 -54.69 1.92 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.309 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.646 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -59.04 -36.46 75.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -67.9 -54.95 14.85 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.426 ' HA ' ' HB ' ' A' ' 138' ' ' ILE . 17.9 t -62.08 -33.39 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -58.86 -53.07 62.56 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.719 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttp -71.57 -30.27 65.67 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 135' ' ' VAL . 1.9 mm -59.58 -45.12 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.397 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.17 -79.23 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.63 100.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 111.106 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.935 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.739 0.304 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m 62.06 30.33 17.86 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.474 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 59.71 37.33 22.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.268 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 65.4 m-20 -119.87 77.16 1.21 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.343 0.592 . . . . 0.0 110.638 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -67.36 -47.47 48.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.096 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 97.5 Cg_endo -87.21 7.96 4.55 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.63 2.22 . . . . 0.0 114.37 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 70.6 m-85 -129.2 -67.96 0.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.679 0.218 . . . . 0.0 111.584 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -58.43 3.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.974 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -60.6 -48.49 81.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.658 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.513 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -42.98 87.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CE2' HG12 ' A' ' 23' ' ' ILE . 30.5 t80 -54.83 -44.13 73.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.454 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -62.59 -35.22 78.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.525 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -63.0 -34.26 77.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 4.6 m-85 -93.93 34.31 1.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.633 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.26 117.13 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.861 0.363 . . . . 0.0 111.219 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -71.34 -50.08 36.01 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.609 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -103.44 -38.72 7.06 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.309 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.67 37.15 4.05 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.466 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -116.81 -8.64 11.34 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.77 7.96 14.65 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -130.56 164.1 25.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.173 0.486 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 HD13 ' A' ' 28' ' ' ILE . 6.4 pt -146.48 137.25 12.52 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.693 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -85.62 171.49 8.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.129 2.552 . . . . 0.0 112.4 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -44.26 -39.31 4.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 p -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.451 0.167 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.9 m -69.87 -46.46 65.47 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.697 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.681 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.15 -33.68 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.32 -73.0 0.45 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.838 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -64.75 -21.32 66.73 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -65.78 -49.4 68.47 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.4 mt -61.71 -26.88 68.32 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.225 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -36.79 70.05 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.795 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.797 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -109.21 31.06 6.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.57 -103.86 0.25 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.732 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.24 179.46 6.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -119.38 113.19 35.29 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.419 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.19 -162.76 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -98.53 163.93 12.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -56.4 -34.17 66.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.68 73.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.838 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.37 -58.66 4.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.608 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -53.62 -47.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 123.098 0.249 . . . . 0.0 111.134 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.6 m -61.84 -44.27 97.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.43 -41.3 80.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.522 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.916 HG23 HG11 ' A' ' 63' ' ' VAL . 12.9 mt -63.65 -48.04 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.936 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.36 -24.57 56.06 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.999 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 p -63.81 -10.27 19.24 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.2 p -117.72 -31.76 5.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -97.18 152.78 38.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 77.9 Cg_exo -38.71 146.53 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.348 2.699 . . . . 0.0 113.055 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.88 -54.91 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -97.53 129.57 44.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.718 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.15 86.08 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.044 0.45 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.3 p30 -83.08 -179.86 7.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.575 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.6 mtm -41.47 -47.55 3.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.847 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -51.68 55.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.995 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.604 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.7 mp0 -57.91 -51.62 68.86 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.099 0.25 . . . . 0.0 111.643 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.74 -49.9 75.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.098 -179.496 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.68 -35.28 77.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.539 0.209 . . . . 0.0 110.972 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.18 -53.98 52.12 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.916 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -67.37 -31.08 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.065 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -55.05 -35.92 65.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.034 179.392 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.0 52.69 2.47 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.472 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.81 -49.94 87.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.762 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 86.1 Cg_endo -82.88 21.46 1.01 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.438 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.7 t30 58.31 76.45 0.34 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.438 . . . . 0.0 110.994 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.82 19.86 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.669 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -99.93 -36.84 9.26 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.293 0.109 . . . . 0.0 111.293 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.71 84.09 3.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.851 0.357 . . . . 0.0 110.25 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.504 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 7.0 tpt 178.01 -51.19 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.726 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 74.1 Cg_exo -41.35 -43.58 5.65 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.039 2.493 . . . . 0.0 113.642 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.21 52.02 0.06 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.071 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.3 m-20 -82.25 169.62 17.68 Favored Pre-proline 0 C--O 1.233 0.216 0 C-N-CA 122.657 0.383 . . . . 0.0 111.425 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.509 ' O ' HG23 ' A' ' 80' ' ' VAL . 45.3 Cg_exo -56.02 -38.61 94.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.565 2.176 . . . . 0.0 111.891 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.3 -31.29 72.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.088 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.91 -46.77 77.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 76' ' ' PRO . 67.7 t -62.97 -40.07 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.799 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -44.72 94.92 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.062 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.634 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -62.13 -45.54 95.85 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.149 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.76 -25.69 65.74 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.14 74.5 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 82' ' ' GLY . 33.6 t -127.52 -60.76 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.194 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -105.49 48.99 0.82 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -115.72 64.63 0.69 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -67.58 -47.47 69.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.81 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.31 -50.19 2.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.33 68.66 0.82 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.44 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 m -128.04 62.99 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.747 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.26 46.98 1.77 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.0 ptm -173.09 144.5 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.766 0.283 . . . . 0.0 111.527 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -118.82 -42.92 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.22 81.32 0.34 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.285 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.813 ' HA ' HD23 ' A' ' 99' ' ' LEU . 46.6 t -44.31 -40.99 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.19 -38.34 18.62 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.617 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.7 mm-40 -81.44 -41.94 21.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.489 0.185 . . . . 0.0 110.513 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.729 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -35.47 65.05 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.662 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.73 -34.33 69.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.634 HG11 ' CA ' ' A' ' 82' ' ' GLY . 40.1 t -82.72 -47.49 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.747 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -70.66 -38.91 73.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.1 m -61.06 -31.15 70.8 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -70.18 -17.13 63.15 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.92 -66.02 0.8 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.51 0.195 . . . . 0.0 111.086 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.65 52.14 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.803 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 57.85 53.56 6.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.747 ' HG2' HD22 ' A' ' 103' ' ' LEU . 2.6 tptp -67.64 -137.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.079 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.94 77.39 0.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.994 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 96.0 p -67.15 -173.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.43 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 24.4 t-20 -48.84 -42.47 36.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.039 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.18 -52.28 65.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.98 -51.59 69.03 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.893 ' HA ' HD23 ' A' ' 118' ' ' LEU . 3.4 ptm -66.88 -27.58 67.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.311 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -49.18 78.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.62 0.248 . . . . 0.0 110.454 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.26 -42.25 88.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.893 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.92 -41.93 99.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -67.18 -35.48 79.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.216 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -38.29 90.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.4 -39.1 36.72 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.046 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 124' ' ' VAL . 48.5 t -85.48 133.12 42.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.854 0.327 . . . . 0.0 111.122 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.08 58.08 6.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.789 2.326 . . . . 0.0 112.826 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 128' ' ' MET . 15.2 m -131.66 176.36 9.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 19.23 11.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.788 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -168.21 25.92 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.687 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 56.83 45.97 90.76 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.961 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.606 ' O ' HG11 ' A' ' 124' ' ' VAL . 1.3 ttt -103.5 115.64 30.89 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.197 0.522 . . . . 0.0 110.751 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.641 ' O ' HG12 ' A' ' 129' ' ' VAL . 39.5 t -141.16 22.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.082 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 58.55 24.11 11.59 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.505 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER 56.18 -166.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t60 72.29 -58.89 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.109 0.164 . . . . 0.0 111.084 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -52.89 -39.99 63.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.537 0.208 . . . . 0.0 111.421 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 21.8 m-85 -67.96 -52.39 36.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.377 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG12 HD12 ' A' ' 139' ' ' LEU . 17.7 t -62.43 -31.65 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.64 -53.37 58.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.53 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.8 ttt -69.11 -26.95 65.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.86 -49.47 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.527 HD12 HG12 ' A' ' 135' ' ' VAL . 0.9 OUTLIER -85.21 -74.89 0.38 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.2 108.18 0.05 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.095 -179.34 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.817 0.342 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m 57.56 41.26 26.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -112.17 -46.65 3.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.208 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.02 101.44 1.4 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.445 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 4.7 t -66.95 -45.63 53.56 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 6' ' ' SER . 2.8 Cg_exo -75.62 -13.39 20.18 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.774 2.316 . . . . 0.0 113.852 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -118.87 -61.68 1.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.58 -59.89 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.247 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.415 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 28.6 tp60 -60.54 -48.21 82.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.45 -38.16 73.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.355 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 14.7 t80 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -62.22 -30.69 71.27 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.733 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -62.83 -39.63 94.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.59 ' O ' HG22 ' A' ' 23' ' ' ILE . 52.6 m-85 -95.69 33.39 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 103.28 15.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -71.2 -35.23 71.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -86.51 -38.67 17.01 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.04 -8.3 63.01 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.252 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -86.76 -32.12 20.56 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.991 0.396 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.9 40.68 0.18 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.414 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.85 157.77 41.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.315 0.246 . . . . 0.0 110.732 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.8 HD12 HD13 ' A' ' 28' ' ' ILE . 4.1 pt -150.51 129.41 6.22 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.09 172.53 8.52 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.058 2.505 . . . . 0.0 112.148 179.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.98 -37.96 4.39 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.8 p -60.91 -43.6 98.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.486 0.184 . . . . 0.0 111.067 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 38.6 m -70.07 -48.82 56.2 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.609 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.8 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.29 -33.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.47 -69.47 1.26 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.389 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -30.99 72.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.346 0.117 . . . . 0.0 111.275 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.32 -51.3 69.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.717 0.294 . . . . 0.0 110.325 179.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.68 -32.29 72.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.17 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -35.98 63.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.128 179.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.36 75.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.631 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.2 t -66.83 -44.33 81.4 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.683 0.277 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.99 -69.46 0.03 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.5 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 166.13 22.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.982 0.42 . . . . 0.0 111.509 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.95 121.92 23.1 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.432 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.94 -161.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.726 2.284 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -90.34 166.17 13.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.235 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -56.68 -29.3 62.2 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.223 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.69 93.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.711 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -53.53 51.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.994 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.635 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.96 -44.82 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -61.4 -39.98 92.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.194 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -57.79 -38.92 76.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 178.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 44' ' ' ILE . 21.0 mt -63.73 -46.75 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.994 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.01 -27.2 61.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.464 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -5.54 6.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 p -118.6 -33.96 4.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.899 0.318 . . . . 0.0 111.436 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.763 HD11 HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -105.03 161.5 22.56 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.487 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD2' ' HG2' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -46.11 162.05 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.131 2.554 . . . . 0.0 113.083 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.35 -67.62 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -83.23 119.75 24.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.614 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.89 96.12 4.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.101 0.476 . . . . 0.0 110.945 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.4 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 22.9 p30 -82.57 174.35 11.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.677 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.4 mtt -42.52 -43.6 3.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.672 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.48 -50.92 56.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.824 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 31.9 mt-30 -57.14 -51.27 69.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.84 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -49.25 77.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.762 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 mt -61.43 -31.44 71.38 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -63.64 -55.05 26.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.495 0.188 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.763 HG21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.69 -42.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -50.07 67.37 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.115 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.47 50.74 1.25 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -60.53 -58.01 22.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.525 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.587 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.7 Cg_endo -86.07 19.45 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.635 2.223 . . . . 0.0 113.637 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.03 87.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.903 0.383 . . . . 0.0 111.529 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.06 -178.33 43.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.817 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -101.3 -60.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.516 0.198 . . . . 0.0 110.773 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -104.09 18.29 22.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.253 179.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 9.2 tpt -87.92 -45.6 0.48 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.57 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 58.1 Cg_exo -52.07 -41.94 61.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.819 2.346 . . . . 0.0 113.083 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.17 111.8 3.35 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.589 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.97 53.57 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 120.509 0.195 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' O ' HG23 ' A' ' 80' ' ' VAL . 50.5 Cg_exo -55.27 -37.26 94.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.584 2.19 . . . . 0.0 112.305 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.3 -27.8 64.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.09 -48.85 55.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.452 0.168 . . . . 0.0 111.288 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -39.73 94.25 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.059 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 76' ' ' PRO . 59.3 t -64.68 -46.36 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.35 -40.03 95.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.779 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -60.67 -45.48 96.3 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.474 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 23.0 m-85 -76.86 -27.48 55.09 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.68 -16.57 63.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -45.29 -56.12 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.3 19.32 4.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.597 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -142.17 68.72 1.32 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.262 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.27 -54.39 29.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.27 -63.62 1.32 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.27 82.92 0.06 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.784 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.99 -53.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.15 42.12 1.45 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.001 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.47 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -170.71 137.26 1.29 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.749 0.275 . . . . 0.0 111.346 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.558 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -112.21 -43.43 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.451 179.532 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.6 79.58 0.17 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.199 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.999 HG11 HD21 ' A' ' 118' ' ' LEU . 91.1 t -45.07 -35.64 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.34 -43.88 20.25 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.741 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.4 mp0 -74.01 -50.18 21.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.279 0.232 . . . . 0.0 110.802 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.13 -36.33 75.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.12 -50.46 68.18 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.603 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -53.05 -42.05 65.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.122 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 82' ' ' GLY . 47.2 t -63.06 -52.16 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 99' ' ' LEU . 4.6 mt -66.12 -40.73 90.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.7 m -58.05 -33.29 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.337 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.1 m -74.47 -17.84 60.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.42 -60.95 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.529 0.204 . . . . 0.0 111.119 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.55 52.73 0.22 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.93 48.69 8.55 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.99 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 5.3 mmtp -68.64 -138.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 114' ' ' GLU . 11.1 mt -68.07 78.56 0.23 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.287 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.3 p -69.29 -171.11 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.013 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 115' ' ' MET . 18.4 t-20 -48.52 -37.41 17.54 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.265 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -67.23 -55.01 15.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.548 0.213 . . . . 0.0 111.478 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG2' HD23 ' A' ' 110' ' ' LEU . 1.3 mp0 -57.12 -49.11 76.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.768 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -67.08 -27.88 67.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.095 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -47.03 85.96 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.33 -44.47 83.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.462 179.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.999 HD21 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.39 -41.7 90.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.265 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 124' ' ' VAL . 2.2 mt -71.55 -29.83 65.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -41.24 97.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.527 0.203 . . . . 0.0 110.598 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.16 -44.35 44.61 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.089 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 124' ' ' VAL . 44.2 t -82.64 131.65 54.32 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.764 0.282 . . . . 0.0 111.174 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.65 61.38 7.48 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.756 2.304 . . . . 0.0 112.666 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.452 HG23 HD23 ' A' ' 119' ' ' LEU . 12.7 m -131.8 177.37 7.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.449 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -126.94 47.3 2.35 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.181 0.515 . . . . 0.0 110.745 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' C ' HD21 ' A' ' 119' ' ' LEU . 5.2 p-10 173.64 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 111.37 51.46 0.58 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.47 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.27 116.96 33.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 0.0 110.671 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.642 ' O ' HG12 ' A' ' 129' ' ' VAL . 25.0 t -142.2 19.64 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.74 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.32 23.42 10.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.544 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 48.11 47.23 19.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 111.599 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 -51.61 2.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.633 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.7 t70 -60.09 -35.21 74.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.784 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 5.7 m-85 -66.04 -58.26 5.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.703 0.287 . . . . 0.0 110.35 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.75 -32.59 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.417 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -60.1 -50.53 73.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.491 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.9 ttt -66.9 -31.88 72.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.1 mm -61.31 -39.79 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -84.03 58.69 4.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.87 79.93 0.08 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.907 -179.847 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t 44.33 45.54 7.36 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.748 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 -52.17 2.8 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 7.5 m-20 -110.51 99.04 8.1 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -66.99 -46.52 53.63 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.957 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 6' ' ' SER . 83.2 Cg_endo -82.97 -3.88 11.17 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.411 2.074 . . . . 0.0 114.045 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 46.4 m-85 -120.83 -62.51 1.44 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.7 -59.44 2.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.072 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -60.59 -47.24 87.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.19 -40.66 82.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.493 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.4 t80 -57.08 -44.37 83.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.604 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -62.06 -33.84 75.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.248 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.84 -30.99 70.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.369 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.32 20.37 4.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -101.73 120.31 40.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.188 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -55.74 31.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.498 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -101.94 -24.46 14.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.801 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . 93.82 44.33 3.65 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.451 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -89.46 -26.03 21.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.041 0.136 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.08 10.17 14.43 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.106 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 2.1 mtt180 -130.24 160.91 32.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.055 0.427 . . . . 0.0 110.551 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.743 HD12 HD13 ' A' ' 28' ' ' ILE . 5.7 pt -146.33 138.51 13.63 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -87.02 171.55 6.7 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.234 2.623 . . . . 0.0 112.482 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.506 ' O ' HG21 ' A' ' 44' ' ' ILE . 10.5 ptpt -42.5 -40.97 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 p -59.9 -44.62 94.15 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 12.5 m -69.1 -48.0 63.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.586 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.743 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -57.04 -34.24 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.09 -68.72 1.51 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.281 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -30.62 71.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.98 -50.88 71.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 110.423 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.47 -30.19 70.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.039 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -57.02 -37.81 72.25 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.842 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.51 -29.12 70.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.8 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -88.28 -42.68 12.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.604 0.24 . . . . 0.0 110.55 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.9 -87.38 0.09 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.512 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -132.61 175.74 9.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 2.5 t-20 -119.37 112.36 35.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.122 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.68 -162.84 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.915 2.41 . . . . 0.0 112.856 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 p -95.59 166.52 11.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.82 -37.17 65.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.34 73.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.813 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -55.97 13.1 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.681 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.01 -48.57 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.584 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.6 m -56.98 -39.74 75.19 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.66 -41.94 87.28 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.357 179.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 44' ' ' ILE . 19.5 mt -62.54 -49.4 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.74 -25.84 55.81 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.384 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -64.8 -8.21 14.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 p -117.83 -49.02 2.54 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.656 0.207 . . . . 0.0 110.968 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.61 158.2 54.41 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.796 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.3 Cg_exo -40.93 149.75 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.188 2.592 . . . . 0.0 113.072 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.05 -63.68 0.18 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -89.68 127.68 35.97 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.791 0.329 . . . . 0.0 110.66 179.716 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.82 89.59 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.284 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.07 179.65 7.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.7 mtp -41.41 -46.27 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.39 -52.37 40.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.96 -50.95 71.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.729 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.23 -48.9 79.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.06 -179.749 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.82 -39.37 88.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.448 0.166 . . . . 0.0 111.396 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -55.43 -49.2 73.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.483 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.659 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -76.4 -35.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 179.92 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.427 HD13 ' CE1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -60.66 -38.36 84.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.42 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.5 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 4.1 m-80 -98.75 43.05 1.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.922 0.391 . . . . 0.0 110.234 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . 2.2 mtp85 -62.39 -65.79 1.93 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.537 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.0 Cg_endo -86.58 18.18 1.62 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.44 2.093 . . . . 0.0 114.975 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 9.7 t-20 156.02 -71.95 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.733 0.413 . . . . 0.0 110.527 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.5 ' HA2' ' CB ' ' A' ' 65' ' ' ASN . . . -177.37 -86.28 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.715 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -115.27 -46.92 2.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.107 0.163 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.23 68.57 9.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.118 0.485 . . . . 0.0 110.87 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.481 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -179.52 -55.47 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.267 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.537 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 85.9 Cg_exo -45.96 -46.49 15.79 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.4 61.29 0.1 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.446 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.84 144.69 56.07 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.345 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 80' ' ' VAL . 25.1 Cg_exo -62.74 -48.7 6.54 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.928 2.419 . . . . 0.0 112.274 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -30.35 71.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -43.67 81.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.42 87.33 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 76' ' ' PRO . 89.6 t -61.38 -47.84 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -31.12 70.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.597 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.721 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -61.81 -47.84 87.72 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.553 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -74.91 -32.78 61.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 0.127 . . . . 0.0 111.052 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.88 73.19 5.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.07 -65.19 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.13 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.508 ' HB2' ' CB ' ' A' ' 98' ' ' GLU . 1.4 m-85 -109.55 34.41 3.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.346 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 49.74 2.29 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -69.89 -54.81 11.72 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.206 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.88 -47.6 11.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.75 66.65 0.97 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -102.04 67.04 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.27 56.05 11.3 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.529 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -174.93 138.65 0.47 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.714 0.293 . . . . 0.0 111.192 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -107.23 -41.65 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.547 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.86 78.95 0.34 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.499 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.796 ' HA ' HD23 ' A' ' 99' ' ' LEU . 70.8 t -44.75 -35.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.53 -41.77 18.57 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.252 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -80.16 -36.71 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.661 0.23 . . . . 0.0 111.549 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -67.25 -40.83 86.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.485 0.183 . . . . 0.0 110.957 179.886 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -38.64 66.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.975 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -56.37 -45.85 80.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.67 0.271 . . . . 0.0 110.924 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.721 HG11 ' CA ' ' A' ' 82' ' ' GLY . 47.6 t -65.77 -46.71 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.222 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.715 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -67.1 -37.55 84.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.371 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 85.3 m -67.19 -42.96 83.3 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.485 0.183 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.1 p -68.0 -16.06 63.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.29 -65.29 0.7 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.709 0.29 . . . . 0.0 110.927 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.5 49.08 0.28 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.121 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 61.16 41.5 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 -179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.715 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -68.9 -137.92 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.987 178.977 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 42.1 mt -68.56 80.02 0.27 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.414 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 79.7 p -66.38 -170.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 115' ' ' MET . 4.6 p-10 -53.26 -33.7 54.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.226 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -48.9 79.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.542 0.21 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.5 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 17.9 mm-40 -59.14 -53.41 58.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.854 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.76 -26.44 66.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.258 179.365 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -47.11 86.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.239 179.125 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.0 -43.77 82.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.0 -42.18 89.47 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.695 179.432 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.636 HD21 ' H ' ' A' ' 127' ' ' GLY . 1.2 mt -67.89 -33.48 74.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -39.78 91.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.0 -48.28 21.04 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.004 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 129' ' ' VAL . 18.8 t -83.89 125.09 73.89 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.792 0.296 . . . . 0.0 111.286 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.56 63.23 7.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.694 2.262 . . . . 0.0 112.549 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.42 HG13 HG12 ' A' ' 122' ' ' VAL . 20.1 m -131.26 179.41 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -119.3 130.28 55.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 70.61 10.69 7.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.829 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.636 ' H ' HD21 ' A' ' 119' ' ' LEU . . . 69.62 44.47 63.5 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.702 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.87 114.39 28.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.372 0.606 . . . . 0.0 110.601 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 129' ' ' VAL . 22.1 t -142.58 26.14 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.083 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.25 21.09 5.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.0 t80 48.97 38.29 12.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -116.88 -38.86 3.35 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.607 ' HB3' HG11 ' A' ' 129' ' ' VAL . 33.0 t70 -66.63 -37.44 84.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.7 m-85 -67.94 -54.91 15.08 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.45 -31.7 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.95 -50.39 72.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 ttm -63.03 -32.24 73.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.37 -48.22 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.82 54.41 0.86 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.729 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.38 60.16 1.71 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.689 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.003 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.4 p -99.98 21.25 12.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.509 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.79 42.02 0.47 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.819 0.343 . . . . 0.0 111.011 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.4 113.05 4.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -64.72 -46.58 76.23 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.624 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.0 Cg_endo -82.17 -11.64 10.87 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.506 2.138 . . . . 0.0 114.072 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -114.5 -60.41 1.89 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.492 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.33 -48.49 81.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.596 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.14 -40.03 76.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.035 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.486 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.9 t80 -59.17 -44.51 92.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.315 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.4 m -62.5 -31.45 72.21 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.747 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 5.8 mt -65.91 -36.95 84.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -95.34 38.53 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.196 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -83.27 88.77 6.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.226 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -62.85 -37.71 87.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -86.54 -36.32 19.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.108 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.28 27.18 56.03 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.452 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.1 p -129.28 10.4 5.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.91 8.63 47.76 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.742 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -129.22 163.16 26.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.355 0.578 . . . . 0.0 110.958 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.819 HD12 HD13 ' A' ' 28' ' ' ILE . 6.3 pt -147.24 138.64 13.32 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.918 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.58 172.27 6.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.455 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.91 -37.63 6.57 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.8 p -60.14 -41.63 93.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.482 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 3.3 m -70.88 -54.73 10.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.372 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.819 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.04 -35.76 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.15 -74.44 0.29 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.535 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -28.56 69.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 23' ' ' ILE . 13.5 tp -61.45 -51.95 66.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 mt -60.92 -29.33 69.53 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.261 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.443 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -55.53 -39.9 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.052 0.22 . . . . 0.0 110.871 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.15 70.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.846 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -90.1 -43.06 10.73 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.681 0.277 . . . . 0.0 110.611 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.08 -88.19 0.1 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.505 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.95 172.79 12.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.962 0.41 . . . . 0.0 112.018 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 3.4 t30 -122.06 110.23 33.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.21 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -84.19 -162.88 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.905 2.403 . . . . 0.0 112.53 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -92.96 166.52 12.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -54.71 -33.53 61.13 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.797 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.51 86.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.828 179.028 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -55.55 16.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.96 -45.39 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.103 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 m -62.16 -41.1 97.97 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.61 -38.27 77.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.923 HG23 HG11 ' A' ' 63' ' ' VAL . 14.4 mt -64.9 -49.82 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.16 -25.33 46.15 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.882 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -64.21 -7.15 8.23 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.2 p -117.78 -46.59 2.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.775 0.261 . . . . 0.0 111.204 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -86.55 157.47 55.49 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.094 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -39.41 150.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.285 2.657 . . . . 0.0 113.39 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.6 -61.34 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.6 130.0 38.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.683 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.37 86.71 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.043 0.449 . . . . 0.0 111.061 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -82.95 -179.56 7.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.672 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 mtm -41.41 -46.79 3.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.944 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -68.66 -50.55 50.28 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.8 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.6 mp0 -58.0 -51.74 68.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.585 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.71 -48.35 82.01 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.78 -36.46 79.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.285 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -52.61 64.67 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.187 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.923 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.6 -38.71 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.314 179.847 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.585 HD13 ' HE1' ' A' ' 60' ' ' PHE . 1.2 tp -55.3 -51.98 64.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.025 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -84.46 61.68 6.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.313 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.591 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 50.4 ttp180 -58.05 -52.15 76.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.533 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 98.0 Cg_endo -80.53 18.66 1.2 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.495 2.13 . . . . 0.0 113.671 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 58.83 98.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.84 0.353 . . . . 0.0 111.787 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.45 176.97 14.63 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.145 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -100.63 -50.57 3.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.461 0.172 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -88.24 62.1 6.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.27 0.557 . . . . 0.0 110.362 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.429 ' H ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -156.76 -57.85 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.009 -179.678 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 53.4 Cg_exo -51.03 -44.23 43.41 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.78 80.88 0.04 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.493 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -80.18 122.83 83.34 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.424 0.154 . . . . 0.0 111.131 -179.802 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' HG23 ' A' ' 80' ' ' VAL . 38.4 Cg_exo -59.94 -41.67 51.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.719 2.279 . . . . 0.0 112.118 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -67.14 -27.64 67.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 8.0 tt0 -68.29 -50.85 50.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.638 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.45 95.77 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.597 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 76' ' ' PRO . 72.3 t -62.29 -39.13 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.706 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -39.05 93.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.513 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.758 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -62.81 -47.23 90.61 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.4 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -74.84 -36.79 62.38 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.964 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -78.86 72.3 5.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.036 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.62 -62.74 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -113.3 23.62 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.498 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.27 73.85 1.56 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.008 0.432 . . . . 0.0 110.863 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -69.34 -43.37 73.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -89.07 -63.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.58 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.421 0.45 . . . . 0.0 111.292 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m 69.28 -74.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.772 0.429 . . . . 0.0 111.349 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.03 61.3 0.42 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 ptp -176.23 131.3 0.23 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.583 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -103.84 145.57 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.583 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -109.61 82.79 0.31 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.825 ' HA ' HD23 ' A' ' 99' ' ' LEU . 59.3 t -37.48 -39.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.6 -42.74 27.88 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.623 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.0 pt-20 -81.24 -37.79 27.98 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.932 -0.157 . . . . 0.0 111.128 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.825 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.55 -39.9 89.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.549 0.214 . . . . 0.0 110.549 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -38.84 59.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.687 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.57 -36.2 71.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.623 0.249 . . . . 0.0 111.324 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 82' ' ' GLY . 26.3 t -82.7 -38.9 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.908 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 2.1 mt -79.71 -48.98 12.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.4 m -53.57 -38.57 64.04 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.9 p -60.5 -25.56 66.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.95 -83.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -133.13 46.14 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.715 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 62.46 50.85 3.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.377 . . . . 0.0 111.157 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 9.4 mmtp -67.92 -137.83 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.282 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.3 mt -68.32 76.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.4 p -68.29 -172.72 0.34 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.65 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -51.28 -42.95 61.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -64.34 -48.48 75.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.52 -53.31 59.64 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.622 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.857 ' HA ' HD23 ' A' ' 118' ' ' LEU . 3.3 ppp? -66.78 -27.67 67.78 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.302 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -46.07 87.19 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.628 0.252 . . . . 0.0 110.474 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.18 -41.83 76.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.635 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.857 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.09 -43.19 99.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.971 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.55 HD21 ' H ' ' A' ' 127' ' ' GLY . 3.2 mt -70.13 -32.9 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.274 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -39.94 95.77 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.015 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.11 -48.74 30.6 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.986 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 124' ' ' VAL . 14.0 t -82.45 125.29 76.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.679 0.24 . . . . 0.0 111.142 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.17 58.54 6.99 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.661 2.241 . . . . 0.0 112.401 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 122' ' ' VAL . 22.8 m -131.33 -178.67 2.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.138 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -119.18 135.86 54.47 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.499 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.49 14.66 9.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.811 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.55 ' H ' HD21 ' A' ' 119' ' ' LEU . . . 64.26 55.65 22.44 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.794 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttp -103.54 113.03 26.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.255 0.55 . . . . 0.0 111.099 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 129' ' ' VAL . 45.5 t -142.94 26.53 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t30 59.23 21.34 9.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.535 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 132' ' ' HIS . 0.5 OUTLIER 54.34 -166.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -178.667 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 131' ' ' TYR . 1.5 m80 71.34 -57.77 0.6 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.579 0.352 . . . . 0.0 111.24 -179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -52.56 -39.37 61.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.541 0.21 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 19.8 m-85 -68.26 -58.0 5.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.584 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.45 -32.21 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.29 -54.61 41.85 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.691 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 42.8 tpp -66.47 -30.49 70.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.4 mm -63.43 -49.98 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.916 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -104.68 64.47 0.74 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -148.65 42.27 0.97 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.16 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.6 p30 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.293 -179.921 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.4 m -74.54 -62.06 1.66 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.53 55.14 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.077 0.465 . . . . 0.0 110.754 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.98 86.01 7.07 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.765 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -66.68 -46.65 56.97 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.767 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 6' ' ' SER . 8.0 Cg_exo -73.41 -21.29 19.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.808 2.339 . . . . 0.0 113.822 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -107.74 -63.52 1.3 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -62.08 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.697 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 5.8 tt0 -56.67 -48.58 77.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.949 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.67 -40.43 87.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.569 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.1 t80 -60.12 -44.84 94.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.758 0.313 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -62.43 -31.29 71.97 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.748 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 20.1 mt -56.99 -40.35 76.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 31' ' ' LEU . 8.5 m-30 -97.73 32.28 2.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -61.63 130.0 43.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.957 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -56.61 8.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.778 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -136.3 26.02 3.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.412 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.94 27.61 72.96 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.728 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.6 p -95.86 -26.65 15.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.454 0.169 . . . . 0.0 111.258 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.34 18.63 8.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.883 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 36.9 mtt180 -129.69 160.51 33.15 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.878 0.339 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.86 HD12 HD13 ' A' ' 28' ' ' ILE . 4.1 pt -143.78 137.67 14.53 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.511 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.73 170.62 7.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.148 2.565 . . . . 0.0 113.027 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 18.7 pttp -43.78 -35.37 1.86 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -61.36 -46.11 91.57 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.466 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.2 t -70.41 -49.47 48.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.621 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.17 -34.94 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.496 -179.678 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.77 -67.7 2.06 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.331 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.22 -28.12 69.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 15' ' ' PHE . 10.4 tp -62.05 -48.6 79.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.9 -32.14 72.5 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.59 -40.29 71.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.816 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.48 70.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.472 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 m -107.14 40.03 1.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 110.498 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.31 -102.94 0.4 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.545 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 171.23 14.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 111.692 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -119.48 114.88 34.29 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.384 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.02 -162.08 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.896 2.397 . . . . 0.0 112.477 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.9 p -94.74 166.95 11.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.7 mm? -56.5 -34.49 67.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.41 75.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.644 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.26 -55.16 17.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.08 -49.3 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.828 179.635 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.0 m -55.65 -42.12 74.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.416 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -59.2 -42.86 91.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 44' ' ' ILE . 41.2 mt -61.64 -41.98 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -56.63 -36.07 69.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -65.85 -1.77 3.23 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 51' ' ' LEU . 5.6 m -118.07 -40.32 2.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.228 0.211 . . . . 0.0 110.937 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.637 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -102.89 156.41 35.34 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.332 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.6 Cg_exo -40.45 143.65 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.085 2.523 . . . . 0.0 113.083 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -22.85 -67.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.2 tt0 -91.66 129.35 37.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.609 0.242 . . . . 0.0 110.518 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -86.75 88.44 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.015 0.436 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.7 p30 -87.01 -179.85 6.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.306 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mtm -41.27 -46.98 3.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -53.41 41.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.18 -52.98 63.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -49.26 78.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.677 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.14 -27.92 69.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.387 0.136 . . . . 0.0 111.264 178.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -65.38 -43.19 91.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.965 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.637 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.12 -38.91 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.995 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -36.26 77.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.488 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -118.03 37.43 3.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.87 0.367 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.456 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -60.18 -52.59 72.2 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.618 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 81.4 Cg_endo -85.15 19.41 1.4 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.647 2.231 . . . . 0.0 113.483 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 t30 54.73 80.26 0.13 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.879 0.371 . . . . 0.0 111.589 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.38 -169.66 25.0 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.993 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -116.93 168.67 10.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.554 0.216 . . . . 0.0 110.724 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 57.24 66.61 1.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.522 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 5.1 ttm 172.13 -50.71 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.277 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 90.3 Cg_exo -42.75 -55.21 2.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 123.123 2.549 . . . . 0.0 113.283 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.0 52.25 0.49 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.636 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -81.1 146.36 58.58 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.467 -179.779 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 80' ' ' VAL . 34.9 Cg_exo -59.92 -44.75 28.21 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.783 2.322 . . . . 0.0 112.105 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HG3' ' HE2' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -66.55 -26.7 67.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 179.467 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -48.24 65.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -37.9 79.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.036 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 76' ' ' PRO . 75.9 t -63.31 -49.77 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.009 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.414 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -63.64 -31.46 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.854 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -65.14 -51.64 48.49 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.643 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -76.59 -36.26 57.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.403 0.144 . . . . 0.0 110.934 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -78.68 73.44 5.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.969 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.43 -61.23 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.29 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.55 43.64 1.6 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.525 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 3.8 m-20 -130.79 75.63 1.67 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -51.67 67.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.05 -49.9 3.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.265 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 58.13 53.97 6.24 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -74.79 -48.09 27.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.178 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.73 58.67 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.665 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 ptm -166.95 147.97 5.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER -125.92 143.35 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.508 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -107.08 81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.052 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.805 ' HA ' HD23 ' A' ' 99' ' ' LEU . 72.6 t -43.3 -38.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.25 -48.2 54.06 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.744 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.4 mm-40 -77.03 -40.68 45.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.253 0.221 . . . . 0.0 110.657 178.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -59.25 -40.59 86.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.552 179.517 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -66.51 -49.35 66.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.518 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -52.13 -37.97 55.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.712 HG11 ' CA ' ' A' ' 82' ' ' GLY . 41.5 t -74.04 -49.26 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.804 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.748 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.8 mt -69.13 -28.3 66.33 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.0 m -64.3 -38.4 90.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.312 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.4 p -70.82 -12.98 61.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.1 -66.14 0.68 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.567 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.14 49.05 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.333 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.31 50.52 6.11 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 111.453 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.748 ' HG2' HD22 ' A' ' 103' ' ' LEU . 26.5 tptt -68.53 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.428 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.502 HD23 ' HG2' ' A' ' 114' ' ' GLU . 6.9 mt -71.21 76.96 0.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -62.43 -176.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.106 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -52.32 -35.98 52.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.99 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -51.02 63.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.424 0.154 . . . . 0.0 111.297 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.502 ' HG2' HD23 ' A' ' 110' ' ' LEU . 2.1 tp10 -58.92 -50.01 75.64 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.906 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.873 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -66.6 -27.43 67.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.905 179.03 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -48.55 80.64 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.603 0.239 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.66 -42.05 87.23 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 179.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.1 -42.37 98.39 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.833 179.457 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.596 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.45 -33.07 70.88 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.03 179.616 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -39.99 92.17 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.45 -46.94 30.52 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.937 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.457 HG11 HG22 ' A' ' 129' ' ' VAL . 14.4 t -87.09 117.87 69.22 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.658 0.229 . . . . 0.0 111.036 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.7 64.66 5.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.463 2.109 . . . . 0.0 112.477 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.3 -178.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -118.92 135.65 54.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.638 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.64 17.62 11.0 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.623 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 61.49 64.05 4.33 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.988 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttt -111.38 116.78 31.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.241 0.543 . . . . 0.0 111.058 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.732 HG11 ' HB2' ' A' ' 133' ' ' ASP . 39.5 t -142.23 26.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.8 26.3 15.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.5 t80 46.69 45.45 14.53 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.768 0.318 . . . . 0.0 111.616 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -119.56 -56.03 2.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.352 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.732 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -60.51 -34.34 73.94 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.471 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 4.5 m-85 -67.69 -55.4 13.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.271 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.431 HG12 HD13 ' A' ' 139' ' ' LEU . 21.2 t -62.9 -33.95 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.55 -51.85 68.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.668 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.05 -33.77 76.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.4 mt -65.62 -30.13 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.248 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.431 HD13 HG12 ' A' ' 135' ' ' VAL . 1.1 mp -99.14 -3.21 35.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.19 89.49 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.035 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.644 0.259 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 t -127.03 32.9 5.01 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.322 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -124.6 -72.88 0.65 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.462 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 54.51 81.41 0.1 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 111.18 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -64.3 -47.87 77.2 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.081 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.41 -13.93 12.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.403 2.069 . . . . 0.0 114.114 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -106.65 -65.87 1.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.638 ' HE3' HD11 ' A' ' 61' ' ' LEU . 8.7 mmtp -73.12 -58.87 3.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.501 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 2.4 tt0 -56.8 -49.9 73.98 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.472 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.55 -41.46 85.62 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 23' ' ' ILE . 16.4 t80 -53.57 -45.21 69.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.39 -36.69 83.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.141 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.8 mt -62.86 -27.41 69.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.392 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 3.5 m-85 -94.23 18.93 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.86 99.26 11.66 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -61.1 -35.34 76.76 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.741 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.24 -29.13 23.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.27 42.86 41.03 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -117.87 -36.28 3.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.24 -11.12 2.78 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.587 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -118.1 147.73 43.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.272 0.536 . . . . 0.0 110.626 -179.831 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.912 HD12 HD13 ' A' ' 28' ' ' ILE . 4.2 pt -127.55 140.88 39.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.848 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.28 173.25 3.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.257 2.638 . . . . 0.0 112.432 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.76 -36.69 2.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 p -59.6 -46.06 90.06 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.495 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 2.5 t -71.33 -49.64 40.52 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.912 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.41 -36.18 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.17 -73.1 0.44 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.67 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -65.12 -21.35 66.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.3 tp -65.93 -48.38 71.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -61.18 -30.55 70.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.841 179.124 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.444 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.47 -40.73 72.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.679 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.87 75.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.49 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.8 m -112.63 43.55 1.63 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 110.669 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.83 -105.39 0.4 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.808 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.37 169.98 15.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.2 t30 -119.11 112.48 36.17 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.157 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.74 -162.62 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.036 2.49 . . . . 0.0 112.737 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 p -97.68 165.33 12.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.499 HD12 ' HE2' ' A' ' 25' ' ' LYS . 1.4 mm? -54.88 -36.62 65.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.21 78.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.539 0.209 . . . . 0.0 110.453 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -51.48 58.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -61.1 -46.18 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.82 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 29.6 m -54.88 -41.52 70.96 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.144 0.278 . . . . 0.0 110.633 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -60.2 -41.98 94.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.63 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.784 HG23 HG11 ' A' ' 63' ' ' VAL . 21.1 mt -61.67 -49.53 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -57.46 -26.4 61.17 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.859 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -63.78 -10.08 18.02 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 p -117.91 -35.56 3.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.722 0.237 . . . . 0.0 111.526 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.583 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -94.25 151.18 39.33 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.461 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.581 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 59.7 Cg_exo -36.97 141.89 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.337 2.691 . . . . 0.0 113.089 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -24.76 -61.31 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -93.63 129.52 39.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.51 86.94 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.03 -179.08 6.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.609 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.5 mtp -41.43 -47.16 3.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.988 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.05 -53.0 35.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.958 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.581 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.8 mp0 -57.49 -51.97 67.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.604 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.1 -45.91 91.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.638 HD11 ' HE3' ' A' ' 9' ' ' LYS . 13.9 mt -60.73 -39.24 87.87 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -52.14 65.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.802 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.784 HG11 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -73.65 -29.12 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.24 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.471 HD13 ' HE1' ' A' ' 60' ' ' PHE . 10.2 tp -60.46 -49.03 79.19 Favored 'General case' 0 C--O 1.227 -0.112 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.942 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.58 44.55 1.06 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -56.07 37.79 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.18 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 86.5 Cg_endo -83.73 18.73 1.47 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.624 2.216 . . . . 0.0 113.264 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.2 m120 59.07 98.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA2' HD11 ' A' ' 139' ' ' LEU . . . 114.7 176.34 18.82 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.427 179.191 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.06 174.15 6.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.187 0.195 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t70 50.9 62.26 2.8 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.389 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.553 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.57 -51.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.079 -179.114 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 37.4 Cg_exo -60.07 -44.39 29.81 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.659 2.239 . . . . 0.0 112.748 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -49.51 -78.49 0.09 OUTLIER Glycine 0 C--N 1.339 0.726 0 O-C-N 123.398 0.436 . . . . 0.0 112.962 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.581 ' HB3' ' CB ' ' A' ' 78' ' ' GLU . 19.6 m-20 -81.82 111.45 26.54 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 80' ' ' VAL . 3.9 Cg_exo -74.44 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.779 2.319 . . . . 0.0 112.786 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -71.94 -23.83 61.52 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' CB ' ' HB3' ' A' ' 75' ' ' ASP . 9.6 tt0 -69.22 -51.56 36.49 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.545 0.212 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -65.78 -39.36 90.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.042 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 76' ' ' PRO . 54.3 t -63.96 -45.61 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.4 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.96 94.34 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.881 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -64.11 -46.08 92.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.759 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -75.61 -36.09 60.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.381 0.134 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.81 72.5 5.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.1 t -140.62 -57.4 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.429 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.38 33.11 4.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.75 65.8 1.39 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -31.85 73.18 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.334 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 3.3 t70 -82.12 -62.04 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.377 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 72.96 -64.15 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.497 0.498 . . . . 0.0 111.799 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.1 p -66.67 95.19 0.33 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.8 -26.87 4.46 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.182 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.3 ptp -157.73 138.8 13.37 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.841 0.321 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -115.32 -40.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.027 -179.608 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 58.69 80.22 0.09 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.547 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.772 HG21 HD21 ' A' ' 118' ' ' LEU . 61.1 t -44.6 -34.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.93 -46.95 25.99 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.989 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.6 mt-10 -75.3 -47.66 26.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.555 0.217 . . . . 0.0 110.991 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -58.48 -38.38 77.48 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.249 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -67.06 -46.96 72.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -53.42 -40.9 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.868 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.881 HG11 ' HA2' ' A' ' 82' ' ' GLY . 4.0 t -77.21 -54.35 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.8 mt -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.6 m -60.5 -38.88 85.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.554 0.216 . . . . 0.0 111.036 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.4 m -71.18 -15.19 62.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.69 -59.5 2.76 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -158.36 43.56 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.463 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.87 52.37 10.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 111.29 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.739 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.41 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.05 179.134 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.44 77.63 0.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.986 0.357 . . . . 0.0 110.334 179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 p -65.79 -172.34 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.411 -178.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -50.75 -39.49 52.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.079 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.37 -49.76 70.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.492 0.187 . . . . 0.0 111.354 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.59 -52.84 63.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.605 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.931 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.9 ppp? -67.29 -26.24 66.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.405 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -49.31 77.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.352 179.274 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.79 -43.17 84.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.21 -40.17 92.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 179.684 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.69 -33.2 70.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.44 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.78 -38.46 91.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.749 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.87 -44.97 9.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.728 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 124' ' ' VAL . 48.2 t -79.42 130.46 68.43 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.516 0.198 . . . . 0.0 111.175 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.02 62.85 8.09 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 122' ' ' VAL . 13.4 m -131.36 176.69 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.229 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 46.78 2.27 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.899 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.94 -35.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.702 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.726 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 111.11 46.09 0.83 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.97 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.46 119.19 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.179 0.514 . . . . 0.0 111.179 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 129' ' ' VAL . 38.7 t -142.5 32.01 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.804 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.718 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 134' ' ' PHE . 2.7 t80 44.66 46.8 8.58 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.809 0.337 . . . . 0.0 111.532 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 -55.07 1.97 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.5 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 129' ' ' VAL . 8.6 t70 -60.09 -33.01 71.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.699 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 131' ' ' TYR . 6.5 m-85 -68.15 -56.31 9.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.43 -33.17 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.507 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.29 -51.25 69.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.299 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 32.5 ttp -74.86 -31.66 61.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.603 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 139' ' ' LEU . 1.1 mt -60.86 -39.94 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.614 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.592 HD11 ' HA2' ' A' ' 69' ' ' GLY . 3.3 mp -88.18 63.67 7.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -153.6 70.73 0.85 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.825 -179.834 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.747 0.308 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.38 -46.61 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.621 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 19.5 m-20 72.39 81.37 0.14 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.689 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.549 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -67.41 -48.94 44.55 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.611 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 72.9 Cg_endo -78.44 -12.63 15.38 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.509 2.139 . . . . 0.0 113.995 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 3.2 m-85 -108.97 -64.86 1.19 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -59.0 2.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.554 -179.233 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.549 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.1 -49.27 78.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.06 -40.86 82.05 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.807 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.0 t80 -53.51 -45.74 69.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.466 179.156 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 m -62.37 -36.48 82.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.9 mt -60.57 -31.65 70.77 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.393 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' O ' HG22 ' A' ' 23' ' ' ILE . 54.6 m-85 -93.77 26.45 3.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.589 0.233 . . . . 0.0 111.591 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -119.11 79.03 1.35 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.222 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -15.98 63.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.37 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -86.0 -24.68 26.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.45 67.02 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.664 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.6 p -105.65 -32.75 8.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.14 0.176 . . . . 0.0 111.397 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.63 23.8 5.53 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.944 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 2.3 mpt_? -130.56 159.63 36.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.741 0.27 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 HD13 ' A' ' 28' ' ' ILE . 3.7 pt -144.46 131.04 10.06 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.92 172.31 8.85 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.121 2.547 . . . . 0.0 112.137 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HB2' HG13 ' A' ' 44' ' ' ILE . 6.2 pttt -44.39 -37.65 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 p -62.43 -45.77 91.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.342 0.115 . . . . 0.0 111.225 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 6.3 m -66.91 -46.59 74.37 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.474 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.83 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -57.98 -35.62 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.052 179.502 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.65 -70.11 1.07 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.518 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -25.58 66.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.67 0.235 . . . . 0.0 111.455 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -61.31 -48.68 80.24 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.59 -35.55 78.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -32.2 68.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.329 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.89 -46.82 64.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -65.44 -33.64 76.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.257 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.97 -67.88 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.284 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.49 160.21 35.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.706 0.289 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -131.98 153.63 81.44 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.252 179.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.84 -162.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.989 2.459 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -98.59 168.15 10.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.222 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.6 mm? -55.66 -32.4 63.18 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.58 94.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.192 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -53.61 53.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.388 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.855 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.81 -47.67 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.562 179.473 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.6 m -57.98 -40.54 80.93 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.175 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -57.35 -39.41 75.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.217 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.855 HD12 ' HA ' ' A' ' 44' ' ' ILE . 15.9 mt -63.78 -46.73 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -56.69 -25.63 54.63 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.34 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -64.16 -6.93 7.49 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.492 ' C ' HD13 ' A' ' 51' ' ' LEU . 9.6 p -118.25 -45.45 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.781 0.264 . . . . 0.0 110.76 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.66 143.48 26.68 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -36.94 150.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.704 2.936 . . . . 0.0 113.534 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.89 -74.48 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -72.73 117.77 14.84 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.728 -179.093 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.98 93.11 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.57 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.2 p30 -81.93 177.92 8.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.685 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -41.79 -47.93 4.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.818 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -67.17 -48.24 68.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.645 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -56.99 -51.62 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.344 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -49.23 76.15 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.3 mt -61.12 -33.91 74.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -61.26 -52.68 63.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.462 HG11 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.37 -37.9 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.247 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -48.42 75.7 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -96.44 54.11 1.35 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -60.42 -52.46 72.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 78.3 Cg_endo -82.76 18.89 1.39 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.682 2.254 . . . . 0.0 113.537 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 m120 60.08 98.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.592 0.357 . . . . 0.0 111.867 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.16 174.69 19.61 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.174 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -100.41 173.6 6.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.529 0.204 . . . . 0.0 111.085 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 54.93 61.9 2.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.149 0.499 . . . . 0.0 110.539 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.653 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 3.0 ttp -178.48 -51.75 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.331 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 72.7 Cg_exo -48.88 -45.36 28.84 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.528 2.152 . . . . 0.0 112.757 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.17 78.17 0.04 OUTLIER Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 3.4 m-20 -81.06 132.64 56.14 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.44 0.162 . . . . 0.0 111.007 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.4 Cg_exo -58.74 -39.07 85.46 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.692 2.261 . . . . 0.0 112.13 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.13 -34.37 77.9 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.64 -47.47 78.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -41.27 92.24 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.708 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 76' ' ' PRO . 68.6 t -61.72 -44.44 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.048 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.28 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.263 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.754 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -62.1 -47.03 92.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.273 179.435 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 15.0 m-85 -68.3 -29.46 68.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.84 1.95 21.64 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -51.08 -38.93 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.542 0.21 . . . . 0.0 111.498 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.67 21.6 1.99 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.46 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 54.09 1.97 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.152 0.501 . . . . 0.0 110.58 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -63.46 -54.19 40.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.28 -62.37 1.64 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.39 71.32 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.436 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -81.14 -41.55 22.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.62 49.1 0.42 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.649 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.5 ptm -176.47 136.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.612 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -105.81 -43.45 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.295 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.71 79.58 0.35 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.522 179.691 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.785 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.7 t -44.88 -37.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -45.36 -45.06 11.08 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 121.437 -0.411 . . . . 0.0 113.391 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 102' ' ' VAL . 7.2 pt-20 -80.07 -39.22 30.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.843 0.322 . . . . 0.0 111.508 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.59 -40.29 96.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.612 0.244 . . . . 0.0 110.819 179.916 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 104' ' ' THR . 1.3 ppt_? -75.54 -35.75 60.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.06 -37.6 74.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.602 0.239 . . . . 0.0 111.329 179.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.754 HG11 ' CA ' ' A' ' 82' ' ' GLY . 18.8 t -77.44 -44.08 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.731 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.2 mt -68.28 -34.12 75.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.278 -179.285 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 100' ' ' ARG . 20.0 p -63.01 -31.91 73.15 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.464 0.173 . . . . 0.0 111.356 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 m -67.6 -18.34 64.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.8 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.09 -61.9 1.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.28 52.68 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.427 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.75 51.94 4.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.731 ' HG2' HD22 ' A' ' 103' ' ' LEU . 9.7 tptt -68.18 -138.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.547 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' A' ' 114' ' ' GLU . 12.4 mt -71.21 76.23 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.457 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 62.2 p -66.39 -174.44 0.28 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.194 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.73 -34.67 27.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.313 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -52.19 58.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.534 0.207 . . . . 0.0 111.246 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.568 ' HG2' HD22 ' A' ' 110' ' ' LEU . 2.3 tp10 -56.62 -52.37 65.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.696 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.85 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -66.85 -26.62 67.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.446 179.495 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -46.36 87.45 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.076 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -66.94 -44.79 79.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.385 179.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.72 -39.77 89.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 179.11 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.1 mt -68.14 -33.92 75.37 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -61.91 -38.46 88.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.45 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.16 31.05 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.881 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.506 HG11 ' CG2' ' A' ' 129' ' ' VAL . 5.7 t -87.79 119.71 70.65 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.724 0.262 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.89 64.56 4.04 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.678 2.252 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.48 -177.76 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.124 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -119.02 126.67 52.25 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.521 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 74.78 0.47 3.56 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.03 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.585 ' N ' HD21 ' A' ' 119' ' ' LEU . . . 80.33 49.92 5.65 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.268 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -103.36 116.38 32.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.491 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 129' ' ' VAL . 40.1 t -142.35 26.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.999 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 61.77 23.65 13.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.795 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.448 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER 49.71 45.44 24.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 111.467 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -120.05 -57.58 1.93 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.145 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.476 ' CB ' HG11 ' A' ' 129' ' ' VAL . 24.3 t70 -54.71 -36.08 64.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.72 -60.25 2.68 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.9 t -62.64 -32.48 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.417 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -58.14 -53.78 54.39 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.9 ttp -68.34 -29.28 67.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.626 HG22 HD12 ' A' ' 139' ' ' LEU . 4.5 mm -64.0 -43.31 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.531 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 138' ' ' ILE . 2.6 mp -95.94 48.16 1.11 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 111.012 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.34 66.38 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.644 179.761 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.88 -179.668 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.851 0.358 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -65.88 -46.16 64.99 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.245 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 6.2 Cg_exo -78.33 -17.13 13.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.787 2.325 . . . . 0.0 113.632 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -110.9 -60.01 1.89 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -60.18 2.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.566 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.0 -48.07 82.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.61 -38.15 77.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 15.4 t80 -57.75 -45.62 85.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -62.56 -33.55 75.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.9 mt -61.04 -36.59 79.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.302 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -92.85 24.5 3.6 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.99 94.78 8.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.801 0.334 . . . . 0.0 110.416 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -33.11 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -86.19 -31.0 22.0 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.467 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.45 26.53 59.11 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -115.93 21.82 13.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.625 0.213 . . . . 0.0 111.26 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.18 19.81 77.61 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.321 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' CD ' ' HB3' ' A' ' 54' ' ' GLU . 6.7 mtt85 -130.4 151.4 50.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.096 0.448 . . . . 0.0 110.631 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 HD13 ' A' ' 28' ' ' ILE . 6.5 pt -140.97 142.42 27.72 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.03 170.95 6.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.283 2.655 . . . . 0.0 112.487 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HB2' HG13 ' A' ' 44' ' ' ILE . 49.5 pttt -44.24 -39.16 4.25 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.8 p -60.41 -43.95 96.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.46 0.171 . . . . 0.0 111.396 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.5 m -70.34 -45.74 65.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.657 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.763 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.45 -33.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.178 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 -68.21 1.8 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.309 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -28.27 69.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.51 -48.11 83.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.52 -33.16 73.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -56.13 -38.98 71.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.087 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.0 70.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.678 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -116.88 46.33 1.68 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.781 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.1 -106.59 0.42 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.974 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.2 -179.46 5.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 111.919 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 28.9 t-20 -118.35 112.55 37.51 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.58 -162.97 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.953 2.435 . . . . 0.0 112.683 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -105.65 163.77 12.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.1 -35.96 62.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.6 82.6 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.815 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.98 -55.78 17.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.85 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.942 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.11 -46.56 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.901 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.7 m -57.53 -41.48 80.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -38.09 78.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.942 HD12 ' HA ' ' A' ' 44' ' ' ILE . 20.4 mt -62.92 -46.58 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -57.24 -28.43 62.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.353 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -13.39 45.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 p -118.13 -46.52 2.61 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.553 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.56 146.55 34.53 Favored Pre-proline 0 N--CA 1.463 0.225 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.2 Cg_exo -36.44 139.01 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.496 2.798 . . . . 0.0 113.039 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.84 -63.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.707 0.63 . . . . 0.0 112.477 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.89 120.66 25.95 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.709 0.29 . . . . 0.0 110.369 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.08 87.18 2.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.4 p30 -84.96 178.35 7.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.589 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -41.14 -44.5 2.55 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.78 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.1 -53.61 29.2 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.404 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -56.76 -52.57 64.48 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.186 0.304 . . . . 0.0 111.703 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.44 81.63 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 61' ' ' LEU . 25.1 mt -61.35 -33.26 73.33 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -51.95 67.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.55 0.214 . . . . 0.0 110.996 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG2' HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.59 -39.24 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.108 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 120.399 0.142 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.09 -43.93 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.342 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -40.14 94.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.669 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.74 ' HA3' HG11 ' A' ' 102' ' ' VAL . . . -63.6 -47.21 88.93 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.696 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.76 -30.15 66.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.454 0.168 . . . . 0.0 111.454 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.05 -14.96 62.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.1 t -47.86 -56.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.403 0.144 . . . . 0.0 111.305 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -113.49 39.84 2.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.027 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.51 62.24 1.46 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -63.74 -50.56 68.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.747 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.34 -54.76 2.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.85 81.17 0.15 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.958 0.409 . . . . 0.0 111.539 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -103.18 64.23 0.83 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.554 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.67 37.9 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.939 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 ptp -174.66 137.29 0.46 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.784 0.292 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.56 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -107.1 -39.96 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.427 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 79.24 0.61 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.83 ' HA ' HD23 ' A' ' 99' ' ' LEU . 54.6 t -45.22 -36.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.98 -42.73 16.1 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.288 -0.482 . . . . 0.0 113.305 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.94 -43.31 35.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.61 0.205 . . . . 0.0 111.135 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.83 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.06 -39.02 80.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.143 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.444 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 10.6 ptp180 -74.54 -37.09 63.12 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.854 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.71 -36.64 72.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.74 HG11 ' HA3' ' A' ' 82' ' ' GLY . 24.7 t -82.87 -52.56 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.715 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.856 HD22 ' HG3' ' A' ' 109' ' ' LYS . 6.0 mt -62.5 -50.1 72.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.5 m -60.73 -38.26 84.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.497 0.189 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.8 t -73.26 -19.05 61.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.73 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.72 -55.83 10.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.618 0.246 . . . . 0.0 111.028 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.19 45.81 0.29 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.371 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.99 48.02 13.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.856 ' HG3' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.49 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.768 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.401 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 18.4 mt -68.16 79.84 0.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 110.691 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.4 p -64.06 -175.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.126 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -47.7 -34.5 8.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.504 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.21 -60.02 4.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -41.11 95.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.199 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.802 ' HA ' HD23 ' A' ' 118' ' ' LEU . 5.5 mmt -66.79 -34.82 78.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.513 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -46.07 86.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.437 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -64.81 -37.94 89.3 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.802 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.5 -44.14 91.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.729 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.462 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.9 mt -65.03 -34.93 79.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -39.76 94.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.902 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.17 -49.52 26.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.752 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 18.7 t -79.85 127.58 76.99 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.612 0.206 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 4.6 Cg_exo -74.11 63.19 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.962 2.441 . . . . 0.0 112.33 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.36 175.9 10.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -121.4 19.1 11.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.739 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.37 26.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.49 ' HA3' ' CG2' ' A' ' 96' ' ' VAL . . . 54.97 50.99 56.74 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.666 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.7 112.8 25.91 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.275 0.559 . . . . 0.0 110.752 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 129' ' ' VAL . 43.2 t -142.35 20.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 59.74 21.88 10.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.843 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.418 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 48.38 41.52 16.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.764 0.316 . . . . 0.0 111.326 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -114.2 -54.46 2.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.401 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.506 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.9 t70 -57.14 -36.33 70.58 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.8 m-85 -68.05 -59.0 3.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.617 0.246 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.7 t -62.56 -33.05 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.463 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -61.63 -56.85 15.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.056 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.8 ttp . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.484 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.845 0.355 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.16 -46.14 95.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.536 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 89.4 Cg_endo -80.73 -16.0 10.53 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.503 2.135 . . . . 0.0 113.96 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -110.68 -60.83 1.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -61.43 1.8 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.341 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.475 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 6.0 tt0 -58.38 -46.85 85.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.839 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.56 -37.51 81.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.074 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 23' ' ' ILE . 20.5 t80 -56.29 -49.76 73.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -61.63 -33.76 74.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.333 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 8.4 mt -59.76 -33.92 72.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.43 0.157 . . . . 0.0 111.221 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 77.3 m-85 -93.28 32.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 121.63 30.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.759 0.314 . . . . 0.0 110.814 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -60.79 -52.22 66.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -107.11 -28.24 10.11 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.25 37.06 4.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.552 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.6 p -104.08 -20.76 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.17 3.61 8.06 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.444 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.619 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -122.59 162.46 21.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.253 0.527 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.789 HD12 HD13 ' A' ' 28' ' ' ILE . 5.1 pt -146.85 133.63 9.91 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.559 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.74 169.71 9.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.998 2.465 . . . . 0.0 112.345 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -43.89 -35.62 2.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.2 p -62.32 -45.04 95.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.493 0.187 . . . . 0.0 111.384 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.516 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 59.9 m -70.59 -44.82 66.53 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.823 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.789 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.83 -35.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.523 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.85 -66.92 2.43 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.67 -29.87 71.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.511 0.155 . . . . 0.0 111.002 179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 7.6 tp -61.11 -47.28 86.99 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.33 -32.72 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.049 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -40.48 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.027 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.18 -30.61 71.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.709 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.6 m -83.39 -44.36 14.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.591 0.234 . . . . 0.0 110.936 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.27 -81.55 0.04 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.707 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.2 -179.82 5.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -118.78 110.32 38.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.628 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.0 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.854 2.369 . . . . 0.0 112.361 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -104.53 166.59 10.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 25' ' ' LYS . 2.0 mm? -54.93 -35.55 64.3 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.88 76.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.761 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -56.43 9.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.706 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.15 -48.39 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.945 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.2 m -58.15 -41.29 83.45 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.04 -42.87 86.28 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.491 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.706 HD12 ' HA ' ' A' ' 44' ' ' ILE . 11.5 mt -63.04 -48.26 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.19 -25.12 58.49 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.844 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -63.86 -13.61 46.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -118.41 7.48 11.93 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.661 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -141.21 151.45 61.72 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 90.2 Cg_exo -38.3 143.76 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.275 2.65 . . . . 0.0 113.018 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.77 -58.62 0.13 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -92.27 125.43 36.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.592 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.1 t -86.79 83.51 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.619 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -81.72 177.29 8.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.562 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 60.9 mtm -40.68 -44.65 2.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.745 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.88 -51.57 46.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.918 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -58.09 -52.35 65.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -48.44 81.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt -61.54 -38.23 86.69 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.173 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.52 -54.39 41.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.661 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.66 -35.33 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.938 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.571 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.373 0.13 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.6 t -64.77 -40.01 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.943 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -48.49 80.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.86 95.91 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.66 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -70.2 -24.45 63.12 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.529 0.164 . . . . 0.0 111.407 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.17 -15.4 61.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.11 -59.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.187 0.195 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.551 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -110.33 44.02 1.3 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.981 0.42 . . . . 0.0 110.558 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.35 51.86 1.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -51.15 69.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -115.68 -59.31 2.01 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.08 90.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.561 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -105.69 56.71 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 110.79 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.51 49.42 1.84 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.927 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.15 135.87 0.48 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.68 0.276 . . . . 0.0 111.127 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -109.01 -42.75 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.336 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.12 81.58 0.33 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.949 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.734 ' HA ' HD23 ' A' ' 99' ' ' LEU . 86.6 t -43.55 -36.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.79 -37.98 15.44 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.594 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.551 ' HG3' ' CB ' ' A' ' 86' ' ' PHE . 2.6 tm-20 -73.2 -51.32 18.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.239 0.215 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.46 -37.18 74.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.489 ' HD3' HG21 ' A' ' 104' ' ' THR . 4.9 tmm_? -65.57 -47.89 74.24 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -53.96 -38.09 64.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.323 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' GLU . 21.4 t -70.73 -49.03 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.299 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.689 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.3 mt -65.02 -38.29 90.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.993 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 23.0 p -64.75 -35.44 81.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.523 0.202 . . . . 0.0 110.878 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -66.93 -19.75 65.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.651 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt -69.46 -61.19 1.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.584 0.23 . . . . 0.0 110.534 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.8 51.63 0.18 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.329 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 59.92 46.74 10.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.868 0.366 . . . . 0.0 110.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.689 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.74 -137.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.277 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.508 HD22 ' HG2' ' A' ' 114' ' ' GLU . 21.4 mt -69.16 79.24 0.35 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 92.6 p -64.36 -172.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.252 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -51.65 -31.17 24.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.265 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.81 -51.18 69.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.508 ' HG2' HD22 ' A' ' 110' ' ' LEU . 4.7 tp10 -58.76 -52.82 64.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.774 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.4 ppp? -66.16 -26.15 67.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -48.51 80.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.16 -45.14 89.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.405 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -58.91 -41.26 86.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.543 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.209 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -36.76 84.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.91 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.68 49.78 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.05 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 129' ' ' VAL . 21.5 t -87.3 128.45 55.19 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.803 0.302 . . . . 0.0 111.14 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.59 58.05 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.63 2.22 . . . . 0.0 112.595 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.39 -177.67 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.284 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 131.53 55.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.649 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.16 9.17 6.95 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.03 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.725 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 71.38 49.96 23.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.554 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -103.78 115.16 29.96 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.206 0.526 . . . . 0.0 110.725 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 129' ' ' VAL . 37.4 t -142.45 25.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.841 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 58.58 22.57 9.92 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.932 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 54.05 -158.7 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 68.78 -60.63 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.406 0.282 . . . . 0.0 111.569 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.01 -38.76 62.61 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.9 m-85 -68.36 -54.58 16.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.714 0.292 . . . . 0.0 110.695 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.5 t -62.15 -32.96 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.511 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.44 -52.19 54.91 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.686 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.9 ttp . . . . . 0 CA--C 1.533 0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.212 179.619 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.936 0.398 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.4 t -66.07 -46.92 63.46 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 6' ' ' SER . 84.6 Cg_endo -79.34 -14.04 13.35 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.516 2.144 . . . . 0.0 114.166 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.15 -61.59 1.7 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -72.29 -62.86 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -58.47 -47.73 83.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -45.26 87.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.936 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CE2' HG12 ' A' ' 23' ' ' ILE . 23.0 t80 -54.49 -45.99 73.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.74 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 m -59.27 -35.37 73.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.392 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 9.0 mt -60.53 -29.34 69.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.325 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 23' ' ' ILE . 49.1 m-85 -95.03 27.69 3.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.71 123.07 40.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 110.551 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -52.3 66.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.369 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -130.86 27.65 4.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.71 49.45 61.49 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.682 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -93.72 -29.01 15.62 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.1 -1.42 16.96 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.108 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.597 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -127.74 167.56 16.31 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.01 0.405 . . . . 0.0 110.607 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 28' ' ' ILE . 9.5 pt -144.23 134.31 11.87 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.56 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 23' ' ' ILE . 4.4 Cg_endo -86.32 171.75 7.46 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.39 2.727 . . . . 0.0 111.852 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.1 pttt -44.24 -36.6 2.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -61.01 -45.89 92.97 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.54 0.209 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.1 m -70.49 -46.6 63.41 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.933 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.645 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.39 -33.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.413 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.71 -68.89 1.41 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.444 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -26.69 68.87 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 111.407 0.151 . . . . 0.0 111.407 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.454 HD13 ' CE2' ' A' ' 15' ' ' PHE . 9.4 tp -64.07 -48.9 74.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.47 -30.61 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.62 -38.71 69.86 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.909 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.593 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.5 -42.31 25.52 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.748 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.3 -79.35 0.03 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.643 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.32 176.59 8.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.489 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -119.72 113.12 34.85 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.464 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.69 -162.63 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.755 2.304 . . . . 0.0 112.459 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -99.28 166.03 11.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.13 -33.64 63.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.887 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.2 79.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.34 -53.98 20.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.641 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.81 -46.88 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.003 0.189 . . . . 0.0 110.766 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 m -60.15 -39.74 87.45 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.34 -37.52 75.33 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.452 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 44' ' ' ILE . 39.0 mt -67.01 -45.63 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.896 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -56.66 -27.12 57.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.524 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -64.61 -7.72 11.56 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 p -117.7 -52.73 2.44 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 117.893 0.315 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.604 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -87.27 154.88 54.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.541 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -38.36 142.74 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.082 2.522 . . . . 0.0 113.07 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.51 -64.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.3 0.64 . . . . 0.0 112.599 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.1 123.18 31.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.494 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.42 86.33 2.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.597 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.7 p30 -85.08 179.66 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.357 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -41.55 -47.59 3.82 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.532 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.58 -52.54 60.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.541 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.79 -53.91 52.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.7 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -49.83 73.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.72 -28.98 69.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -63.77 -49.76 71.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.606 0.241 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.36 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.6 t -64.53 -53.76 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.552 0.215 . . . . 0.0 110.97 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -29.46 70.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.69 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.812 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -65.19 -49.04 63.77 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.555 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.09 -37.76 69.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.427 0.156 . . . . 0.0 110.969 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -78.91 73.16 5.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.9 t -135.1 -64.71 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.96 34.95 4.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.531 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -129.32 51.85 2.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.457 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 64.97 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.231 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -136.52 -72.88 0.44 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.69 45.82 27.21 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.626 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.37 44.6 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.11 33.7 3.92 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.624 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 ttt -171.73 134.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.152 0.476 . . . . 0.0 111.531 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.643 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -114.52 -42.1 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.28 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.66 80.49 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.22 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.745 ' HA ' HD23 ' A' ' 99' ' ' LEU . 81.7 t -44.41 -34.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -40.06 11.01 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.824 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.1 mp0 -76.09 -50.71 13.94 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.457 0.17 . . . . 0.0 110.783 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.745 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.13 -35.34 73.3 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -55.96 12.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.101 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -52.45 -38.59 59.61 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.812 HG11 ' CA ' ' A' ' 82' ' ' GLY . 42.1 t -72.12 -58.0 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.738 HD22 ' HG2' ' A' ' 109' ' ' LYS . 2.8 mt -60.99 -36.41 79.39 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 m -61.68 -36.84 82.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.588 0.232 . . . . 0.0 111.093 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.6 t -65.02 -22.8 67.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.994 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 3.7 mt -64.88 -72.95 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.508 0.194 . . . . 0.0 111.232 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.85 50.98 0.46 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 64.23 47.24 3.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.175 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.738 ' HG2' HD22 ' A' ' 103' ' ' LEU . 14.4 tptt -68.57 -138.12 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.455 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.9 mm? -69.18 77.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.8 p -69.89 -175.27 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.59 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -51.02 -38.83 53.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.704 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.47 -48.89 63.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.576 0.227 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 5.2 mm-40 -59.01 -51.64 69.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.635 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.3 -27.36 67.86 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -46.34 86.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -65.68 -44.34 86.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.369 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.99 -43.5 95.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.405 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -69.2 -32.97 72.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.35 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -61.68 -38.39 87.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.986 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 -46.62 43.66 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.953 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.92 127.12 63.51 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.706 0.253 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 59.61 6.19 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.72 2.28 . . . . 0.0 112.647 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.61 176.63 8.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.264 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -119.3 132.16 55.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.535 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t70 76.61 -1.92 2.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.887 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 78.26 51.02 5.89 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttp -104.2 113.17 26.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.54 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 129' ' ' VAL . 40.5 t -142.35 19.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.03 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 59.37 22.14 10.53 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.632 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 53.65 -158.12 0.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.5 t60 69.62 -60.19 0.48 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.168 0.187 . . . . 0.0 111.206 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.67 -41.76 64.13 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.5 m-85 -65.44 -57.06 9.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.07 -28.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.507 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.61 -49.83 73.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.683 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t -67.03 -47.37 52.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 6' ' ' SER . 75.4 Cg_endo -79.55 -13.17 13.53 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.534 2.156 . . . . 0.0 114.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.75 -63.16 1.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -72.85 -61.45 1.8 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.433 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.03 81.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.731 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.1 -44.27 87.58 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.481 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.5 t80 -52.05 -46.39 65.07 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.197 0.311 . . . . 0.0 110.471 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.6 t -60.5 -36.38 78.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.216 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.9 mt -59.78 -28.51 67.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.389 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 m-85 -89.02 19.99 3.86 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.24 92.36 4.48 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -61.66 -36.37 80.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -86.76 -37.01 18.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.117 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.34 45.32 5.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.439 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -109.25 -30.21 8.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.44 8.15 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.272 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -127.06 163.63 23.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.152 0.476 . . . . 0.0 110.655 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.786 HD12 HD13 ' A' ' 28' ' ' ILE . 3.7 pt -143.7 136.03 13.34 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.98 171.93 5.57 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.256 2.637 . . . . 0.0 112.287 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.508 ' HB2' HG13 ' A' ' 44' ' ' ILE . 14.3 pttm -43.83 -38.4 3.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -60.31 -44.89 95.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.496 0.189 . . . . 0.0 111.22 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.7 m -71.01 -47.41 58.93 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.786 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.19 -35.61 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.635 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.88 -68.08 1.79 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.456 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -28.09 69.26 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 5.7 tp -61.98 -46.46 89.15 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.63 -31.8 71.91 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -58.26 -41.83 85.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.16 68.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.488 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.25 42.59 2.67 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.16 -107.77 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.949 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.22 179.55 6.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.829 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 28.6 t-20 -118.57 106.38 44.47 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.78 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.55 -163.71 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.053 2.502 . . . . 0.0 112.576 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -104.95 164.31 11.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.868 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.15 -37.65 62.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.994 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.15 77.91 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.695 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.12 -55.14 17.91 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.3 -46.89 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.875 -0.148 . . . . 0.0 111.106 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -55.37 -43.84 75.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -37.76 76.14 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.755 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.786 HG23 HG11 ' A' ' 63' ' ' VAL . 64.7 mt -61.09 -51.78 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -56.86 -27.45 60.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.753 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.76 -13.86 47.46 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 p -119.06 5.84 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.688 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -140.19 157.67 68.44 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 110.523 -0.176 . . . . 0.0 110.523 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 92.8 Cg_exo -42.05 146.39 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.141 2.561 . . . . 0.0 113.164 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.4 -63.02 0.09 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -95.1 131.15 41.42 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.477 0.18 . . . . 0.0 110.65 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.05 87.16 2.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.045 0.45 . . . . 0.0 110.924 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.97 -177.56 6.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.459 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mtt -41.21 -46.97 3.24 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -52.84 32.38 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.586 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.88 -49.77 75.6 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -48.64 79.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.833 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.87 -29.3 70.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.451 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -65.77 -48.08 73.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.994 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.786 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.19 -43.17 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.983 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.427 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 120.313 0.102 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.57 -50.25 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.013 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.03 67.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -71.59 -56.35 6.77 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.161 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -77.98 -39.82 41.24 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.13 73.54 4.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.186 0.517 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 86' ' ' PHE . 10.9 p -118.09 -43.69 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 86' ' ' PHE . 9.4 t80 -154.46 25.78 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 110.393 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.67 51.41 0.75 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.928 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -28.84 64.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.382 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.24 -57.79 3.23 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.037 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.98 -174.21 0.11 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p 44.64 59.98 3.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.038 0.447 . . . . 0.0 111.314 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.24 -33.43 0.27 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.08 144.24 9.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.556 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.66 -41.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.249 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.9 77.9 0.25 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.559 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.778 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.0 t -45.28 -42.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.89 -37.26 9.24 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.856 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.6 mm-40 -80.59 -47.23 14.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.5 0.191 . . . . 0.0 110.544 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.778 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -41.93 84.34 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -34.83 65.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.803 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -55.57 -38.34 69.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.561 0.219 . . . . 0.0 110.939 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.544 HG11 ' HA2' ' A' ' 82' ' ' GLY . 2.5 t -78.55 -46.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.236 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.3 mt -65.99 -46.21 78.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.9 m -55.88 -35.51 66.58 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.469 0.176 . . . . 0.0 111.43 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 t -71.81 -19.01 62.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.843 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.18 -68.22 0.41 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.444 0.164 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.89 55.85 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.566 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 58.69 45.54 15.72 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.333 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 10.4 mmtp -68.9 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.222 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.47 78.4 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.8 p -64.87 -176.6 0.28 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -52.62 -32.58 42.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.787 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -53.79 52.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.75 -51.45 69.5 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.953 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.871 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.38 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -49.07 78.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.639 0.257 . . . . 0.0 110.471 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -42.12 86.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.99 -43.55 98.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -71.07 -31.91 68.44 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.262 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -61.74 -40.83 96.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.634 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 -46.23 19.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.922 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.481 HG11 ' CG2' ' A' ' 129' ' ' VAL . 21.4 t -85.35 119.15 72.02 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 116.787 0.294 . . . . 0.0 111.13 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.07 63.9 6.91 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.56 2.173 . . . . 0.0 112.588 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 122' ' ' VAL . 23.3 m -130.77 -175.95 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.253 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -118.87 127.3 53.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 t70 72.53 6.86 5.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.852 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 72.85 53.67 7.92 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.915 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -104.03 116.97 33.19 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 129' ' ' VAL . 40.3 t -142.39 30.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 36.6 t30 61.38 19.0 9.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.946 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 56.36 -176.67 0.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.8 -52.04 0.68 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.384 0.273 . . . . 0.0 111.667 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.89 -45.72 67.65 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -68.78 -49.87 55.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.99 -31.68 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.411 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -66.08 -51.07 61.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.5 ttt . . . . . 0 CA--C 1.531 0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.697 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.786 0.327 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 5.0 t -65.22 -46.07 71.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.379 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.15 -15.21 11.69 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.514 2.143 . . . . 0.0 113.824 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -110.14 -60.43 1.8 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -72.6 -61.02 1.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.444 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.402 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 9.5 tp60 -59.03 -47.52 84.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.25 -39.23 82.17 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.012 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.7 t80 -56.03 -44.66 78.97 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -62.33 -35.97 80.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.272 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.57 -33.94 73.43 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.428 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -91.04 20.06 5.22 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.44 89.82 3.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 120.839 0.352 . . . . 0.0 110.193 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -66.41 -29.16 69.25 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.878 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -85.97 -28.35 24.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.52 31.67 65.34 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.1 p -101.02 -30.0 11.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.282 0.233 . . . . 0.0 111.246 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.05 11.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.266 -0.493 . . . . 0.0 113.092 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.56 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -119.53 157.91 27.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.01 0.405 . . . . 0.0 110.742 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.852 HD12 HD13 ' A' ' 28' ' ' ILE . 4.3 pt -138.3 139.75 26.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.46 170.42 7.9 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.096 2.531 . . . . 0.0 112.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HB2' HG13 ' A' ' 44' ' ' ILE . 10.7 pttp -45.14 -39.12 5.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 p -60.03 -43.3 95.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.545 0.212 . . . . 0.0 111.197 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.9 t -68.55 -51.95 37.2 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.167 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.852 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.92 -36.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.519 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.83 -71.98 0.58 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.649 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -27.98 69.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.8 -50.58 70.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.607 0.241 . . . . 0.0 110.356 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -61.44 -29.53 70.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.267 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.34 -38.75 69.16 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.061 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.51 69.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.704 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 t -114.66 40.04 2.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.33 -107.15 0.36 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 174.81 9.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.909 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 3.8 t-20 -119.5 107.04 41.45 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.156 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.91 -162.76 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.89 2.394 . . . . 0.0 112.75 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -93.63 166.53 12.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.188 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.46 -34.73 67.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.81 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.18 79.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.585 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.84 -55.17 24.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.055 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.615 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.96 -47.16 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.689 179.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -58.55 -39.9 81.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.42 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -58.71 -40.82 84.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.372 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.54 ' O ' HD22 ' A' ' 51' ' ' LEU . 55.1 mt -61.73 -50.21 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -56.98 -23.9 49.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.696 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -7.75 10.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 p -117.89 -45.44 2.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 117.627 0.194 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.6 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -89.97 159.01 43.69 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 72.0 Cg_exo -40.17 146.08 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 113.026 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -31.1 -60.37 0.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.205 0.602 . . . . 0.0 112.597 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -91.07 127.12 36.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.641 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.7 t -86.91 86.81 2.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.56 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.8 p30 -84.55 178.81 7.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.38 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtm -41.56 -47.94 3.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.689 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.95 -50.54 62.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.851 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.592 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -56.81 -51.07 70.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.586 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -48.28 80.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 61' ' ' LEU . 35.9 mt -61.17 -34.28 74.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.425 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -60.96 -53.11 61.28 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.492 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -64.05 -42.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.889 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.17 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.77 -56.73 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.182 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -35.05 79.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.818 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.99 -47.12 86.16 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.637 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -77.56 -36.71 51.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.776 0.288 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -74.94 75.51 2.18 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.518 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 102' ' ' VAL . 45.1 t -127.31 -66.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.81 38.24 2.32 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 111.79 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.665 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 5.3 p30 -130.06 72.6 1.49 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.001 0.429 . . . . 0.0 110.782 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -31.16 68.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.655 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.18 -53.94 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . . . 60.58 69.06 0.71 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.271 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 -40.55 6.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.368 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -166.5 62.01 0.22 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.446 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 ptt? -175.68 140.24 0.45 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.268 0.227 . . . . 0.0 110.483 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.589 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.12 -43.32 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.599 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.75 81.15 0.1 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.158 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.741 HG21 HD21 ' A' ' 118' ' ' LEU . 70.6 t -42.84 -33.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.81 -39.12 17.0 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.749 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.677 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.3 pt-20 -76.9 -44.59 31.23 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.609 0.205 . . . . 0.0 111.202 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -64.8 -37.44 87.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.531 0.205 . . . . 0.0 111.223 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -49.79 60.29 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.763 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -53.79 -42.39 68.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.296 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.818 HG21 ' O ' ' A' ' 82' ' ' GLY . 48.0 t -66.76 -51.17 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.522 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 5.0 mt -64.63 -50.69 66.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.977 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -56.86 -31.37 64.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.6 t -66.95 -24.85 66.11 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.25 -67.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.79 55.84 0.29 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 45.13 7.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.952 0.406 . . . . 0.0 111.215 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 2.3 mmtm -68.61 -137.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.24 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.648 HD22 ' HG2' ' A' ' 114' ' ' GLU . 17.5 mt -69.41 78.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.656 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.7 p -68.65 -171.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -52.54 -33.17 44.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.385 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.52 -51.81 63.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.52 0.2 . . . . 0.0 111.497 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.648 ' HG2' HD22 ' A' ' 110' ' ' LEU . 2.5 tp10 -57.38 -51.56 68.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.79 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.899 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -66.77 -26.72 67.1 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -46.81 86.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.28 -43.97 84.89 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.899 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.7 -41.55 95.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.564 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -69.54 -30.82 68.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -62.99 -40.18 96.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.502 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -45.43 42.06 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.736 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.467 HG11 ' CG2' ' A' ' 129' ' ' VAL . 12.7 t -90.68 116.33 66.17 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.612 0.206 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.56 64.59 4.67 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.591 2.194 . . . . 0.0 112.658 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 122' ' ' VAL . 25.1 m -130.05 -175.44 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.084 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -118.62 124.59 47.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.443 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t70 76.55 -2.36 2.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.949 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 81.13 50.97 4.9 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.789 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 ttt -104.45 119.35 38.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 133' ' ' ASP . 27.9 t -141.14 28.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.62 24.27 13.08 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.027 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.3 t80 46.11 48.16 12.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 111.556 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -122.91 -53.05 1.87 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.507 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.658 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -59.57 -35.09 73.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.0 m-85 -68.15 -55.41 12.47 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.584 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.7 -34.09 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.021 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.54 -52.64 64.34 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.5 ttt . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.197 179.673 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 1.8 m-20 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.454 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.6 t -67.32 -48.02 47.73 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.706 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 6' ' ' SER . 80.3 Cg_endo -78.54 -9.05 16.11 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.483 2.122 . . . . 0.0 114.237 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.456 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 84.7 m-85 -118.94 -59.65 1.84 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -72.2 -56.87 4.82 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.221 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.8 -48.03 80.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.448 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.54 -38.18 77.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 23' ' ' ILE . 26.5 t80 -59.14 -46.87 87.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.431 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 1.1 t -62.76 -30.44 71.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.692 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 18.2 mt -57.32 -38.35 73.92 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.13 31.55 2.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -101.81 91.69 4.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.582 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -25.63 63.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.654 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -86.38 -35.57 19.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.062 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.64 26.37 59.04 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.618 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -109.64 -19.83 13.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.1 19.94 6.96 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.992 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtp180 -130.2 150.09 51.61 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.978 0.389 . . . . 0.0 110.687 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.703 HD12 HD13 ' A' ' 28' ' ' ILE . 7.9 pt -136.88 138.07 24.99 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.749 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.76 171.8 6.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.177 2.585 . . . . 0.0 112.52 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -45.28 -36.85 4.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -60.83 -44.89 96.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.459 0.171 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.553 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 24.1 m -70.81 -45.61 64.29 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.703 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.06 -33.27 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.76 -68.12 1.86 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.453 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -29.47 70.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.406 0.146 . . . . 0.0 111.24 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 tp -62.01 -50.47 71.93 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.13 -28.38 69.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.04 -41.04 74.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.048 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.0 -26.51 68.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -121.74 39.4 3.87 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.699 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.66 -110.1 0.43 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.798 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.7 178.21 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.082 0.468 . . . . 0.0 111.938 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 20.4 t-20 -119.68 97.27 49.86 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.443 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.07 -162.55 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.822 2.348 . . . . 0.0 112.587 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 169.23 9.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.1 mm? -56.04 -33.85 65.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.6 78.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.671 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -54.2 41.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.249 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.792 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -59.74 -47.8 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.865 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.41 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 57.7 m -54.42 -43.53 71.6 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -56.49 -38.93 72.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.57 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 44' ' ' ILE . 33.2 mt -63.03 -49.77 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -56.39 -24.94 47.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.99 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -63.88 -8.23 10.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.4 p -118.03 -46.32 2.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.584 0.174 . . . . 0.0 111.014 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.607 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.44 156.03 41.81 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 87.6 Cg_exo -41.84 150.24 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.238 2.625 . . . . 0.0 113.088 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.65 -62.86 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.373 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -84.77 121.66 28.0 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.44 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.13 89.28 2.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -83.68 178.03 8.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.3 mtm -41.18 -46.73 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.834 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.32 -52.08 50.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.889 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.472 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.8 -51.26 69.65 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.476 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.1 -48.77 80.14 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.013 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.35 -35.16 76.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.69 -54.99 39.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.487 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.04 -36.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.87 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD13 ' HE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.339 0.137 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.104 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.465 0.174 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.9 t -64.52 -40.97 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.75 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -40.26 95.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.901 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -62.97 -48.07 83.59 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.07 -33.12 75.07 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.48 0.181 . . . . 0.0 110.865 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -62.26 -29.04 70.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.073 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.715 ' HB ' HG21 ' A' ' 102' ' ' VAL . 89.1 t -58.31 138.51 19.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.851 0.357 . . . . 0.0 110.393 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.35 22.79 3.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.728 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -136.71 62.12 1.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -70.79 -55.68 8.04 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.31 -60.08 1.6 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.046 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 67.81 -76.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.412 0.445 . . . . 0.0 111.764 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m 69.08 -77.6 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.755 0.422 . . . . 0.0 111.23 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.32 53.16 0.79 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.447 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.5 135.97 0.57 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.729 0.299 . . . . 0.0 110.786 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.83 -42.85 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.279 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 98' ' ' GLU . . . 66.25 81.84 0.14 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.858 HG21 HD21 ' A' ' 118' ' ' LEU . 78.8 t -43.38 -32.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.84 -36.09 32.72 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.103 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -79.84 -40.66 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.936 0.368 . . . . 0.0 111.181 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -65.44 -37.12 85.96 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.029 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.517 ' CB ' ' HE2' ' A' ' 115' ' ' MET . 0.0 OUTLIER -77.13 -37.21 54.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.218 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -60.1 -36.54 77.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.571 0.224 . . . . 0.0 110.911 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.901 HG11 ' HA2' ' A' ' 82' ' ' GLY . 21.4 t -82.65 -47.24 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.702 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.89 HD22 ' HG2' ' A' ' 109' ' ' LYS . 6.1 mt -70.35 -49.95 44.02 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.9 m -60.57 -34.25 73.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.441 0.163 . . . . 0.0 111.19 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -72.02 -20.29 61.72 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.548 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.57 0.224 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.7 53.2 0.28 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.405 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.71 45.37 10.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.89 ' HG2' HD22 ' A' ' 103' ' ' LEU . 4.2 tptt -68.63 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.117 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.828 HD22 ' HG3' ' A' ' 114' ' ' GLU . 54.7 mt -67.41 79.11 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -64.55 -168.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.99 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.48 ' HA ' ' HE3' ' A' ' 115' ' ' MET . 34.5 m120 -53.19 -31.05 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.381 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.4 -50.78 72.65 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.554 0.216 . . . . 0.0 111.297 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.828 ' HG3' HD22 ' A' ' 110' ' ' LEU . 5.0 tm-20 -56.26 -53.66 54.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.797 ' HA ' HD23 ' A' ' 118' ' ' LEU . 16.0 ptp -66.68 -25.1 66.39 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.368 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -47.72 83.15 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.732 0.301 . . . . 0.0 110.267 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -40.52 68.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -65.11 -43.77 90.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.178 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 8.7 mt -72.55 -26.91 61.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.362 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -66.54 -43.77 84.21 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.603 0.239 . . . . 0.0 110.728 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.1 -40.47 34.6 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.964 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 129' ' ' VAL . 47.3 t -83.88 130.46 55.12 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.679 0.24 . . . . 0.0 111.192 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.21 61.96 6.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.733 2.289 . . . . 0.0 112.38 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.561 HG21 ' H ' ' A' ' 128' ' ' MET . 5.2 p -131.19 168.05 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.76 50.52 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.098 0.475 . . . . 0.0 111.314 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.82 -36.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.413 ' HA3' HG23 ' A' ' 96' ' ' VAL . . . 114.7 35.62 1.38 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.034 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.561 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -103.38 117.35 34.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 129' ' ' VAL . 39.8 t -142.1 20.77 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 62.44 22.78 13.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.54 -167.43 0.11 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.21 -59.05 0.57 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.185 0.194 . . . . 0.0 111.165 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.95 -41.06 64.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 111.2 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 26.9 m-85 -68.28 -50.0 56.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.175 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.1 t -62.07 -27.56 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.352 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.83 -42.63 66.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.03 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.1 t -55.94 -46.24 99.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.753 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 6' ' ' SER . 86.1 Cg_endo -83.28 -8.95 10.59 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.563 2.175 . . . . 0.0 114.531 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -119.96 -63.99 1.31 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -60.1 2.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.232 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.43 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.55 -47.45 85.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.01 -41.07 82.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.228 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.0 t80 -57.94 -46.48 84.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.357 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -29.64 70.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.872 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 19.5 mt -59.04 -31.6 69.0 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -92.14 22.57 4.31 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.42 95.96 6.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.197 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -47.51 81.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.8 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.85 -30.48 21.43 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.74 40.08 8.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.389 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 p -95.62 -29.13 14.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.112 0.165 . . . . 0.0 111.313 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.64 12.77 7.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.417 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.58 162.35 29.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.085 0.442 . . . . 0.0 110.91 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.861 HD12 HD13 ' A' ' 28' ' ' ILE . 3.1 pt -143.77 140.57 17.42 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.565 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.75 171.82 8.13 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.185 2.59 . . . . 0.0 112.302 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.6 -39.61 3.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.2 p -60.29 -45.94 91.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.141 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.2 m -66.79 -45.59 77.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.833 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.861 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.54 -35.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.396 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -66.89 2.45 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.654 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.29 -27.94 69.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.702 0.251 . . . . 0.0 111.142 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.08 -48.65 80.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.15 -35.88 78.28 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -40.61 68.36 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.67 74.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.466 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 m -98.26 42.92 1.08 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.733 0.302 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.3 -93.77 0.58 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.95 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.8 167.36 19.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.907 0.384 . . . . 0.0 111.633 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.08 141.73 42.2 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.449 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.2 Cg_endo -86.77 -162.33 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.15 2.567 . . . . 0.0 112.29 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 p -97.65 167.33 11.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.939 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.4 mm? -54.14 -37.46 64.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.6 84.58 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -64.93 -52.27 57.27 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.804 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.19 -45.36 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.596 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -59.41 -42.97 93.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -40.37 79.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.541 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.971 HG23 HG11 ' A' ' 63' ' ' VAL . 17.6 mt -63.3 -47.91 89.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.38 -24.35 54.82 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.759 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.9 t -64.14 -10.31 21.97 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 p -117.88 -33.32 4.52 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.385 -0.197 . . . . 0.0 111.466 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -97.46 156.82 35.73 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 96.1 Cg_exo -41.87 148.11 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.12 2.547 . . . . 0.0 112.814 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -33.04 -52.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -97.76 126.75 43.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.784 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -87.26 89.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.6 p30 -84.58 178.56 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.394 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 40.5 mtm -41.09 -45.7 2.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.016 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.77 -52.55 42.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.969 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.586 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.25 -50.91 71.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -49.5 77.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.811 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.59 -32.61 72.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.484 0.183 . . . . 0.0 111.22 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -50.6 71.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.252 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.971 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.32 -44.8 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.2 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.092 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 120.298 0.094 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -64.65 -65.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 tppt? -58.85 -23.76 61.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.053 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.717 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -67.88 -51.37 35.18 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.695 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -75.38 -42.92 52.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.545 0.212 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.32 5.3 12.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 86' ' ' PHE . 7.1 p -49.7 -45.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.414 ' N ' HG13 ' A' ' 85' ' ' VAL . 41.0 m-85 -148.57 46.48 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 110.89 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -129.33 66.58 1.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -35.86 82.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.21 -64.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.725 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.67 -174.67 0.1 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.889 0.376 . . . . 0.0 111.773 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 56.96 29.51 16.46 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.727 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.32 36.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.241 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 167.93 132.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.805 0.442 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.459 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -103.43 -45.37 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.337 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.57 77.35 0.23 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.864 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.863 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.4 t -45.41 -33.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.16 -54.47 15.08 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.693 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 pm0 -72.95 -39.24 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.549 0.175 . . . . 0.0 111.32 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.863 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.67 -38.97 89.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.2 -47.27 74.46 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -54.29 -36.55 63.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.154 0.284 . . . . 0.0 111.196 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.717 HG21 ' O ' ' A' ' 82' ' ' GLY . 24.1 t -74.85 -47.52 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.709 HD12 ' CD1' ' A' ' 99' ' ' LEU . 7.3 mt -66.39 -34.43 77.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 17.6 p -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.415 0.15 . . . . 0.0 111.3 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 t -74.82 -16.77 60.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.827 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.421 HD12 HD23 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -68.25 -57.49 5.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.692 0.282 . . . . 0.0 110.941 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.42 55.73 0.07 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.221 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 60.0 43.74 14.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 36.3 mmtt -68.86 -138.56 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.23 77.03 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 77.4 p -72.66 -175.79 1.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.964 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -49.24 -37.51 23.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.416 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.28 -52.73 37.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.637 0.256 . . . . 0.0 111.323 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.07 -50.73 72.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.843 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.7 ppp? -66.77 -27.73 67.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.286 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -47.66 83.36 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.5 -41.34 93.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.785 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.843 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.98 -41.89 97.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.724 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.548 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.091 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.1 -40.03 92.2 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.74 -46.69 29.47 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.014 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.505 HG11 ' CG2' ' A' ' 129' ' ' VAL . 17.6 t -86.17 121.49 72.67 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.803 0.301 . . . . 0.0 111.179 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.4 63.98 7.2 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.58 2.187 . . . . 0.0 112.568 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 122' ' ' VAL . 23.3 m -131.02 -179.85 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.241 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.17 135.28 54.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 68.07 11.91 8.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.862 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.719 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 67.79 48.55 54.72 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.101 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.82 119.22 38.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 129' ' ' VAL . 28.3 t -141.2 29.45 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.4 t30 56.1 21.87 5.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.8 t80 47.41 39.78 9.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -116.95 -39.84 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' HB3' HG11 ' A' ' 129' ' ' VAL . 24.4 t70 -69.6 -35.45 75.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -67.54 -54.73 17.55 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.232 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.39 -34.52 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.459 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -62.68 -52.48 63.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 33.4 tpp . . . . . 0 CA--C 1.53 0.211 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.583 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.321 0.582 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.417 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -68.53 -45.53 35.73 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.69 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 88.2 Cg_endo -79.86 -20.56 8.93 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.466 2.111 . . . . 0.0 114.901 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 14.1 m-30 -105.76 -59.41 1.77 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.1 0.409 . . . . 0.0 111.806 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -73.03 -63.31 1.2 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.49 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -57.62 -49.18 77.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.222 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.66 -38.28 81.01 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.456 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' HG12 ' A' ' 23' ' ' ILE . 33.5 t80 -58.43 -44.15 89.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.694 0.283 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -61.88 -35.32 78.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -61.96 -39.03 90.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.91 22.99 7.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 130.79 41.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.579 0.228 . . . . 0.0 110.85 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -52.49 -58.0 8.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -133.97 24.41 3.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.398 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.61 30.75 78.11 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.934 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -95.15 -27.61 15.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.587 0.194 . . . . 0.0 111.295 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.69 10.9 6.78 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.292 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.53 160.41 34.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.272 0.536 . . . . 0.0 110.88 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 28' ' ' ILE . 6.1 pt -147.34 135.68 11.0 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.873 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 90.7 Cg_endo -89.42 171.5 4.37 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.179 2.586 . . . . 0.0 112.541 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HG13 ' A' ' 44' ' ' ILE . 5.3 pttm -43.05 -40.29 3.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 p -59.82 -42.71 94.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.472 0.177 . . . . 0.0 111.185 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 4.5 t -70.75 -52.82 18.29 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.453 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.767 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.03 -37.39 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.19 -69.1 1.34 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.474 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.55 69.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.27 -50.78 68.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.688 0.28 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -61.37 -30.43 70.53 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.023 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -35.44 67.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.95 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.86 70.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.665 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.91 -45.68 9.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.651 0.262 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.63 -87.86 0.15 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.43 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.25 175.81 9.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.987 0.422 . . . . 0.0 111.826 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.57 112.95 35.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.697 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -82.03 -162.98 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 113.024 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -95.17 165.37 12.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.89 -37.08 63.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.49 73.11 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.916 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.64 -53.91 16.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.291 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -59.91 -47.67 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.291 -0.164 . . . . 0.0 110.91 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.3 m -59.27 -38.53 80.36 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -41.78 90.61 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.367 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 44' ' ' ILE . 10.5 mt -63.43 -49.12 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.979 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.37 -26.84 61.67 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.728 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.99 -12.7 40.34 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -118.33 2.47 11.9 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -136.65 154.73 76.79 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 70.8 Cg_exo -38.59 140.98 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.28 2.653 . . . . 0.0 112.966 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -26.13 -60.69 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.761 0.663 . . . . 0.0 112.755 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -91.44 125.93 36.36 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.411 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.9 t -86.27 86.35 2.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 121.161 0.505 . . . . 0.0 110.44 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.3 p-10 -83.27 177.24 8.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.2 mtm -41.9 -45.37 3.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.543 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -51.17 56.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.853 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -56.41 -53.61 55.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.486 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -49.3 76.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.192 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.18 -33.29 73.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.49 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -61.33 -50.55 72.5 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.259 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.531 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.64 -37.46 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.606 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 120.508 0.194 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.67 -45.78 97.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.855 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -33.93 76.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.266 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.699 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -60.23 -44.63 97.24 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.085 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -70.24 -34.06 72.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.479 0.181 . . . . 0.0 110.624 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.96 73.15 5.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.857 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.43 -64.2 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.854 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.78 28.44 6.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -139.91 70.0 1.36 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.133 0.492 . . . . 0.0 110.149 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -61.09 -44.58 97.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.894 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -49.2 10.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.43 55.52 7.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.492 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 m -82.81 -57.37 3.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.35 57.78 0.22 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.798 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.52 119.6 0.9 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.584 0.231 . . . . 0.0 110.991 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -103.92 139.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.909 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -105.14 82.73 0.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.883 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.81 ' HA ' HD23 ' A' ' 99' ' ' LEU . 55.0 t -41.74 -34.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.39 -50.05 58.05 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.917 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.2 pt-20 -75.65 -34.95 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.356 0.122 . . . . 0.0 110.92 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -63.02 -41.42 99.55 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 110.493 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -67.42 -47.45 70.19 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -51.7 -46.99 64.08 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.174 0.296 . . . . 0.0 111.385 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.699 HG11 ' CA ' ' A' ' 82' ' ' GLY . 53.2 t -61.05 -49.49 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.363 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 99' ' ' LEU . 3.8 mt -67.81 -28.15 67.33 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.1 m -65.33 -41.52 93.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.574 0.226 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -74.52 -7.86 54.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -50.74 20.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.644 0.259 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.67 53.73 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.558 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.42 41.72 15.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HG3' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.81 -138.91 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.301 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 114' ' ' GLU . 3.6 mt -68.74 78.85 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -64.52 -174.61 0.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.143 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.439 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 8.8 p30 -49.22 -35.36 17.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.573 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -57.49 -51.08 70.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.547 ' HG3' HD23 ' A' ' 110' ' ' LEU . 11.3 mm-40 -56.74 -52.46 64.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.869 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.82 ' HA ' HD23 ' A' ' 118' ' ' LEU . 9.1 ptm -67.0 -25.99 66.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -48.11 81.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.661 0.267 . . . . 0.0 110.43 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.77 -41.96 78.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.66 -41.72 99.22 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.148 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER -70.85 -33.12 70.32 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.514 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -63.54 -41.38 98.46 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.952 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.24 -40.97 39.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.985 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.559 HG11 ' CG2' ' A' ' 129' ' ' VAL . 63.9 t -81.83 132.79 53.36 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.874 0.337 . . . . 0.0 111.193 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.9 58.68 7.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.802 2.334 . . . . 0.0 112.614 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.488 HG22 HG12 ' A' ' 122' ' ' VAL . 25.1 m -131.48 175.03 12.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -125.5 18.71 8.13 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.835 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -159.96 22.63 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 54.39 40.82 70.1 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.811 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.96 112.96 26.16 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.271 0.558 . . . . 0.0 111.353 -179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 129' ' ' VAL . 32.3 t -142.84 25.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.292 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.48 26.6 16.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.434 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.5 t80 45.62 41.53 7.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.416 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -114.8 -53.56 2.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.406 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.5 ' CB ' HG11 ' A' ' 129' ' ' VAL . 34.7 t70 -61.13 -34.7 75.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.51 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 4.9 m-85 -67.76 -56.62 8.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.371 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.92 -32.66 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.124 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -62.81 -48.37 79.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.83 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.5 ttm . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 179.418 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 22.0 m-20 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.993 0.425 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.423 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -62.41 -47.14 89.78 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.5 Cg_endo -83.75 1.64 8.76 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.574 2.183 . . . . 0.0 114.371 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 86.6 m-85 -126.9 -63.5 1.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.795 0.27 . . . . 0.0 111.609 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 2.1 mtpm? -72.44 -58.01 3.72 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.065 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -48.4 80.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.592 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.546 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.91 -38.25 78.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.289 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 23' ' ' ILE . 13.8 t80 -59.16 -45.81 90.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.374 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 m -62.65 -32.62 73.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.643 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.2 mt -61.03 -33.67 73.64 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 23' ' ' ILE . 66.5 m-85 -94.26 33.1 1.42 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.16 127.66 33.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.961 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -70.9 -56.72 5.64 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -112.2 -21.38 11.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.907 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.81 30.67 5.1 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.917 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -105.84 -29.02 10.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.622 0.211 . . . . 0.0 111.263 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.69 28.34 1.44 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.322 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.536 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.75 156.02 45.66 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.987 0.393 . . . . 0.0 110.183 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.743 HD12 HD13 ' A' ' 28' ' ' ILE . 5.6 pt -143.22 133.17 11.98 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.79 170.06 11.55 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.049 2.499 . . . . 0.0 112.309 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.68 -38.6 4.47 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 p -60.95 -43.91 98.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.512 0.196 . . . . 0.0 111.109 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.467 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 20.7 m -68.22 -46.47 70.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.565 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.743 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.35 -35.66 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.462 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.64 -69.22 1.33 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.584 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -26.03 68.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.529 0.164 . . . . 0.0 111.313 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 12.0 tp -61.62 -49.15 77.72 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -61.79 -32.27 72.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.056 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -55.36 -39.18 69.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.216 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.8 71.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.699 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.61 -45.47 13.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.99 -80.34 0.03 OUTLIER Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.942 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.97 178.79 6.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.651 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 6.5 t-20 -119.02 118.81 32.64 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.501 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 -162.43 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.397 . . . . 0.0 112.601 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 p -102.69 162.43 12.93 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.22 -33.94 63.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.98 80.74 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.933 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.68 -56.37 9.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.225 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.646 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.83 -47.24 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.327 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -61.17 -43.38 98.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.71 -40.01 78.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 44' ' ' ILE . 24.8 mt -61.63 -52.66 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -56.63 -23.41 40.99 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.826 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -63.74 -8.19 9.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.9 p -118.17 -46.74 2.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.599 0.181 . . . . 0.0 111.001 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.25 156.54 57.05 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.627 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.9 Cg_exo -39.32 145.43 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.359 2.706 . . . . 0.0 113.317 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.24 -64.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.471 0.708 . . . . 0.0 112.805 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -88.58 127.52 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.448 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -86.42 84.56 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.01 0.433 . . . . 0.0 110.512 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -81.71 179.24 7.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -41.1 -45.57 2.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -68.67 -52.05 35.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.627 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.2 mp0 -56.86 -51.83 67.5 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.563 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -48.85 79.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.624 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 61' ' ' LEU . 27.7 mt -61.5 -31.69 71.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -61.46 -50.49 72.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.604 0.24 . . . . 0.0 111.01 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.559 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.57 -40.62 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.95 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.4 -43.87 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.715 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -30.21 69.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.303 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -62.81 -50.54 63.04 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.026 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.75 -41.0 72.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.73 0.3 . . . . 0.0 110.219 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -79.81 70.54 6.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.028 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.9 t -124.94 -64.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.455 ' HB2' ' HG2' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -99.37 43.15 1.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 1.8 m-20 -137.96 71.2 1.39 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -51.38 68.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.13 -54.89 3.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.674 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 51.47 56.27 8.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.656 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -110.3 69.4 0.69 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.95 49.3 1.63 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.99 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.98 144.84 0.62 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.788 0.327 . . . . 0.0 111.378 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.88 -44.38 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.285 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.47 80.84 0.21 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.368 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.789 ' HA ' HD23 ' A' ' 99' ' ' LEU . 72.8 t -44.27 -36.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.99 -42.03 22.38 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.565 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.4 tm-20 -71.98 -50.97 24.33 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.524 0.202 . . . . 0.0 110.518 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.91 -35.19 70.71 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.226 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -66.25 -48.95 68.86 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.678 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.61 -36.18 69.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 98' ' ' GLU . 43.4 t -72.04 -46.79 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.786 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 99' ' ' LEU . 3.8 mt -74.78 -49.32 21.27 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -57.32 -36.04 70.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.4 t -69.42 -21.69 63.74 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.79 -62.61 1.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.529 0.204 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.76 52.54 0.26 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 59.92 45.23 12.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.966 0.412 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 4.6 mmmm -68.55 -137.97 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.078 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -68.21 79.04 0.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.1 p -62.12 178.88 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.52 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.55 -30.99 14.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.207 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.4 -54.59 41.61 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -58.31 -46.6 85.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.827 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.8 mmt -67.12 -31.84 72.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.41 77.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.581 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.26 -42.63 93.08 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.529 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.827 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.97 -42.68 94.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.464 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.571 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -68.33 -33.08 73.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -39.43 92.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.76 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -48.81 32.56 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.92 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 129' ' ' VAL . 14.8 t -84.31 121.43 75.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.741 0.27 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 62.96 5.7 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.668 2.245 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.51 177.9 6.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -119.34 133.43 55.73 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.732 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 73.03 5.57 5.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.938 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 72.12 51.19 14.67 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.97 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -106.06 115.64 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 129' ' ' VAL . 38.8 t -142.34 30.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.74 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 57.69 25.35 11.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.439 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 47.24 45.78 16.52 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.774 0.321 . . . . 0.0 111.499 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -120.57 -54.26 2.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.259 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.501 ' CB ' HG11 ' A' ' 129' ' ' VAL . 31.3 t70 -58.0 -38.88 76.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.723 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.4 m-85 -66.43 -56.93 8.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.574 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.3 t -61.84 -31.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.313 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -57.74 -55.95 28.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.953 0.406 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.8 -46.62 92.87 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.7 Cg_endo -82.6 -12.94 9.86 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.585 2.19 . . . . 0.0 114.077 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -111.35 -61.28 1.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -72.57 -62.1 1.56 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.394 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.44 -48.86 79.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.809 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.86 -41.6 82.76 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.522 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.2 t80 -54.21 -44.68 71.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.325 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.59 -36.1 81.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.339 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.7 mt -60.91 -35.87 77.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.447 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.93 33.74 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.18 133.17 49.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.689 0.28 . . . . 0.0 111.053 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -54.63 12.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.483 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.47 25.24 2.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.454 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.7 40.67 99.09 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.736 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 p -106.08 -31.27 8.8 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.79 -8.91 6.83 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.46 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -118.91 162.64 18.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.12 0.46 . . . . 0.0 111.037 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.711 HD12 HD13 ' A' ' 28' ' ' ILE . 5.8 pt -138.54 132.21 16.39 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.71 169.25 13.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.944 2.429 . . . . 0.0 112.435 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -45.16 -36.28 3.68 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.119 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.5 p -62.13 -44.18 97.19 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.404 0.145 . . . . 0.0 111.334 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 32.6 m -69.19 -45.7 69.29 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.711 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.94 -35.26 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.36 -67.66 2.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.678 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.92 71.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.549 0.174 . . . . 0.0 111.058 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -59.18 -50.14 75.18 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . 47.0 mt -59.06 -32.52 69.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -55.41 -41.18 72.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -69.68 -28.79 66.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 32' ' ' LEU . 30.8 p -113.79 36.29 3.71 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.064 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.94 -104.6 0.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.658 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 175.84 8.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 111.562 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.54 105.26 19.18 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.45 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.05 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.762 2.308 . . . . 0.0 112.535 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.54 167.51 11.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 25' ' ' LYS . 2.9 mm? -55.78 -33.05 64.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.07 75.51 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.014 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -56.53 9.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.011 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.755 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.45 -45.65 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.208 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -59.45 -42.69 92.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -57.42 -38.36 74.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.721 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 44' ' ' ILE . 39.4 mt -62.69 -51.29 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -56.79 -24.05 47.78 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.659 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.0 m -64.62 -8.67 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -118.01 -46.43 2.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.706 0.23 . . . . 0.0 111.179 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.587 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -91.07 158.24 41.84 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.3 Cg_exo -40.95 147.76 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.416 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.98 -67.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.597 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.54 124.9 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.624 0.249 . . . . 0.0 110.392 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 59' ' ' GLN . 57.0 t -86.47 90.81 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -87.67 -179.31 6.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.7 mtp -40.86 -49.91 3.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.603 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -63.29 -53.31 54.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.554 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -56.51 -53.55 56.18 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -49.57 76.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.92 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 mt -61.69 -29.68 70.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -65.33 -48.15 74.04 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.594 0.235 . . . . 0.0 111.264 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -41.77 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.163 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.231 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 CA-C-O 120.433 0.159 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.37 -43.67 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.088 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.69 -35.04 79.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.582 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.887 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -70.75 -43.88 58.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.561 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -76.48 -39.09 54.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.509 0.155 . . . . 0.0 111.302 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.45 73.66 5.0 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.106 0.479 . . . . 0.0 110.704 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 86' ' ' PHE . 13.2 p -131.83 -45.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.5 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.431 ' N ' HG13 ' A' ' 85' ' ' VAL . 10.0 m-85 -134.36 39.84 3.04 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -109.81 60.58 0.6 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -39.72 79.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.81 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.57 -64.8 1.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.26 -86.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.429 0.456 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t 42.62 45.78 4.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.03 40.09 0.39 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.329 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.6 ptp -176.68 136.05 0.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.93 0.365 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.55 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.87 -43.26 8.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.22 80.53 0.15 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.747 ' HA ' HD23 ' A' ' 99' ' ' LEU . 97.0 t -44.09 -36.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.24 -38.65 19.4 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.777 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.5 mt-10 -74.11 -52.26 13.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.522 0.201 . . . . 0.0 110.684 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.16 -38.25 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -73.46 -41.02 63.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.935 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -53.51 -42.13 67.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.527 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.887 HG11 ' HA2' ' A' ' 82' ' ' GLY . 4.1 t -74.11 -50.77 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.436 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 99' ' ' LEU . 2.9 mt -58.67 -45.76 88.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.884 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 56.3 m -65.41 -36.83 85.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.567 0.222 . . . . 0.0 110.952 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 t -63.62 -23.13 67.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.31 -70.67 0.23 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.518 0.199 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.25 48.95 0.49 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 61.16 45.99 8.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 111.012 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.62 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.985 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 114' ' ' GLU . 55.6 mt -66.94 79.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.291 0.496 . . . . 0.0 110.679 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.437 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 99.5 p -63.59 -170.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.045 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -52.67 -32.7 43.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.148 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -57.29 -50.58 72.46 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.704 ' HG2' HD22 ' A' ' 110' ' ' LEU . 11.4 tp10 -56.18 -54.47 44.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.742 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.889 ' HA ' HD23 ' A' ' 118' ' ' LEU . 4.1 ptt? -66.68 -25.41 66.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.457 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -46.32 87.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.97 -45.83 73.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.294 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.889 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.09 -40.57 90.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.594 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.9 mt -69.5 -32.13 70.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -61.27 -40.93 95.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.362 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.38 51.65 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.989 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 129' ' ' VAL . 10.8 t -91.23 116.67 66.9 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.749 0.274 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.08 65.03 4.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.492 2.128 . . . . 0.0 112.632 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.12 -179.24 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -118.68 132.7 56.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.567 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.99 6.18 5.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.955 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.619 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 71.03 53.33 10.95 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.909 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttt -106.83 119.61 39.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 129' ' ' VAL . 39.3 t -142.34 20.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.56 22.06 10.66 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.09 -164.53 0.14 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 m170 71.37 -58.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.28 0.232 . . . . 0.0 111.209 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -52.72 -39.68 62.3 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.509 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 17.8 m-85 -68.11 -52.72 31.73 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 t -61.73 -30.79 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.225 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -62.51 -54.14 44.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.846 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.6 ttt . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.587 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 62.1 m-20 . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.932 0.396 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.3 t -58.69 -45.79 99.62 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.343 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 85.3 Cg_endo -84.63 -3.74 9.95 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.543 2.162 . . . . 0.0 114.641 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 59.0 m-85 -123.99 -62.64 1.27 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.972 0.351 . . . . 0.0 111.809 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -72.66 -60.84 2.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.944 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.51 -45.57 93.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.11 -44.88 87.92 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.181 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 23' ' ' ILE . 25.9 t80 -56.78 -43.12 80.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.823 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -62.48 -34.05 76.08 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -59.5 -34.05 72.1 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 23' ' ' ILE . 44.1 m-85 -94.25 33.22 1.4 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.92 129.4 39.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.618 0.247 . . . . 0.0 111.015 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.58 -61.89 1.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.512 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -130.95 25.75 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.184 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.75 39.18 95.09 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.535 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -104.57 -24.43 12.99 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.49 11.63 17.01 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.891 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 4.8 mtt-85 -129.0 163.17 25.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.746 0.273 . . . . 0.0 110.445 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.781 HD12 HD13 ' A' ' 28' ' ' ILE . 5.4 pt -140.14 133.74 15.3 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.49 172.43 8.11 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.158 2.572 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.6 pttp -43.49 -40.97 4.13 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -60.06 -43.13 95.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.507 0.194 . . . . 0.0 111.404 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.0 m -70.95 -45.57 63.93 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.766 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.781 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.32 -33.06 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.477 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.53 -67.54 2.16 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.25 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.4 -28.13 69.48 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.46 -46.76 88.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.28 -34.85 75.87 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.753 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.419 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.33 -41.08 65.37 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.794 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -63.68 -34.9 78.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.682 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -101.03 44.35 1.02 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.845 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.69 -97.78 0.57 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.817 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.68 170.43 14.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.721 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -122.47 131.96 24.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 59.3 Cg_endo -85.82 -163.27 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.973 2.449 . . . . 0.0 112.743 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p -98.15 163.25 12.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -51.53 -37.51 49.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.145 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.606 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -61.24 -55.12 35.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.0 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.73 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.58 -47.97 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.819 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -57.56 -41.73 81.59 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.75 -40.7 76.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 44' ' ' ILE . 20.2 mt -62.79 -51.01 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.037 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -56.44 -23.54 39.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.905 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 t -63.97 -7.6 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 p -118.23 -46.17 2.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.684 0.22 . . . . 0.0 111.146 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.76 156.57 49.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.7 Cg_exo -39.01 146.11 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.355 2.703 . . . . 0.0 113.279 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.08 -68.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.744 0.653 . . . . 0.0 112.609 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.5 tt0 -85.84 127.68 34.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.643 0.259 . . . . 0.0 110.399 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.65 87.77 2.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.032 0.444 . . . . 0.0 111.314 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -82.33 177.56 8.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 ttm -41.61 -45.09 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.78 -51.54 47.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.572 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mp0 -56.82 -51.85 67.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.527 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -48.88 79.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.93 -32.6 72.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.427 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -61.47 -51.77 67.29 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.066 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -70.43 -41.7 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.563 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.936 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -26.56 66.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.672 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.81 -50.4 58.6 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.466 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -72.96 -37.51 67.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.562 0.22 . . . . 0.0 111.008 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -79.12 4.78 13.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.76 -43.8 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -145.75 33.6 1.03 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.765 0.316 . . . . 0.0 111.413 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.448 ' CG ' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -130.92 76.24 1.71 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.063 0.459 . . . . 0.0 110.347 179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.93 -48.94 78.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.178 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -91.82 -64.02 1.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.99 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.448 ' HB2' ' CG ' ' A' ' 87' ' ' ASP . . . 48.82 52.86 13.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.803 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.4 p -102.73 -48.05 4.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.85 26.22 9.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.0 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.491 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -174.59 148.64 1.18 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.862 0.331 . . . . 0.0 110.974 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.521 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -118.11 -44.25 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.79 81.15 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.337 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.75 ' HA ' HD23 ' A' ' 99' ' ' LEU . 73.3 t -44.3 -34.81 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.68 -35.73 17.29 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.093 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -80.65 -46.34 15.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.619 0.21 . . . . 0.0 110.916 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.99 -39.92 83.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.857 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.471 ' HG2' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -75.07 -36.12 61.79 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.611 179.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.78 -40.54 63.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.905 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 82' ' ' GLY . 21.3 t -82.33 -51.46 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.532 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 99' ' ' LEU . 2.4 mt -58.31 -49.85 75.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 m -59.7 -39.3 84.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.445 0.164 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -72.13 -19.82 61.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.81 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt -65.35 -66.69 0.51 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.603 0.239 . . . . 0.0 110.97 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.92 47.86 0.47 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.336 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.61 45.89 7.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.8 mmmm -68.77 -137.7 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.158 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.843 HD22 ' HG2' ' A' ' 114' ' ' GLU . 34.6 mt -69.43 79.33 0.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.619 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -64.97 -173.02 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.913 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 4.3 p-10 -51.88 -34.89 43.09 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.606 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.6 -55.44 30.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.843 ' HG2' HD22 ' A' ' 110' ' ' LEU . 3.2 tp10 -55.34 -51.28 67.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.848 ' HA ' HD23 ' A' ' 118' ' ' LEU . 22.0 ptm -66.82 -27.6 67.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -47.3 83.58 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.82 -43.47 79.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.848 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.49 -43.11 97.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.634 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.451 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.4 mt -67.95 -32.62 73.19 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.236 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -41.58 98.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.617 0.246 . . . . 0.0 110.724 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.99 -44.2 37.53 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.878 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 124' ' ' VAL . 58.6 t -78.97 133.21 61.84 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.675 0.237 . . . . 0.0 111.189 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.39 59.94 7.31 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.788 2.326 . . . . 0.0 112.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 128' ' ' MET . 17.2 m -131.49 174.12 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 48.2 2.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.27 0.557 . . . . 0.0 110.555 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 175.13 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.834 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 112.71 50.3 0.56 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.922 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.35 114.46 28.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.268 0.556 . . . . 0.0 110.698 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 129' ' ' VAL . 40.4 t -142.18 26.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.101 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 62.67 24.34 14.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.122 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.451 ' CD1' HG13 ' A' ' 94' ' ' ILE . 4.8 t80 48.45 51.97 14.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 111.372 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.06 -54.31 1.12 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.564 ' CB ' HG11 ' A' ' 129' ' ' VAL . 19.5 t70 -57.82 -36.52 72.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.676 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' A' ' 94' ' ' ILE . 1.8 m-85 -68.46 -55.49 11.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.697 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.3 -31.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.568 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.03 -47.85 78.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.191 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.6 ttt . . . . . 0 CA--C 1.533 0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.504 -179.935 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 38.9 m-20 . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -67.2 -47.1 51.32 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.864 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 3.3 Cg_exo -75.17 -16.27 19.93 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.758 2.305 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -110.88 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 14.5 mmmt -72.3 -57.97 3.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 9.8 tp60 -58.82 -45.95 88.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.603 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -63.82 -35.52 80.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.125 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.0 t80 -57.89 -47.95 81.27 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 m -62.71 -33.87 75.99 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.198 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -58.59 -37.15 75.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.344 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 89.0 m-85 -95.75 34.0 1.57 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 83.11 6.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.681 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -68.16 -30.84 70.06 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -86.22 -29.93 22.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.554 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.34 30.26 58.87 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.631 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -129.77 27.81 5.17 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.74 21.82 71.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.986 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 42.7 mtt180 -130.23 157.04 43.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.916 0.358 . . . . 0.0 110.805 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.818 HD12 HD13 ' A' ' 28' ' ' ILE . 3.8 pt -146.86 133.93 10.08 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.816 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.01 168.34 12.18 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.992 2.461 . . . . 0.0 112.172 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.5 -38.01 3.87 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -60.46 -43.74 96.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 111.145 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.3 m -71.03 -46.57 61.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.647 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.818 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.64 -34.06 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.099 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.03 -70.37 0.99 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.504 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.68 68.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.496 0.148 . . . . 0.0 111.297 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 9.2 tp -62.34 -48.41 79.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.33 -33.19 73.19 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.769 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.454 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.43 -36.85 66.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.74 -36.69 58.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.713 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t -93.64 53.51 1.86 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 111.001 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.84 -89.51 0.81 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.854 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 169.11 14.87 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.441 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 11.1 p-10 -133.77 155.32 80.5 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.329 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 68.1 Cg_endo -84.02 -162.09 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.415 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -102.54 168.06 9.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -54.63 -33.17 60.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.19 85.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.71 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -67.37 -55.0 15.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.065 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.66 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.49 -46.04 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.934 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.6 m -61.47 -39.62 91.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -58.11 -38.4 76.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.316 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 44' ' ' ILE . 50.0 mt -63.55 -46.72 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.898 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.8 -28.77 61.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 m -63.88 -12.21 34.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.8 p -118.28 -14.66 9.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.735 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -125.05 153.36 71.34 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.549 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.3 Cg_exo -39.38 146.65 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.366 2.711 . . . . 0.0 113.077 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.05 -65.4 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -88.12 125.88 34.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.576 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 59' ' ' GLN . 58.8 t -86.55 89.82 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.2 p30 -83.17 176.94 8.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.388 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -41.49 -44.65 2.99 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.717 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -52.04 46.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.966 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.549 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.95 78.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.6 mt -61.38 -31.87 71.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.571 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -63.18 -52.16 63.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.161 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.735 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.06 -43.84 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.282 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.579 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.352 0.12 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.85 -53.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.317 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -40.68 97.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.277 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.596 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.14 -47.1 88.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.544 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.08 -26.45 65.84 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.496 0.148 . . . . 0.0 111.357 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.03 73.58 3.61 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.854 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.96 -66.32 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.523 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CB ' ' HG2' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -135.58 33.21 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.652 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -137.25 53.2 1.89 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.617 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.492 ' N ' ' HE2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -70.95 -3.21 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.475 ' N ' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -97.87 -60.69 1.51 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.722 0.237 . . . . 0.0 111.056 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.57 51.4 12.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.304 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 p -142.19 80.81 1.72 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.77 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.7 15.89 50.93 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.292 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptm -172.57 131.37 0.56 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.12 0.46 . . . . 0.0 111.402 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.596 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.9 -35.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.42 80.31 0.26 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.686 ' HA ' HD23 ' A' ' 99' ' ' LEU . 81.4 t -44.86 -34.43 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.21 -37.26 17.24 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.51 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.5 mp0 -75.57 -53.36 8.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.548 0.214 . . . . 0.0 110.63 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.27 -36.82 73.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.287 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.46 ' HG3' ' HG2' ' A' ' 115' ' ' MET . 2.1 tmt_? -68.48 -49.95 56.0 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -57.61 -36.85 72.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.34 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 98' ' ' GLU . 48.7 t -71.97 -47.75 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.763 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 110' ' ' LEU . 1.6 mt -73.4 -52.5 13.55 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 84.8 m -55.3 -37.03 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 t -76.79 -17.67 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -66.57 0.53 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.509 0.195 . . . . 0.0 111.212 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 58.67 0.27 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.59 39.38 17.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.404 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -68.92 -137.77 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.197 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.596 HD23 ' HG2' ' A' ' 114' ' ' GLU . 9.4 mt -68.79 78.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 110.754 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -66.07 -170.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.938 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -51.0 -38.37 50.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.943 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.31 -51.17 68.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HG2' HD23 ' A' ' 110' ' ' LEU . 2.2 mp0 -57.69 -53.21 60.8 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.848 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.855 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.83 -27.88 67.91 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -45.23 89.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.677 0.275 . . . . 0.0 110.555 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.38 -40.29 74.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.79 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.97 -42.22 99.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.826 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.411 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -73.52 -30.86 63.37 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.407 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -63.14 -41.14 99.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.77 -0.195 . . . . 0.0 110.958 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.36 -43.16 39.25 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.985 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.478 HG11 ' CG2' ' A' ' 129' ' ' VAL . 46.2 t -81.83 130.29 61.47 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.705 0.253 . . . . 0.0 111.155 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.96 62.45 6.62 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.585 HG21 ' H ' ' A' ' 128' ' ' MET . 4.7 p -131.2 167.42 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.444 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.5 OUTLIER -127.48 54.44 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.088 0.47 . . . . 0.0 111.154 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.4 -37.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.561 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.521 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 113.96 39.19 1.08 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.296 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.585 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -103.16 113.96 27.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.26 0.552 . . . . 0.0 110.762 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 129' ' ' VAL . 37.9 t -142.31 21.39 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.433 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.75 22.39 12.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.446 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 2.1 t80 46.63 45.42 14.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 -51.08 2.52 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.407 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.83 -36.62 77.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.788 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -68.16 -55.74 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.685 0.278 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.57 -32.73 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.232 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.84 -49.7 76.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.712 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.2 ttt . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 179.273 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.442 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t -64.0 -48.31 78.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.771 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 6' ' ' SER . 71.5 Cg_endo -78.75 -14.36 14.04 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.389 2.06 . . . . 0.0 114.074 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -111.26 -61.41 1.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -60.13 2.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.597 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.463 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 8.1 tt0 -58.97 -47.04 86.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.631 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.6 -36.3 78.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.096 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.455 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.6 t80 -58.47 -49.31 77.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -61.92 -34.3 75.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 14.2 mt -55.62 -36.95 67.52 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 111.358 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -96.15 33.5 1.73 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -84.67 84.31 7.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.242 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -67.26 -34.49 77.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.46 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -86.55 -32.59 20.61 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.4 26.79 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.508 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.2 p -137.25 30.16 2.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.668 0.27 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.23 20.63 71.41 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.812 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 13.3 mtt180 -130.65 158.62 39.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.777 0.288 . . . . 0.0 110.533 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 28' ' ' ILE . 5.7 pt -145.49 138.08 13.7 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 95.7 Cg_endo -88.67 172.73 4.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.207 2.605 . . . . 0.0 112.131 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 4.5 pttm -44.33 -36.25 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -59.9 -46.25 89.93 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -71.22 -50.51 32.21 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.84 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.85 -35.45 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.338 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.18 -70.95 0.83 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.235 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.17 -28.26 69.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.59 0.195 . . . . 0.0 111.453 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.72 -48.01 83.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.6 -34.47 75.7 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.858 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -32.41 64.71 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.297 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.56 -43.48 65.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.5 m -64.32 -43.73 93.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.925 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.18 -65.97 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.984 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.63 163.46 28.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -136.07 151.72 74.17 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.477 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.7 Cg_endo -86.47 -163.28 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.138 2.559 . . . . 0.0 112.74 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -99.58 169.05 9.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.261 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.3 mm? -54.09 -36.09 62.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.113 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.52 80.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.559 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -67.71 -52.23 40.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.834 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.85 -45.65 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.337 -0.145 . . . . 0.0 110.641 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -40.02 78.05 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -40.92 88.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.614 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 44' ' ' ILE . 18.7 mt -63.36 -49.08 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -57.22 -24.86 57.45 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.678 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -64.03 -10.69 23.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.4 p -117.92 -41.54 2.89 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 120.34 0.114 . . . . 0.0 111.025 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -92.84 150.78 40.06 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.544 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.3 Cg_exo -38.32 143.31 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.233 2.622 . . . . 0.0 112.821 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.25 -61.35 0.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.73 0.644 . . . . 0.0 112.659 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -87.29 121.01 29.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.491 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.64 83.64 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.3 p30 -82.77 178.11 8.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.494 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.9 mtp -41.43 -46.01 3.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.59 -52.16 54.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.962 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.544 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.57 -52.59 64.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -49.31 75.92 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.121 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.57 -30.04 70.41 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -64.2 -49.46 71.93 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.433 0.159 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.616 HG21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.51 -45.92 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.849 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.334 -0.066 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 120.356 0.122 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.85 -56.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -24.77 67.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.687 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -65.21 -52.72 38.29 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.4 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -77.69 -41.47 37.92 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.437 0.16 . . . . 0.0 111.053 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -78.65 71.76 5.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.957 0.408 . . . . 0.0 110.986 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.646 ' HB ' HG21 ' A' ' 102' ' ' VAL . 14.9 p -111.99 -42.01 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.29 40.36 1.76 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -125.25 57.53 1.31 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -49.24 74.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.556 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -97.83 -48.31 5.24 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.444 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.02 73.48 0.47 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 91' ' ' THR . 10.1 t -92.06 70.29 5.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.29 57.34 17.27 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.62 135.74 1.97 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 111.015 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -108.89 -44.16 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.46 80.12 0.12 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.422 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.794 ' HA ' HD23 ' A' ' 99' ' ' LEU . 95.4 t -44.44 -40.07 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.71 -36.15 8.09 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.163 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 mm-40 -80.85 -46.01 15.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.63 0.215 . . . . 0.0 110.909 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -42.08 84.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.893 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -75.01 -36.06 61.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.828 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -52.82 -41.34 64.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.522 0.201 . . . . 0.0 111.014 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.646 HG21 ' HB ' ' A' ' 85' ' ' VAL . 2.6 t -83.04 -52.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.649 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -56.45 -47.12 79.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -58.22 -35.38 71.58 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -67.86 -21.47 65.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.1 mt -66.35 -67.43 0.45 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.512 0.196 . . . . 0.0 111.026 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.31 49.65 0.46 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.542 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.2 48.68 4.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.345 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -68.49 -138.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.125 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.803 HD22 ' HG2' ' A' ' 114' ' ' GLU . 15.1 mt -69.68 78.01 0.44 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.885 0.374 . . . . 0.0 110.639 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.3 p -68.78 -171.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.867 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -50.88 -39.54 54.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.03 -53.52 48.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.524 0.202 . . . . 0.0 111.275 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.803 ' HG2' HD22 ' A' ' 110' ' ' LEU . 4.1 tp10 -54.78 -52.86 61.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.88 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -65.61 -27.76 68.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -44.77 90.46 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.32 -43.82 80.69 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.92 -42.5 98.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.06 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.3 mt -71.52 -28.95 64.25 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.146 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -63.97 -41.21 97.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.572 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.12 -48.79 24.33 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.829 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.497 HG11 HG22 ' A' ' 129' ' ' VAL . 21.4 t -81.73 123.69 80.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.62 0.21 . . . . 0.0 110.808 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.75 62.23 6.41 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.565 2.177 . . . . 0.0 112.864 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.73 178.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.212 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -119.29 130.43 55.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.48 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 22.8 m-20 80.7 -34.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.061 0.544 . . . . 0.0 111.814 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 118.07 50.69 0.34 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.457 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.425 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.7 OUTLIER -104.01 116.84 32.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.705 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 129' ' ' VAL . 36.7 t -142.32 20.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.258 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 56.72 25.31 10.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.7 t80 44.77 44.49 7.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -53.54 2.53 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.575 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.9 t70 -56.13 -37.08 68.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.3 m-85 -68.2 -58.95 3.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.83 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -62.27 -32.99 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -61.2 -52.66 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 110.645 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.461 0.085 0 CA-C-O 120.807 0.336 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -59.41 -48.04 96.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.69 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.0 Cg_endo -81.74 -14.39 10.13 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.513 2.142 . . . . 0.0 114.123 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -110.52 -61.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -62.7 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.547 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -57.29 -47.6 81.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.677 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.2 -41.92 85.02 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.6 t80 -56.71 -42.82 79.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.592 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -61.4 -36.49 80.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.2 mt -63.26 -34.1 76.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -93.96 29.65 2.06 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.08 125.02 29.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.733 0.301 . . . . 0.0 110.821 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.53 -58.3 3.84 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.398 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -108.28 6.03 26.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.17 43.13 99.8 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.792 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.0 p -118.41 10.83 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 1.19 68.95 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.381 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -125.04 167.29 14.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.149 0.475 . . . . 0.0 110.898 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.74 HD12 HD13 ' A' ' 28' ' ' ILE . 7.6 pt -147.41 136.43 11.53 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -87.38 172.01 6.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.245 2.63 . . . . 0.0 112.488 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 6.0 pttt -44.41 -39.27 4.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.2 p -59.5 -43.31 93.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.453 0.168 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 25.4 m -71.16 -52.37 19.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.614 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.74 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.86 -35.36 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.76 -71.22 0.75 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -26.59 68.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.8 -50.14 67.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.702 0.287 . . . . 0.0 110.276 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.33 -28.11 68.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -54.75 -37.95 66.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.519 0.2 . . . . 0.0 110.749 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.18 72.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.577 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -83.74 -41.89 17.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.476 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.39 -84.32 0.05 OUTLIER Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.59 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.1 171.65 13.7 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.6 t-20 -123.3 108.77 31.6 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.317 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.38 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.849 2.366 . . . . 0.0 112.552 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 p -90.42 166.4 13.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.5 mm? -55.7 -34.53 65.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.789 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.54 -37.22 77.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.52 -54.2 31.56 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.653 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.06 -44.29 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.748 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 m -58.07 -43.59 87.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.343 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.47 -40.12 74.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.645 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 44' ' ' ILE . 24.6 mt -64.99 -49.35 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.8 -23.37 43.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.748 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -64.56 -6.49 7.65 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -117.76 -45.59 2.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.789 0.268 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.606 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -89.36 156.19 48.48 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.4 Cg_exo -41.67 149.31 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 113.116 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.72 -64.18 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.646 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.1 mt-10 -86.44 123.58 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.704 0.288 . . . . 0.0 110.614 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.92 87.85 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.9 p30 -83.92 -179.93 7.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 37.2 mtt -41.41 -44.59 2.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -69.12 -52.27 29.98 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.56 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.27 -51.57 68.83 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.614 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.437 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.68 -48.54 81.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.921 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 61' ' ' LEU . 35.0 mt -61.01 -34.51 74.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.505 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -60.28 -49.81 76.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.577 0.227 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.477 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.57 -36.49 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD13 ' HE1' ' A' ' 60' ' ' PHE . 1.6 tp . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.03 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.55 0.214 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.92 -39.04 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.926 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -35.36 77.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.324 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' C ' HG11 ' A' ' 102' ' ' VAL . . . -71.63 -54.69 8.25 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.755 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -57.9 -45.64 86.15 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.512 0.196 . . . . 0.0 110.666 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.98 65.13 5.04 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.85 -41.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.496 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -121.83 32.16 5.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.01 75.0 1.48 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.548 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -44.15 92.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.5 -59.28 2.36 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.846 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 55.71 70.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -128.22 68.36 1.35 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.0 38.76 3.27 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.802 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.41 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.0 OUTLIER -172.86 134.56 0.59 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.675 0.238 . . . . 0.0 110.976 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -107.26 -41.78 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.12 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.54 80.96 0.38 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.328 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.756 ' HA ' HD23 ' A' ' 99' ' ' LEU . 79.6 t -45.12 -39.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.03 -40.04 42.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.258 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.4 tt0 -71.93 -47.92 49.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.225 0.21 . . . . 0.0 110.474 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.35 -37.74 75.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.207 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.489 ' HG3' ' HG3' ' A' ' 115' ' ' MET . 0.2 OUTLIER -68.16 -43.99 77.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.675 179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -58.47 -36.79 74.25 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.361 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 98' ' ' GLU . 16.1 t -77.8 -50.28 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.602 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.557 HD12 ' CD1' ' A' ' 99' ' ' LEU . 4.6 mt -63.73 -42.61 97.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.6 m -64.73 -41.72 95.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.499 0.19 . . . . 0.0 111.007 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.5 p -70.37 -15.2 62.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.861 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.55 -56.92 4.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.46 42.99 0.23 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.84 47.28 15.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 46.9 mmtm -68.52 -138.66 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.51 79.67 0.57 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.0 p -62.21 -177.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.933 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.416 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 7.2 p30 -48.9 -29.75 5.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.468 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -60.0 -62.75 1.64 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -42.04 86.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.793 ' HA ' HD23 ' A' ' 118' ' ' LEU . 6.0 mmt -65.95 -33.84 76.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -48.9 77.98 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.233 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.59 -40.65 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.33 -42.16 95.08 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.409 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.436 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -68.91 -31.17 69.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.324 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -62.94 -42.24 99.74 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.5 65.62 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.902 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.73 126.35 71.06 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.667 0.234 . . . . 0.0 111.176 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.25 61.07 5.79 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.598 2.199 . . . . 0.0 112.333 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 125' ' ' LYS . 2.2 p -131.87 171.46 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.294 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -118.28 132.17 56.31 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 26.8 m-20 81.35 -47.51 0.24 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.523 0.514 . . . . 0.0 110.841 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.2 53.16 0.16 Allowed Glycine 0 C--N 1.339 0.71 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.711 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.454 ' O ' HG21 ' A' ' 124' ' ' VAL . 0.3 OUTLIER -107.22 107.41 18.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.544 0.688 . . . . 0.0 110.904 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 129' ' ' VAL . 47.7 t -142.32 19.59 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.624 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.85 21.69 7.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.853 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.413 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.9 OUTLIER 54.79 -164.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.21 -57.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.235 0.214 . . . . 0.0 111.359 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -52.65 -39.18 61.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.7 m-85 -68.65 -54.81 14.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.637 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.03 -31.31 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.293 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -69.6 -54.23 15.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.492 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.46 0.031 0 CA-C-O 120.772 0.32 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.6 t -61.72 -46.02 93.11 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 5.0 Cg_exo -75.39 -14.4 20.33 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.987 2.458 . . . . 0.0 114.046 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -118.12 -63.13 1.46 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -66.21 -60.68 2.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 8.0 tt0 -60.56 -47.14 87.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.61 -37.05 80.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 23' ' ' ILE . 24.7 t80 -59.01 -46.77 87.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.326 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -62.41 -32.73 73.61 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.266 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -59.95 -34.07 72.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.497 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -102.05 36.33 2.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.92 101.68 14.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -50.05 67.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -86.84 -35.79 18.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.386 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.08 40.01 6.74 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.584 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.3 p -127.83 32.72 4.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.06 19.2 73.62 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.984 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 1.1 mtt-85 -130.98 157.2 43.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.794 0.297 . . . . 0.0 110.688 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.806 HD12 HD13 ' A' ' 28' ' ' ILE . 7.0 pt -143.57 137.94 14.93 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 84.1 Cg_endo -88.3 171.53 5.4 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.166 2.577 . . . . 0.0 112.702 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 15.8 pttm -44.19 -36.63 2.75 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.5 p -60.15 -46.21 90.45 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -70.72 -49.95 41.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.94 -34.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.346 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.12 -72.56 0.56 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.215 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -27.19 65.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.593 0.196 . . . . 0.0 111.456 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.13 -48.38 78.74 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -61.55 -31.5 71.53 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.962 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.426 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -56.13 -33.67 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.142 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.3 -38.02 68.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.28 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -92.66 58.15 3.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.0 0.428 . . . . 0.0 110.477 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.41 -91.71 1.09 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.406 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 172.37 12.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 12.4 p-10 -132.05 155.82 80.87 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 65.3 Cg_endo -85.03 -161.91 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.034 2.489 . . . . 0.0 112.41 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 p -102.17 167.32 10.08 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.076 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.407 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.5 mm? -53.58 -35.23 60.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.17 88.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.708 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -66.76 -52.22 46.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.271 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.598 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -54.95 -46.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -58.42 -43.08 88.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.307 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.51 -40.97 75.9 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.562 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 44' ' ' ILE . 38.8 mt -63.59 -48.2 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.23 -23.58 48.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -63.69 -12.09 31.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.4 p -118.04 -41.11 2.91 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.946 0.098 . . . . 0.0 110.911 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.499 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -91.2 148.35 37.6 Favored Pre-proline 0 N--CA 1.465 0.286 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.47 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -36.62 140.43 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.391 2.727 . . . . 0.0 113.148 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.86 -58.5 0.13 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.636 . . . . 0.0 112.448 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -89.4 122.32 32.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.185 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.36 88.49 2.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 121.029 0.443 . . . . 0.0 110.647 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.2 p30 -82.6 177.77 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.498 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.9 mtm -41.36 -43.73 2.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.907 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.84 -51.19 35.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.47 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -56.29 -50.74 70.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.504 0.192 . . . . 0.0 111.08 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -47.59 83.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.86 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 61' ' ' LEU . 26.8 mt -62.1 -30.93 71.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -63.65 -54.58 33.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.507 0.194 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.24 -40.9 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.903 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.859 179.631 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.393 0 CA-C-O 120.461 0.172 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.84 -50.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.602 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.466 ' O ' HG11 ' A' ' 102' ' ' VAL . 1.4 tppt? -60.13 -32.87 71.42 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -63.21 -54.08 35.22 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.502 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -78.02 -22.37 49.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.66 75.02 4.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.1 0.476 . . . . 0.0 111.031 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 86' ' ' PHE . 7.1 p -141.75 -49.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.906 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.447 ' N ' HG13 ' A' ' 85' ' ' VAL . 9.6 m-85 -156.29 43.44 0.4 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 110.722 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.96 59.95 1.72 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -50.23 74.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.93 -46.08 5.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.888 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.24 38.77 28.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.54 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 p -118.47 82.55 1.87 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.7 -18.02 5.44 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.157 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.1 OUTLIER -163.77 132.37 3.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.085 0.442 . . . . 0.0 110.898 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.587 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.38 -41.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.853 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.52 80.4 0.2 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.705 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.782 ' HA ' HD23 ' A' ' 99' ' ' LEU . 96.9 t -45.12 -38.61 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 122.3 0.24 . . . . 0.0 111.641 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.55 -36.36 17.79 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.9 mm-40 -77.45 -48.1 18.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 0.173 . . . . 0.0 110.71 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.72 -39.36 80.61 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.744 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HD3' ' HG2' ' A' ' 115' ' ' MET . 14.1 ttp180 -75.71 -39.47 57.32 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -53.9 -40.78 66.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 98' ' ' GLU . 3.8 t -77.91 -52.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.653 0.264 . . . . 0.0 111.412 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.899 HD22 ' HG2' ' A' ' 109' ' ' LYS . 5.7 mt -56.5 -46.77 80.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.948 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.2 m -66.56 -35.59 80.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -66.02 -22.07 66.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.728 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.01 -67.86 0.43 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 110.983 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.55 44.68 0.56 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.258 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.4 50.41 4.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 111.182 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.899 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -68.51 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.902 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.617 HD22 ' HG3' ' A' ' 114' ' ' GLU . 62.3 mt -67.23 79.44 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.372 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.8 p -63.8 -169.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.438 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 115' ' ' MET . 3.5 m120 -50.43 -33.71 21.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.521 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -56.37 -51.72 67.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.568 0.223 . . . . 0.0 111.483 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.617 ' HG3' HD22 ' A' ' 110' ' ' LEU . 1.6 tm-20 -56.58 -56.79 16.93 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.922 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.6 OUTLIER -65.45 -24.68 67.24 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.638 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -48.28 81.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -68.01 -43.54 78.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.71 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.922 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.73 -42.19 96.82 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.944 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 4.1 mt -69.79 -30.24 67.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.073 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -40.39 96.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.625 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.48 -47.48 16.26 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.952 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.458 HG11 HG22 ' A' ' 129' ' ' VAL . 26.2 t -81.35 125.8 78.08 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.688 0.244 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.49 61.61 7.96 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.652 2.235 . . . . 0.0 112.662 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 128' ' ' MET . 22.9 m -131.57 -177.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.236 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.05 129.91 55.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.083 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 78.71 -49.38 0.45 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.851 0.46 . . . . 0.0 111.049 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 136.14 51.27 0.07 OUTLIER Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.618 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.488 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 1.9 ttp -104.17 116.73 32.71 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.121 0.486 . . . . 0.0 110.659 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 129' ' ' VAL . 29.7 t -142.03 20.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.463 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 59.92 25.77 14.95 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.472 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 3.0 t80 44.31 41.63 4.58 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.236 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -52.98 2.69 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.839 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.526 ' HB3' HG11 ' A' ' 129' ' ' VAL . 23.6 t70 -56.9 -36.75 70.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.8 m-85 -67.93 -57.35 6.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.55 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.94 -35.19 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.41 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.77 -56.03 26.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.2 tpp . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.074 179.385 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 4.1 t -67.31 -47.64 48.66 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.785 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 6' ' ' SER . 98.8 Cg_endo -80.73 -13.34 11.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.466 2.11 . . . . 0.0 114.193 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.37 -61.27 1.69 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -59.62 2.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.336 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.35 -47.42 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.716 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.79 -41.02 85.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.966 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.454 ' CE2' HG12 ' A' ' 23' ' ' ILE . 6.1 t80 -56.39 -45.39 80.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.456 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.8 m -62.64 -33.82 75.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.733 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 16.1 mt -57.52 -30.28 65.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 23' ' ' ILE . 69.5 m-85 -91.69 33.22 1.03 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.54 112.3 14.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.909 0.385 . . . . 0.0 110.846 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -49.72 42.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -115.53 -0.92 12.91 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 48.5 33.57 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.559 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.5 p -121.38 16.64 11.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.65 14.01 80.01 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.194 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -130.29 158.45 39.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.922 0.361 . . . . 0.0 110.668 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.61 HD12 HD13 ' A' ' 28' ' ' ILE . 8.8 pt -140.96 135.04 15.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.73 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.25 170.66 9.36 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.074 2.516 . . . . 0.0 112.477 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -42.81 -38.16 2.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.6 p -60.41 -45.38 93.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.506 0.193 . . . . 0.0 111.293 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.459 ' CB ' ' HB ' ' A' ' 23' ' ' ILE . 2.9 m -69.97 -44.73 68.85 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.61 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.21 -33.47 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.411 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.45 -65.99 3.15 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.392 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -28.02 69.24 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.56 -49.18 77.7 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.32 -29.48 69.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.076 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -36.63 70.6 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.85 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.23 -30.14 71.0 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.418 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -109.4 32.05 5.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.799 0.333 . . . . 0.0 110.84 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.55 -105.08 0.28 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.366 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -132.4 178.81 6.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.615 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.74 116.04 34.88 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.369 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -84.57 -162.63 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.016 2.478 . . . . 0.0 112.764 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 p -98.16 164.06 12.48 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.24 -36.48 63.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.021 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.82 80.59 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.02 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -54.6 20.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.64 -44.95 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.484 0.183 . . . . 0.0 110.632 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.7 m -59.1 -38.99 80.86 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -40.5 85.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.277 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 44' ' ' ILE . 22.5 mt -63.56 -47.94 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -56.82 -25.48 56.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.414 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 t -64.47 -7.42 9.97 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -117.75 -50.52 2.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.748 0.249 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -87.27 153.66 53.92 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.507 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 85.6 Cg_exo -38.85 144.95 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.265 2.643 . . . . 0.0 113.044 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.68 -68.66 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.74 126.78 33.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.637 0.256 . . . . 0.0 110.601 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.55 89.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.5 p30 -86.08 -179.69 6.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.539 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -41.28 -45.15 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.817 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -67.55 -53.62 26.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.507 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.31 -51.99 67.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -50.1 75.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.46 -32.47 72.46 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.414 0.15 . . . . 0.0 111.326 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.19 -50.3 74.57 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.025 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.57 -34.45 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.356 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.635 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 120.48 0.181 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.43 -44.56 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.276 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -34.62 77.6 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.65 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.818 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -61.07 -48.36 86.46 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.214 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -70.97 -34.36 71.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.508 0.194 . . . . 0.0 110.724 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -78.78 72.27 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.2 -63.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.475 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -116.5 42.21 2.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.141 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.33 65.42 0.67 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.671 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -59.64 -53.51 57.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.87 -66.95 1.0 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.595 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.21 63.75 1.84 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.572 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -64.84 -47.72 76.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.27 64.77 0.5 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.403 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -178.1 150.22 0.59 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.224 0.21 . . . . 0.0 110.487 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.588 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.25 -41.53 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.507 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.51 80.34 0.18 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.334 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.704 ' HA ' HD23 ' A' ' 99' ' ' LEU . 91.3 t -45.14 -33.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -43.76 15.62 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.109 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -76.93 -49.91 14.49 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.583 0.192 . . . . 0.0 111.045 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.725 HD12 HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -57.32 -37.58 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.272 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 104' ' ' THR . 35.7 ttp85 -70.8 -46.98 61.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.79 -38.05 54.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.284 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.818 HG11 ' HA2' ' A' ' 82' ' ' GLY . 22.4 t -75.11 -49.03 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.815 HD22 ' HG2' ' A' ' 109' ' ' LYS . 9.4 mt -63.07 -35.27 79.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.407 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 111' ' ' SER . 68.2 p -63.75 -37.8 88.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.603 0.24 . . . . 0.0 111.021 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.1 m -72.74 -17.05 61.64 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.05 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -67.34 -56.91 7.79 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 110.772 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.06 48.78 0.07 OUTLIER Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.156 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 64.01 39.12 8.16 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 111.035 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.815 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.66 -137.05 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.593 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.804 HD23 ' HB3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -67.51 83.56 0.17 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.603 ' HA ' HG22 ' A' ' 104' ' ' THR . 0.0 OUTLIER -86.71 -167.55 1.92 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.967 -178.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 11.1 p30 -55.43 -28.86 56.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -67.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.804 ' HB3' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -55.71 -44.98 77.95 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.148 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.804 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.54 -29.27 69.32 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.106 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER -58.69 -47.52 84.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.25 -42.71 99.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.8 -41.72 98.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.742 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.456 HD12 ' SD ' ' A' ' 115' ' ' MET . 4.3 mt -67.7 -32.18 72.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -45.22 91.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.967 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.94 -45.66 41.01 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.785 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 129' ' ' VAL . 86.7 t -75.63 133.49 73.62 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.488 0.185 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 58.48 6.5 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.84 2.36 . . . . 0.0 112.657 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.593 HG21 ' H ' ' A' ' 128' ' ' MET . 5.1 p -131.43 166.84 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 124' ' ' VAL . 3.0 mtpp -124.33 55.56 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.92 0.391 . . . . 0.0 111.25 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.7 p-10 170.26 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 116.45 40.98 0.76 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.593 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -103.25 114.26 28.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 110.618 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 129' ' ' VAL . 25.8 t -142.44 27.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.225 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 60.21 20.23 9.61 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.5 t80 46.61 41.75 10.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.821 0.343 . . . . 0.0 111.187 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -50.07 2.37 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.667 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' HB3' HG11 ' A' ' 129' ' ' VAL . 20.6 t70 -56.37 -41.29 75.95 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -66.4 -57.85 6.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.77 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.11 -30.09 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.512 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.17 -57.4 12.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.659 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.902 179.235 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 12.0 m-20 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.1 0.476 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.433 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -67.41 -46.64 48.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.984 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.3 Cg_endo -82.82 1.98 8.78 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.438 2.092 . . . . 0.0 114.106 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.506 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 56.9 m-85 -124.27 -66.76 0.96 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -55.27 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 1.4 tp60 -62.36 -49.33 75.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.676 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.51 -38.2 77.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.9 t80 -58.83 -46.48 87.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.401 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -62.57 -31.6 72.44 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.656 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 12.8 mt -60.31 -38.1 82.62 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 23' ' ' ILE . 24.3 m-85 -96.04 34.47 1.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.4 95.27 9.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.07 -36.43 77.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.566 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -86.91 -41.28 14.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.369 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.22 10.51 55.92 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.165 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -103.96 -12.91 16.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.075 0.437 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.45 28.85 3.61 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.54 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -130.56 155.59 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.371 0.268 . . . . 0.0 110.367 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.745 HD12 HD13 ' A' ' 28' ' ' ILE . 5.4 pt -145.24 132.5 10.19 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.43 171.4 9.97 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.975 2.45 . . . . 0.0 111.985 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.17 -37.83 7.52 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.3 p -61.94 -41.89 98.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.372 0.13 . . . . 0.0 111.152 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 9.8 m -70.41 -46.35 64.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.403 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.745 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.03 -34.87 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.482 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.01 -70.63 0.9 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.54 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -27.86 69.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.349 0.119 . . . . 0.0 111.291 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -61.54 -50.91 70.77 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.645 0.26 . . . . 0.0 110.366 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.58 -31.53 71.59 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.119 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.45 -39.64 70.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.01 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.84 75.5 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.533 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -77.45 -44.03 30.39 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.662 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.43 -76.98 0.02 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 168.5 17.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.879 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -122.45 117.12 29.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.447 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.31 -162.25 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.893 2.396 . . . . 0.0 112.464 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -94.26 164.28 13.1 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.107 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.8 mm? -56.71 -30.95 64.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.44 86.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.723 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -55.53 16.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.83 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.18 -45.11 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.906 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.2 m -61.27 -40.15 93.05 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.57 -38.68 78.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 44' ' ' ILE . 23.3 mt -61.9 -51.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.6 -23.78 43.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.72 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -9.58 15.21 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -118.24 -46.42 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.647 0.203 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.555 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -90.24 158.39 43.82 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.8 Cg_exo -42.49 150.21 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.14 2.56 . . . . 0.0 113.214 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.14 -64.92 0.33 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.099 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.39 119.83 24.66 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 59' ' ' GLN . 59.7 t -86.8 89.47 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.212 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 4.2 p30 -84.48 -179.89 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.49 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 mtt -41.92 -46.59 4.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.827 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -67.11 -51.03 59.21 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.586 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.17 -51.12 70.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -50.89 69.72 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.724 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.12 -26.15 68.14 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.473 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -65.57 -51.47 59.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.67 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.61 -41.58 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.828 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.08 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.873 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.296 0.109 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -65.41 -53.04 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.465 0.174 . . . . 0.0 110.843 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -60.82 -29.49 69.51 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.689 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.79 -53.38 15.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.063 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -77.89 -36.81 49.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.93 74.05 2.16 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.201 0.524 . . . . 0.0 111.243 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.88 -55.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.232 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -144.14 49.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.317 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 1.1 m-20 -129.63 74.82 1.61 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.709 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -47.34 78.22 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.73 -71.3 0.51 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.69 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 57.34 -170.14 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.218 0.324 . . . . 0.0 111.657 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 m 72.11 -69.93 0.17 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.666 0.386 . . . . 0.0 111.542 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.72 6.45 83.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.562 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 143.86 5.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.274 0.537 . . . . 0.0 111.025 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -124.32 141.12 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -109.27 81.22 0.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.058 -0.591 . . . . 0.0 111.639 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.021 HG11 HD21 ' A' ' 118' ' ' LEU . 93.9 t -43.32 -41.18 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.06 -46.65 33.22 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.038 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -81.59 -41.12 21.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.101 0.161 . . . . 0.0 110.958 179.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.01 -47.18 78.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.704 0.288 . . . . 0.0 110.702 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' HD3' HG13 ' A' ' 96' ' ' VAL . 3.0 mpt_? -72.57 -37.08 68.32 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.33 -38.68 63.46 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.538 0.209 . . . . 0.0 111.123 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.689 HG11 ' HA2' ' A' ' 82' ' ' GLY . 2.6 t -75.13 -49.12 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.456 HD23 HD12 ' A' ' 106' ' ' LEU . 1.1 mt -63.54 -34.99 79.02 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.36 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.9 m -62.24 -32.45 73.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.567 0.223 . . . . 0.0 111.163 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 m -69.54 -17.0 63.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.456 HD12 HD23 ' A' ' 103' ' ' LEU . 3.7 mt -63.97 -71.81 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 110.977 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.4 51.3 0.43 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.974 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 61.14 49.1 5.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.013 0.435 . . . . 0.0 110.732 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -68.32 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.495 HD22 ' OE2' ' A' ' 114' ' ' GLU . 19.0 mt -70.21 79.82 0.52 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.5 p -61.7 -175.39 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.011 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -50.22 -32.57 16.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.408 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.89 -51.84 67.57 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.495 ' OE2' HD22 ' A' ' 110' ' ' LEU . 1.2 tp10 -57.48 -53.36 59.04 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.894 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -66.3 -26.8 67.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.402 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.86 -48.59 80.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.676 0.274 . . . . 0.0 110.339 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.88 -40.62 87.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.021 HD21 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.42 -41.6 98.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.694 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.427 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.1 mt -68.54 -33.26 73.8 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.983 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -63.32 -41.0 98.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.66 -45.06 18.74 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.844 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.8 t -79.24 125.22 83.74 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.693 0.247 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 5.2 Cg_exo -73.76 62.79 4.76 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.909 2.406 . . . . 0.0 112.32 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 128' ' ' MET . 16.0 m -131.35 175.15 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.242 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -124.19 47.62 2.05 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.084 0.469 . . . . 0.0 110.855 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.8 p-10 173.03 -34.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.72 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 110.7 48.49 0.73 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -103.87 117.66 34.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 129' ' ' VAL . 38.4 t -142.37 31.16 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.989 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 59.24 23.12 11.45 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 46.33 44.5 12.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.926 0.394 . . . . 0.0 111.297 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.84 -52.69 2.43 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.35 -37.24 80.06 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.181 0.301 . . . . 0.0 111.757 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -66.39 -56.46 10.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.83 -31.28 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.462 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.42 -55.14 37.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.5 ttt . . . . . 0 CA--C 1.531 0.224 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.57 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.993 0.425 . . . . 0.0 110.895 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.448 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -66.75 -46.55 56.2 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.412 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 6' ' ' SER . 11.5 Cg_exo -71.36 -17.95 30.3 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.898 2.398 . . . . 0.0 113.85 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -114.46 -63.41 1.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 5' ' ' ASP . 8.0 tptt -65.88 -61.11 2.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.369 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -59.85 -45.69 91.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.401 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.57 -40.51 87.57 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CE2' HG12 ' A' ' 23' ' ' ILE . 10.6 t80 -54.69 -45.64 73.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.297 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -36.38 81.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.14 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.547 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 6.0 mt -62.14 -33.23 74.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.382 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -93.29 34.12 1.17 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.51 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.51 96.23 8.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -42.4 99.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.048 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -87.39 -37.26 17.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.42 33.11 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.712 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.1 p -117.38 -11.42 10.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.17 2.94 9.92 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.353 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 2.6 mtt-85 -117.08 163.14 16.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 117.241 0.52 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.801 HD12 HD13 ' A' ' 28' ' ' ILE . 5.2 pt -144.98 131.21 9.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.668 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 89.1 Cg_endo -84.61 169.74 10.62 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.066 2.511 . . . . 0.0 112.412 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.43 -37.9 5.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -60.78 -44.07 97.25 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.538 0.209 . . . . 0.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 7.5 t -67.99 -51.07 51.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.801 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.17 -37.33 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -70.58 0.9 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.668 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -26.14 68.54 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -64.71 -48.31 75.13 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -29.62 70.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.232 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -41.52 68.02 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.704 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.02 69.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.711 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.88 39.38 1.87 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.809 0.338 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.2 -102.3 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.748 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.05 -176.43 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -118.68 114.75 35.69 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.823 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.78 -162.54 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.796 2.331 . . . . 0.0 112.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 p -102.97 162.16 13.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -55.06 -32.9 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.13 79.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.696 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.37 -54.43 20.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -60.21 -47.78 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.895 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.2 m -59.21 -38.86 80.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.69 -38.07 80.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.516 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 44' ' ' ILE . 19.2 mt -65.36 -50.16 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.99 -24.23 51.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.048 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 p -64.65 -7.34 10.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 p -117.75 -43.6 2.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.652 0.206 . . . . 0.0 111.269 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.579 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -93.37 158.92 36.2 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 99.0 Cg_exo -42.82 151.71 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.151 2.568 . . . . 0.0 113.12 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.64 -64.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.61 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.1 mt-10 -87.5 124.4 33.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.516 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 59' ' ' GLN . 48.3 t -86.61 88.92 2.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -82.21 177.2 8.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.405 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -41.38 -45.47 3.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.662 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -66.9 -51.38 56.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.043 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.53 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.71 -51.44 68.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -49.83 74.02 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.498 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.63 -47.98 79.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.115 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.47 -39.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.164 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.669 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 120.407 0.146 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.72 -48.4 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.826 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -31.05 70.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.849 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.17 -55.79 9.91 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.344 0.116 . . . . 0.0 110.7 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -79.01 69.15 5.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.052 0.453 . . . . 0.0 110.683 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.14 -45.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.04 19.69 7.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.45 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.7 80.49 1.73 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -55.48 33.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.75 -35.51 9.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . . . 62.18 65.77 0.86 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -69.12 -38.0 78.63 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.73 64.78 0.06 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.031 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.63 129.82 0.43 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.507 0.194 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -103.76 -45.88 9.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.356 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 94' ' ' ILE . . . 57.1 80.26 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.469 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.781 ' HA ' HD23 ' A' ' 99' ' ' LEU . 77.8 t -44.08 -36.62 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.38 -39.89 14.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.764 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.2 mm-40 -80.92 -45.01 17.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.444 0.164 . . . . 0.0 110.809 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.16 -40.54 90.26 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.957 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 104' ' ' THR . 0.7 OUTLIER -72.49 -41.27 66.15 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.612 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -52.33 -39.52 60.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.693 0.282 . . . . 0.0 111.034 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.849 HG11 ' HA2' ' A' ' 82' ' ' GLY . 30.6 t -73.21 -49.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.629 HD12 HD12 ' A' ' 99' ' ' LEU . 2.9 mt -64.48 -44.3 91.45 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.007 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 111' ' ' SER . 54.7 p -57.85 -40.86 81.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.507 0.194 . . . . 0.0 111.229 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.0 t -78.33 -12.21 59.99 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -61.34 1.91 Allowed 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 111.281 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 57.81 0.12 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.368 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.35 39.61 18.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 111.022 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 49.3 mmtt -68.68 -137.93 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.036 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD22 ' HG2' ' A' ' 114' ' ' GLU . 19.7 mt -68.49 79.63 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.667 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.757 ' HA ' HG22 ' A' ' 104' ' ' THR . 80.3 p -65.1 -170.21 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.069 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 115' ' ' MET . 78.3 m-20 -53.44 -36.87 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.07 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.02 -51.23 70.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.67 ' HG2' HD22 ' A' ' 110' ' ' LEU . 5.3 tp10 -57.34 -53.65 55.71 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.85 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.88 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.44 -25.85 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.419 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -47.85 83.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.97 -43.16 75.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.795 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.27 -42.68 95.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 127' ' ' GLY . 1.3 mt -72.17 -30.71 65.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -61.16 -41.21 96.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.804 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.19 20.46 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.917 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 129' ' ' VAL . 16.4 t -84.75 117.97 69.96 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.739 0.269 . . . . 0.0 111.019 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.85 63.95 6.74 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.628 2.219 . . . . 0.0 112.461 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.467 HG13 HG12 ' A' ' 122' ' ' VAL . 31.6 m -131.16 -176.43 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.77 132.49 56.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.323 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 67.04 14.77 9.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.366 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 63.3 49.89 67.02 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.075 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 ttp -103.47 120.21 40.4 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.515 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 129' ' ' VAL . 24.1 t -142.31 24.02 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.663 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 60.84 24.9 14.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.495 0.188 . . . . 0.0 111.405 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.448 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.1 t80 46.14 42.21 9.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.775 0.322 . . . . 0.0 111.377 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -115.49 -51.37 2.69 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.518 ' CB ' HG11 ' A' ' 129' ' ' VAL . 29.4 t70 -57.39 -38.24 73.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.79 -56.68 7.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.766 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.0 t -62.65 -34.66 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.308 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -64.26 -53.9 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ttp . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.063 179.6 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 8.8 m-20 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.916 0.388 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.457 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 4.0 t -67.03 -48.35 50.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.294 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 83.9 Cg_endo -83.46 -3.42 10.75 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.525 2.15 . . . . 0.0 114.294 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 77.6 m-85 -118.26 -66.69 1.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 4.9 ttmm -72.72 -57.8 3.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.424 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.535 ' OE1' HD21 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -57.75 -49.19 77.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.688 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.49 -40.31 90.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.542 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.5 t80 -56.5 -42.97 79.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.479 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.85 -36.11 82.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.045 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.535 HD21 ' OE1' ' A' ' 10' ' ' GLN . 9.6 mt -60.71 -33.14 72.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.302 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 32.58 2.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -93.19 91.55 7.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -63.38 -33.15 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.459 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -86.52 -35.58 19.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.133 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.29 32.32 52.24 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.774 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -118.73 -19.02 8.82 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.66 -8.04 5.54 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.086 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.656 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -121.57 162.86 19.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.065 0.432 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.785 HD12 HD13 ' A' ' 28' ' ' ILE . 5.8 pt -135.79 134.92 20.99 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.755 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.87 169.42 9.08 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.08 2.52 . . . . 0.0 112.612 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 44' ' ' ILE . 16.0 pttm -43.85 -38.52 3.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.9 p -60.13 -44.31 95.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.498 0.189 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.432 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 49.3 m -70.43 -46.74 63.32 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.875 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.785 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.79 -35.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.04 3.13 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.286 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 121.961 0.105 . . . . 0.0 111.108 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.32 -46.01 88.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.49 -31.61 70.64 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -51.42 -38.67 54.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -53.36 -44.55 68.64 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.65 -47.05 82.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.681 0.277 . . . . 0.0 110.774 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.85 -66.11 0.03 OUTLIER Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.094 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.99 173.36 11.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.862 0.363 . . . . 0.0 111.282 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -125.81 133.83 25.29 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.591 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -81.5 -163.17 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.849 2.366 . . . . 0.0 112.764 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 p -103.08 164.46 11.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.9 mm? -52.07 -37.71 54.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.46 86.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -53.93 29.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.811 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.03 -46.56 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -56.9 -39.97 75.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -40.85 83.99 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 44' ' ' ILE . 21.6 mt -59.89 -52.08 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -56.74 -25.02 53.84 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.699 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -10.42 22.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 p -118.1 -50.37 2.47 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.59 0.177 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.3 156.85 56.79 Favored Pre-proline 0 N--CA 1.464 0.263 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.536 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 78.2 Cg_exo -39.78 145.01 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.216 2.611 . . . . 0.0 113.199 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.18 -61.27 0.16 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.658 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -89.79 125.31 35.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.671 179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.0 t -87.19 90.14 3.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.5 p30 -86.59 -179.73 6.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.601 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.16 -46.5 3.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.817 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -67.77 -52.16 40.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.058 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.536 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.82 -50.75 72.23 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -48.91 79.68 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.912 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.59 -34.36 75.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.338 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -60.06 -48.05 83.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.308 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.465 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.72 -42.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.386 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.407 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 120.384 0.135 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.14 -49.03 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.139 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -26.51 68.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.684 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.82 -53.67 14.78 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.27 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.92 -47.18 47.94 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.31 71.4 5.85 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 86' ' ' PHE . 11.8 p -133.29 -45.76 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.462 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.418 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 4.4 m-85 -144.74 58.07 1.3 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 111.036 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -116.42 66.89 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.543 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.27 -36.18 79.34 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.84 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.79 -70.13 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.36 154.73 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.997 0.427 . . . . 0.0 112.018 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.5 m 59.8 80.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.261 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.84 -0.25 11.97 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.437 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -163.97 138.97 6.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 117.184 0.492 . . . . 0.0 110.629 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.541 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.36 -39.86 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.442 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.44 81.41 0.15 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.323 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.767 HG21 HD21 ' A' ' 118' ' ' LEU . 79.5 t -43.73 -36.49 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.97 -38.65 17.54 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.602 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -77.45 -46.47 22.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.24 0.216 . . . . 0.0 110.968 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -60.81 -42.16 97.08 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.464 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 104' ' ' THR . 0.2 OUTLIER -72.18 -36.39 69.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.093 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -59.31 -37.53 77.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.595 0.236 . . . . 0.0 111.078 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.684 HG11 ' HA2' ' A' ' 82' ' ' GLY . 29.6 t -77.56 -42.07 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.302 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.5 mt -72.42 -33.39 67.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 100' ' ' ARG . 15.1 p -59.47 -35.02 73.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.6 p -70.45 -18.04 63.0 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.14 -62.32 1.49 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.756 0.313 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.84 49.51 0.18 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.169 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.49 49.85 3.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 110.624 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 8.8 mmtp -68.55 -137.89 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.759 HD22 ' HG2' ' A' ' 114' ' ' GLU . 12.2 mt -69.96 77.5 0.48 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.888 0.375 . . . . 0.0 110.549 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.5 p -74.93 -165.66 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.873 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 115' ' ' MET . 15.1 m120 -51.4 -40.06 58.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.21 -52.93 61.8 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.52 0.2 . . . . 0.0 111.523 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.759 ' HG2' HD22 ' A' ' 110' ' ' LEU . 1.6 tp10 -57.23 -51.35 69.71 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.902 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.2 ptt? -67.14 -26.88 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.442 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -48.12 82.15 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.58 -43.56 84.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.902 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.56 -40.99 93.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.556 HD21 ' N ' ' A' ' 127' ' ' GLY . 2.4 mt -71.27 -30.13 65.92 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.155 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.41 -40.44 97.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.575 0.226 . . . . 0.0 110.72 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.27 -46.44 26.89 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.847 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.614 HG11 ' CG2' ' A' ' 129' ' ' VAL . 16.9 t -86.15 121.68 72.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.805 0.302 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 62.98 7.29 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.689 2.26 . . . . 0.0 112.546 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 122' ' ' VAL . 30.4 m -131.42 -177.35 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -119.21 126.22 51.01 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.45 -2.96 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.087 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 82.77 49.57 5.04 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.768 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.6 OUTLIER -103.99 113.64 27.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.233 0.54 . . . . 0.0 110.674 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 129' ' ' VAL . 35.8 t -142.91 30.35 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.063 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.53 23.16 11.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.781 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.443 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.4 t80 47.62 48.18 17.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.9 0.381 . . . . 0.0 111.438 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -121.93 -54.69 1.92 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.309 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.646 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -59.04 -36.46 75.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -67.9 -54.95 14.85 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.9 t -62.08 -33.39 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -58.86 -53.07 62.56 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.719 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttp . . . . . 0 CA--C 1.532 0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.443 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 65.4 m-20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.343 0.592 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -67.36 -47.47 48.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.096 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 97.5 Cg_endo -87.21 7.96 4.55 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.63 2.22 . . . . 0.0 114.37 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 70.6 m-85 -129.2 -67.96 0.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.679 0.218 . . . . 0.0 111.584 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -58.43 3.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.974 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -60.6 -48.49 81.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.658 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.513 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -42.98 87.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CE2' HG12 ' A' ' 23' ' ' ILE . 30.5 t80 -54.83 -44.13 73.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.454 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -62.59 -35.22 78.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.525 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -63.0 -34.26 77.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 4.6 m-85 -93.93 34.31 1.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.633 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.26 117.13 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.861 0.363 . . . . 0.0 111.219 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -71.34 -50.08 36.01 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.609 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -103.44 -38.72 7.06 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.309 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.67 37.15 4.05 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.466 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -116.81 -8.64 11.34 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.77 7.96 14.65 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -130.56 164.1 25.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.173 0.486 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 HD13 ' A' ' 28' ' ' ILE . 6.4 pt -146.48 137.25 12.52 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.693 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -85.62 171.49 8.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.129 2.552 . . . . 0.0 112.4 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -44.26 -39.31 4.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 p -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.451 0.167 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.9 m -69.87 -46.46 65.47 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.697 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.681 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.15 -33.68 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.32 -73.0 0.45 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.838 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -64.75 -21.32 66.73 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -65.78 -49.4 68.47 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.4 mt -61.71 -26.88 68.32 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.225 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -36.79 70.05 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.795 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.797 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -109.21 31.06 6.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.57 -103.86 0.25 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.732 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.24 179.46 6.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -119.38 113.19 35.29 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.419 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.19 -162.76 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -98.53 163.93 12.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -56.4 -34.17 66.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.68 73.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.838 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.37 -58.66 4.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.608 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -53.62 -47.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 123.098 0.249 . . . . 0.0 111.134 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.6 m -61.84 -44.27 97.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.43 -41.3 80.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.522 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.916 HG23 HG11 ' A' ' 63' ' ' VAL . 12.9 mt -63.65 -48.04 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.936 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.36 -24.57 56.06 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.999 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 p -63.81 -10.27 19.24 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.2 p -117.72 -31.76 5.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -97.18 152.78 38.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 77.9 Cg_exo -38.71 146.53 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.348 2.699 . . . . 0.0 113.055 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.88 -54.91 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -97.53 129.57 44.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.718 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.15 86.08 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.044 0.45 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.3 p30 -83.08 -179.86 7.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.575 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.6 mtm -41.47 -47.55 3.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.847 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -51.68 55.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.995 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.604 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.6 mp0 -57.91 -51.62 68.86 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.099 0.25 . . . . 0.0 111.643 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.74 -49.9 75.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.098 -179.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.68 -35.28 77.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.539 0.209 . . . . 0.0 110.972 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.18 -53.98 52.12 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.916 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -67.37 -31.08 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.065 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.034 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.429 0.156 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.97 -40.07 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.799 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -44.72 94.92 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.062 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.634 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -62.13 -45.54 95.85 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.149 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.76 -25.69 65.74 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.14 74.5 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 82' ' ' GLY . 33.6 t -127.52 -60.76 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.194 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -105.49 48.99 0.82 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -115.72 64.63 0.69 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -67.58 -47.47 69.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.81 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.31 -50.19 2.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.33 68.66 0.82 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.44 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 m -128.04 62.99 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.747 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.26 46.98 1.77 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.0 ptm -173.09 144.5 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.766 0.283 . . . . 0.0 111.527 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -118.82 -42.92 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.22 81.32 0.34 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.285 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.813 ' HA ' HD23 ' A' ' 99' ' ' LEU . 46.6 t -44.31 -40.99 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.19 -38.34 18.62 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.617 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.7 mm-40 -81.44 -41.94 21.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.489 0.185 . . . . 0.0 110.513 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.729 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -35.47 65.05 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.662 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.73 -34.33 69.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.634 HG11 ' CA ' ' A' ' 82' ' ' GLY . 40.1 t -82.72 -47.49 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.747 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -70.66 -38.91 73.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.1 m -61.06 -31.15 70.8 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -70.18 -17.13 63.15 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.92 -66.02 0.8 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.51 0.195 . . . . 0.0 111.086 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.65 52.14 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.803 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 57.85 53.56 6.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.747 ' HG2' HD22 ' A' ' 103' ' ' LEU . 2.6 tptp -67.64 -137.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.079 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.94 77.39 0.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.994 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 96.0 p -67.15 -173.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.43 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 24.4 t-20 -48.84 -42.47 36.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.039 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.18 -52.28 65.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.98 -51.59 69.03 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.893 ' HA ' HD23 ' A' ' 118' ' ' LEU . 3.4 ptm -66.88 -27.58 67.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.311 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -49.18 78.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.62 0.248 . . . . 0.0 110.454 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.26 -42.25 88.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.893 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.92 -41.93 99.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -67.18 -35.48 79.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.216 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -38.29 90.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.4 -39.1 36.72 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.046 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 124' ' ' VAL . 48.5 t -85.48 133.12 42.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.854 0.327 . . . . 0.0 111.122 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.08 58.08 6.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.789 2.326 . . . . 0.0 112.826 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 128' ' ' MET . 15.2 m -131.66 176.36 9.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 19.23 11.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.788 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -168.21 25.92 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.687 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 56.83 45.97 90.76 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.961 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.606 ' O ' HG11 ' A' ' 124' ' ' VAL . 1.3 ttt -103.5 115.64 30.89 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.197 0.522 . . . . 0.0 110.751 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 129' ' ' VAL . 39.5 t -141.16 22.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.082 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 58.55 24.11 11.59 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.505 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER 56.18 -166.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t60 72.29 -58.89 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.109 0.164 . . . . 0.0 111.084 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -52.89 -39.99 63.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.537 0.208 . . . . 0.0 111.421 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 21.8 m-85 -67.96 -52.39 36.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.377 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.7 t -62.43 -31.65 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.64 -53.37 58.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.53 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 178.957 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.445 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 4.7 t -66.95 -45.63 53.56 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 6' ' ' SER . 2.8 Cg_exo -75.62 -13.39 20.18 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.774 2.316 . . . . 0.0 113.852 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -118.87 -61.68 1.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.58 -59.89 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.247 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.415 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 28.6 tp60 -60.54 -48.21 82.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.45 -38.16 73.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.355 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 14.7 t80 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -62.22 -30.69 71.27 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.733 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -62.83 -39.63 94.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.59 ' O ' HG22 ' A' ' 23' ' ' ILE . 52.6 m-85 -95.69 33.39 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 103.28 15.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -71.2 -35.23 71.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -86.51 -38.67 17.01 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.04 -8.3 63.01 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.252 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -86.76 -32.12 20.56 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.991 0.396 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.9 40.68 0.18 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.414 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.85 157.77 41.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.315 0.246 . . . . 0.0 110.732 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.8 HD12 HD13 ' A' ' 28' ' ' ILE . 4.1 pt -150.51 129.41 6.22 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.09 172.53 8.52 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.058 2.505 . . . . 0.0 112.148 179.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.98 -37.96 4.39 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.8 p -60.91 -43.6 98.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.486 0.184 . . . . 0.0 111.067 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 38.6 m -70.07 -48.82 56.2 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.609 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.8 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.29 -33.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.47 -69.47 1.26 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.389 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -30.99 72.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.346 0.117 . . . . 0.0 111.275 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.32 -51.3 69.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.717 0.294 . . . . 0.0 110.325 179.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.68 -32.29 72.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.17 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -35.98 63.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.128 179.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.36 75.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.631 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.2 t -66.83 -44.33 81.4 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.683 0.277 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.99 -69.46 0.03 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.5 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 166.13 22.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.982 0.42 . . . . 0.0 111.509 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.95 121.92 23.1 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.432 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.94 -161.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.726 2.284 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -90.34 166.17 13.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.235 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -56.68 -29.3 62.2 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.223 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.69 93.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.711 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -53.53 51.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.994 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.635 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.96 -44.82 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -61.4 -39.98 92.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.194 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -57.79 -38.92 76.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 178.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 44' ' ' ILE . 21.0 mt -63.73 -46.75 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.994 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.01 -27.2 61.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.464 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -5.54 6.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 p -118.6 -33.96 4.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.899 0.318 . . . . 0.0 111.436 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.763 HD11 HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -105.03 161.5 22.56 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.487 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD2' ' HG2' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -46.11 162.05 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.131 2.554 . . . . 0.0 113.083 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.35 -67.62 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -83.23 119.75 24.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.614 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.89 96.12 4.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.101 0.476 . . . . 0.0 110.945 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.4 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 22.9 p30 -82.57 174.35 11.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.677 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.4 mtt -42.52 -43.6 3.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.672 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.48 -50.92 56.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.824 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 31.9 mt-30 -57.14 -51.27 69.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.84 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -49.25 77.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.762 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 mt -61.43 -31.44 71.38 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -63.64 -55.05 26.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.495 0.188 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.763 HG21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.69 -42.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.115 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.39 0 CA-C-O 120.431 0.158 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.68 -46.36 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.999 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.35 -40.03 95.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.779 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -60.67 -45.48 96.3 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.474 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 23.0 m-85 -76.86 -27.48 55.09 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.68 -16.57 63.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -45.29 -56.12 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.3 19.32 4.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.597 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -142.17 68.72 1.32 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.262 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.27 -54.39 29.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.27 -63.62 1.32 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.27 82.92 0.06 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.784 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.99 -53.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.15 42.12 1.45 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.001 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.47 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -170.71 137.26 1.29 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.749 0.275 . . . . 0.0 111.346 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.558 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -112.21 -43.43 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.451 179.532 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.6 79.58 0.17 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.199 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.999 HG11 HD21 ' A' ' 118' ' ' LEU . 91.1 t -45.07 -35.64 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.34 -43.88 20.25 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.741 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.4 mp0 -74.01 -50.18 21.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.279 0.232 . . . . 0.0 110.802 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.13 -36.33 75.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.12 -50.46 68.18 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -53.05 -42.05 65.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.122 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 82' ' ' GLY . 47.2 t -63.06 -52.16 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 99' ' ' LEU . 4.6 mt -66.12 -40.73 90.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.7 m -58.05 -33.29 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.337 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.1 m -74.47 -17.84 60.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.42 -60.95 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.529 0.204 . . . . 0.0 111.119 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.55 52.73 0.22 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.93 48.69 8.55 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.99 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 5.3 mmtp -68.64 -138.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 114' ' ' GLU . 11.1 mt -68.07 78.56 0.23 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.287 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.3 p -69.29 -171.11 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.013 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 115' ' ' MET . 18.4 t-20 -48.52 -37.41 17.54 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.265 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -67.23 -55.01 15.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.548 0.213 . . . . 0.0 111.478 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG2' HD23 ' A' ' 110' ' ' LEU . 1.3 mp0 -57.12 -49.11 76.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.768 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -67.08 -27.88 67.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.095 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -47.03 85.96 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.33 -44.47 83.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.462 179.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.999 HD21 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.39 -41.7 90.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.265 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 124' ' ' VAL . 2.2 mt -71.55 -29.83 65.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -41.24 97.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.527 0.203 . . . . 0.0 110.598 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.16 -44.35 44.61 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.089 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 124' ' ' VAL . 44.2 t -82.64 131.65 54.32 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.764 0.282 . . . . 0.0 111.174 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.65 61.38 7.48 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.756 2.304 . . . . 0.0 112.666 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.452 HG23 HD23 ' A' ' 119' ' ' LEU . 12.7 m -131.8 177.37 7.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.449 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -126.94 47.3 2.35 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.181 0.515 . . . . 0.0 110.745 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' C ' HD21 ' A' ' 119' ' ' LEU . 5.2 p-10 173.64 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 111.37 51.46 0.58 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.47 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.27 116.96 33.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 0.0 110.671 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 129' ' ' VAL . 25.0 t -142.2 19.64 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.74 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.32 23.42 10.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.544 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 48.11 47.23 19.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 111.599 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 -51.61 2.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.633 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.7 t70 -60.09 -35.21 74.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.784 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 5.7 m-85 -66.04 -58.26 5.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.703 0.287 . . . . 0.0 110.35 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.75 -32.59 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.417 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -60.1 -50.53 73.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.491 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.015 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 7.5 m-20 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -66.99 -46.52 53.63 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.957 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 6' ' ' SER . 83.2 Cg_endo -82.97 -3.88 11.17 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.411 2.074 . . . . 0.0 114.045 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 46.4 m-85 -120.83 -62.51 1.44 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.7 -59.44 2.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.072 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -60.59 -47.24 87.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.19 -40.66 82.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.493 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.4 t80 -57.08 -44.37 83.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.604 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -62.06 -33.84 75.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.248 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.84 -30.99 70.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.369 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.32 20.37 4.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -101.73 120.31 40.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.188 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -55.74 31.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.498 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -101.94 -24.46 14.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.801 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . 93.82 44.33 3.65 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.451 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -89.46 -26.03 21.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.041 0.136 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.08 10.17 14.43 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.106 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 2.1 mtt180 -130.24 160.91 32.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.055 0.427 . . . . 0.0 110.551 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.743 HD12 HD13 ' A' ' 28' ' ' ILE . 5.7 pt -146.33 138.51 13.63 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -87.02 171.55 6.7 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.234 2.623 . . . . 0.0 112.482 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.506 ' O ' HG21 ' A' ' 44' ' ' ILE . 10.5 ptpt -42.5 -40.97 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 p -59.9 -44.62 94.15 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 12.5 m -69.1 -48.0 63.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.586 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.743 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -57.04 -34.24 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.09 -68.72 1.51 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.281 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -30.62 71.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.98 -50.88 71.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 110.423 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.47 -30.19 70.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.039 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -57.02 -37.81 72.25 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.842 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.51 -29.12 70.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.8 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -88.28 -42.68 12.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.604 0.24 . . . . 0.0 110.55 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.9 -87.38 0.09 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.512 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -132.61 175.74 9.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 2.5 t-20 -119.37 112.36 35.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.122 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.68 -162.84 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.915 2.41 . . . . 0.0 112.856 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 p -95.59 166.52 11.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.82 -37.17 65.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.34 73.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.813 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -55.97 13.1 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.681 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.01 -48.57 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.584 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.6 m -56.98 -39.74 75.19 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.66 -41.94 87.28 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.357 179.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 44' ' ' ILE . 19.5 mt -62.54 -49.4 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.74 -25.84 55.81 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.384 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -64.8 -8.21 14.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 p -117.83 -49.02 2.54 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.656 0.207 . . . . 0.0 110.968 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.61 158.2 54.41 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.3 Cg_exo -40.93 149.75 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.188 2.592 . . . . 0.0 113.072 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.05 -63.68 0.18 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -89.68 127.68 35.97 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.791 0.329 . . . . 0.0 110.66 179.716 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.82 89.59 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.284 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.07 179.65 7.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.7 mtp -41.41 -46.27 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.39 -52.37 40.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.96 -50.95 71.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.729 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.23 -48.9 79.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.06 -179.749 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.82 -39.37 88.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.448 0.166 . . . . 0.0 111.396 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -55.43 -49.2 73.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.483 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.659 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -76.4 -35.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 179.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.427 HD13 ' CE1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.42 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 120.448 0.166 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.38 -47.84 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.875 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -31.12 70.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.597 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.721 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -61.81 -47.84 87.72 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.553 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -74.91 -32.78 61.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 0.127 . . . . 0.0 111.052 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.88 73.19 5.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.07 -65.19 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.13 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.508 ' HB2' ' CB ' ' A' ' 98' ' ' GLU . 1.4 m-85 -109.55 34.41 3.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.346 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 49.74 2.29 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -69.89 -54.81 11.72 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.206 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.88 -47.6 11.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.75 66.65 0.97 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -102.04 67.04 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.27 56.05 11.3 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.529 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -174.93 138.65 0.47 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.714 0.293 . . . . 0.0 111.192 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -107.23 -41.65 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.547 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.86 78.95 0.34 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.499 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.796 ' HA ' HD23 ' A' ' 99' ' ' LEU . 70.8 t -44.75 -35.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.53 -41.77 18.57 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.252 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -80.16 -36.71 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.661 0.23 . . . . 0.0 111.549 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -67.25 -40.83 86.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.485 0.183 . . . . 0.0 110.957 179.886 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -38.64 66.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.975 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -56.37 -45.85 80.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.67 0.271 . . . . 0.0 110.924 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.721 HG11 ' CA ' ' A' ' 82' ' ' GLY . 47.6 t -65.77 -46.71 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.222 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.715 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -67.1 -37.55 84.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.371 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 85.3 m -67.19 -42.96 83.3 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.485 0.183 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.1 p -68.0 -16.06 63.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.29 -65.29 0.7 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.709 0.29 . . . . 0.0 110.927 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.5 49.08 0.28 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.121 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 61.16 41.5 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 -179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.715 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -68.9 -137.92 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.987 178.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 42.1 mt -68.56 80.02 0.27 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.414 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 79.7 p -66.38 -170.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 115' ' ' MET . 4.6 p-10 -53.26 -33.7 54.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.226 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -48.9 79.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.542 0.21 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.5 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 17.9 mm-40 -59.14 -53.41 58.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.854 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.76 -26.44 66.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.258 179.365 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -47.11 86.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.239 179.125 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.0 -43.77 82.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.0 -42.18 89.47 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.695 179.432 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.636 HD21 ' H ' ' A' ' 127' ' ' GLY . 1.2 mt -67.89 -33.48 74.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -39.78 91.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.0 -48.28 21.04 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.004 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 129' ' ' VAL . 18.8 t -83.89 125.09 73.89 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.792 0.296 . . . . 0.0 111.286 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.56 63.23 7.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.694 2.262 . . . . 0.0 112.549 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.42 HG13 HG12 ' A' ' 122' ' ' VAL . 20.1 m -131.26 179.41 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -119.3 130.28 55.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 70.61 10.69 7.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.829 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.636 ' H ' HD21 ' A' ' 119' ' ' LEU . . . 69.62 44.47 63.5 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.702 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.87 114.39 28.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.372 0.606 . . . . 0.0 110.601 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 129' ' ' VAL . 22.1 t -142.58 26.14 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.083 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.25 21.09 5.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.0 t80 48.97 38.29 12.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -116.88 -38.86 3.35 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.607 ' HB3' HG11 ' A' ' 129' ' ' VAL . 33.0 t70 -66.63 -37.44 84.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.7 m-85 -67.94 -54.91 15.08 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.45 -31.7 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.95 -50.39 72.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 ttm . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.245 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.837 0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -64.72 -46.58 76.23 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.624 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.0 Cg_endo -82.17 -11.64 10.87 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.506 2.138 . . . . 0.0 114.072 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -114.5 -60.41 1.89 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.33 -48.49 81.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.596 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.14 -40.03 76.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.035 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.486 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.9 t80 -59.17 -44.51 92.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.315 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.4 m -62.5 -31.45 72.21 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.747 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 5.8 mt -65.91 -36.95 84.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -95.34 38.53 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.196 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -83.27 88.77 6.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.226 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -62.85 -37.71 87.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -86.54 -36.32 19.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.108 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.28 27.18 56.03 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.452 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.1 p -129.28 10.4 5.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.91 8.63 47.76 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.742 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -129.22 163.16 26.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.355 0.578 . . . . 0.0 110.958 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.819 HD12 HD13 ' A' ' 28' ' ' ILE . 6.3 pt -147.24 138.64 13.32 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.918 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.58 172.27 6.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.455 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.91 -37.63 6.57 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.8 p -60.14 -41.63 93.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.482 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 3.3 m -70.88 -54.73 10.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.372 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.819 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.04 -35.76 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.15 -74.44 0.29 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.535 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -28.56 69.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 23' ' ' ILE . 13.5 tp -61.45 -51.95 66.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 mt -60.92 -29.33 69.53 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.261 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.443 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -55.53 -39.9 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.052 0.22 . . . . 0.0 110.871 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.15 70.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.846 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -90.1 -43.06 10.73 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.681 0.277 . . . . 0.0 110.611 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.08 -88.19 0.1 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.505 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.95 172.79 12.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.962 0.41 . . . . 0.0 112.018 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.9 t-20 -122.06 110.23 33.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.21 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -84.19 -162.88 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.905 2.403 . . . . 0.0 112.53 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -92.96 166.52 12.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -54.71 -33.53 61.13 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.797 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.51 86.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.828 179.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -55.55 16.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.96 -45.39 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.103 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 m -62.16 -41.1 97.97 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.61 -38.27 77.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.923 HG23 HG11 ' A' ' 63' ' ' VAL . 14.4 mt -64.9 -49.82 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.16 -25.33 46.15 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.882 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -64.21 -7.15 8.23 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.2 p -117.78 -46.59 2.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.775 0.261 . . . . 0.0 111.204 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -86.55 157.47 55.49 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.094 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -39.41 150.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.285 2.657 . . . . 0.0 113.39 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.6 -61.34 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.6 130.0 38.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.683 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.37 86.71 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.043 0.449 . . . . 0.0 111.061 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.486 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -82.95 -179.56 7.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.672 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 mtm -41.41 -46.79 3.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.944 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -68.66 -50.55 50.28 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.8 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.4 mp0 -58.0 -51.74 68.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.585 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.71 -48.35 82.01 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.78 -36.46 79.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.285 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -52.61 64.67 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.187 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.923 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.6 -38.71 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.314 179.847 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.585 HD13 ' HE1' ' A' ' 60' ' ' PHE . 1.2 tp . . . . . 0 C--O 1.234 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.025 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 120.651 0.262 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.29 -39.13 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.706 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -39.05 93.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.513 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.758 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -62.81 -47.23 90.61 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.4 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -74.84 -36.79 62.38 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.964 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -78.86 72.3 5.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.036 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.62 -62.74 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -113.3 23.62 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.498 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.27 73.85 1.56 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.008 0.432 . . . . 0.0 110.863 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -69.34 -43.37 73.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -89.07 -63.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.58 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.421 0.45 . . . . 0.0 111.292 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m 69.28 -74.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.772 0.429 . . . . 0.0 111.349 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.03 61.3 0.42 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 ptp -176.23 131.3 0.23 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.583 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -103.84 145.57 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.583 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -109.61 82.79 0.31 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.825 ' HA ' HD23 ' A' ' 99' ' ' LEU . 59.3 t -37.48 -39.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.6 -42.74 27.88 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.623 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.0 pt-20 -81.24 -37.79 27.98 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.932 -0.157 . . . . 0.0 111.128 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.825 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.55 -39.9 89.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.549 0.214 . . . . 0.0 110.549 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -38.84 59.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.687 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.57 -36.2 71.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.623 0.249 . . . . 0.0 111.324 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 82' ' ' GLY . 26.3 t -82.7 -38.9 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.908 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 2.1 mt -79.71 -48.98 12.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.4 m -53.57 -38.57 64.04 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.9 p -60.5 -25.56 66.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.95 -83.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -133.13 46.14 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.715 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 62.46 50.85 3.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.377 . . . . 0.0 111.157 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 9.4 mmtp -67.92 -137.83 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.282 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.3 mt -68.32 76.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.4 p -68.29 -172.72 0.34 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.65 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -51.28 -42.95 61.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -64.34 -48.48 75.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.52 -53.31 59.64 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.622 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.857 ' HA ' HD23 ' A' ' 118' ' ' LEU . 3.3 ppp? -66.78 -27.67 67.78 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.302 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -46.07 87.19 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.628 0.252 . . . . 0.0 110.474 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.18 -41.83 76.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.635 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.857 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.09 -43.19 99.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.971 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.55 HD21 ' H ' ' A' ' 127' ' ' GLY . 3.2 mt -70.13 -32.9 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.274 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -39.94 95.77 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.015 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.11 -48.74 30.6 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.986 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 124' ' ' VAL . 14.0 t -82.45 125.29 76.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.679 0.24 . . . . 0.0 111.142 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.17 58.54 6.99 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.661 2.241 . . . . 0.0 112.401 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 122' ' ' VAL . 22.8 m -131.33 -178.67 2.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.138 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -119.18 135.86 54.47 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.499 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.49 14.66 9.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.811 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.55 ' H ' HD21 ' A' ' 119' ' ' LEU . . . 64.26 55.65 22.44 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.794 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttp -103.54 113.03 26.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.255 0.55 . . . . 0.0 111.099 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 129' ' ' VAL . 45.5 t -142.94 26.53 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.23 21.34 9.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.535 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 132' ' ' HIS . 0.5 OUTLIER 54.34 -166.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -178.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 131' ' ' TYR . 12.3 m170 71.34 -57.77 0.6 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.579 0.352 . . . . 0.0 111.24 -179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -52.56 -39.37 61.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.541 0.21 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 19.8 m-85 -68.26 -58.0 5.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.584 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.45 -32.21 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.29 -54.61 41.85 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.691 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 42.8 tpp . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.391 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.46 0.051 0 CA-C-O 121.059 0.456 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -66.68 -46.65 56.97 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.767 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 6' ' ' SER . 8.0 Cg_exo -73.41 -21.29 19.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.808 2.339 . . . . 0.0 113.822 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -107.74 -63.52 1.3 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -62.08 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.697 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 5.8 tt0 -56.67 -48.58 77.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.949 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.67 -40.43 87.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.569 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.1 t80 -60.12 -44.84 94.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.758 0.313 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -62.43 -31.29 71.97 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.748 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 20.1 mt -56.99 -40.35 76.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 31' ' ' LEU . 8.5 m-30 -97.73 32.28 2.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -61.63 130.0 43.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.957 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -56.61 8.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.778 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -136.3 26.02 3.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.412 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.94 27.61 72.96 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.728 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.6 p -95.86 -26.65 15.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.454 0.169 . . . . 0.0 111.258 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.34 18.63 8.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.883 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 36.9 mtt180 -129.69 160.51 33.15 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.878 0.339 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.86 HD12 HD13 ' A' ' 28' ' ' ILE . 4.1 pt -143.78 137.67 14.53 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.511 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.73 170.62 7.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.148 2.565 . . . . 0.0 113.027 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 18.7 pttp -43.78 -35.37 1.86 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -61.36 -46.11 91.57 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.466 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.2 t -70.41 -49.47 48.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.621 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.17 -34.94 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.496 -179.678 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.77 -67.7 2.06 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.331 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.22 -28.12 69.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 15' ' ' PHE . 10.4 tp -62.05 -48.6 79.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.9 -32.14 72.5 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.59 -40.29 71.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.816 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.48 70.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.472 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 m -107.14 40.03 1.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 110.498 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.31 -102.94 0.4 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.545 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 171.23 14.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 111.692 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -119.48 114.88 34.29 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.384 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.02 -162.08 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.896 2.397 . . . . 0.0 112.477 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.9 p -94.74 166.95 11.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.7 mm? -56.5 -34.49 67.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.41 75.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.644 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.26 -55.16 17.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.08 -49.3 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.828 179.635 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.0 m -55.65 -42.12 74.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.416 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -59.2 -42.86 91.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 44' ' ' ILE . 41.2 mt -61.64 -41.98 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -56.63 -36.07 69.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -65.85 -1.77 3.23 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 51' ' ' LEU . 5.6 m -118.07 -40.32 2.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.228 0.211 . . . . 0.0 110.937 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.637 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -102.89 156.41 35.34 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.332 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.6 Cg_exo -40.45 143.65 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.085 2.523 . . . . 0.0 113.083 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -22.85 -67.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.2 tt0 -91.66 129.35 37.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.609 0.242 . . . . 0.0 110.518 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -86.75 88.44 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.015 0.436 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.7 p30 -87.01 -179.85 6.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.306 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mtm -41.27 -46.98 3.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -53.41 41.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.18 -52.98 63.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -49.26 78.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.677 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.14 -27.92 69.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.387 0.136 . . . . 0.0 111.264 178.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -65.38 -43.19 91.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.965 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.637 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.12 -38.91 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.995 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.488 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.429 0.157 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.31 -49.77 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.009 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.64 -31.46 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.854 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -65.14 -51.64 48.49 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.643 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -76.59 -36.26 57.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.403 0.144 . . . . 0.0 110.934 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -78.68 73.44 5.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.969 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.43 -61.23 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.29 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.55 43.64 1.6 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.525 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 3.8 m-20 -130.79 75.63 1.67 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -51.67 67.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.05 -49.9 3.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.265 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 58.13 53.97 6.24 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -74.79 -48.09 27.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.178 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.73 58.67 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.665 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 ptm -166.95 147.97 5.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER -125.92 143.35 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.508 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -107.08 81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.052 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.805 ' HA ' HD23 ' A' ' 99' ' ' LEU . 72.6 t -43.3 -38.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.25 -48.2 54.06 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.744 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.4 mm-40 -77.03 -40.68 45.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.253 0.221 . . . . 0.0 110.657 178.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -59.25 -40.59 86.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.552 179.517 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -66.51 -49.35 66.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.518 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -52.13 -37.97 55.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.712 HG11 ' CA ' ' A' ' 82' ' ' GLY . 41.5 t -74.04 -49.26 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.804 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.748 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.8 mt -69.13 -28.3 66.33 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.0 m -64.3 -38.4 90.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.312 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.4 p -70.82 -12.98 61.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.1 -66.14 0.68 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.567 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.14 49.05 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.333 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.31 50.52 6.11 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 111.453 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.748 ' HG2' HD22 ' A' ' 103' ' ' LEU . 26.5 tptt -68.53 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.428 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.502 HD23 ' HG2' ' A' ' 114' ' ' GLU . 6.9 mt -71.21 76.96 0.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -62.43 -176.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.106 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -52.32 -35.98 52.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.99 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -51.02 63.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.424 0.154 . . . . 0.0 111.297 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.502 ' HG2' HD23 ' A' ' 110' ' ' LEU . 2.1 tp10 -58.92 -50.01 75.64 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.906 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.873 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -66.6 -27.43 67.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.905 179.03 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -48.55 80.64 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.603 0.239 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.66 -42.05 87.23 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 179.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.1 -42.37 98.39 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.833 179.457 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.596 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.45 -33.07 70.88 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.03 179.616 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -39.99 92.17 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.45 -46.94 30.52 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.937 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.457 HG11 HG22 ' A' ' 129' ' ' VAL . 14.4 t -87.09 117.87 69.22 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.658 0.229 . . . . 0.0 111.036 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.7 64.66 5.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.463 2.109 . . . . 0.0 112.477 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.3 -178.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -118.92 135.65 54.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.638 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.64 17.62 11.0 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.623 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 61.49 64.05 4.33 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.988 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttt -111.38 116.78 31.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.241 0.543 . . . . 0.0 111.058 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.732 HG11 ' HB2' ' A' ' 133' ' ' ASP . 39.5 t -142.23 26.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.8 26.3 15.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.5 t80 46.69 45.45 14.53 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.768 0.318 . . . . 0.0 111.616 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -119.56 -56.03 2.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.352 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.732 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -60.51 -34.34 73.94 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.471 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 4.5 m-85 -67.69 -55.4 13.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.271 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.9 -33.95 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.55 -51.85 68.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.668 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 ttp . . . . . 0 CA--C 1.531 0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.326 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -64.3 -47.87 77.2 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.081 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.41 -13.93 12.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.403 2.069 . . . . 0.0 114.114 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -106.65 -65.87 1.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.638 ' HE3' HD11 ' A' ' 61' ' ' LEU . 8.7 mmtp -73.12 -58.87 3.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.501 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 2.4 tt0 -56.8 -49.9 73.98 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.472 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.55 -41.46 85.62 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 23' ' ' ILE . 16.4 t80 -53.57 -45.21 69.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.39 -36.69 83.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.141 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.8 mt -62.86 -27.41 69.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.392 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 3.5 m-85 -94.23 18.93 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.86 99.26 11.66 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -61.1 -35.34 76.76 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.741 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.24 -29.13 23.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.27 42.86 41.03 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -117.87 -36.28 3.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.24 -11.12 2.78 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.587 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -118.1 147.73 43.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.272 0.536 . . . . 0.0 110.626 -179.831 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.912 HD12 HD13 ' A' ' 28' ' ' ILE . 4.2 pt -127.55 140.88 39.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.848 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.28 173.25 3.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.257 2.638 . . . . 0.0 112.432 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.76 -36.69 2.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 p -59.6 -46.06 90.06 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.495 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 2.5 t -71.33 -49.64 40.52 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.912 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.41 -36.18 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.17 -73.1 0.44 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.67 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -65.12 -21.35 66.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.3 tp -65.93 -48.38 71.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -61.18 -30.55 70.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.841 179.124 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.444 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.47 -40.73 72.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.679 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.87 75.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.49 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.8 m -112.63 43.55 1.63 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 110.669 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.83 -105.39 0.4 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.808 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.37 169.98 15.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -119.11 112.48 36.17 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.157 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.74 -162.62 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.036 2.49 . . . . 0.0 112.737 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 p -97.68 165.33 12.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.499 HD12 ' HE2' ' A' ' 25' ' ' LYS . 1.4 mm? -54.88 -36.62 65.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.21 78.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.539 0.209 . . . . 0.0 110.453 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -51.48 58.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -61.1 -46.18 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.82 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 29.6 m -54.88 -41.52 70.96 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.144 0.278 . . . . 0.0 110.633 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -60.2 -41.98 94.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.63 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.784 HG23 HG11 ' A' ' 63' ' ' VAL . 21.1 mt -61.67 -49.53 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -57.46 -26.4 61.17 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.859 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -63.78 -10.08 18.02 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 p -117.91 -35.56 3.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.722 0.237 . . . . 0.0 111.526 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.583 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -94.25 151.18 39.33 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.461 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.581 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 59.7 Cg_exo -36.97 141.89 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.337 2.691 . . . . 0.0 113.089 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -24.76 -61.31 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -93.63 129.52 39.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.51 86.94 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.03 -179.08 6.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.609 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.5 mtp -41.43 -47.16 3.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.988 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.05 -53.0 35.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.958 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.581 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.8 mp0 -57.49 -51.97 67.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.604 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.1 -45.91 91.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.638 HD11 ' HE3' ' A' ' 9' ' ' LYS . 13.9 mt -60.73 -39.24 87.87 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -52.14 65.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.802 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.784 HG11 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -73.65 -29.12 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.24 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.471 HD13 ' HE1' ' A' ' 60' ' ' PHE . 10.2 tp . . . . . 0 C--O 1.227 -0.112 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.942 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 120.476 0.179 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.96 -45.61 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.4 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.96 94.34 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.881 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -64.11 -46.08 92.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.759 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -75.61 -36.09 60.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.381 0.134 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.81 72.5 5.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.1 t -140.62 -57.4 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.429 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.38 33.11 4.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.75 65.8 1.39 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -31.85 73.18 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.334 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 3.3 t70 -82.12 -62.04 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.377 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 72.96 -64.15 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.497 0.498 . . . . 0.0 111.799 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.1 p -66.67 95.19 0.33 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.8 -26.87 4.46 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.182 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.3 ptp -157.73 138.8 13.37 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.841 0.321 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -115.32 -40.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.027 -179.608 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 58.69 80.22 0.09 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.547 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.772 HG21 HD21 ' A' ' 118' ' ' LEU . 61.1 t -44.6 -34.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.93 -46.95 25.99 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.989 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.6 mt-10 -75.3 -47.66 26.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.555 0.217 . . . . 0.0 110.991 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -58.48 -38.38 77.48 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.249 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -67.06 -46.96 72.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -53.42 -40.9 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.868 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.881 HG11 ' HA2' ' A' ' 82' ' ' GLY . 4.0 t -77.21 -54.35 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.8 mt -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.6 m -60.5 -38.88 85.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.554 0.216 . . . . 0.0 111.036 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.4 m -71.18 -15.19 62.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.69 -59.5 2.76 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -158.36 43.56 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.463 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.87 52.37 10.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 111.29 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.739 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.41 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.05 179.134 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.44 77.63 0.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.986 0.357 . . . . 0.0 110.334 179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 p -65.79 -172.34 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.411 -178.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -50.75 -39.49 52.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.079 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.37 -49.76 70.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.492 0.187 . . . . 0.0 111.354 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.59 -52.84 63.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.605 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.931 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.9 ppp? -67.29 -26.24 66.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.405 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -49.31 77.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.352 179.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.79 -43.17 84.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.21 -40.17 92.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 179.684 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.69 -33.2 70.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.44 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.78 -38.46 91.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.749 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.87 -44.97 9.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.728 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 124' ' ' VAL . 48.2 t -79.42 130.46 68.43 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.516 0.198 . . . . 0.0 111.175 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.02 62.85 8.09 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 122' ' ' VAL . 13.4 m -131.36 176.69 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.229 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 46.78 2.27 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.899 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.94 -35.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.702 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.726 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 111.11 46.09 0.83 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.97 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.46 119.19 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.179 0.514 . . . . 0.0 111.179 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 129' ' ' VAL . 38.7 t -142.5 32.01 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.804 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.718 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 134' ' ' PHE . 2.7 t80 44.66 46.8 8.58 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.809 0.337 . . . . 0.0 111.532 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 -55.07 1.97 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.5 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 129' ' ' VAL . 8.6 t70 -60.09 -33.01 71.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.699 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 131' ' ' TYR . 6.5 m-85 -68.15 -56.31 9.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.43 -33.17 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.507 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.29 -51.25 69.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.299 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 32.5 ttp . . . . . 0 CA--C 1.533 0.317 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.603 -179.955 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 19.5 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.251 0.548 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.549 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -67.41 -48.94 44.55 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.611 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 72.9 Cg_endo -78.44 -12.63 15.38 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.509 2.139 . . . . 0.0 113.995 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 3.2 m-85 -108.97 -64.86 1.19 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -59.0 2.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.554 -179.233 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.549 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.1 -49.27 78.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.06 -40.86 82.05 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.807 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.0 t80 -53.51 -45.74 69.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.466 179.156 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 m -62.37 -36.48 82.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.9 mt -60.57 -31.65 70.77 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.393 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' O ' HG22 ' A' ' 23' ' ' ILE . 54.6 m-85 -93.77 26.45 3.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.589 0.233 . . . . 0.0 111.591 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -119.11 79.03 1.35 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.222 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -15.98 63.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.37 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -86.0 -24.68 26.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.45 67.02 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.664 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.6 p -105.65 -32.75 8.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.14 0.176 . . . . 0.0 111.397 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.63 23.8 5.53 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.944 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 2.3 mpt_? -130.56 159.63 36.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.741 0.27 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 HD13 ' A' ' 28' ' ' ILE . 3.7 pt -144.46 131.04 10.06 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.92 172.31 8.85 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.121 2.547 . . . . 0.0 112.137 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HB2' HG13 ' A' ' 44' ' ' ILE . 6.2 pttt -44.39 -37.65 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 p -62.43 -45.77 91.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.342 0.115 . . . . 0.0 111.225 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 6.3 m -66.91 -46.59 74.37 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.474 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.83 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -57.98 -35.62 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.052 179.502 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.65 -70.11 1.07 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.518 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -25.58 66.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.67 0.235 . . . . 0.0 111.455 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -61.31 -48.68 80.24 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.59 -35.55 78.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -32.2 68.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.329 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.89 -46.82 64.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -65.44 -33.64 76.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.257 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.97 -67.88 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.284 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.49 160.21 35.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.706 0.289 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -131.98 153.63 81.44 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.252 179.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.84 -162.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.989 2.459 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -98.59 168.15 10.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.222 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.6 mm? -55.66 -32.4 63.18 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.58 94.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.192 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -53.61 53.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.388 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.855 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.81 -47.67 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.562 179.473 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.6 m -57.98 -40.54 80.93 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -57.35 -39.41 75.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.217 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.855 HD12 ' HA ' ' A' ' 44' ' ' ILE . 15.9 mt -63.78 -46.73 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -56.69 -25.63 54.63 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.34 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -64.16 -6.93 7.49 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.492 ' C ' HD13 ' A' ' 51' ' ' LEU . 9.6 p -118.25 -45.45 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.781 0.264 . . . . 0.0 110.76 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.66 143.48 26.68 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -36.94 150.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.704 2.936 . . . . 0.0 113.534 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.89 -74.48 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -72.73 117.77 14.84 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.728 -179.093 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.98 93.11 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.57 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.2 p30 -81.93 177.92 8.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.685 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -41.79 -47.93 4.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.818 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -67.17 -48.24 68.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.645 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -56.99 -51.62 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.344 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -49.23 76.15 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.3 mt -61.12 -33.91 74.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -61.26 -52.68 63.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.462 HG11 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.37 -37.9 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.247 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.129 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.503 0.192 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.6 t -61.72 -44.44 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.048 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.28 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.263 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.754 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -62.1 -47.03 92.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.273 179.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 15.0 m-85 -68.3 -29.46 68.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.84 1.95 21.64 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -51.08 -38.93 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.542 0.21 . . . . 0.0 111.498 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.67 21.6 1.99 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.46 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 54.09 1.97 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.152 0.501 . . . . 0.0 110.58 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -63.46 -54.19 40.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.28 -62.37 1.64 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.39 71.32 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.436 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -81.14 -41.55 22.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.62 49.1 0.42 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.649 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.5 ptm -176.47 136.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.612 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -105.81 -43.45 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.295 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.71 79.58 0.35 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.522 179.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.785 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.7 t -44.88 -37.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -45.36 -45.06 11.08 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 121.437 -0.411 . . . . 0.0 113.391 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 102' ' ' VAL . 7.2 pt-20 -80.07 -39.22 30.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.843 0.322 . . . . 0.0 111.508 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.59 -40.29 96.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.612 0.244 . . . . 0.0 110.819 179.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 104' ' ' THR . 1.3 ppt_? -75.54 -35.75 60.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.06 -37.6 74.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.602 0.239 . . . . 0.0 111.329 179.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.754 HG11 ' CA ' ' A' ' 82' ' ' GLY . 18.8 t -77.44 -44.08 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.731 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.2 mt -68.28 -34.12 75.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.278 -179.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 100' ' ' ARG . 20.0 p -63.01 -31.91 73.15 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.464 0.173 . . . . 0.0 111.356 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 m -67.6 -18.34 64.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.8 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.09 -61.9 1.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.28 52.68 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.427 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.75 51.94 4.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.731 ' HG2' HD22 ' A' ' 103' ' ' LEU . 9.7 tptt -68.18 -138.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.547 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' A' ' 114' ' ' GLU . 12.4 mt -71.21 76.23 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.457 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 62.2 p -66.39 -174.44 0.28 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.194 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.73 -34.67 27.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.313 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -52.19 58.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.534 0.207 . . . . 0.0 111.246 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.568 ' HG2' HD22 ' A' ' 110' ' ' LEU . 2.3 tp10 -56.62 -52.37 65.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.696 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.85 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -66.85 -26.62 67.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.446 179.495 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -46.36 87.45 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.076 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -66.94 -44.79 79.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.385 179.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.72 -39.77 89.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 179.11 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.1 mt -68.14 -33.92 75.37 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -61.91 -38.46 88.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.45 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.16 31.05 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.881 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.506 HG11 ' CG2' ' A' ' 129' ' ' VAL . 5.7 t -87.79 119.71 70.65 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.724 0.262 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.89 64.56 4.04 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.678 2.252 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.48 -177.76 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.124 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -119.02 126.67 52.25 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.521 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 74.78 0.47 3.56 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.03 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.585 ' N ' HD21 ' A' ' 119' ' ' LEU . . . 80.33 49.92 5.65 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.268 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -103.36 116.38 32.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.491 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 129' ' ' VAL . 40.1 t -142.35 26.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.999 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 61.77 23.65 13.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.795 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.448 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER 49.71 45.44 24.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 111.467 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -120.05 -57.58 1.93 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.145 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.476 ' CB ' HG11 ' A' ' 129' ' ' VAL . 24.3 t70 -54.71 -36.08 64.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.72 -60.25 2.68 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.9 t -62.64 -32.48 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.417 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -58.14 -53.78 54.39 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.9 ttp . . . . . 0 CA--C 1.532 0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.213 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.3 p -93.21 25.15 3.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.601 0.239 . . . . 0.0 111.562 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.66 52.97 0.59 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.04 0.447 . . . . 0.0 110.591 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.42 114.08 10.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.871 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -65.88 -46.16 64.99 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.245 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 6.2 Cg_exo -78.33 -17.13 13.3 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.787 2.325 . . . . 0.0 113.632 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -110.9 -60.01 1.89 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -60.18 2.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.566 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.0 -48.07 82.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.58 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.61 -38.15 77.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 15.4 t80 -57.75 -45.62 85.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.367 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -62.56 -33.55 75.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.9 mt -61.04 -36.59 79.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.302 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -92.85 24.5 3.6 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.99 94.78 8.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.801 0.334 . . . . 0.0 110.416 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -33.11 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -86.19 -31.0 22.0 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.467 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.45 26.53 59.11 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.623 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.5 p -115.93 21.82 13.5 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.625 0.213 . . . . 0.0 111.26 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.18 19.81 77.61 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.321 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' CD ' ' HB3' ' A' ' 54' ' ' GLU . 6.7 mtt85 -130.4 151.4 50.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.096 0.448 . . . . 0.0 110.631 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 HD13 ' A' ' 28' ' ' ILE . 6.5 pt -140.97 142.42 27.72 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.03 170.95 6.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.283 2.655 . . . . 0.0 112.487 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HB2' HG13 ' A' ' 44' ' ' ILE . 49.5 pttt -44.24 -39.16 4.25 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.8 p -60.41 -43.95 96.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.46 0.171 . . . . 0.0 111.396 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.5 m -70.34 -45.74 65.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.657 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.763 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.45 -33.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.178 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 -68.21 1.8 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.309 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.5 -28.27 69.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.51 -48.11 83.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.52 -33.16 73.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -56.13 -38.98 71.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.087 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.0 70.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.678 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -116.88 46.33 1.68 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.781 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.1 -106.59 0.42 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.974 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.2 -179.46 5.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 111.919 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 28.9 t-20 -118.35 112.55 37.51 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.58 -162.97 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.953 2.435 . . . . 0.0 112.683 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -105.65 163.77 12.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.1 -35.96 62.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.6 82.6 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.815 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.98 -55.78 17.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.85 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.942 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.11 -46.56 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.901 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.7 m -57.53 -41.48 80.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -38.09 78.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.942 HD12 ' HA ' ' A' ' 44' ' ' ILE . 20.4 mt -62.92 -46.58 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -57.24 -28.43 62.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.353 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -13.39 45.63 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 p -118.13 -46.52 2.61 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.553 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.56 146.55 34.53 Favored Pre-proline 0 N--CA 1.463 0.225 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.2 Cg_exo -36.44 139.01 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.496 2.798 . . . . 0.0 113.039 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.84 -63.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.707 0.63 . . . . 0.0 112.477 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.89 120.66 25.95 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.709 0.29 . . . . 0.0 110.369 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.08 87.18 2.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.094 0.473 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.4 p30 -84.96 178.35 7.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.589 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -41.14 -44.5 2.55 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.78 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -67.1 -53.61 29.2 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.404 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -56.76 -52.57 64.48 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.186 0.304 . . . . 0.0 111.703 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.44 81.63 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 61' ' ' LEU . 25.1 mt -61.35 -33.26 73.33 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -51.95 67.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.55 0.214 . . . . 0.0 110.996 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG2' HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.59 -39.24 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -53.16 58.4 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.108 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -83.67 61.19 6.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 1.8 ttt180 -56.81 -49.47 93.62 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.781 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 94.5 Cg_endo -83.8 19.44 1.35 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.525 2.15 . . . . 0.0 113.58 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m120 61.2 99.73 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.598 0.359 . . . . 0.0 111.893 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.45 -179.13 24.53 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.273 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.77 175.46 5.63 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.648 0.261 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' HG2' ' A' ' 78' ' ' GLU . 4.3 t70 56.29 62.4 2.35 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 110.657 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.563 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 21.9 ttt -179.89 -50.81 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 81.7 Cg_exo -45.75 -40.19 19.01 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.675 2.25 . . . . 0.0 113.159 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.14 54.24 0.31 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.428 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.03 145.15 56.18 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-O 120.503 0.192 . . . . 0.0 110.949 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.3 Cg_exo -59.1 -39.45 79.59 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.686 2.257 . . . . 0.0 112.375 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.04 -26.4 61.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.523 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.509 ' HG2' ' HA ' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -66.77 -49.07 67.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.568 0.223 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -37.74 81.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.322 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 76' ' ' PRO . 56.1 t -64.09 -43.93 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.342 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -40.14 94.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.669 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.74 ' HA3' HG11 ' A' ' 102' ' ' VAL . . . -63.6 -47.21 88.93 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.696 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.76 -30.15 66.57 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.454 0.168 . . . . 0.0 111.454 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.05 -14.96 62.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.1 t -47.86 -56.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.403 0.144 . . . . 0.0 111.305 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -113.49 39.84 2.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 111.027 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.51 62.24 1.46 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -63.74 -50.56 68.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.747 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -120.34 -54.76 2.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.85 81.17 0.15 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.958 0.409 . . . . 0.0 111.539 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -103.18 64.23 0.83 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.554 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.67 37.9 2.5 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.939 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.8 ptp -174.66 137.29 0.46 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.784 0.292 . . . . 0.0 111.126 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.56 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -107.1 -39.96 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.427 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 79.24 0.61 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.83 ' HA ' HD23 ' A' ' 99' ' ' LEU . 54.6 t -45.22 -36.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.98 -42.73 16.1 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.288 -0.482 . . . . 0.0 113.305 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -76.94 -43.31 35.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.61 0.205 . . . . 0.0 111.135 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.83 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.06 -39.02 80.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.143 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.444 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 10.6 ptp180 -74.54 -37.09 63.12 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.854 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.71 -36.64 72.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.267 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.74 HG11 ' HA3' ' A' ' 82' ' ' GLY . 24.7 t -82.87 -52.56 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.715 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.856 HD22 ' HG3' ' A' ' 109' ' ' LYS . 6.0 mt -62.5 -50.1 72.73 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.5 m -60.73 -38.26 84.52 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.497 0.189 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.8 t -73.26 -19.05 61.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.73 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.72 -55.83 10.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.618 0.246 . . . . 0.0 111.028 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.19 45.81 0.29 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.371 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.99 48.02 13.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.856 ' HG3' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.49 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.768 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.401 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 18.4 mt -68.16 79.84 0.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.008 0.432 . . . . 0.0 110.691 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.4 p -64.06 -175.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.126 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -47.7 -34.5 8.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.504 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.21 -60.02 4.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -41.11 95.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.199 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.802 ' HA ' HD23 ' A' ' 118' ' ' LEU . 5.5 mmt -66.79 -34.82 78.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.513 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -46.07 86.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.437 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -64.81 -37.94 89.3 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.802 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.5 -44.14 91.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.729 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.462 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.9 mt -65.03 -34.93 79.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.96 -39.76 94.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.902 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.17 -49.52 26.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.752 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 18.7 t -79.85 127.58 76.99 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 116.612 0.206 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 4.6 Cg_exo -74.11 63.19 5.14 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.962 2.441 . . . . 0.0 112.33 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.36 175.9 10.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -121.4 19.1 11.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.739 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.37 26.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.49 ' HA3' ' CG2' ' A' ' 96' ' ' VAL . . . 54.97 50.99 56.74 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.666 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.7 112.8 25.91 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.275 0.559 . . . . 0.0 110.752 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 129' ' ' VAL . 43.2 t -142.35 20.42 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 59.74 21.88 10.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.843 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.418 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 48.38 41.52 16.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.764 0.316 . . . . 0.0 111.326 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -114.2 -54.46 2.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.401 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.506 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.9 t70 -57.14 -36.33 70.58 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.8 m-85 -68.05 -59.0 3.58 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.617 0.246 . . . . 0.0 110.656 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 139' ' ' LEU . 19.7 t -62.56 -33.05 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.463 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -61.63 -56.85 15.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.056 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 22.8 ttp -66.88 -31.21 71.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.484 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.492 HG22 HD12 ' A' ' 139' ' ' LEU . 3.5 mt -66.79 -41.6 88.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.476 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 138' ' ' ILE . 1.4 mp -88.94 -3.66 58.67 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -111.58 90.32 3.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.827 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.062 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.419 0.152 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 t -116.52 30.68 7.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.37 50.89 0.57 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.86 112.6 2.98 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.321 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.16 -46.14 95.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.536 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 89.4 Cg_endo -80.73 -16.0 10.53 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.503 2.135 . . . . 0.0 113.96 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -110.68 -60.83 1.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 -61.43 1.8 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.341 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.475 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 6.0 tt0 -58.38 -46.85 85.56 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.839 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.56 -37.51 81.52 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.074 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 23' ' ' ILE . 20.5 t80 -56.29 -49.76 73.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -61.63 -33.76 74.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.333 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 8.4 mt -59.76 -33.92 72.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.43 0.157 . . . . 0.0 111.221 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 77.3 m-85 -93.28 32.19 1.37 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 121.63 30.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.759 0.314 . . . . 0.0 110.814 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -60.79 -52.22 66.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -107.11 -28.24 10.11 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.25 37.06 4.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.552 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.6 p -104.08 -20.76 13.73 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.17 3.61 8.06 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.444 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.619 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -122.59 162.46 21.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.253 0.527 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.789 HD12 HD13 ' A' ' 28' ' ' ILE . 5.1 pt -146.85 133.63 9.91 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.559 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -85.74 169.71 9.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.998 2.465 . . . . 0.0 112.345 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -43.89 -35.62 2.06 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.2 p -62.32 -45.04 95.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.493 0.187 . . . . 0.0 111.384 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.516 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 59.9 m -70.59 -44.82 66.53 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.823 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.789 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.83 -35.53 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.523 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.85 -66.92 2.43 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -63.67 -29.87 71.05 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.511 0.155 . . . . 0.0 111.002 179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 7.6 tp -61.11 -47.28 86.99 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.33 -32.72 72.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.049 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -40.48 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.027 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.18 -30.61 71.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.709 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.6 m -83.39 -44.36 14.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.591 0.234 . . . . 0.0 110.936 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.27 -81.55 0.04 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.707 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.2 -179.82 5.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -118.78 110.32 38.68 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.628 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.0 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.854 2.369 . . . . 0.0 112.361 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -104.53 166.59 10.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 25' ' ' LYS . 2.0 mm? -54.93 -35.55 64.3 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.88 76.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.761 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -56.43 9.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.706 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.15 -48.39 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.945 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.2 m -58.15 -41.29 83.45 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -58.04 -42.87 86.28 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.491 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.706 HD12 ' HA ' ' A' ' 44' ' ' ILE . 11.5 mt -63.04 -48.26 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.19 -25.12 58.49 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.844 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -63.86 -13.61 46.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.0 p -118.41 7.48 11.93 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -141.21 151.45 61.72 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 90.2 Cg_exo -38.3 143.76 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.275 2.65 . . . . 0.0 113.018 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.77 -58.62 0.13 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -92.27 125.43 36.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.592 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.1 t -86.79 83.51 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.049 0.452 . . . . 0.0 110.654 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.619 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -81.72 177.29 8.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.562 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 60.9 mtm -40.68 -44.65 2.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.745 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.88 -51.57 46.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.918 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -58.09 -52.35 65.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -48.44 81.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.714 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt -61.54 -38.23 86.69 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.173 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.52 -54.39 41.79 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.661 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.66 -35.33 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.938 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -33.87 71.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.571 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.555 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 4.4 m120 -96.27 42.96 1.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.66 0.267 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.656 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 1.3 ttt180 -61.74 -62.76 5.25 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 48.6 Cg_endo -89.76 17.4 1.56 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.383 2.056 . . . . 0.0 114.688 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.489 ' HB3' ' CB ' ' A' ' 72' ' ' MET . 12.2 t-20 158.29 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.633 0.373 . . . . 0.0 110.853 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.555 ' HA2' ' CB ' ' A' ' 65' ' ' ASN . . . 174.58 -70.85 0.09 OUTLIER Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.325 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -110.29 -59.44 1.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.2 82.07 3.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 111.167 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.489 ' CB ' ' HB3' ' A' ' 68' ' ' ASN . 0.0 OUTLIER 173.23 -52.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.784 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 26.9 Cg_exo -61.62 91.33 0.11 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.807 2.338 . . . . 0.0 112.123 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.92 25.12 74.37 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.184 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 172.36 10.08 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.996 0.398 . . . . 0.0 111.302 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' O ' HG23 ' A' ' 80' ' ' VAL . 50.4 Cg_exo -53.84 -42.16 68.77 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.78 2.32 . . . . 0.0 112.362 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -67.47 -27.08 66.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.504 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.47 -50.67 50.69 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 111.025 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -36.99 84.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.163 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 76' ' ' PRO . 81.6 t -64.77 -40.01 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.943 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -48.49 80.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.86 95.91 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.66 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -70.2 -24.45 63.12 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.529 0.164 . . . . 0.0 111.407 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -74.17 -15.4 61.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.11 -59.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 122.187 0.195 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.551 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -110.33 44.02 1.3 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.981 0.42 . . . . 0.0 110.558 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.35 51.86 1.57 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -51.15 69.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -115.68 -59.31 2.01 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.08 90.88 0.07 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.561 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 t -105.69 56.71 0.67 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 110.79 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.51 49.42 1.84 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.927 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.15 135.87 0.48 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.68 0.276 . . . . 0.0 111.127 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -109.01 -42.75 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.336 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.12 81.58 0.33 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.949 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.734 ' HA ' HD23 ' A' ' 99' ' ' LEU . 86.6 t -43.55 -36.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.79 -37.98 15.44 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.594 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.551 ' HG3' ' CB ' ' A' ' 86' ' ' PHE . 2.6 tm-20 -73.2 -51.32 18.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.239 0.215 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.46 -37.18 74.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.174 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.489 ' HD3' HG21 ' A' ' 104' ' ' THR . 4.9 tmm_? -65.57 -47.89 74.24 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -53.96 -38.09 64.62 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.323 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' GLU . 21.4 t -70.73 -49.03 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.299 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.689 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.3 mt -65.02 -38.29 90.43 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.993 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 23.0 p -64.75 -35.44 81.07 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.523 0.202 . . . . 0.0 110.878 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -66.93 -19.75 65.78 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.651 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt -69.46 -61.19 1.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.584 0.23 . . . . 0.0 110.534 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.8 51.63 0.18 Allowed Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.329 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 59.92 46.74 10.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.868 0.366 . . . . 0.0 110.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.689 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.74 -137.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.277 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.508 HD22 ' HG2' ' A' ' 114' ' ' GLU . 21.4 mt -69.16 79.24 0.35 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 92.6 p -64.36 -172.43 0.07 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.252 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -51.65 -31.17 24.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.265 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.81 -51.18 69.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.508 ' HG2' HD22 ' A' ' 110' ' ' LEU . 4.7 tp10 -58.76 -52.82 64.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.774 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.4 ppp? -66.16 -26.15 67.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -48.51 80.77 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.16 -45.14 89.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.405 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.774 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -58.91 -41.26 86.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.538 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.543 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -64.13 -37.5 87.69 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.209 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -36.76 84.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.91 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.68 49.78 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.05 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 129' ' ' VAL . 21.5 t -87.3 128.45 55.19 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.803 0.302 . . . . 0.0 111.14 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.59 58.05 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.63 2.22 . . . . 0.0 112.595 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.39 -177.67 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.284 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 131.53 55.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.649 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.16 9.17 6.95 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.03 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.725 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 71.38 49.96 23.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.554 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -103.78 115.16 29.96 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.206 0.526 . . . . 0.0 110.725 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 129' ' ' VAL . 37.4 t -142.45 25.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.841 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 58.58 22.57 9.92 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.932 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 54.05 -158.7 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 68.78 -60.63 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.406 0.282 . . . . 0.0 111.569 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.01 -38.76 62.61 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.9 m-85 -68.36 -54.58 16.33 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.714 0.292 . . . . 0.0 110.695 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.5 t -62.15 -32.96 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.511 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.44 -52.19 54.91 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.686 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.34 -34.23 76.9 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.212 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 mt -62.85 -45.55 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.3 mp -91.72 54.57 2.5 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.922 0.392 . . . . 0.0 110.727 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.38 111.19 0.4 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.789 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.212 -179.691 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.53 0.205 . . . . 0.0 111.431 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t 46.21 45.04 12.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.677 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.63 -58.37 2.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.703 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -140.4 95.81 2.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.4 t -66.07 -46.92 63.46 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 6' ' ' SER . 84.6 Cg_endo -79.34 -14.04 13.35 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.516 2.144 . . . . 0.0 114.166 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.15 -61.59 1.7 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -72.29 -62.86 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.463 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -58.47 -47.73 83.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -45.26 87.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.936 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CE2' HG12 ' A' ' 23' ' ' ILE . 23.0 t80 -54.49 -45.99 73.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.74 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 m -59.27 -35.37 73.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.392 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 9.0 mt -60.53 -29.34 69.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.325 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 23' ' ' ILE . 49.1 m-85 -95.03 27.69 3.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.71 123.07 40.28 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 110.551 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -52.3 66.05 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.369 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -130.86 27.65 4.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.71 49.45 61.49 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.682 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -93.72 -29.01 15.62 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.1 -1.42 16.96 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.23 -0.509 . . . . 0.0 113.108 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.597 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -127.74 167.56 16.31 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.01 0.405 . . . . 0.0 110.607 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 28' ' ' ILE . 9.5 pt -144.23 134.31 11.87 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.56 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 23' ' ' ILE . 4.4 Cg_endo -86.32 171.75 7.46 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.39 2.727 . . . . 0.0 111.852 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.1 pttt -44.24 -36.6 2.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -61.01 -45.89 92.97 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.54 0.209 . . . . 0.0 111.449 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.1 m -70.49 -46.6 63.41 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.933 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.645 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.39 -33.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.413 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.71 -68.89 1.41 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.444 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -26.69 68.87 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 111.407 0.151 . . . . 0.0 111.407 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.454 HD13 ' CE2' ' A' ' 15' ' ' PHE . 9.4 tp -64.07 -48.9 74.39 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.5 mt -61.47 -30.61 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.009 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.62 -38.71 69.86 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.909 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.92 73.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.593 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.5 -42.31 25.52 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.748 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.3 -79.35 0.03 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.643 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.32 176.59 8.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.913 0.387 . . . . 0.0 111.489 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -119.72 113.12 34.85 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.464 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.69 -162.63 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.755 2.304 . . . . 0.0 112.459 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -99.28 166.03 11.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -55.13 -33.64 63.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.887 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -37.2 79.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.923 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.34 -53.98 20.44 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.641 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.81 -46.88 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.003 0.189 . . . . 0.0 110.766 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.5 m -60.15 -39.74 87.45 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.34 -37.52 75.33 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.452 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 44' ' ' ILE . 39.0 mt -67.01 -45.63 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.896 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -56.66 -27.12 57.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.524 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -64.61 -7.72 11.56 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 p -117.7 -52.73 2.44 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 117.893 0.315 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.604 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -87.27 154.88 54.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.541 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -38.36 142.74 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.082 2.522 . . . . 0.0 113.07 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.51 -64.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.3 0.64 . . . . 0.0 112.599 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.1 123.18 31.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.494 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.42 86.33 2.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.597 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.7 p30 -85.08 179.66 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.357 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -41.55 -47.59 3.82 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.532 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.58 -52.54 60.53 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.541 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.79 -53.91 52.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.7 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -49.83 73.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.72 -28.98 69.81 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -63.77 -49.76 71.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.606 0.241 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.36 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.493 HD23 ' OD1' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -73.49 -61.93 1.66 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.312 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.493 ' OD1' HD23 ' A' ' 64' ' ' LEU . 78.5 m-20 -83.26 59.87 5.24 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.814 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.408 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.3 mtp180 -58.3 -49.13 95.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.467 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 72' ' ' MET . 66.2 Cg_endo -83.94 19.23 1.39 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.655 2.237 . . . . 0.0 113.885 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 55.29 88.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.901 0.382 . . . . 0.0 111.446 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA3' ' CG ' ' A' ' 72' ' ' MET . . . 159.42 -166.79 34.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.674 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -115.54 -51.54 2.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.214 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -98.17 19.39 14.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.769 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.649 ' HB2' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -92.78 -48.83 0.29 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.455 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 72' ' ' MET . 81.8 Cg_exo -46.64 -36.59 19.17 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.799 2.333 . . . . 0.0 113.0 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.04 87.22 1.98 Allowed Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.765 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 78' ' ' GLU . 13.5 m-20 -80.93 145.43 57.2 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.465 0.174 . . . . 0.0 111.006 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' O ' HG23 ' A' ' 80' ' ' VAL . 34.3 Cg_exo -57.58 -49.5 13.27 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.788 2.325 . . . . 0.0 112.449 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.05 -20.91 65.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.55 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 tt0 -68.88 -50.17 51.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.913 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -36.78 81.59 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.452 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 76' ' ' PRO . 51.6 t -64.53 -53.76 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.552 0.215 . . . . 0.0 110.97 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -29.46 70.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.69 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.812 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -65.19 -49.04 63.77 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.555 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.09 -37.76 69.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.427 0.156 . . . . 0.0 110.969 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -78.91 73.16 5.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.9 t -135.1 -64.71 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.96 34.95 4.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.531 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -129.32 51.85 2.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.457 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.25 64.97 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.231 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -136.52 -72.88 0.44 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.69 45.82 27.21 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.626 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.37 44.6 1.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.11 33.7 3.92 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.624 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 ttt -171.73 134.5 0.81 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.152 0.476 . . . . 0.0 111.531 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.643 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -114.52 -42.1 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.28 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.66 80.49 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.22 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.745 ' HA ' HD23 ' A' ' 99' ' ' LEU . 81.7 t -44.41 -34.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -40.06 11.01 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.824 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.1 mp0 -76.09 -50.71 13.94 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.457 0.17 . . . . 0.0 110.783 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.745 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -59.13 -35.34 73.3 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.257 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -55.96 12.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.101 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -52.45 -38.59 59.61 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.812 HG11 ' CA ' ' A' ' 82' ' ' GLY . 42.1 t -72.12 -58.0 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.738 HD22 ' HG2' ' A' ' 109' ' ' LYS . 2.8 mt -60.99 -36.41 79.39 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 m -61.68 -36.84 82.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.588 0.232 . . . . 0.0 111.093 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.6 t -65.02 -22.8 67.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.994 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 3.7 mt -64.88 -72.95 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.508 0.194 . . . . 0.0 111.232 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.85 50.98 0.46 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 64.23 47.24 3.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.175 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.738 ' HG2' HD22 ' A' ' 103' ' ' LEU . 14.4 tptt -68.57 -138.12 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.455 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.9 mm? -69.18 77.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.483 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.8 p -69.89 -175.27 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.59 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -51.02 -38.83 53.73 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.704 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.47 -48.89 63.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.576 0.227 . . . . 0.0 111.384 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 5.2 mm-40 -59.01 -51.64 69.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.635 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.3 -27.36 67.86 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -46.34 86.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -65.68 -44.34 86.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.369 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.99 -43.5 95.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.405 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -69.2 -32.97 72.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.35 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -61.68 -38.39 87.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.986 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 -46.62 43.66 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.953 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.92 127.12 63.51 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.706 0.253 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 59.61 6.19 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.72 2.28 . . . . 0.0 112.647 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.61 176.63 8.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.264 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -119.3 132.16 55.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.535 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t70 76.61 -1.92 2.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.887 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 78.26 51.02 5.89 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttp -104.2 113.17 26.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.229 0.538 . . . . 0.0 110.54 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 129' ' ' VAL . 40.5 t -142.35 19.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.03 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 59.37 22.14 10.53 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.632 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 53.65 -158.12 0.17 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.5 t60 69.62 -60.19 0.48 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.168 0.187 . . . . 0.0 111.206 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.67 -41.76 64.13 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.5 m-85 -65.44 -57.06 9.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.703 0.287 . . . . 0.0 110.403 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.688 HG12 HD13 ' A' ' 139' ' ' LEU . 4.1 t -62.07 -28.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.507 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.61 -49.83 73.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.854 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.67 -33.81 76.76 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.683 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.36 -38.81 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.688 HD13 HG12 ' A' ' 135' ' ' VAL . 1.8 mp -90.96 64.34 5.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.814 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.41 44.41 2.93 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.311 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t -108.44 28.36 8.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.348 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.28 1.33 16.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -78.31 97.01 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t -67.03 -47.37 52.57 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.095 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 6' ' ' SER . 75.4 Cg_endo -79.55 -13.17 13.53 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.534 2.156 . . . . 0.0 114.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.75 -63.16 1.45 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -72.85 -61.45 1.8 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.433 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.03 81.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.731 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.1 -44.27 87.58 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.5 t80 -52.05 -46.39 65.07 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.197 0.311 . . . . 0.0 110.471 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.6 t -60.5 -36.38 78.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.216 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.9 mt -59.78 -28.51 67.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.389 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 m-85 -89.02 19.99 3.86 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.24 92.36 4.48 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -61.66 -36.37 80.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -86.76 -37.01 18.26 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.117 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.34 45.32 5.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.439 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -109.25 -30.21 8.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.44 8.15 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.272 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -127.06 163.63 23.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.152 0.476 . . . . 0.0 110.655 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.786 HD12 HD13 ' A' ' 28' ' ' ILE . 3.7 pt -143.7 136.03 13.34 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.98 171.93 5.57 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.256 2.637 . . . . 0.0 112.287 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.508 ' HB2' HG13 ' A' ' 44' ' ' ILE . 14.3 pttm -43.83 -38.4 3.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.3 p -60.31 -44.89 95.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.496 0.189 . . . . 0.0 111.22 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 18.7 m -71.01 -47.41 58.93 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.786 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.19 -35.61 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.635 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.88 -68.08 1.79 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.456 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -28.09 69.26 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 5.7 tp -61.98 -46.46 89.15 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.63 -31.8 71.91 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -58.26 -41.83 85.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.875 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.16 68.9 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.488 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -118.25 42.59 2.67 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.16 -107.77 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.949 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.22 179.55 6.04 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.023 0.44 . . . . 0.0 111.829 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 28.6 t-20 -118.57 106.38 44.47 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.78 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.55 -163.71 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.053 2.502 . . . . 0.0 112.576 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.723 HG21 ' HG ' ' A' ' 139' ' ' LEU . 2.7 p -104.95 164.31 11.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.868 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.15 -37.65 62.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.994 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.15 77.91 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.695 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.12 -55.14 17.91 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.3 -46.89 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.875 -0.148 . . . . 0.0 111.106 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -55.37 -43.84 75.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -37.76 76.14 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.755 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.786 HG23 HG11 ' A' ' 63' ' ' VAL . 64.7 mt -61.09 -51.78 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -56.86 -27.45 60.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.753 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.76 -13.86 47.46 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.7 p -119.06 5.84 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.688 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -140.19 157.67 68.44 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 110.523 -0.176 . . . . 0.0 110.523 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 92.8 Cg_exo -42.05 146.39 0.64 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.141 2.561 . . . . 0.0 113.164 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -27.4 -63.02 0.09 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -95.1 131.15 41.42 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.477 0.18 . . . . 0.0 110.65 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.05 87.16 2.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.045 0.45 . . . . 0.0 110.924 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.97 -177.56 6.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.459 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mtt -41.21 -46.97 3.24 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -52.84 32.38 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.586 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.88 -49.77 75.6 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -48.64 79.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.833 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 mt -61.87 -29.3 70.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.451 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -65.77 -48.08 73.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.994 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.786 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.19 -43.17 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.983 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -44.24 92.71 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.427 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -111.14 45.91 1.13 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -51.51 79.48 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.652 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 92.8 Cg_endo -83.07 19.9 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.636 2.224 . . . . 0.0 113.574 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.05 77.29 0.32 Allowed 'General case' 0 C--N 1.343 0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 111.163 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.4 172.64 26.81 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.772 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -104.68 -48.71 3.71 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.408 0.147 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -93.0 78.9 4.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.154 0.502 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.544 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 8.6 tpt 179.12 -54.6 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.972 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 77.9 Cg_exo -40.15 -46.91 4.11 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.339 2.693 . . . . 0.0 113.626 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.8 42.76 0.95 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.759 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HB2' ' HD2' ' A' ' 76' ' ' PRO . 50.7 p-10 -80.92 163.29 56.38 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 111.277 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 75' ' ' ASP . 50.5 Cg_exo -54.58 -35.85 87.4 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.977 2.451 . . . . 0.0 112.86 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -34.65 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.404 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -46.32 67.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -42.03 96.44 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.149 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.57 -50.25 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.013 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.03 67.91 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -71.59 -56.35 6.77 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.161 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -77.98 -39.82 41.24 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.13 73.54 4.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.186 0.517 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 86' ' ' PHE . 10.9 p -118.09 -43.69 2.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 86' ' ' PHE . 9.4 t80 -154.46 25.78 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.526 0.679 . . . . 0.0 110.393 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -109.67 51.41 0.75 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.928 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -28.84 64.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.382 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.24 -57.79 3.23 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.037 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.98 -174.21 0.11 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p 44.64 59.98 3.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.038 0.447 . . . . 0.0 111.314 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.24 -33.43 0.27 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.08 144.24 9.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.556 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.66 -41.55 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.249 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.9 77.9 0.25 Allowed Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.559 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.778 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.0 t -45.28 -42.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.89 -37.26 9.24 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.856 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.6 mm-40 -80.59 -47.23 14.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.5 0.191 . . . . 0.0 110.544 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.778 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -41.93 84.34 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.839 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -34.83 65.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.803 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -55.57 -38.34 69.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.561 0.219 . . . . 0.0 110.939 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.544 HG11 ' HA2' ' A' ' 82' ' ' GLY . 2.5 t -78.55 -46.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.236 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.3 mt -65.99 -46.21 78.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.9 m -55.88 -35.51 66.58 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.469 0.176 . . . . 0.0 111.43 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.0 t -71.81 -19.01 62.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.843 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.18 -68.22 0.41 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.444 0.164 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.89 55.85 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.566 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 58.69 45.54 15.72 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.333 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 10.4 mmtp -68.9 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.222 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.47 78.4 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.8 p -64.87 -176.6 0.28 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.851 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -52.62 -32.58 42.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.787 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -53.79 52.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.75 -51.45 69.5 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.953 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.871 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.38 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -49.07 78.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.639 0.257 . . . . 0.0 110.471 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -42.12 86.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.747 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.99 -43.55 98.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -71.07 -31.91 68.44 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.262 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -61.74 -40.83 96.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.634 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 -46.23 19.09 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.922 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.481 HG11 ' CG2' ' A' ' 129' ' ' VAL . 21.4 t -85.35 119.15 72.02 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 116.787 0.294 . . . . 0.0 111.13 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.07 63.9 6.91 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.56 2.173 . . . . 0.0 112.588 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 122' ' ' VAL . 23.3 m -130.77 -175.95 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.253 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -118.87 127.3 53.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 t70 72.53 6.86 5.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.852 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 72.85 53.67 7.92 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.915 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -104.03 116.97 33.19 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.108 0.48 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 129' ' ' VAL . 40.3 t -142.39 30.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 36.6 t30 61.38 19.0 9.83 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.946 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 56.36 -176.67 0.05 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.8 -52.04 0.68 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.384 0.273 . . . . 0.0 111.667 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.89 -45.72 67.65 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -68.78 -49.87 55.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.99 -31.68 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.411 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -66.08 -51.07 61.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.905 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.5 ttt -62.24 -35.86 80.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.19 -35.49 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.052 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.723 ' HG ' HG21 ' A' ' 40' ' ' THR . 1.1 mp -89.14 17.26 6.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -157.1 95.15 1.47 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 110.757 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.256 -179.535 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.809 0.338 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -134.69 48.54 2.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 t70 61.6 51.7 3.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.312 0.577 . . . . 0.0 110.143 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -55.54 114.31 1.79 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.524 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 5.0 t -65.22 -46.07 71.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.379 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.15 -15.21 11.69 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.514 2.143 . . . . 0.0 113.824 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -110.14 -60.43 1.8 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -72.6 -61.02 1.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.444 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 9.5 tp60 -59.03 -47.52 84.92 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.25 -39.23 82.17 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.012 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.7 t80 -56.03 -44.66 78.97 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -62.33 -35.97 80.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.272 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.57 -33.94 73.43 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.428 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -91.04 20.06 5.22 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.44 89.82 3.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 120.839 0.352 . . . . 0.0 110.193 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -66.41 -29.16 69.25 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.878 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -85.97 -28.35 24.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.52 31.67 65.34 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.383 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.1 p -101.02 -30.0 11.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 122.282 0.233 . . . . 0.0 111.246 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.6 -3.05 11.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.266 -0.493 . . . . 0.0 113.092 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.56 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -119.53 157.91 27.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 117.01 0.405 . . . . 0.0 110.742 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.852 HD12 HD13 ' A' ' 28' ' ' ILE . 4.3 pt -138.3 139.75 26.28 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.46 170.42 7.9 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.096 2.531 . . . . 0.0 112.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HB2' HG13 ' A' ' 44' ' ' ILE . 10.7 pttp -45.14 -39.12 5.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.2 p -60.03 -43.3 95.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.545 0.212 . . . . 0.0 111.197 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.9 t -68.55 -51.95 37.2 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.167 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.852 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.92 -36.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.519 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.83 -71.98 0.58 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.649 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -27.98 69.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.8 -50.58 70.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.607 0.241 . . . . 0.0 110.356 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -61.44 -29.53 70.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.267 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.34 -38.75 69.16 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.061 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.51 69.89 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.704 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 t -114.66 40.04 2.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.714 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.33 -107.15 0.36 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 174.81 9.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.909 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 3.8 t-20 -119.5 107.04 41.45 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.156 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.91 -162.76 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.89 2.394 . . . . 0.0 112.75 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 p -93.63 166.53 12.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.188 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.46 -34.73 67.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.81 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.18 79.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.585 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.84 -55.17 24.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.055 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.615 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.96 -47.16 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.689 179.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -58.55 -39.9 81.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.42 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -58.71 -40.82 84.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.372 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.54 ' O ' HD22 ' A' ' 51' ' ' LEU . 55.1 mt -61.73 -50.21 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -56.98 -23.9 49.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.696 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -7.75 10.88 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 p -117.89 -45.44 2.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 117.627 0.194 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.6 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -89.97 159.01 43.69 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 72.0 Cg_exo -40.17 146.08 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 113.026 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -31.1 -60.37 0.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.205 0.602 . . . . 0.0 112.597 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -91.07 127.12 36.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.641 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.7 t -86.91 86.81 2.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 111.1 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.56 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.8 p30 -84.55 178.81 7.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.38 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 53.1 mtm -41.56 -47.94 3.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.689 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.95 -50.54 62.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.851 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.592 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -56.81 -51.07 70.41 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.586 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -48.28 80.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 61' ' ' LEU . 35.9 mt -61.17 -34.28 74.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.425 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -60.96 -53.11 61.28 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.2 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.492 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -64.05 -42.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.889 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -46.77 88.06 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.17 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -98.2 49.39 1.0 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.702 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.93 69.88 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.136 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.542 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 65.7 Cg_endo -85.51 19.53 1.38 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.824 2.349 . . . . 0.0 113.321 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.46 78.86 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.214 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.17 172.33 19.4 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.923 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.11 -42.98 5.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.483 0.182 . . . . 0.0 110.972 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.42 72.57 7.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.138 0.494 . . . . 0.0 110.139 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.635 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.7 -53.6 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.263 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 80.5 Cg_exo -43.67 -52.07 5.62 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.819 2.346 . . . . 0.0 113.041 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.72 58.75 0.02 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.729 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -80.59 140.5 51.58 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-O 120.476 0.179 . . . . 0.0 111.008 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.7 Cg_exo -58.25 -45.3 32.04 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.36 -24.92 59.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.293 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -47.33 70.22 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.557 0.218 . . . . 0.0 110.983 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -35.33 63.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.556 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 76' ' ' PRO . 48.9 t -66.77 -56.73 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.182 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -35.05 79.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.754 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.818 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.99 -47.12 86.16 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.637 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -77.56 -36.71 51.86 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.776 0.288 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -74.94 75.51 2.18 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.518 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 102' ' ' VAL . 45.1 t -127.31 -66.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.81 38.24 2.32 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.726 0.298 . . . . 0.0 111.79 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.665 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 5.3 p30 -130.06 72.6 1.49 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.001 0.429 . . . . 0.0 110.782 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -31.16 68.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.655 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -113.18 -53.94 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.665 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . . . 60.58 69.06 0.71 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 111.271 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 -40.55 6.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.368 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -166.5 62.01 0.22 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.446 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 ptt? -175.68 140.24 0.45 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.268 0.227 . . . . 0.0 110.483 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.589 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.12 -43.32 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.599 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.75 81.15 0.1 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.158 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.741 HG21 HD21 ' A' ' 118' ' ' LEU . 70.6 t -42.84 -33.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.81 -39.12 17.0 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.749 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.677 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.3 pt-20 -76.9 -44.59 31.23 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.609 0.205 . . . . 0.0 111.202 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -64.8 -37.44 87.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.531 0.205 . . . . 0.0 111.223 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -49.79 60.29 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.763 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -53.79 -42.39 68.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.296 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.818 HG21 ' O ' ' A' ' 82' ' ' GLY . 48.0 t -66.76 -51.17 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.522 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 5.0 mt -64.63 -50.69 66.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.977 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 m -56.86 -31.37 64.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.6 t -66.95 -24.85 66.11 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.25 -67.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.578 0.228 . . . . 0.0 111.13 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.79 55.84 0.29 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 45.13 7.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.952 0.406 . . . . 0.0 111.215 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 2.3 mmtm -68.61 -137.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.24 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.648 HD22 ' HG2' ' A' ' 114' ' ' GLU . 17.5 mt -69.41 78.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.656 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 59.7 p -68.65 -171.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.967 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -52.54 -33.17 44.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.385 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.52 -51.81 63.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.52 0.2 . . . . 0.0 111.497 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.648 ' HG2' HD22 ' A' ' 110' ' ' LEU . 2.5 tp10 -57.38 -51.56 68.93 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.79 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.899 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -66.77 -26.72 67.1 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.79 -46.81 86.7 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.28 -43.97 84.89 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.489 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.899 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.7 -41.55 95.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.564 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -69.54 -30.82 68.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.007 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.3 mttp -62.99 -40.18 96.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.502 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -45.43 42.06 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.736 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.467 HG11 ' CG2' ' A' ' 129' ' ' VAL . 12.7 t -90.68 116.33 66.17 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.612 0.206 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.56 64.59 4.67 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.591 2.194 . . . . 0.0 112.658 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.45 HG13 HG12 ' A' ' 122' ' ' VAL . 25.1 m -130.05 -175.44 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.084 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -118.62 124.59 47.82 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.443 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t70 76.55 -2.36 2.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.949 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 81.13 50.97 4.9 Favored Glycine 0 C--N 1.342 0.872 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.789 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 ttt -104.45 119.35 38.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 133' ' ' ASP . 27.9 t -141.14 28.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 59.62 24.27 13.08 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.027 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.3 t80 46.11 48.16 12.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 111.556 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -122.91 -53.05 1.87 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.507 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.658 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -59.57 -35.09 73.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 3.0 m-85 -68.15 -55.41 12.47 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.832 0.349 . . . . 0.0 110.584 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.7 -34.09 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.021 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.54 -52.64 64.34 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.5 ttt -64.54 -33.77 76.67 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.197 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 139' ' ' LEU . 3.2 mt -63.98 -45.29 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.894 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.467 HD12 HG22 ' A' ' 138' ' ' ILE . 2.0 mp -96.86 59.83 1.73 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.111 0.481 . . . . 0.0 110.754 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -154.75 54.8 0.67 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.975 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.0 -179.792 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.704 0.288 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 2.5 m 60.04 63.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.776 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.23 -50.33 2.36 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.187 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 1.8 m-20 -76.06 102.02 5.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.052 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.454 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.6 t -67.32 -48.02 47.73 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.706 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 6' ' ' SER . 80.3 Cg_endo -78.54 -9.05 16.11 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.483 2.122 . . . . 0.0 114.237 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.456 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 84.7 m-85 -118.94 -59.65 1.84 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -72.2 -56.87 4.82 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.221 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.8 -48.03 80.88 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.448 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.54 -38.18 77.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 23' ' ' ILE . 26.5 t80 -59.14 -46.87 87.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.431 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 1.1 t -62.76 -30.44 71.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.692 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 18.2 mt -57.32 -38.35 73.92 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.13 31.55 2.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -101.81 91.69 4.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.582 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -25.63 63.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.654 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -86.38 -35.57 19.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.062 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.64 26.37 59.04 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.618 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.3 p -109.64 -19.83 13.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.1 19.94 6.96 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.992 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 4.3 mtp180 -130.2 150.09 51.61 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.978 0.389 . . . . 0.0 110.687 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.703 HD12 HD13 ' A' ' 28' ' ' ILE . 7.9 pt -136.88 138.07 24.99 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.749 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -86.76 171.8 6.9 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.177 2.585 . . . . 0.0 112.52 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -45.28 -36.85 4.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.8 p -60.83 -44.89 96.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.459 0.171 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.553 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 24.1 m -70.81 -45.61 64.29 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.703 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.06 -33.27 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.76 -68.12 1.86 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.453 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.36 -29.47 70.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.406 0.146 . . . . 0.0 111.24 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.1 tp -62.01 -50.47 71.93 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.13 -28.38 69.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.04 -41.04 74.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.048 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.0 -26.51 68.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -121.74 39.4 3.87 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.699 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.66 -110.1 0.43 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.798 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.7 178.21 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.082 0.468 . . . . 0.0 111.938 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 20.4 t-20 -119.68 97.27 49.86 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.443 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.07 -162.55 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.822 2.348 . . . . 0.0 112.587 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 169.23 9.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.1 mm? -56.04 -33.85 65.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.6 78.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.671 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -54.2 41.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.249 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.792 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -59.74 -47.8 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.865 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.41 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 57.7 m -54.42 -43.53 71.6 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -56.49 -38.93 72.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.57 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.792 HD12 ' HA ' ' A' ' 44' ' ' ILE . 33.2 mt -63.03 -49.77 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -56.39 -24.94 47.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.99 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -63.88 -8.23 10.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.4 p -118.03 -46.32 2.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.584 0.174 . . . . 0.0 111.014 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.607 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.44 156.03 41.81 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 87.6 Cg_exo -41.84 150.24 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.238 2.625 . . . . 0.0 113.088 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.65 -62.86 0.39 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.373 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -84.77 121.66 28.0 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.44 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.13 89.28 2.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -83.68 178.03 8.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.458 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.3 mtm -41.18 -46.73 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.834 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.32 -52.08 50.81 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.889 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.472 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.8 -51.26 69.65 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.476 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.1 -48.77 80.14 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.013 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.35 -35.16 76.66 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -59.69 -54.99 39.97 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.487 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.04 -36.9 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.87 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD13 ' HE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -60.71 -44.78 96.17 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.104 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -92.04 51.59 1.84 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.952 0.405 . . . . 0.0 110.745 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -60.83 -51.46 79.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HG2' ' HB2' ' A' ' 72' ' ' MET . 44.7 Cg_endo -88.06 37.65 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 112.83 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 39.98 49.34 2.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.846 0.458 . . . . 0.0 111.754 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA3' ' HG2' ' A' ' 72' ' ' MET . . . -159.4 174.55 36.3 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.938 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -100.41 -50.71 3.84 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -99.99 19.13 16.82 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.612 ' HB2' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -94.8 -44.33 0.28 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 87.9 Cg_exo -47.79 -52.83 7.48 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.656 2.237 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.08 61.07 0.07 OUTLIER Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.869 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.89 161.67 62.63 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-O 120.499 0.19 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' O ' HG23 ' A' ' 80' ' ' VAL . 49.7 Cg_exo -55.75 -38.81 93.93 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.865 2.376 . . . . 0.0 112.366 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.45 -32.49 73.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.39 -45.49 79.86 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.861 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -39.79 92.35 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.834 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 76' ' ' PRO . 99.9 t -64.52 -40.97 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.75 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -40.26 95.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.34 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.901 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -62.97 -48.07 83.59 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.384 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.07 -33.12 75.07 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.48 0.181 . . . . 0.0 110.865 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -62.26 -29.04 70.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.073 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.715 ' HB ' HG21 ' A' ' 102' ' ' VAL . 89.1 t -58.31 138.51 19.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.851 0.357 . . . . 0.0 110.393 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.35 22.79 3.96 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.728 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -136.71 62.12 1.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.963 0.411 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -70.79 -55.68 8.04 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.31 -60.08 1.6 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.046 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 67.81 -76.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.412 0.445 . . . . 0.0 111.764 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m 69.08 -77.6 0.05 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.755 0.422 . . . . 0.0 111.23 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.32 53.16 0.79 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.447 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.5 135.97 0.57 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.729 0.299 . . . . 0.0 110.786 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.83 -42.85 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.279 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 98' ' ' GLU . . . 66.25 81.84 0.14 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.858 HG21 HD21 ' A' ' 118' ' ' LEU . 78.8 t -43.38 -32.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.84 -36.09 32.72 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.103 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -79.84 -40.66 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.936 0.368 . . . . 0.0 111.181 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -65.44 -37.12 85.96 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.029 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.517 ' CB ' ' HE2' ' A' ' 115' ' ' MET . 0.0 OUTLIER -77.13 -37.21 54.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.218 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -60.1 -36.54 77.67 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.571 0.224 . . . . 0.0 110.911 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.901 HG11 ' HA2' ' A' ' 82' ' ' GLY . 21.4 t -82.65 -47.24 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.702 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.89 HD22 ' HG2' ' A' ' 109' ' ' LYS . 6.1 mt -70.35 -49.95 44.02 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.9 m -60.57 -34.25 73.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.441 0.163 . . . . 0.0 111.19 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -72.02 -20.29 61.72 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.548 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.86 -63.42 1.12 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.57 0.224 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.7 53.2 0.28 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.405 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.71 45.37 10.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.89 ' HG2' HD22 ' A' ' 103' ' ' LEU . 4.2 tptt -68.63 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.117 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.828 HD22 ' HG3' ' A' ' 114' ' ' GLU . 54.7 mt -67.41 79.11 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.875 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.5 p -64.55 -168.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.99 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.48 ' HA ' ' HE3' ' A' ' 115' ' ' MET . 34.5 m120 -53.19 -31.05 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.381 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.4 -50.78 72.65 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.554 0.216 . . . . 0.0 111.297 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.828 ' HG3' HD22 ' A' ' 110' ' ' LEU . 5.0 tm-20 -56.26 -53.66 54.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.797 ' HA ' HD23 ' A' ' 118' ' ' LEU . 16.0 ptp -66.68 -25.1 66.39 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.368 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -47.72 83.15 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.732 0.301 . . . . 0.0 110.267 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -40.52 68.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.894 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -65.11 -43.77 90.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.178 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.435 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 8.7 mt -72.55 -26.91 61.92 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.362 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -66.54 -43.77 84.21 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.603 0.239 . . . . 0.0 110.728 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.1 -40.47 34.6 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.964 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 129' ' ' VAL . 47.3 t -83.88 130.46 55.12 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.679 0.24 . . . . 0.0 111.192 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.21 61.96 6.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.733 2.289 . . . . 0.0 112.38 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.561 HG21 ' H ' ' A' ' 128' ' ' MET . 5.2 p -131.19 168.05 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -127.76 50.52 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.098 0.475 . . . . 0.0 111.314 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.82 -36.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.593 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.413 ' HA3' HG23 ' A' ' 96' ' ' VAL . . . 114.7 35.62 1.38 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.034 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.561 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -103.38 117.35 34.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 129' ' ' VAL . 39.8 t -142.1 20.77 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.316 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 62.44 22.78 13.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.54 -167.43 0.11 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.21 -59.05 0.57 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.185 0.194 . . . . 0.0 111.165 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.95 -41.06 64.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.518 0.199 . . . . 0.0 111.2 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 26.9 m-85 -68.28 -50.0 56.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.175 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.1 t -62.07 -27.56 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.352 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.83 -42.63 66.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.03 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.0 mt -83.41 -56.39 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.365 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -85.19 -52.71 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.473 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 139' ' ' LEU . . . 73.69 96.92 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.032 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.062 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.654 0.264 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m 61.84 46.03 7.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.97 62.58 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -42.03 107.06 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.629 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.455 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.1 t -55.94 -46.24 99.79 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.753 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 6' ' ' SER . 86.1 Cg_endo -83.28 -8.95 10.59 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.563 2.175 . . . . 0.0 114.531 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -119.96 -63.99 1.31 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -60.1 2.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.232 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.43 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -59.55 -47.45 85.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.552 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.01 -41.07 82.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.228 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.0 t80 -57.94 -46.48 84.97 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.357 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -29.64 70.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.872 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 19.5 mt -59.04 -31.6 69.0 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -92.14 22.57 4.31 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.42 95.96 6.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.197 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -47.51 81.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.8 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.85 -30.48 21.43 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.74 40.08 8.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.389 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 p -95.62 -29.13 14.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.112 0.165 . . . . 0.0 111.313 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.64 12.77 7.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.417 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.58 162.35 29.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.085 0.442 . . . . 0.0 110.91 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.861 HD12 HD13 ' A' ' 28' ' ' ILE . 3.1 pt -143.77 140.57 17.42 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.565 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.75 171.82 8.13 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.185 2.59 . . . . 0.0 112.302 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.6 -39.61 3.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.2 p -60.29 -45.94 91.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.141 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.2 m -66.79 -45.59 77.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.833 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.861 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.54 -35.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.396 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -66.89 2.45 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.654 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.29 -27.94 69.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.702 0.251 . . . . 0.0 111.142 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.08 -48.65 80.83 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.15 -35.88 78.28 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -40.61 68.36 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.67 74.12 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.466 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 m -98.26 42.92 1.08 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.733 0.302 . . . . 0.0 111.122 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.3 -93.77 0.58 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.95 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.8 167.36 19.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.907 0.384 . . . . 0.0 111.633 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -128.08 141.73 42.2 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.449 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.2 Cg_endo -86.77 -162.33 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.15 2.567 . . . . 0.0 112.29 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 p -97.65 167.33 11.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.939 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 44' ' ' ILE . 2.4 mm? -54.14 -37.46 64.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.973 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.6 84.58 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -64.93 -52.27 57.27 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.212 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.804 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.19 -45.36 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.596 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -59.41 -42.97 93.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -40.37 79.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.541 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.971 HG23 HG11 ' A' ' 63' ' ' VAL . 17.6 mt -63.3 -47.91 89.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.38 -24.35 54.82 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.759 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.9 t -64.14 -10.31 21.97 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 p -117.88 -33.32 4.52 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.385 -0.197 . . . . 0.0 111.466 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -97.46 156.82 35.73 Favored Pre-proline 0 N--CA 1.464 0.275 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 96.1 Cg_exo -41.87 148.11 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.12 2.547 . . . . 0.0 112.814 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -33.04 -52.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -97.76 126.75 43.28 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.784 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -87.26 89.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.798 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 1.6 p30 -84.58 178.56 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.394 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 40.5 mtm -41.09 -45.7 2.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.016 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.77 -52.55 42.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.969 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.586 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.25 -50.91 71.4 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -49.5 77.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.811 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.8 mt -61.59 -32.61 72.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.484 0.183 . . . . 0.0 111.22 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 -50.6 71.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.252 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.971 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.32 -44.8 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.2 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -47.7 83.67 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -101.25 52.3 0.84 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.045 0.45 . . . . 0.0 110.467 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.573 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 57.8 ttp180 -58.66 -52.02 77.71 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.091 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 81.0 Cg_endo -83.99 19.5 1.35 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.55 2.166 . . . . 0.0 113.111 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 56.87 79.24 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.635 0.374 . . . . 0.0 111.454 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.63 173.76 13.61 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.091 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -104.25 167.05 10.01 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.621 0.248 . . . . 0.0 111.002 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 57.05 66.54 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.061 0.458 . . . . 0.0 110.487 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.571 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.6 ttp 174.96 -50.82 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.892 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.571 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 88.1 Cg_exo -45.06 -47.34 12.32 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.776 2.318 . . . . 0.0 112.928 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.13 56.58 0.49 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -75.58 120.81 83.38 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-O 120.494 0.188 . . . . 0.0 110.897 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.06 -44.34 35.56 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.628 2.219 . . . . 0.0 112.39 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -33.15 74.61 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.366 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -65.67 -43.57 88.93 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -46.73 54.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -64.65 -65.94 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 84' ' ' GLN . 1.4 tppt? -58.85 -23.76 61.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.053 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.717 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -67.88 -51.37 35.18 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.695 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -75.38 -42.92 52.82 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.545 0.212 . . . . 0.0 110.868 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.32 5.3 12.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 86' ' ' PHE . 7.1 p -49.7 -45.5 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.414 ' N ' HG13 ' A' ' 85' ' ' VAL . 41.0 m-85 -148.57 46.48 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 110.89 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -129.33 66.58 1.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -35.86 82.02 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.454 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.21 -64.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.725 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.67 -174.67 0.1 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.889 0.376 . . . . 0.0 111.773 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 56.96 29.51 16.46 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.727 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.32 36.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.241 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 167.93 132.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.805 0.442 . . . . 0.0 110.283 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.459 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -103.43 -45.37 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.337 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.57 77.35 0.23 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.864 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.863 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.4 t -45.41 -33.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.16 -54.47 15.08 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.693 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 pm0 -72.95 -39.24 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.549 0.175 . . . . 0.0 111.32 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.863 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -61.67 -38.97 89.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -66.2 -47.27 74.46 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -54.29 -36.55 63.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.154 0.284 . . . . 0.0 111.196 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.717 HG21 ' O ' ' A' ' 82' ' ' GLY . 24.1 t -74.85 -47.52 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.709 HD12 ' CD1' ' A' ' 99' ' ' LEU . 7.3 mt -66.39 -34.43 77.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 111' ' ' SER . 17.6 p -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.415 0.15 . . . . 0.0 111.3 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 t -74.82 -16.77 60.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.827 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.421 HD12 HD23 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -68.25 -57.49 5.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.692 0.282 . . . . 0.0 110.941 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.42 55.73 0.07 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.221 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 60.0 43.74 14.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 36.3 mmtt -68.86 -138.56 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.23 77.03 0.25 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 77.4 p -72.66 -175.79 1.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.964 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -49.24 -37.51 23.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.416 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.28 -52.73 37.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.637 0.256 . . . . 0.0 111.323 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.07 -50.73 72.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.843 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.7 ppp? -66.77 -27.73 67.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.286 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -47.66 83.36 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.5 -41.34 93.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.785 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.843 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.98 -41.89 97.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.724 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.548 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.091 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.1 -40.03 92.2 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.74 -46.69 29.47 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.014 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.505 HG11 ' CG2' ' A' ' 129' ' ' VAL . 17.6 t -86.17 121.49 72.67 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.803 0.301 . . . . 0.0 111.179 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.4 63.98 7.2 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.58 2.187 . . . . 0.0 112.568 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 122' ' ' VAL . 23.3 m -131.02 -179.85 3.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.241 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.17 135.28 54.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 68.07 11.91 8.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.862 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.719 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 67.79 48.55 54.72 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.101 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.82 119.22 38.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 129' ' ' VAL . 28.3 t -141.2 29.45 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.232 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.4 t30 56.1 21.87 5.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.8 t80 47.41 39.78 9.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -116.95 -39.84 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' HB3' HG11 ' A' ' 129' ' ' VAL . 24.4 t70 -69.6 -35.45 75.32 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -67.54 -54.73 17.55 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.718 0.294 . . . . 0.0 110.232 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.773 HG12 HD12 ' A' ' 139' ' ' LEU . 21.2 t -63.39 -34.52 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.459 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -62.68 -52.48 63.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.944 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 33.4 tpp -63.09 -36.41 83.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.96 -32.24 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.274 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.773 HD12 HG12 ' A' ' 135' ' ' VAL . 2.1 mt -92.56 -4.9 52.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -96.14 96.01 8.54 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.845 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.219 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.58 0.228 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.0 m -103.84 65.07 0.81 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.147 0.498 . . . . 0.0 110.176 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.92 34.21 17.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.49 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -158.36 80.74 0.82 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.321 0.582 . . . . 0.0 111.403 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.417 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -68.53 -45.53 35.73 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.69 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 88.2 Cg_endo -79.86 -20.56 8.93 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.466 2.111 . . . . 0.0 114.901 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 14.1 m-30 -105.76 -59.41 1.77 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.1 0.409 . . . . 0.0 111.806 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -73.03 -63.31 1.2 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.49 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -57.62 -49.18 77.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.222 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.66 -38.28 81.01 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.456 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' CE2' HG12 ' A' ' 23' ' ' ILE . 33.5 t80 -58.43 -44.15 89.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.694 0.283 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -61.88 -35.32 78.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -61.96 -39.03 90.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.143 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.91 22.99 7.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.07 130.79 41.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.579 0.228 . . . . 0.0 110.85 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -52.49 -58.0 8.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -133.97 24.41 3.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.398 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.61 30.75 78.11 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.934 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -95.15 -27.61 15.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.587 0.194 . . . . 0.0 111.295 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.69 10.9 6.78 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.292 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.53 160.41 34.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.272 0.536 . . . . 0.0 110.88 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 28' ' ' ILE . 6.1 pt -147.34 135.68 11.0 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.873 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 90.7 Cg_endo -89.42 171.5 4.37 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.179 2.586 . . . . 0.0 112.541 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HB2' HG13 ' A' ' 44' ' ' ILE . 5.3 pttm -43.05 -40.29 3.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 p -59.82 -42.71 94.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.472 0.177 . . . . 0.0 111.185 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 4.5 t -70.75 -52.82 18.29 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.453 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.767 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.03 -37.39 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.19 -69.1 1.34 Allowed Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.474 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -28.55 69.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.27 -50.78 68.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.688 0.28 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -61.37 -30.43 70.53 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.023 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -35.44 67.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.95 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.86 70.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.665 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.91 -45.68 9.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.651 0.262 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.63 -87.86 0.15 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.43 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.25 175.81 9.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.987 0.422 . . . . 0.0 111.826 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -119.57 112.95 35.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.697 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -82.03 -162.98 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.892 2.395 . . . . 0.0 113.024 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -95.17 165.37 12.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -53.89 -37.08 63.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.49 73.11 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.916 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.64 -53.91 16.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.291 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -59.91 -47.67 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.291 -0.164 . . . . 0.0 110.91 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.3 m -59.27 -38.53 80.36 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.48 -41.78 90.61 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.367 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 44' ' ' ILE . 10.5 mt -63.43 -49.12 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.979 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HG2' ' CG2' ' A' ' 55' ' ' VAL . 41.5 mt-10 -57.37 -26.84 61.67 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.728 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -63.99 -12.7 40.34 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -118.33 2.47 11.9 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -136.65 154.73 76.79 Favored Pre-proline 0 N--CA 1.464 0.23 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 70.8 Cg_exo -38.59 140.98 0.34 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.28 2.653 . . . . 0.0 112.966 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -26.13 -60.69 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.761 0.663 . . . . 0.0 112.755 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -91.44 125.93 36.36 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.411 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 48' ' ' GLU . 64.9 t -86.27 86.35 2.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 121.161 0.505 . . . . 0.0 110.44 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.3 p-10 -83.27 177.24 8.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.2 mtm -41.9 -45.37 3.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.543 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -51.17 56.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.853 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -56.41 -53.61 55.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.486 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -49.3 76.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.192 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.18 -33.29 73.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.49 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -61.33 -50.55 72.5 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.259 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.531 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.64 -37.46 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.606 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -74.04 -33.5 63.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -112.99 39.48 2.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.937 0.399 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -59.91 -55.29 47.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.502 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 61.6 Cg_endo -87.6 20.0 1.26 Allowed 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.884 2.39 . . . . 0.0 113.232 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 m120 60.74 79.37 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.969 0.414 . . . . 0.0 111.052 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 158.4 -177.35 35.1 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.82 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -105.07 -52.55 2.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.497 0.189 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 72' ' ' MET . 7.3 m-20 -95.78 94.46 7.69 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.324 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.532 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 16.2 ttm 170.5 -49.48 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.929 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 81.4 Cg_exo -43.33 -48.6 8.1 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 123.126 2.55 . . . . 0.0 113.223 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.5 58.91 0.29 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.763 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.72 170.85 13.99 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 120.426 0.155 . . . . 0.0 111.097 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' VAL . 73.7 Cg_exo -50.51 -47.39 24.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.924 2.416 . . . . 0.0 112.799 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.39 -26.0 60.8 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.334 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -47.5 69.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.457 0.17 . . . . 0.0 110.808 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -37.09 80.86 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.952 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 76' ' ' PRO . 56.0 t -62.67 -45.78 97.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.855 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -33.93 76.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.266 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.699 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -60.23 -44.63 97.24 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.085 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -70.24 -34.06 72.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.479 0.181 . . . . 0.0 110.624 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.96 73.15 5.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.857 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.43 -64.2 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.854 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.78 28.44 6.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -139.91 70.0 1.36 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.133 0.492 . . . . 0.0 110.149 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -61.09 -44.58 97.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.894 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -49.2 10.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.088 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.43 55.52 7.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.492 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 m -82.81 -57.37 3.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.35 57.78 0.22 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.798 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.52 119.6 0.9 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.584 0.231 . . . . 0.0 110.991 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -103.92 139.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.909 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -105.14 82.73 0.35 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.883 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.81 ' HA ' HD23 ' A' ' 99' ' ' LEU . 55.0 t -41.74 -34.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.39 -50.05 58.05 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.917 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.2 pt-20 -75.65 -34.95 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.356 0.122 . . . . 0.0 110.92 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -63.02 -41.42 99.55 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 110.493 179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -67.42 -47.45 70.19 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -51.7 -46.99 64.08 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.174 0.296 . . . . 0.0 111.385 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.699 HG11 ' CA ' ' A' ' 82' ' ' GLY . 53.2 t -61.05 -49.49 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.363 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 99' ' ' LEU . 3.8 mt -67.81 -28.15 67.33 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.1 m -65.33 -41.52 93.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.574 0.226 . . . . 0.0 111.165 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.0 m -74.52 -7.86 54.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.25 -50.74 20.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.644 0.259 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.67 53.73 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.558 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.42 41.72 15.6 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HG3' ' CD2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.81 -138.91 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.301 179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 114' ' ' GLU . 3.6 mt -68.74 78.85 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 110.919 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -64.52 -174.61 0.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.143 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.439 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 8.8 p30 -49.22 -35.36 17.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.573 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -57.49 -51.08 70.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.547 ' HG3' HD23 ' A' ' 110' ' ' LEU . 11.3 mm-40 -56.74 -52.46 64.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.869 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.82 ' HA ' HD23 ' A' ' 118' ' ' LEU . 9.1 ptm -67.0 -25.99 66.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -48.11 81.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.661 0.267 . . . . 0.0 110.43 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -68.77 -41.96 78.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.752 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.66 -41.72 99.22 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.148 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.9 OUTLIER -70.85 -33.12 70.32 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.514 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -63.54 -41.38 98.46 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.952 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.24 -40.97 39.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.985 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.559 HG11 ' CG2' ' A' ' 129' ' ' VAL . 63.9 t -81.83 132.79 53.36 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.874 0.337 . . . . 0.0 111.193 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.9 58.68 7.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.802 2.334 . . . . 0.0 112.614 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.488 HG22 HG12 ' A' ' 122' ' ' VAL . 25.1 m -131.48 175.03 12.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -125.5 18.71 8.13 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.835 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -159.96 22.63 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 54.39 40.82 70.1 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.811 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.96 112.96 26.16 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.271 0.558 . . . . 0.0 111.353 -179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 129' ' ' VAL . 32.3 t -142.84 25.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.292 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.48 26.6 16.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.434 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.5 t80 45.62 41.53 7.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.781 0.324 . . . . 0.0 111.416 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -114.8 -53.56 2.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.406 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.5 ' CB ' HG11 ' A' ' 129' ' ' VAL . 34.7 t70 -61.13 -34.7 75.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.51 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 4.9 m-85 -67.76 -56.62 8.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.371 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 139' ' ' LEU . 18.7 t -62.92 -32.66 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.124 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -62.81 -48.37 79.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.83 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.5 ttm -64.16 -34.58 78.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.496 HG22 HD12 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -68.43 -43.3 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.861 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.496 HD12 HG22 ' A' ' 138' ' ' ILE . 2.2 mp -93.75 63.53 3.36 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.932 0.396 . . . . 0.0 110.789 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.86 62.53 0.68 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.531 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.967 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.751 0.31 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -114.38 -49.72 2.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.039 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.92 -58.39 0.51 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.724 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 22.0 m-20 -139.73 87.24 2.16 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.993 0.425 . . . . 0.0 110.345 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.423 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -62.41 -47.14 89.78 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.048 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.5 Cg_endo -83.75 1.64 8.76 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.574 2.183 . . . . 0.0 114.371 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 86.6 m-85 -126.9 -63.5 1.06 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.795 0.27 . . . . 0.0 111.609 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 2.1 mtpm? -72.44 -58.01 3.72 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.065 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -48.4 80.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.592 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.546 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.91 -38.25 78.5 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.289 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 23' ' ' ILE . 13.8 t80 -59.16 -45.81 90.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.374 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.7 m -62.65 -32.62 73.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.643 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.2 mt -61.03 -33.67 73.64 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 23' ' ' ILE . 66.5 m-85 -94.26 33.1 1.42 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.16 127.66 33.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.694 0.283 . . . . 0.0 110.961 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -70.9 -56.72 5.64 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -112.2 -21.38 11.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.907 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.81 30.67 5.1 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.917 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.3 p -105.84 -29.02 10.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.622 0.211 . . . . 0.0 111.263 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.69 28.34 1.44 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.322 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.536 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.75 156.02 45.66 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.987 0.393 . . . . 0.0 110.183 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.743 HD12 HD13 ' A' ' 28' ' ' ILE . 5.6 pt -143.22 133.17 11.98 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.79 170.06 11.55 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.049 2.499 . . . . 0.0 112.309 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.68 -38.6 4.47 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 p -60.95 -43.91 98.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.512 0.196 . . . . 0.0 111.109 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.467 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 20.7 m -68.22 -46.47 70.49 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.565 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.743 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.35 -35.66 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.462 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.64 -69.22 1.33 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.584 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -26.03 68.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.529 0.164 . . . . 0.0 111.313 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 12.0 tp -61.62 -49.15 77.72 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -61.79 -32.27 72.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.056 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -55.36 -39.18 69.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.216 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.8 71.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.699 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.61 -45.47 13.46 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.99 -80.34 0.03 OUTLIER Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.942 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.97 178.79 6.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.651 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 6.5 t-20 -119.02 118.81 32.64 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.501 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 -162.43 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.397 . . . . 0.0 112.601 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 p -102.69 162.43 12.93 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.22 -33.94 63.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.98 80.74 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.933 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.68 -56.37 9.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.225 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.646 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.83 -47.24 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.327 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -61.17 -43.38 98.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.71 -40.01 78.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 44' ' ' ILE . 24.8 mt -61.63 -52.66 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -56.63 -23.41 40.99 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.826 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -63.74 -8.19 9.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.9 p -118.17 -46.74 2.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.599 0.181 . . . . 0.0 111.001 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.25 156.54 57.05 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.627 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.9 Cg_exo -39.32 145.43 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.359 2.706 . . . . 0.0 113.317 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.24 -64.5 0.1 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.471 0.708 . . . . 0.0 112.805 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -88.58 127.52 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.448 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -86.42 84.56 2.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.01 0.433 . . . . 0.0 110.512 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -81.71 179.24 7.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -41.1 -45.57 2.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.769 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -68.67 -52.05 35.26 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.872 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.627 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.2 mp0 -56.86 -51.83 67.5 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.563 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -48.85 79.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.624 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 61' ' ' LEU . 27.7 mt -61.5 -31.69 71.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -61.46 -50.49 72.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.604 0.24 . . . . 0.0 111.01 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.559 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -73.57 -40.62 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -58.55 6.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.95 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -83.19 63.14 7.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.4 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 11.8 mtm180 -53.23 -50.21 83.69 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.457 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.597 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 67.2 Cg_endo -85.12 18.69 1.53 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.66 2.24 . . . . 0.0 113.445 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 59.97 102.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.746 0.418 . . . . 0.0 112.08 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.97 -179.31 19.54 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.393 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.37 166.85 10.53 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.565 0.222 . . . . 0.0 110.975 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' HA ' ' CG ' ' A' ' 75' ' ' ASP . 19.1 m-20 55.8 66.57 1.18 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.137 0.494 . . . . 0.0 110.425 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.605 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.8 tpt -177.63 -52.1 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.591 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 86.2 Cg_exo -45.92 -46.32 15.92 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.494 2.129 . . . . 0.0 112.824 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.98 51.32 0.07 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.49 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.438 ' CG ' ' HA ' ' A' ' 71' ' ' ASP . 1.2 m-20 -81.47 157.64 69.88 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 120.65 0.262 . . . . 0.0 111.442 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -57.78 -41.83 65.81 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.862 2.375 . . . . 0.0 112.058 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.33 -35.32 79.98 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -40.19 96.74 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.922 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -45.1 89.06 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.525 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.4 -43.87 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.715 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -30.21 69.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.303 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -62.81 -50.54 63.04 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.026 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.75 -41.0 72.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.73 0.3 . . . . 0.0 110.219 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -79.81 70.54 6.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.028 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.9 t -124.94 -64.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.455 ' HB2' ' HG2' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -99.37 43.15 1.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 1.8 m-20 -137.96 71.2 1.39 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -51.38 68.57 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.13 -54.89 3.9 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.674 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 51.47 56.27 8.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.656 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -110.3 69.4 0.69 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.091 0.472 . . . . 0.0 110.8 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.95 49.3 1.63 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.99 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.98 144.84 0.62 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.788 0.327 . . . . 0.0 111.378 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.88 -44.38 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.285 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.47 80.84 0.21 Allowed Glycine 0 C--N 1.34 0.772 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.368 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.789 ' HA ' HD23 ' A' ' 99' ' ' LEU . 72.8 t -44.27 -36.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.99 -42.03 22.38 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.565 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.4 tm-20 -71.98 -50.97 24.33 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.524 0.202 . . . . 0.0 110.518 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.91 -35.19 70.71 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.226 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -66.25 -48.95 68.86 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.678 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.61 -36.18 69.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 98' ' ' GLU . 43.4 t -72.04 -46.79 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.786 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 99' ' ' LEU . 3.8 mt -74.78 -49.32 21.27 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.0 m -57.32 -36.04 70.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.4 t -69.42 -21.69 63.74 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.79 -62.61 1.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.529 0.204 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.76 52.54 0.26 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 59.92 45.23 12.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.966 0.412 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 4.6 mmmm -68.55 -137.97 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.078 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -68.21 79.04 0.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 94.1 p -62.12 178.88 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.52 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -50.55 -30.99 14.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.207 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.4 -54.59 41.61 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -58.31 -46.6 85.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.827 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.8 mmt -67.12 -31.84 72.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.41 77.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.581 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.26 -42.63 93.08 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.529 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.827 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.97 -42.68 94.67 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.464 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.571 HD21 ' N ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -68.33 -33.08 73.65 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -39.43 92.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.76 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -48.81 32.56 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.92 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 129' ' ' VAL . 14.8 t -84.31 121.43 75.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.741 0.27 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 62.96 5.7 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.668 2.245 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.51 177.9 6.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -119.34 133.43 55.73 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.732 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 73.03 5.57 5.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.938 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 72.12 51.19 14.67 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.97 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.1 ttp -106.06 115.64 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 129' ' ' VAL . 38.8 t -142.34 30.75 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.74 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 57.69 25.35 11.67 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.9 t80 47.24 45.78 16.52 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.774 0.321 . . . . 0.0 111.499 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -120.57 -54.26 2.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.259 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.501 ' CB ' HG11 ' A' ' 129' ' ' VAL . 31.3 t70 -58.0 -38.88 76.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.723 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.4 m-85 -66.43 -56.93 8.66 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.574 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.503 ' HA ' ' HB ' ' A' ' 138' ' ' ILE . 19.3 t -61.84 -31.92 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.313 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -57.74 -55.95 28.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -29.26 63.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 135' ' ' VAL . 2.0 mm -62.72 -42.54 96.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.372 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 135' ' ' VAL . 1.4 mt -67.55 -89.91 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.91 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.72 91.64 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.4 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.114 -179.328 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.492 0.186 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p -141.74 -63.18 0.45 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.165 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.85 59.37 0.09 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.34 109.21 2.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.281 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -61.8 -46.62 92.87 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.7 Cg_endo -82.6 -12.94 9.86 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.585 2.19 . . . . 0.0 114.077 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -111.35 -61.28 1.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -72.57 -62.1 1.56 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.394 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.44 -48.86 79.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.809 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.86 -41.6 82.76 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.522 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.2 t80 -54.21 -44.68 71.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.325 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.59 -36.1 81.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.339 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.7 mt -60.91 -35.87 77.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.691 -0.232 . . . . 0.0 111.447 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.93 33.74 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.18 133.17 49.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.689 0.28 . . . . 0.0 111.053 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -54.63 12.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.483 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.47 25.24 2.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.454 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.7 40.67 99.09 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.736 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 p -106.08 -31.27 8.8 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.79 -8.91 6.83 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.46 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -118.91 162.64 18.17 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.12 0.46 . . . . 0.0 111.037 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.711 HD12 HD13 ' A' ' 28' ' ' ILE . 5.8 pt -138.54 132.21 16.39 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.71 169.25 13.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.944 2.429 . . . . 0.0 112.435 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -45.16 -36.28 3.68 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.119 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.5 p -62.13 -44.18 97.19 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.404 0.145 . . . . 0.0 111.334 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 32.6 m -69.19 -45.7 69.29 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.711 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.94 -35.26 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.36 -67.66 2.06 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.678 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.92 71.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.549 0.174 . . . . 0.0 111.058 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tp -59.18 -50.14 75.18 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . 47.0 mt -59.06 -32.52 69.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.961 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -55.41 -41.18 72.38 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -69.68 -28.79 66.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.812 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 32' ' ' LEU . 30.8 p -113.79 36.29 3.71 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.064 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.94 -104.6 0.3 Allowed Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.658 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 175.84 8.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 111.562 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.54 105.26 19.18 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.45 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.05 -162.71 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.762 2.308 . . . . 0.0 112.535 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.54 167.51 11.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.486 HD12 ' HD2' ' A' ' 25' ' ' LYS . 2.9 mm? -55.78 -33.05 64.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.07 75.51 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.014 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -56.53 9.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.011 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.755 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.45 -45.65 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.208 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -59.45 -42.69 92.53 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -57.42 -38.36 74.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.721 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 44' ' ' ILE . 39.4 mt -62.69 -51.29 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -56.79 -24.05 47.78 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.659 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.0 m -64.62 -8.67 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.1 p -118.01 -46.43 2.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.706 0.23 . . . . 0.0 111.179 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.587 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -91.07 158.24 41.84 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.3 Cg_exo -40.95 147.76 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.153 2.568 . . . . 0.0 113.416 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.98 -67.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.597 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.54 124.9 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.624 0.249 . . . . 0.0 110.392 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 59' ' ' GLN . 57.0 t -86.47 90.81 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -87.67 -179.31 6.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.7 mtp -40.86 -49.91 3.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.603 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -63.29 -53.31 54.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.554 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -56.51 -53.55 56.18 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -49.57 76.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.92 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 mt -61.69 -29.68 70.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -65.33 -48.15 74.04 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.594 0.235 . . . . 0.0 111.264 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -41.77 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.163 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -57.66 5.65 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.231 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -88.95 58.45 4.58 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.988 0.423 . . . . 0.0 110.804 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -60.26 -51.79 77.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.42 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.509 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 85.0 Cg_endo -84.35 18.78 1.48 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.631 2.221 . . . . 0.0 113.715 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 61.62 105.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.683 0.393 . . . . 0.0 111.975 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.97 173.99 23.61 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.161 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.72 172.05 7.31 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 t70 57.45 60.19 2.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.526 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.602 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 10.9 tpt -177.89 -52.44 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.301 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 83.8 Cg_exo -45.29 -43.86 16.53 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.61 2.207 . . . . 0.0 113.046 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.2 55.55 0.09 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.509 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.93 160.85 65.25 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-O 120.635 0.255 . . . . 0.0 111.204 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' O ' HG23 ' A' ' 80' ' ' VAL . 46.1 Cg_exo -55.79 -39.95 88.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.886 2.391 . . . . 0.0 112.413 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -31.24 72.08 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.386 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.28 -45.68 87.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -37.94 79.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 76' ' ' PRO . 99.1 t -64.37 -43.67 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.088 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.69 -35.04 79.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.582 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.887 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -70.75 -43.88 58.23 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.561 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -76.48 -39.09 54.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.509 0.155 . . . . 0.0 111.302 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.45 73.66 5.0 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.106 0.479 . . . . 0.0 110.704 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 86' ' ' PHE . 13.2 p -131.83 -45.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.5 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.431 ' N ' HG13 ' A' ' 85' ' ' VAL . 10.0 m-85 -134.36 39.84 3.04 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -109.81 60.58 0.6 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -39.72 79.35 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.81 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.57 -64.8 1.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.26 -86.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.429 0.456 . . . . 0.0 111.457 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t 42.62 45.78 4.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.03 40.09 0.39 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.329 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.6 ptp -176.68 136.05 0.24 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.93 0.365 . . . . 0.0 110.91 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.55 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.87 -43.26 8.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 65.22 80.53 0.15 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.747 ' HA ' HD23 ' A' ' 99' ' ' LEU . 97.0 t -44.09 -36.35 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.24 -38.65 19.4 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.777 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.5 mt-10 -74.11 -52.26 13.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.522 0.201 . . . . 0.0 110.684 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -57.16 -38.25 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -73.46 -41.02 63.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.935 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -53.51 -42.13 67.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.527 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.887 HG11 ' HA2' ' A' ' 82' ' ' GLY . 4.1 t -74.11 -50.77 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.436 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 99' ' ' LEU . 2.9 mt -58.67 -45.76 88.7 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.884 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 56.3 m -65.41 -36.83 85.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.567 0.222 . . . . 0.0 110.952 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 t -63.62 -23.13 67.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.31 -70.67 0.23 Allowed 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.518 0.199 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.25 48.95 0.49 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.29 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 61.16 45.99 8.5 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 111.012 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.62 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.985 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 114' ' ' GLU . 55.6 mt -66.94 79.79 0.12 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.291 0.496 . . . . 0.0 110.679 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.437 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 99.5 p -63.59 -170.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.045 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -52.67 -32.7 43.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.148 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -57.29 -50.58 72.46 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.704 ' HG2' HD22 ' A' ' 110' ' ' LEU . 11.4 tp10 -56.18 -54.47 44.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.742 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.889 ' HA ' HD23 ' A' ' 118' ' ' LEU . 4.1 ptt? -66.68 -25.41 66.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.457 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -46.32 87.59 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.97 -45.83 73.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.294 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.889 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.09 -40.57 90.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.442 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.594 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.9 mt -69.5 -32.13 70.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -61.27 -40.93 95.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.362 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.38 51.65 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.989 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 129' ' ' VAL . 10.8 t -91.23 116.67 66.9 Favored Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.749 0.274 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.08 65.03 4.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.492 2.128 . . . . 0.0 112.632 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.12 -179.24 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.033 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -118.68 132.7 56.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.567 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.99 6.18 5.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.955 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.619 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 71.03 53.33 10.95 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.909 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 ttt -106.83 119.61 39.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 110.821 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 129' ' ' VAL . 39.3 t -142.34 20.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.295 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.56 22.06 10.66 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.09 -164.53 0.14 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 m170 71.37 -58.93 0.56 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.28 0.232 . . . . 0.0 111.209 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -52.72 -39.68 62.3 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.509 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 17.8 m-85 -68.11 -52.72 31.73 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.417 HG12 HD13 ' A' ' 139' ' ' LEU . 20.2 t -61.73 -30.79 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.225 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -62.51 -54.14 44.32 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.846 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.6 ttt -67.21 -34.85 78.37 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 139' ' ' LEU . 1.7 mt -65.33 -41.12 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.962 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 138' ' ' ILE . 1.8 mp -98.57 46.66 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.902 0.382 . . . . 0.0 110.948 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.0 50.24 1.1 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.138 -179.592 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.723 0.297 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 t -139.58 -49.3 0.48 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.41 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.91 -63.38 0.57 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.407 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 62.1 m-20 -130.28 89.28 2.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.121 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.3 t -58.69 -45.79 99.62 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.343 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 85.3 Cg_endo -84.63 -3.74 9.95 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.543 2.162 . . . . 0.0 114.641 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 59.0 m-85 -123.99 -62.64 1.27 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.972 0.351 . . . . 0.0 111.809 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -72.66 -60.84 2.04 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.944 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.51 -45.57 93.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.11 -44.88 87.92 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.181 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 23' ' ' ILE . 25.9 t80 -56.78 -43.12 80.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.823 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -62.48 -34.05 76.08 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -59.5 -34.05 72.1 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.575 ' O ' HG22 ' A' ' 23' ' ' ILE . 44.1 m-85 -94.25 33.22 1.4 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.92 129.4 39.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.618 0.247 . . . . 0.0 111.015 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.58 -61.89 1.68 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.512 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -130.95 25.75 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.184 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.75 39.18 95.09 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.535 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -104.57 -24.43 12.99 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.49 11.63 17.01 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.891 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 4.8 mtt-85 -129.0 163.17 25.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.746 0.273 . . . . 0.0 110.445 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.781 HD12 HD13 ' A' ' 28' ' ' ILE . 5.4 pt -140.14 133.74 15.3 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -85.49 172.43 8.11 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.158 2.572 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HB2' HG13 ' A' ' 44' ' ' ILE . 12.6 pttp -43.49 -40.97 4.13 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -60.06 -43.13 95.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.507 0.194 . . . . 0.0 111.404 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 14.0 m -70.95 -45.57 63.93 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.766 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.781 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.32 -33.06 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.477 179.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.53 -67.54 2.16 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.25 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.4 -28.13 69.48 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.46 -46.76 88.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.28 -34.85 75.87 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.753 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.419 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.33 -41.08 65.37 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.794 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -63.68 -34.9 78.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.682 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -101.03 44.35 1.02 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.851 0.358 . . . . 0.0 110.845 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.69 -97.78 0.57 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.817 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.68 170.43 14.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.721 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -122.47 131.96 24.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 59.3 Cg_endo -85.82 -163.27 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.973 2.449 . . . . 0.0 112.743 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 p -98.15 163.25 12.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -51.53 -37.51 49.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.145 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.606 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -61.24 -55.12 35.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.0 179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.73 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.58 -47.97 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.819 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -57.56 -41.73 81.59 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.75 -40.7 76.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 44' ' ' ILE . 20.2 mt -62.79 -51.01 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.037 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -56.44 -23.54 39.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.905 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 t -63.97 -7.6 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 p -118.23 -46.17 2.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.684 0.22 . . . . 0.0 111.146 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.76 156.57 49.88 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 65.7 Cg_exo -39.01 146.11 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.355 2.703 . . . . 0.0 113.279 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.08 -68.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.744 0.653 . . . . 0.0 112.609 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.5 tt0 -85.84 127.68 34.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.643 0.259 . . . . 0.0 110.399 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.65 87.77 2.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.032 0.444 . . . . 0.0 111.314 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -82.33 177.56 8.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.371 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 ttm -41.61 -45.09 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.78 -51.54 47.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.572 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.5 mp0 -56.82 -51.85 67.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.527 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -48.88 79.81 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.93 -32.6 72.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.427 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -61.47 -51.77 67.29 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.066 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.496 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -70.43 -41.7 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -42.58 98.54 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.563 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -105.27 50.68 0.78 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.086 0.469 . . . . 0.0 110.455 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.411 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . 7.0 mtm180 -57.28 -58.15 20.03 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.246 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 66.3 Cg_endo -86.34 18.88 1.49 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.736 2.291 . . . . 0.0 113.173 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 53.78 82.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.565 0.346 . . . . 0.0 111.657 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.7 -167.11 35.16 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.188 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.53 154.33 45.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.547 0.213 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.06 65.61 1.35 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.071 0.462 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.561 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 3.7 ttt 177.73 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.584 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 80.2 Cg_exo -42.25 -52.98 3.88 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.891 2.394 . . . . 0.0 112.996 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.16 45.52 0.58 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.503 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 154.68 73.21 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.581 0.229 . . . . 0.0 111.272 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' O ' HG23 ' A' ' 80' ' ' VAL . 33.1 Cg_exo -59.39 -39.5 76.12 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.922 2.415 . . . . 0.0 112.464 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.73 -30.12 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.361 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.9 -47.46 68.75 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.921 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -40.59 96.54 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.63 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 76' ' ' PRO . 73.4 t -61.78 -49.9 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.936 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -26.56 66.31 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.672 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.81 -50.4 58.6 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.466 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -72.96 -37.51 67.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.562 0.22 . . . . 0.0 111.008 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -79.12 4.78 13.68 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.76 -43.8 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -145.75 33.6 1.03 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.765 0.316 . . . . 0.0 111.413 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.448 ' CG ' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -130.92 76.24 1.71 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.063 0.459 . . . . 0.0 110.347 179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.93 -48.94 78.17 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.178 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -91.82 -64.02 1.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.99 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.448 ' HB2' ' CG ' ' A' ' 87' ' ' ASP . . . 48.82 52.86 13.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 111.803 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.4 p -102.73 -48.05 4.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.85 26.22 9.02 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.035 -0.603 . . . . 0.0 113.0 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.491 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -174.59 148.64 1.18 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.862 0.331 . . . . 0.0 110.974 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.521 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -118.11 -44.25 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.939 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.79 81.15 0.21 Allowed Glycine 0 C--N 1.339 0.715 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.337 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.75 ' HA ' HD23 ' A' ' 99' ' ' LEU . 73.3 t -44.3 -34.81 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.68 -35.73 17.29 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.093 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -80.65 -46.34 15.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.619 0.21 . . . . 0.0 110.916 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -58.99 -39.92 83.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.857 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.471 ' HG2' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -75.07 -36.12 61.79 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.611 179.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.78 -40.54 63.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.905 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 82' ' ' GLY . 21.3 t -82.33 -51.46 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.532 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 99' ' ' LEU . 2.4 mt -58.31 -49.85 75.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 m -59.7 -39.3 84.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.445 0.164 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -72.13 -19.82 61.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.81 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 2.5 mt -65.35 -66.69 0.51 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.603 0.239 . . . . 0.0 110.97 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.92 47.86 0.47 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.336 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.61 45.89 7.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.908 0.385 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.8 mmmm -68.77 -137.7 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.158 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.843 HD22 ' HG2' ' A' ' 114' ' ' GLU . 34.6 mt -69.43 79.33 0.39 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.907 0.384 . . . . 0.0 110.619 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -64.97 -173.02 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.913 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 4.3 p-10 -51.88 -34.89 43.09 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.606 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.6 -55.44 30.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.843 ' HG2' HD22 ' A' ' 110' ' ' LEU . 3.2 tp10 -55.34 -51.28 67.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.906 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.848 ' HA ' HD23 ' A' ' 118' ' ' LEU . 22.0 ptm -66.82 -27.6 67.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.523 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -47.3 83.58 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.82 -43.47 79.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.848 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.49 -43.11 97.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.634 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.451 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.4 mt -67.95 -32.62 73.19 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.236 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.14 -41.58 98.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.617 0.246 . . . . 0.0 110.724 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.99 -44.2 37.53 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.878 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 124' ' ' VAL . 58.6 t -78.97 133.21 61.84 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.675 0.237 . . . . 0.0 111.189 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.39 59.94 7.31 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.788 2.326 . . . . 0.0 112.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 128' ' ' MET . 17.2 m -131.49 174.12 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.382 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 48.2 2.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.27 0.557 . . . . 0.0 110.555 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 175.13 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.834 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 112.71 50.3 0.56 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.922 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.491 ' SD ' ' HA ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.35 114.46 28.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.268 0.556 . . . . 0.0 110.698 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 129' ' ' VAL . 40.4 t -142.18 26.73 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.101 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.9 t30 62.67 24.34 14.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.122 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' CD1' HG13 ' A' ' 94' ' ' ILE . 4.8 t80 48.45 51.97 14.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.922 0.392 . . . . 0.0 111.372 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.06 -54.31 1.12 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.564 ' CB ' HG11 ' A' ' 129' ' ' VAL . 19.5 t70 -57.82 -36.52 72.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.676 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' A' ' 94' ' ' ILE . 1.8 m-85 -68.46 -55.49 11.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.697 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.416 HG12 HD13 ' A' ' 139' ' ' LEU . 21.7 t -62.3 -31.84 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.568 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -64.03 -47.85 78.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.191 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 20.6 ttt -73.57 -32.02 63.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.524 HG22 HD12 ' A' ' 139' ' ' LEU . 1.5 mt -66.56 -46.97 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.408 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 138' ' ' ILE . 2.5 mp -83.4 -55.4 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.208 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' LEU . . . 69.88 107.09 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.356 0.41 . . . . 0.0 111.015 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.039 -0.982 . . . . 0.0 111.055 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.714 0.292 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -97.27 28.29 3.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -131.38 13.69 5.05 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 38.9 m-20 57.38 80.28 0.17 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.435 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -67.2 -47.1 51.32 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.864 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 6' ' ' SER . 3.3 Cg_exo -75.17 -16.27 19.93 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.758 2.305 . . . . 0.0 113.89 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -110.88 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 14.5 mmmt -72.3 -57.97 3.78 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 9.8 tp60 -58.82 -45.95 88.77 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.603 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -63.82 -35.52 80.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.125 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' A' ' 23' ' ' ILE . 12.0 t80 -57.89 -47.95 81.27 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 m -62.71 -33.87 75.99 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.198 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -58.59 -37.15 75.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.344 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 89.0 m-85 -95.75 34.0 1.57 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 83.11 6.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.681 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -68.16 -30.84 70.06 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -86.22 -29.93 22.78 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.554 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.34 30.26 58.87 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.631 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.6 p -129.77 27.81 5.17 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.74 21.82 71.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.986 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 42.7 mtt180 -130.23 157.04 43.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.916 0.358 . . . . 0.0 110.805 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.818 HD12 HD13 ' A' ' 28' ' ' ILE . 3.8 pt -146.86 133.93 10.08 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.816 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.01 168.34 12.18 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.992 2.461 . . . . 0.0 112.172 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.5 -38.01 3.87 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -60.46 -43.74 96.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 111.145 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 23.3 m -71.03 -46.57 61.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.647 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.818 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.64 -34.06 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.099 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.03 -70.37 0.99 Allowed Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.504 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.68 68.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.496 0.148 . . . . 0.0 111.297 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 9.2 tp -62.34 -48.41 79.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.33 -33.19 73.19 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.769 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.454 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.43 -36.85 66.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.74 -36.69 58.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.713 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t -93.64 53.51 1.86 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 111.001 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.84 -89.51 0.81 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.854 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 169.11 14.87 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.441 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 11.1 p-10 -133.77 155.32 80.5 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.329 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 68.1 Cg_endo -84.02 -162.09 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.032 2.488 . . . . 0.0 112.415 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -102.54 168.06 9.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -54.63 -33.17 60.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.19 85.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.71 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -67.37 -55.0 15.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.065 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.66 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.49 -46.04 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.934 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.6 m -61.47 -39.62 91.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -58.11 -38.4 76.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.316 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 44' ' ' ILE . 50.0 mt -63.55 -46.72 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.898 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -56.8 -28.77 61.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 m -63.88 -12.21 34.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.8 p -118.28 -14.66 9.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.735 HD21 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -125.05 153.36 71.34 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.426 0.155 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.549 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.3 Cg_exo -39.38 146.65 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.366 2.711 . . . . 0.0 113.077 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.05 -65.4 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -88.12 125.88 34.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.576 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 59' ' ' GLN . 58.8 t -86.55 89.82 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.2 p30 -83.17 176.94 8.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.388 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -41.49 -44.65 2.99 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.717 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.14 -52.04 46.48 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.966 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.549 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.4 OUTLIER -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -48.95 78.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.6 mt -61.38 -31.87 71.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.571 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -63.18 -52.16 63.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.563 0.22 . . . . 0.0 111.161 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.735 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.06 -43.84 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.282 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.61 -51.5 59.15 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.579 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -98.85 53.91 1.0 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -55.75 42.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.205 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 67.5 Cg_endo -86.83 18.72 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.645 2.23 . . . . 0.0 113.431 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 52.25 87.32 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.61 0.364 . . . . 0.0 111.963 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.6 172.21 18.21 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.157 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -103.93 152.03 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.538 0.209 . . . . 0.0 110.732 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 57.86 70.32 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.05 0.452 . . . . 0.0 110.244 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.584 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 26.1 ttt -179.69 -52.97 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.049 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 99.7 Cg_exo -42.3 -43.38 7.84 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.898 2.399 . . . . 0.0 113.217 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.74 92.96 0.84 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.583 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.11 135.33 94.83 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 120.448 0.166 . . . . 0.0 110.959 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' O ' HG23 ' A' ' 80' ' ' VAL . 52.4 Cg_exo -54.79 -46.5 32.86 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.804 2.336 . . . . 0.0 112.456 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -65.46 -35.5 81.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.408 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.37 -43.26 81.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.371 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -44.74 59.63 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.184 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 76' ' ' PRO . 52.9 t -59.85 -53.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.317 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -40.68 97.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.277 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.596 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -64.14 -47.1 88.53 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.544 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.08 -26.45 65.84 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.496 0.148 . . . . 0.0 111.357 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -77.03 73.58 3.61 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.919 0.39 . . . . 0.0 110.854 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.96 -66.32 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.523 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CB ' ' HG2' ' A' ' 98' ' ' GLU . 0.2 OUTLIER -135.58 33.21 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.652 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -137.25 53.2 1.89 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.617 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.492 ' N ' ' HE2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -70.95 -3.21 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.475 ' N ' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -97.87 -60.69 1.51 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.722 0.237 . . . . 0.0 111.056 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.57 51.4 12.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.304 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.7 p -142.19 80.81 1.72 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.77 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.7 15.89 50.93 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.292 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptm -172.57 131.37 0.56 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.12 0.46 . . . . 0.0 111.402 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.596 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.9 -35.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.42 80.31 0.26 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.686 ' HA ' HD23 ' A' ' 99' ' ' LEU . 81.4 t -44.86 -34.43 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.21 -37.26 17.24 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.51 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.5 mp0 -75.57 -53.36 8.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.548 0.214 . . . . 0.0 110.63 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.27 -36.82 73.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.287 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.46 ' HG3' ' HG2' ' A' ' 115' ' ' MET . 2.1 tmt_? -68.48 -49.95 56.0 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -57.61 -36.85 72.31 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.34 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 98' ' ' GLU . 48.7 t -71.97 -47.75 53.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.763 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 110' ' ' LEU . 1.6 mt -73.4 -52.5 13.55 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 84.8 m -55.3 -37.03 66.84 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 t -76.79 -17.67 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -66.57 0.53 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.509 0.195 . . . . 0.0 111.212 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 58.67 0.27 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.59 39.38 17.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 111.404 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -68.92 -137.77 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.197 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.596 HD23 ' HG2' ' A' ' 114' ' ' GLU . 9.4 mt -68.79 78.91 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.962 0.41 . . . . 0.0 110.754 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -66.07 -170.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.938 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -51.0 -38.37 50.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.943 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.31 -51.17 68.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HG2' HD23 ' A' ' 110' ' ' LEU . 2.2 mp0 -57.69 -53.21 60.8 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.848 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.855 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.83 -27.88 67.91 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.271 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -45.23 89.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.677 0.275 . . . . 0.0 110.555 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -70.38 -40.29 74.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.79 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.97 -42.22 99.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.826 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.411 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -73.52 -30.86 63.37 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.407 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -63.14 -41.14 99.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.77 -0.195 . . . . 0.0 110.958 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.36 -43.16 39.25 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.985 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.478 HG11 ' CG2' ' A' ' 129' ' ' VAL . 46.2 t -81.83 130.29 61.47 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.705 0.253 . . . . 0.0 111.155 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.96 62.45 6.62 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.585 HG21 ' H ' ' A' ' 128' ' ' MET . 4.7 p -131.2 167.42 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.824 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.444 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.5 OUTLIER -127.48 54.44 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.088 0.47 . . . . 0.0 111.154 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.4 -37.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.561 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.521 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 113.96 39.19 1.08 Allowed Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.296 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.585 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -103.16 113.96 27.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.26 0.552 . . . . 0.0 110.762 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 129' ' ' VAL . 37.9 t -142.31 21.39 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.433 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.75 22.39 12.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.615 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.446 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 2.1 t80 46.63 45.42 14.32 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.43 -51.08 2.52 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.407 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.83 -36.62 77.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.788 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.2 m-85 -68.16 -55.74 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.685 0.278 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.601 ' O ' HD12 ' A' ' 139' ' ' LEU . 23.1 t -62.57 -32.73 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.232 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -59.84 -49.7 76.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.712 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.2 ttt -70.8 -27.11 63.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 138' ' ' ILE . 1.6 mm -60.5 -39.56 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.888 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 135' ' ' VAL . 2.1 mp -100.01 43.98 1.04 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 110.78 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.72 83.19 1.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.1 -0.952 . . . . 0.0 111.066 -179.664 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.99 34.59 5.12 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.999 0.428 . . . . 0.0 110.36 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -147.73 44.11 1.09 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.618 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -119.94 108.03 13.84 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.916 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.442 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t -64.0 -48.31 78.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.771 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 6' ' ' SER . 71.5 Cg_endo -78.75 -14.36 14.04 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.389 2.06 . . . . 0.0 114.074 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -111.26 -61.41 1.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -60.13 2.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.597 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.463 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 8.1 tt0 -58.97 -47.04 86.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.631 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.6 -36.3 78.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.096 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.455 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.6 t80 -58.47 -49.31 77.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.951 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -61.92 -34.3 75.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 14.2 mt -55.62 -36.95 67.52 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 111.358 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -96.15 33.5 1.73 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -84.67 84.31 7.72 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.242 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.6 mmm-85 -67.26 -34.49 77.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.46 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -86.55 -32.59 20.61 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.4 26.79 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.508 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.2 p -137.25 30.16 2.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.668 0.27 . . . . 0.0 111.072 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.23 20.63 71.41 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.812 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 13.3 mtt180 -130.65 158.62 39.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.777 0.288 . . . . 0.0 110.533 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 28' ' ' ILE . 5.7 pt -145.49 138.08 13.7 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 95.7 Cg_endo -88.67 172.73 4.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.207 2.605 . . . . 0.0 112.131 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 4.5 pttm -44.33 -36.25 2.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -59.9 -46.25 89.93 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -71.22 -50.51 32.21 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.84 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.85 -35.45 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 121.324 -0.15 . . . . 0.0 111.338 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.18 -70.95 0.83 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.235 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.17 -28.26 69.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.59 0.195 . . . . 0.0 111.453 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.72 -48.01 83.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.6 -34.47 75.7 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.858 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -32.41 64.71 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.297 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -52.56 -43.48 65.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.5 m -64.32 -43.73 93.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.925 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.18 -65.97 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.984 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.63 163.46 28.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -136.07 151.72 74.17 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.477 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 56.7 Cg_endo -86.47 -163.28 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.138 2.559 . . . . 0.0 112.74 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -99.58 169.05 9.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.261 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.3 mm? -54.09 -36.09 62.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.113 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.52 80.06 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.559 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -67.71 -52.23 40.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.206 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.834 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.85 -45.65 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 121.337 -0.145 . . . . 0.0 110.641 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 m -57.57 -40.02 78.05 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -40.92 88.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.614 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 44' ' ' ILE . 18.7 mt -63.36 -49.08 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -57.22 -24.86 57.45 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.678 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -64.03 -10.69 23.39 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.4 p -117.92 -41.54 2.89 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 120.34 0.114 . . . . 0.0 111.025 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD11 HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -92.84 150.78 40.06 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.544 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.3 Cg_exo -38.32 143.31 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.233 2.622 . . . . 0.0 112.821 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -29.25 -61.35 0.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.73 0.644 . . . . 0.0 112.659 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -87.29 121.01 29.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.491 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.64 83.64 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.386 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.3 p30 -82.77 178.11 8.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.494 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 55.9 mtp -41.43 -46.01 3.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -65.59 -52.16 54.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.962 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.544 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.57 -52.59 64.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -49.31 75.92 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.121 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.57 -30.04 70.41 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -64.2 -49.46 71.93 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.433 0.159 . . . . 0.0 110.868 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.616 HG21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.51 -45.92 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.849 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -57.9 8.11 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -91.26 55.66 2.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 110.78 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -51.89 76.95 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.247 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.532 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 69.5 Cg_endo -86.74 19.02 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.754 2.302 . . . . 0.0 113.249 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 62.96 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.679 0.392 . . . . 0.0 111.812 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.37 176.46 22.61 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.285 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.77 166.8 10.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.536 0.208 . . . . 0.0 111.011 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 56.34 69.72 0.71 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 110.657 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.562 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER 177.46 -51.95 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.796 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 72.4 Cg_exo -41.02 -45.35 5.12 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.988 2.458 . . . . 0.0 113.4 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.74 82.83 0.72 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.452 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.71 137.78 73.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.999 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' O ' HG23 ' A' ' 80' ' ' VAL . 32.2 Cg_exo -57.95 -41.62 66.89 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.568 2.179 . . . . 0.0 112.136 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.49 -33.54 73.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -65.3 -41.85 93.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.032 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -42.31 68.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.988 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 76' ' ' PRO . 75.2 t -61.85 -56.46 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -24.77 67.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.687 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -65.21 -52.72 38.29 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.4 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -77.69 -41.47 37.92 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.437 0.16 . . . . 0.0 111.053 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -78.65 71.76 5.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.957 0.408 . . . . 0.0 110.986 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.646 ' HB ' HG21 ' A' ' 102' ' ' VAL . 14.9 p -111.99 -42.01 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.29 40.36 1.76 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -125.25 57.53 1.31 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -49.24 74.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.556 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -97.83 -48.31 5.24 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.444 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.02 73.48 0.47 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.014 0.435 . . . . 0.0 110.782 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 91' ' ' THR . 10.1 t -92.06 70.29 5.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.29 57.34 17.27 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -168.62 135.74 1.97 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 111.015 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -108.89 -44.16 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.46 80.12 0.12 Allowed Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.422 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.794 ' HA ' HD23 ' A' ' 99' ' ' LEU . 95.4 t -44.44 -40.07 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.71 -36.15 8.09 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.163 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.3 mm-40 -80.85 -46.01 15.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.63 0.215 . . . . 0.0 110.909 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.05 -42.08 84.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.893 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -75.01 -36.06 61.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.828 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -52.82 -41.34 64.1 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.522 0.201 . . . . 0.0 111.014 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.646 HG21 ' HB ' ' A' ' 85' ' ' VAL . 2.6 t -83.04 -52.94 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.649 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -56.45 -47.12 79.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -58.22 -35.38 71.58 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -67.86 -21.47 65.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 4.1 mt -66.35 -67.43 0.45 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.512 0.196 . . . . 0.0 111.026 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.31 49.65 0.46 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.542 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.2 48.68 4.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.345 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -68.49 -138.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.125 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.803 HD22 ' HG2' ' A' ' 114' ' ' GLU . 15.1 mt -69.68 78.01 0.44 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.885 0.374 . . . . 0.0 110.639 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.3 p -68.78 -171.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.867 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -50.88 -39.54 54.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.03 -53.52 48.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.524 0.202 . . . . 0.0 111.275 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.803 ' HG2' HD22 ' A' ' 110' ' ' LEU . 4.1 tp10 -54.78 -52.86 61.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.88 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -65.61 -27.76 68.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -44.77 90.46 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.32 -43.82 80.69 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.92 -42.5 98.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.06 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.3 mt -71.52 -28.95 64.25 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.146 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -63.97 -41.21 97.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.572 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.12 -48.79 24.33 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.829 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.497 HG11 HG22 ' A' ' 129' ' ' VAL . 21.4 t -81.73 123.69 80.24 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.62 0.21 . . . . 0.0 110.808 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.75 62.23 6.41 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.565 2.177 . . . . 0.0 112.864 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.73 178.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.212 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -119.29 130.43 55.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.48 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 22.8 m-20 80.7 -34.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.061 0.544 . . . . 0.0 111.814 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 118.07 50.69 0.34 Allowed Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.457 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.425 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.7 OUTLIER -104.01 116.84 32.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.705 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 129' ' ' VAL . 36.7 t -142.32 20.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.258 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 56.72 25.31 10.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CD1' HG13 ' A' ' 94' ' ' ILE . 1.7 t80 44.77 44.49 7.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -53.54 2.53 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.575 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.9 t70 -56.13 -37.08 68.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.3 m-85 -68.2 -58.95 3.62 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.83 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 t -62.27 -32.99 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -61.2 -52.66 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 110.645 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.53 -27.7 67.19 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.046 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.8 mm -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.333 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.65 40.39 1.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.702 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.36 67.28 1.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.877 -179.71 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.782 0.325 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -120.44 -46.63 2.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -135.68 -58.7 0.77 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.636 0.255 . . . . 0.0 110.62 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -141.39 112.09 7.1 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.609 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -59.41 -48.04 96.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.69 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 6' ' ' SER . 88.0 Cg_endo -81.74 -14.39 10.13 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.513 2.142 . . . . 0.0 114.123 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -110.52 -61.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -62.7 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.547 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -57.29 -47.6 81.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.677 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.464 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.2 -41.92 85.02 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE2' HG12 ' A' ' 23' ' ' ILE . 22.6 t80 -56.71 -42.82 79.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.592 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -61.4 -36.49 80.44 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.2 mt -63.26 -34.1 76.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -93.96 29.65 2.06 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.08 125.02 29.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.733 0.301 . . . . 0.0 110.821 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.53 -58.3 3.84 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.398 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -108.28 6.03 26.19 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.17 43.13 99.8 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.792 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.0 p -118.41 10.83 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 1.19 68.95 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.381 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -125.04 167.29 14.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.149 0.475 . . . . 0.0 110.898 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.74 HD12 HD13 ' A' ' 28' ' ' ILE . 7.6 pt -147.41 136.43 11.53 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -87.38 172.01 6.13 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.245 2.63 . . . . 0.0 112.488 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 6.0 pttt -44.41 -39.27 4.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.2 p -59.5 -43.31 93.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.453 0.168 . . . . 0.0 111.164 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 25.4 m -71.16 -52.37 19.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.614 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.74 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.86 -35.36 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.76 -71.22 0.75 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -26.59 68.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.8 -50.14 67.91 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.702 0.287 . . . . 0.0 110.276 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.33 -28.11 68.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -54.75 -37.95 66.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.519 0.2 . . . . 0.0 110.749 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.18 72.28 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.577 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -83.74 -41.89 17.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.476 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.39 -84.32 0.05 OUTLIER Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.59 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.1 171.65 13.7 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.6 t-20 -123.3 108.77 31.6 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.317 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.38 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.849 2.366 . . . . 0.0 112.552 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 p -90.42 166.4 13.29 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.5 mm? -55.7 -34.53 65.17 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.789 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.54 -37.22 77.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.646 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.52 -54.2 31.56 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.653 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.06 -44.29 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.748 179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 m -58.07 -43.59 87.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.343 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.47 -40.12 74.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.645 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 44' ' ' ILE . 24.6 mt -64.99 -49.35 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.8 -23.37 43.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.748 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -64.56 -6.49 7.65 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -117.76 -45.59 2.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.789 0.268 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.606 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -89.36 156.19 48.48 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 94.4 Cg_exo -41.67 149.31 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.056 2.504 . . . . 0.0 113.116 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.72 -64.18 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.646 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.1 mt-10 -86.44 123.58 31.82 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.704 0.288 . . . . 0.0 110.614 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.92 87.85 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 2.9 p30 -83.92 -179.93 7.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 37.2 mtt -41.41 -44.59 2.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.98 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -69.12 -52.27 29.98 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.56 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.27 -51.57 68.83 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.614 -179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.437 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.68 -48.54 81.35 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.921 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 61' ' ' LEU . 35.0 mt -61.01 -34.51 74.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.505 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -60.28 -49.81 76.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.577 0.227 . . . . 0.0 111.013 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.57 -36.49 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.97 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD13 ' HE1' ' A' ' 60' ' ' PHE . 1.6 tp -62.05 -51.59 67.36 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.03 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -96.35 48.45 1.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.49 -49.15 91.4 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.436 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 85.6 Cg_endo -83.97 18.85 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.621 2.214 . . . . 0.0 113.563 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 55.4 92.13 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.638 0.375 . . . . 0.0 111.947 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.47 176.93 14.93 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.287 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -101.97 169.04 9.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.56 0.219 . . . . 0.0 110.806 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.458 ' HA ' ' CG ' ' A' ' 75' ' ' ASP . 3.3 m-20 54.64 68.06 0.92 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.061 0.458 . . . . 0.0 110.745 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.581 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 11.6 tpt -179.67 -51.37 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.332 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 51.4 Cg_exo -51.89 -57.85 1.92 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.376 2.05 . . . . 0.0 112.484 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.33 36.16 0.7 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.499 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' CG ' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -81.14 173.28 7.94 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.466 0.174 . . . . 0.0 110.86 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 69.1 Cg_exo -51.62 -36.17 59.68 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.719 2.279 . . . . 0.0 112.322 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -38.44 91.19 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.892 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.09 -42.56 96.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.847 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -44.1 97.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.92 -39.04 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.926 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -35.36 77.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.324 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' C ' HG11 ' A' ' 102' ' ' VAL . . . -71.63 -54.69 8.25 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.755 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -57.9 -45.64 86.15 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.512 0.196 . . . . 0.0 110.666 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.98 65.13 5.04 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.85 -41.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.496 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -121.83 32.16 5.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.01 75.0 1.48 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.921 0.391 . . . . 0.0 110.548 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -44.15 92.79 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.5 -59.28 2.36 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.846 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 55.71 70.16 0.66 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -128.22 68.36 1.35 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.76 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.0 38.76 3.27 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.802 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.41 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.0 OUTLIER -172.86 134.56 0.59 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.675 0.238 . . . . 0.0 110.976 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -107.26 -41.78 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.12 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.54 80.96 0.38 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.328 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.756 ' HA ' HD23 ' A' ' 99' ' ' LEU . 79.6 t -45.12 -39.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.03 -40.04 42.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.258 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.4 tt0 -71.93 -47.92 49.07 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.225 0.21 . . . . 0.0 110.474 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.756 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.35 -37.74 75.79 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.207 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.489 ' HG3' ' HG3' ' A' ' 115' ' ' MET . 0.2 OUTLIER -68.16 -43.99 77.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.675 179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -58.47 -36.79 74.25 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.361 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 98' ' ' GLU . 16.1 t -77.8 -50.28 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.602 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.557 HD12 ' CD1' ' A' ' 99' ' ' LEU . 4.6 mt -63.73 -42.61 97.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.6 m -64.73 -41.72 95.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.499 0.19 . . . . 0.0 111.007 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.5 p -70.37 -15.2 62.83 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.861 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 mt -74.55 -56.92 4.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.46 42.99 0.23 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.84 47.28 15.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 46.9 mmtm -68.52 -138.66 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 mt -70.51 79.67 0.57 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.0 p -62.21 -177.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.933 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.416 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 7.2 p30 -48.9 -29.75 5.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.468 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -60.0 -62.75 1.64 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -42.04 86.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.793 ' HA ' HD23 ' A' ' 118' ' ' LEU . 6.0 mmt -65.95 -33.84 76.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -48.9 77.98 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.233 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.59 -40.65 95.56 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.33 -42.16 95.08 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.409 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.436 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -68.91 -31.17 69.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.324 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -62.94 -42.24 99.74 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.5 65.62 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.902 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.73 126.35 71.06 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.667 0.234 . . . . 0.0 111.176 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.25 61.07 5.79 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.598 2.199 . . . . 0.0 112.333 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 125' ' ' LYS . 2.2 p -131.87 171.46 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.294 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -118.28 132.17 56.31 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 26.8 m-20 81.35 -47.51 0.24 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.523 0.514 . . . . 0.0 110.841 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.2 53.16 0.16 Allowed Glycine 0 C--N 1.339 0.71 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.711 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.454 ' O ' HG21 ' A' ' 124' ' ' VAL . 0.3 OUTLIER -107.22 107.41 18.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.544 0.688 . . . . 0.0 110.904 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 129' ' ' VAL . 47.7 t -142.32 19.59 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.624 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.85 21.69 7.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.853 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.413 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.9 OUTLIER 54.79 -164.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.21 -57.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.235 0.214 . . . . 0.0 111.359 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -52.65 -39.18 61.55 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 2.7 m-85 -68.65 -54.81 14.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.637 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.03 -31.31 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.293 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -69.6 -54.23 15.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -34.68 78.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.492 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 134' ' ' PHE . 1.9 mt -69.4 -47.95 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.084 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.3 mp -99.17 53.69 0.97 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -171.02 112.65 0.38 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.725 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.136 -179.676 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 51.14 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.189 0.596 . . . . 0.0 111.76 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -136.18 -56.3 0.76 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.617 0.246 . . . . 0.0 110.863 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -128.34 98.34 5.03 Favored 'General case' 0 N--CA 1.46 0.031 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.699 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.456 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.6 t -61.72 -46.02 93.11 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 6' ' ' SER . 5.0 Cg_exo -75.39 -14.4 20.33 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.987 2.458 . . . . 0.0 114.046 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -118.12 -63.13 1.46 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -66.21 -60.68 2.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 8.0 tt0 -60.56 -47.14 87.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.61 -37.05 80.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 23' ' ' ILE . 24.7 t80 -59.01 -46.77 87.35 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.326 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 m -62.41 -32.73 73.61 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.266 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -59.95 -34.07 72.77 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.497 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -102.05 36.33 2.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.92 101.68 14.44 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -50.05 67.79 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -86.84 -35.79 18.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.386 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.08 40.01 6.74 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.584 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.3 p -127.83 32.72 4.91 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.06 19.2 73.62 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.984 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 1.1 mtt-85 -130.98 157.2 43.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.794 0.297 . . . . 0.0 110.688 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.806 HD12 HD13 ' A' ' 28' ' ' ILE . 7.0 pt -143.57 137.94 14.93 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 84.1 Cg_endo -88.3 171.53 5.4 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.166 2.577 . . . . 0.0 112.702 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 15.8 pttm -44.19 -36.63 2.75 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.5 p -60.15 -46.21 90.45 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -70.72 -49.95 41.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.94 -34.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.346 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.12 -72.56 0.56 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.215 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -27.19 65.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.593 0.196 . . . . 0.0 111.456 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.13 -48.38 78.74 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -61.55 -31.5 71.53 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.962 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.426 ' N ' ' HB3' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -56.13 -33.67 65.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.142 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.3 -38.02 68.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.28 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -92.66 58.15 3.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.0 0.428 . . . . 0.0 110.477 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.41 -91.71 1.09 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.406 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 172.37 12.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB3' ' N ' ' A' ' 33' ' ' ARG . 12.4 p-10 -132.05 155.82 80.87 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.688 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' HB2' ' CB ' ' A' ' 43' ' ' GLU . 65.3 Cg_endo -85.03 -161.91 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.034 2.489 . . . . 0.0 112.41 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 p -102.17 167.32 10.08 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.076 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.407 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.5 mm? -53.58 -35.23 60.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.17 88.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.708 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -66.76 -52.22 46.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.271 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.598 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -54.95 -46.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.7 m -58.42 -43.08 88.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.307 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.51 -40.97 75.9 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.562 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 44' ' ' ILE . 38.8 mt -63.59 -48.2 87.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.23 -23.58 48.96 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.858 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -63.69 -12.09 31.38 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.4 p -118.04 -41.11 2.91 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.946 0.098 . . . . 0.0 110.911 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -91.2 148.35 37.6 Favored Pre-proline 0 N--CA 1.465 0.286 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.47 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -36.62 140.43 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.391 2.727 . . . . 0.0 113.148 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.86 -58.5 0.13 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.636 . . . . 0.0 112.448 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -89.4 122.32 32.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.185 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.36 88.49 2.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 121.029 0.443 . . . . 0.0 110.647 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.2 p30 -82.6 177.77 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.498 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.9 mtm -41.36 -43.73 2.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.907 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.84 -51.19 35.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.47 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.3 mp0 -56.29 -50.74 70.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.504 0.192 . . . . 0.0 111.08 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -47.59 83.54 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.86 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 61' ' ' LEU . 26.8 mt -62.1 -30.93 71.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -63.65 -54.58 33.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.507 0.194 . . . . 0.0 110.88 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -64.24 -40.9 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.903 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.1 -63.79 1.06 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.859 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.03 63.33 7.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.348 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -55.12 -54.14 53.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.707 -179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.53 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 74.2 Cg_endo -84.8 19.14 1.44 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.625 2.216 . . . . 0.0 113.548 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 m120 54.17 75.87 0.26 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.77 0.319 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.65 -172.6 38.75 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.167 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -121.65 156.43 33.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.776 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 57.39 62.05 2.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.162 0.505 . . . . 0.0 110.274 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.561 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 6.9 tpt 179.46 -52.8 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.933 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 94.9 Cg_exo -42.46 -48.16 7.04 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 122.885 2.39 . . . . 0.0 113.429 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.8 80.16 0.06 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.898 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.628 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . 24.1 m-20 -80.97 117.57 68.63 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 120.432 0.158 . . . . 0.0 110.725 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 80' ' ' VAL . 29.6 Cg_exo -61.76 -51.13 4.27 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.758 2.306 . . . . 0.0 112.487 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -24.17 65.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.676 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 38.1 tt0 -71.84 -52.32 18.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.48 0.181 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -39.85 95.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.973 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 76' ' ' PRO . 53.9 t -61.84 -50.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.602 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.466 ' O ' HG11 ' A' ' 102' ' ' VAL . 1.4 tppt? -60.13 -32.87 71.42 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -63.21 -54.08 35.22 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.502 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -78.02 -22.37 49.35 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.66 75.02 4.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.1 0.476 . . . . 0.0 111.031 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 86' ' ' PHE . 7.1 p -141.75 -49.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.906 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.447 ' N ' HG13 ' A' ' 85' ' ' VAL . 9.6 m-85 -156.29 43.44 0.4 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 110.722 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.96 59.95 1.72 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -50.23 74.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.93 -46.08 5.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.888 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.24 38.77 28.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.54 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 p -118.47 82.55 1.87 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.6 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.7 -18.02 5.44 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.157 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.1 OUTLIER -163.77 132.37 3.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.085 0.442 . . . . 0.0 110.898 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.587 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.38 -41.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.853 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.52 80.4 0.2 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.705 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.782 ' HA ' HD23 ' A' ' 99' ' ' LEU . 96.9 t -45.12 -38.61 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 122.3 0.24 . . . . 0.0 111.641 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.55 -36.36 17.79 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.9 mm-40 -77.45 -48.1 18.0 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 0.173 . . . . 0.0 110.71 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -58.72 -39.36 80.61 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.744 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HD3' ' HG2' ' A' ' 115' ' ' MET . 14.1 ttp180 -75.71 -39.47 57.32 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -53.9 -40.78 66.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 98' ' ' GLU . 3.8 t -77.91 -52.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.653 0.264 . . . . 0.0 111.412 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.899 HD22 ' HG2' ' A' ' 109' ' ' LYS . 5.7 mt -56.5 -46.77 80.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.948 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.2 m -66.56 -35.59 80.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -66.02 -22.07 66.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.728 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.01 -67.86 0.43 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 110.983 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.55 44.68 0.56 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.258 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.4 50.41 4.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 111.182 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.899 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -68.51 -137.59 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.902 178.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.617 HD22 ' HG3' ' A' ' 114' ' ' GLU . 62.3 mt -67.23 79.44 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.372 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.8 p -63.8 -169.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.438 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 115' ' ' MET . 3.5 m120 -50.43 -33.71 21.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.521 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -56.37 -51.72 67.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.568 0.223 . . . . 0.0 111.483 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.617 ' HG3' HD22 ' A' ' 110' ' ' LEU . 1.6 tm-20 -56.58 -56.79 16.93 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.922 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.6 OUTLIER -65.45 -24.68 67.24 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.638 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -48.28 81.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -68.01 -43.54 78.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.71 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.922 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.73 -42.19 96.82 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.944 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 4.1 mt -69.79 -30.24 67.74 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.073 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -40.39 96.53 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.625 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.48 -47.48 16.26 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.952 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.458 HG11 HG22 ' A' ' 129' ' ' VAL . 26.2 t -81.35 125.8 78.08 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.688 0.244 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.49 61.61 7.96 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.652 2.235 . . . . 0.0 112.662 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 128' ' ' MET . 22.9 m -131.57 -177.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.236 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.05 129.91 55.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.083 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 78.71 -49.38 0.45 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.851 0.46 . . . . 0.0 111.049 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 136.14 51.27 0.07 OUTLIER Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.618 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.488 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 1.9 ttp -104.17 116.73 32.71 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.121 0.486 . . . . 0.0 110.659 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 129' ' ' VAL . 29.7 t -142.03 20.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.463 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 59.92 25.77 14.95 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.472 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 3.0 t80 44.31 41.63 4.58 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.236 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -52.98 2.69 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.839 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.526 ' HB3' HG11 ' A' ' 129' ' ' VAL . 23.6 t70 -56.9 -36.75 70.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 2.8 m-85 -67.93 -57.35 6.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.55 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.94 -35.19 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.41 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -60.77 -56.03 26.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.889 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.2 tpp -64.0 -29.66 70.79 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.074 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mt -64.92 -43.11 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.967 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.23 33.06 3.65 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.604 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.52 110.11 0.23 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.951 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.861 -179.676 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.593 0.235 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.79 32.54 21.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.452 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.57 -41.53 3.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -106.83 99.3 8.88 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.54 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 4.1 t -67.31 -47.64 48.66 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.785 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 6' ' ' SER . 98.8 Cg_endo -80.73 -13.34 11.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.466 2.11 . . . . 0.0 114.193 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.37 -61.27 1.69 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -59.62 2.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.336 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.35 -47.42 85.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.716 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.79 -41.02 85.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.966 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.454 ' CE2' HG12 ' A' ' 23' ' ' ILE . 6.1 t80 -56.39 -45.39 80.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.456 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.8 m -62.64 -33.82 75.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.733 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 16.1 mt -57.52 -30.28 65.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 23' ' ' ILE . 69.5 m-85 -91.69 33.22 1.03 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.54 112.3 14.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.909 0.385 . . . . 0.0 110.846 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -49.72 42.31 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.73 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -115.53 -0.92 12.91 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 48.5 33.57 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.559 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.5 p -121.38 16.64 11.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.65 14.01 80.01 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.194 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -130.29 158.45 39.76 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.922 0.361 . . . . 0.0 110.668 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.61 HD12 HD13 ' A' ' 28' ' ' ILE . 8.8 pt -140.96 135.04 15.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.73 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.25 170.66 9.36 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.074 2.516 . . . . 0.0 112.477 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' O ' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -42.81 -38.16 2.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.6 p -60.41 -45.38 93.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.506 0.193 . . . . 0.0 111.293 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.459 ' CB ' ' HB ' ' A' ' 23' ' ' ILE . 2.9 m -69.97 -44.73 68.85 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.61 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.21 -33.47 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.411 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.45 -65.99 3.15 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.392 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -28.02 69.24 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.56 -49.18 77.7 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.32 -29.48 69.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.076 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -36.63 70.6 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.85 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.23 -30.14 71.0 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.418 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -109.4 32.05 5.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.799 0.333 . . . . 0.0 110.84 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.55 -105.08 0.28 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.366 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -132.4 178.81 6.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.924 0.392 . . . . 0.0 111.615 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -118.74 116.04 34.88 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.369 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -84.57 -162.63 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.016 2.478 . . . . 0.0 112.764 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 p -98.16 164.06 12.48 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.24 -36.48 63.61 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.021 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.82 80.59 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.02 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.83 -54.6 20.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.091 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.64 -44.95 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.484 0.183 . . . . 0.0 110.632 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.7 m -59.1 -38.99 80.86 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.11 -40.5 85.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.277 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 44' ' ' ILE . 22.5 mt -63.56 -47.94 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -56.82 -25.48 56.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.414 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 t -64.47 -7.42 9.97 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -117.75 -50.52 2.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.748 0.249 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -87.27 153.66 53.92 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.507 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 85.6 Cg_exo -38.85 144.95 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.265 2.643 . . . . 0.0 113.044 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -28.68 -68.66 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -84.74 126.78 33.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.637 0.256 . . . . 0.0 110.601 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.55 89.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.816 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.5 p30 -86.08 -179.69 6.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.539 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -41.28 -45.15 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.817 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -67.55 -53.62 26.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.507 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -57.31 -51.99 67.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -50.1 75.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.46 -32.47 72.46 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.414 0.15 . . . . 0.0 111.326 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.19 -50.3 74.57 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.025 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.57 -34.45 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.356 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.52 -46.16 67.16 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.635 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -93.45 51.77 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 21.6 mtm180 -60.33 -55.24 47.2 Favored Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.785 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.559 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 58.9 Cg_endo -86.86 29.96 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.991 2.461 . . . . 0.0 113.057 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 39.81 71.13 0.19 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.974 0.51 . . . . 0.0 111.808 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.07 173.33 46.2 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.967 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -100.79 -57.1 2.17 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.565 0.221 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.33 72.97 2.83 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.051 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.57 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -165.98 -54.69 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.003 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD3' ' CG ' ' A' ' 72' ' ' MET . 81.1 Cg_exo -43.72 -48.93 8.45 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.596 2.198 . . . . 0.0 113.206 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -139.15 52.74 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.484 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.63 152.82 72.96 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.497 0.189 . . . . 0.0 111.247 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.3 Cg_exo -58.8 -38.74 87.16 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.887 2.391 . . . . 0.0 112.512 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -35.97 82.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.369 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -65.37 -42.14 93.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.023 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -43.42 69.64 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.903 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 76' ' ' PRO . 78.1 t -60.43 -44.56 96.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.276 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -34.62 77.6 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.65 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.818 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -61.07 -48.36 86.46 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.214 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -70.97 -34.36 71.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.508 0.194 . . . . 0.0 110.724 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -78.78 72.27 5.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.2 -63.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.342 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.475 ' CB ' ' HG3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -116.5 42.21 2.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.141 179.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.33 65.42 0.67 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.671 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -59.64 -53.51 57.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.87 -66.95 1.0 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.595 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.21 63.75 1.84 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.572 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -64.84 -47.72 76.94 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.27 64.77 0.5 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.403 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -178.1 150.22 0.59 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.224 0.21 . . . . 0.0 110.487 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.588 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -114.25 -41.53 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.507 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.51 80.34 0.18 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.334 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.704 ' HA ' HD23 ' A' ' 99' ' ' LEU . 91.3 t -45.14 -33.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -46.54 -43.76 15.62 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.109 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -76.93 -49.91 14.49 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.583 0.192 . . . . 0.0 111.045 179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.725 HD12 HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -57.32 -37.58 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.272 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 104' ' ' THR . 35.7 ttp85 -70.8 -46.98 61.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.79 -38.05 54.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.284 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.818 HG11 ' HA2' ' A' ' 82' ' ' GLY . 22.4 t -75.11 -49.03 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.815 HD22 ' HG2' ' A' ' 109' ' ' LYS . 9.4 mt -63.07 -35.27 79.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.407 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 111' ' ' SER . 68.2 p -63.75 -37.8 88.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.603 0.24 . . . . 0.0 111.021 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.1 m -72.74 -17.05 61.64 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.05 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 mt -67.34 -56.91 7.79 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.724 0.297 . . . . 0.0 110.772 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.06 48.78 0.07 OUTLIER Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.156 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 64.01 39.12 8.16 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 111.035 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.815 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.66 -137.05 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.593 178.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.804 HD23 ' HB3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -67.51 83.56 0.17 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.603 ' HA ' HG22 ' A' ' 104' ' ' THR . 0.0 OUTLIER -86.71 -167.55 1.92 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.967 -178.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 11.1 p30 -55.43 -28.86 56.95 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.27 -67.17 0.45 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.804 ' HB3' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -55.71 -44.98 77.95 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.148 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.804 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.54 -29.27 69.32 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.106 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER -58.69 -47.52 84.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.25 -42.71 99.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.8 -41.72 98.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.742 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.456 HD12 ' SD ' ' A' ' 115' ' ' MET . 4.3 mt -67.7 -32.18 72.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.146 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -45.22 91.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.967 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.94 -45.66 41.01 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.785 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 129' ' ' VAL . 86.7 t -75.63 133.49 73.62 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.488 0.185 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 58.48 6.5 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.84 2.36 . . . . 0.0 112.657 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.593 HG21 ' H ' ' A' ' 128' ' ' MET . 5.1 p -131.43 166.84 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 124' ' ' VAL . 3.0 mtpp -124.33 55.56 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.92 0.391 . . . . 0.0 111.25 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.7 p-10 170.26 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 116.45 40.98 0.76 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.593 ' H ' HG21 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -103.25 114.26 28.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 110.618 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 129' ' ' VAL . 25.8 t -142.44 27.08 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.225 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 60.21 20.23 9.61 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.5 t80 46.61 41.75 10.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.821 0.343 . . . . 0.0 111.187 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -50.07 2.37 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.667 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' HB3' HG11 ' A' ' 129' ' ' VAL . 20.6 t70 -56.37 -41.29 75.95 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -66.4 -57.85 6.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.77 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.491 ' CG1' HD13 ' A' ' 139' ' ' LEU . 14.4 t -62.11 -30.09 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.512 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -60.17 -57.4 12.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.659 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.3 ttm -68.97 -32.02 71.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.902 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 139' ' ' LEU . 2.2 mm -62.36 -49.23 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.803 HD12 HG22 ' A' ' 138' ' ' ILE . 2.6 mp -94.22 64.1 3.18 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.928 0.394 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -161.77 67.62 0.27 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.0 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.905 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.561 0.219 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.6 t -129.59 29.42 5.05 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.098 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.91 -46.83 4.77 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 12.0 m-20 -79.32 83.09 5.39 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.1 0.476 . . . . 0.0 110.657 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.433 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.3 t -67.41 -46.64 48.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.984 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.3 Cg_endo -82.82 1.98 8.78 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.438 2.092 . . . . 0.0 114.106 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.506 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 56.9 m-85 -124.27 -66.76 0.96 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -55.27 6.74 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 1.4 tp60 -62.36 -49.33 75.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.676 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.51 -38.2 77.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.9 t80 -58.83 -46.48 87.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.401 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -62.57 -31.6 72.44 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.656 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 12.8 mt -60.31 -38.1 82.62 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 23' ' ' ILE . 24.3 m-85 -96.04 34.47 1.55 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.4 95.27 9.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.241 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.07 -36.43 77.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.566 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -86.91 -41.28 14.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.369 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.22 10.51 55.92 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.165 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.1 p -103.96 -12.91 16.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.075 0.437 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.45 28.85 3.61 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.54 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HD2' ' HB3' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -130.56 155.59 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.371 0.268 . . . . 0.0 110.367 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.745 HD12 HD13 ' A' ' 28' ' ' ILE . 5.4 pt -145.24 132.5 10.19 Favored Pre-proline 0 N--CA 1.465 0.285 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.43 171.4 9.97 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.975 2.45 . . . . 0.0 111.985 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -46.17 -37.83 7.52 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.3 p -61.94 -41.89 98.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.372 0.13 . . . . 0.0 111.152 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 9.8 m -70.41 -46.35 64.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.403 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.745 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.03 -34.87 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.482 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.01 -70.63 0.9 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.54 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -27.86 69.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.349 0.119 . . . . 0.0 111.291 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -61.54 -50.91 70.77 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.645 0.26 . . . . 0.0 110.366 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.58 -31.53 71.59 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.119 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.45 -39.64 70.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.01 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.84 75.5 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.533 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -77.45 -44.03 30.39 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.662 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' ' 77' ' ' GLU . . . -156.43 -76.98 0.02 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.749 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.05 168.5 17.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.879 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -122.45 117.12 29.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.447 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -81.31 -162.25 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.893 2.396 . . . . 0.0 112.464 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -94.26 164.28 13.1 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.107 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.8 mm? -56.71 -30.95 64.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.802 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.36 -38.44 86.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.723 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -55.53 16.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.83 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -56.18 -45.11 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.906 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.2 m -61.27 -40.15 93.05 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -58.57 -38.68 78.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 44' ' ' ILE . 23.3 mt -61.9 -51.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.6 -23.78 43.18 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.72 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -9.58 15.21 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -118.24 -46.42 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.647 0.203 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.555 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -90.24 158.39 43.82 Favored Pre-proline 0 N--CA 1.467 0.399 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.036 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 91.8 Cg_exo -42.49 150.21 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.14 2.56 . . . . 0.0 113.214 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -37.14 -64.92 0.33 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.099 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -82.39 119.83 24.66 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 59' ' ' GLN . 59.7 t -86.8 89.47 3.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.212 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HA ' ' HZ ' ' A' ' 12' ' ' PHE . 4.2 p30 -84.48 -179.89 7.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.49 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 mtt -41.92 -46.59 4.1 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.827 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -67.11 -51.03 59.21 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.586 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -57.17 -51.12 70.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -50.89 69.72 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.724 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.2 mt -62.12 -26.15 68.14 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.473 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -65.57 -51.47 59.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.556 0.217 . . . . 0.0 110.67 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.61 -41.58 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.828 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.533 HD23 ' ND2' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -69.13 -60.05 2.61 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.873 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.533 ' ND2' HD23 ' A' ' 64' ' ' LEU . 1.6 m120 -87.52 62.87 7.34 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.489 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.428 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -56.4 -54.5 52.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.135 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.8 Cg_endo -85.6 19.07 1.45 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.799 2.333 . . . . 0.0 113.188 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.5 m120 66.0 113.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.814 0.446 . . . . 0.0 111.826 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 168.15 14.64 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.136 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -103.52 171.97 7.07 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.564 -0.162 . . . . 0.0 110.564 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 38.32 64.59 0.7 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.125 0.488 . . . . 0.0 111.384 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.63 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 18.7 ttt -174.23 -53.17 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.802 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 83.7 Cg_exo -48.01 -39.28 32.79 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.557 2.171 . . . . 0.0 112.602 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 91.36 2.14 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.43 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -61.3 142.77 93.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 120.501 0.191 . . . . 0.0 111.028 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.605 ' O ' HG23 ' A' ' 80' ' ' VAL . 51.0 Cg_exo -55.8 -55.2 3.16 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.798 2.332 . . . . 0.0 112.498 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' HG3' ' HA3' ' A' ' 36' ' ' GLY . 1.2 pm0 -69.4 -26.55 64.69 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.665 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -71.94 -49.83 34.25 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.198 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.26 90.45 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.296 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 76' ' ' PRO . 89.2 t -65.41 -53.04 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.465 0.174 . . . . 0.0 110.843 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -60.82 -29.49 69.51 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.689 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.79 -53.38 15.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.063 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -77.89 -36.81 49.21 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.93 74.05 2.16 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.201 0.524 . . . . 0.0 111.243 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.88 -55.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.232 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -144.14 49.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.317 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 1.1 m-20 -129.63 74.82 1.61 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.709 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -47.34 78.22 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.73 -71.3 0.51 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.69 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 57.34 -170.14 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.218 0.324 . . . . 0.0 111.657 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 m 72.11 -69.93 0.17 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.666 0.386 . . . . 0.0 111.542 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.72 6.45 83.42 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.562 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 143.86 5.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.274 0.537 . . . . 0.0 111.025 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -124.32 141.12 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -109.27 81.22 0.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.058 -0.591 . . . . 0.0 111.639 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.021 HG11 HD21 ' A' ' 118' ' ' LEU . 93.9 t -43.32 -41.18 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.06 -46.65 33.22 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.038 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -81.59 -41.12 21.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.101 0.161 . . . . 0.0 110.958 179.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.01 -47.18 78.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.704 0.288 . . . . 0.0 110.702 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' HD3' HG13 ' A' ' 96' ' ' VAL . 3.0 mpt_? -72.57 -37.08 68.32 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.33 -38.68 63.46 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.538 0.209 . . . . 0.0 111.123 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.689 HG11 ' HA2' ' A' ' 82' ' ' GLY . 2.6 t -75.13 -49.12 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.456 HD23 HD12 ' A' ' 106' ' ' LEU . 1.1 mt -63.54 -34.99 79.02 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.36 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.9 m -62.24 -32.45 73.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.567 0.223 . . . . 0.0 111.163 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 m -69.54 -17.0 63.54 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.456 HD12 HD23 ' A' ' 103' ' ' LEU . 3.7 mt -63.97 -71.81 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 110.977 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.4 51.3 0.43 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.207 -0.521 . . . . 0.0 111.974 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 61.14 49.1 5.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.013 0.435 . . . . 0.0 110.732 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -68.32 -138.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.843 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.495 HD22 ' OE2' ' A' ' 114' ' ' GLU . 19.0 mt -70.21 79.82 0.52 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.5 p -61.7 -175.39 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.011 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -50.22 -32.57 16.87 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.408 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.89 -51.84 67.57 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.495 ' OE2' HD22 ' A' ' 110' ' ' LEU . 1.2 tp10 -57.48 -53.36 59.04 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.894 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -66.3 -26.8 67.49 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.402 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.86 -48.59 80.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.676 0.274 . . . . 0.0 110.339 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.88 -40.62 87.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.021 HD21 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.42 -41.6 98.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.694 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.427 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 1.1 mt -68.54 -33.26 73.8 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.983 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -63.32 -41.0 98.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.667 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.66 -45.06 18.74 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.844 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.8 t -79.24 125.22 83.74 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.693 0.247 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 122' ' ' VAL . 5.2 Cg_exo -73.76 62.79 4.76 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.909 2.406 . . . . 0.0 112.32 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 128' ' ' MET . 16.0 m -131.35 175.15 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.242 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 0.1 OUTLIER -124.19 47.62 2.05 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.084 0.469 . . . . 0.0 110.855 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 125' ' ' LYS . 6.8 p-10 173.03 -34.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.72 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 110.7 48.49 0.73 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -103.87 117.66 34.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 129' ' ' VAL . 38.4 t -142.37 31.16 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.989 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 59.24 23.12 11.45 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.493 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 46.33 44.5 12.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.926 0.394 . . . . 0.0 111.297 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.84 -52.69 2.43 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.35 -37.24 80.06 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.181 0.301 . . . . 0.0 111.757 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -66.39 -56.46 10.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.563 HG12 HD13 ' A' ' 139' ' ' LEU . 21.4 t -62.83 -31.28 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.462 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.42 -55.14 37.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 6.5 ttt -62.76 -36.26 82.48 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.025 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.757 HG22 HD12 ' A' ' 139' ' ' LEU . 3.2 mt -66.35 -39.32 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.119 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.757 HD12 HG22 ' A' ' 138' ' ' ILE . 2.4 mp -95.74 48.81 1.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.99 0.424 . . . . 0.0 110.879 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -166.52 80.44 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.097 -179.67 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.38 0.133 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 p 72.17 -54.7 0.68 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.592 0.757 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -131.99 -72.51 0.53 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.459 0.171 . . . . 0.0 110.581 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -174.16 97.78 0.1 Allowed 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.993 0.425 . . . . 0.0 110.895 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.448 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 2.9 t -66.75 -46.55 56.2 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.412 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 6' ' ' SER . 11.5 Cg_exo -71.36 -17.95 30.3 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.898 2.398 . . . . 0.0 113.85 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -114.46 -63.41 1.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 5' ' ' ASP . 8.0 tptt -65.88 -61.11 2.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.369 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -59.85 -45.69 91.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.401 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.57 -40.51 87.57 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CE2' HG12 ' A' ' 23' ' ' ILE . 10.6 t80 -54.69 -45.64 73.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.297 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -36.38 81.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.14 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.547 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 6.0 mt -62.14 -33.23 74.1 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.382 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -93.29 34.12 1.17 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.51 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.51 96.23 8.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -42.4 99.48 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.048 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -87.39 -37.26 17.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.42 33.11 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.712 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.1 p -117.38 -11.42 10.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 122.17 2.94 9.92 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.353 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 2.6 mtt-85 -117.08 163.14 16.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 117.241 0.52 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.801 HD12 HD13 ' A' ' 28' ' ' ILE . 5.2 pt -144.98 131.21 9.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.668 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 27' ' ' SER . 89.1 Cg_endo -84.61 169.74 10.62 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.066 2.511 . . . . 0.0 112.412 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.43 -37.9 5.55 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -60.78 -44.07 97.25 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.538 0.209 . . . . 0.0 110.935 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 7.5 t -67.99 -51.07 51.46 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.801 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.17 -37.33 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.91 -70.58 0.9 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.668 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -26.14 68.54 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -64.71 -48.31 75.13 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -29.62 70.2 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.232 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -41.52 68.02 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.704 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.02 69.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.711 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.88 39.38 1.87 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.809 0.338 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.2 -102.3 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.748 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.05 -176.43 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 111.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -118.68 114.75 35.69 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.823 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.78 -162.54 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.796 2.331 . . . . 0.0 112.406 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 p -102.97 162.16 13.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -55.06 -32.9 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.13 79.97 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.696 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.37 -54.43 20.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -60.21 -47.78 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.895 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.2 m -59.21 -38.86 80.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.415 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -59.69 -38.07 80.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.516 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 44' ' ' ILE . 19.2 mt -65.36 -50.16 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.99 -24.23 51.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.048 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 p -64.65 -7.34 10.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 p -117.75 -43.6 2.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.652 0.206 . . . . 0.0 111.269 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.579 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -93.37 158.92 36.2 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 59' ' ' GLN . 99.0 Cg_exo -42.82 151.71 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.151 2.568 . . . . 0.0 113.12 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.64 -64.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.61 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.1 mt-10 -87.5 124.4 33.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.516 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 59' ' ' GLN . 48.3 t -86.61 88.92 2.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.4 p30 -82.21 177.2 8.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.405 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -41.38 -45.47 3.08 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.662 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -66.9 -51.38 56.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.043 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.53 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.71 -51.44 68.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -49.83 74.02 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.498 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -63.63 -47.98 79.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.115 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.47 -39.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.164 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -41.59 86.05 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.669 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -109.6 45.47 1.08 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.894 0.378 . . . . 0.0 110.848 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 2.4 ttm180 -60.05 -53.01 69.31 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.229 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 66.0 Cg_endo -87.17 19.54 1.36 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.691 2.261 . . . . 0.0 113.314 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.64 81.98 0.15 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 111.321 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.7 -171.07 28.34 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.103 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.21 167.1 15.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.094 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.16 64.54 1.79 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.745 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.564 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 22.2 tpp 174.46 -52.44 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.987 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 85.2 Cg_exo -42.28 -53.99 3.32 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.019 2.479 . . . . 0.0 113.379 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.72 60.04 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.678 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-20 -79.77 167.61 32.55 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 122.123 0.169 . . . . 0.0 110.622 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 80' ' ' VAL . 57.1 Cg_exo -51.71 -38.17 65.99 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.655 2.237 . . . . 0.0 112.297 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.29 -33.72 76.12 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.268 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.88 -47.19 63.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.262 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -41.3 98.68 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.134 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 76' ' ' PRO . 98.9 t -64.72 -48.4 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.826 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -31.05 70.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.849 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.17 -55.79 9.91 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.446 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -43.62 98.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.344 0.116 . . . . 0.0 110.7 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -79.01 69.15 5.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.052 0.453 . . . . 0.0 110.683 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.14 -45.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.04 19.69 7.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.45 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -141.7 80.49 1.73 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -55.48 33.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.75 -35.51 9.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . . . 62.18 65.77 0.86 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -69.12 -38.0 78.63 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.73 64.78 0.06 OUTLIER Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.031 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.63 129.82 0.43 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.507 0.194 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -103.76 -45.88 9.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.356 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 94' ' ' ILE . . . 57.1 80.26 0.08 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.469 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.781 ' HA ' HD23 ' A' ' 99' ' ' LEU . 77.8 t -44.08 -36.62 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.38 -39.89 14.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.764 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.2 mm-40 -80.92 -45.01 17.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.444 0.164 . . . . 0.0 110.809 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.781 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.16 -40.54 90.26 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.957 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 104' ' ' THR . 0.7 OUTLIER -72.49 -41.27 66.15 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.612 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -52.33 -39.52 60.76 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.693 0.282 . . . . 0.0 111.034 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.849 HG11 ' HA2' ' A' ' 82' ' ' GLY . 30.6 t -73.21 -49.61 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.629 HD12 HD12 ' A' ' 99' ' ' LEU . 2.9 mt -64.48 -44.3 91.45 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.007 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 111' ' ' SER . 54.7 p -57.85 -40.86 81.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.507 0.194 . . . . 0.0 111.229 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.0 t -78.33 -12.21 59.99 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -61.34 1.91 Allowed 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 111.281 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 57.81 0.12 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.368 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.35 39.61 18.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 111.022 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 49.3 mmtt -68.68 -137.93 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.036 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD22 ' HG2' ' A' ' 114' ' ' GLU . 19.7 mt -68.49 79.63 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.667 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.757 ' HA ' HG22 ' A' ' 104' ' ' THR . 80.3 p -65.1 -170.21 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.069 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 115' ' ' MET . 78.3 m-20 -53.44 -36.87 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.07 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -60.02 -51.23 70.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.67 ' HG2' HD22 ' A' ' 110' ' ' LEU . 5.3 tp10 -57.34 -53.65 55.71 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.85 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.88 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.44 -25.85 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.419 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -47.85 83.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.97 -43.16 75.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.795 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.27 -42.68 95.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 127' ' ' GLY . 1.3 mt -72.17 -30.71 65.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -61.16 -41.21 96.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.804 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.19 20.46 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.917 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 129' ' ' VAL . 16.4 t -84.75 117.97 69.96 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.739 0.269 . . . . 0.0 111.019 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.85 63.95 6.74 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.628 2.219 . . . . 0.0 112.461 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.467 HG13 HG12 ' A' ' 122' ' ' VAL . 31.6 m -131.16 -176.43 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.142 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.77 132.49 56.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.323 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 67.04 14.77 9.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.366 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 63.3 49.89 67.02 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.075 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.4 ttp -103.47 120.21 40.4 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.515 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 129' ' ' VAL . 24.1 t -142.31 24.02 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.663 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 60.84 24.9 14.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.495 0.188 . . . . 0.0 111.405 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.448 ' CD1' HG13 ' A' ' 94' ' ' ILE . 2.1 t80 46.14 42.21 9.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.775 0.322 . . . . 0.0 111.377 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -115.49 -51.37 2.69 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.639 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.518 ' CB ' HG11 ' A' ' 129' ' ' VAL . 29.4 t70 -57.39 -38.24 73.94 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.79 -56.68 7.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.766 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 139' ' ' LEU . 20.0 t -62.65 -34.66 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.308 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -64.26 -53.9 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.777 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ttp -62.65 -34.47 77.14 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.063 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 139' ' ' LEU . 3.3 mt -69.7 -39.25 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.005 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.64 HD12 HG22 ' A' ' 138' ' ' ILE . 2.5 mp -93.03 50.94 1.6 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 110.675 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -153.81 32.9 0.44 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.3 p30 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.193 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.776 0.322 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m -114.68 19.06 16.29 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.792 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.17 -36.91 17.76 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.487 -0.133 . . . . 0.0 111.173 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 8.8 m-20 59.33 84.36 0.11 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.916 0.388 . . . . 0.0 111.033 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.457 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 4.0 t -67.03 -48.35 50.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.294 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 83.9 Cg_endo -83.46 -3.42 10.75 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.525 2.15 . . . . 0.0 114.294 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 77.6 m-85 -118.26 -66.69 1.05 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 4.9 ttmm -72.72 -57.8 3.83 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.424 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.535 ' OE1' HD21 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -57.75 -49.19 77.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.688 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -60.49 -40.31 90.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' CE2' HG12 ' A' ' 23' ' ' ILE . 9.5 t80 -56.5 -42.97 79.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.479 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.85 -36.11 82.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.045 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.535 HD21 ' OE1' ' A' ' 10' ' ' GLN . 9.6 mt -60.71 -33.14 72.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.302 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 32.58 2.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HA ' HG22 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -93.19 91.55 7.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.568 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -63.38 -33.15 74.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.459 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -86.52 -35.58 19.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.133 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.29 32.32 52.24 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.774 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.9 p -118.73 -19.02 8.82 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.66 -8.04 5.54 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.086 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.656 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -121.57 162.86 19.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.065 0.432 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.785 HD12 HD13 ' A' ' 28' ' ' ILE . 5.8 pt -135.79 134.92 20.99 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.755 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.87 169.42 9.08 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.08 2.52 . . . . 0.0 112.612 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 44' ' ' ILE . 16.0 pttm -43.85 -38.52 3.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.9 p -60.13 -44.31 95.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.498 0.189 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.432 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 49.3 m -70.43 -46.74 63.32 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.875 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.785 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.79 -35.05 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.04 3.13 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.286 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 121.961 0.105 . . . . 0.0 111.108 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.32 -46.01 88.63 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.49 -31.61 70.64 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -51.42 -38.67 54.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.178 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 33' ' ' ARG . . . -53.36 -44.55 68.64 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.65 -47.05 82.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.681 0.277 . . . . 0.0 110.774 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.85 -66.11 0.03 OUTLIER Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.094 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.99 173.36 11.28 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.862 0.363 . . . . 0.0 111.282 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -125.81 133.83 25.29 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.591 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -81.5 -163.17 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.849 2.366 . . . . 0.0 112.764 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 p -103.08 164.46 11.6 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 1.9 mm? -52.07 -37.71 54.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.974 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.46 86.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -53.93 29.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.299 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.811 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.03 -46.56 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.3 m -56.9 -39.97 75.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.5 -40.85 83.99 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 44' ' ' ILE . 21.6 mt -59.89 -52.08 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -56.74 -25.02 53.84 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.699 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -10.42 22.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 p -118.1 -50.37 2.47 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.59 0.177 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.3 156.85 56.79 Favored Pre-proline 0 N--CA 1.464 0.263 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.536 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 78.2 Cg_exo -39.78 145.01 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.216 2.611 . . . . 0.0 113.199 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.18 -61.27 0.16 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.658 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -89.79 125.31 35.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.671 179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.0 t -87.19 90.14 3.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.656 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.5 p30 -86.59 -179.73 6.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.601 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.16 -46.5 3.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.817 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -67.77 -52.16 40.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.058 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.536 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -57.82 -50.75 72.23 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -48.91 79.68 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.912 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.59 -34.36 75.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.338 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -60.06 -48.05 83.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.308 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.465 ' CG1' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.72 -42.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.386 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.04 -54.59 45.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.407 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -84.62 62.55 7.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -57.7 -52.12 76.69 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.409 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 79.9 Cg_endo -84.89 19.1 1.45 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.638 2.225 . . . . 0.0 113.614 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 57.82 94.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.775 0.321 . . . . 0.0 111.795 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.96 17.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.112 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -100.54 -56.91 2.23 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -86.63 74.88 9.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.658 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 9.0 tpt -170.51 -56.17 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.398 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.658 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 84.2 Cg_exo -43.19 -49.33 7.32 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.553 2.169 . . . . 0.0 112.743 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.33 47.67 0.03 OUTLIER Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.186 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.501 ' HB3' ' CB ' ' A' ' 78' ' ' GLU . 40.2 m-20 -81.8 111.36 25.69 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.748 0.274 . . . . 0.0 110.832 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.46 ' O ' HG23 ' A' ' 80' ' ' VAL . 5.9 Cg_exo -77.74 -58.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.865 2.377 . . . . 0.0 112.472 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.74 -30.19 65.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.501 ' CB ' ' HB3' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -69.76 -48.08 60.63 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.359 0.123 . . . . 0.0 111.114 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -63.5 -39.62 94.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.984 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 76' ' ' PRO . 53.2 t -63.14 -49.03 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.139 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -26.51 68.08 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.684 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -69.82 -53.67 14.78 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.27 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.92 -47.18 47.94 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.31 71.4 5.85 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 86' ' ' PHE . 11.8 p -133.29 -45.76 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.462 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.418 ' HB2' ' HG3' ' A' ' 98' ' ' GLU . 4.4 m-85 -144.74 58.07 1.3 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 111.036 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -116.42 66.89 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.543 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.27 -36.18 79.34 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.84 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.79 -70.13 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.36 154.73 0.07 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.997 0.427 . . . . 0.0 112.018 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.5 m 59.8 80.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.261 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.84 -0.25 11.97 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.437 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -163.97 138.97 6.0 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 117.184 0.492 . . . . 0.0 110.629 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.541 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.36 -39.86 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.442 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.44 81.41 0.15 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.323 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.767 HG21 HD21 ' A' ' 118' ' ' LEU . 79.5 t -43.73 -36.49 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.97 -38.65 17.54 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.602 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -77.45 -46.47 22.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.24 0.216 . . . . 0.0 110.968 179.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -60.81 -42.16 97.08 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.464 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 104' ' ' THR . 0.2 OUTLIER -72.18 -36.39 69.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.093 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -59.31 -37.53 77.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.595 0.236 . . . . 0.0 111.078 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.684 HG11 ' HA2' ' A' ' 82' ' ' GLY . 29.6 t -77.56 -42.07 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.302 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 1.5 mt -72.42 -33.39 67.09 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 100' ' ' ARG . 15.1 p -59.47 -35.02 73.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.6 p -70.45 -18.04 63.0 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.14 -62.32 1.49 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.756 0.313 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.84 49.51 0.18 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.169 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.49 49.85 3.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 110.624 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 8.8 mmtp -68.55 -137.89 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.368 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.759 HD22 ' HG2' ' A' ' 114' ' ' GLU . 12.2 mt -69.96 77.5 0.48 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.888 0.375 . . . . 0.0 110.549 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.5 p -74.93 -165.66 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.873 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 115' ' ' MET . 15.1 m120 -51.4 -40.06 58.48 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.21 -52.93 61.8 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.52 0.2 . . . . 0.0 111.523 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.759 ' HG2' HD22 ' A' ' 110' ' ' LEU . 1.6 tp10 -57.23 -51.35 69.71 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.916 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.902 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.2 ptt? -67.14 -26.88 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.442 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -48.12 82.15 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.58 -43.56 84.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.902 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.56 -40.99 93.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.556 HD21 ' N ' ' A' ' 127' ' ' GLY . 2.4 mt -71.27 -30.13 65.92 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.155 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.41 -40.44 97.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.575 0.226 . . . . 0.0 110.72 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.27 -46.44 26.89 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.847 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.614 HG11 ' CG2' ' A' ' 129' ' ' VAL . 16.9 t -86.15 121.68 72.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.805 0.302 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 62.98 7.29 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.689 2.26 . . . . 0.0 112.546 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 122' ' ' VAL . 30.4 m -131.42 -177.35 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -119.21 126.22 51.01 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.45 -2.96 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.087 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 82.77 49.57 5.04 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.768 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.6 OUTLIER -103.99 113.64 27.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.233 0.54 . . . . 0.0 110.674 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 129' ' ' VAL . 35.8 t -142.91 30.35 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.063 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.53 23.16 11.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.781 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.443 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 1.4 t80 47.62 48.18 17.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.9 0.381 . . . . 0.0 111.438 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -121.93 -54.69 1.92 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.309 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.646 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -59.04 -36.46 75.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.6 m-85 -67.9 -54.95 14.85 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.426 ' HA ' ' HB ' ' A' ' 138' ' ' ILE . 17.9 t -62.08 -33.39 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.17 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -58.86 -53.07 62.56 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.719 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttp -71.57 -30.27 65.67 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 135' ' ' VAL . 1.9 mm -59.58 -45.12 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.397 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.17 -79.23 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.63 100.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 111.106 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.935 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.739 0.304 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m 62.06 30.33 17.86 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.474 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 59.71 37.33 22.26 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.268 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 65.4 m-20 -119.87 77.16 1.21 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.343 0.592 . . . . 0.0 110.638 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -67.36 -47.47 48.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.096 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 97.5 Cg_endo -87.21 7.96 4.55 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.63 2.22 . . . . 0.0 114.37 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 70.6 m-85 -129.2 -67.96 0.75 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.679 0.218 . . . . 0.0 111.584 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.21 -58.43 3.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.974 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -60.6 -48.49 81.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.658 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.513 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.16 -42.98 87.16 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CE2' HG12 ' A' ' 23' ' ' ILE . 30.5 t80 -54.83 -44.13 73.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.683 0.278 . . . . 0.0 110.454 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -62.59 -35.22 78.85 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.525 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.3 mt -63.0 -34.26 77.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 4.6 m-85 -93.93 34.31 1.24 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.633 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.26 117.13 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.861 0.363 . . . . 0.0 111.219 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -71.34 -50.08 36.01 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.609 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -103.44 -38.72 7.06 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.309 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.67 37.15 4.05 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.466 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -116.81 -8.64 11.34 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.77 7.96 14.65 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -130.56 164.1 25.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.173 0.486 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 HD13 ' A' ' 28' ' ' ILE . 6.4 pt -146.48 137.25 12.52 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.693 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -85.62 171.49 8.47 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.129 2.552 . . . . 0.0 112.4 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -44.26 -39.31 4.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 p -60.06 -43.77 95.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.451 0.167 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 13.9 m -69.87 -46.46 65.47 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.697 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.681 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -58.15 -33.68 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.32 -73.0 0.45 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.838 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -64.75 -21.32 66.73 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.439 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -65.78 -49.4 68.47 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.4 mt -61.71 -26.88 68.32 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.225 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -36.79 70.05 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.795 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -29.3 70.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.797 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -109.21 31.06 6.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.57 -103.86 0.25 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.732 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.24 179.46 6.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -119.38 113.19 35.29 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.419 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.19 -162.76 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.835 2.357 . . . . 0.0 112.496 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 p -98.53 163.93 12.47 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 2.1 mm? -56.4 -34.17 66.47 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.09 -36.68 73.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.838 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.37 -58.66 4.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.99 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.608 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -53.62 -47.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 123.098 0.249 . . . . 0.0 111.134 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.6 m -61.84 -44.27 97.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.43 -41.3 80.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.522 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.916 HG23 HG11 ' A' ' 63' ' ' VAL . 12.9 mt -63.65 -48.04 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.936 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.36 -24.57 56.06 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.999 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 p -63.81 -10.27 19.24 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.2 p -117.72 -31.76 5.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -97.18 152.78 38.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 77.9 Cg_exo -38.71 146.53 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.348 2.699 . . . . 0.0 113.055 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.88 -54.91 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -97.53 129.57 44.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.718 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.15 86.08 2.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.044 0.45 . . . . 0.0 110.784 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.3 p30 -83.08 -179.86 7.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.575 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.6 mtm -41.47 -47.55 3.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.847 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -51.68 55.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.995 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.604 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.6 mp0 -57.91 -51.62 68.86 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.099 0.25 . . . . 0.0 111.643 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.74 -49.9 75.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.098 -179.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.68 -35.28 77.55 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.539 0.209 . . . . 0.0 110.972 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -58.18 -53.98 52.12 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.916 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -67.37 -31.08 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.065 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -55.05 -35.92 65.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.034 179.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.0 52.69 2.47 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.472 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.81 -49.94 87.23 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.762 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 66' ' ' ARG . 86.1 Cg_endo -82.88 21.46 1.01 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.438 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.7 t30 58.31 76.45 0.34 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.438 . . . . 0.0 110.994 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.82 19.86 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.669 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -99.93 -36.84 9.26 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.293 0.109 . . . . 0.0 111.293 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.71 84.09 3.08 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.851 0.357 . . . . 0.0 110.25 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.504 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 7.0 tpt 178.01 -51.19 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.726 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 74.1 Cg_exo -41.35 -43.58 5.65 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.039 2.493 . . . . 0.0 113.642 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.21 52.02 0.06 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.071 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.3 m-20 -82.25 169.62 17.68 Favored Pre-proline 0 C--O 1.233 0.216 0 C-N-CA 122.657 0.383 . . . . 0.0 111.425 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.509 ' O ' HG23 ' A' ' 80' ' ' VAL . 45.3 Cg_exo -56.02 -38.61 94.47 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.565 2.176 . . . . 0.0 111.891 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.3 -31.29 72.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.088 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.91 -46.77 77.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 76' ' ' PRO . 67.7 t -62.97 -40.07 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.799 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -44.72 94.92 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.062 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.634 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -62.13 -45.54 95.85 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.149 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.76 -25.69 65.74 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.14 74.5 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 82' ' ' GLY . 33.6 t -127.52 -60.76 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.194 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -105.49 48.99 0.82 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -115.72 64.63 0.69 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -67.58 -47.47 69.65 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.81 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.31 -50.19 2.95 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 54.33 68.66 0.82 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.44 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 m -128.04 62.99 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.747 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.26 46.98 1.77 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.0 ptm -173.09 144.5 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.766 0.283 . . . . 0.0 111.527 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -118.82 -42.92 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.325 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.22 81.32 0.34 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.285 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.813 ' HA ' HD23 ' A' ' 99' ' ' LEU . 46.6 t -44.31 -40.99 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.19 -38.34 18.62 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.617 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.7 mm-40 -81.44 -41.94 21.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.489 0.185 . . . . 0.0 110.513 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.729 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -35.47 65.05 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.662 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.73 -34.33 69.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.634 HG11 ' CA ' ' A' ' 82' ' ' GLY . 40.1 t -82.72 -47.49 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.747 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -70.66 -38.91 73.85 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.1 m -61.06 -31.15 70.8 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -70.18 -17.13 63.15 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.92 -66.02 0.8 Allowed 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.51 0.195 . . . . 0.0 111.086 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.65 52.14 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.803 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 57.85 53.56 6.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.217 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.747 ' HG2' HD22 ' A' ' 103' ' ' LEU . 2.6 tptp -67.64 -137.73 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.079 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.94 77.39 0.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.994 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 96.0 p -67.15 -173.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.43 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 115' ' ' MET . 24.4 t-20 -48.84 -42.47 36.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.039 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.18 -52.28 65.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.98 -51.59 69.03 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.893 ' HA ' HD23 ' A' ' 118' ' ' LEU . 3.4 ptm -66.88 -27.58 67.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.311 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -49.18 78.47 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.62 0.248 . . . . 0.0 110.454 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.26 -42.25 88.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.893 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.92 -41.93 99.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -67.18 -35.48 79.73 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.216 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -38.29 90.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.4 -39.1 36.72 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.046 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 124' ' ' VAL . 48.5 t -85.48 133.12 42.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.854 0.327 . . . . 0.0 111.122 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.08 58.08 6.42 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.789 2.326 . . . . 0.0 112.826 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 128' ' ' MET . 15.2 m -131.66 176.36 9.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 19.23 11.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.788 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -168.21 25.92 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.687 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 56.83 45.97 90.76 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.961 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.606 ' O ' HG11 ' A' ' 124' ' ' VAL . 1.3 ttt -103.5 115.64 30.89 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.197 0.522 . . . . 0.0 110.751 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 129' ' ' VAL . 39.5 t -141.16 22.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.082 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 58.55 24.11 11.59 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.505 ' CD1' HG13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER 56.18 -166.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t60 72.29 -58.89 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.109 0.164 . . . . 0.0 111.084 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -52.89 -39.99 63.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.537 0.208 . . . . 0.0 111.421 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 21.8 m-85 -67.96 -52.39 36.49 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.377 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG12 HD12 ' A' ' 139' ' ' LEU . 17.7 t -62.43 -31.65 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.64 -53.37 58.24 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.53 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.8 ttt -69.11 -26.95 65.17 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.2 mm -63.86 -49.47 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.527 HD12 HG12 ' A' ' 135' ' ' VAL . 0.9 OUTLIER -85.21 -74.89 0.38 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.2 108.18 0.05 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.095 -179.34 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.817 0.342 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m 57.56 41.26 26.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -112.17 -46.65 3.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.208 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.02 101.44 1.4 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.445 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 4.7 t -66.95 -45.63 53.56 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 6' ' ' SER . 2.8 Cg_exo -75.62 -13.39 20.18 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.774 2.316 . . . . 0.0 113.852 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -118.87 -61.68 1.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.58 -59.89 2.81 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.247 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.415 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 28.6 tp60 -60.54 -48.21 82.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.45 -38.16 73.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.355 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CE2' HG12 ' A' ' 23' ' ' ILE . 14.7 t80 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.42 179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -62.22 -30.69 71.27 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.733 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 10.1 mt -62.83 -39.63 94.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.59 ' O ' HG22 ' A' ' 23' ' ' ILE . 52.6 m-85 -95.69 33.39 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 103.28 15.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.92 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -71.2 -35.23 71.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -86.51 -38.67 17.01 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.04 -8.3 63.01 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.252 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -86.76 -32.12 20.56 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.991 0.396 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.9 40.68 0.18 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.414 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.85 157.77 41.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.315 0.246 . . . . 0.0 110.732 -179.766 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.8 HD12 HD13 ' A' ' 28' ' ' ILE . 4.1 pt -150.51 129.41 6.22 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.09 172.53 8.52 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.058 2.505 . . . . 0.0 112.148 179.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -44.98 -37.96 4.39 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.8 p -60.91 -43.6 98.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.486 0.184 . . . . 0.0 111.067 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 38.6 m -70.07 -48.82 56.2 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.609 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.8 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.29 -33.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.47 -69.47 1.26 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.389 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -30.99 72.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.346 0.117 . . . . 0.0 111.275 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.32 -51.3 69.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.717 0.294 . . . . 0.0 110.325 179.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.68 -32.29 72.47 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.17 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.55 -35.98 63.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.128 179.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.36 75.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.631 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.2 t -66.83 -44.33 81.4 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.683 0.277 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.99 -69.46 0.03 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.5 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 166.13 22.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.982 0.42 . . . . 0.0 111.509 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.95 121.92 23.1 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.432 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.94 -161.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.726 2.284 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -90.34 166.17 13.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.235 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -56.68 -29.3 62.2 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.223 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.69 93.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.711 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -53.53 51.0 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.994 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.635 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.96 -44.82 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -61.4 -39.98 92.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.194 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -57.79 -38.92 76.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 178.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 44' ' ' ILE . 21.0 mt -63.73 -46.75 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.994 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -57.01 -27.2 61.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.464 178.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -5.54 6.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 p -118.6 -33.96 4.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.899 0.318 . . . . 0.0 111.436 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.763 HD11 HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -105.03 161.5 22.56 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.487 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD2' ' HG2' ' A' ' 59' ' ' GLN . 75.4 Cg_exo -46.11 162.05 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.131 2.554 . . . . 0.0 113.083 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -43.35 -67.62 0.26 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -83.23 119.75 24.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.614 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.89 96.12 4.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.101 0.476 . . . . 0.0 110.945 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.4 ' HB3' ' HD3' ' A' ' 22' ' ' ARG . 22.9 p30 -82.57 174.35 11.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.677 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.4 mtt -42.52 -43.6 3.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.672 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.48 -50.92 56.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.824 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG2' ' HD2' ' A' ' 52' ' ' PRO . 31.9 mt-30 -57.14 -51.27 69.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.84 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -49.25 77.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.762 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 mt -61.43 -31.44 71.38 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -63.64 -55.05 26.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.495 0.188 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.763 HG21 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.69 -42.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.955 179.769 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -50.07 67.37 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.115 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.47 50.74 1.25 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -60.53 -58.01 22.38 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.525 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.587 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.7 Cg_endo -86.07 19.45 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.635 2.223 . . . . 0.0 113.637 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.03 87.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.903 0.383 . . . . 0.0 111.529 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.06 -178.33 43.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.817 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -101.3 -60.37 1.54 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.516 0.198 . . . . 0.0 110.773 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -104.09 18.29 22.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.253 179.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 9.2 tpt -87.92 -45.6 0.48 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.57 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 58.1 Cg_exo -52.07 -41.94 61.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.819 2.346 . . . . 0.0 113.083 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.17 111.8 3.35 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.589 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.97 53.57 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 120.509 0.195 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' O ' HG23 ' A' ' 80' ' ' VAL . 50.5 Cg_exo -55.27 -37.26 94.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.584 2.19 . . . . 0.0 112.305 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.3 -27.8 64.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.09 -48.85 55.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.452 0.168 . . . . 0.0 111.288 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -39.73 94.25 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.059 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 76' ' ' PRO . 59.3 t -64.68 -46.36 92.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -62.35 -40.03 95.08 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.779 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -60.67 -45.48 96.3 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.474 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 23.0 m-85 -76.86 -27.48 55.09 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.68 -16.57 63.87 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -45.29 -56.12 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.3 19.32 4.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.597 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -142.17 68.72 1.32 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.262 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.27 -54.39 29.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.27 -63.62 1.32 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.27 82.92 0.06 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.784 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.99 -53.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.15 42.12 1.45 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.001 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.47 ' HG2' ' HB2' ' A' ' 128' ' ' MET . 0.4 OUTLIER -170.71 137.26 1.29 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.749 0.275 . . . . 0.0 111.346 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.558 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -112.21 -43.43 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.451 179.532 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.6 79.58 0.17 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.199 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.999 HG11 HD21 ' A' ' 118' ' ' LEU . 91.1 t -45.07 -35.64 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.34 -43.88 20.25 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.741 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.4 mp0 -74.01 -50.18 21.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.279 0.232 . . . . 0.0 110.802 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.13 -36.33 75.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.103 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 115' ' ' MET . 0.2 OUTLIER -64.12 -50.46 68.18 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.8 179.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -53.05 -42.05 65.39 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.122 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 82' ' ' GLY . 47.2 t -63.06 -52.16 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.282 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 99' ' ' LEU . 4.6 mt -66.12 -40.73 90.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.7 m -58.05 -33.29 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.337 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.1 m -74.47 -17.84 60.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.42 -60.95 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.529 0.204 . . . . 0.0 111.119 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.55 52.73 0.22 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.93 48.69 8.55 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.99 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 5.3 mmtp -68.64 -138.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 114' ' ' GLU . 11.1 mt -68.07 78.56 0.23 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 110.287 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 86.3 p -69.29 -171.11 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.013 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 115' ' ' MET . 18.4 t-20 -48.52 -37.41 17.54 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.265 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -67.23 -55.01 15.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.548 0.213 . . . . 0.0 111.478 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG2' HD23 ' A' ' 110' ' ' LEU . 1.3 mp0 -57.12 -49.11 76.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.768 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -67.08 -27.88 67.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.095 179.095 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -47.03 85.96 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.33 -44.47 83.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.462 179.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.999 HD21 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -59.39 -41.7 90.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.265 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 124' ' ' VAL . 2.2 mt -71.55 -29.83 65.19 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.208 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -41.24 97.83 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.527 0.203 . . . . 0.0 110.598 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.16 -44.35 44.61 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.089 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 124' ' ' VAL . 44.2 t -82.64 131.65 54.32 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.764 0.282 . . . . 0.0 111.174 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.65 61.38 7.48 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.756 2.304 . . . . 0.0 112.666 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.452 HG23 HD23 ' A' ' 119' ' ' LEU . 12.7 m -131.8 177.37 7.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.449 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -126.94 47.3 2.35 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.181 0.515 . . . . 0.0 110.745 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' C ' HD21 ' A' ' 119' ' ' LEU . 5.2 p-10 173.64 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 111.37 51.46 0.58 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.97 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.47 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 0.0 OUTLIER -103.27 116.96 33.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.272 0.558 . . . . 0.0 110.671 -179.651 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 129' ' ' VAL . 25.0 t -142.2 19.64 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.74 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.32 23.42 10.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.544 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER 48.11 47.23 19.31 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 111.599 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 -51.61 2.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.633 ' HB3' HG11 ' A' ' 129' ' ' VAL . 19.7 t70 -60.09 -35.21 74.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.784 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 131' ' ' TYR . 5.7 m-85 -66.04 -58.26 5.9 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.703 0.287 . . . . 0.0 110.35 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.75 -32.59 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.417 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -60.1 -50.53 73.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.491 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.9 ttt -66.9 -31.88 72.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.1 mm -61.31 -39.79 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -84.03 58.69 4.86 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.675 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.87 79.93 0.08 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.907 -179.847 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t 44.33 45.54 7.36 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.748 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 -52.17 2.8 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 7.5 m-20 -110.51 99.04 8.1 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.1 t -66.99 -46.52 53.63 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.957 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 6' ' ' SER . 83.2 Cg_endo -82.97 -3.88 11.17 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.411 2.074 . . . . 0.0 114.045 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 46.4 m-85 -120.83 -62.51 1.44 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.7 -59.44 2.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.072 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -60.59 -47.24 87.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.5 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.19 -40.66 82.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.493 ' CE2' HG12 ' A' ' 23' ' ' ILE . 17.4 t80 -57.08 -44.37 83.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.604 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -62.06 -33.84 75.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.248 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 11.2 mt -60.84 -30.99 70.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.369 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.32 20.37 4.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -101.73 120.31 40.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.188 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -55.74 31.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.498 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -101.94 -24.46 14.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.801 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . 93.82 44.33 3.65 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.451 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -89.46 -26.03 21.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.041 0.136 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.08 10.17 14.43 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.106 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 2.1 mtt180 -130.24 160.91 32.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 117.055 0.427 . . . . 0.0 110.551 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.743 HD12 HD13 ' A' ' 28' ' ' ILE . 5.7 pt -146.33 138.51 13.63 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -87.02 171.55 6.7 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.234 2.623 . . . . 0.0 112.482 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.506 ' O ' HG21 ' A' ' 44' ' ' ILE . 10.5 ptpt -42.5 -40.97 2.81 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 p -59.9 -44.62 94.15 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 12.5 m -69.1 -48.0 63.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.586 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.743 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -57.04 -34.24 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.09 -68.72 1.51 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.281 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -30.62 71.63 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.98 -50.88 71.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.641 0.258 . . . . 0.0 110.423 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.47 -30.19 70.45 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.039 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -57.02 -37.81 72.25 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.842 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.51 -29.12 70.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.8 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.2 t -88.28 -42.68 12.09 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.604 0.24 . . . . 0.0 110.55 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.9 -87.38 0.09 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.512 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -132.61 175.74 9.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.952 0.406 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' ARG . 2.5 t-20 -119.37 112.36 35.88 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.122 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.68 -162.84 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.915 2.41 . . . . 0.0 112.856 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 p -95.59 166.52 11.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.82 -37.17 65.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.34 73.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.813 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -55.97 13.1 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.681 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -57.01 -48.57 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.584 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.6 m -56.98 -39.74 75.19 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.66 -41.94 87.28 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.357 179.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 44' ' ' ILE . 19.5 mt -62.54 -49.4 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.74 -25.84 55.81 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.384 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -64.8 -8.21 14.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 p -117.83 -49.02 2.54 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.656 0.207 . . . . 0.0 110.968 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.61 158.2 54.41 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 93.3 Cg_exo -40.93 149.75 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.188 2.592 . . . . 0.0 113.072 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.05 -63.68 0.18 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -89.68 127.68 35.97 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.791 0.329 . . . . 0.0 110.66 179.716 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.82 89.59 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.284 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.07 179.65 7.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.7 mtp -41.41 -46.27 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.39 -52.37 40.65 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -56.96 -50.95 71.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.729 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.23 -48.9 79.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.06 -179.749 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.1 mt -60.82 -39.37 88.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.448 0.166 . . . . 0.0 111.396 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -55.43 -49.2 73.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.483 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.659 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -76.4 -35.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 179.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.427 HD13 ' CE1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -60.66 -38.36 84.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.42 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.5 ' CB ' ' HA2' ' A' ' 69' ' ' GLY . 4.1 m-80 -98.75 43.05 1.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.922 0.391 . . . . 0.0 110.234 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . 2.2 mtp85 -62.39 -65.79 1.93 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.537 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 68.0 Cg_endo -86.58 18.18 1.62 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.44 2.093 . . . . 0.0 114.975 -177.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 9.7 t-20 156.02 -71.95 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.733 0.413 . . . . 0.0 110.527 179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.5 ' HA2' ' CB ' ' A' ' 65' ' ' ASN . . . -177.37 -86.28 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.715 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -115.27 -46.92 2.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 122.107 0.163 . . . . 0.0 111.093 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.23 68.57 9.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.118 0.485 . . . . 0.0 110.87 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.481 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -179.52 -55.47 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.267 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.537 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 85.9 Cg_exo -45.96 -46.49 15.79 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.835 2.357 . . . . 0.0 112.722 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.4 61.29 0.1 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.446 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.84 144.69 56.07 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.345 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 80' ' ' VAL . 25.1 Cg_exo -62.74 -48.7 6.54 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.928 2.419 . . . . 0.0 112.274 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -30.35 71.48 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.191 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -43.67 81.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.42 87.33 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 76' ' ' PRO . 89.6 t -61.38 -47.84 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -31.12 70.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.597 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.721 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -61.81 -47.84 87.72 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.553 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -74.91 -32.78 61.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 0.127 . . . . 0.0 111.052 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.88 73.19 5.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.07 -65.19 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.13 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.508 ' HB2' ' CB ' ' A' ' 98' ' ' GLU . 1.4 m-85 -109.55 34.41 3.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.346 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 49.74 2.29 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.809 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -69.89 -54.81 11.72 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.206 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.88 -47.6 11.66 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.75 66.65 0.97 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -102.04 67.04 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.594 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.27 56.05 11.3 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.529 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -174.93 138.65 0.47 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.714 0.293 . . . . 0.0 111.192 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.59 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -107.23 -41.65 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.005 179.547 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.86 78.95 0.34 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.499 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.796 ' HA ' HD23 ' A' ' 99' ' ' LEU . 70.8 t -44.75 -35.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.53 -41.77 18.57 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.252 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -80.16 -36.71 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.661 0.23 . . . . 0.0 111.549 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -67.25 -40.83 86.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.485 0.183 . . . . 0.0 110.957 179.886 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -38.64 66.39 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.975 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -56.37 -45.85 80.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.67 0.271 . . . . 0.0 110.924 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.721 HG11 ' CA ' ' A' ' 82' ' ' GLY . 47.6 t -65.77 -46.71 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.222 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.715 HD22 ' HG2' ' A' ' 109' ' ' LYS . 3.9 mt -67.1 -37.55 84.13 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.371 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 111' ' ' SER . 85.3 m -67.19 -42.96 83.3 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.485 0.183 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.1 p -68.0 -16.06 63.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mt -67.29 -65.29 0.7 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.709 0.29 . . . . 0.0 110.927 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.5 49.08 0.28 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.121 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 61.16 41.5 13.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.887 0.375 . . . . 0.0 111.093 -179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.715 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -68.9 -137.92 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.987 178.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 42.1 mt -68.56 80.02 0.27 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.414 ' HA ' ' OG1' ' A' ' 104' ' ' THR . 79.7 p -66.38 -170.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 115' ' ' MET . 4.6 p-10 -53.26 -33.7 54.18 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.226 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -48.9 79.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.542 0.21 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.5 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 17.9 mm-40 -59.14 -53.41 58.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.854 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -66.76 -26.44 66.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.258 179.365 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -47.11 86.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.722 0.296 . . . . 0.0 110.239 179.125 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.0 -43.77 82.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -59.0 -42.18 89.47 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.695 179.432 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.636 HD21 ' H ' ' A' ' 127' ' ' GLY . 1.2 mt -67.89 -33.48 74.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -39.78 91.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.0 -48.28 21.04 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.004 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 129' ' ' VAL . 18.8 t -83.89 125.09 73.89 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.792 0.296 . . . . 0.0 111.286 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.56 63.23 7.91 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.694 2.262 . . . . 0.0 112.549 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.42 HG13 HG12 ' A' ' 122' ' ' VAL . 20.1 m -131.26 179.41 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -119.3 130.28 55.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 70.61 10.69 7.18 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.829 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.636 ' H ' HD21 ' A' ' 119' ' ' LEU . . . 69.62 44.47 63.5 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.702 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.87 114.39 28.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.372 0.606 . . . . 0.0 110.601 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 129' ' ' VAL . 22.1 t -142.58 26.14 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.083 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.0 t30 56.25 21.09 5.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.0 t80 48.97 38.29 12.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -116.88 -38.86 3.35 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.607 ' HB3' HG11 ' A' ' 129' ' ' VAL . 33.0 t70 -66.63 -37.44 84.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 1.7 m-85 -67.94 -54.91 15.08 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.45 -31.7 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -61.95 -50.39 72.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 ttm -63.03 -32.24 73.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.37 -48.22 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.675 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.82 54.41 0.86 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.729 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.38 60.16 1.71 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.689 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.003 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.4 p -99.98 21.25 12.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.509 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -154.79 42.02 0.47 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.819 0.343 . . . . 0.0 111.011 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.4 113.05 4.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 3.0 t -64.72 -46.58 76.23 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.624 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 6' ' ' SER . 84.0 Cg_endo -82.17 -11.64 10.87 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.506 2.138 . . . . 0.0 114.072 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -114.5 -60.41 1.89 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 -179.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.33 -48.49 81.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.596 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -57.14 -40.03 76.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.035 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.486 ' CE2' HG12 ' A' ' 23' ' ' ILE . 19.9 t80 -59.17 -44.51 92.15 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.315 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.4 m -62.5 -31.45 72.21 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.747 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 5.8 mt -65.91 -36.95 84.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -95.34 38.53 1.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 111.196 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -83.27 88.77 6.93 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.226 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -62.85 -37.71 87.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -86.54 -36.32 19.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.108 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.28 27.18 56.03 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.452 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.1 p -129.28 10.4 5.77 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.91 8.63 47.76 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.742 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -129.22 163.16 26.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.355 0.578 . . . . 0.0 110.958 -179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.819 HD12 HD13 ' A' ' 28' ' ' ILE . 6.3 pt -147.24 138.64 13.32 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.918 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -86.58 172.27 6.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.455 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -45.91 -37.63 6.57 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.8 p -60.14 -41.63 93.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.51 0.195 . . . . 0.0 111.138 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.482 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 3.3 m -70.88 -54.73 10.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.372 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.819 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.04 -35.76 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.15 -74.44 0.29 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.535 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -28.56 69.72 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 23' ' ' ILE . 13.5 tp -61.45 -51.95 66.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 mt -60.92 -29.33 69.53 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.261 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.443 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -55.53 -39.9 71.15 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.052 0.22 . . . . 0.0 110.871 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.15 70.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.846 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -90.1 -43.06 10.73 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.681 0.277 . . . . 0.0 110.611 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.08 -88.19 0.1 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.505 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.95 172.79 12.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.962 0.41 . . . . 0.0 112.018 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 1.9 t-20 -122.06 110.23 33.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.21 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -84.19 -162.88 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.905 2.403 . . . . 0.0 112.53 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -92.96 166.52 12.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.019 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -54.71 -33.53 61.13 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.797 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.51 86.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.828 179.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -55.55 16.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -55.96 -45.39 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.103 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 m -62.16 -41.1 97.97 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.61 -38.27 77.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.512 178.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.923 HG23 HG11 ' A' ' 63' ' ' VAL . 14.4 mt -64.9 -49.82 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.16 -25.33 46.15 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.882 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -64.21 -7.15 8.23 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.2 p -117.78 -46.59 2.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.775 0.261 . . . . 0.0 111.204 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -86.55 157.47 55.49 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.094 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 73.2 Cg_exo -39.41 150.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.285 2.657 . . . . 0.0 113.39 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -32.6 -61.34 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.6 130.0 38.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.683 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.37 86.71 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.043 0.449 . . . . 0.0 111.061 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.4 p30 -82.95 -179.56 7.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.672 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.6 mtm -41.41 -46.79 3.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.944 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -68.66 -50.55 50.28 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.8 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 1.4 mp0 -58.0 -51.74 68.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.585 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.71 -48.35 82.01 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.9 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.78 -36.46 79.04 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.285 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -52.61 64.67 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.187 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.923 HG11 HG23 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -72.6 -38.71 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.314 179.847 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.585 HD13 ' HE1' ' A' ' 60' ' ' PHE . 1.2 tp -55.3 -51.98 64.93 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.025 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -84.46 61.68 6.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.313 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.591 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 50.4 ttp180 -58.05 -52.15 76.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.533 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 98.0 Cg_endo -80.53 18.66 1.2 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.495 2.13 . . . . 0.0 113.671 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 58.83 98.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.84 0.353 . . . . 0.0 111.787 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.45 176.97 14.63 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.145 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -100.63 -50.57 3.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.461 0.172 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -88.24 62.1 6.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.27 0.557 . . . . 0.0 110.362 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.429 ' H ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -156.76 -57.85 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.009 -179.678 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 53.4 Cg_exo -51.03 -44.23 43.41 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.78 80.88 0.04 OUTLIER Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.493 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -80.18 122.83 83.34 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.424 0.154 . . . . 0.0 111.131 -179.802 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' HG23 ' A' ' 80' ' ' VAL . 38.4 Cg_exo -59.94 -41.67 51.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.719 2.279 . . . . 0.0 112.118 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -67.14 -27.64 67.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 8.0 tt0 -68.29 -50.85 50.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.638 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.45 95.77 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.597 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 76' ' ' PRO . 72.3 t -62.29 -39.13 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.706 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -39.05 93.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.513 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.758 ' O ' HG21 ' A' ' 102' ' ' VAL . . . -62.81 -47.23 90.61 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.4 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -74.84 -36.79 62.38 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.477 0.18 . . . . 0.0 110.964 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -78.86 72.3 5.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.878 0.371 . . . . 0.0 111.036 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.62 -62.74 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -113.3 23.62 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.498 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.27 73.85 1.56 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.008 0.432 . . . . 0.0 110.863 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -69.34 -43.37 73.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -89.07 -63.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.58 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.421 0.45 . . . . 0.0 111.292 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.0 m 69.28 -74.77 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.772 0.429 . . . . 0.0 111.349 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.03 61.3 0.42 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 ptp -176.23 131.3 0.23 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.667 0.27 . . . . 0.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.583 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -103.84 145.57 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.583 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -109.61 82.79 0.31 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.897 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.825 ' HA ' HD23 ' A' ' 99' ' ' LEU . 59.3 t -37.48 -39.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -48.6 -42.74 27.88 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.623 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 102' ' ' VAL . 2.0 pt-20 -81.24 -37.79 27.98 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.932 -0.157 . . . . 0.0 111.128 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.825 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.55 -39.9 89.64 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.549 0.214 . . . . 0.0 110.549 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -38.84 59.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.687 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.57 -36.2 71.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.623 0.249 . . . . 0.0 111.324 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 82' ' ' GLY . 26.3 t -82.7 -38.9 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.908 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 109' ' ' LYS . 2.1 mt -79.71 -48.98 12.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.4 m -53.57 -38.57 64.04 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.9 p -60.5 -25.56 66.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.95 -83.25 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -133.13 46.14 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.715 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 62.46 50.85 3.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.377 . . . . 0.0 111.157 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 103' ' ' LEU . 9.4 mmtp -67.92 -137.83 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.282 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.3 mt -68.32 76.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.4 p -68.29 -172.72 0.34 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.65 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -51.28 -42.95 61.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -64.34 -48.48 75.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.52 -53.31 59.64 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.622 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.857 ' HA ' HD23 ' A' ' 118' ' ' LEU . 3.3 ppp? -66.78 -27.67 67.78 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.302 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -46.07 87.19 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.628 0.252 . . . . 0.0 110.474 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -69.18 -41.83 76.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.635 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.857 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -62.09 -43.19 99.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.971 179.725 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.55 HD21 ' H ' ' A' ' 127' ' ' GLY . 3.2 mt -70.13 -32.9 71.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.274 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -39.94 95.77 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.015 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.11 -48.74 30.6 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.986 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 124' ' ' VAL . 14.0 t -82.45 125.29 76.69 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.679 0.24 . . . . 0.0 111.142 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.17 58.54 6.99 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.661 2.241 . . . . 0.0 112.401 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 122' ' ' VAL . 22.8 m -131.33 -178.67 2.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.138 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -119.18 135.86 54.47 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.499 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.49 14.66 9.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.811 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.55 ' H ' HD21 ' A' ' 119' ' ' LEU . . . 64.26 55.65 22.44 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.794 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttp -103.54 113.03 26.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.255 0.55 . . . . 0.0 111.099 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 129' ' ' VAL . 45.5 t -142.94 26.53 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.23 21.34 9.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.535 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 132' ' ' HIS . 0.5 OUTLIER 54.34 -166.07 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -178.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 131' ' ' TYR . 12.3 m170 71.34 -57.77 0.6 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.579 0.352 . . . . 0.0 111.24 -179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -52.56 -39.37 61.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.541 0.21 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 19.8 m-85 -68.26 -58.0 5.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.584 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.45 -32.21 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.29 -54.61 41.85 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.691 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 42.8 tpp -66.47 -30.49 70.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.4 mm -63.43 -49.98 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.916 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -104.68 64.47 0.74 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.026 0.441 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -148.65 42.27 0.97 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.16 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.6 p30 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.293 -179.921 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.4 m -74.54 -62.06 1.66 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.822 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -170.53 55.14 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.077 0.465 . . . . 0.0 110.754 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.98 86.01 7.07 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.765 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -66.68 -46.65 56.97 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.767 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 6' ' ' SER . 8.0 Cg_exo -73.41 -21.29 19.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.808 2.339 . . . . 0.0 113.822 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -107.74 -63.52 1.3 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -62.08 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.697 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 5.8 tt0 -56.67 -48.58 77.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.949 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -59.67 -40.43 87.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.569 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.1 t80 -60.12 -44.84 94.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.758 0.313 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -62.43 -31.29 71.97 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.748 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 20.1 mt -56.99 -40.35 76.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 31' ' ' LEU . 8.5 m-30 -97.73 32.28 2.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -61.63 130.0 43.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.957 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -56.61 8.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.778 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -136.3 26.02 3.2 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.412 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.94 27.61 72.96 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.728 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.6 p -95.86 -26.65 15.54 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.454 0.169 . . . . 0.0 111.258 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.34 18.63 8.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.883 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 56' ' ' ASP . 36.9 mtt180 -129.69 160.51 33.15 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.878 0.339 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.86 HD12 HD13 ' A' ' 28' ' ' ILE . 4.1 pt -143.78 137.67 14.53 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.511 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.73 170.62 7.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.148 2.565 . . . . 0.0 113.027 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' CB ' ' HB ' ' A' ' 44' ' ' ILE . 18.7 pttp -43.78 -35.37 1.86 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.1 p -61.36 -46.11 91.57 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.466 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 6.2 t -70.41 -49.47 48.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.621 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.17 -34.94 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.496 -179.678 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.77 -67.7 2.06 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.331 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.22 -28.12 69.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 15' ' ' PHE . 10.4 tp -62.05 -48.6 79.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.9 -32.14 72.5 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.59 -40.29 71.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.816 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.09 -30.48 70.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.472 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 m -107.14 40.03 1.75 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 110.498 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.31 -102.94 0.4 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.545 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 171.23 14.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 111.692 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -119.48 114.88 34.29 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.384 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.02 -162.08 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.896 2.397 . . . . 0.0 112.477 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.9 p -94.74 166.95 11.74 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.7 mm? -56.5 -34.49 67.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.41 75.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.644 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.26 -55.16 17.46 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CG2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -58.08 -49.3 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.828 179.635 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.0 m -55.65 -42.12 74.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.416 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -59.2 -42.86 91.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 44' ' ' ILE . 41.2 mt -61.64 -41.98 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -56.63 -36.07 69.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.786 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 t -65.85 -1.77 3.23 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 51' ' ' LEU . 5.6 m -118.07 -40.32 2.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.228 0.211 . . . . 0.0 110.937 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.637 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -102.89 156.41 35.34 Favored Pre-proline 0 N--CA 1.467 0.386 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.332 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 88.6 Cg_exo -40.45 143.65 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.085 2.523 . . . . 0.0 113.083 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -22.85 -67.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 1.2 tt0 -91.66 129.35 37.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.609 0.242 . . . . 0.0 110.518 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -86.75 88.44 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.015 0.436 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 1.7 p30 -87.01 -179.85 6.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.306 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mtm -41.27 -46.98 3.34 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -53.41 41.46 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -57.18 -52.98 63.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -49.26 78.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.677 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.14 -27.92 69.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.387 0.136 . . . . 0.0 111.264 178.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -65.38 -43.19 91.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.965 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.637 HG13 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -80.12 -38.91 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.995 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -36.26 77.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.488 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -118.03 37.43 3.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.87 0.367 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.456 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -60.18 -52.59 72.2 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.618 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 81.4 Cg_endo -85.15 19.41 1.4 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.647 2.231 . . . . 0.0 113.483 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 t30 54.73 80.26 0.13 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.879 0.371 . . . . 0.0 111.589 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.38 -169.66 25.0 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.993 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -116.93 168.67 10.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.554 0.216 . . . . 0.0 110.724 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 57.24 66.61 1.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.522 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 5.1 ttm 172.13 -50.71 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.277 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 90.3 Cg_exo -42.75 -55.21 2.82 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 123.123 2.549 . . . . 0.0 113.283 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.0 52.25 0.49 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.636 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -81.1 146.36 58.58 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.467 -179.779 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 80' ' ' VAL . 34.9 Cg_exo -59.92 -44.75 28.21 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.783 2.322 . . . . 0.0 112.105 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HG3' ' HE2' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -66.55 -26.7 67.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.362 179.467 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -48.24 65.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -37.9 79.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.036 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 76' ' ' PRO . 75.9 t -63.31 -49.77 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.009 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.414 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -63.64 -31.46 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.854 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -65.14 -51.64 48.49 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.643 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -76.59 -36.26 57.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.403 0.144 . . . . 0.0 110.934 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -78.68 73.44 5.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.969 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.43 -61.23 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.29 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.55 43.64 1.6 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.525 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 90' ' ' ALA . 3.8 m-20 -130.79 75.63 1.67 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -51.67 67.69 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.022 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.05 -49.9 3.64 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.265 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . . . 58.13 53.97 6.24 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.6 p -74.79 -48.09 27.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.178 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.73 58.67 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.665 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 ptm -166.95 147.97 5.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER -125.92 143.35 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.819 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.508 ' H ' HD13 ' A' ' 94' ' ' ILE . . . -107.08 81.48 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.052 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.805 ' HA ' HD23 ' A' ' 99' ' ' LEU . 72.6 t -43.3 -38.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.25 -48.2 54.06 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.744 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.4 mm-40 -77.03 -40.68 45.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.253 0.221 . . . . 0.0 110.657 178.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -59.25 -40.59 86.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.552 179.517 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -66.51 -49.35 66.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.518 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -52.13 -37.97 55.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.712 HG11 ' CA ' ' A' ' 82' ' ' GLY . 41.5 t -74.04 -49.26 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.804 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.748 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.8 mt -69.13 -28.3 66.33 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.0 m -64.3 -38.4 90.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.312 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.4 p -70.82 -12.98 61.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.1 -66.14 0.68 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.626 0.25 . . . . 0.0 110.567 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.14 49.05 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.333 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.31 50.52 6.11 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 111.453 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.748 ' HG2' HD22 ' A' ' 103' ' ' LEU . 26.5 tptt -68.53 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.428 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.502 HD23 ' HG2' ' A' ' 114' ' ' GLU . 6.9 mt -71.21 76.96 0.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.5 p -62.43 -176.26 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.106 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -52.32 -35.98 52.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.99 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -51.02 63.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.424 0.154 . . . . 0.0 111.297 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.502 ' HG2' HD23 ' A' ' 110' ' ' LEU . 2.1 tp10 -58.92 -50.01 75.64 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.906 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.873 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -66.6 -27.43 67.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.905 179.03 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -48.55 80.64 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.603 0.239 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.66 -42.05 87.23 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 179.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.1 -42.37 98.39 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.833 179.457 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.596 HD21 ' H ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.45 -33.07 70.88 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.03 179.616 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -39.99 92.17 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.45 -46.94 30.52 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.937 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.457 HG11 HG22 ' A' ' 129' ' ' VAL . 14.4 t -87.09 117.87 69.22 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.658 0.229 . . . . 0.0 111.036 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.7 64.66 5.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.463 2.109 . . . . 0.0 112.477 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.3 -178.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -118.92 135.65 54.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.638 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.64 17.62 11.0 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.623 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 61.49 64.05 4.33 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.988 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 1.6 ttt -111.38 116.78 31.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.241 0.543 . . . . 0.0 111.058 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.732 HG11 ' HB2' ' A' ' 133' ' ' ASP . 39.5 t -142.23 26.28 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.045 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.8 26.3 15.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.5 t80 46.69 45.45 14.53 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.768 0.318 . . . . 0.0 111.616 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -119.56 -56.03 2.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.352 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.732 ' HB2' HG11 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -60.51 -34.34 73.94 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.471 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 129' ' ' VAL . 4.5 m-85 -67.69 -55.4 13.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.271 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.431 HG12 HD13 ' A' ' 139' ' ' LEU . 21.2 t -62.9 -33.95 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.55 -51.85 68.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.668 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 ttp -66.05 -33.77 76.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.4 mt -65.62 -30.13 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.248 179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.431 HD13 HG12 ' A' ' 135' ' ' VAL . 1.1 mp -99.14 -3.21 35.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.19 89.49 3.12 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.035 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.644 0.259 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 t -127.03 32.9 5.01 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.322 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -124.6 -72.88 0.65 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.462 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 54.51 81.41 0.1 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 111.18 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -64.3 -47.87 77.2 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.081 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 6' ' ' SER . 96.9 Cg_endo -80.41 -13.93 12.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.403 2.069 . . . . 0.0 114.114 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -106.65 -65.87 1.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.638 ' HE3' HD11 ' A' ' 61' ' ' LEU . 8.7 mmtp -73.12 -58.87 3.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.501 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 2.4 tt0 -56.8 -49.9 73.98 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.472 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.55 -41.46 85.62 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 23' ' ' ILE . 16.4 t80 -53.57 -45.21 69.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.704 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.39 -36.69 83.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.141 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 4.8 mt -62.86 -27.41 69.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.392 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 31' ' ' LEU . 3.5 m-85 -94.23 18.93 10.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.86 99.26 11.66 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -61.1 -35.34 76.76 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.741 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.24 -29.13 23.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.27 42.86 41.03 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.446 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 p -117.87 -36.28 3.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.24 -11.12 2.78 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.587 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -118.1 147.73 43.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.272 0.536 . . . . 0.0 110.626 -179.831 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.912 HD12 HD13 ' A' ' 28' ' ' ILE . 4.2 pt -127.55 140.88 39.26 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.848 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -90.28 173.25 3.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.257 2.638 . . . . 0.0 112.432 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -43.76 -36.69 2.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.5 p -59.6 -46.06 90.06 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.495 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 2.5 t -71.33 -49.64 40.52 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.912 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -51.41 -36.18 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.17 -73.1 0.44 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.67 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -65.12 -21.35 66.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.3 tp -65.93 -48.38 71.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -61.18 -30.55 70.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.841 179.124 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.444 ' CB ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -55.47 -40.73 72.01 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.679 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.87 75.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.49 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.8 m -112.63 43.55 1.63 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 110.669 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.83 -105.39 0.4 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.808 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.37 169.98 15.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.022 0.439 . . . . 0.0 111.953 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB2' ' CB ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -119.11 112.48 36.17 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.157 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -84.74 -162.62 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.036 2.49 . . . . 0.0 112.737 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 p -97.68 165.33 12.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.499 HD12 ' HE2' ' A' ' 25' ' ' LYS . 1.4 mm? -54.88 -36.62 65.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.21 78.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.539 0.209 . . . . 0.0 110.453 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -51.48 58.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -61.1 -46.18 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.82 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 29.6 m -54.88 -41.52 70.96 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.144 0.278 . . . . 0.0 110.633 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -60.2 -41.98 94.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.63 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.784 HG23 HG11 ' A' ' 63' ' ' VAL . 21.1 mt -61.67 -49.53 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -57.46 -26.4 61.17 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.859 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -63.78 -10.08 18.02 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 p -117.91 -35.56 3.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.722 0.237 . . . . 0.0 111.526 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.583 HD21 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -94.25 151.18 39.33 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.461 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.581 ' HD2' ' HG3' ' A' ' 59' ' ' GLN . 59.7 Cg_exo -36.97 141.89 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.337 2.691 . . . . 0.0 113.089 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -24.76 -61.31 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -93.63 129.52 39.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.51 86.94 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.102 0.477 . . . . 0.0 110.903 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.03 -179.08 6.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.609 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.5 mtp -41.43 -47.16 3.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.988 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.05 -53.0 35.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.958 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.581 ' HG3' ' HD2' ' A' ' 52' ' ' PRO . 2.8 mp0 -57.49 -51.97 67.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.604 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' HE1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.1 -45.91 91.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.638 HD11 ' HE3' ' A' ' 9' ' ' LYS . 13.9 mt -60.73 -39.24 87.87 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -52.14 65.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.802 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.784 HG11 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -73.65 -29.12 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.24 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.471 HD13 ' HE1' ' A' ' 60' ' ' PHE . 10.2 tp -60.46 -49.03 79.19 Favored 'General case' 0 C--O 1.227 -0.112 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.942 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.58 44.55 1.06 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -56.07 37.79 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.18 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 86.5 Cg_endo -83.73 18.73 1.47 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.624 2.216 . . . . 0.0 113.264 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.2 m120 59.07 98.31 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA2' HD11 ' A' ' 139' ' ' LEU . . . 114.7 176.34 18.82 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.427 179.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.06 174.15 6.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.187 0.195 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t70 50.9 62.26 2.8 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.389 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.553 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.57 -51.6 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.079 -179.114 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 37.4 Cg_exo -60.07 -44.39 29.81 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.659 2.239 . . . . 0.0 112.748 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -49.51 -78.49 0.09 OUTLIER Glycine 0 C--N 1.339 0.726 0 O-C-N 123.398 0.436 . . . . 0.0 112.962 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.581 ' HB3' ' CB ' ' A' ' 78' ' ' GLU . 19.6 m-20 -81.82 111.45 26.54 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 80' ' ' VAL . 3.9 Cg_exo -74.44 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.779 2.319 . . . . 0.0 112.786 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -71.94 -23.83 61.52 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' CB ' ' HB3' ' A' ' 75' ' ' ASP . 9.6 tt0 -69.22 -51.56 36.49 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.545 0.212 . . . . 0.0 110.913 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -65.78 -39.36 90.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.042 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 76' ' ' PRO . 54.3 t -63.96 -45.61 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.4 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.96 94.34 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.881 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -64.11 -46.08 92.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.759 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -75.61 -36.09 60.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.381 0.134 . . . . 0.0 111.164 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.81 72.5 5.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.1 t -140.62 -57.4 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.429 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.38 33.11 4.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.75 65.8 1.39 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -31.85 73.18 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.334 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 3.3 t70 -82.12 -62.04 1.74 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.377 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 72.96 -64.15 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.497 0.498 . . . . 0.0 111.799 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.1 p -66.67 95.19 0.33 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.8 -26.87 4.46 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.182 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.3 ptp -157.73 138.8 13.37 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.841 0.321 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -115.32 -40.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.027 -179.608 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 58.69 80.22 0.09 OUTLIER Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.547 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.772 HG21 HD21 ' A' ' 118' ' ' LEU . 61.1 t -44.6 -34.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -47.93 -46.95 25.99 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.989 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 102' ' ' VAL . 1.6 mt-10 -75.3 -47.66 26.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.555 0.217 . . . . 0.0 110.991 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -58.48 -38.38 77.48 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.249 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -67.06 -46.96 72.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -53.42 -40.9 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.868 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.881 HG11 ' HA2' ' A' ' 82' ' ' GLY . 4.0 t -77.21 -54.35 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.739 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.8 mt -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.6 m -60.5 -38.88 85.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.554 0.216 . . . . 0.0 111.036 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.4 m -71.18 -15.19 62.46 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.69 -59.5 2.76 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -158.36 43.56 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.463 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.87 52.37 10.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 111.29 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.739 ' HG2' HD22 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -68.41 -138.57 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.05 179.134 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.44 77.63 0.27 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.986 0.357 . . . . 0.0 110.334 179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.1 p -65.79 -172.34 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.411 -178.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -50.75 -39.49 52.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.079 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.37 -49.76 70.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.492 0.187 . . . . 0.0 111.354 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.59 -52.84 63.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.605 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.931 ' HA ' HD23 ' A' ' 118' ' ' LEU . 2.9 ppp? -67.29 -26.24 66.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.405 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.53 -49.31 77.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.352 179.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.79 -43.17 84.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -61.21 -40.17 92.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.987 179.684 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.69 -33.2 70.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.44 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -63.78 -38.46 91.19 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.749 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.87 -44.97 9.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.728 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 124' ' ' VAL . 48.2 t -79.42 130.46 68.43 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.516 0.198 . . . . 0.0 111.175 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.02 62.85 8.09 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 122' ' ' VAL . 13.4 m -131.36 176.69 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.229 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.98 46.78 2.27 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.899 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.94 -35.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.702 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.726 ' O ' HG23 ' A' ' 96' ' ' VAL . . . 111.11 46.09 0.83 Allowed Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.97 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.46 119.19 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.179 0.514 . . . . 0.0 111.179 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 129' ' ' VAL . 38.7 t -142.5 32.01 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.804 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.718 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 134' ' ' PHE . 2.7 t80 44.66 46.8 8.58 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.809 0.337 . . . . 0.0 111.532 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 -55.07 1.97 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.5 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 129' ' ' VAL . 8.6 t70 -60.09 -33.01 71.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.699 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 131' ' ' TYR . 6.5 m-85 -68.15 -56.31 9.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.371 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.43 -33.17 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.507 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.29 -51.25 69.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.299 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 32.5 ttp -74.86 -31.66 61.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.603 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 139' ' ' LEU . 1.1 mt -60.86 -39.94 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.614 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.592 HD11 ' HA2' ' A' ' 69' ' ' GLY . 3.3 mp -88.18 63.67 7.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -153.6 70.73 0.85 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.03 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.825 -179.834 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.747 0.308 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.38 -46.61 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.28 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.04 -16.21 61.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.621 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 19.5 m-20 72.39 81.37 0.14 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.689 -179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.549 ' HA ' ' HB2' ' A' ' 10' ' ' GLN . 3.0 t -67.41 -48.94 44.55 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.611 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 6' ' ' SER . 72.9 Cg_endo -78.44 -12.63 15.38 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.509 2.139 . . . . 0.0 113.995 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 5' ' ' ASP . 3.2 m-85 -108.97 -64.86 1.19 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -59.0 2.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.554 -179.233 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.549 ' HB2' ' HA ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -59.1 -49.27 78.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HA ' ' HG ' ' A' ' 14' ' ' LEU . . . -58.06 -40.86 82.05 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.807 179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CE2' HG12 ' A' ' 23' ' ' ILE . 18.0 t80 -53.51 -45.74 69.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.466 179.156 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.5 m -62.37 -36.48 82.4 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 11' ' ' ALA . 7.9 mt -60.57 -31.65 70.77 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.393 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' O ' HG22 ' A' ' 23' ' ' ILE . 54.6 m-85 -93.77 26.45 3.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.589 0.233 . . . . 0.0 111.591 179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -119.11 79.03 1.35 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.222 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -15.98 63.43 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.37 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -86.0 -24.68 26.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.45 67.02 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.664 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.6 p -105.65 -32.75 8.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.14 0.176 . . . . 0.0 111.397 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.63 23.8 5.53 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.944 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 2.3 mpt_? -130.56 159.63 36.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.741 0.27 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 HD13 ' A' ' 28' ' ' ILE . 3.7 pt -144.46 131.04 10.06 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.92 172.31 8.85 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.121 2.547 . . . . 0.0 112.137 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HB2' HG13 ' A' ' 44' ' ' ILE . 6.2 pttt -44.39 -37.65 3.51 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 p -62.43 -45.77 91.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.342 0.115 . . . . 0.0 111.225 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 6.3 m -66.91 -46.59 74.37 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.474 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.83 HD13 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -57.98 -35.62 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.052 179.502 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.65 -70.11 1.07 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.518 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -25.58 66.42 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.67 0.235 . . . . 0.0 111.455 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 10.1 tp -61.31 -48.68 80.24 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.59 -35.55 78.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -32.2 68.55 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.329 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.89 -46.82 64.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -65.44 -33.64 76.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.257 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.97 -67.88 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.284 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.49 160.21 35.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.706 0.289 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -131.98 153.63 81.44 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.252 179.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.84 -162.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.989 2.459 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -98.59 168.15 10.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.222 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 44' ' ' ILE . 1.6 mm? -55.66 -32.4 63.18 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.58 94.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.192 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -53.61 53.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.388 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.855 ' HA ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -58.81 -47.67 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.562 179.473 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.6 m -57.98 -40.54 80.93 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -57.35 -39.41 75.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.217 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.855 HD12 ' HA ' ' A' ' 44' ' ' ILE . 15.9 mt -63.78 -46.73 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -56.69 -25.63 54.63 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.34 178.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -64.16 -6.93 7.49 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.492 ' C ' HD13 ' A' ' 51' ' ' LEU . 9.6 p -118.25 -45.45 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.781 0.264 . . . . 0.0 110.76 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -101.66 143.48 26.68 Favored Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -36.94 150.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.704 2.936 . . . . 0.0 113.534 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -30.89 -74.48 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HG2' ' CB ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -72.73 117.77 14.84 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.933 0.397 . . . . 0.0 111.728 -179.093 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.98 93.11 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.57 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 1.2 p30 -81.93 177.92 8.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.685 179.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -41.79 -47.93 4.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.818 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -67.17 -48.24 68.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.645 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -56.99 -51.62 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.344 -179.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -49.23 76.15 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.3 mt -61.12 -33.91 74.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -61.26 -52.68 63.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.462 HG11 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -70.37 -37.9 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.247 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -48.42 75.7 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -96.44 54.11 1.35 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 110.798 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -60.42 -52.46 72.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 78.3 Cg_endo -82.76 18.89 1.39 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.682 2.254 . . . . 0.0 113.537 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 m120 60.08 98.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.592 0.357 . . . . 0.0 111.867 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.16 174.69 19.61 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.174 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -100.41 173.6 6.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.529 0.204 . . . . 0.0 111.085 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 54.93 61.9 2.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.149 0.499 . . . . 0.0 110.539 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.653 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 3.0 ttp -178.48 -51.75 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.331 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 72' ' ' MET . 72.7 Cg_exo -48.88 -45.36 28.84 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.528 2.152 . . . . 0.0 112.757 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.17 78.17 0.04 OUTLIER Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 3.4 m-20 -81.06 132.64 56.14 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 120.44 0.162 . . . . 0.0 111.007 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' O ' HG23 ' A' ' 80' ' ' VAL . 31.4 Cg_exo -58.74 -39.07 85.46 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.692 2.261 . . . . 0.0 112.13 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.13 -34.37 77.9 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.64 -47.47 78.4 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -41.27 92.24 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.708 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 76' ' ' PRO . 68.6 t -61.72 -44.44 98.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.048 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.28 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.263 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.754 ' CA ' HG11 ' A' ' 102' ' ' VAL . . . -62.1 -47.03 92.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.273 179.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 15.0 m-85 -68.3 -29.46 68.23 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.84 1.95 21.64 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.5 p -51.08 -38.93 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.542 0.21 . . . . 0.0 111.498 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.67 21.6 1.99 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.46 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.16 54.09 1.97 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.152 0.501 . . . . 0.0 110.58 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -63.46 -54.19 40.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.28 -62.37 1.64 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 57.39 71.32 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.436 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -81.14 -41.55 22.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.62 49.1 0.42 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.649 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.5 ptm -176.47 136.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.612 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -105.81 -43.45 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.295 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.71 79.58 0.35 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.522 179.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.785 ' HA ' HD23 ' A' ' 99' ' ' LEU . 90.7 t -44.88 -37.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -45.36 -45.06 11.08 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 121.437 -0.411 . . . . 0.0 113.391 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 102' ' ' VAL . 7.2 pt-20 -80.07 -39.22 30.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.843 0.322 . . . . 0.0 111.508 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -62.59 -40.29 96.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.612 0.244 . . . . 0.0 110.819 179.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 104' ' ' THR . 1.3 ppt_? -75.54 -35.75 60.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.906 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -58.06 -37.6 74.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.602 0.239 . . . . 0.0 111.329 179.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.754 HG11 ' CA ' ' A' ' 82' ' ' GLY . 18.8 t -77.44 -44.08 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.731 HD22 ' HG2' ' A' ' 109' ' ' LYS . 4.2 mt -68.28 -34.12 75.59 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.278 -179.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 100' ' ' ARG . 20.0 p -63.01 -31.91 73.15 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.464 0.173 . . . . 0.0 111.356 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.5 m -67.6 -18.34 64.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.8 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.09 -61.9 1.6 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 110.759 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.28 52.68 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.427 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.75 51.94 4.61 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.731 ' HG2' HD22 ' A' ' 103' ' ' LEU . 9.7 tptt -68.18 -138.32 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.547 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' A' ' 114' ' ' GLU . 12.4 mt -71.21 76.23 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.457 ' HA ' ' CG2' ' A' ' 104' ' ' THR . 62.2 p -66.39 -174.44 0.28 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.05 -179.194 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.73 -34.67 27.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.313 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -52.19 58.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.534 0.207 . . . . 0.0 111.246 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.568 ' HG2' HD22 ' A' ' 110' ' ' LEU . 2.3 tp10 -56.62 -52.37 65.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.696 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.85 ' HA ' HD23 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -66.85 -26.62 67.0 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.446 179.495 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -46.36 87.45 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.076 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -66.94 -44.79 79.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.385 179.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 115' ' ' MET . 0.2 OUTLIER -60.72 -39.77 89.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 179.11 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 127' ' ' GLY . 1.1 mt -68.14 -33.92 75.37 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -61.91 -38.46 88.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.45 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.16 31.05 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.881 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.506 HG11 ' CG2' ' A' ' 129' ' ' VAL . 5.7 t -87.79 119.71 70.65 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.724 0.262 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.89 64.56 4.04 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.678 2.252 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.48 -177.76 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.124 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -119.02 126.67 52.25 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.521 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 t70 74.78 0.47 3.56 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.03 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.585 ' N ' HD21 ' A' ' 119' ' ' LEU . . . 80.33 49.92 5.65 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.268 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -103.36 116.38 32.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.491 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 129' ' ' VAL . 40.1 t -142.35 26.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.999 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 61.77 23.65 13.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.795 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.448 ' CD2' HG13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER 49.71 45.44 24.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 111.467 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -120.05 -57.58 1.93 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.145 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.476 ' CB ' HG11 ' A' ' 129' ' ' VAL . 24.3 t70 -54.71 -36.08 64.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.72 -60.25 2.68 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.9 t -62.64 -32.48 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.417 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -58.14 -53.78 54.39 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.9 ttp -68.34 -29.28 67.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.626 HG22 HD12 ' A' ' 139' ' ' LEU . 4.5 mm -64.0 -43.31 97.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.531 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 138' ' ' ILE . 2.6 mp -95.94 48.16 1.11 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 111.012 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.34 66.38 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.644 179.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.88 -179.668 . . . . . . . . 0 0 . 1 stop_ save_